propranolol has been researched along with Blood Pressure, High in 2467 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The cost effectiveness of labetalol and propranolol in the treatment of black adults with mild to moderate hypertension was assessed using published reports from US clinical trials of these agents among such patients." | 10.16 | Cost effectiveness of labetalol and propranolol in the treatment of hypertension among blacks. ( Colditz, GA; Delea, TE; Huse, DM; Oster, G; Savage, DD, 1987) |
| "The objective was to assess the effect of propranolol on oxidative stress and anti-oxidant potential in patients with resistant hypertension as a secondary analysis of the APPROPRIATE trial." | 9.34 | The impact of propranolol on nitric oxide and total antioxidant capacity in patients with resistant hypertension-evidence from the APPROPRIATE trial. ( Constantine, GR; Fernando, N; Galappatthy, P; Handunnetti, S; Katulanda, P; Rajapakse, S; Ranasinghe, HN; Weeratunga, PN, 2020) |
| "To our knowledge this is one of the first randomized controlled trials evaluating the effects of propranolol in resistant hypertension." | 9.24 | Addition of Propranolol in Resistant Arterial hypertension Treatment (APROPRIATE study): study protocol for a randomized double-blind placebo-controlled trial. ( Constantine, GR; Galappatthy, P; Katulanda, P; Rajapakse, S; Ranasinghe, P; Senarath, U; Weeraratne, C; Weeratunga, P, 2017) |
| "To compare the effects of carvedilol and propranolol on oxidative stress in leukocytes and C-reactive protein levels in patients with hypertension." | 9.11 | Effects of carvedilol on oxidative stress in polymorphonuclear and mononuclear cells in patients with essential hypertension. ( Asada, A; Maeda, K; Nakamura, M; Watanabe, T; Yasunari, K; Yoshikawa, J, 2004) |
| "Propranolol inhibits platelet aggregation more than atenolol and may have a favorable effect on the management of hypertension especially in patients with increased cardiovascular risk." | 9.11 | Effects of atenolol and propranolol on platelet aggregation in moderate essential hypertension: randomized crossover trial. ( Bagatin, J; Lukin, A; Marković, V; Polić, S; Punda, A; Rumboldt, Z, 2005) |
| "We sought to determine whether propranolol has adverse effects on cognitive function, depressive symptoms, and sexual function in patients treated for diastolic hypertension." | 9.09 | The effects of propranolol on cognitive function and quality of life: a randomized trial among patients with diastolic hypertension. ( Acree, M; Baron, RB; Coates, TJ; Gardiner, PS; Halliday, R; Hauck, WW; Pérez-Stable, EJ, 2000) |
| "To compare the management of mild diastolic hypertension (90 to 104 mm Hg) using a nonpharmacologic intervention with that using propranolol or placebo." | 9.08 | Comparison of a lifestyle modification program with propranolol use in the management of diastolic hypertension. ( Baron, RB; Biró, BS; Coates, TJ; Feigal, D; Gardiner, PS; Hauck, WW; McHenry, KS; Pérez-Stable, EJ, 1995) |
| "A multicenter, controlled, open, randomized trial of antihypertensive and life quality (LQ) effects of monotherapy with captopril vs propranolol, hydrochlorothiazide and nifedipine included 345 males aged 35-60 years with mild and moderate hypertension." | 9.08 | [The effect of long-term monotherapy with preparations from the 4 basic groups of antihypertensive agents on the quality of life in patients with mild and moderate arterial hypertension. The Multicenter Captopril and the Quality of Life Study. The working ( Broer, M; Duda, SG; Filatova, NP; Metelitsa, VI; Mukhamedzhanova, GF; Ostrovskaia, TP; Siegrist, J; Vygodin, VA, 1995) |
| "Chronopharmacodynamics of long-action propranolol hydrochloride-betacap (Natko, India) was studied in 48 patients with essential hypertension stage II." | 9.08 | [Chronopharmacodynamics of betacap (long-acting propranolol) in patients with hypertension stage II]. ( Teĭblium, MM; Zaslavskaia, RM; Zhamankulov, KA; Zhumabaeva, TN, 1998) |
| " In this study the effect of ten weeks treatment with the beta-adrenoreceptor (beta-AR) blockers propranolol and ridazolol on melatonin synthesis and on sleep quality was examined in 42 patients suffering from essential hypertension." | 9.07 | Influence of chronic beta-adrenoreceptor blocker treatment on melatonin secretion and sleep quality in patients with essential hypertension. ( Demisch, L; Rommel, T, 1994) |
| "In patients with essential hypertension, the beta-blockers bevantolol or propranolol were administered once or twice a day for twelve weeks to evaluate the effects on blood pressure, and lipid metabolism." | 9.07 | Effect of bevantolol and propranolol on serum lipids in patients with essential hypertension. ( Arakawa, K; Kajiyama, G; Koga, S; Kusukawa, R; Mori, H; Ogawa, N; Sasaki, J; Takagi, R; Tanaka, N, 1994) |
| "In a randomized, double-blind study oral doses of 50 mg carvedilol (Dilatrend) were compared with 40 mg propranolol in 16 male patients with coronary heart disease, CHD [12 without significant stenoses following percutaneous transluminal coronary angioplasty (PTCA), 4 with multivessel disease]." | 9.07 | Acute hemodynamic effects of carvedilol in comparison with propranolol in patients with coronary heart disease. ( Wendt, T, 1992) |
| "Nitrendipine (bypress) manufactured by Bayer Company in the form of 10 and 20 mg tablets and administered in a dose of 20-40 mg/day turned out an effective antihypertensive remedy in 65% of patients with arterial hypertension largely running a mild course." | 9.07 | [The efficacy of nitrendipine in patients with stable arterial hypertension. The data from a cooperative study in the USSR. The Working Group for the Cooperative Study of Nitrendipine]. ( Metelitsa, VI; Ostrovskaia, TP, 1992) |
| "The new alpha 1-blocker alfuzosin was compared with propranolol as monotherapy for hypertension in a double-blind, parallel group study of 8-week duration in 40 patients with essential hypertension." | 9.07 | Comparison of the new alpha 1-blocker alfuzosin with propranolol as first-line therapy in hypertension. ( Antonacci, A; Bombelli, M; Leto di Priolo, S; Libretti, A; Marazzi, ME; Pirrelli, A; Sega, R; Vulpis, V, 1991) |
| "We compared the effects of nonpharmacologic therapy, propranolol monotherapy, and placebo on blood pressure, metabolic, exercise, and quality of life variables in a 12-week, randomized, placebo-controlled trial of 79 male patients with hypertension." | 9.07 | Superiority of nonpharmacologic therapy compared to propranolol and placebo in men with mild hypertension: a randomized, prospective trial. ( Brondolo, E; Kostis, JB; Rosen, RC; Smith, DE; Taska, L; Wilson, AC, 1992) |
| "Hemodynamic Effects of Isradipine and Nifedipine in Hypertension Myocardial wall tension is an important determinant of the oxygen demand, the function and the degree of hypertrophy of the left ventricle." | 9.07 | [The hemodynamic effects of isradipine and nifedipine in hypertension]. ( Burger, KJ; Distler, GA; Gross, P; Koppenhagen, K; Welzel, D; Wudel, E, 1991) |
| "The objectives of this study were (a) to evaluate the dose-response effect of isradipine, a dihydropyridine calcium antagonist, on the heart rate and blood pressure of males with mild to moderate hypertension; and (b) to compare these results with those obtained with propranolol, a beta-adrenoceptor blocker, on a matched patient population." | 9.06 | Isotonic and isometric responses of blood pressure and heart rate in mild to moderate hypertension with isradipine and propranolol. ( Cantor, A; Cristal, N, 1990) |
| "9 kg; mean +/- SD) with arterial hypertension (WHO stages I and II) were administered single oral doses of placebo, 80 mg of propranolol, as well as 50 and 100 mg of brefanolol (a beta-adrenergic blocking agent with vasodilating properties) in order to determine the resulting hemodynamic effects." | 9.06 | Hemodynamic effects of brefanolol and propranolol assessed by noninvasive methods in patients with arterial hypertension. ( Endell, W; Halabi, A; Halabi, I; Kirch, W, 1990) |
| " The influence of long-acting propranolol and of atenolol on the circadian rhythm of heart rate was assessed using 24 h electrocardiographic recordings in elderly patients with essential hypertension." | 9.06 | Influences of propranolol and atenolol on the circadian rhythm of heart rate in elderly patients with essential hypertension. ( Sakata, S; Shimamoto, H; Shimamoto, Y, 1990) |
| "We report the results of a randomized, double-blind, parallel group multicentre study in 120 patients with moderate to severe hypertension, comparing two different types of antihypertensive treatment: a) the standard 'triple therapy' with hydrochlorothiazide, propranolol and hydralazine, and b) the combination of an ACE inhibitor, enalapril with hydrochlorothiazide (HCTZ) and methyldopa." | 9.06 | Evaluation of the efficacy and safety of enalapril plus hydrochlorothiazide plus methyldopa vs standard triple therapy in the treatment of moderate to severe hypertension: results from a multicentre study. ( Ambrosioni, E; Cinotti, G; Cuspidi, C; Leonetti, G; Malini, PL; Morabito, S; Pessina, A; Rappelli, A; Sampieri, L; Semplicini, A, 1990) |
| "We studied the effect of phenylpropanolamine on blood pressures in seven patients whose hypertension was controlled with beta blockers." | 9.06 | The effect of single-dose phenylpropanolamine on blood pressure in patients with hypertension controlled by beta blockers. ( Gross, CR; O'Connell, MB, 1990) |
| " In two, randomized, placebo-controlled, 5-way crossover trials, the pulmonary effects of celiprolol 200 and 400 mg, propranolol 40 mg and atenolol 100 mg were compared in 34 asthmatic patients." | 9.06 | Celiprolol, atenolol and propranolol: a comparison of pulmonary effects in asthmatic patients. ( Applin, WJ; Brown, R; Caruso, FS; Doshan, HD; Rosenthal, RR; Slutsky, A, 1986) |
| "A randomized double-blind study compared the antihypertensive efficacy of single daily oral doses of celiprolol 200 or 400 mg to twice daily doses of propranolol 40 or 80 mg in 58 patients with uncomplicated essential hypertension (supine diastolic blood pressure range 95-114 mm Hg)." | 9.06 | Celiprolol in the treatment of hypertension: a comparison with propranolol. ( Beattie, A; Silke, B; Taylor, SH, 1986) |
| "The bronchopulmonary effects of celiprolol were studied in 12 male asthmatic patients who showed mean maximum changes of -24% in forced one-second expiratory volume (FEV1) and 130% in airways resistance (Raw) following a single, 80 mg dose of propranolol." | 9.06 | Bronchosparing properties of celiprolol, a new beta 1, alpha 2-blocker, in propranolol-sensitive asthmatic patients. ( Applin, WJ; Braig, H; Doshan, HD; Matthys, H; Pohl, M; Rühle, KH, 1986) |
| "In order to assess the medium-term efficacy of ketanserin in comparison with that of the beta-blocker, propranolol, a randomized double-blind crossover trial was conducted involving 13 patients suffering from mild or moderate essential hypertension." | 9.06 | Ketanserin versus propranolol in the treatment of mild and moderate essential hypertension: corroboration with ambulatory blood pressure monitoring. ( Alaimo, G; Giordano, U; Novo, S; Raineri, A; Strano, A, 1987) |
| "The blood-pressure (BP)-lowering efficacy of sustained-release verapamil, using both clinic and ambulatory measurements, was assessed in patients with essential hypertension." | 9.06 | The efficacy and duration of action of sustained-release verapamil in essential hypertension. ( Atkins, N; Latham, AN; McCormack, PM; Mee, F; O'Brien, ET; O'Malley, K, 1989) |
| "The efficacy of sustained-release propranolol 160 mg (Inderal LA), bendrofluazide 5 mg and the combination preparation Inderex (bendrofluazide 5 mg and Inderal LA) in the treatment of hypertension was investigated." | 9.06 | Treatment of hypertension with a fixed ratio combination of long-acting propranolol and bendrofluazide, and influence of age of the subject. ( Davis, JM; Herrick, AL; Weir, RJ, 1989) |
| "This randomized, single-blind, crossover study compared three formulations of propranolol, each given once daily for hypertension." | 9.06 | Once-daily propranolol for hypertension: a comparison of regular-release, long-acting, and generic formulations. ( Carter, BL; Gersema, LM; Schabold, K; Williams, GO, 1989) |
| " A multi-center, double-blind, parallel group study compared the safety and efficacy of labetalol to propranolol in the treatment of patients with both exertional angina and mild to moderate systemic hypertension." | 9.06 | Labetalol compared with propranolol in patients with both angina pectoris and systemic hypertension: a double-blind study. ( Charlap, S; Frishman, WH; Shapiro, W, 1989) |
| " We evaluated the relative efficacies and tolerability of various low-dose combinations of nicardipine and propranolol in patients with mild-moderate essential hypertension (DBP Phase V of greater than 90-125 mmHg; WHO Grades I and II) in order to select the best one." | 9.06 | Comparison of the efficacy and acceptability of nicardipine and propranolol, alone and in combination, in mild to moderate hypertension. ( Dow, RJ; Gough, KJ; Laing, EM; Macdonald, FC; Maclean, D; McDevitt, DG; Mitchell, ET, 1989) |
| "Quality of life was evaluated in a four-month randomised double-blind trial of verapamil compared with propranolol in the treatment of hypertension in 94 patients in the UK." | 9.06 | The effects of verapamil and propranolol on quality of life in hypertension. ( Bulpitt, CJ; Chester, PC; Fletcher, AE; Hawkins, CM; Latham, AN; Pike, LA, 1989) |
| "The effects of bunazosin and propranolol administration on hypertension and serum levels of lipids, lipoproteins and apolipoproteins were studied in a controlled, randomized multicenter study." | 9.06 | Comparative effects of bunazosin and propranolol on serum lipids and apolipoproteins in patients with essential hypertension. ( Arakawa, K; Koga, S; Sasaki, J; Uzawa, H, 1989) |
| "The short-term continuous treatment with propranolol and nadolol, a long-acting nonselective beta-adrenoblocker without own sympathomimetic activity, conducted in two randomized groups of men with stable arterial hypertension (the diastolic AP greater than or equal to 95 mm Hg) has shown that by its hypotensive and negative chronotropic effects nadolol given in the mean dose 87 mg/day compared very favourably with propranolol administered in a dose of 144 mg/day." | 9.06 | [The comparative results of a short course of nadolol and propranolol treatment of arterial hypertension patients (cooperative research). The Working Group of the Cooperative Program for the Study of New Preparations in Preventing Arterial Hypertension]. ( , 1989) |
| " Preliminary experience suggests that the gastrointestinal therapeutic system (GITS) push-pull osmotic pump formulation of nifedipine is safe and efficacious in the treatment of hypertension." | 9.06 | The nifedipine gastrointestinal therapeutic system in the treatment of hypertension. ( Frishman, WH; Garofalo, JL; Greenberg, SM; Rothschild, A; Rothschild, M; Soberman, J, 1989) |
| "We compared the central and renal haemodynamic effects of tertatolol, a new non-cardioselective beta-adrenergic blocking drug without partial agonist activity, with those of an equipotent dosage of propranolol in two groups of 10 patients each with acute cerebral injury who had developed systemic hypertension." | 9.06 | Acute central and renal haemodynamic responses to tertatolol and propranolol in patients with arterial hypertension following head injury. ( Brackman, F; Degaute, JP; Leeman, M; Naeije, R; Prost, JF, 1986) |
| "To determine if a sustained-release form of the calcium entry blocker diltiazem would be a satisfactory substitute for the combination of beta-adrenergic blocking agent and thiazide diuretic in the treatment of systemic hypertension and angina pectoris, 38 patients were studied in a 4-center trial." | 9.06 | Efficacy and safety of sustained-release diltiazem as replacement therapy for beta blockers and diuretics for stable angina pectoris and coexisting essential hypertension: a multicenter trial. ( Kawanishi, DT; Leman, RB; O'Rourke, RA; Pratt, CM, 1987) |
| " The Study Group evaluated its therapeutic utility (100-300 mg bid) compared with propranolol (80-240 mg bid) in 266 patients with mild to moderate essential hypertension (WHO Grades I and II, sitting diastolic blood pressure (DBP) greater than or equal to 95 mmHg)." | 9.06 | Bevantolol vs propranolol: a double-blind controlled trial in essential hypertension. ( Maclean, D, 1988) |
| "A double-blind, multicenter study compared the safety and efficacy of oral betaxolol 10 to 40 mg once daily (n = 68) with propranolol 40 to 160 mg twice daily (n = 73) in the treatment of mild to moderate essential hypertension." | 9.06 | Comparison of betaxolol, a new beta 1-adrenergic antagonist, to propranolol in the treatment of mild to moderate hypertension. ( Cangiano, J; Davidov, ME; Glazer, N; Wollam, G; Zager, PG, 1988) |
| "The safety and efficacy of ketanserin, a competitive serotonin blocking agent, and propranolol were compared in 33 patients with mild to moderate hypertension (sitting diastolic blood pressure [DBP] 95-115 mm Hg) using a placebo run-in, randomized, double-blind parallel study design." | 9.06 | Serotonergic blockade compared with beta-adrenergic blockade in systemic hypertension: a double-blind comparison of ketanserin with propranolol. ( Charlap, S; Frishman, WH; Greenberg, S; Huberfeld, SI; Laifer, L; Lapsker, J; Okin, S; Soberman, J; Strom, JA, 1988) |
| " A trial was carried out on medium-term treatment with ketanserin or propranolol in subjects suffering from mild to moderate hypertension." | 9.06 | Effects of ketanserin on ambulatory blood pressure monitoring in patients with essential hypertension. ( Abrignani, MG; Alaimo, G; Cutietta, A; Novo, S; Raineri, A; Strano, A, 1986) |
| "The safety and antihypertensive efficacy of PN 200-110 (isradipine), a novel calcium antagonist, are discussed in a preliminary report of double-blind, multicenter, controlled, phase III clinical trials for essential hypertension." | 9.06 | Treatment of essential hypertension with PN 200-110 (isradipine). ( Hamilton, BP, 1987) |
| "In 40 patients with essential hypertension, enalapril was compared with propranolol as an antihypertensive agent in a double-blind study." | 9.06 | Comparison of enalapril and propranolol in essential hypertension. ( Boer, P; Geyskes, GG; Kettner, N; Mees, EJ; van Schaik, BA, 1986) |
| " We studied 10 white patients with mild essential hypertension in a randomized, double-blind design to assess the effects of indomethacin with or without the addition of propranolol on blood pressure and vascular prostacyclin biosynthesis, as assessed by the urinary excretion of the major enzymatically produced metabolite of prostacyclin, 2,3-dinor-6-keto-prostaglandin F1 alpha (PGF1 alpha), F1 alpha (PGF1 alpha), measured by gas chromatography-mass spectrometry." | 9.06 | Propranolol increases prostacyclin synthesis in patients with essential hypertension. ( Beckmann, ML; Byyny, RL; Gerber, JG; LoVerde, M; Nies, AS, 1988) |
| "The efficacy, safety and toleration of sustained release verapamil (Securon SR, Knoll) and long acting propranolol (Inderal LA, ICI) in the treatment of mild to moderate hypertension were compared in a randomized, double-blind, parallel group study." | 9.06 | Verapamil SR and propranolol LA: a comparison of efficacy and side effects in the treatment of mild to moderate hypertension. ( Bochsler, JA; Chester, PC; Latham, AN; Simmons, RL; Ward, PJ, 1988) |
| "To clarify the antihypertensive effect, safety and clinical usefulness of ketanserin, a comparative double-blind study was carried out in 277 patients with essential hypertension using propranolol as a control drug." | 9.06 | Comparative double-blind study of ketanserin versus propranolol in the treatment of essential hypertension. ( Iimura, O; Ikeda, M; Ishii, M; Ito, K; Kaneko, Y; Masuyama, Y; Mizuno, Y; Omae, T; Takeda, T; Yoshinaga, K, 1988) |
| "Eighty one patients with uncomplicated hypertension who required additional antihypertensive medication (diastolic Phase V [dBP] greater than or equal to 95 mm Hg) after 4 weeks treatment with hydrochlorothiazide (HCTZ) 25 mg o." | 9.06 | A comparison of felodipine and propranolol as additions to hydrochlorothiazide in the treatment of hypertension. ( Carle, WK; Latta, D; Lees, CT; Lough, JR; Peers, EM; Pender, J; Richardson, PD; Ross, JR; Sefton, S, 1988) |
| "Thirty patients with mild to moderate essential hypertension entered a randomised double-blind parallel group study for 6 months to compare the effects of the new calcium channel blocker nicardipine 90 mg/day and propranolol 240 mg/day." | 9.06 | Nicardipine in the treatment of essential hypertension controlled 6-month-study comparing nicardipine with propranolol at rest and during exercise. ( Bjerle, P; Danielsson, A; Ek, B; Steen, L; Suhr, O, 1987) |
| "In a double-blind controlled trial 22 patients with mild or moderate essential hypertension were treated with nicardipine 30 mg t." | 9.06 | Comparison of nicardipine and propranolol in the treatment of mild and moderate hypertension. ( Karppinen, K; Naukkarinen, VA; Sarna, S, 1987) |
| "The efficacy and safety of nifedipine in a gastrointestinal therapeutic system (GITS) push-pull osmotic pump formulation was compared with long-acting propranolol in 49 patients with mild to moderate hypertension already receiving diuretics." | 9.06 | Multicenter comparison of the nifedipine gastrointestinal therapeutic system and long-acting propranolol in patients with mild to moderate systemic hypertension receiving diuretics. A preliminary experience. ( Frishman, WH; Garofalo, JL; Greenberg, SM; Rothschild, A; Rothschild, M; Soberman, J, 1987) |
| " Verapamil is such a drug, but its clinical role in the management of hypertension is not clear." | 9.06 | Twice-daily verapamil for hypertension: a comparison with propranolol. ( Gould, BA; Hornung, RS; Jones, RI; Raftery, EB; Sonecha, T, 1986) |
| "The clinical effect of the peripheral vasodilator prazosin (Adwersuten, GDR) was studied in 51 patients with second-stage essential hypertension." | 9.06 | [Analysis of hypotensive and hemodynamic effects of prazosin in patients with hypertension]. ( Dobrotvorskaia, TE; Ostapiuk, FE; Samofanova, MS; Shengeliia, RG, 1986) |
| "Thirty-two patients with mild to moderate essential hypertension completed this double-blind cross-over clinical trial of propranolol and metoprolol." | 9.06 | Double-blind, randomized, cross-over clinical trial of metoprolol and propranolol in mild to moderate essential hypertension. ( Pandhi, P; Sahai, J; Sharma, BK; Sharma, PL; Wahi, PL, 1987) |
| "The effects of the nonselective beta blocker, propranolol, on coarctectomy-induced hypertension were evaluated relative to changes in cardiac function, sympathetic tone, and plasma renin activity (PRA)." | 9.06 | Postoperative hypertension after repair of coarctation of aorta in children: protective effect of propranolol? ( Balfe, JA; Balfe, JW; Barker, GA; Leenen, FH; Olley, PM; Pelech, AN, 1987) |
| " Therefore, the effects of 4-week treatment periods with verapamil and propranolol on metabolic parameters during an endurance bicycle ergometer test were studied in eight patients with mild to moderate essential hypertension." | 9.06 | Metabolic effects of verapamil and propranolol during submaximal endurance exercise in patients with essential hypertension. ( Böhm, RO; Petri, J; Rahn, KH; van Baak, MA, 1987) |
| "A twelve-week parallel study was conducted to compare the efficacy and safety of nicardipine plus propranolol with that of propranolol alone in 67 patients with mild to moderate essential hypertension." | 9.06 | Comparison of concomitant nicardipine hydrochloride and propranolol with propranolol alone in patients with essential hypertension. ( Douglas-Jones, AP; Havard, CW; Nievel, JG, 1987) |
| "The efficacy of MK-421 was compared with that of propranolol in patients with mild to moderate essential hypertension, using a placebo-controlled double-blind randomized protocol." | 9.05 | Effect of oral MK-421 and propranolol on the forearm arterial circulation in essential hypertension: a preliminary report. ( Levenson, JA; Maarek, BE; Safar, ME; Simon, AC, 1983) |
| "Participants in the Medical Research Council treatment trial for mild hypertension are randomly allocated to one of four treatment groups: bendrofluazide, propranolol, or a placebo for either of these drugs." | 9.05 | Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Report of Medical Research Council Working Party on Mild to Moderate Hypertension. ( , 1981) |
| "The relative efficacies of oral verapamil, a calcium-entry blocking drug, and propranolol, a beta-adrenergic blocking drug, were compared in 12 patients who had both stable angina pectoris and mild to moderate systemic hypertension, using a placebo-controlled, double-blind, randomized crossover protocol." | 9.05 | Comparison of oral propranolol and verapamil for combined systemic hypertension and angina pectoris. A placebo-controlled double-blind randomized crossover trial. ( Frishman, WH; Klein, NA; Klein, P; LeJemtel, TH; Pollack, S; Roth, S; Sonnenblick, EH; Strair, R; Strom, JA; Tawil, R; Wong, B, 1982) |
| "9 years) with mild to moderate essential hypertension a comparison between equipotent beta-blocking doses of propranolol, metoprolol and labetalol was carried out." | 9.05 | Propranolol vs metoprolol vs labetalol: a comparative study in essential hypertension. ( Coote, JH; Kubik, MM, 1984) |
| "The effect of 4-6 weeks' treatment with propranolol and nadolol on effective renal plasma flow (ERPF) and glomerular filtration rate (GFR) was studied, in 14 patients with essential hypertension, in single blind, random and cross-over design." | 9.05 | Comparison between short-term renal haemodynamic effects of propranolol and nadolol in essential hypertension: a cross-over study. ( Brunton, J; Danesh, BJ; Sumner, DJ, 1984) |
| "The effects of minoxidil used in combination with propranolol were assessed in the management of moderate hypertension." | 9.05 | Minoxidil in the management of moderate hypertension. ( Alleyne, GA; Nicholson, GD; Valdes, G; Westerman, RL, 1980) |
| "The effects of captopril and propranolol on blood pressure, heart rate and plasma noradrenaline, renin and aldosterone, and on the responses to changes in posture and to isometric exercise were measured in patients with essential hypertension." | 9.05 | The effect of captopril and propranolol on the responses to posture and isometric exercise in patients with essential hypertension. ( Goodwin, FJ; Holly, JM; Marsh, FP; Sharman, VL; Vandenburg, MJ, 1983) |
| "The efficacy of MK 421 and propranolol was compared in 48 patients with mild to moderate hypertension." | 9.05 | Comparison of oral MK 421 and propranolol in mild to moderate essential hypertension and their effects on arterial and venous vessels of the forearm. ( Achimastos, A; Benetos, A; Bouthier, JD; Fouchard, M; Levenson, JA; Maarek, BC; Safar, ME; Simon, AC, 1984) |
| "We report the first comparative study on enalapril maleate, a new angiotensin converting enzyme inhibitor, in patients with uncomplicated mild to moderate essential hypertension." | 9.05 | Enalapril in essential hypertension: a comparative study with propranolol. Enalapril in Hypertension Study Group (UK). ( , 1984) |
| "24 mg/day) and propranolol (average 105 mg/day) on home blood pressure readings in 16 patients with borderline hypertension was investigated in a randomized, double-blind, placebo crossover design." | 9.05 | Use of clonidine and propranolol as monotherapy in borderline hypertension. ( Cottier, C; Julius, S, 1983) |
| "The Beta-Blocker Heart Attack Trial (BHAT) was a multicenter, randomized, double-blind, placebo-controlled trial that tested the effectiveness of propranolol in reducing the mortality rate in patients after myocardial infarction (MI)." | 9.05 | Effect of propranolol on ventricular arrhythmia. The beta-blocker heart attack trial experience. ( Harrist, R; Hubble, E; Lichstein, E; Morganroth, J, 1983) |
| "The efficacy of a propranolol-hydralazine combination tablet was compared with that of each of its two components in the twice-daily treatment of mild to moderate essential hypertension (diastolic blood pressure: 100 to 125 mmHg)." | 9.05 | Propranolol-hydralazine combination in essential hypertension. ( Binstok, G; del Greco, F; Huang, C; Morledge, JH; Mullane, JF; Pittman, AW; Stevens, JD; Woods, JW, 1983) |
| "An open study was carried out to assess the efficacy of indoramin used as second step therapy in 30 patients with moderate to severe hypertension who had failed to respond adequately to monotherapy with a thiazide or beta-blocker." | 9.05 | Indoramin as second step therapy in the management of benign essential hypertension. ( Gherardi, S; Manzoli, U; Mazzari, M; Montenero, AS; Schiavoni, G, 1983) |
| "This report describes a double-blind, parallel, comparative study of trimazosin (+/- polythiazide) and propranolol (+/- polythiazide) in 130 patients with essential hypertension." | 9.05 | Double-blind comparison of trimazosin and propranolol in essential hypertension. ( Helgeland, A, 1983) |
| "In a double-blind study, patients with moderate to severe essential hypertension were treated randomly with either indoramin or propranolol orally." | 9.05 | A double-blind comparison of indoramin and propranolol in the treatment of moderate to severe essential hypertension. ( Antani, J; Buckle, JW; Cohen, M; Turner, J, 1983) |
| "A prospective study of propranolol versus chlorthalidone has been performed in eleven patients with renal hypertension and one with essential hypertension." | 9.05 | Propranolol versus chlorthalidone--a prospective therapeutic trial in children with chronic hypertension. ( Bachmann, H, 1984) |
| " Their clinical place in the management of hypertension has yet to be clearly defined, and thus we have performed an open crossover trial to compare the 24-hour profiles of blood pressure reduction after chronic therapy with propranolol and verapamil." | 9.05 | Propranolol versus verapamil for the treatment of essential hypertension. ( Gould, BA; Hornung, RS; Jones, RI; Raftery, EB; Sonecha, T, 1984) |
| "Seventy-four patients from four short-term studies of captopril in mild-moderate essential hypertension continued in a cooperative long-term efficacy and tolerance program." | 9.05 | A long-term follow-up of patients with essential hypertension treated with captopril. ( Asplund, J; Aurell, M; Conradsson, T; Delin, K; Forslund, T; Frithz, G; Fyhrquist, F; Herlitz, H; Karlberg, B; Ohman, P, 1984) |
| "The effects of prazosin and propranolol on total serum cholesterol concentration, low-density lipoprotein and high-density lipoprotein cholesterol fractions, and serum triglyceride concentration were compared in a crossover study in 29 patients with mild to moderate essential hypertension." | 9.05 | Effects of prazosin and propranolol on serum lipids in patients with essential hypertension. ( Lowenstein, J; Neusy, AJ, 1984) |
| "We compared hydrochlorothiazide and propranolol hydrochloride for monotherapy of hypertension by a double-blind study of 683 men who were titrated to less than 90 mm Hg diastolic BP or to 640 mg of propranolol or 200 mg of hydrochlorothiazide." | 9.05 | Comparison of propranolol and hydrochlorothiazide for thr initial treatment of hypertension. I. Results of short-term titration with emphasis on racial differences in response. Veterans Administration Cooperative Study Group on Antihypertensive agents. ( , 1982) |
| "An open, randomized crossover study was carried out in 8 patients with accelerated hypertension to compare the antihypertensive efficacy of oxprenolol with that of propranolol." | 9.05 | Comparison of antihypertensive efficacy: propranolol versus oxprenolol in accelerated hypertension. ( Fernandez, PG; Galway, AB; Granter, S; Kim, BK; Sharma, JN; Zachariah, PK, 1982) |
| "The acute effects of oral administration of niludipine (Bay a 7168), a new dihydropyridine derivative Ca2+-antagonist, on blood pressure (BP), hemodynamics and plasma renin activity (PRA) were investigated in patients with essential hypertension (n = 28) and normotensive volunteers (n = 7)." | 9.05 | Acute hypotensive, hemodynamic effects of long-term treatment with niludipine, a Ca2+-antagonist, in patients with essential hypertension. Niludipine monotherapy and combination with a beta-blocker and a diuretic). ( Aoki, K; Sato, K, 1982) |
| "The effect of once daily conventional or long acting propranolol on blood pressure was examined in a double-blind crossover trial in 15 patients with moderate hypertension previously responsive to beta-blocking drugs." | 9.05 | Single dose administration of propranolol in hypertension: a comparison of two formulations using clinic and home blood pressure measurements. ( Beilin, LJ; Lalor, C; Vandongen, R; Wall, BP, 1982) |
| "A double-blind crossover trial was undertaken to compare the efficacy of sustained-release clonidine and long-acting propranolol in the treatment of 20 patients (8 males and 12 females) with sustained hypertension." | 9.05 | Comparison of sustained-release clonidine and long-acting propranolol in the treatment of hypertension. ( Lawson, AA; Rodrigues, E, 1982) |
| "Prazosin was compared with hydralazine in 39 patients (mean age 49 years), who were already on beta-blockade for arterial hypertension." | 9.05 | Peripheral vasodilatation in the treatment of hypertension. Prazosin compared with hydralazine in patients not responding to beta-receptor blockade. ( Fagerberg, SE; Frithz, G; Malmberg, L, 1982) |
| "The clinical efficacy of propranolol and metoprolol slow-release tablets (Durules) was compared in 20 patients with typical angina pectoris and concomitant hypertension." | 9.05 | Metoprolol in angina pectoris complicated by essential hypertension. A clinical comparison of the antianginal efficacy of metoprolol slow-release tablets (Durules) given once daily and propranolol tablets given twice daily. ( BLoem, TJ; Lindner, PC, 1981) |
| "Twenty-four patients with moderate to severe hypertension were treated for four weeks with captopril, an oral inhibitor of angiotensin-converting enzyme." | 9.05 | Captopril in essential hypertension; contrasting effects of adding hydrochlorothiazide or propranolol. ( Banks, RA; Bayliss, J; Jones, JC; MacGregor, GA; Markandu, ND; Roulston, JE, 1982) |
| "We compared propranolol with methyldopa in a randomized prospective study of 28 women with pregnancy associated hypertension." | 9.05 | Propranolol in pregnancy three year prospective study. ( Bevan, EB; Craswell, PW; Eadie, MJ; Livingstone, I; Smith, MT, 1983) |
| " In a double-blind cross-over study the antihypertensive action and side-effects of labetalol and propranolol were compared in 18 previously untreated outpatients with hypertension, WHO stage I--III." | 9.05 | Labetalol in the treatment of hypertension in patients with normal and impaired renal function. ( Berg, KJ; Nilsen, OG; Walstad, RA; Wessel-Aas, T, 1982) |
| "1 Labetalol has been compared with propranolol in a double-blind, double-dummy study of 24 patients with mild or moderate essential hypertension." | 9.05 | Comparison of labetalol and propranolol in hypertension. ( Bulpitt, CJ; Butler, AG; Husaini, MH; Nicholls, DP; Stephens, MD, 1980) |
| "1 The effects of propranolol and atenolol given in random order in a cross-over study to fifteen patients with essential hypertension have been studied." | 9.05 | A study of the effects of atenolol and propranolol on renal function in patients with essential hypertension. ( Harry, JD; Hawkins, T; Kerr, DN; Pickering, M; Robson, V; Stevens, IM; Wilkinson, R, 1980) |
| " A double-blind cross-over comparison of penbutolol given in a single daily dose and propranolol given twice daily in the treatment of ambulant patients with moderate hypertension is described." | 9.05 | Single daily dose penbutolol in the treatment of hypertension: a double blind crossover comparison with propranolol. ( Hanks, GW; Kubik, MM, 1980) |
| "The antihypertensive effects of the oral converting enzyme inhibitor captopril and of propranolol were evaluated in a single-blind trial of 12 weeks in 19 ambulatory men with moderated essential hypertension (supine diastolic blood pressure [DPB], 100 to 120 mm Hg after receiving placebo for two weeks) whose sodium intake was unrestricted." | 9.05 | Comparison of antihypertensive effects of captopril and propranolol in essential hypertension. ( del Greco, F; Huang, CM; Molteni, A; Quintanilla, A, 1981) |
| "Atenolol, Pindolol and Propranolol in single daily doses administered to 18 selected patients with mild essential hypertension achieved adequate control of blood pressure." | 9.05 | Beta adrenoreceptor-blocking drugs once daily in essential hypertension: a comparison of propranolol, pindolol and atenolol. ( England, JD, 1981) |
| "After a two-week run-in period on placebo, fifty-two patients with benign essential hypertension (WHO classes I or II) were treated with individually titrated doses of metoprolol or propranolol for 36 weeks." | 9.05 | Metoprolol and propranolol in the treatment of essential hypertension - a long-term comparative study. ( Sjöberg, KH, 1981) |
| "Thirty patients with mild or moderate essential hypertension, and a fixed elevation of diastolic blood pressure, were randomly allocated to three groups and treated with propranolol 40 mg x 4 (Group 1), 80 mg x 4 (group 2) and 160 mg x 4 (Group 3)." | 9.05 | Correlation between propranolol in plasma and urine, renin-aldosterone system and blood pressure in essential hypertension. ( Andreasen, F; Bjerregaard, P; Kornerup, HJ; Pedersen, EB; Pedersen, OL, 1981) |
| "The effect of a propranolol-hydrochlorothiazide combination tablet was compared with the effects of its two components alone in the twice-daily treatment of mild to moderate essential hypertension (100 to 125 mmHg diastolic blood pressure)." | 9.05 | Propranolol-hydrochlorothiazide combination in essential hypertension. ( Mullane, JF; Stevens, JD, 1982) |
| "1 Pindolol and propranolol were administered orally in equipotent antihypertensive doses to 14 subjects with mild to moderate hypertension in an open cross-over study." | 9.05 | Effect of pindolol and propranolol on renal function of patients with hypertension. ( Pasternack, A; Pörsti, P; Pöyhönen, L, 1982) |
| "The antihypertensive effect of propranolol, in fixed combinations with two dosages of triamteren and hydrochlorothiazide (Dociteren), was evaluated in a double-blind test on 19 patients with uncomplicated essential hypertension." | 9.05 | [Propranolol, triamteren and hydrochlorothiazide in fixed combinations in the treatment of hypertension (author's transl)]. ( Herrmann, JM; Hiemstra, S; Hoenig, B, 1981) |
| "Forty patients completed a double-blind parallel group study comparing furosemide (FUR) and hydrochlorothiazide (HCT) when added to a stable dose of beta blocker in the treatment of mild to moderate hypertension." | 9.05 | Controlled comparison of the effects of furosemide and hydrochlorothiazide added to propranolol in the treatment of hypertension. ( Dombey, SL; Lawrence, J; Vander Elst, E; Vlassak, W, 1981) |
| "The effect of conventional propranolol and bendrofluazide tablets given twice daily has been compared with an equivalent dosage combined in a single capsule given twice daily in fourteen patients with essential hypertension." | 9.05 | Treatment of essential hypertension with a combination of propranolol and bendrofluazide. ( Dawes, PM; Solomon, LR, 1980) |
| "A total of 270 patients with mild to moderate essential hypertension were evaluated in a multicenter double-blind randomized study that compared the effect of captopril plus a thiazide diuretic with that of propranolol plus a diuretic." | 9.05 | Clinical effects of low-dose captopril plus a thiazide diuretic on mild to moderate essential hypertension: a multicenter double-blind comparison with propranolol. Captopril Research Group of Japan. ( , 1985) |
| "Two double-blind multicenter studies compared acebutolol with placebo (acebutolol, N = 121; placebo, N = 116) and with propranolol (acebutolol, N = 186; propranolol, N = 190) in essential hypertension." | 9.05 | Acebutolol in essential hypertension: results of two multicenter studies against placebo and propranolol. ( Davidov, M, 1985) |
| "The antihypertensive effect of enalapril maleate, a new converting enzyme inhibitor, was evaluated in a multiclinic, double-blind, randomized study in patients with mild to moderate essential hypertension." | 9.05 | Long-term enalapril--a new converting enzyme inhibitor--in the treatment of mild to moderate essential hypertension, results of a worldwide multiclinic study. Comparing two ways of analyzing data. ( Espie, J; Lessem, JN; Rucinska, E; Sromovsky, JA; Vickers, FF, 1985) |
| "A multicenter, double-blind study compared oral acebutolol (n = 186) with propranolol (n = 190) in the treatment of mild to moderately severe essential hypertension (diastolic greater than or equal to 95 to 129 mm Hg)." | 9.05 | Comparison of acebutolol and propranolol in essential hypertension. ( Singh, BN; Turlapaty, P; Wahl, J, 1985) |
| "The efficacy of captopril treatment was compared with that of propranolol in a single-blind crossover study in 14 patients with essential hypertension uncontrolled on diuretic alone." | 9.05 | Crossover comparison of captopril and propranolol as step 2 agents in hypertension. ( Ferguson, RK; Koplin, JR; Oren, A; Riley, LJ; Rotmensch, HH; Tadros, SS; Vlasses, PH, 1985) |
| "The efficacy and safety of labetalol was compared in a double-blind crossover design with propranolol in 27 patients suffering from essential hypertension with a supine diastolic blood pressure of more than 100 mm Hg." | 9.05 | A double-blind crossover clinical trial of labetalol and propranolol in patients of essential hypertension. ( Aslam, S; Pandhi, P; Sharma, BK; Sharma, PL; Wahi, PL, 1985) |
| "Previous studies have shown that labetalol, a new alpha- and beta-adrenergic antagonist, is relatively safe for the treatment of hypertension in patients with chronic obstructive pulmonary disease (COPD)." | 9.05 | Comparison of the effects of labetalol and hydrochlorothiazide on the ventilatory function of hypertensive patients with asthma and propranolol sensitivity. ( Burford, JG; Chetty, K; Conrad, SA; George, RB; Hudson, LD; Light, RW; Manocha, K, 1985) |
| "Twenty patients with mild to moderate essential hypertension completed this double-blind cross-over randomized clinical trial of propranolol and acebutolol." | 9.05 | Double-blind cross-over clinical trial of acebutolol and propranolol in mild to moderate essential hypertension. ( Pandhi, P; Sethi, V; Sharma, BK; Sharma, PL; Wahl, PL, 1985) |
| "The antihypertensive mechanisms of single and combined therapy with a beta-adrenergic antagonist (propranolol) and a vasodilator (hydralazine) were investigated in 9 patients with moderately severe hypertension, who were receiving maintenance diuretic (hydrochlorothiazide) treatment." | 9.05 | Single and combined therapy for systemic hypertension with propranolol, hydralazine and hydrochlorothiazide: hemodynamic and neuroendocrine mechanisms of action. ( Blomqvist, CG; Gaffney, FA; Graham, RM; Mulvihill-Wilson, J; Neal, WW; Pettinger, WA, 1985) |
| "The effect of timolol versus propranolol on hypertension, hemodynamics, and plasms renin activity was evaluated in 20 men." | 9.04 | Effect of timolol versus propranolol on hypertension and hemodynamics. ( Aronow, WS; Cassidy, J; Del Vicario, M; Ferlinz, J; King, J; Moorthy, K, 1976) |
| "Minoxidil has been administered to 16 patients with severe hypertension and renal failure." | 9.04 | Minoxidil in severe hypertension. ( Mäkelä, M; Oka, M, 1978) |
| "Effect of long-term administration of propranolol was studied in 90 unselected patients with essential hypertension." | 9.04 | [Treatment of essential hypertension with propranolol (author's transl)]. ( Braun, B; Klaus, D; Klumpp, F; Lemke, R; Zehner, J, 1976) |
| " Indomethacin was administered alone or in addition to either diuretic or propranolol therapy to three groups of patients with essential hypertension on a free sodium diet." | 9.04 | Effects of indomethacin alone and during diuretic or beta-adrenoreceptor-blockade therapy on blood pressure and the renin system in essential hypertension. ( Drayer, JI; Laragh, JH; Lopez-Ovejero, JA; Sealey, JE; Weber, MA, 1978) |
| "In a series of 450 patients with mild essential hypertension, propranolol alone (P), propranolol plus hydrochlorothiazide (P+T), propranolol plus hydralazine (P+H), and propranolol plus hydrochlorothiazide plus hydralazine (P+T+H) were compared to reserpine plus hydrochlorothiazide (R+T)." | 9.04 | Propranolol in the treatment of essential hypertension. ( , 1977) |
| "Eighteen patients with diastolic hypertension (100 to 120 mm Hg), in addition to propranolol, 160 mg daily, and hydrochlorothiazide, 100 mg daily, received progressively increased doses of either minoxidil or placebo in a double-blind crossover study." | 9.04 | Effect of minoxidil on blood pressure and hemodynamics in severe hypertension. ( Bryan, RK; Hoobler, SW; Purdy, JM; Rosenzweig, J; Weller, JM, 1977) |
| "1 A double-blind cross over trial between clonidine, propranolol and a placebo in patients with moderate hypertension has been performed." | 9.04 | A comparative trial of clonidine, propranolol and placebo in the treatment of moderate hypertension. ( Raftery, EB; Wilkinson, PR, 1977) |
| "A double-blind crossover trial was completed in 15 patients with moderate hypertension and the effects of propranolol (Inderal) 80 mg twice a day and atenolol (Tenormin) 100 mg twice a day were assessed on blood pressure, pulse rate and plasma renin activity (PRA), while patients were maintained on 1 cyclopenthiazide tablet (Navidrex K) per day." | 9.04 | Effects of propranolol and atenolol on blood pressure and plasma renin activity in patients with moderate hypertension. ( Epstein, SE; LUbbe, WF, 1977) |
| "Propranolol was administered in a single dose of 80 mg, 120 mg, 160 mg, 240 mg, or 320 mg, to 23 patients with essential mild to moderate hypertension in a randomised, double-blind cross-over study." | 9.04 | Once daily propranolol in the treatment of mild to moderate hypertension: a dose range finding study. ( Baber, NS; Douglas-Jones, AP; Lee, A, 1978) |
| " Labetalol, a new drug combining alpha-and beta-adrenoceptor blocking properties, has been compared with placebo in a double-blind crossover study of a group of patients with mild to moderate essential hypertension (blood pressure 150/100 to 189/114 mmHg)." | 9.04 | A controlled trial of labetalol (Trandate), propranolol and placebo in the management of mild to moderate hypertension. ( Armstrong, BK; Beilin, L; Nassim, M; Pugsley, DJ, 1979) |
| "The effect of conventional propranolol tablets given twice daily has been compared with an equivalent dosage of a long-acting formulation of propranolol ('Inderal' LA)p given once daily in twenty-nine patients with mild to moderate hypertension." | 9.04 | Comparison of a once daily long-acting formulation of propranolol with conventional propranolol given twice daily in patients with mild to moderate hypertension. ( Douglas-Jones, AP, 1979) |
| "A randomised open trial was carried out to test the efficacy and safety of Captopril and propranolol in 20 patients with mild and moderate essential hypertension." | 9.04 | Captopril and propranolol in mild and moderate essential hypertension: preliminary report. ( Friedlander, DH, 1979) |
| "Captopril (SQ 14,225), an angiotensin-converting enzyme inhibitor, was used in combination with propranolol, a beta-adrenergic blocking agent, in the treatment of mild and moderate hypertension." | 9.04 | Comparison of captopril with propranolol in the treatment of mild and moderate essential hypertension. ( Seedat, YK, 1979) |
| "More recent investigations on the duration of effect and plasma half-life of propranolol suggest a simplification of dosage for the beta-blocker in the treatment of hypertension." | 9.04 | [Treatment of hypertension with propranolol in internal medicine and general practice. A field trial with a simplified twice daily administration of Dociton 80 (author's transl)]. ( Hiemstra, S; Steichele, C; Ziegler, E, 1977) |
| " The effect of a single dose of propranolol and metoprolol were compared with placebo in two groups of patients with untreated essential hypertension." | 9.04 | Objective measurement of performance during acute stress in patients with essential hypertension: assessment of the effects of propranolol and metoprolol. ( Dunn, FG; Lawrie, TD; Lorimer, AR, 1979) |
| "1 Using a standardized form of mental stress, 21 patients with idiopathic hypertension were investigated before and after treatment with placebo (n=8), propranolol (n=7) or methyldopa (n=6)." | 9.04 | Standardized stress and hypertension: comparison of effect of propranolol and methyldopa. ( Dunn, FG; Jones, JV; Lawrie, TD; Lorimer, AR; Melville, DI, 1978) |
| "In 61 out-patients with essential hypertension, grade I or II, propranolol was administered alone in increasing doses (3 x 40 mg/d or 3 x 80 mg/d) or, if there was insufficient response, with a double or triple combination consisting additionally of spironolactone (50 mg/d)-thiabutazide (5 mg/d) and dihydralazine (3 x 25 mg/d)." | 9.04 | [Treatment of essential hypertension with a combination of propranolol, spironolactone-thiabutazide and dihydralazine (author's transl)]. ( Ebel, H; Klaus, D; Lübke, H; Witzgall, H; Zehner, J, 1978) |
| "15 patients who had benign, uncomplicated essential hypertension, were treated with chlorthiazide (500 mg twice a day) with or without propranolol (10--20 mg 4 times a day), and the effect of the treatment on plasma renin activity (PRA), urinary aldosterone excretion, total body potassium (TBK) and plasma sodium and potassium was evaluated." | 9.04 | The renin-aldosterone system and thiazide-induced depletion of total body potassium in essential hypertension. ( Carroll, HJ; Oh, MS, 1978) |
| "In 19 patients with arterial hypertension the hemodynamics were determined with a Swan-Ganz-thermodilution catheter at rest and during supine ergometer exercise before and after 5 mg intravenous Propranolol (P) (10 pats." | 9.04 | [Hemodynamic changes in patients with arterial hypertension after beta-receptor blockade with propranolol and metoprolol (author's transl)]. ( Greding, H; Isbary, J; König, E; Nechwatal, W, 1978) |
| "In a crossover study 32 patients with hypertension were randomly allocated to treatment with spironolactone 200 mg/day for two months, propranolol 320 mg/day for two months, and a combination of both drugs at half the dose." | 9.04 | Renin concentrations and effects of propranolol and spironolactone in patients with hypertension. ( Kågedal, B; Karlberg, BE; Tegler, L; Tolagen, K, 1976) |
| "This double-blind clinical study was carried out in order to compare the therapeutic activity of propranolol, and a new beta-adrenergic blocker, acebutolol, in essential hypertension." | 9.04 | [Comparative study of acebutolol and propranolol in the treatment of arterial hypertension]. ( Tacquet, A, 1975) |
| "We studied the antihypertensive effect of propranolol alone and in combination with diuretics in 13 patients with high, 18 with normal and nine with low-renin essential hypertension whose blood-pressure response to diuretics was previously established." | 9.04 | Proposed mechanisms of propranolol's antihypertensive effect in essential hypertension. ( Hollifield, JW; Shand, DG; Sherman, K; Zwagg, RV, 1976) |
| "The effect of a low dose of methyldopa combined with (a) a non-selective and (b) a selective beta-adrenoceptor antagonist was studied in a double-blind crossover trial in 24 carefully selected patients with moderate hypertension (mean initial lying blood pressure 189/117 mm Hg)." | 9.04 | Methyldopa and propranolol or practolol in moderate hypertension. ( Galloway, DB; Jeffers, TA; Lewis, JA; Millar, HR; Petrie, JC; Simpson, WT; Smith, MC; Wood, RA, 1976) |
| "1 Labetalol, a new hypotensive drug combining alpha- and beta-adrenoreceptor antagonist properties, has been compared with propranolol in the treatment of severe hypertension (blood pressure 190/115-249/139 mmHg) in a double-blind trial lasting 14 weeks." | 9.04 | Controlled comparison of labetalol and propranolol in the management of severe hypertension. ( Armstrong, BK; Beilin, LJ; Nassim, MA; Pugsley, DJ, 1976) |
| " Serial measurements of plasma renin activity (PRA), plasma aldosterone concentration (PA) and blood pressure were performed overnight in patients with borderline (group 1) and sustained essential hypertension (group 2) before and after acute and chronic administration of either propranolol or pindolol." | 9.04 | Differential effects of acute and chronic beta-adrenoreceptor blockade on blood pressure and the renin-angiotensin-aldosterone system in essential hypertension. ( Gramann, W; Kolloch, R; Krück, F; Stumpe, KO; Vetter, H, 1976) |
| " Propranolol was given to eight haemodialysed patients with resistant arterial hypertension for periods ranging from 6 to 16 months." | 9.04 | Long-term propranolol treatment of resistant arterial hypertension in haemodialysed patients. ( Biagini, M; Maggiore, Q; Misefari, M; Zoccali, C, 1975) |
| "In 36 patients with essential hypertension the action and side effects of hydrochlorothiazide (25 mg/d), hydrochlorothiazide-triamterene (25 and 50 mg/d) and propranolol (160 mg/d) were investigated." | 9.04 | [Triamterene in the treatment of hypertension with hydrochlorothiazide and propranolol (author's transl)]. ( Düsing, R; Kramer, HJ, 1977) |
| " Labetalol has been compared with propranolol and placebo for the treatment of mild to moderate hypertension (150/100 to 189/114 mmHg), in a double-blind cross-over trial with three 10 week treatment periods." | 9.04 | Combined alpha- and beta-adrenoreceptor blockade in hypertension: a controlled trial of labetalol (AH 5158) compared with propranolol and placebo. ( Armstrong, B; Beilin, LJ; Nassim, M; Pugsley, D, 1976) |
| " Group A: In 14 patients with essential hypertension on chlorthalidone treatment, an additional daily dose of 640 mg propranolol for two months led to a significant reduction of the MAP (from 124 to 105 mm Hg) and PRA (from 5." | 9.04 | Effect of salt depletion and propranolol on blood pressure and plasma renin activity in various forms of hypertension. ( Boer, P; Geyskes, GG; Leenen, FH; Mees, EJ; Vos, J, 1975) |
| "The antihypertensive effect of two adrenergic blocking agents (Alprenolol and Propranolol) have been studied in a group of 107 patients with essential hypertension." | 9.04 | Effect of beta adrenergic blocking agents (alprenolol and propranolol) in essential hypertension. ( Khakpour, M; Nik-Akhtar, B; Rashed, MA, 1975) |
| "Multiclinic controlled studies have shown that enalapril alone 10 to 40 mg/day orally is effective in lowering blood pressure in patients with essential hypertension." | 8.77 | Enalapril in hypertension and congestive heart failure. Overall review of efficacy and safety. ( Davies, RO; Moncloa, F; Sromovsky, JA; Walker, JF, 1985) |
| "A review if given of the use of propranolol in hypertension emphasizing the importance of the studies by Prichard and Gillam in 1964 and 1969." | 8.75 | The use of propranolol in hypertension: a review. ( Hansson, L, 1976) |
| "Only recently approved for use in the treatment of hypertension in the US, the beta-adrenergic receptor blocking compound propranolol has been used elsewhere for this purpose since 1964." | 8.75 | Pathophysiology of propranolol in hypertension. ( Frohlich, ED, 1977) |
| "Like hypertension which is a multifactorial disease, the blood pressure response to propranolol cannot be explained by one mechanism alone to the exclusion of all others." | 8.75 | Haemodynamic effects of propranolol in hypertension: a review. ( Bravo, EL; Dustan, HP; Tarazi, RC, 1976) |
| "This study aimed to investigate the role of insulin-like growth factor-binding protein-3 (IGFBP-3) in erectile dysfunction (ED) in two-kidney one-clip (2K-1C) hypertensive rats treated with the β-blocking agent propranolol." | 7.77 | Increased expression of insulin-like growth factor-binding protein-3 is implicated in erectile dysfunction in two-kidney one-clip hypertensive rats after propranolol treatment. ( Cao, H; Chen, D; Liu, QL; Peng, M; Wan, SP; Wang, XH; Wang, YZ; Yang, ZH; Zhou, HH; Zhou, ZY, 2011) |
| "To establish whether propranolol can reverse left ventricular hypertrophy in hypertensive rats." | 7.73 | Reversal of left ventricular hypertrophy by propranolol in hypertensive rats. ( Maina, CI; Ogunde, M, 2005) |
| "The aims of the study were to characterize the rate and extent of the rebound effect after abrupt cessation of a chronic exposure of l-propranolol in spontaneous hypertensive rats, using exercise-induced tachycardia as a pharmacodynamic endpoint." | 7.70 | Mechanism-based modeling of rebound tachycardia after chronic l-propranolol infusion in spontaneous hypertensive rats. ( Brynne, L; Karlsson, MO; Paalzow, LK, 1999) |
| "The acute hemodynamic effects of nisoldipine (Bay K552) in patients with essential hypertension were studied using nuclear ventriculography." | 7.69 | Cardiovascular effects of nisoldipine in essential hypertension. ( Battler, A; Blau, A; Eliahou, HE; Herz, I; Herzog, D; Schechter, P, 1994) |
| " do secretion of volume related hormones in patients with EH pre- and post treatment with propranolol differ from normotensive subjects if examined in thermal dehydration conditions; 2." | 7.68 | [Effect of thermal dehydration on blood levels of volume- regulating hormones and sweat electrolytes in patients with essential hypertension treated with propranolol]. ( Grzeszczak, W; Irzyniec, T; Kokot, F; Wiecek, A; Woch, W; Zukowska-Szczechowska, E, 1992) |
| "Hypertension is a potential complication following ephedrine and pseudoephedrine overdoses." | 7.68 | Intravenous propranolol reverses hypertension after sympathomimetic overdose: two case reports. ( Burkhart, KK, 1992) |
| "The efficacy and safety of nitrendipine in oral doses of 5-40 mg twice daily, alone or in combination with hydrochlorothiazide (50-150 mg/day) and/or propranolol (40-120 mg/day), were evaluated in an open study of 50 patients with severe hypertension with supine diastolic blood pressure (BP) greater than 115 mm Hg." | 7.67 | Efficacy and safety of nitrendipine in patients with severe hypertension: a multiclinic study. ( Jain, AK; Maronde, R; McMahon, FG; Mroczek, W; Ryan, JR; Vlachakis, N, 1984) |
| " Therefore, a study was designed to compare the efficacy and the effects on left ventricular function of hydrochlorothiazide, propranolol and prazosin in 13 patients with mild to moderate hypertension." | 7.67 | Monotherapy in mild to moderate hypertension: comparison of hydrochlorothiazide, propranolol and prazosin. ( Benowitz, N; Inouye, I; Loge, D; Massie, B; Simpson, P; Topic, N, 1984) |
| "In a patient with severe hypertension in association with insulin-induced hypoglycemia and prior therapy with propranolol hydrochloride, intravenous 50% dextrose significantly reduced arterial pressure on two occasions." | 7.67 | Hypertensive crisis caused by hypoglycemia and propranolol. ( Krakoff, LR; Mann, SJ, 1984) |
| "Studies were carried out in 15 patients with renal insufficiency and hypertension to compare the long-term effects of methyldopa and propranolol on renal hemodynamics." | 7.67 | Comparison of long-term renal hemodynamic effects of methyldopa and propranolol in patients with hypertension and renal insufficiency. ( Alterman, L; Bank, DE; Bank, N; Lowenstein, I; Zelen, R, 1984) |
| "Twenty patients with essential hypertension, who were receiving a diuretic plus propranolol qid, were instructed to take their entire daily requirement of propranolol as a single morning dose." | 7.67 | Once-daily propranolol for hypertension. ( Gefter, ML; Hemmes, RJ; Lopez, LM, 1984) |
| "Twenty-four subjects with mild to moderate essential hypertension completed this 9-wk parallel, randomized, double-blind study of the antihypertensive effects of verapamil (V) (240 to 480 mg%) and propranolol (P) (120 to 360 mg%)." | 7.67 | Verapamil and propranolol in essential hypertension. ( Cubeddu, LX; Gross, KM; Halperin, AK; Rogers, JF, 1984) |
| "The use of nifedipine in patients with hypertension, heart failure, and acute myocardial infarction is discussed." | 7.67 | Nifedipine in hypertension and heart failure. ( Matsui, S; Murakami, E; Murakami, H; Takekoshi, N, 1984) |
| "The ability of propranolol, a beta-adrenergic blocking agent, to decrease blood pressure and inhibit the development of hypertension was assessed in spontaneously hypertensive rats (SHR)." | 7.67 | Propranolol can inhibit the development of hypertension in SHR. ( Weissinger, J, 1984) |
| "6 years (WHO II-III)] with severe hypertension and not responding to previous drug treatment were included in the study to evaluate the effect of nitrendipine (NTP) as monotherapy and also in combination with propranolol (PRO)." | 7.67 | Nitrendipine treatment in so-called therapy-resistant arterial hypertension; effect as monotherapy and in combination with propranolol on blood pressure, heart rate, other hemodynamic parameters, plasma renin activity, and catecholamines. ( Faulhaber, HD; Gruner, R; Hartrodt, W; Homuth, V; Menz, M; Mohnike, W; Naumann, E; Schmidt, J, 1988) |
| "This multicenter study evaluated nitrendipine, a dihydropyridine calcium antagonist, alone or in combination with hydrochlorothiazide and/or propranolol in severe essential hypertension (baseline supine diastolic BP greater than or equal to 115 mm Hg)." | 7.67 | Long-term efficacy and safety of nitrendipine in severe essential hypertension. ( Burris, JF; Mroczek, WJ; Nash, DT, 1988) |
| " The resulting cardiac hypertrophy was reduced and the hypertension corrected by propranolol." | 7.67 | [The heart in patients with hypertension: effects of rilmenidine on experimental cardiac hypertrophy of hypertensive origin in rats]. ( Callens-el Amrani, F; Paolaggi, F; Swynghedauw, B, 1989) |
| "In 59 patients with mild or moderate essential hypertension effects of propranolol and hydrochlorothiazide on serum lipids, fibrynogen, glucose and uric acid concentrations as well as serum euglobulins fibrynolysis time were studied." | 7.67 | [Effect of long-term treatment with propranolol or hydrochlorothiazide on biochemical risk factors of coronary disease in patients with hypertension]. ( Karolko, B; Kawecka, M; Lukasik, S; Moszczyńska, J; Witkowska, M, 1989) |
| "Fifty patients with essential hypertension were studied for the antihypertensive effect of timolol and propranolol." | 7.67 | Comparative evaluation of the antihypertensive effect of timolol and propranolol in patients with essential hypertension. ( Rajvanshi, P; Rizvi, SN, 1989) |
| "A group of 20 patients with primary hypertension (NT) were studied for the influence of six-week propranolol therapy on the secretion of immunoreactive insulin (IR-I), gastrin glucagon (IR-G) and pancreatic polypeptide (IR-PP) induced by a high-fat test meal." | 7.67 | [Effect of propranolol therapy on the secretion of insulin, glucagon, gastrin and pancreatic polypeptide in patients with essential hypertension]. ( Kokot, F; Zukowska-Szczechowska, E, 1989) |
| "The roles of the autonomic nervous system, renin-angiotensin system, and arginine vasopressin (AVP) during the onset of ACTH-induced hypertension were investigated in conscious sheep." | 7.67 | Role of the autonomic nervous system, renin-angiotensin system, and arginine vasopressin during the onset and maintenance of ACTH hypertension in sheep. ( Coghlan, JP; Denton, DA; Mills, EH; Nelson, MA; Scoggins, BA; Spence, CD; Whitworth, JA, 1987) |
| "The density of beta 2-receptors in intact lymphocytes was studied by binding with 125iodo-cyanopindolol in 18 male patients with mild or moderate hypertension before and after monotherapy with propranolol." | 7.67 | Characteristics of lymphocyte beta-adrenoceptors in essential hypertension: effects of propranolol treatment and dynamic exercise. ( Korichneva, IL; Krasnikova, TL; Parfyonova, EV; Suvorov, YI, 1988) |
| " Its central and renal hemodynamic effects were compared to those of an equipotent dosage of propranolol in two groups of 10 patients each who developed arterial hypertension and a hyperdynamic circulatory state after head injury." | 7.67 | Tertatolol preserves renal perfusion in patients with arterial hypertension after head injury. ( Brackman, F; Degaute, JP; Leeman, M; Naeije, R; Prost, JF; Thomas, J, 1986) |
| "Tertatolol, a new beta-blocker, and propranolol, considered a reference beta-blocker, were given orally (5 and 160 mg slow release, respectively) for 15 days to two groups of patients with essential hypertension in order to compare their effects on renal hemodynamics." | 7.67 | Renal hemodynamic effects of tertatolol in essential hypertension. ( Ardaillou, R; Lantz, B; Leviel, F; Paillard, F, 1986) |
| "Arterial blood pressure and central hemodynamic changes were assessed in 44 patients with essential hypertension, uncontrollable by prazosin alone, after propranolol (anaprilin), celiprolol, clonidine (clofelin) or verapamil were added to the treatment schedule." | 7.67 | [Hemodynamic effect of a combination of prazosin with cardiac depressants in the treatment of hypertension]. ( Akopian, LM; Basem, AS; Ivleva, AIa; Krasnobaeva, GM; Moiseev, VS, 1988) |
| "Components of the renin-angiotensin system (plasma renin activity, total and inactive renin, angiotensinogen and angiotensin II) were examined in 90 patients with labile and stable essential hypertension before and after functional and pharmacologic tests." | 7.67 | [Correlation of the total activity of blood plasma renin with levels of active and inactive renin, angiotensinogen and angiotensin II under different functional loads in patients with hypertension]. ( Masenko, VP; Uchitel', IA; Ustinova, SE, 1988) |
| "Therapeutic efficiency and hemodynamic effects of prazosin were examined in 42 patients with essential hypertension in the course of prolonged treatment." | 7.67 | [Long-term use of prazosin alone and combined with propranolol in patients with essential hypertension]. ( D'iakonova, EG; Erina, EV; Prokopova, TN, 1986) |
| "The ability of propranolol to inhibit the development of polyploidy in aortic vascular smooth muscle cells associated with hypertension was studied in deoxycorticosterone (DOC)-salt treated rats." | 7.67 | Inhibition of nuclear polyploidy by propranolol in aortic smooth muscle cells of hypertensive rats. ( Chobanian, AV; Leitschuh, M, 1987) |
| "2 mg propranolol intravenously resulted in acute pulmonary edema." | 7.67 | Severe hypertension, propranolol, and acute pulmonary edema. ( Desai, SP; Fleming, TC; Pierce, EC, 1987) |
| "Effect of long-term oral administration of the converting enzyme inhibitor (2R, 4R)-2-(o-hydroxyphenyl)-3-(mercaptopropionyl)-4-thiazolidinecarboxylic acid (SA446) in combination with hydrochlorothiazide or propranolol on the development of hypertension was examined in spontaneously hypertensive rats (SHR)." | 7.67 | [Combined effect of (2R, 4R)-2-(o-hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidinecarbo xyl ic acid (SA446) with hydrochlorothiazide or propranolol on development of hypertension in spontaneously hypertensive rats (SHR) by long-term administration]. ( Iso, T; Nakata, K; Takada, T; Yamauchi, H, 1986) |
| "The effect of propranolol on renal haemodynamics was studied in nine patients with arterial hypertension and moderate to severe chronic renal failure." | 7.67 | Renal haemodynamics during propranolol treatment in patients with arterial hypertension and chronic renal failure. ( Fjeldborg, P; Jacobsen, BA, 1986) |
| "Plasma propranolol concentrations were analyzed after Obsidan (VEB Isis-Chemie, Zwickau, GDR) (= preparation A) and another propranolol-preparation (= preparation B) in 10 patients with arterial hypertension of clinical stage I-II in a cross-over design." | 7.67 | [Comparative pharmacokinetic studies on the relative biologic availability of two propranolol preparations in patients with steady state essential hypertension]. ( Faulhaber, HD; Gohlke, HR; Prehm, C; Rostock, G, 1986) |
| "Captopril in low doses has been used recently with success in the treatment of mild to moderate hypertension." | 7.67 | Comparison of low-dose captopril and propranolol as second-line drugs in mild and moderate hypertension. ( Rosenfeld, JB; Traub, YM, 1985) |
| "The effect of propranolol on baroreflex control of heart rate was studied in 12 young patients with essential hypertension and was compared with that of 12 age-matched normotensive subjects." | 7.67 | Effect of propranolol on baroreflex control of heart rate in young patients with essential hypertension. ( Hattori, N; Ikeda, T; Iwase, N; Ogawa, J; Okuwa, H; Takata, S; Yagi, S, 1986) |
| "Phenylpropanolamine (PPA) overdose can cause severe hypertension, intracerebral hemorrhage, and death." | 7.67 | Propranolol antagonism of phenylpropanolamine-induced hypertension. ( Asinger, RW; Benowitz, NL; Pentel, PR, 1985) |
| "To determine the efficacy of nifedipine combined with propranolol in the treatment of hypertension, 23 patients with essential hypertension uncontrolled while they were receiving propranolol, 120 mg/d, entered a dose response trial of four 8-week periods while continuing propranolol therapy." | 7.67 | Effect of nifedipine and propranolol on blood flow, venous compliance and blood pressure in essential hypertension. ( Ogilvie, RI, 1985) |
| "The treatment of the mentioned forms of hypertension with propranolol during pregnancy either as monotherapy or in combination with dihydralazine and after careful exclusion of the contraindications described represents a further effective therapy." | 7.67 | [Experiences with propranolol (Obsidan25) in hypertension therapy in pregnancy]. ( Glöckner, R; Peiker, G; Siegert, C; Traeger, A; Völkner, E, 1985) |
| "All Wistar rats showed hypertension when they were given heat-stress and administered metyrapone (200 micrograms/kg/day), a cholesterol-11-beta-hydroxylase inhibitor." | 7.67 | [Hypertension in rats caused by metyrapone and heat-stress treatment]. ( Arakawa, K, 1985) |
| "Twenty-nine patients with severe hypertension (n = 14) or hypertensive crisis (n = 15) were treated with diazoxide infusion and intravenous injection of a beta blocker." | 7.66 | Combined intravenous administration of diazoxide and beta-blocking agent in acute treatment of severe hypertension or hypertensive crisis. ( Huysmans, FT; Koene, RA; Thien, TA, 1982) |
| "Five patients presenting with severe hypertension who failed to exhibit diastolic blood pressures less than 120 mm Hg following the oral administration of propranolol (60--80 mg) and furosemide (40 mg) received minoxidil (20 mg, p." | 7.66 | Rapid reduction of severe hypertension with minoxidil. ( Alpert, MA; Bauer, JH, 1980) |
| "The effect of exercise on the urinary excretion of albumin, beta 2-microglobulin, renal plasma flow (RPF) and glomerular filtration rate (GFR) was studied in two groups of young patients with mild essential hypertension, one comprising nine untreated patients (1) and one comprising eight patients treated with propranolol (2), and in a group comprising ten normotensive healthy control subjects (3)." | 7.66 | Effects of exercise on urinary excretion of albumin and beta 2-microglobulin in young patients with mild essential hypertension without treatment and during long-term propranolol treatment. ( Larsen, JS; Mogensen, CE; Pedersen, EB, 1981) |
| "The antihypertensive effect of captopril was tested on 19 patients with essential hypertension, WHO grade I or II." | 7.66 | [Captopril in the treatment of essential hypertension (author's transl)]. ( Braun, B; Klaus, D; Lederle, RM, 1980) |
| " The plasma aldosterone responses to exogenous angiotensin II and adrenocorticotropic hormone (ACTH) were studied before and after 1 month of propranolol therapy (120-240 mg/day) in eight patients with essential hypertension." | 7.66 | Effect of propranolol therapy on aldosterone responses to angiotensin II and adrenocorticotropic hormone in essential hypertension. ( Fittingoff, DB; Golub, MS; Tuck, ML, 1981) |
| "Sixteen patients with uncomplicated systemic hypertension were treated with placebo, diltiazem (180 mg/day) and propranolol (60 mg/day) for 1 month each." | 7.66 | Effects of diltiazem on cardiovascular responses during exercise in systemic hypertension and comparison with propranolol. ( Kondo, S; Nakano, T; Noziri, A; Oonishi, N; Takezawa, H; Yamakado, T, 1983) |
| "Twenty-seven patients with moderate to moderately severe hypertension who had not responded optimally to treatment with a standard step 2 regimen were treated with a three-drug regimen of hydrochlorothiazide, propranolol, and guanadrel." | 7.66 | Safety and efficacy of a three-drug regimen for the treatment of hypertension: hydrochlorothiazide, propranolol, and guanadrel. ( Gore, RD, 1983) |
| "The technique of non-invasive blood pressure monitoring was used to compare the 24-hr control of blood pressure in 10 patients with essential hypertension taking either twice daily propranolol or a once daily long-acting formulation of propranolol (propranolol LA)." | 7.66 | Comparison of propranolol and propranolol LA in hypertension using 24-hr noninvasive blood pressure monitoring. ( Coomes, EN; Rustin, MH, 1983) |
| "The role of the renin-aldosterone axis in mediating responses to antihypertensive treatment was examined in patients with essential hypertension treated with propranolol (n=50) or chlorthalidone (n=50)." | 7.66 | The role of aldosterone in the response to treatment of primary hypertension. ( Drayer, JI; Laragh, JH; Purdy, RE; Weber, MA, 1982) |
| "The effect of an acute intravenous and repeated oral doses of propranolol on haemodynamics, plasma and urinary catecholamines and plasma renin activity was studied in patients with essential hypertension." | 7.66 | Effects of acute and long-term beta-adrenoceptor blockade with propranolol on haemodynamics, plasma catecholamines and renin in essential hypertension. ( Kho, TL; Rahn, KH; Thijssen, H; van Baak, MA, 1982) |
| "Plasma renin activity (PRA) and systolic time intervals (STI), including total electromechanical systole (QS2), left ventricular ejection time (LVET), pre-ejection period (PEP) and isovolumetric contraction time (ICT), were measured in patients with borderline hypertension (n = 23) before and after oral treatment with atenolol and propranolol." | 7.66 | Effects of propranolol and atenolol on plasma renin activity and systolic time intervals in borderline hypertension. ( Fong Chi, S; Gamio Capestany, F; García-Barreto, D; González-Gómez, A; Hernández-Cañero, A, 1982) |
| "Serum concentrations of LH, FSH, testosterone and prolactin were measured in patients with hypertension treated with propranolol (34 cases), methyldopa (13 cases), and methyldopa + propranolol (11 cases)." | 7.66 | Plasma sex hormone concentrations in men with hypertension treated with methyldopa and/or propranolol. ( Crisp, AJ; Hoffbrand, BI; Jacobs, HS; Maguire, A; Taylor, RG, 1981) |
| "The 24-h urinary excretion of prostaglandins (PG) E2 and F2 alpha, which reflects the renal synthesis of these substances, was measured by radioimmunoassay in 10 patients with essential hypertension before and after treatment with propranolol." | 7.66 | Effect of propranolol treatment on the urinary excretion of prostaglandins E2 and F2 alpha in patients with essential hypertension. ( Bernheim, J; Rathaus, M, 1982) |
| "Sclerosing peritonitis developed in a 56-year-old white man who had been receiving propranolol (320 mg/day) for hypertension and angina pectoris since December 1976." | 7.66 | Sclerosing peritonitis and propranolol. ( Ahmad, S, 1981) |
| "The hypotensive effect of nifedipine was studied in 9 patients with severe hypertension." | 7.66 | Management of severe hypertension with nifedipine in combination with clonidine or propranolol. ( Abe, K; Chiba, S; Haruyama, T; Imai, Y; Irokawa, N; Ito, T; Miura, Y; Otsuka, Y; Saito, K; Sakurai, Y; Sato, M; Yasujima, M; Yoshinaga, K, 1980) |
| "A case of severe hypertension resistant to multiple drug therapy was controlled with minoxidil, captopril, and propranolol hydrochloride after treatment with these drugs alone or in other combinations had failed." | 7.66 | Interaction of minoxidil and captopril in the treatment of refractory hypertension. ( Matson, JR; Norby, LH; Robillard, JE, 1981) |
| "26 patients with severe hypertension (10 essential, 9 renal parenchymatous, 7 renovascular) and a mean age of 42 years were treated with the new oral converting enzyme inhibitor captopril (SQ 14225)." | 7.66 | [Captopril in treatment-resistant hypertension (author's transl)]. ( Lüscher, T; Siegenthaler, W; Studer, A; Vetter, W, 1980) |
| "Combined use of prazosin and propranolol was effective in preoperative management of three patients with norepinephrine(NE)-secreting pheochromocytoma (PHEO)." | 7.66 | Prazosin and propranolol in preoperative management of pheochromocytoma. ( Cubeddu, LX; Rosales, CB; Zarate, NA; Zschaeck, DW, 1982) |
| "Two studies of systolic time intervals (STIs) in patients with mild to moderate hypertension (HBP) revealed that no mean change in systolic intervals occurred with pindolol therapy, although some patients had significant alterations in their STIs." | 7.66 | Pindolol and systolic time intervals in patients with hypertension. ( Carliner, NH; Fisher, ML; Hamilton, BP; Hamilton, JH; Hammond, JJ; Jacks-Nagle, VL; Janoski, AH; Kirkendall, WM; Plotnick, GD; Robinson, M, 1982) |
| "Propranolol is widely employed in hemodialysis patients for the control of renin-dependent hypertension." | 7.66 | Propranolol-associated hypoglycemia in patients on maintenance hemodialysis. ( Gelfand, M; Knepshield, J; Novello, A; Preuss, HG; Zarate, A, 1981) |
| "1 The rates of noradrenaline spillover to, and removal from, plasma were measured in ten patients with essential hypertension treated with propranolol, to ascertain if long-term administration of this drug reduces sympathetic nervous system tone." | 7.66 | Effect of propranolol on noradrenaline kinetics in patients with essential hypertension. ( Bobik, A; Esler, M; Jackman, G; Jennings, G; Leonard, P; Skews, H, 1981) |
| "Eighty-seven patients with intractable hypertension received minoxidil for a mean duration of 27 months (range three months to five years)." | 7.66 | Minoxidil in the management of intractable hypertension. ( Fife, R; Henderson, I; Isles, C; Kennedy, AC; Mackay, A, 1981) |
| "A hypertensive women was treated throughout pregnancy with propranolol 40 mg daily without complication." | 7.66 | Anti-hypertensive therapy with propranolol during pregnancy and lactation. ( Taylor, EA; Turner, P, 1981) |
| "In 26 patients with essential hypertension who were on continuous chlorthalidone therapy, 1 and 3 daily doses of propranolol were compared in a crossover study." | 7.66 | One and three doses of propranolol a day in hypertension. ( Boer, P; Dorhout Mees, EJ; Geyskes, GG; van Asten, P; van den Brink, G, 1980) |
| "Three patients with no history of asthma or allergy developed bronchospasm while taking propranolol for hypertension." | 7.66 | Propranolol-related bronchospasm in patients without history of asthma. ( Adler, S; Bruns, FJ; Fraley, DS; Segel, DP, 1980) |
| "The effects of propranolol on blood pressure, plasma catecholamine concentration and platelet aggregation were examined in 16 patients with uncomplicated primary hypertension." | 7.66 | Hypertension and propranolol therapy: effect on blood pressure, plasma catecholamines and platelet aggregation. ( Aledort, L; Vlachakis, ND, 1980) |
| "A combination of propranolol and hydrallazine was administered to 13 patients with longstanding hypertension during 15 pregnancies." | 7.66 | Propranolol and hydrallazine in the management of essential hypertension in pregnancy. ( Bott-Kanner, G; Joel-Cohen, SJ; Reisner, SH; Rosenfeld, JB; Schweitzer, A, 1980) |
| " The common factor in all 5 patients was propranolol administration for the treatment of hypertension." | 7.66 | Hypoglycemia in chronic hemodialysis patients: association with propranolol use. ( Albin, J; Grajower, MM; Walter, L, 1980) |
| "Pericardial effusions are occasionally observed in patients treated with the new oral vasodilator, minoxidil." | 7.66 | Pericardial effusion associated with minoxidil therapy. ( Chatterjee, K; Houston, MC; McChesney, JA, 1981) |
| "We have described two patients with propranolol-induced severe diarrhea, confirmed by rechallenge with the drug." | 7.66 | Severe diarrhea secondary to propranolol. ( Fuller, TJ; Horvath, F; Marbury, TC; Nelson, EW; Uhlemann, ER, 1979) |
| "A case is presented herein of alopecia developing in a patient receiving propranolol." | 7.66 | Propranolol and alopecia. ( Hilder, RJ, 1979) |
| "Total exchangeable body potassium (KE) was determined in fifteen patients with essential hypertension, and total exchangeable body sodium (NaE) in ten, before and after propranolol administration for 2-3 months." | 7.66 | Effect of propranolol on total exchangeable body potassium and total exchangeable body sodium in essential hypertension. ( Pedersen, A; Pedersen, EB; Pedersen, G, 1979) |
| "The onset of DOCA-salt hypertension in male Sprague-Dawley rats was prevented during 11 weeks of oral treatment with indapamide (0." | 7.66 | The effects of long term oral treatment with indapamide on the development of DOCA-salt hypertension in rats: vascular reactivity studies. ( Hicks, PE, 1979) |
| "The effect of long-term treatment of hypertension with propranolol, alone or in combination with hydrochlorothiazide and/or dihydralazine, was investigated in 93 patients with various types of hypertension." | 7.66 | [Long-term treatment of arterial hypertension with propranolol. Combination with diuretics and dihydrazinophthalazine]. ( Ambrosio, G; Corgnati, A; Dal Palù, C; Palatini, P; Pessina, AC, 1978) |
| "The effect of abrupt withdrawal of propranolol on serum concentrations of triiodothyronine (T3) and thyroxine (T4) was investigated in 5 patients with uncomplicated essential hypertension." | 7.66 | Propranolol withdrawal and thyroid hormones in patients with essential hypertension. ( Kristensen, BO; Steiness, E; Weeke, J, 1978) |
| "Eleven patients with essential hypertension were given hydralazine (25 mg b." | 7.66 | Renal plasma flow and cardiac output during hydralazine and propranolol treatment in essential hypertension. ( Falch, DK; Norman, N; Odegaard, AE, 1978) |
| "Twenty-five women were treated with propranolol during 26 pregnancies complicated by hypertension." | 7.66 | Propranolol for the treatment of hypertension in pregnancy. ( Eliahou, HE; Mashiach, S; Reisin, E; Romem, I; Serr, DM; Silverberg, DS, 1978) |
| "In 16 patients with hypertension, BP could not be controlled satisfactorily by treatment with propranolol alone (mean dosage 325 mg/day)." | 7.66 | Changes in plasma volume and extracellular fluid volume and after addition of hydralazine to propranolol treatment in patients with hypertension. ( Ibsen, H; Jensen, HA; Leth, A; Rasmussen, K, 1978) |
| "A retrospective study is presented of the effect of propranolol on fetal outcome in pregnancies complicated by maternal hypertension." | 7.66 | The possible adverse effect of propranolol on the fetus in pregnancies complicated by severe hypertension. ( Beard, RW; Belsey, E; Cohen, SL; Lieberman, BA; Pinker, GD; Stirrat, GM, 1978) |
| "In fifteen patients with hypertension, inadequately controlled during treatment with propranolol alone (mean dosage 333 mg/day), plasma volume (PV) and extracellular fluid volume (ECV) were determined." | 7.66 | Changes in plasma volume and extracellular fluid volume after addition of prazosin to propranolol treatment in patients with hypertension. ( Ibsen, H; Jensen, HA; Leth, A; Rasmussen, K, 1978) |
| "The hemodynamic mechanism of the hypotensive effect of propranolol was studied by quantitative radiocardiography in 8 patients with dialysis-resistant hypertension." | 7.66 | Chronic hemodynamic effects of propranolol treatment in dialysis-refractory hypertension. ( Contini, C; Maggiore, Q; Monzani, G; Zoccali, C, 1978) |
| "In the dog, the intra-venous injection of practolol (1 to 3 mg/kg) reduces the hypertension provoked by vagotomy and sino-aortic nerves section, or by intra-venous administration of potassium cyanide." | 7.65 | [Effect of practolol on experimental hypertension in dogs]. ( Baïsset, A; Besombes, JP; Montastruc, P, 1975) |
| "The blood pressure response to propranolol treatment was analyzed retrospectively in 187 patients with benign essential hypertension." | 7.65 | Unexpected pressor responses to propranolol in essential hypertension. An interaction between renin, aldosterone and sympathetic activity. ( Case, DB; Drayer, JI; Keim, HJ; Laragh, JH; Weber, MA, 1976) |
| "To understand the role of the renin-angiotensin-aldosterone system in the pathogenesis of human hypertension, in serial studies we have blocked the system using three different pharmacologic probes: 1) reduction of renin secretion by administration of the beta receptor blocker, propranolol; 2) blockade of the action of angiotensin II by infusion of saralasin, a competitive antagonist of angiotensin II; and 3) blockade of the enzymatic conversion of angiotensin I to angiotensin II by infusing a nonapeptide competitive inhibitor." | 7.65 | Blockade of renin or angiotensin for understanding human hypertension: a comparison of propranolol, saralasin and converting enzyme blockade. ( Case, DB; Keim, H; Laragh, JH; Wallace, JM, 1977) |
| "Ten children with hypertension poorly controlled with other drugs and high peripheral plasma renin activity after renal transplantation were treated with propranolol." | 7.65 | Treatment of high-renin hypertension with propranolol in children after renal transplantation. ( Holliday, MA; Orloff, S; Potter, DE; Salvatierra, O; Schambelan, M, 1977) |
| "Ten hypertensive patients were treated with propranolol throughout pregnancy." | 7.65 | [Treatment of arterial hypertension with propranolol in pregnant women. 10 cases]. ( Kreft, C; Tcherdakoff, Ph, 1977) |
| "In a study of 10 patients suffering from hypertension the results showed that combination treatment with prazosin, cyclopenthiazide and a beta-blocker produced a significant fall in blood pressure." | 7.65 | Prazosin combined with thiazide diuretic and beta-blocker in the treatment of hypertension. ( Bhoola, R; Seedat, MA; Seedat, YK, 1977) |
| "Sixteen patients with essentialy hypertension were treated with propranolol 160 to 640 mg daily for three months." | 7.65 | Plasma concentrations of propranolol in patients with essential hypertension. ( Kanto, J; Kleimola, T; Lehtonen, A, 1977) |
| "The therapeutic efficacy of four antihypertensive regimens (minoxidil, propranolol, and hydrochlorothiazide; propranolol and hydrochlorothiazide; methyldopa and hydroch-orothiazide; and hydrochlorothiazide alone) was evaluated in one child with systolic hypertension and in eight children with systolic and diastolic hypertension." | 7.65 | Management of severe childhood hypertension with minoxidil: a controlled clinical study. ( Mirkin, BL; Sinaiko, AR, 1977) |
| " Propranolol and furosemide were administered concomitantly to control reflex tachycardia and fluid retention." | 7.65 | The outpatient treatment of refractory hypertension with minoxidil. ( Ball, JH; Kleiner, JP; Nelson, WP; Norton, JD, 1977) |
| "To investigate the importance of plasma renin activity in determining the antihypertensive action of propranolol and of heart rate in guiding propranolol therapy, the effect of a graded oral dose of propranolol on blood pressure, plasma renin and heart rate was studied in 24 men with essential hypertension and differing initial levels of renin activity." | 7.65 | Blood pressure, renin activity and heart rate changes during propranolol therapy of hypertension. ( Esler, M; Zweifler, A, 1977) |
| "The effect of propranolol on serum levels of total and free thyroxine, total and free triiodothyronine, and thyroid-stimulating hormone (TSH) was investigated in 15 clinical euthyroid patients with essential hypertension." | 7.65 | Propranolol-induced increments in total and free serum thyroxine in patients with essential hypertension. ( Kristensen, BO; Weeke, J, 1977) |
| " The immediate short-term effects of intravenous injections of propranolol on plasma renin activity were studied in thirty-one normal subjects, 102 patients with benign essential and sixty-six patients with renal hypertension." | 7.65 | The immediate plasma renin response to propranolol: evidence for a different mode of renin release in essential and renal hypertension. ( Braunsteiner, H; Czaykowska, W; Dittrich, P; Skrabal, F, 1976) |
| " The hypotensive effect of propranolol and its correlation with the changes in heart rate, plasma volume and plasma renin activity produced by this drug were studied in normotensive rats and in rats with spontaneous, renovascular and deoxycorticosterone-induced hypertension." | 7.65 | The effects of propranolol on spontaneous and experimental hypertension in the rat. ( Corgnati, A; Oneglia, C; Palatini, P; Palu, CD; Pessina, AC, 1976) |
| " Propranolol, when used for treating arterial hypertension, may influence determinants of both cardiac and vascular function; the consequent changes in cardiac performance may result from the interaction of different and possibly opposite effects." | 7.65 | Cardiac function in the treatment of arterial hypertension with propranolol. ( Bartorelli, C; Fiorentini, C; Guazzi, M; Magrini, F; Olivari, MT; Polese, A, 1976) |
| "Thirteen patients with severe hypertension were treated with combined minoxidil, propranolol, and furosemide (mean daily doses 33 mg, 475 mg, and 578 mg, respectively) for nine to twenty-five months (mean 13." | 7.65 | Long-term treatment of severe hypertension with minoxidil, propranolol and furosemide. ( Bennet, CM; Blaufuss, A; Wilburn, RL, 1975) |
| "Twenty-six patients were selected for treatment with minoxidil on the basis of hypertension which could not be controlled either because of (1) drug failures and/or (2) side effects of drugs." | 7.65 | Minoxidil in severe hypertension: value when conventional drugs have failed. ( Dormois, JC; Nies, AS; Young, JL, 1975) |
| " Propranolol and diuretics were given to prevent reflex tachycardia and fluid retention." | 7.65 | Severe hypertension. Treatment with minoxidil. ( Dunea, G; Mahurkar, SD; Mamdani, B; Mehta, PK; Shansky, RM, 1975) |
| "In 16 normal subjects, in 29 patients with essential hypertension and in 25 patients with renal hypertension plasma renin activity was measured together with pulse rate and blood pressure under resting conditions and 15 minutes after the intravenous administration of 5 mg d-1-propranolol subsequently." | 7.65 | [Different reaction of plasma renin activity after propranolol in essential and renal hypertension]. ( Skrabal, F, 1975) |
| "The effects of propranolol on the circulation and respiration were studied in 38 patients with essential hypertension and symptomatic renal hypertension." | 7.65 | Effects of propranolol on haemodynamic changes and gas exchange at rest, in orthostasis, and on exercise in patients with arterial hypertension. ( Glezer, GA; Megrelishvili, RI; Moskalenko, NP; Zilbert, NL, 1976) |
| "An in vivo study of skeletal muscle paralysis induced by intravenous barium chloride has been made in curarized and non-curarized rats." | 7.65 | Barium-induced skeletal muscle paralysis in the rat, and its relationship to human familial periodic paralysis. ( McArdle, B; Schott, GD, 1974) |
| "When used in the treatment of hypertension propranolol is at least of similar potency to bethanidine, guanethidine, and methyldopa." | 7.65 | Treatment of hypertension with propranolol. ( Gillam, PM; Prichard, BN, 1969) |
| "Propranolol CR is an effective antihypertensive formulation that may reduce blood pressure during the morning period of maximum cardiovascular risk." | 6.71 | The antihypertensive efficacy and safety of a chronotherapeutic formulation of propranolol in patients with hypertension. ( Manowitz, N; Neutel, JM; Sica, DA; Weber, MA, 2004) |
| "Propranolol treatment significantly reduced HDL-cholesterol (p < 0." | 6.67 | Metabolic effects of propranolol and hydroflumethiazide treatment in Kenyans with mild to moderate essential hypertension. ( Ogola, EN; Orinda, DA; Yonga, GO, 1993) |
| "Treatment with verapamil caused significant increase of EDF from 61." | 6.67 | [Effects of verapamil and propranolol on the left-ventricular diastolic function in patients with primary arterial hypertension]. ( Markiewicz, M; Rymar, B; Trojnar, R; Wysokiński, A, 1991) |
| "Guanadrel sulfate was also associated with significant decreases in mean fasting plasma glucose and total serum cholesterol, whereas propranolol resulted in an increase in serum triglycerides (p less than 0." | 6.67 | Comparison of the effects of guanadrel sulfate and propranolol on blood pressure, functional capacity, serum lipoproteins and glucose in systemic hypertension. ( Darga, LL; Franklin, BA; Hakim, MJ; Lucas, CP, 1991) |
| "Treatment with reserpine hampered mental activity, including the functions of memory and attention." | 6.67 | [Effect of reserpine and propranolol on mental work capacity and psychological status of workers with hypertension after exposure to neuro-emotional stress]. ( Akhunova, NT; Bokovikov, AN; Dasaeva, LA, 1991) |
| "Propranolol treatment resulted in a decrease of plasma norepinephrine, plasma renin activity, and thromboxane B2 formation." | 6.67 | Fish oil amplifies the effect of propranolol in mild essential hypertension. ( Augustin, S; Goschel, M; Melzer, S; Singer, P, 1990) |
| "Both drugs were effective in the treatment of hypertension." | 6.67 | Nicardipine and propranolol in the treatment of hypertension: similar antihypertensive but dissimilar hemodynamic actions. ( Featherston, W; Gonzalez, DG; Kaplan, NM; Lugo, C; Ralakis, J; Ram, CV, 1990) |
| "Nifedipine was associated with a significant increase in cardiac output and stroke volume at rest and at peak exercise, while propranolol decreased cardiac output at rest and at peak exercise." | 6.66 | Nifedipine, but not propranolol, improves left ventricular systolic and diastolic function in patients with hypertension. ( Boucher, CA; Christensen, DM; Federman, EB; Miller, DD; Ruddy, TD; Zusman, RM, 1989) |
| "Acebutolol was superior to placebo, propranolol, and hydrochlorothiazide in terms of response rate." | 6.66 | Effects of age and race on clinical response to acebutolol in essential hypertension. ( Boyles, PW, 1985) |
| "Acebutolol was shown to be a safe, effective and reliable antihypertensive drug, at least comparable to and probably slightly better than, propranolol in the treatment of hypertension in Black Nigerians." | 6.66 | A double-blind comparison of acebutolol (Sectral) and propranolol (Inderal) in the treatment of hypertension in black Nigerian patients. ( Abengowe, CU, 1985) |
| "Ketanserin is a new strong antiserotoninergic drug that, unlike the previous ones, is selective for 5-hydroxytryptamine receptors." | 6.66 | Effects of ketanserin on blood pressure, peripheral circulation and haemocoagulative parameters in essential hypertensives with or without arteriosclerosis obliterans of the lower limbs. ( Abrignani, MG; Adamo, L; Alaimo, G; Avellone, G; Cutietta, A; Giordano, U; Indovina, A; Novo, S; Pinto, A; Strano, A, 1986) |
| "Hydrochlorothiazide was added for patients not achieving the treatment goal." | 6.66 | Diltiazem and propranolol in mild to moderate essential hypertension as monotherapy or with hydrochlorothiazide. ( Anderson, M; Bartels, D; Eidelson, BA; Labreche, DG; MacCarthy, EP; Massie, B; Ramanathan, KB; Tubau, JF; Ulep, D; Weiss, RJ, 1987) |
| "Nifedipine therapy was associated with an increase in high-density lipoprotein cholesterol levels and a decrease in serum triglyceride levels." | 6.66 | Comparison of nifedipine and propranolol used in combination with diuretics for the treatment of hypertension. ( Christensen, D; Federman, E; Kochar, MS; McCarron, D; Porush, JG; Spitalewitz, S; Zusman, R, 1987) |
| "Enalapril is an effective anti-hypertensive agent with a favourable effect on renal haemodynamics." | 6.65 | Effects of enalapril on blood pressure and renal haemodynamics in essential hypertension. ( de Jong, PE; de Zeeuw, D; Donker, AJ; Navis, GJ, 1983) |
| "Captopril is an effective alternative in the treatment of hypertensive patients not readily controlled with conventional therapy." | 6.65 | The renin-angiotensin system during converting enzyme inhibition with captopril in patients with severe treatment-resistant hypertension. ( Damkjaer Nielsen, M; Giese, J; Ibsen, H; Leth, A; Rasmussen, S, 1984) |
| " Apart from the hydrochlorothiazide dosage which was fixed, the dosage of the other active drugs was titrated incrementally until the target blood pressure level was achieved." | 6.65 | An appraisal of antihypertensive efficacy and adverse reactions with two drug regimens: enalapril maleate as part of triple therapy compared to conventional triple therapy in moderate to severe hypertension. ( Fernandez, PG; Galway, AB; Kim, BK, 1984) |
| " The double regimen caused a drop in pressure of 16/11 mm Hg after one month (daily doses 25 mg chlorthalidone, 103 +/- 25 mg propranolol), and this reduction did not change at the third month in spite of dosage increases (daily doses 25 mg chlorthalidone, 222 +/- 77 mg propranolol)." | 6.65 | A crossover trial of oxdralazine in hypertension. ( Criscuolo, D; Galli, F; Salvadeo, A; Segagni, S; Villa, G, 1983) |
| "The possibility to apply impedance cardiography technique and individual statistical analysis based on Dixon's criterion to pharmacodynamic studies of single hydralazine ( apressine ), prazosine ( pratsiol ), endralazine ( mirethilan ), propranolol (obsidan) doses is discussed." | 6.65 | [Methodologic approach to individual evaluation of the pharmacodynamic effects of single doses of hydralazine, endralazine, prazosine and propranolol in hypertension patients]. ( Izotov, AI; Postol'nikov, SF; Vygodin, VA, 1984) |
| " Also during treatment, fewer patients receiving hydrochlorothiazide required termination as compared with those receiving propranolol; comparative dosage requirements were lower; additional titration during long-term treatment was required less often, and BP remained lower after withdrawal of the active drugs." | 6.65 | Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension. II. Results of long-term therapy. Veterans Administration Cooperative Study Group on Antihypertensive Agents. ( , 1982) |
| "1 The effects on heart rate and blood pressure after single and multiple dosing (1 month) of a long acting formulation of propranolol 160 mg daily, and conventional propranolol, 80 mg twice daily, or 160 mg daily were compared in 11 moderately hypertensive subjects previously shown to respond to propranolol." | 6.65 | The pharmacodynamics and pharmacokinetics of conventional and long-acting propranolol in patients with moderate hypertension. ( Breckenridge, AM; Green, GJ; MacIver, M; Orme, ML; Serlin, MJ; Sibeon, RG, 1983) |
| "Nifedipine, 30 mg/day, was added and the dose was titrated upwards to 90 mg/day to achieve normal blood pressure." | 6.65 | The combination of propranolol and nifedipine in the treatment of hypertension: acute and long term effects. ( Ishay, DB; Kobrin, I; Leibel, B; Stessman, J; Yagil, Y, 1983) |
| " They received in random order: placebo; tienilic acid 250 mg/day; propranolol 80 mg twice daily; and tienilic acid 250 mg/day combined with propranolol 80 mg twice daily." | 6.65 | Biochemical and haematological changes induced by tienilic acid combined with propranolol in essential hypertension. ( Bulpitt, CJ; Havard, CW; Pearson, RM, 1979) |
| "Oxprenolol is a beta-adrenergic blocker with intrinsic sympathomimetic activity." | 6.65 | Hemodynamic effects of oxprenolol and propranolol in hypertension. ( Franciosa, JA; Johnson, SM; Tobian, LJ, 1979) |
| "Prazosin appears to be a potent and appropriate third agent." | 6.64 | Evaluation of beta blockade bendrofluazide, and prazosin in severe hypertension. ( Barritt, DW; Heaton, ST; Marshall, AJ; Pocock, J, 1977) |
| "Metoprolol 120 mg/d was significantly superior to propranolol 240 mg/d in holding the diastolic supine blood pressure at less than or equal to 90 mmHg." | 6.64 | South African multicentre study of metoprolol and propranolol in essential hypertension. ( Bosman, AR; Goldberg, B; McKechnie, JK; Offermeier, J; Oosthuizen, OJ, 1977) |
| "Propranolol 60 mg/day was no better than placebo in reducing blood pressure." | 6.64 | Propranolol in hypertension: a dose-response study. ( Galloway, DB; Glover, SC; Hendry, WG; Lewis, JA; Logie, AW; Petrie, JC; Simpson, WT; Smith, MC, 1976) |
| "Labetalol was more effective in lowering blood pressure but less effective in reducing pulse rate of plasma angiotensin II concentration." | 6.64 | Effect of blood pressure angiotensin II and aldosterone concentrations during treatment of severe hypertension with intravenous labetalol: comparison with propranolol. ( Brown, JJ; Fraser, R; Lever, AF; Morton, JJ; Robertson, JI; Rosei, EA; Trust, PM, 1976) |
| "5." | 6.64 | Clinical evaluation of atenolol in hypertension. ( Aberg, H; Hansson, L; Henningsen, NC; Jameson, S; Karlberg, BE; Westerlund, A, 1976) |
| "Increments in heart rate during the TNG test (sublingual nitroglycerin with assumption of upright posture), passive head-up tilt, and postrecumbency standing were compared to the effects of intravenous isoproterenol in 15 mild hypertensives during administration of placebo and two dosage levels of propranolol." | 6.64 | Heart rate responses during treatment of hypertension with propranolol. The clinical usefulness of the nitroglycerin test. ( Hansson, L; Zweifler, AJ, 1976) |
| "Treatment with propranolol resulted in marked suppression of the plasma renin activity (1." | 6.64 | Intrapatient comparison of treatment with chlorthalidone, spironolactone and propranolol in normoreninemic essential hypertension. ( Benraad, TJ; Drayer, JI; Festen, J; Kloppenborg, PW; van't Laar, A, 1975) |
| "Labile hypertension is often associated with elevated cardiac output, increased plasma renin activity (PRA) and urinary cyclic AMP excretion in response to upright posture and to isoproterenol." | 6.64 | Effect of propranolol on cyclic AMP excretion and plasma renin activity in labile essentrial hypertension. ( Boucher, R; Cuche, JL; Genest, J; Hamet, P; Kuchel, O, 1973) |
| "When propranolol was withdrawn blood pressures rapidly rose to hypertensive levels, though not to untreated levels." | 6.63 | Controlled trial of propranolol in hypertension. ( Cowen, KJ; Zacharias, FJ, 1970) |
| "The cost effectiveness of labetalol and propranolol in the treatment of black adults with mild to moderate hypertension was assessed using published reports from US clinical trials of these agents among such patients." | 6.16 | Cost effectiveness of labetalol and propranolol in the treatment of hypertension among blacks. ( Colditz, GA; Delea, TE; Huse, DM; Oster, G; Savage, DD, 1987) |
| "The objective was to assess the effect of propranolol on oxidative stress and anti-oxidant potential in patients with resistant hypertension as a secondary analysis of the APPROPRIATE trial." | 5.34 | The impact of propranolol on nitric oxide and total antioxidant capacity in patients with resistant hypertension-evidence from the APPROPRIATE trial. ( Constantine, GR; Fernando, N; Galappatthy, P; Handunnetti, S; Katulanda, P; Rajapakse, S; Ranasinghe, HN; Weeratunga, PN, 2020) |
| " Chronic administration of propranolol (5 or 50 mg." | 5.29 | Effects of propranolol and atenolol on immobilization stress-induced hypertension and down-regulation of central beta-adrenoceptors in rats. ( Kigoshi, S; Muramatsu, I; Oda, Y; Takita, M, 1995) |
| "Propranolol has been suggested to slow aortic aneurysm (AAA) expansion by a mechanism independent of simple blood pressure (BP) reduction." | 5.29 | Effects of hypertension and propranolol upon aneurysm expansion in the Anidjar/Dobrin aneurysm model. ( Gadowski, GR; Hendley, ED; Nichols, P; Pilcher, DB; Ricci, MA; Slaiby, JM, 1996) |
| " It was found that in a part of patients the long-term administration of antihypertensive drugs led to an increased accumulation of kynurenine as a manifestation of pyridoxal-5-phosphate deficiency." | 5.28 | Increased blood kynurenine level as a factor inhibiting the therapeutic effect of antihypertensive agents in combined long-term treatment of essential hypertension. ( Liepinja, DJ; Rudzite, VK; Silava, AK; Vitols, AV, 1990) |
| " Patients were treated with propranolol 40 to 160 mg bid for 8 weeks, followed by atenolol 50 to 100 mg given once daily for 8 weeks, and then rechallenged with the required dosage of propranolol for 8 weeks." | 5.27 | A comparison of the side effects of atenolol and propranolol in the treatment of patients with hypertension. ( Chockalingam, A; Drover, A; Fifield, F; Fodor, JG; Pauls, CJ, 1987) |
| "Hydrochlorothiazide and binazine treatment decreased systolic and diastolic blood pressure, the total electromechanical systolic time index (QS2I) and the left ventricular ejection time index (LVETI), and increased the PEP/LVET index at rest and after exercise." | 5.27 | Post-exertion changes in left ventricular systolic time intervals in patients with primary hypertension treated with hydrochlorothiazide, binazine, and propranolol. ( Cholewa, M; Górski, L; Markiewicz, K, 1985) |
| " No significant change in plasma half-life occurred and there was no correlation between the mean steady-state propranolol concentration and beta-adrenergic blockade or antihypertensive effect." | 5.26 | Relationship of propranolol pharmacokinetics to antihypertensive effect and beta-adrenergic blockade in the treatment of hypertension. ( Dunning, AJ; Krediet, RT; Offerhaus, L, 1980) |
| "Captopril was helpful in the management of refractory hypertension in most cases." | 5.26 | Efficacy of an oral angiotensin-converting enzyme inhibitor (captopril) in severe hypertension. ( Julius, S; Nicholls, MG; Zweifler, AJ, 1981) |
| " A booster dosage of 5 to 20 mg of minoxidil was given at four hours if the diastolic BP exceeded 100 mm Hg." | 5.26 | Rapid control of severe hypertension with minoxidil. ( Alpert, MA; Bauer, JH, 1982) |
| "Seven patients (4 with subarachnoid hemorrhage, 2 with intracerebral hemorrhage, and 1 with massive cerebral infarction) had acute arterial hypertension refractory to control by several antihypertensive drugs (hydralazine, sodium nitroprusside, alpha-methyldopa, and trimethaphan camsylate) used singly or in combination." | 5.26 | Catecholamine-associated refractory hypertension following acute intracranial hemorrhage: control with propranolol. ( Baldwin, CA; Feibel, JH; Joynt, RJ, 1981) |
| "The hypotensive effect of nifedipine (a Ca2+-antagonist) was studied in acute tests and during the long-term administration of the drug together with propranolol." | 5.26 | Hypotensive action of nifedipine (Ca2+-antagonist) and propranolol in acute trials and its long-term therapy of hypertensive coronary heart disease patients. ( Aoki, K; Kato, K; Kawaguchi, Y; Kondo, S; Mochizuki, A; Sato, K; Yamamoto, M, 1981) |
| " The resting heart rate is faster with labetalol than with an equivalent dosage of propranolol." | 5.26 | Comparison of labetalol and propranolol in treatment of hypertension. ( Harvald, B, 1980) |
| " During long-term use alpha-methyldopa frequently reduces the total peripheral resistance and the reduction in cardiac output is usually modest, at rest as well as during exercise." | 5.26 | alpha-Methyldopa and beta-blockers in hypertension--a comparison of their haemodynamic effects. ( Lund-Johansen, P, 1978) |
| "The isoproterenol-induced increase in plasma cyclic adenosine 3':5'-monophosphate (cAMP) reflects the response of adenylate cyclase to beta-adrenergic stimulation, whereas a non-beta-receptor-mediated increase occurs with the administration of glucagon." | 5.26 | Plasma cyclic adenosine 3':5'-monophosphate response to isoproterenol and glucagon in hyperkinetic borderline (labile) hypertension. ( Fraysse, J; Genest, J; Guthrie, GP; Hamet, P; Kuchel, O; Messerli, FH; Nowaczynski, W; Tolis, G, 1976) |
| "Prazosin appears to be a suitable substitute for hydralazine as an effective vasodialator if thiazides plus propranolol or thiazides plus reserpine or alpha-methyldopa are not effective." | 5.26 | Propranolol and newer antihypertensive drugs in the management of hypertension. ( Moser, M, 1979) |
| "7 years) with severe essential hypertension (n = 21) and renovascular hypertension (n = 1) were treated with a mean daily dosage of 16." | 5.26 | [Minoxidil in treatment resistant hypertension]. ( Furrer, J; Nussberger, J; Reuteler, H; Siegenthaler, W; Studer, A; Tenschert, W; Vetter, W, 1979) |
| "Treatment with propranolol and hydralazine was effective in controlling her blood pressure and was continued throughout her next two pregnancies, both of which were successful." | 5.26 | Treatment with propranolol and hydralazine throughout pregnancy in a hypertensive patient. A case report. ( Bott-Kanner, G; Joel-Cohen, J; Rosenfeld, JB; Schoenfeld, A; Schweitzer, A, 1978) |
| "Treatment with propranolol hydrochloride (Deralin [Israel]; Inderal, comparable US product) intravenously administered in a total dose of 284 mg during a period of 18 hours, was followed by clinical remission associated with a decline in urinary excretion of porphyrin precursors." | 5.26 | Treatment of acute intermittent porphyria with large doses of propranolol. ( Atsmon, A; Douer, D; Pinkhas, J; Weinberger, A, 1978) |
| " The biological half-life was reduced and the central volume of distribution, volume of distribution at pseudo-equilibrium and total clearance (TC) were markedly increased." | 5.26 | Comparison of the pharmacokinetics of intravenous dl-propranolol in borderline and permanent hypertension. ( Alexandre, JM; Chevillard, C; Frydman, A; Lemaire, P; Safar, ME; Simon, A; Weiss, YA, 1976) |
| "Propranolol, when given in high dosage to rats, did not induce an increase in hepatic delta-aminolaevulic acid synthetase, an enzyme which is raised in human and drug-induced animal porphyria." | 5.25 | Acute intermittent porphyria: response of tachycardia and hypertension to propranolol. ( Beattie, AD; Goldberg, A; Moore, MR; Ward, RL, 1973) |
| "To our knowledge this is one of the first randomized controlled trials evaluating the effects of propranolol in resistant hypertension." | 5.24 | Addition of Propranolol in Resistant Arterial hypertension Treatment (APROPRIATE study): study protocol for a randomized double-blind placebo-controlled trial. ( Constantine, GR; Galappatthy, P; Katulanda, P; Rajapakse, S; Ranasinghe, P; Senarath, U; Weeraratne, C; Weeratunga, P, 2017) |
| "Beta-blockers have solid documentation in preventing cardiovascular complications in the treatment of hypertension; atenolol, metoprolol, oxprenolol and propranolol demonstrate proven cardiovascular prevention in hypertension mega-trials." | 5.22 | Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified. ( Esler, M; Grassi, G; Kjeldsen, SE; Kreutz, R; Mancia, G; Pathak, A, 2022) |
| "To compare the effects of carvedilol and propranolol on oxidative stress in leukocytes and C-reactive protein levels in patients with hypertension." | 5.11 | Effects of carvedilol on oxidative stress in polymorphonuclear and mononuclear cells in patients with essential hypertension. ( Asada, A; Maeda, K; Nakamura, M; Watanabe, T; Yasunari, K; Yoshikawa, J, 2004) |
| "Propranolol inhibits platelet aggregation more than atenolol and may have a favorable effect on the management of hypertension especially in patients with increased cardiovascular risk." | 5.11 | Effects of atenolol and propranolol on platelet aggregation in moderate essential hypertension: randomized crossover trial. ( Bagatin, J; Lukin, A; Marković, V; Polić, S; Punda, A; Rumboldt, Z, 2005) |
| "We sought to determine whether propranolol has adverse effects on cognitive function, depressive symptoms, and sexual function in patients treated for diastolic hypertension." | 5.09 | The effects of propranolol on cognitive function and quality of life: a randomized trial among patients with diastolic hypertension. ( Acree, M; Baron, RB; Coates, TJ; Gardiner, PS; Halliday, R; Hauck, WW; Pérez-Stable, EJ, 2000) |
| "To compare the management of mild diastolic hypertension (90 to 104 mm Hg) using a nonpharmacologic intervention with that using propranolol or placebo." | 5.08 | Comparison of a lifestyle modification program with propranolol use in the management of diastolic hypertension. ( Baron, RB; Biró, BS; Coates, TJ; Feigal, D; Gardiner, PS; Hauck, WW; McHenry, KS; Pérez-Stable, EJ, 1995) |
| "A multicenter, controlled, open, randomized trial of antihypertensive and life quality (LQ) effects of monotherapy with captopril vs propranolol, hydrochlorothiazide and nifedipine included 345 males aged 35-60 years with mild and moderate hypertension." | 5.08 | [The effect of long-term monotherapy with preparations from the 4 basic groups of antihypertensive agents on the quality of life in patients with mild and moderate arterial hypertension. The Multicenter Captopril and the Quality of Life Study. The working ( Broer, M; Duda, SG; Filatova, NP; Metelitsa, VI; Mukhamedzhanova, GF; Ostrovskaia, TP; Siegrist, J; Vygodin, VA, 1995) |
| "Fifty-one women with pregnancy-induced hypertension (PIH) were randomly allocated to one of three treatment groups: A: hydralazine (13); B: hydralazine and propranolol (17); and C: hydralazine and pindolol (19)." | 5.08 | Beta-adrenergic blocking agents in the treatment of pregnancy-induced hypertension. ( Holzberg, G; Insler, V; Mazor, M; Paran, E; Zmora, E, 1995) |
| "Chronopharmacodynamics of long-action propranolol hydrochloride-betacap (Natko, India) was studied in 48 patients with essential hypertension stage II." | 5.08 | [Chronopharmacodynamics of betacap (long-acting propranolol) in patients with hypertension stage II]. ( Teĭblium, MM; Zaslavskaia, RM; Zhamankulov, KA; Zhumabaeva, TN, 1998) |
| " In this study the effect of ten weeks treatment with the beta-adrenoreceptor (beta-AR) blockers propranolol and ridazolol on melatonin synthesis and on sleep quality was examined in 42 patients suffering from essential hypertension." | 5.07 | Influence of chronic beta-adrenoreceptor blocker treatment on melatonin secretion and sleep quality in patients with essential hypertension. ( Demisch, L; Rommel, T, 1994) |
| "In patients with essential hypertension, the beta-blockers bevantolol or propranolol were administered once or twice a day for twelve weeks to evaluate the effects on blood pressure, and lipid metabolism." | 5.07 | Effect of bevantolol and propranolol on serum lipids in patients with essential hypertension. ( Arakawa, K; Kajiyama, G; Koga, S; Kusukawa, R; Mori, H; Ogawa, N; Sasaki, J; Takagi, R; Tanaka, N, 1994) |
| " We assessed pharmacokinetic and pharmacodynamic interactions of the ACE inhibitor cilazapril and the beta-blocker propranolol in healthy volunteers and patients with essential hypertension." | 5.07 | Review of studies on the clinical pharmacodynamics of cilazapril. ( Belz, GG; Breithaupt, K; Erb, K, 1994) |
| "A relationship between individual variations of the oxidative and acetylating metabolism rates of penbutolol, propranolol, acebutolol which produce a hypotensive effect was studied in patients with arterial hypertension." | 5.07 | [Pharmaco -- genetic approach to the improvement of beta-adrenoblocker therapy in the treatment of hypertension]. ( Bredikhin, VT; Dementéva, NG; Filippenko, NG; Povetkin, SV; Smirnova, II, 1993) |
| "We evaluated exercise performance in 14 patients with uncomplicated essential hypertension 1 h after the administration of a single dose of placebo, nifedipine (20 mg), captopril (50 mg), and propranolol (80 mg)." | 5.07 | Modification of exercise performance by sharp reduction of blood pressure. A study in patients with uncomplicated hypertension. ( Agostoni, PG; Alimento, M; Doria, E; Muratori, M; Riva, S; Tamborini, G, 1993) |
| "In a randomized, double-blind study oral doses of 50 mg carvedilol (Dilatrend) were compared with 40 mg propranolol in 16 male patients with coronary heart disease, CHD [12 without significant stenoses following percutaneous transluminal coronary angioplasty (PTCA), 4 with multivessel disease]." | 5.07 | Acute hemodynamic effects of carvedilol in comparison with propranolol in patients with coronary heart disease. ( Wendt, T, 1992) |
| "Metabolic effects of pindolol and propranolol were investigated in a randomised study of double-blind, double-dummy design in 39 Caucasians with newly detected hypertension." | 5.07 | Metabolic effects of pindolol and propranolol in a double-blind cross-over study in hypertensive patients. ( Lithell, H; Pollare, T; Vessby, B, 1992) |
| "Nitrendipine (bypress) manufactured by Bayer Company in the form of 10 and 20 mg tablets and administered in a dose of 20-40 mg/day turned out an effective antihypertensive remedy in 65% of patients with arterial hypertension largely running a mild course." | 5.07 | [The efficacy of nitrendipine in patients with stable arterial hypertension. The data from a cooperative study in the USSR. The Working Group for the Cooperative Study of Nitrendipine]. ( Metelitsa, VI; Ostrovskaia, TP, 1992) |
| "The new alpha 1-blocker alfuzosin was compared with propranolol as monotherapy for hypertension in a double-blind, parallel group study of 8-week duration in 40 patients with essential hypertension." | 5.07 | Comparison of the new alpha 1-blocker alfuzosin with propranolol as first-line therapy in hypertension. ( Antonacci, A; Bombelli, M; Leto di Priolo, S; Libretti, A; Marazzi, ME; Pirrelli, A; Sega, R; Vulpis, V, 1991) |
| "We evaluated the degree of inhibition of angiotensin converting enzyme (ACE), principally by cilazapril, by assessing the blood pressure response to a continuous infusion of increasing doses of angiotensin I, and assessed the possible pharmacokinetic and pharmacodynamic interactions between cilazapril and propranolol in healthy volunteers and patients with mild to severe essential hypertension." | 5.07 | Clinical pharmacodynamic studies with cilazapril and a combination of cilazapril and propranolol. ( Belz, GG; Breithaupt, K; Erb, KA; Essig, J, 1991) |
| "We compared the effects of nonpharmacologic therapy, propranolol monotherapy, and placebo on blood pressure, metabolic, exercise, and quality of life variables in a 12-week, randomized, placebo-controlled trial of 79 male patients with hypertension." | 5.07 | Superiority of nonpharmacologic therapy compared to propranolol and placebo in men with mild hypertension: a randomized, prospective trial. ( Brondolo, E; Kostis, JB; Rosen, RC; Smith, DE; Taska, L; Wilson, AC, 1992) |
| "Hemodynamic Effects of Isradipine and Nifedipine in Hypertension Myocardial wall tension is an important determinant of the oxygen demand, the function and the degree of hypertrophy of the left ventricle." | 5.07 | [The hemodynamic effects of isradipine and nifedipine in hypertension]. ( Burger, KJ; Distler, GA; Gross, P; Koppenhagen, K; Welzel, D; Wudel, E, 1991) |
| "The effects of nicardipine and propranolol on patients' quality of life were compared during a double-blind, multicentre, parallel, randomised study of hypertension therapy." | 5.07 | Nicardipine as antihypertensive monotherapy: positive effects on quality of life. ( Champion, D; Ekelund, LG; Josselson, J; Korc, M; Pool, JL; Stein, GH; Weir, MR; Wolbach, RA, 1991) |
| "Sixty-two patients with mild hypertension were randomly assigned to receive no treatment, or 160 mg propranolol, or 200 mg metoprolol daily starting one week before elective surgery under anesthesia." | 5.07 | A pressor effect of noncardioselective beta blockers in mildly hypertensive patients during surgery under anesthesia. ( Asselt, LM; Cleophas, TJ; Oudshoorn, NH; Quadir, SU, 1991) |
| "1 mg/kg) to patients with hypertension after 3 days of randomized, double-blind pretreatment with either propranolol or placebo." | 5.07 | Acute hemodynamic effects of pinacidil in hypertensive patients with and without propranolol pretreatment. ( Liang, CS; Stone, CK; Sullebarger, JT; Wellington, KL; Willick, A, 1991) |
| "The objectives of this study were (a) to evaluate the dose-response effect of isradipine, a dihydropyridine calcium antagonist, on the heart rate and blood pressure of males with mild to moderate hypertension; and (b) to compare these results with those obtained with propranolol, a beta-adrenoceptor blocker, on a matched patient population." | 5.06 | Isotonic and isometric responses of blood pressure and heart rate in mild to moderate hypertension with isradipine and propranolol. ( Cantor, A; Cristal, N, 1990) |
| "9 kg; mean +/- SD) with arterial hypertension (WHO stages I and II) were administered single oral doses of placebo, 80 mg of propranolol, as well as 50 and 100 mg of brefanolol (a beta-adrenergic blocking agent with vasodilating properties) in order to determine the resulting hemodynamic effects." | 5.06 | Hemodynamic effects of brefanolol and propranolol assessed by noninvasive methods in patients with arterial hypertension. ( Endell, W; Halabi, A; Halabi, I; Kirch, W, 1990) |
| " The influence of long-acting propranolol and of atenolol on the circadian rhythm of heart rate was assessed using 24 h electrocardiographic recordings in elderly patients with essential hypertension." | 5.06 | Influences of propranolol and atenolol on the circadian rhythm of heart rate in elderly patients with essential hypertension. ( Sakata, S; Shimamoto, H; Shimamoto, Y, 1990) |
| "We report the results of a randomized, double-blind, parallel group multicentre study in 120 patients with moderate to severe hypertension, comparing two different types of antihypertensive treatment: a) the standard 'triple therapy' with hydrochlorothiazide, propranolol and hydralazine, and b) the combination of an ACE inhibitor, enalapril with hydrochlorothiazide (HCTZ) and methyldopa." | 5.06 | Evaluation of the efficacy and safety of enalapril plus hydrochlorothiazide plus methyldopa vs standard triple therapy in the treatment of moderate to severe hypertension: results from a multicentre study. ( Ambrosioni, E; Cinotti, G; Cuspidi, C; Leonetti, G; Malini, PL; Morabito, S; Pessina, A; Rappelli, A; Sampieri, L; Semplicini, A, 1990) |
| "This randomized, double-blind parallel study compared the effects of atenolol, captopril, enalapril and propranolol in 360 men with mild-to-moderate essential hypertension." | 5.06 | Antihypertensive therapy and quality of life: a comparison of atenolol, captopril, enalapril and propranolol. ( Friedhoff, AJ; Santo, JP; Steiner, SS; Wecker, JR; Wilson, BL, 1990) |
| "The purpose of the study was to evaluate the effect of 6 weeks treatment with hydrochlorothiazide or propranolol on gastric acid and gastrin secretion in essential hypertension." | 5.06 | [Effect of adrenergic beta receptor blockaders and thiazide diuretics on gastric acid and gastrin secretion in patients with essential hypertension]. ( Grzeszczak, W; Kokot, F; Zukowska-Szczechowska, E, 1990) |
| "The effect of anapriline, corinfar and reserpine on parameters of hemodynamics and plasma testosterone was evaluated in 60 juvenile hypertension patients who achieved pronounced hypotensive response." | 5.06 | [Effect of the treatment on hemodynamic indicators and plasma testosterone level in patients with juvenile hypertension]. ( Chernoguz, LS; Krishchuk, AA; Kupchinskaia, EG; Popova, LI; Savitskiĭ, SIu; Zanozdra, NS, 1990) |
| "We studied the effect of phenylpropanolamine on blood pressures in seven patients whose hypertension was controlled with beta blockers." | 5.06 | The effect of single-dose phenylpropanolamine on blood pressure in patients with hypertension controlled by beta blockers. ( Gross, CR; O'Connell, MB, 1990) |
| " In two, randomized, placebo-controlled, 5-way crossover trials, the pulmonary effects of celiprolol 200 and 400 mg, propranolol 40 mg and atenolol 100 mg were compared in 34 asthmatic patients." | 5.06 | Celiprolol, atenolol and propranolol: a comparison of pulmonary effects in asthmatic patients. ( Applin, WJ; Brown, R; Caruso, FS; Doshan, HD; Rosenthal, RR; Slutsky, A, 1986) |
| "A randomized double-blind study compared the antihypertensive efficacy of single daily oral doses of celiprolol 200 or 400 mg to twice daily doses of propranolol 40 or 80 mg in 58 patients with uncomplicated essential hypertension (supine diastolic blood pressure range 95-114 mm Hg)." | 5.06 | Celiprolol in the treatment of hypertension: a comparison with propranolol. ( Beattie, A; Silke, B; Taylor, SH, 1986) |
| "The bronchopulmonary effects of celiprolol were studied in 12 male asthmatic patients who showed mean maximum changes of -24% in forced one-second expiratory volume (FEV1) and 130% in airways resistance (Raw) following a single, 80 mg dose of propranolol." | 5.06 | Bronchosparing properties of celiprolol, a new beta 1, alpha 2-blocker, in propranolol-sensitive asthmatic patients. ( Applin, WJ; Braig, H; Doshan, HD; Matthys, H; Pohl, M; Rühle, KH, 1986) |
| "In order to assess the medium-term efficacy of ketanserin in comparison with that of the beta-blocker, propranolol, a randomized double-blind crossover trial was conducted involving 13 patients suffering from mild or moderate essential hypertension." | 5.06 | Ketanserin versus propranolol in the treatment of mild and moderate essential hypertension: corroboration with ambulatory blood pressure monitoring. ( Alaimo, G; Giordano, U; Novo, S; Raineri, A; Strano, A, 1987) |
| " oral propranolol (OP) was evaluated in 32 patients with mild essential hypertension (mean BP 150/95 mm Hg)." | 5.06 | Randomized, double-blind comparison of transdermal clonidine with oral propranolol. ( Dobak, JD; Franklin, SS; Kirschenbaum, MA; Tonkon, MJ, 1987) |
| "A multicenter, randomized, double-blind, comparative study was conducted in 274 patients with mild to moderate hypertension to assess the impact of nitrendipine and propranolol on quality of life." | 5.06 | Comparison of quality of life on nitrendipine and propranolol. ( Brobyn, R; Kann, J; Levy, B; Margolis, R; McMahon, FG; Reeves, R; Sperling, DC; Sweet, D; Zachariah, PK; Zager, P, 1988) |
| "The blood-pressure (BP)-lowering efficacy of sustained-release verapamil, using both clinic and ambulatory measurements, was assessed in patients with essential hypertension." | 5.06 | The efficacy and duration of action of sustained-release verapamil in essential hypertension. ( Atkins, N; Latham, AN; McCormack, PM; Mee, F; O'Brien, ET; O'Malley, K, 1989) |
| "The metabolic effects of celiprolol, a new beta-adrenoceptor blocking agent with intrinsic sympathomimetic activity and alpha 2-blocking properties, were evaluated in a series of patients with hypertension, both with and without hyperlipidemia." | 5.06 | Lipid effects of celiprolol, a new cardioselective beta-blocker, versus propranolol. ( Cremoncini, M; Dujovne, CA; Gianfranceschi, G; Johnson, B; Montanari, G; Sirtori, CR; Sirtori, M; Vaccarino, V, 1989) |
| "The efficacy of sustained-release propranolol 160 mg (Inderal LA), bendrofluazide 5 mg and the combination preparation Inderex (bendrofluazide 5 mg and Inderal LA) in the treatment of hypertension was investigated." | 5.06 | Treatment of hypertension with a fixed ratio combination of long-acting propranolol and bendrofluazide, and influence of age of the subject. ( Davis, JM; Herrick, AL; Weir, RJ, 1989) |
| "The long-term effects of prazosin and propranolol therapy were compared over the course of one year in 93 patients with mild-to-moderate hypertension." | 5.06 | Evaluation of the efficacy of prazosin versus propranolol as initial antihypertensive therapy. ( Alderman, MH, 1989) |
| "This randomized, single-blind, crossover study compared three formulations of propranolol, each given once daily for hypertension." | 5.06 | Once-daily propranolol for hypertension: a comparison of regular-release, long-acting, and generic formulations. ( Carter, BL; Gersema, LM; Schabold, K; Williams, GO, 1989) |
| "The effects of one month's treatment with each of nifedipine, verapamil, diltiazem, propranolol and placebo, given in random order, on fasting plasma glucose, haemoglobin Alc, serum fructosamine, immunoreactive insulin, cholesterol, and triglyceride were studied in a group of 19 patients with hypertension and non-insulin dependent diabetes mellitus." | 5.06 | The effects of verapamil, diltiazem, nifedipine and propranolol on metabolic control in hypertensives with non-insulin dependent diabetes mellitus. ( Chellingsworth, MC; Kendall, MJ; Pasi, J; Singh, BM; Wright, AD, 1989) |
| " A multi-center, double-blind, parallel group study compared the safety and efficacy of labetalol to propranolol in the treatment of patients with both exertional angina and mild to moderate systemic hypertension." | 5.06 | Labetalol compared with propranolol in patients with both angina pectoris and systemic hypertension: a double-blind study. ( Charlap, S; Frishman, WH; Shapiro, W, 1989) |
| "Seventeen patients with hypertension and osteoarthritis participated in a single-blind crossover study comparing the effects of sulindac 200 mg twice daily, naproxen 500 mg twice daily, and placebo on blood pressure." | 5.06 | Lack of interaction between sulindac or naproxen and propranolol in hypertensive patients. ( Day, R; Goodfriend, TL; Hiatt, JG; Kochar, M; Schuna, AA; Vejraska, BD, 1989) |
| " We evaluated the relative efficacies and tolerability of various low-dose combinations of nicardipine and propranolol in patients with mild-moderate essential hypertension (DBP Phase V of greater than 90-125 mmHg; WHO Grades I and II) in order to select the best one." | 5.06 | Comparison of the efficacy and acceptability of nicardipine and propranolol, alone and in combination, in mild to moderate hypertension. ( Dow, RJ; Gough, KJ; Laing, EM; Macdonald, FC; Maclean, D; McDevitt, DG; Mitchell, ET, 1989) |
| "Quality of life was evaluated in a four-month randomised double-blind trial of verapamil compared with propranolol in the treatment of hypertension in 94 patients in the UK." | 5.06 | The effects of verapamil and propranolol on quality of life in hypertension. ( Bulpitt, CJ; Chester, PC; Fletcher, AE; Hawkins, CM; Latham, AN; Pike, LA, 1989) |
| "The effects of bunazosin and propranolol administration on hypertension and serum levels of lipids, lipoproteins and apolipoproteins were studied in a controlled, randomized multicenter study." | 5.06 | Comparative effects of bunazosin and propranolol on serum lipids and apolipoproteins in patients with essential hypertension. ( Arakawa, K; Koga, S; Sasaki, J; Uzawa, H, 1989) |
| "The short-term continuous treatment with propranolol and nadolol, a long-acting nonselective beta-adrenoblocker without own sympathomimetic activity, conducted in two randomized groups of men with stable arterial hypertension (the diastolic AP greater than or equal to 95 mm Hg) has shown that by its hypotensive and negative chronotropic effects nadolol given in the mean dose 87 mg/day compared very favourably with propranolol administered in a dose of 144 mg/day." | 5.06 | [The comparative results of a short course of nadolol and propranolol treatment of arterial hypertension patients (cooperative research). The Working Group of the Cooperative Program for the Study of New Preparations in Preventing Arterial Hypertension]. ( , 1989) |
| " Preliminary experience suggests that the gastrointestinal therapeutic system (GITS) push-pull osmotic pump formulation of nifedipine is safe and efficacious in the treatment of hypertension." | 5.06 | The nifedipine gastrointestinal therapeutic system in the treatment of hypertension. ( Frishman, WH; Garofalo, JL; Greenberg, SM; Rothschild, A; Rothschild, M; Soberman, J, 1989) |
| "Under influence of a 6-month treatment with 75-100 mg/d propranolol (Obsidan) a significant decrease of the proportions of eicosapentaenoic acid (C20:5) in the serum was observed in 18 patients with primary hypertension stage I." | 5.06 | [Modification of vasoprotective omega-3-fatty acids--a previously unknown side effect of propranolol therapy?]. ( Mädebach, H; Reuter, W; Zander, B, 1988) |
| "We compared the central and renal haemodynamic effects of tertatolol, a new non-cardioselective beta-adrenergic blocking drug without partial agonist activity, with those of an equipotent dosage of propranolol in two groups of 10 patients each with acute cerebral injury who had developed systemic hypertension." | 5.06 | Acute central and renal haemodynamic responses to tertatolol and propranolol in patients with arterial hypertension following head injury. ( Brackman, F; Degaute, JP; Leeman, M; Naeije, R; Prost, JF, 1986) |
| "The effects of long-term (6 months) antihypertensive treatment with three different types of beta-blockers (propranolol, nonselective without ISA; pindolol, nonselective with ISA; metoprolol, beta 1-selective without ISA) on submaximal exercise capacity and metabolic variables during submaximal endurance exercise were studied in seven subjects with essential hypertension." | 5.06 | Long-term antihypertensive therapy with beta-blockers: submaximal exercise capacity and metabolic effects during exercise. ( Arends, BG; Böhm, RO; Rahn, KH; van Baak, MA; van Hooff, ME, 1987) |
| "To determine if a sustained-release form of the calcium entry blocker diltiazem would be a satisfactory substitute for the combination of beta-adrenergic blocking agent and thiazide diuretic in the treatment of systemic hypertension and angina pectoris, 38 patients were studied in a 4-center trial." | 5.06 | Efficacy and safety of sustained-release diltiazem as replacement therapy for beta blockers and diuretics for stable angina pectoris and coexisting essential hypertension: a multicenter trial. ( Kawanishi, DT; Leman, RB; O'Rourke, RA; Pratt, CM, 1987) |
| "Twenty-four men with mild essential hypertension were assigned randomly to receive propranolol (n = 9), atenolol (n = 7), or a placebo (n = 8)." | 5.06 | Effects of beta-blockade and exercise on cardiovascular and cognitive functioning. ( Blumenthal, JA; Ekelund, LG; Madden, DJ, 1988) |
| " The Study Group evaluated its therapeutic utility (100-300 mg bid) compared with propranolol (80-240 mg bid) in 266 patients with mild to moderate essential hypertension (WHO Grades I and II, sitting diastolic blood pressure (DBP) greater than or equal to 95 mmHg)." | 5.06 | Bevantolol vs propranolol: a double-blind controlled trial in essential hypertension. ( Maclean, D, 1988) |
| "A double-blind, multicenter study compared the safety and efficacy of oral betaxolol 10 to 40 mg once daily (n = 68) with propranolol 40 to 160 mg twice daily (n = 73) in the treatment of mild to moderate essential hypertension." | 5.06 | Comparison of betaxolol, a new beta 1-adrenergic antagonist, to propranolol in the treatment of mild to moderate hypertension. ( Cangiano, J; Davidov, ME; Glazer, N; Wollam, G; Zager, PG, 1988) |
| "The safety and efficacy of ketanserin, a competitive serotonin blocking agent, and propranolol were compared in 33 patients with mild to moderate hypertension (sitting diastolic blood pressure [DBP] 95-115 mm Hg) using a placebo run-in, randomized, double-blind parallel study design." | 5.06 | Serotonergic blockade compared with beta-adrenergic blockade in systemic hypertension: a double-blind comparison of ketanserin with propranolol. ( Charlap, S; Frishman, WH; Greenberg, S; Huberfeld, SI; Laifer, L; Lapsker, J; Okin, S; Soberman, J; Strom, JA, 1988) |
| "In an open crossover comparison of propranolol and nitrendipine, 19 patients with hypertension received 40 to 160 mg propranolol and 5 to 20 mg nitrendipine twice a day." | 5.06 | Hemodynamic and metabolic effects of the calcium channel blocking agent nitrendipine. ( Johnson, BF; Marwaha, R; Romero, L, 1986) |
| " A trial was carried out on medium-term treatment with ketanserin or propranolol in subjects suffering from mild to moderate hypertension." | 5.06 | Effects of ketanserin on ambulatory blood pressure monitoring in patients with essential hypertension. ( Abrignani, MG; Alaimo, G; Cutietta, A; Novo, S; Raineri, A; Strano, A, 1986) |
| "The safety and antihypertensive efficacy of PN 200-110 (isradipine), a novel calcium antagonist, are discussed in a preliminary report of double-blind, multicenter, controlled, phase III clinical trials for essential hypertension." | 5.06 | Treatment of essential hypertension with PN 200-110 (isradipine). ( Hamilton, BP, 1987) |
| "The antihypertensive efficacy of timed-release diltiazem was compared with propranolol in a randomized, double-blind study of 40 patients with mild to moderate hypertension." | 5.06 | Diltiazem-induced left ventricular mass regression in hypertensive patients. ( Bent, B; Weiss, RJ, 1987) |
| "In 40 patients with essential hypertension, enalapril was compared with propranolol as an antihypertensive agent in a double-blind study." | 5.06 | Comparison of enalapril and propranolol in essential hypertension. ( Boer, P; Geyskes, GG; Kettner, N; Mees, EJ; van Schaik, BA, 1986) |
| "Ten patients with uncomplicated moderate essential hypertension were recruited to evaluate the effect of the non-selective beta-blocker propranolol and the beta 1-selective beta-blocker metoprolol on platelet aggregation and cAMP formation." | 5.06 | Effect of metoprolol and propranolol on platelet aggregation and cAMP level in hypertensive patients. ( Gormsen, J; Jensen, J; Knudsen, JB; Winther, K, 1986) |
| " We studied 10 white patients with mild essential hypertension in a randomized, double-blind design to assess the effects of indomethacin with or without the addition of propranolol on blood pressure and vascular prostacyclin biosynthesis, as assessed by the urinary excretion of the major enzymatically produced metabolite of prostacyclin, 2,3-dinor-6-keto-prostaglandin F1 alpha (PGF1 alpha), F1 alpha (PGF1 alpha), measured by gas chromatography-mass spectrometry." | 5.06 | Propranolol increases prostacyclin synthesis in patients with essential hypertension. ( Beckmann, ML; Byyny, RL; Gerber, JG; LoVerde, M; Nies, AS, 1988) |
| "The efficacy, safety and toleration of sustained release verapamil (Securon SR, Knoll) and long acting propranolol (Inderal LA, ICI) in the treatment of mild to moderate hypertension were compared in a randomized, double-blind, parallel group study." | 5.06 | Verapamil SR and propranolol LA: a comparison of efficacy and side effects in the treatment of mild to moderate hypertension. ( Bochsler, JA; Chester, PC; Latham, AN; Simmons, RL; Ward, PJ, 1988) |
| "To clarify the antihypertensive effect, safety and clinical usefulness of ketanserin, a comparative double-blind study was carried out in 277 patients with essential hypertension using propranolol as a control drug." | 5.06 | Comparative double-blind study of ketanserin versus propranolol in the treatment of essential hypertension. ( Iimura, O; Ikeda, M; Ishii, M; Ito, K; Kaneko, Y; Masuyama, Y; Mizuno, Y; Omae, T; Takeda, T; Yoshinaga, K, 1988) |
| " Twenty-six adult men with mild essential hypertension received either a placebo or a beta blocker (atenolol or propranolol) for 2 weeks." | 5.06 | Memory performance by mild hypertensives following beta-adrenergic blockade. ( Blumenthal, JA; Ekelund, LG; Krantz, DS; Light, KC; Madden, DJ; McKee, DC, 1986) |
| "A comparative study between prazosin and propranolol with twenty male patients with mild to moderate essential hypertension was used to study the effects of these antihypertensive agents on plasma lipoproteins, and more specifically high density lipoproteins-2 and Apo A-I." | 5.06 | Effect of prazosin and propranolol on lipoproteins of hypertensive patients. ( Camejo, G; Hurt, E; Silva, H; Velasco, M, 1987) |
| "The effects of captopril, methyldopa, and propranolol hydrochloride on reported distress over sexual symptoms over a 24-week treatment period were examined as part of a multicenter, randomized, double-blind clinical trial in which 626 men with mild to moderate hypertension participated." | 5.06 | Sexual symptoms in hypertensive patients. A clinical trial of antihypertensive medications. ( Baume, RM; Clive, J; Croog, SH; Levine, S; Sudilovsky, A, 1988) |
| "Eighty one patients with uncomplicated hypertension who required additional antihypertensive medication (diastolic Phase V [dBP] greater than or equal to 95 mm Hg) after 4 weeks treatment with hydrochlorothiazide (HCTZ) 25 mg o." | 5.06 | A comparison of felodipine and propranolol as additions to hydrochlorothiazide in the treatment of hypertension. ( Carle, WK; Latta, D; Lees, CT; Lough, JR; Peers, EM; Pender, J; Richardson, PD; Ross, JR; Sefton, S, 1988) |
| "The effects of captopril, methyldopa, and propranolol were assessed for sense of well-being and vitality among 626 men with mild to moderate hypertension in a multicenter, randomized, double-blind clinical trial." | 5.06 | Effects of antihypertensive medications on vitality and well-being. ( Croog, SH; Levine, S; Sudilovsky, A; Testa, MA, 1987) |
| "A double-blind parallel group study was conducted to examine the effects of oral labetalol, in doses from 100 to 800 mg BID, and propranolol, 40 to 320 mg, in patients with mild to moderate hypertension." | 5.06 | Labetalol compared with propranolol in the treatment of black hypertensive patients. ( Curry, C; Hinds, J; Kong, BW; Medakovic, M; Poland, M; Roper, K; Saunders, E, 1987) |
| "Thirty patients with mild to moderate essential hypertension entered a randomised double-blind parallel group study for 6 months to compare the effects of the new calcium channel blocker nicardipine 90 mg/day and propranolol 240 mg/day." | 5.06 | Nicardipine in the treatment of essential hypertension controlled 6-month-study comparing nicardipine with propranolol at rest and during exercise. ( Bjerle, P; Danielsson, A; Ek, B; Steen, L; Suhr, O, 1987) |
| "In a double-blind controlled trial 22 patients with mild or moderate essential hypertension were treated with nicardipine 30 mg t." | 5.06 | Comparison of nicardipine and propranolol in the treatment of mild and moderate hypertension. ( Karppinen, K; Naukkarinen, VA; Sarna, S, 1987) |
| "The influences of verapamil, propranolol and their combination on blood pressure and heart rate during cold pressor testing and isometric exercise were examined in 13 patients with essential hypertension." | 5.06 | Effects of calcium antagonism and beta-blockade on haemodynamic responses to stress. ( Dargie, HJ; Findlay, IN; McInnes, GT; Murray, GD, 1987) |
| " Haemodynamic changes during the onset of the antihypertensive action of pindolol, 10 mg twice daily, and propranolol, 80 mg three times daily, were studied for 24 h in two groups of 10 patients with uncomplicated essential hypertension." | 5.06 | Comparison of the onset of the antihypertensive action of pindolol and propranolol. A 24 h haemodynamic study. ( Man in't Veld, AJ; Schalekamp, MA; van den Meiracker, AH, 1987) |
| "The efficacy and safety of nifedipine in a gastrointestinal therapeutic system (GITS) push-pull osmotic pump formulation was compared with long-acting propranolol in 49 patients with mild to moderate hypertension already receiving diuretics." | 5.06 | Multicenter comparison of the nifedipine gastrointestinal therapeutic system and long-acting propranolol in patients with mild to moderate systemic hypertension receiving diuretics. A preliminary experience. ( Frishman, WH; Garofalo, JL; Greenberg, SM; Rothschild, A; Rothschild, M; Soberman, J, 1987) |
| "We have carried out randomized 12-week multicentre study to compare the effects of prazosin and propranolol on blood pressure and serum lipids in 70 patients with essential hypertension after a 4 week minimum period of treatment with thiazide diuretics." | 5.06 | The effects of prazosin and propranolol in combination with thiazide diuretics on blood pressure and serum lipids: a multicentre study. ( Abe, A; Fujimori, I; Fukui, T; Goto, Y; Iyori, S; Maeda, T; Ogasawara, Y; Takei, Y; Tamura, T; Tanabe, T, 1987) |
| " Verapamil is such a drug, but its clinical role in the management of hypertension is not clear." | 5.06 | Twice-daily verapamil for hypertension: a comparison with propranolol. ( Gould, BA; Hornung, RS; Jones, RI; Raftery, EB; Sonecha, T, 1986) |
| "The clinical effect of the peripheral vasodilator prazosin (Adwersuten, GDR) was studied in 51 patients with second-stage essential hypertension." | 5.06 | [Analysis of hypotensive and hemodynamic effects of prazosin in patients with hypertension]. ( Dobrotvorskaia, TE; Ostapiuk, FE; Samofanova, MS; Shengeliia, RG, 1986) |
| "After a clinical trial was completed in which two commonly used antihypertensive agents (prazosin and propranolol) were compared, 20 previously untreated men with moderate, asymptomatic, essential hypertension returned to the care of their general practitioners." | 5.06 | Effect of trial therapy on subsequent therapy. A review of patients with hypertension who have completed a pharmacological intervention study. ( Carney, SL; Floate, LF; Gillies, AH; Smith, AJ, 1986) |
| "We conducted a multicenter randomized double-blind clinical trial among 626 men with mild to moderate hypertension to determine the effects of captopril, methyldopa, and propranolol on their quality of life." | 5.06 | The effects of antihypertensive therapy on the quality of life. ( Brown, B; Bulpitt, CJ; Croog, SH; Jenkins, CD; Klerman, GL; Levine, S; Testa, MA; Williams, GH, 1986) |
| "The effects of oral nitrendipine and oral propranolol, alone and in combination, on AV conduction have been examined in 11 patients with essential hypertension in whom arterial pressure was not adequately controlled despite treatment with thiazide diuretics." | 5.06 | The effects of oral nitrendipine and propranolol, alone and in combination, on hypertensive patients with special reference to AV conduction. ( Banim, SO; Camm, AJ; Creamer, JE; Davies, DW; Lau, CP; Maltz, MB, 1986) |
| "Penbutolol and propranolol were administered orally in a dosage of 40 mg once daily and 80 mg twice daily, respectively to 12 patients with hypertension and impaired renal function." | 5.06 | Comparison of the effects of penbutolol and propranolol on glomerular filtration rate in hypertensive patients with impaired renal function. ( Donker, AJ; Heidendal, GA; Oe, PL; Reijn, E; van der Meulen, J, 1986) |
| "Thirty-two patients with mild to moderate essential hypertension completed this double-blind cross-over clinical trial of propranolol and metoprolol." | 5.06 | Double-blind, randomized, cross-over clinical trial of metoprolol and propranolol in mild to moderate essential hypertension. ( Pandhi, P; Sahai, J; Sharma, BK; Sharma, PL; Wahi, PL, 1987) |
| "In a single-blind, placebo-controlled crossover study the effects of verapamil (450 +/- 30 mg/day) and propranolol (160 +/- 20 mg/day) on endurance time during submaximal exercise were compared in eight patients with essential hypertension." | 5.06 | The effects of verapamil and propranolol on exercise tolerance in hypertensive patients. ( Böhm, R; Does, R; Mooy, J; Petri, H; Rahn, KH; van Baak, M; van Kemenade, J, 1987) |
| "The antihypertensive efficacy of propranolol in the treatment of mild hypertension was significantly impaired in cigarette smokers, whereas that of bendrofluazide was not affected by smoking habit." | 5.06 | The relationship between smoking and the response to anti-hypertensive treatment in mild hypertensives in the Medical Research Council's trial of treatment. ( Brennan, PJ; Greenberg, G; Thompson, SG, 1987) |
| "The effects of the nonselective beta blocker, propranolol, on coarctectomy-induced hypertension were evaluated relative to changes in cardiac function, sympathetic tone, and plasma renin activity (PRA)." | 5.06 | Postoperative hypertension after repair of coarctation of aorta in children: protective effect of propranolol? ( Balfe, JA; Balfe, JW; Barker, GA; Leenen, FH; Olley, PM; Pelech, AN, 1987) |
| "The effect of 2 weeks treatment with propranolol or metoprolol on skin blood flow (SBF) at rest was examined in 12 diabetic patients with essential hypertension in whom gross large vessel disease had been excluded." | 5.06 | The effects of propranolol and metoprolol on skin blood flow in diabetic patients. ( Barham, J; Hyer, SL; Shaw, J; Taylor, D; Vince, FP; Wilson, J, 1987) |
| " Therefore, the effects of 4-week treatment periods with verapamil and propranolol on metabolic parameters during an endurance bicycle ergometer test were studied in eight patients with mild to moderate essential hypertension." | 5.06 | Metabolic effects of verapamil and propranolol during submaximal endurance exercise in patients with essential hypertension. ( Böhm, RO; Petri, J; Rahn, KH; van Baak, MA, 1987) |
| "A twelve-week parallel study was conducted to compare the efficacy and safety of nicardipine plus propranolol with that of propranolol alone in 67 patients with mild to moderate essential hypertension." | 5.06 | Comparison of concomitant nicardipine hydrochloride and propranolol with propranolol alone in patients with essential hypertension. ( Douglas-Jones, AP; Havard, CW; Nievel, JG, 1987) |
| "The pharmacodynamic effects of single oral doses of atenolol (100 mg), labetalol (300 mg), and propranolol (80 mg) were compared with those of placebo in a randomized, double-blind, Latin square design in 12 patients with hypertension." | 5.06 | The effects of single-dose atenolol, labetalol, and propranolol on cardiac and vascular function. ( Berry, DA; Finley, D; Holtzman, JL; Johnson, B; Sirgo, MA, 1986) |
| "The efficacy of MK-421 was compared with that of propranolol in patients with mild to moderate essential hypertension, using a placebo-controlled double-blind randomized protocol." | 5.05 | Effect of oral MK-421 and propranolol on the forearm arterial circulation in essential hypertension: a preliminary report. ( Levenson, JA; Maarek, BE; Safar, ME; Simon, AC, 1983) |
| "In a double-blind crossover study, it has been shown that the hypotensive response to propranolol in 24 patients with essential hypertension was no greater at doses of 80, 160, or 240 mg twice daily than at 40 mg twice daily." | 5.05 | Propranolol in the control of blood pressure: a dose-response study. ( Baber, NS; Breckenridge, A; Laws, E; Orme, ML; Serlin, MJ; Sibeon, RG, 1980) |
| "The antihypertensive effect and metabolic side effects of bendroflumethiazide have been compared with those of propranolol in two randomly selected groups, of 53 previously untreated middle-aged men during 6 years' treatment for mild to moderately severe essential hypertension." | 5.05 | beta-blockers or diuretics in hypertension? A six year follow-up of blood pressure and metabolic side effects. ( Andersson, O; Berglund, G, 1981) |
| "Participants in the Medical Research Council treatment trial for mild hypertension are randomly allocated to one of four treatment groups: bendrofluazide, propranolol, or a placebo for either of these drugs." | 5.05 | Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Report of Medical Research Council Working Party on Mild to Moderate Hypertension. ( , 1981) |
| "Two beta-blocking agents, non-selective propranolol and beta1-selective metoprolol, were investigated with respect to their effects on glucose metabolism in 10 hypertensive patients with non-insulin dependent diabetes mellitus (NIDDM)." | 5.05 | Influence of beta-blocking drugs on glucose metabolism in patients with non-insulin dependent diabetes mellitus. ( Gordin, A; Groop, L; Harno, K; Tötterman, KJ, 1982) |
| "The mechanisms of the changes in plasma lipids concentrations observed after beta-blockade were examined in 53 patients with hypertension receiving treatment with atenolol, metoprolol, propranolol, and oxprenolol in a randomised cross-over trial." | 5.05 | Adrenergic mechanisms in control of plasma lipid concentrations. ( Day, JL; Metcalfe, J; Simpson, CN, 1982) |
| "The relative efficacies of oral verapamil, a calcium-entry blocking drug, and propranolol, a beta-adrenergic blocking drug, were compared in 12 patients who had both stable angina pectoris and mild to moderate systemic hypertension, using a placebo-controlled, double-blind, randomized crossover protocol." | 5.05 | Comparison of oral propranolol and verapamil for combined systemic hypertension and angina pectoris. A placebo-controlled double-blind randomized crossover trial. ( Frishman, WH; Klein, NA; Klein, P; LeJemtel, TH; Pollack, S; Roth, S; Sonnenblick, EH; Strair, R; Strom, JA; Tawil, R; Wong, B, 1982) |
| "The effect of a four-week treatment with propranolol and metoprolol on blood pressure and regional haemodynamics of the lower extremity at rest, after exercise and during reactive hyperaemia was studied in 34 patients with essential hypertension, but without peripheral arterial disease, in a randomized placebo-controlled trial." | 5.05 | Effect of long-term beta-adrenergic-blockade on calf blood flow in hypertensive patients. ( Lepäntalo, M; Tötterman, KJ, 1983) |
| "9 years) with mild to moderate essential hypertension a comparison between equipotent beta-blocking doses of propranolol, metoprolol and labetalol was carried out." | 5.05 | Propranolol vs metoprolol vs labetalol: a comparative study in essential hypertension. ( Coote, JH; Kubik, MM, 1984) |
| "The effect of 4-6 weeks' treatment with propranolol and nadolol on effective renal plasma flow (ERPF) and glomerular filtration rate (GFR) was studied, in 14 patients with essential hypertension, in single blind, random and cross-over design." | 5.05 | Comparison between short-term renal haemodynamic effects of propranolol and nadolol in essential hypertension: a cross-over study. ( Brunton, J; Danesh, BJ; Sumner, DJ, 1984) |
| "The effects of minoxidil used in combination with propranolol were assessed in the management of moderate hypertension." | 5.05 | Minoxidil in the management of moderate hypertension. ( Alleyne, GA; Nicholson, GD; Valdes, G; Westerman, RL, 1980) |
| "The effects of propranolol and prazosin on plasma lipoproteins in patients with essential hypertension were evaluated according to a crossover protocol of two 8-week periods with a washout of 4 to 6 weeks." | 5.05 | Plasma lipid and lipoprotein changes in hypertensive patients treated with propranolol and prazosin. ( Franceschini, G; Gemma, G; Mantero, O; Montanari, G; Paralovo, A; Sirtori, CR; Suppa, G, 1982) |
| "The effects of captopril and propranolol on blood pressure, heart rate and plasma noradrenaline, renin and aldosterone, and on the responses to changes in posture and to isometric exercise were measured in patients with essential hypertension." | 5.05 | The effect of captopril and propranolol on the responses to posture and isometric exercise in patients with essential hypertension. ( Goodwin, FJ; Holly, JM; Marsh, FP; Sharman, VL; Vandenburg, MJ, 1983) |
| "The efficacy of MK 421 and propranolol was compared in 48 patients with mild to moderate hypertension." | 5.05 | Comparison of oral MK 421 and propranolol in mild to moderate essential hypertension and their effects on arterial and venous vessels of the forearm. ( Achimastos, A; Benetos, A; Bouthier, JD; Fouchard, M; Levenson, JA; Maarek, BC; Safar, ME; Simon, AC, 1984) |
| "We report the first comparative study on enalapril maleate, a new angiotensin converting enzyme inhibitor, in patients with uncomplicated mild to moderate essential hypertension." | 5.05 | Enalapril in essential hypertension: a comparative study with propranolol. Enalapril in Hypertension Study Group (UK). ( , 1984) |
| "24 mg/day) and propranolol (average 105 mg/day) on home blood pressure readings in 16 patients with borderline hypertension was investigated in a randomized, double-blind, placebo crossover design." | 5.05 | Use of clonidine and propranolol as monotherapy in borderline hypertension. ( Cottier, C; Julius, S, 1983) |
| "In eight patients with normal-renin, moderate hypertension, the antihypertensive effects of increasing doses of propranolol (80, 160, 320 and, in three patients, 640 mg/day, each dose for 2 weeks) were evaluated at rest and during exercise in relation to the degree of beta-adrenoceptor blockade induced." | 5.05 | Antihypertensive effect of propranolol at rest and during exercise. ( Boer, P; Dorhout Mees, EJ; Leenen, FH, 1983) |
| "The Beta-Blocker Heart Attack Trial (BHAT) was a multicenter, randomized, double-blind, placebo-controlled trial that tested the effectiveness of propranolol in reducing the mortality rate in patients after myocardial infarction (MI)." | 5.05 | Effect of propranolol on ventricular arrhythmia. The beta-blocker heart attack trial experience. ( Harrist, R; Hubble, E; Lichstein, E; Morganroth, J, 1983) |
| "The efficacy of a propranolol-hydralazine combination tablet was compared with that of each of its two components in the twice-daily treatment of mild to moderate essential hypertension (diastolic blood pressure: 100 to 125 mmHg)." | 5.05 | Propranolol-hydralazine combination in essential hypertension. ( Binstok, G; del Greco, F; Huang, C; Morledge, JH; Mullane, JF; Pittman, AW; Stevens, JD; Woods, JW, 1983) |
| "An open study was carried out to assess the efficacy of indoramin used as second step therapy in 30 patients with moderate to severe hypertension who had failed to respond adequately to monotherapy with a thiazide or beta-blocker." | 5.05 | Indoramin as second step therapy in the management of benign essential hypertension. ( Gherardi, S; Manzoli, U; Mazzari, M; Montenero, AS; Schiavoni, G, 1983) |
| "This report describes a double-blind, parallel, comparative study of trimazosin (+/- polythiazide) and propranolol (+/- polythiazide) in 130 patients with essential hypertension." | 5.05 | Double-blind comparison of trimazosin and propranolol in essential hypertension. ( Helgeland, A, 1983) |
| "Twenty-seven patients with uncontrolled hypertension (diastolic blood pressure greater than or equal to 95 mm Hg) receiving thiazide diuretics were treated with the addition of either propranolol (n = 10) or prazosin (n = 17)." | 5.05 | Comparison of blood pressure, plasma lipid and cardiac performance responses to prazosin versus propranolol in thiazide-treated hypertensive patients. ( Cutler, RE; Merkel, T; Misson, R, 1984) |
| "In a double-blind study, patients with moderate to severe essential hypertension were treated randomly with either indoramin or propranolol orally." | 5.05 | A double-blind comparison of indoramin and propranolol in the treatment of moderate to severe essential hypertension. ( Antani, J; Buckle, JW; Cohen, M; Turner, J, 1983) |
| "A multi-centre, single-blind trial was carried out in general practice to compare the therapeutic efficacy, tolerance and compliance of penbutolol and long-acting propranolol, both given once daily, in patients with mild to moderate hypertension." | 5.05 | Single-blind comparison of penbutolol and long-acting propranolol in general practice. ( Hayes, G, 1983) |
| "The antihypertensive action of prazosin and propranolol, as well their effect on serum lipid levels, were evaluated in a crossover study in 20 men with untreated mild to moderate hypertension in a general practice environment." | 5.05 | Changes in serum lipid levels during antihypertensive therapy. ( , 1984) |
| "A prospective study of propranolol versus chlorthalidone has been performed in eleven patients with renal hypertension and one with essential hypertension." | 5.05 | Propranolol versus chlorthalidone--a prospective therapeutic trial in children with chronic hypertension. ( Bachmann, H, 1984) |
| " Their clinical place in the management of hypertension has yet to be clearly defined, and thus we have performed an open crossover trial to compare the 24-hour profiles of blood pressure reduction after chronic therapy with propranolol and verapamil." | 5.05 | Propranolol versus verapamil for the treatment of essential hypertension. ( Gould, BA; Hornung, RS; Jones, RI; Raftery, EB; Sonecha, T, 1984) |
| "Seventy-four patients from four short-term studies of captopril in mild-moderate essential hypertension continued in a cooperative long-term efficacy and tolerance program." | 5.05 | A long-term follow-up of patients with essential hypertension treated with captopril. ( Asplund, J; Aurell, M; Conradsson, T; Delin, K; Forslund, T; Frithz, G; Fyhrquist, F; Herlitz, H; Karlberg, B; Ohman, P, 1984) |
| "The effects of prazosin and propranolol on total serum cholesterol concentration, low-density lipoprotein and high-density lipoprotein cholesterol fractions, and serum triglyceride concentration were compared in a crossover study in 29 patients with mild to moderate essential hypertension." | 5.05 | Effects of prazosin and propranolol on serum lipids in patients with essential hypertension. ( Lowenstein, J; Neusy, AJ, 1984) |
| " This possibility has been investigated in 12 patients with hypertension by infusing increasing intravenous doses of phenylephrine after 2 wk on propranolol, metoprolol, or placebo within a randomized, double-blind, crossover study design." | 5.05 | Beta adrenoceptor antagonism and pressor response to phenylephrine. ( Myers, MG, 1984) |
| "We compared hydrochlorothiazide and propranolol hydrochloride for monotherapy of hypertension by a double-blind study of 683 men who were titrated to less than 90 mm Hg diastolic BP or to 640 mg of propranolol or 200 mg of hydrochlorothiazide." | 5.05 | Comparison of propranolol and hydrochlorothiazide for thr initial treatment of hypertension. I. Results of short-term titration with emphasis on racial differences in response. Veterans Administration Cooperative Study Group on Antihypertensive agents. ( , 1982) |
| "An open, randomized crossover study was carried out in 8 patients with accelerated hypertension to compare the antihypertensive efficacy of oxprenolol with that of propranolol." | 5.05 | Comparison of antihypertensive efficacy: propranolol versus oxprenolol in accelerated hypertension. ( Fernandez, PG; Galway, AB; Granter, S; Kim, BK; Sharma, JN; Zachariah, PK, 1982) |
| "The acute effects of oral administration of niludipine (Bay a 7168), a new dihydropyridine derivative Ca2+-antagonist, on blood pressure (BP), hemodynamics and plasma renin activity (PRA) were investigated in patients with essential hypertension (n = 28) and normotensive volunteers (n = 7)." | 5.05 | Acute hypotensive, hemodynamic effects of long-term treatment with niludipine, a Ca2+-antagonist, in patients with essential hypertension. Niludipine monotherapy and combination with a beta-blocker and a diuretic). ( Aoki, K; Sato, K, 1982) |
| "The effect of once daily conventional or long acting propranolol on blood pressure was examined in a double-blind crossover trial in 15 patients with moderate hypertension previously responsive to beta-blocking drugs." | 5.05 | Single dose administration of propranolol in hypertension: a comparison of two formulations using clinic and home blood pressure measurements. ( Beilin, LJ; Lalor, C; Vandongen, R; Wall, BP, 1982) |
| "A double-blind crossover trial was undertaken to compare the efficacy of sustained-release clonidine and long-acting propranolol in the treatment of 20 patients (8 males and 12 females) with sustained hypertension." | 5.05 | Comparison of sustained-release clonidine and long-acting propranolol in the treatment of hypertension. ( Lawson, AA; Rodrigues, E, 1982) |
| "Prazosin was compared with hydralazine in 39 patients (mean age 49 years), who were already on beta-blockade for arterial hypertension." | 5.05 | Peripheral vasodilatation in the treatment of hypertension. Prazosin compared with hydralazine in patients not responding to beta-receptor blockade. ( Fagerberg, SE; Frithz, G; Malmberg, L, 1982) |
| "The clinical efficacy of propranolol and metoprolol slow-release tablets (Durules) was compared in 20 patients with typical angina pectoris and concomitant hypertension." | 5.05 | Metoprolol in angina pectoris complicated by essential hypertension. A clinical comparison of the antianginal efficacy of metoprolol slow-release tablets (Durules) given once daily and propranolol tablets given twice daily. ( BLoem, TJ; Lindner, PC, 1981) |
| "Twenty-four patients with moderate to severe hypertension were treated for four weeks with captopril, an oral inhibitor of angiotensin-converting enzyme." | 5.05 | Captopril in essential hypertension; contrasting effects of adding hydrochlorothiazide or propranolol. ( Banks, RA; Bayliss, J; Jones, JC; MacGregor, GA; Markandu, ND; Roulston, JE, 1982) |
| "Intra-arterial ambulatory blood pressure was measured over 24 hours, in 34 patients with newly diagnosed hypertension, both before and after double-blind randomisation to treatment with atenolol (n=9), metoprolol (n=9), pindolol (n=9), or propranolol in its slow-release form (n=7)." | 5.05 | Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol. ( Floras, JS; Hassan, MO; Jones, JV; Sleight, P, 1982) |
| "We compared propranolol with methyldopa in a randomized prospective study of 28 women with pregnancy associated hypertension." | 5.05 | Propranolol in pregnancy three year prospective study. ( Bevan, EB; Craswell, PW; Eadie, MJ; Livingstone, I; Smith, MT, 1983) |
| " In a double-blind cross-over study the antihypertensive action and side-effects of labetalol and propranolol were compared in 18 previously untreated outpatients with hypertension, WHO stage I--III." | 5.05 | Labetalol in the treatment of hypertension in patients with normal and impaired renal function. ( Berg, KJ; Nilsen, OG; Walstad, RA; Wessel-Aas, T, 1982) |
| "Eleven patients with essential hypertension participated in a double-blind cross-over comparison of labetalol (L) and propranolol (P)." | 5.05 | Effects of labetalol and propranolol on the peripheral circulation in hypertensive patients. ( Berglund, G; Nyberg, G, 1982) |
| "1 Labetalol has been compared with propranolol in a double-blind, double-dummy study of 24 patients with mild or moderate essential hypertension." | 5.05 | Comparison of labetalol and propranolol in hypertension. ( Bulpitt, CJ; Butler, AG; Husaini, MH; Nicholls, DP; Stephens, MD, 1980) |
| " To compare the effects of long-term administration of oxprenolol on hypertension and hemodynamics with the effects of propranolol, 20 patients with essential hypertension were divided in a double-blind random manner into two 10-patient groups and given placebo for 2 wk, followed by equipotent doses of oxprenolol or propranolol for 5 wk and by placebo for another 2 wk." | 5.05 | Antihypertensive and hemodynamic effects of oxprenolol versus propranolol. ( Aronow, WS; Easthope, JL; Ferlinz, J; Hughes, D; Siegel, J; Tobis, J, 1980) |
| "1 The effects of propranolol and atenolol given in random order in a cross-over study to fifteen patients with essential hypertension have been studied." | 5.05 | A study of the effects of atenolol and propranolol on renal function in patients with essential hypertension. ( Harry, JD; Hawkins, T; Kerr, DN; Pickering, M; Robson, V; Stevens, IM; Wilkinson, R, 1980) |
| " A double-blind cross-over comparison of penbutolol given in a single daily dose and propranolol given twice daily in the treatment of ambulant patients with moderate hypertension is described." | 5.05 | Single daily dose penbutolol in the treatment of hypertension: a double blind crossover comparison with propranolol. ( Hanks, GW; Kubik, MM, 1980) |
| "The antihypertensive effects of the oral converting enzyme inhibitor captopril and of propranolol were evaluated in a single-blind trial of 12 weeks in 19 ambulatory men with moderated essential hypertension (supine diastolic blood pressure [DPB], 100 to 120 mm Hg after receiving placebo for two weeks) whose sodium intake was unrestricted." | 5.05 | Comparison of antihypertensive effects of captopril and propranolol in essential hypertension. ( del Greco, F; Huang, CM; Molteni, A; Quintanilla, A, 1981) |
| "Atenolol, Pindolol and Propranolol in single daily doses administered to 18 selected patients with mild essential hypertension achieved adequate control of blood pressure." | 5.05 | Beta adrenoreceptor-blocking drugs once daily in essential hypertension: a comparison of propranolol, pindolol and atenolol. ( England, JD, 1981) |
| "After a two-week run-in period on placebo, fifty-two patients with benign essential hypertension (WHO classes I or II) were treated with individually titrated doses of metoprolol or propranolol for 36 weeks." | 5.05 | Metoprolol and propranolol in the treatment of essential hypertension - a long-term comparative study. ( Sjöberg, KH, 1981) |
| "Thirty patients with mild or moderate essential hypertension, and a fixed elevation of diastolic blood pressure, were randomly allocated to three groups and treated with propranolol 40 mg x 4 (Group 1), 80 mg x 4 (group 2) and 160 mg x 4 (Group 3)." | 5.05 | Correlation between propranolol in plasma and urine, renin-aldosterone system and blood pressure in essential hypertension. ( Andreasen, F; Bjerregaard, P; Kornerup, HJ; Pedersen, EB; Pedersen, OL, 1981) |
| "The effect of a propranolol-hydrochlorothiazide combination tablet was compared with the effects of its two components alone in the twice-daily treatment of mild to moderate essential hypertension (100 to 125 mmHg diastolic blood pressure)." | 5.05 | Propranolol-hydrochlorothiazide combination in essential hypertension. ( Mullane, JF; Stevens, JD, 1982) |
| "Pulmonary function was measured serially in two separate randomized trials of pindolol in the treatment of essential hypertension." | 5.05 | Pulmonary function in hypertensive patients treated with pindolol: a report of two studies. ( Hamilton, BP; Hamilton, J; Kirkendall, WM, 1982) |
| "More than 1200 patients who received pindolol for the treatment of hypertension, angina pectoris, and various arrhythmias in studies conducted in the United States were included in the New Drug Application submitted to the FDA." | 5.05 | Adverse reactions to pindolol administration. ( Gonasun, LM; Langrall, H, 1982) |
| "The effects of metropolol (beta 1-selective), propranolol (nonselective) and clonidine (central alpha-stimulant) on plasma norepinephrine, blood pressure and heart rate were assessed at rest, during isometric work and dynamic exercise in 15 patients with moderate hypertension." | 5.05 | Response of blood pressure and plasma norepinephrine to propranolol, metoprolol and clonidine during isometric and dynamic exercise in hypertensive patients. ( Frick, MH; Jänne, J; Virtanen, K, 1982) |
| "1 Pindolol and propranolol were administered orally in equipotent antihypertensive doses to 14 subjects with mild to moderate hypertension in an open cross-over study." | 5.05 | Effect of pindolol and propranolol on renal function of patients with hypertension. ( Pasternack, A; Pörsti, P; Pöyhönen, L, 1982) |
| "1 The effects of oxprenolol and propranolol on peripheral blood flow were compared in patients with mild and moderate essential hypertension." | 5.05 | The acute and chronic effect of oxprenolol and propranolol on peripheral blood flow in hypertensive patients. ( Vandenburg, MJ, 1982) |
| "The antihypertensive effect of propranolol, in fixed combinations with two dosages of triamteren and hydrochlorothiazide (Dociteren), was evaluated in a double-blind test on 19 patients with uncomplicated essential hypertension." | 5.05 | [Propranolol, triamteren and hydrochlorothiazide in fixed combinations in the treatment of hypertension (author's transl)]. ( Herrmann, JM; Hiemstra, S; Hoenig, B, 1981) |
| "Forty patients completed a double-blind parallel group study comparing furosemide (FUR) and hydrochlorothiazide (HCT) when added to a stable dose of beta blocker in the treatment of mild to moderate hypertension." | 5.05 | Controlled comparison of the effects of furosemide and hydrochlorothiazide added to propranolol in the treatment of hypertension. ( Dombey, SL; Lawrence, J; Vander Elst, E; Vlassak, W, 1981) |
| "The effect of conventional propranolol and bendrofluazide tablets given twice daily has been compared with an equivalent dosage combined in a single capsule given twice daily in fourteen patients with essential hypertension." | 5.05 | Treatment of essential hypertension with a combination of propranolol and bendrofluazide. ( Dawes, PM; Solomon, LR, 1980) |
| "The effects of 100 mg indomethacin daily for three weeks on blood pressure and urinary excretion of prostaglandin F2 alpha were studied in a double-blind, placebo-controlled comparison of two groups of patients with essential hypertension, eight receiving propranolol and seven thiazide diuretics." | 5.05 | Attenuation of hypotensive effect of propranolol and thiazide diuretics by indomethacin. ( Abbott, EC; Dollery, CT; Hensby, CN; Watkins, J; Webster, J, 1980) |
| " Fifty-five patients with uncomplicated essential hypertension were admitted to hospital, where 25 of them were treated with propranolol (average daily dose 240 mg) and 30 were left untreated." | 5.05 | Renal blood flow and noradrenaline secretion during treatment with propranolol. ( Birkenhäger, WH; de Leeuw, PW; Punt, R, 1980) |
| "A total of 270 patients with mild to moderate essential hypertension were evaluated in a multicenter double-blind randomized study that compared the effect of captopril plus a thiazide diuretic with that of propranolol plus a diuretic." | 5.05 | Clinical effects of low-dose captopril plus a thiazide diuretic on mild to moderate essential hypertension: a multicenter double-blind comparison with propranolol. Captopril Research Group of Japan. ( , 1985) |
| "Because captopril alone does not control blood pressure in all patients with essential hypertension, studies were performed to assess the effect of sodium intake and of captopril combined with hydrochlorothiazide, propranolol, and nifedipine." | 5.05 | Captopril: contrasting effects of adding hydrochlorothiazide, propranolol, or nifedipine. ( MacGregor, GA; Markandu, ND; Sagnella, GA; Smith, SJ, 1985) |
| "Two double-blind multicenter studies compared acebutolol with placebo (acebutolol, N = 121; placebo, N = 116) and with propranolol (acebutolol, N = 186; propranolol, N = 190) in essential hypertension." | 5.05 | Acebutolol in essential hypertension: results of two multicenter studies against placebo and propranolol. ( Davidov, M, 1985) |
| "In series of 20 patients suffering from atrial arrhythmias, hypertension or hyperkinetic heart syndrome in euthyroid subjects the effect of the new cardioselective beta-blocker celiprolol was examined when orally administered in doses of 300 mg per day against propranolol in a dosage of 160 mg per day." | 5.05 | [Effect of celiprolol compared to propranolol on thyroid metabolism]. ( Eber, O; Langsteger, W; Lind, P, 1985) |
| " A study was conducted on 19 black South Africans with mild or moderate essential hypertension; enalapril was compared with propranolol as monotherapy or together with hydrochlorothiazide in a 1-year randomized, double-blind, parallel study." | 5.05 | Comparison of the antihypertensive effect of enalapril and propranolol in black South Africans. ( Coull, A; Goodman, C; Rosendorff, C, 1985) |
| "The antihypertensive effect of enalapril maleate, a new converting enzyme inhibitor, was evaluated in a multiclinic, double-blind, randomized study in patients with mild to moderate essential hypertension." | 5.05 | Long-term enalapril--a new converting enzyme inhibitor--in the treatment of mild to moderate essential hypertension, results of a worldwide multiclinic study. Comparing two ways of analyzing data. ( Espie, J; Lessem, JN; Rucinska, E; Sromovsky, JA; Vickers, FF, 1985) |
| "A multicenter, double-blind study compared oral acebutolol (n = 186) with propranolol (n = 190) in the treatment of mild to moderately severe essential hypertension (diastolic greater than or equal to 95 to 129 mm Hg)." | 5.05 | Comparison of acebutolol and propranolol in essential hypertension. ( Singh, BN; Turlapaty, P; Wahl, J, 1985) |
| "The efficacy of captopril treatment was compared with that of propranolol in a single-blind crossover study in 14 patients with essential hypertension uncontrolled on diuretic alone." | 5.05 | Crossover comparison of captopril and propranolol as step 2 agents in hypertension. ( Ferguson, RK; Koplin, JR; Oren, A; Riley, LJ; Rotmensch, HH; Tadros, SS; Vlasses, PH, 1985) |
| "The efficacy and safety of labetalol was compared in a double-blind crossover design with propranolol in 27 patients suffering from essential hypertension with a supine diastolic blood pressure of more than 100 mm Hg." | 5.05 | A double-blind crossover clinical trial of labetalol and propranolol in patients of essential hypertension. ( Aslam, S; Pandhi, P; Sharma, BK; Sharma, PL; Wahi, PL, 1985) |
| "Previous studies have shown that labetalol, a new alpha- and beta-adrenergic antagonist, is relatively safe for the treatment of hypertension in patients with chronic obstructive pulmonary disease (COPD)." | 5.05 | Comparison of the effects of labetalol and hydrochlorothiazide on the ventilatory function of hypertensive patients with asthma and propranolol sensitivity. ( Burford, JG; Chetty, K; Conrad, SA; George, RB; Hudson, LD; Light, RW; Manocha, K, 1985) |
| "Twenty patients with mild to moderate essential hypertension completed this double-blind cross-over randomized clinical trial of propranolol and acebutolol." | 5.05 | Double-blind cross-over clinical trial of acebutolol and propranolol in mild to moderate essential hypertension. ( Pandhi, P; Sethi, V; Sharma, BK; Sharma, PL; Wahl, PL, 1985) |
| "In 20 patients with long-standing essential hypertension, a comparison was made in a randomized cross-over study of the effect of once and twice daily prazosin administration on blood pressure levels." | 5.05 | Prazosin once or twice daily? ( Hengeveld, WL; Schouten, JA; Westerman, RF, 1985) |
| "Eleven physically active men with systemic hypertension were studied after 5 weeks of treatment with placebo, atenolol or propranolol." | 5.05 | Effect of beta 1-selective and nonselective beta blockade on blood pressure relative to physical performance in men with systemic hypertension. ( Eliasson, K; Hylander, B; Kaijser, L; Kaiser, P, 1985) |
| "The antihypertensive mechanisms of single and combined therapy with a beta-adrenergic antagonist (propranolol) and a vasodilator (hydralazine) were investigated in 9 patients with moderately severe hypertension, who were receiving maintenance diuretic (hydrochlorothiazide) treatment." | 5.05 | Single and combined therapy for systemic hypertension with propranolol, hydralazine and hydrochlorothiazide: hemodynamic and neuroendocrine mechanisms of action. ( Blomqvist, CG; Gaffney, FA; Graham, RM; Mulvihill-Wilson, J; Neal, WW; Pettinger, WA, 1985) |
| "In a double-blind, balanced and randomised study we used treadmill exercise to assess the effects of long-acting propranolol (LA propranolol) 160 or 320 mg or placebo, given once daily for 4 weeks, on heart rate (HR) and blood pressure (BP) in 15 Chinese subjects with mild primary hypertension (PHT)." | 5.05 | Effects of long-acting propranolol on blood pressure and heart rate in hypertensive Chinese. ( Chia, BL; Oh, VM; Taylor, EA, 1985) |
| " No significant differences were found for blood pressure, heart rate, body weight or serum uric acid." | 5.04 | Comparison between metoprolol and propranolol as antihypertensive agents. A double-blind cross-over study. ( Bengtsson, C, 1976) |
| "The effect of timolol versus propranolol on hypertension, hemodynamics, and plasms renin activity was evaluated in 20 men." | 5.04 | Effect of timolol versus propranolol on hypertension and hemodynamics. ( Aronow, WS; Cassidy, J; Del Vicario, M; Ferlinz, J; King, J; Moorthy, K, 1976) |
| "Studies in 55 patients with benign essential hypertension showed that the beta-blockers bufuralol (22 patients) and propranolol (33 patients) at a dose ratio of 1:4, possess comparable antihypertensive efficacy despite different properties regarding intrinsic sympathomimetic activity." | 5.04 | [Interrelations between blood pressure, blood volume, plasma renin and urinary catecholamines during beta-blockade in essential hypertension (author's transl)]. ( Beretta-Piccoli, C; de Châtel, RD; Hirsch, D; Reubi, FC; Weidmann, P; Ziegler, W, 1976) |
| "Minoxidil has been administered to 16 patients with severe hypertension and renal failure." | 5.04 | Minoxidil in severe hypertension. ( Mäkelä, M; Oka, M, 1978) |
| "The changes in plasma renin activity (PRA) during short-term salt depletion (and peroral furosemide on the first day) and after bolus injection of propranolol were compared to the change during long-term treatment with diuretic and with propranolol in 19 patients with benign primary hypertension." | 5.04 | Acute and long-term salt depletion and beta-blockade: plasma renin activity response and its relation to blood pressure reduction in long-term treatment. ( Hesse, B; Nielsen, I; Steiness, E, 1978) |
| "Atenolol was compared with five other beta-blockers and a thiazide diuretic in a randomised cross-over trial of once-daily treatment of essential hypertension." | 5.04 | Randomised study of six beta-blockers and a thiazide diuretic in essential hypertension. ( Wilcox, RG, 1978) |
| " The cardiovascular responses to handgrip exercise have been studied in ten patients with uncomplicated essential hypertension in a randomized crossover study of propranolol and prazosin." | 5.04 | The effects of alpha- and beta-adrenergic receptor blockers on the pressure responses to isometric exercise in hypertensive patients. ( Blake, P; Gale, EV; Reuben, SR, 1979) |
| "The influence of the beta receptor blocking agent propranolol on plasma catecholamine concentrations was studied in eight patients with essential hypertension." | 5.04 | Studies on the effects of propanolol on plasma catecholamine levels in patients with essential hypertension. ( Gierlichs, HW; Planz, G; Planz, R; Rahn, KH; Schols, M; Stephany, W, 1978) |
| "Effect of long-term administration of propranolol was studied in 90 unselected patients with essential hypertension." | 5.04 | [Treatment of essential hypertension with propranolol (author's transl)]. ( Braun, B; Klaus, D; Klumpp, F; Lemke, R; Zehner, J, 1976) |
| " Indomethacin was administered alone or in addition to either diuretic or propranolol therapy to three groups of patients with essential hypertension on a free sodium diet." | 5.04 | Effects of indomethacin alone and during diuretic or beta-adrenoreceptor-blockade therapy on blood pressure and the renin system in essential hypertension. ( Drayer, JI; Laragh, JH; Lopez-Ovejero, JA; Sealey, JE; Weber, MA, 1978) |
| "The effectiveness of 5 sets of acupuncture loci in decreasing systemic blood pressure was compared with chlorthalidone and propranolol in patients with essential hypertension." | 5.04 | An unsuccessful attempt to treat hypertension with acupuncture. ( Mao, W; Mueller, RA; Sugioka, K; Woods, J, 1977) |
| "In a series of 450 patients with mild essential hypertension, propranolol alone (P), propranolol plus hydrochlorothiazide (P+T), propranolol plus hydralazine (P+H), and propranolol plus hydrochlorothiazide plus hydralazine (P+T+H) were compared to reserpine plus hydrochlorothiazide (R+T)." | 5.04 | Propranolol in the treatment of essential hypertension. ( , 1977) |
| "Eighteen patients with diastolic hypertension (100 to 120 mm Hg), in addition to propranolol, 160 mg daily, and hydrochlorothiazide, 100 mg daily, received progressively increased doses of either minoxidil or placebo in a double-blind crossover study." | 5.04 | Effect of minoxidil on blood pressure and hemodynamics in severe hypertension. ( Bryan, RK; Hoobler, SW; Purdy, JM; Rosenzweig, J; Weller, JM, 1977) |
| "High-pressure baroreceptor reflex sensitivity (BRS) was estimated by measuring the reflex heart rate response to pharmacologic elevation of blood pressure (phenylephrine, 150 to 200 microgram intravenously) in 18 patients with essential hypertension on two occasions: after a 4-wk placebo period and after 9 wk of incremental doses of oral timolol (20, 40, and 60 mg daily)." | 5.04 | Effect of beta adrenoceptor antagonists on baroreceptor reflex sensitivity in hypertension. ( Julius, S; Kiowski, W; Simon, G, 1977) |
| "The tendency for patients with essential hypertension to differ markedly in antihypertensive response to propranolol could arise from pathophysiologic or pharmacokinetic differences between them." | 5.04 | Pathophysiologic and pharmacokinetic determinants of the antihypertensive response to propranolol. ( DeQuattro, V; Esler, M; Randall, O; Zweifler, A, 1977) |
| "1 A double-blind cross over trial between clonidine, propranolol and a placebo in patients with moderate hypertension has been performed." | 5.04 | A comparative trial of clonidine, propranolol and placebo in the treatment of moderate hypertension. ( Raftery, EB; Wilkinson, PR, 1977) |
| "A double-blind crossover trial was completed in 15 patients with moderate hypertension and the effects of propranolol (Inderal) 80 mg twice a day and atenolol (Tenormin) 100 mg twice a day were assessed on blood pressure, pulse rate and plasma renin activity (PRA), while patients were maintained on 1 cyclopenthiazide tablet (Navidrex K) per day." | 5.04 | Effects of propranolol and atenolol on blood pressure and plasma renin activity in patients with moderate hypertension. ( Epstein, SE; LUbbe, WF, 1977) |
| "Minoxidil was used to treat 26 patients (17 to 67 years old) with severe hypertension and varying degrees of renal function." | 5.04 | Long-term clinical effects, bioavailability, and kinetics of minoxidil in relation to renal function. ( Affrime, M; Busby, P; Kim, KE; Lowenthal, DT; Martinez, EW; Mutterperl, R; Onesti, G; Shirk, J; Swartz, C, 1978) |
| "Propranolol was administered in a single dose of 80 mg, 120 mg, 160 mg, 240 mg, or 320 mg, to 23 patients with essential mild to moderate hypertension in a randomised, double-blind cross-over study." | 5.04 | Once daily propranolol in the treatment of mild to moderate hypertension: a dose range finding study. ( Baber, NS; Douglas-Jones, AP; Lee, A, 1978) |
| "082 (atenolol or Tenormin), alone or in combination with other drugs for treatment of hypertension in a total of 104 patients, including 15 with a chronic obstructive lung disease." | 5.04 | Long-term clinical experience with atenolol--a new selective beta-1-blocker with few side-effects from the central nervous system. ( Henningsen, NC; Mattiasson, I, 1979) |
| " Labetalol, a new drug combining alpha-and beta-adrenoceptor blocking properties, has been compared with placebo in a double-blind crossover study of a group of patients with mild to moderate essential hypertension (blood pressure 150/100 to 189/114 mmHg)." | 5.04 | A controlled trial of labetalol (Trandate), propranolol and placebo in the management of mild to moderate hypertension. ( Armstrong, BK; Beilin, L; Nassim, M; Pugsley, DJ, 1979) |
| "The effect of conventional propranolol tablets given twice daily has been compared with an equivalent dosage of a long-acting formulation of propranolol ('Inderal' LA)p given once daily in twenty-nine patients with mild to moderate hypertension." | 5.04 | Comparison of a once daily long-acting formulation of propranolol with conventional propranolol given twice daily in patients with mild to moderate hypertension. ( Douglas-Jones, AP, 1979) |
| "A randomised open trial was carried out to test the efficacy and safety of Captopril and propranolol in 20 patients with mild and moderate essential hypertension." | 5.04 | Captopril and propranolol in mild and moderate essential hypertension: preliminary report. ( Friedlander, DH, 1979) |
| "Captopril (SQ 14,225), an angiotensin-converting enzyme inhibitor, was used in combination with propranolol, a beta-adrenergic blocking agent, in the treatment of mild and moderate hypertension." | 5.04 | Comparison of captopril with propranolol in the treatment of mild and moderate essential hypertension. ( Seedat, YK, 1979) |
| "More recent investigations on the duration of effect and plasma half-life of propranolol suggest a simplification of dosage for the beta-blocker in the treatment of hypertension." | 5.04 | [Treatment of hypertension with propranolol in internal medicine and general practice. A field trial with a simplified twice daily administration of Dociton 80 (author's transl)]. ( Hiemstra, S; Steichele, C; Ziegler, E, 1977) |
| "Seventeen outpatients suffering from essential hypertension were treated in a double-blind cross-over study with labetalol or with a combination of propranolol and dihydrallazine." | 5.04 | Antihypertensive effect and plasma levels of labetalol. A comparison with propranolol and dihydrallazine. ( Allonen, H; Kleimola, T; Lehtonen, A, 1979) |
| "The antihypertensive effects of atenolol and propranolol were compared in a double-blind crossover study of 19 patients with essential hypertension (World Health Organization, I and II) who were receiving long-term diuretic treatment (chlorthalidone, 50 mg daily) during the study." | 5.04 | Effects of atenolol and propranolol when added to long-term antihypertensive diuretic therapy. ( Boer, P; Dorhout Mees, EJ; Geyskes, GG; van Rooijen, GJ, 1979) |
| " The effect of a single dose of propranolol and metoprolol were compared with placebo in two groups of patients with untreated essential hypertension." | 5.04 | Objective measurement of performance during acute stress in patients with essential hypertension: assessment of the effects of propranolol and metoprolol. ( Dunn, FG; Lawrie, TD; Lorimer, AR, 1979) |
| "1 Using a standardized form of mental stress, 21 patients with idiopathic hypertension were investigated before and after treatment with placebo (n=8), propranolol (n=7) or methyldopa (n=6)." | 5.04 | Standardized stress and hypertension: comparison of effect of propranolol and methyldopa. ( Dunn, FG; Jones, JV; Lawrie, TD; Lorimer, AR; Melville, DI, 1978) |
| "In 61 out-patients with essential hypertension, grade I or II, propranolol was administered alone in increasing doses (3 x 40 mg/d or 3 x 80 mg/d) or, if there was insufficient response, with a double or triple combination consisting additionally of spironolactone (50 mg/d)-thiabutazide (5 mg/d) and dihydralazine (3 x 25 mg/d)." | 5.04 | [Treatment of essential hypertension with a combination of propranolol, spironolactone-thiabutazide and dihydralazine (author's transl)]. ( Ebel, H; Klaus, D; Lübke, H; Witzgall, H; Zehner, J, 1978) |
| "15 patients who had benign, uncomplicated essential hypertension, were treated with chlorthiazide (500 mg twice a day) with or without propranolol (10--20 mg 4 times a day), and the effect of the treatment on plasma renin activity (PRA), urinary aldosterone excretion, total body potassium (TBK) and plasma sodium and potassium was evaluated." | 5.04 | The renin-aldosterone system and thiazide-induced depletion of total body potassium in essential hypertension. ( Carroll, HJ; Oh, MS, 1978) |
| "The effects of single doses of propranolol and metoprolol on skin temperature and skin and muscle blood flow were compared in 10 normal subjects and four patients with essential hypertension." | 5.04 | Effects of propranolol and metoprolol on the peripheral circulation. ( McSorley, PD; Warren, DJ, 1978) |
| "In 19 patients with arterial hypertension the hemodynamics were determined with a Swan-Ganz-thermodilution catheter at rest and during supine ergometer exercise before and after 5 mg intravenous Propranolol (P) (10 pats." | 5.04 | [Hemodynamic changes in patients with arterial hypertension after beta-receptor blockade with propranolol and metoprolol (author's transl)]. ( Greding, H; Isbary, J; König, E; Nechwatal, W, 1978) |
| "In a crossover study 32 patients with hypertension were randomly allocated to treatment with spironolactone 200 mg/day for two months, propranolol 320 mg/day for two months, and a combination of both drugs at half the dose." | 5.04 | Renin concentrations and effects of propranolol and spironolactone in patients with hypertension. ( Kågedal, B; Karlberg, BE; Tegler, L; Tolagen, K, 1976) |
| "This double-blind clinical study was carried out in order to compare the therapeutic activity of propranolol, and a new beta-adrenergic blocker, acebutolol, in essential hypertension." | 5.04 | [Comparative study of acebutolol and propranolol in the treatment of arterial hypertension]. ( Tacquet, A, 1975) |
| "We studied the antihypertensive effect of propranolol alone and in combination with diuretics in 13 patients with high, 18 with normal and nine with low-renin essential hypertension whose blood-pressure response to diuretics was previously established." | 5.04 | Proposed mechanisms of propranolol's antihypertensive effect in essential hypertension. ( Hollifield, JW; Shand, DG; Sherman, K; Zwagg, RV, 1976) |
| "The effect of a low dose of methyldopa combined with (a) a non-selective and (b) a selective beta-adrenoceptor antagonist was studied in a double-blind crossover trial in 24 carefully selected patients with moderate hypertension (mean initial lying blood pressure 189/117 mm Hg)." | 5.04 | Methyldopa and propranolol or practolol in moderate hypertension. ( Galloway, DB; Jeffers, TA; Lewis, JA; Millar, HR; Petrie, JC; Simpson, WT; Smith, MC; Wood, RA, 1976) |
| "Propranolol was given to 30 patients with essential hypertension following randomised, double-blind administration of either placebo or a new cardioselective beta-adrenergic receptor antagonist, atenolol (Tenormin, ICI 66 082)." | 5.04 | A comparison of the antihypertensive effect of atenolol (ICI 66 082) and propranolol. ( Aberg, H; Hansson, L; Karlberg, BE; Westerlund, A, 1976) |
| "A double blind cross-over trial of fixed doses of propranolol (640 mg/day) and the cardioselective drug practolol (1600 mg/day) was performed in 28 patients with essential hypertension whose blood pressure was not adequately controlled by chlorthalidone (100 mg 3 times weekly) alone." | 5.04 | Comparison of the antihypertensive effect of propranolol and practolol combined with chlorthalidone. ( Boer, P; Geyskes, GG; Mees, EJ; Stutterheim, A, 1975) |
| "The comparative potency of two beta-blockers, propranolol and atenolol, in the inhibition of exercise tachycardia and isoproterenol-tachycardia has been studied in two groups of hypertensive patients, using oral doses which were increased weekly." | 5.04 | Comparative potency of atenolol and propranolol as beta-adrenergic blocking agents in man. ( Amery, A; De Plaen, JF; Reybrouck, T, 1976) |
| "1 Labetalol, a new hypotensive drug combining alpha- and beta-adrenoreceptor antagonist properties, has been compared with propranolol in the treatment of severe hypertension (blood pressure 190/115-249/139 mmHg) in a double-blind trial lasting 14 weeks." | 5.04 | Controlled comparison of labetalol and propranolol in the management of severe hypertension. ( Armstrong, BK; Beilin, LJ; Nassim, MA; Pugsley, DJ, 1976) |
| " Serial measurements of plasma renin activity (PRA), plasma aldosterone concentration (PA) and blood pressure were performed overnight in patients with borderline (group 1) and sustained essential hypertension (group 2) before and after acute and chronic administration of either propranolol or pindolol." | 5.04 | Differential effects of acute and chronic beta-adrenoreceptor blockade on blood pressure and the renin-angiotensin-aldosterone system in essential hypertension. ( Gramann, W; Kolloch, R; Krück, F; Stumpe, KO; Vetter, H, 1976) |
| "The pilot phase of the British multicentre randomized controlled trial of treatment for mild hypertension has shown: (1) that unselected subjects, aged 35-64 years, with mild hypertension are willing to enter and remain in a long-term trial even though asymptomatic; (2) that the differences of mean systolic and mean diastolic pressure achieved between treated and control subjects is sufficient to produce the expected difference in terminating events with the 18000 patients calculated as needed for the full-scale trial; (3) that side effects with the two selected active primary regimens (bendrofluazide and propranolol) are common but mild (no serious side effects or toxic reactions have been reported); (4) that the work load imposed by the trial, though considerable during screening and the initiation of patients into the trial, can largely be taken by specially trained nursing staff, and when screening is completed the trial does not impose a heavy burden of follow-up examinations; (5) that there are no adverse psychological effects caused by alerting asymptomatic people to their raised pressure and enrolling them into a prolonged programme of clinical attendance; (6) that the total costs of carrying out a full-scale trial--estimated at about lb." | 5.04 | Medical Research Council's Treatment Trial for mild hypertension: an interim report. ( Brennan, PJ; Mann, AH; Miall, WE, 1976) |
| " Propranolol was given to eight haemodialysed patients with resistant arterial hypertension for periods ranging from 6 to 16 months." | 5.04 | Long-term propranolol treatment of resistant arterial hypertension in haemodialysed patients. ( Biagini, M; Maggiore, Q; Misefari, M; Zoccali, C, 1975) |
| "In 36 patients with essential hypertension the action and side effects of hydrochlorothiazide (25 mg/d), hydrochlorothiazide-triamterene (25 and 50 mg/d) and propranolol (160 mg/d) were investigated." | 5.04 | [Triamterene in the treatment of hypertension with hydrochlorothiazide and propranolol (author's transl)]. ( Düsing, R; Kramer, HJ, 1977) |
| " Labetalol has been compared with propranolol and placebo for the treatment of mild to moderate hypertension (150/100 to 189/114 mmHg), in a double-blind cross-over trial with three 10 week treatment periods." | 5.04 | Combined alpha- and beta-adrenoreceptor blockade in hypertension: a controlled trial of labetalol (AH 5158) compared with propranolol and placebo. ( Armstrong, B; Beilin, LJ; Nassim, M; Pugsley, D, 1976) |
| " Group A: In 14 patients with essential hypertension on chlorthalidone treatment, an additional daily dose of 640 mg propranolol for two months led to a significant reduction of the MAP (from 124 to 105 mm Hg) and PRA (from 5." | 5.04 | Effect of salt depletion and propranolol on blood pressure and plasma renin activity in various forms of hypertension. ( Boer, P; Geyskes, GG; Leenen, FH; Mees, EJ; Vos, J, 1975) |
| "The antihypertensive effect of two adrenergic blocking agents (Alprenolol and Propranolol) have been studied in a group of 107 patients with essential hypertension." | 5.04 | Effect of beta adrenergic blocking agents (alprenolol and propranolol) in essential hypertension. ( Khakpour, M; Nik-Akhtar, B; Rashed, MA, 1975) |
| " We obtained the following results: (1) plasma cyclic AMP increases in response to upright posture in control subjects and hypertensive patients; (2) values of cyclic AMP in the recumbent and upright positions are comparable in control subjects and patients with essential hypertension, but are significantly higher in those with true renovascular hypertension due to bilateral renal artery stenosis; (3) propranolol inhibits the increase of plasma cyclic AMP in response to posture in control subjects, but has an opposite effect in labile hypertension where there is a further increase; (4) the rise in blood pressure in pheochromocytoma is associated with a considerable increase in plasma cyclic AMP." | 5.04 | Plasma adenosine 3',5'-cyclic monophosphate in human hypertension. ( Fraysse, J; Genest, J; Hamet, P; Kuchel, O, 1974) |
| "A clinically significant interaction between epinephrine or levonordefrin with nonselective beta-adrenergic blocking agents, although apparently rare in the dental setting, is potentially serious and can lead to significant hypertension with a concomitant reflex bradycardia." | 4.86 | Beta-adrenergic blocking agents and dental vasoconstrictors. ( Giannakopoulos, H; Hersh, EV, 2010) |
| "Multiclinic controlled studies have shown that enalapril alone 10 to 40 mg/day orally is effective in lowering blood pressure in patients with essential hypertension." | 4.77 | Enalapril in hypertension and congestive heart failure. Overall review of efficacy and safety. ( Davies, RO; Moncloa, F; Sromovsky, JA; Walker, JF, 1985) |
| " Its inherently long duration of activity makes it suitable for once daily administration in both hypertension and angina pectoris, and in these conditions it has been as effective as propranolol given in a traditional regimen 4 times daily." | 4.76 | Nadolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris. ( Avery, GS; Brogden, RN; Heel, RC; Pakes, GE; Speight, TM, 1980) |
| " Beta-adrenergic receptor blockade with propranolol is indicated only after adequate alpha-adrenergic blockade in patients with tachycardia and catecholamine-induced arrhythmias." | 4.76 | Pharmacologic agents in the management of pheochromocytoma. ( Juan, D, 1982) |
| "After the clinical studies with pronethalol and propranolol confirmed Black's hypothesis that drugs which block beta-adrenoceptors were of value in the treatment of patients with angina pectoris and cardiac arrhythmias, other compounds have been described which block beta-adrenoceptors." | 4.75 | The properties of beta-adrenoceptor antagonists. ( Shanks, RG, 1976) |
| "A review if given of the use of propranolol in hypertension emphasizing the importance of the studies by Prichard and Gillam in 1964 and 1969." | 4.75 | The use of propranolol in hypertension: a review. ( Hansson, L, 1976) |
| "Only recently approved for use in the treatment of hypertension in the US, the beta-adrenergic receptor blocking compound propranolol has been used elsewhere for this purpose since 1964." | 4.75 | Pathophysiology of propranolol in hypertension. ( Frohlich, ED, 1977) |
| "The antihypertensive effect of intravenous (acute) and oral (long-term) beta-adrenergic blockade with propranolol or pindolol was evaluated in 46 male patients with either borderline (group I; 23 patients) or sustained (group II; 23 patients) essential hypertension." | 4.75 | Acute and long-term studies of the mechanisms of action of beta-blocking drugs in lowering blood pressure. ( Gramann, W; Higuchi, M; Kolloch, R; Krück, F; Ressel, C; Stumpe, KO; Vetter, H, 1976) |
| "Like hypertension which is a multifactorial disease, the blood pressure response to propranolol cannot be explained by one mechanism alone to the exclusion of all others." | 4.75 | Haemodynamic effects of propranolol in hypertension: a review. ( Bravo, EL; Dustan, HP; Tarazi, RC, 1976) |
| "In a retrospective controlled study, a tumor-protective effect, regarding breast cancer, was determined for the medicines metformin and glitazone (anti-diabetics), bisoprolol, and propranolol (cardioselective β1 adrenoceptor antagonists)." | 3.78 | A retrospective in vitro study of the impact of anti-diabetics and cardioselective pharmaceuticals on breast cancer. ( Briese, V; Richter, C; Richter, DU; Szewczyk, M, 2012) |
| "This study aimed to investigate the role of insulin-like growth factor-binding protein-3 (IGFBP-3) in erectile dysfunction (ED) in two-kidney one-clip (2K-1C) hypertensive rats treated with the β-blocking agent propranolol." | 3.77 | Increased expression of insulin-like growth factor-binding protein-3 is implicated in erectile dysfunction in two-kidney one-clip hypertensive rats after propranolol treatment. ( Cao, H; Chen, D; Liu, QL; Peng, M; Wan, SP; Wang, XH; Wang, YZ; Yang, ZH; Zhou, HH; Zhou, ZY, 2011) |
| "Propranolol was found to cause depression as a side effect with a statistically greater frequency than the control medications used in these trials." | 3.76 | Propranolol and depression: evidence from the antihypertensive trials. ( Patten, SB, 1990) |
| "Clonidine reduced pretreatment BP and CSF NE levels by 27% (p less than 0." | 3.76 | Cerebrospinal fluid norepinephrine levels in essential hypertension: effects of drug treatment and withdrawal. ( Cubeddu, LX; Hoffman, IS, 1987) |
| "Celiprolol hydrochloride is a highly cardioselective beta1-adrenergic antagonist with a unique pharmacologic profile." | 3.76 | Safety profile of celiprolol. ( Lamon, KD, 1988) |
| " All adverse events reported in connection with administration of pindolol have been carefully analyzed since this drug was marketed 10 years ago." | 3.75 | Pindolol: experience gained in 10 years of safety monitoring. ( Fanchamps, A; Krupp, P, 1982) |
| "To establish whether propranolol can reverse left ventricular hypertrophy in hypertensive rats." | 3.73 | Reversal of left ventricular hypertrophy by propranolol in hypertensive rats. ( Maina, CI; Ogunde, M, 2005) |
| " To assess whether these differential structural effects do translate into different effects on LV function and on heart failure mortality, Bd or sham Bd 8-week-old rats were randomized to vehicle treatment (Vh), chemical sympathectomy ([Sx] 6-hydroxydopamine, 150 mg/kg IP twice a week), beta-adrenoceptor blockade (propranolol [Pro], 40 mg/kg per day PO), or alpha-adrenoceptor blockade (doxazosin [Dox], 5 mg/kg per day PO)." | 3.73 | Survival benefits of different antiadrenergic interventions in pressure overload left ventricular hypertrophy/failure. ( Busca, G; Cesana, F; Clari, F; Ferrari, AU; Ferrero, I; Gatti, C; Janetti, MB; Mancia, G; Palladini, G; Perlini, S; Tozzi, R; Vezzoli, M, 2006) |
| " The patient had been on 30 mg of propranolol during 7 years for arterial hypertension." | 3.73 | Mitochondrial disorder aggravated by propranolol. ( Finsterer, J; Gelpi, E, 2006) |
| " However, nipradilol, at doses of 10 and 15 mg/kg/day, significantly decreased proteinuria and glomerulosclerosis, while propranolol did not." | 3.72 | A nitric oxide-generating beta-blocking agent prevents renal injury in the rat remnant kidney model. Comparative study of two beta-blocking drugs, nipradilol and propranolol. ( Hasuike, Y; Hiraoka, K; Inoue, T; Itahana, R; Izumi, M; Miyagawa, K; Nakanishi, T; Nishihara, F; Takamitsu, Y, 2003) |
| "We analysed the influence of aging on the acute effect of clenbuterol, a beta(2)-adrenoceptor agonist, on the vasoconstrictor response induced by electrical field stimulation in mesenteric arteries from young and old spontaneously hypertensive rats (SHRs)." | 3.72 | Different effects of acute clenbuterol on vasomotor response in mesenteric arteries from young and old spontaneously hypertensive rats. ( Balfagón, G; Ferrer, M; Salaices, M; Sánchez, M, 2003) |
| " We also made an ex-vivo study of the changes in intracellular ionized magnesium in lymphocytes in 20 subjects with essential arterial hypertension, 10 treated with 120 mg/d of propranolol and 10 with placebo." | 3.72 | Catecholamine-induced regulation in vitro and ex vivo of intralymphocyte ionized magnesium. ( Degan, M; Delva, P; Lechi, A; Montesi, G; Pastori, C, 2004) |
| "We examined the effects of the angiotensin-converting enzyme inhibitor perindopril and the beta-blocker propranolol on dilator responses of cerebral arterioles in chronic hypertension." | 3.71 | Effects of an angiotensin-converting enzyme inhibitor and a beta-blocker on cerebral arteriolar dilatation in hypertensive rats. ( Baumbach, GL; Chillon, JM, 2001) |
| "The effects of propranolol and atenolol were investigated on arterial hypertension, cardiomyocyte hypertrophy, and ventricular ischaemic lesions induced by an 8-week treatment with the nitric oxide synthase inhibitor N(omega)-nitro-L-arginine methyl ester (L-NAME; 20 mg/rat per day) in Wistar rats." | 3.71 | Attenuation of hypertension, cardiomyocyte hypertrophy, and myocardial fibrosis by beta-adrenoceptor blockers in rats under long-term blockade of nitric oxide synthesis. ( Antunes, E; de Azevedo, AP; De Luca, IM; De Nucci, G; De Oliveira, CF; Pacca, SR, 2002) |
| "To assess the efficacy of long-acting propranolol in elderly patients with essential hypertension (EH) and coronary disease (CD)." | 3.70 | [Betacap efficiency in elderly patients with coronary heart disease and essential hypertension]. ( Bisengalieva, GK; Goncharov, LF; Zaslavskaia, RM; Zholdin, BK, 1998) |
| "The aims of the study were to characterize the rate and extent of the rebound effect after abrupt cessation of a chronic exposure of l-propranolol in spontaneous hypertensive rats, using exercise-induced tachycardia as a pharmacodynamic endpoint." | 3.70 | Mechanism-based modeling of rebound tachycardia after chronic l-propranolol infusion in spontaneous hypertensive rats. ( Brynne, L; Karlsson, MO; Paalzow, LK, 1999) |
| "To investigate the effects of perindopril, propranolol, and dihydrochlorothiazide on artery wall thickening, left ventricular hypertrophy, and cardiac fibrosis in spontaneously hypertensive rats (SHR)." | 3.70 | Effects of perindopril, propranolol, and dihydrochlorothiazide on cardiovascular remodelling in spontaneously hypertensive rats. ( Chen, DG; Chen, SC; Rui, HB; Su, JZ; Wang, HJ; Wang, XY; Wu, KG, 1999) |
| "The acute hemodynamic effects of nisoldipine (Bay K552) in patients with essential hypertension were studied using nuclear ventriculography." | 3.69 | Cardiovascular effects of nisoldipine in essential hypertension. ( Battler, A; Blau, A; Eliahou, HE; Herz, I; Herzog, D; Schechter, P, 1994) |
| " The effect of in vitro treatment with isoproterenol (ISO), a beta-adrenergic drug, on phagocytosis and respiratory burst by splenic macrophages (SpMø) from normotensive Wistar-Kyoto rats (WKY) and SHR with established hypertension, respectively, was evaluated." | 3.69 | Beta-adrenoceptor responsiveness of splenic macrophages in normotensive and hypertensive rats. ( Jirillo, E; Mansi, G; Mitolo-Chieppa, D; Montagnani, M; Potenza, MA; Serio, M, 1996) |
| "Propranolol, a non-selective beta-blocker, is used for treatment of portal hypertension as it is believed to diminish splanchnic blood flow both by reducing cardiac output (beta(1)-blockade) and by increasing splanchnic arteriolar resistance (beta(2)-blockade)." | 3.69 | Divergent effects of propranolol and nadolol in isolated mesenteric arteries from normal and portal hypertensive rats. ( Heinemann, A; Krejs, GJ; Stauber, RE; Trauner, M, 1996) |
| "05) and the hypertension was significantly decreased by phentolamine and propranolol pretreatments (P < 0." | 3.69 | Cardiovascular reflex mechanisms by topical instillation of capsaicin and distilled water into the larynx in anesthetized dogs. ( Mutoh, T; Nishimura, R; Sasaki, N; Tsubone, H, 1997) |
| "We describe a case of carpal tunnel syndrome (CTS) in a hypertensive man on long term treatment with a beta-blocker, propranolol." | 3.68 | Clinical and electromyographic evidence of carpal tunnel syndrome in a hypertensive patient with chronic beta-blocker treatment. ( Antonicelli, R; Gaetti, R; Lipponi, G; Lucantoni, C, 1992) |
| " do secretion of volume related hormones in patients with EH pre- and post treatment with propranolol differ from normotensive subjects if examined in thermal dehydration conditions; 2." | 3.68 | [Effect of thermal dehydration on blood levels of volume- regulating hormones and sweat electrolytes in patients with essential hypertension treated with propranolol]. ( Grzeszczak, W; Irzyniec, T; Kokot, F; Wiecek, A; Woch, W; Zukowska-Szczechowska, E, 1992) |
| "Hypertension is a potential complication following ephedrine and pseudoephedrine overdoses." | 3.68 | Intravenous propranolol reverses hypertension after sympathomimetic overdose: two case reports. ( Burkhart, KK, 1992) |
| "Preoperative beta-adrenergic blockade with propranolol, by allowing unopposed alpha-adrenergic stimulation in response to stress, has been suggested as a factor contributing to hypertension following coronary artery bypass surgery (CABG)." | 3.68 | Does propranolol alter the vascular response to phenylephrine before or during halothane anaesthesia in patients with coronary artery disease? ( Azmy, SS; Grum, DF, 1992) |
| " Acute hypertension was induced using infusions of epinephrine during the control period and later propranolol (1." | 3.68 | Effects of muscarinic and beta-adrenergic blockade on the aortic elastic response to epinephrine induced acute hypertension in conscious dogs. ( Armentano, R; Barra, J; Breitbart, G; Cabrera, E; Levenson, J; Pichel, R; Simon, A, 1990) |
| "5 mg cilazapril, a new potent long-acting angiotensin-converting enzyme (ACE) inhibitor, 120 mg propranolol, and the combination of both, were compared in 17 patients suffering from essential hypertension." | 3.68 | Does the combination of cilazapril and propranolol lower blood pressure at rest and during exercise more pronouncedly than either of the two components given alone? ( Belz, GG; Breithaupt, K; Erb, KA; Kleinbloesem, CH; Wolf, GK, 1990) |
| " Comparisons of the efficacy and safety of the centrally acting agent, guanabenz, with those of propranolol and pindolol in patients with mild to moderately severe hypertension, are reported." | 3.67 | Comparison of a centrally acting antihypertensive agent and beta-adrenergic blocking agents for the treatment of hypertension. ( Morgan, TO, 1984) |
| "The efficacy and safety of nitrendipine in oral doses of 5-40 mg twice daily, alone or in combination with hydrochlorothiazide (50-150 mg/day) and/or propranolol (40-120 mg/day), were evaluated in an open study of 50 patients with severe hypertension with supine diastolic blood pressure (BP) greater than 115 mm Hg." | 3.67 | Efficacy and safety of nitrendipine in patients with severe hypertension: a multiclinic study. ( Jain, AK; Maronde, R; McMahon, FG; Mroczek, W; Ryan, JR; Vlachakis, N, 1984) |
| "Severe anaphylaxis is reported in a bee venom-sensitive 31-year-old male while receiving propranolol." | 3.67 | Insect sting anaphylaxis and beta-adrenergic blockade: a relative contraindication. ( Awai, LE; Mekori, YA, 1984) |
| "In patients with normal-renin, mild (n = 6) or moderate (n = 6) hypertension, the antihypertensive effects of propranolol (80 mg/day) for 1 day or for 2 weeks were evaluated in relation to the degree of beta-adrenoceptor blockade induced." | 3.67 | Antihypertensive effect and degree of beta-adrenoceptor blockade after short-term and semi-chronic propranolol therapy. ( Boer, P; Dorhout Mees, EJ; Leenen, FH, 1984) |
| "We assessed the effects on renal haemodynamics in 18 black patients with essential hypertension of acute and chronic beta-adrenergic blockade with three agents having different properties: atenolol, nadolol or propranolol." | 3.67 | Beta-adrenergic blockade alone does not decrease renal perfusion in black hypertensives. ( Anderson, S; Brater, DC; Kaplan, NM; Ram, CV, 1984) |
| "Treatment of hypertension with diuretics and beta-blockers is often associated with changes in lipids and uric acid levels." | 3.67 | The impact on serum lipids of combinations of diuretics and beta-blockers and of beta-blockers alone. ( Helgeland, A, 1984) |
| " Therefore, a study was designed to compare the efficacy and the effects on left ventricular function of hydrochlorothiazide, propranolol and prazosin in 13 patients with mild to moderate hypertension." | 3.67 | Monotherapy in mild to moderate hypertension: comparison of hydrochlorothiazide, propranolol and prazosin. ( Benowitz, N; Inouye, I; Loge, D; Massie, B; Simpson, P; Topic, N, 1984) |
| "The role of the renin system in the maintenance of the elevated systolic blood pressure in isolated systolic hypertension was investigated in 31 patients who received long-term treatment with propranolol (120 mg daily) and in another group of 22 patients with isolated systolic hypertension who received a test dose of captopril (25 or 50 mg)." | 3.67 | Renin dependency of blood pressure in isolated systolic hypertension. ( Laragh, JH; Niarchos, AP, 1984) |
| "In a patient with severe hypertension in association with insulin-induced hypoglycemia and prior therapy with propranolol hydrochloride, intravenous 50% dextrose significantly reduced arterial pressure on two occasions." | 3.67 | Hypertensive crisis caused by hypoglycemia and propranolol. ( Krakoff, LR; Mann, SJ, 1984) |
| "Studies were carried out in 15 patients with renal insufficiency and hypertension to compare the long-term effects of methyldopa and propranolol on renal hemodynamics." | 3.67 | Comparison of long-term renal hemodynamic effects of methyldopa and propranolol in patients with hypertension and renal insufficiency. ( Alterman, L; Bank, DE; Bank, N; Lowenstein, I; Zelen, R, 1984) |
| "Twenty patients with essential hypertension, who were receiving a diuretic plus propranolol qid, were instructed to take their entire daily requirement of propranolol as a single morning dose." | 3.67 | Once-daily propranolol for hypertension. ( Gefter, ML; Hemmes, RJ; Lopez, LM, 1984) |
| "Twenty-four subjects with mild to moderate essential hypertension completed this 9-wk parallel, randomized, double-blind study of the antihypertensive effects of verapamil (V) (240 to 480 mg%) and propranolol (P) (120 to 360 mg%)." | 3.67 | Verapamil and propranolol in essential hypertension. ( Cubeddu, LX; Gross, KM; Halperin, AK; Rogers, JF, 1984) |
| "In patients with mild hypertension, flurbiprofen in a dose of 100 mg daily for 7 days attenuated the hypotensive effect of a single dose of propranolol 80 mg but not of atenolol 100 mg." | 3.67 | Flurbiprofen interaction with single doses of atenolol and propranolol. ( Hawksworth, GM; McLean, I; Petrie, JC; Webster, J, 1984) |
| "The antihypertensive efficacy of prazosin was compared with that of a combination of prazosin and propranolol in 14 patients with essential hypertension." | 3.67 | Prazosin versus propranolol plus prazosin: a comparison in diuretic-treated hypertensive patients. ( Blumenthal, SS; Kalbfleisch, JH; Kochar, MS; Maierhofer, WJ, 1984) |
| "The use of nifedipine in patients with hypertension, heart failure, and acute myocardial infarction is discussed." | 3.67 | Nifedipine in hypertension and heart failure. ( Matsui, S; Murakami, E; Murakami, H; Takekoshi, N, 1984) |
| "The effects of beta adrenoceptor blockade with propranolol or pindolol on serum total cholesterol, low density lipoprotein cholesterol (LDL), high density lipoprotein cholesterol (HDL), and its subfractions HDL2 and HDL3, serum triglyceride, and Intralipid clearance were studied in 17 normolipidaemic, non-diabetic patients with hypertension or angina pectoris." | 3.67 | Effects of short term beta adrenoreceptor blockade on serum lipids and lipoproteins in patients with hypertension or coronary artery disease. ( Dollery, CT; Kaufman, S; Murphy, MB; Sugrue, D; Thompson, GR; Trayner, I; Yasuhara, H, 1984) |
| "The ability of propranolol, a beta-adrenergic blocking agent, to decrease blood pressure and inhibit the development of hypertension was assessed in spontaneously hypertensive rats (SHR)." | 3.67 | Propranolol can inhibit the development of hypertension in SHR. ( Weissinger, J, 1984) |
| "The responses to a supine rest, norepinephrine (NE) and angiotensin II (Ang II) were investigated in the absence and presence of calcium antagonist nifedipine or diltiazem in essential (genetic, arterial) hypertension and normotension in humans." | 3.67 | Increased cardiovascular responses to norepinephrine and calcium antagonists in essential hypertension compared with normotension in humans. ( Aoki, K; Kawaguchi, Y; Sato, K, 1985) |
| "6 years (WHO II-III)] with severe hypertension and not responding to previous drug treatment were included in the study to evaluate the effect of nitrendipine (NTP) as monotherapy and also in combination with propranolol (PRO)." | 3.67 | Nitrendipine treatment in so-called therapy-resistant arterial hypertension; effect as monotherapy and in combination with propranolol on blood pressure, heart rate, other hemodynamic parameters, plasma renin activity, and catecholamines. ( Faulhaber, HD; Gruner, R; Hartrodt, W; Homuth, V; Menz, M; Mohnike, W; Naumann, E; Schmidt, J, 1988) |
| "This multicenter study evaluated nitrendipine, a dihydropyridine calcium antagonist, alone or in combination with hydrochlorothiazide and/or propranolol in severe essential hypertension (baseline supine diastolic BP greater than or equal to 115 mm Hg)." | 3.67 | Long-term efficacy and safety of nitrendipine in severe essential hypertension. ( Burris, JF; Mroczek, WJ; Nash, DT, 1988) |
| "In stroke-prone spontaneously hypertensive rats, oral long-term treatment with verapamil, propranolol, hydrochlorothiazide, and dihydralazine attenuated the development of hypertension." | 3.67 | Development of hypertension and life span in stroke-prone spontaneously hypertensive rats during oral long-term treatment with various antihypertensive drugs. ( Gries, J; Kretzschmar, R; Neumann, BW, 1989) |
| " The resulting cardiac hypertrophy was reduced and the hypertension corrected by propranolol." | 3.67 | [The heart in patients with hypertension: effects of rilmenidine on experimental cardiac hypertrophy of hypertensive origin in rats]. ( Callens-el Amrani, F; Paolaggi, F; Swynghedauw, B, 1989) |
| "We studied 14 patients to determine whether sustained-release diltiazem is a satisfactory long-term substitute for the combination of propranolol plus hydrochlorothiazide (HCTZ), control phase, in the treatment of systemic hypertension with coexisting chronic stable angina pectoris." | 3.67 | Response of blood pressure, cardiac output, peripheral resistance, and exercise performance to substitution of calcium blocker for beta-blocker plus thiazide diuretic therapy in patients with both systemic hypertension and mild stable angina. ( Gonzales, A; Kawanishi, DT; O'Rourke, RA; Rahimtoola, SH; Reid, CL, 1989) |
| "The effects of rilmenidine [(N-dicyclopropylmethyl) amino-2-oxazoline; S 3341], an alpha 2 agonist, on the hypertensive rat heart have been compared with those of propranolol, using a model of deoxycorticosterone acetate (DOCA)-salt hypertension." | 3.67 | Remodelling of the heart in DOCA-salt hypertensive rats by propranolol and by an alpha-2 agonist, rilmenidine. ( Callens-el Amrani, F; Paolaggi, F; Swynghedauw, B, 1989) |
| "In 59 patients with mild or moderate essential hypertension effects of propranolol and hydrochlorothiazide on serum lipids, fibrynogen, glucose and uric acid concentrations as well as serum euglobulins fibrynolysis time were studied." | 3.67 | [Effect of long-term treatment with propranolol or hydrochlorothiazide on biochemical risk factors of coronary disease in patients with hypertension]. ( Karolko, B; Kawecka, M; Lukasik, S; Moszczyńska, J; Witkowska, M, 1989) |
| "Fifty patients with essential hypertension were studied for the antihypertensive effect of timolol and propranolol." | 3.67 | Comparative evaluation of the antihypertensive effect of timolol and propranolol in patients with essential hypertension. ( Rajvanshi, P; Rizvi, SN, 1989) |
| "A group of 20 patients with primary hypertension (NT) were studied for the influence of six-week propranolol therapy on the secretion of immunoreactive insulin (IR-I), gastrin glucagon (IR-G) and pancreatic polypeptide (IR-PP) induced by a high-fat test meal." | 3.67 | [Effect of propranolol therapy on the secretion of insulin, glucagon, gastrin and pancreatic polypeptide in patients with essential hypertension]. ( Kokot, F; Zukowska-Szczechowska, E, 1989) |
| "The effects of placebo, propranolol, and clonidine on blood pressure and blood pressure variability were examined in 14 subjects who had moderate essential hypertension." | 3.67 | Blood pressure and blood pressure variability following withdrawal of propranolol and clonidine. ( Lowenstein, J; Neusy, AJ, 1989) |
| "The roles of the autonomic nervous system, renin-angiotensin system, and arginine vasopressin (AVP) during the onset of ACTH-induced hypertension were investigated in conscious sheep." | 3.67 | Role of the autonomic nervous system, renin-angiotensin system, and arginine vasopressin during the onset and maintenance of ACTH hypertension in sheep. ( Coghlan, JP; Denton, DA; Mills, EH; Nelson, MA; Scoggins, BA; Spence, CD; Whitworth, JA, 1987) |
| " Acute hypertension was induced by infusions of angiotensin performed 1) during the control period, 2) after propranolol (1." | 3.67 | Constricting and stiffening action of atropine on aortic response to angiotensin in dogs. ( Armentano, R; Barra, J; Cabrera, E; Levenson, J; Pichel, R; Simon, A, 1988) |
| "Lymphocytes beta 2-receptor density (LBRD) was studied by binding with 125ICYP in 18 male patients with mild/moderate essential hypertension (EH) before and after propranolol monotherapy." | 3.67 | [Effect of physical load and brief monotherapy with obsidan on the characteristics of beta 2-adrenoreceptors of intact lymphocytes in patients with hypertension]. ( Aripova, NA; Korichneva, IL; Nauman, E; Parfenova, EV; Suvorov, IuI, 1988) |
| "The density of beta 2-receptors in intact lymphocytes was studied by binding with 125iodo-cyanopindolol in 18 male patients with mild or moderate hypertension before and after monotherapy with propranolol." | 3.67 | Characteristics of lymphocyte beta-adrenoceptors in essential hypertension: effects of propranolol treatment and dynamic exercise. ( Korichneva, IL; Krasnikova, TL; Parfyonova, EV; Suvorov, YI, 1988) |
| "Six elderly patients with established hypertension and six young healthy subjects were studied after 8 days of treatment with atenolol 50 mg day-1, metoprolol 50 mg day-1, oxprenolol 80 mg day-1 and propranolol 80 mg day-1." | 3.67 | A comparison of the pharmacokinetics of atenolol, metoprolol, oxprenolol and propranolol in elderly hypertensive and young healthy subjects. ( Hawksworth, GM; Petrie, JC; Rigby, JW; Scott, AK, 1985) |
| "The effect of long-term treatment with propranolol (45 patients), trasicor (15), visken (23) and combinations thereof with phentolamine and labetalol (12) on submaximum exercise tolerance was studied in patients with second-stage essential hypertension." | 3.67 | [Effect of beta-adrenergic blockaders and their combination with an alpha-adrenergic blockader on physical exertion tolerance in patients with hypertension]. ( Smirnov, GB, 1986) |
| "A short-term effect of propranolol on beta 2-adrenoceptor density in mononuclear lymphocytes was studied in 15 male patients with essential hypertension." | 3.67 | [Effect of a beta 2-blocker on the adrenergic receptors of lymphocytes in hypertension]. ( Krasnikova, TL; Parfenova, EV; Radiukhin, VA; Suvorov, IuI; Ustinova, SE, 1986) |
| "In the Medical Research Council trial for the treatment of mild hypertension, bendrofluazide showed an unexpected and sizeable benefit compared with propranolol in the reduction of stroke." | 3.67 | Does angiotensin-II protect against strokes? ( Brown, J; Brown, MJ, 1986) |
| " Its central and renal hemodynamic effects were compared to those of an equipotent dosage of propranolol in two groups of 10 patients each who developed arterial hypertension and a hyperdynamic circulatory state after head injury." | 3.67 | Tertatolol preserves renal perfusion in patients with arterial hypertension after head injury. ( Brackman, F; Degaute, JP; Leeman, M; Naeije, R; Prost, JF; Thomas, J, 1986) |
| "Tertatolol, a new beta-blocker, and propranolol, considered a reference beta-blocker, were given orally (5 and 160 mg slow release, respectively) for 15 days to two groups of patients with essential hypertension in order to compare their effects on renal hemodynamics." | 3.67 | Renal hemodynamic effects of tertatolol in essential hypertension. ( Ardaillou, R; Lantz, B; Leviel, F; Paillard, F, 1986) |
| " L-Glutamate-induced hypertension was prevented by spinal transection and pretreatment with atropine (1 mg/kg iv) reversed the bradycardia." | 3.67 | Acute central effects of L-glutamate in pentobarbital-anesthetized dogs. ( Buckley, JP; Chelly, JE; Doursout, MF, 1987) |
| " After short-term propranolol administration the lymphocyte blastogenic response in essential hypertension increased by 30--100%." | 3.67 | Beta-blocker action on lymphocyte proliferative response in essential hypertension. ( Kalentchuk, VU; Kozlova, MV; Krasnikova, TL; Parfenova, EV; Radiukhin, VA; Shkhvatsabaya, IK, 1988) |
| "Arterial blood pressure and central hemodynamic changes were assessed in 44 patients with essential hypertension, uncontrollable by prazosin alone, after propranolol (anaprilin), celiprolol, clonidine (clofelin) or verapamil were added to the treatment schedule." | 3.67 | [Hemodynamic effect of a combination of prazosin with cardiac depressants in the treatment of hypertension]. ( Akopian, LM; Basem, AS; Ivleva, AIa; Krasnobaeva, GM; Moiseev, VS, 1988) |
| "Captopril Research Group of Japan made an evaluation of clinical usefulness of captopril in the treatment of mild to moderate essential hypertension." | 3.67 | Side effects and metabolic effects of converting enzyme inhibitors. ( Kawano, Y; Omae, T; Yoshida, K, 1987) |
| "We report the development of the carpal tunnel syndrome in 3 hypertensive men (aged 46-58) treated with beta-blockers (propranolol in two patients and metoprolol in the 3rd) for 8-11 years." | 3.67 | The carpal tunnel syndrome in hypertensive patients treated with beta-blockers. ( Emara, MK; Saadah, AM, 1988) |
| "Components of the renin-angiotensin system (plasma renin activity, total and inactive renin, angiotensinogen and angiotensin II) were examined in 90 patients with labile and stable essential hypertension before and after functional and pharmacologic tests." | 3.67 | [Correlation of the total activity of blood plasma renin with levels of active and inactive renin, angiotensinogen and angiotensin II under different functional loads in patients with hypertension]. ( Masenko, VP; Uchitel', IA; Ustinova, SE, 1988) |
| "Therapeutic efficiency and hemodynamic effects of prazosin were examined in 42 patients with essential hypertension in the course of prolonged treatment." | 3.67 | [Long-term use of prazosin alone and combined with propranolol in patients with essential hypertension]. ( D'iakonova, EG; Erina, EV; Prokopova, TN, 1986) |
| "The ability of propranolol to inhibit the development of polyploidy in aortic vascular smooth muscle cells associated with hypertension was studied in deoxycorticosterone (DOC)-salt treated rats." | 3.67 | Inhibition of nuclear polyploidy by propranolol in aortic smooth muscle cells of hypertensive rats. ( Chobanian, AV; Leitschuh, M, 1987) |
| "2 mg propranolol intravenously resulted in acute pulmonary edema." | 3.67 | Severe hypertension, propranolol, and acute pulmonary edema. ( Desai, SP; Fleming, TC; Pierce, EC, 1987) |
| "An elderly, mildly demented, hypertensive male patient developed hypersomnolence on administration of propranolol for treatment of hypertension; no other cause for hypersomnolence was detected." | 3.67 | Hypersomnolence with beta-adrenergic blockers. ( Kochar, MS; Thachil, J; Zeller, JR, 1987) |
| "The effects of propranolol (10 mg/kg) on systolic blood pressure (SBP), resting and exercising heart rates (HR), and body weight (BW) were examined in 11-week swim-trained spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats." | 3.67 | Attenuation by propranolol of exercise training effects in spontaneously hypertensive rats. ( Allevard, AM; Augoyard, G; Desplanches, D; Favier, R; Gauquelin, G; Ghaemmaghami, F; Gharib, C, 1987) |
| "Effect of long-term oral administration of the converting enzyme inhibitor (2R, 4R)-2-(o-hydroxyphenyl)-3-(mercaptopropionyl)-4-thiazolidinecarboxylic acid (SA446) in combination with hydrochlorothiazide or propranolol on the development of hypertension was examined in spontaneously hypertensive rats (SHR)." | 3.67 | [Combined effect of (2R, 4R)-2-(o-hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidinecarbo xyl ic acid (SA446) with hydrochlorothiazide or propranolol on development of hypertension in spontaneously hypertensive rats (SHR) by long-term administration]. ( Iso, T; Nakata, K; Takada, T; Yamauchi, H, 1986) |
| "The effect of propranolol on renal haemodynamics was studied in nine patients with arterial hypertension and moderate to severe chronic renal failure." | 3.67 | Renal haemodynamics during propranolol treatment in patients with arterial hypertension and chronic renal failure. ( Fjeldborg, P; Jacobsen, BA, 1986) |
| "Plasma propranolol concentrations were analyzed after Obsidan (VEB Isis-Chemie, Zwickau, GDR) (= preparation A) and another propranolol-preparation (= preparation B) in 10 patients with arterial hypertension of clinical stage I-II in a cross-over design." | 3.67 | [Comparative pharmacokinetic studies on the relative biologic availability of two propranolol preparations in patients with steady state essential hypertension]. ( Faulhaber, HD; Gohlke, HR; Prehm, C; Rostock, G, 1986) |
| "A study of the effect of propranolol on the central hemodynamics using the polycardiographic method in 90 patients with essential hypertension showed that in 83% of them, disregarding the type of hemodynamics, beta-blocker made a negative chronotropic effect, and in 17% of the patients it increased the heart rate." | 3.67 | [Evaluation of the effect of obsidan in essential hypertension patients with different types of circulation]. ( Goloshchapov, OA; Kotova, LN; Nozhnova, LP; Pribylova, NN, 1986) |
| "Captopril in low doses has been used recently with success in the treatment of mild to moderate hypertension." | 3.67 | Comparison of low-dose captopril and propranolol as second-line drugs in mild and moderate hypertension. ( Rosenfeld, JB; Traub, YM, 1985) |
| "The effect of propranolol on baroreflex control of heart rate was studied in 12 young patients with essential hypertension and was compared with that of 12 age-matched normotensive subjects." | 3.67 | Effect of propranolol on baroreflex control of heart rate in young patients with essential hypertension. ( Hattori, N; Ikeda, T; Iwase, N; Ogawa, J; Okuwa, H; Takata, S; Yagi, S, 1986) |
| "As part of the Veterans Administration cooperative studies on antihypertensive agents, systolic time intervals (STIs) were recorded before and after 2 or 4 weeks of treatment with hydrochlorothiazide (HCTZ) alone in 320 asymptomatic patients with mild to moderate hypertension." | 3.67 | Serial measurements of systolic time intervals during treatment with hydrochlorothiazide alone and combined with other antihypertensive agents. ( Freis, ED; Kyle, MC, 1985) |
| "Phenylpropanolamine (PPA) overdose can cause severe hypertension, intracerebral hemorrhage, and death." | 3.67 | Propranolol antagonism of phenylpropanolamine-induced hypertension. ( Asinger, RW; Benowitz, NL; Pentel, PR, 1985) |
| "To determine the efficacy of nifedipine combined with propranolol in the treatment of hypertension, 23 patients with essential hypertension uncontrolled while they were receiving propranolol, 120 mg/d, entered a dose response trial of four 8-week periods while continuing propranolol therapy." | 3.67 | Effect of nifedipine and propranolol on blood flow, venous compliance and blood pressure in essential hypertension. ( Ogilvie, RI, 1985) |
| "The effect of an 8-week monotherapy with propranolol and pratsiol on plasma lipid levels and apo-Al and apo-B, apoproteins of high- and low-density lipoproteins (HDLP, LDLP) was studied in 20 patients with second-stage essential hypertension." | 3.67 | [Effect of obzidan and pratsiol therapy on the blood plasma lipid profile and on the high- and low-density lipoprotein apoproteins in hypertension patients]. ( Metel'skaia, VA; Mustafaev, II; Oganov, RG; Perova, NV; Postol'nikov, SF, 1985) |
| "The treatment of the mentioned forms of hypertension with propranolol during pregnancy either as monotherapy or in combination with dihydralazine and after careful exclusion of the contraindications described represents a further effective therapy." | 3.67 | [Experiences with propranolol (Obsidan25) in hypertension therapy in pregnancy]. ( Glöckner, R; Peiker, G; Siegert, C; Traeger, A; Völkner, E, 1985) |
| "All Wistar rats showed hypertension when they were given heat-stress and administered metyrapone (200 micrograms/kg/day), a cholesterol-11-beta-hydroxylase inhibitor." | 3.67 | [Hypertension in rats caused by metyrapone and heat-stress treatment]. ( Arakawa, K, 1985) |
| " Propranolol, acebutolol and practolol, at a daily dose of 50 mg/kg, prevented the occurrence of hypertension, not only during the 4 weeks of treatment, but also during 6,9 and 11 weeks respectively after cessation of treatment." | 3.66 | Variability in the preventive action of the B-blockers on genetic hypertension in the rat. ( Brotelle, R; Colot, M; de Clavière, M; Heyndrickx, JP, 1980) |
| "Twenty-nine patients with severe hypertension (n = 14) or hypertensive crisis (n = 15) were treated with diazoxide infusion and intravenous injection of a beta blocker." | 3.66 | Combined intravenous administration of diazoxide and beta-blocking agent in acute treatment of severe hypertension or hypertensive crisis. ( Huysmans, FT; Koene, RA; Thien, TA, 1982) |
| "Heart rate (HR), blood pressure and systolic time intervals (STI), including total electromechanical systole (QS2), left ventricular ejection time (LVETc), pre-ejection period (PEPc), the PEP/LVET index and the time to the peak of carotid upstroke (Ut), were measured in 24 patients with moderate essential hypertension after 15 days of treatment with oral furosemide (F), hydrochlorothiazide (H), propranolol (P), atenolol (A), furosemide + propranolol (F + P) and hydrochlorothiazide + propranolol (H + P)." | 3.66 | Modification of blood pressure and systolic time intervals by diuretics and beta-blockers in essential hypertension. ( Gamio Capestany, F; García-Barreto, D; González-Gómez, A; Hernández-Cañero, A, 1983) |
| "Hemodynamic variables were measured in 34 patients with isolated systolic hypertension before and after acute administration of propranolol." | 3.66 | Comparative effects of beta-adrenergic blockade in systolic hypertension according to age. ( Bouthier, J; Gitelman, R; Levenson, J; Maarek, B; Safar, M; Simon, A; Totomoukouo, J, 1983) |
| "Five patients presenting with severe hypertension who failed to exhibit diastolic blood pressures less than 120 mm Hg following the oral administration of propranolol (60--80 mg) and furosemide (40 mg) received minoxidil (20 mg, p." | 3.66 | Rapid reduction of severe hypertension with minoxidil. ( Alpert, MA; Bauer, JH, 1980) |
| "The effect of exercise on the urinary excretion of albumin, beta 2-microglobulin, renal plasma flow (RPF) and glomerular filtration rate (GFR) was studied in two groups of young patients with mild essential hypertension, one comprising nine untreated patients (1) and one comprising eight patients treated with propranolol (2), and in a group comprising ten normotensive healthy control subjects (3)." | 3.66 | Effects of exercise on urinary excretion of albumin and beta 2-microglobulin in young patients with mild essential hypertension without treatment and during long-term propranolol treatment. ( Larsen, JS; Mogensen, CE; Pedersen, EB, 1981) |
| "Nifedipine was given to 15 patients with essential hypertension for 6 weeks and to 8 normotensive subjects for 5 days." | 3.66 | Contrasting effects of nifedipine, captopril, and propranolol in normotensive and hypertensive subjects. ( MacGregor, GA; Markandu, ND; Rotellar, C; Sagnella, GA; Smith, SJ, 1982) |
| "The antihypertensive effect of captopril was tested on 19 patients with essential hypertension, WHO grade I or II." | 3.66 | [Captopril in the treatment of essential hypertension (author's transl)]. ( Braun, B; Klaus, D; Lederle, RM, 1980) |
| " The plasma aldosterone responses to exogenous angiotensin II and adrenocorticotropic hormone (ACTH) were studied before and after 1 month of propranolol therapy (120-240 mg/day) in eight patients with essential hypertension." | 3.66 | Effect of propranolol therapy on aldosterone responses to angiotensin II and adrenocorticotropic hormone in essential hypertension. ( Fittingoff, DB; Golub, MS; Tuck, ML, 1981) |
| " The development of hypertension in SHR rats were attenuated by treatment but none of the drugs was able to restore the impairment in isoproterenol, secretin and glucagon responsiveness of cardiac adenylate cyclase activity which is characteristic of these animals." | 3.66 | Comparative effects of alpha-methyldopa, propranolol and hydralazine therapy on cardiac adenylate cyclase activity in normal and spontaneously hypertensive rats. ( Camus, JC; Chatelain, P; Christophe, J; De Neef, P; Roba, J; Robberecht, P; Waelbroeck, M, 1981) |
| " Pre-operative control of both diabetes and hypertension was achieved with propranolol and phenoxybenzamine, but not with propranolol alone." | 3.66 | Phaeochromocytoma and diabetes mellitus: further evidence that alpha 2 receptors inhibit insulin release in man. ( Isles, CG; Johnson, JK, 1983) |
| "The effects of metoprolol, propranolol and hydrochlorothiazide on lipoprotein metabolism were studied in three different but comparable groups of middle-aged men with previously untreated hypertension (n=10, n=10, and n=11, respectively)." | 3.66 | Effects of anti-hypertensive therapy on serum lipoproteins. Treatment with metoprolol, propranolol and hydrochlorothiazide. ( Berglund, G; Bondjers, G; Elmfeldt, D; Fager, G; Lager, I; Olofsson, SO; Smith, U; Wiklund, O, 1983) |
| "Sixteen patients with uncomplicated systemic hypertension were treated with placebo, diltiazem (180 mg/day) and propranolol (60 mg/day) for 1 month each." | 3.66 | Effects of diltiazem on cardiovascular responses during exercise in systemic hypertension and comparison with propranolol. ( Kondo, S; Nakano, T; Noziri, A; Oonishi, N; Takezawa, H; Yamakado, T, 1983) |
| "Thirty-three patients with essential hypertension and two with symptomatic arterial hypertension (Stage I-III) were treated for about two years with the drug obsilazin containing 50 mg propranolol and 50 mg dihydralazin per tablet (the maximum average dose of each drug was 174 mg/day)." | 3.66 | [Long-term treatment of arterial hypertension with a new combined preparation obsilazin]. ( Diuk, KD, 1983) |
| "Twenty-seven patients with moderate to moderately severe hypertension who had not responded optimally to treatment with a standard step 2 regimen were treated with a three-drug regimen of hydrochlorothiazide, propranolol, and guanadrel." | 3.66 | Safety and efficacy of a three-drug regimen for the treatment of hypertension: hydrochlorothiazide, propranolol, and guanadrel. ( Gore, RD, 1983) |
| "Fourteen hypertensive men underwent assessment of renal function and body fluid composition following short-term (three to six weeks), long-term (five to six months), and withdrawal (two weeks) of propranolol hydrochloride monotherapy for the treatment of hypertension." | 3.66 | Effects of propranolol therapy on renal function and body fluid composition. ( Bauer, JH, 1983) |
| "The technique of non-invasive blood pressure monitoring was used to compare the 24-hr control of blood pressure in 10 patients with essential hypertension taking either twice daily propranolol or a once daily long-acting formulation of propranolol (propranolol LA)." | 3.66 | Comparison of propranolol and propranolol LA in hypertension using 24-hr noninvasive blood pressure monitoring. ( Coomes, EN; Rustin, MH, 1983) |
| "The role of the renin-aldosterone axis in mediating responses to antihypertensive treatment was examined in patients with essential hypertension treated with propranolol (n=50) or chlorthalidone (n=50)." | 3.66 | The role of aldosterone in the response to treatment of primary hypertension. ( Drayer, JI; Laragh, JH; Purdy, RE; Weber, MA, 1982) |
| "The effect of an acute intravenous and repeated oral doses of propranolol on haemodynamics, plasma and urinary catecholamines and plasma renin activity was studied in patients with essential hypertension." | 3.66 | Effects of acute and long-term beta-adrenoceptor blockade with propranolol on haemodynamics, plasma catecholamines and renin in essential hypertension. ( Kho, TL; Rahn, KH; Thijssen, H; van Baak, MA, 1982) |
| "Plasma renin activity (PRA) and systolic time intervals (STI), including total electromechanical systole (QS2), left ventricular ejection time (LVET), pre-ejection period (PEP) and isovolumetric contraction time (ICT), were measured in patients with borderline hypertension (n = 23) before and after oral treatment with atenolol and propranolol." | 3.66 | Effects of propranolol and atenolol on plasma renin activity and systolic time intervals in borderline hypertension. ( Fong Chi, S; Gamio Capestany, F; García-Barreto, D; González-Gómez, A; Hernández-Cañero, A, 1982) |
| "Serum concentrations of LH, FSH, testosterone and prolactin were measured in patients with hypertension treated with propranolol (34 cases), methyldopa (13 cases), and methyldopa + propranolol (11 cases)." | 3.66 | Plasma sex hormone concentrations in men with hypertension treated with methyldopa and/or propranolol. ( Crisp, AJ; Hoffbrand, BI; Jacobs, HS; Maguire, A; Taylor, RG, 1981) |
| "The 24-h urinary excretion of prostaglandins (PG) E2 and F2 alpha, which reflects the renal synthesis of these substances, was measured by radioimmunoassay in 10 patients with essential hypertension before and after treatment with propranolol." | 3.66 | Effect of propranolol treatment on the urinary excretion of prostaglandins E2 and F2 alpha in patients with essential hypertension. ( Bernheim, J; Rathaus, M, 1982) |
| "Sclerosing peritonitis developed in a 56-year-old white man who had been receiving propranolol (320 mg/day) for hypertension and angina pectoris since December 1976." | 3.66 | Sclerosing peritonitis and propranolol. ( Ahmad, S, 1981) |
| "Maximal exercise testing of middle-aged men with either risk factors or prior clinical manifestations of coronary heart disease (CHD), identifies subsets at increased risk for primary or secondary CHD events, aids selection of patients of coronary artery bypass surgery and reveals a subgroup at greater risk if treated with propranolol." | 3.66 | Predictive value of symptom-limited exercise for risk assessment of primary and secondary events due to coronary heart disease in men. ( Bruce, RA; DeRouen, TA; Hossack, KF, 1981) |
| "The hypotensive effect of nifedipine was studied in 9 patients with severe hypertension." | 3.66 | Management of severe hypertension with nifedipine in combination with clonidine or propranolol. ( Abe, K; Chiba, S; Haruyama, T; Imai, Y; Irokawa, N; Ito, T; Miura, Y; Otsuka, Y; Saito, K; Sakurai, Y; Sato, M; Yasujima, M; Yoshinaga, K, 1980) |
| "The effects of propranolol (100 mg/kg), atenolol (200 mg/kg) and acebutolol (1000 mg/kg) administered daily by gavage to spontaneously hypertensive rats (SHRs) from their 6th to 20th weeks of age were investigated on genetic hypertension development (GHD) and at regular intervals on heart rate (HR), cardiac output (CO), stroke volume (SV), peripheral resistence (PR), plasma renin concentration (PRC) and heart weight/body weight ratio (HW/BW)." | 3.66 | beta-Adrenoreceptor blockage and genetic hypertension development in rats. ( Boissier, JR; Giudicelli, JF; Richer, C; Venturini-Souto, N, 1980) |
| "A case of severe hypertension resistant to multiple drug therapy was controlled with minoxidil, captopril, and propranolol hydrochloride after treatment with these drugs alone or in other combinations had failed." | 3.66 | Interaction of minoxidil and captopril in the treatment of refractory hypertension. ( Matson, JR; Norby, LH; Robillard, JE, 1981) |
| " We have measured plasma concentrations of renin, renin substrate and angiotensins I and II as well as plasma renin activity in nine patients with severe or malignant hypertension during treatment with captopril, hydrochlorothiazide and propranolol." | 3.66 | Captopril combined with thiazide lowers renin substrate concentration: implications for methodology in renin assays. ( Damkjaer Nielsen, M; Giese, J; Rasmussen, S, 1981) |
| "26 patients with severe hypertension (10 essential, 9 renal parenchymatous, 7 renovascular) and a mean age of 42 years were treated with the new oral converting enzyme inhibitor captopril (SQ 14225)." | 3.66 | [Captopril in treatment-resistant hypertension (author's transl)]. ( Lüscher, T; Siegenthaler, W; Studer, A; Vetter, W, 1980) |
| "Combined use of prazosin and propranolol was effective in preoperative management of three patients with norepinephrine(NE)-secreting pheochromocytoma (PHEO)." | 3.66 | Prazosin and propranolol in preoperative management of pheochromocytoma. ( Cubeddu, LX; Rosales, CB; Zarate, NA; Zschaeck, DW, 1982) |
| "Two studies of systolic time intervals (STIs) in patients with mild to moderate hypertension (HBP) revealed that no mean change in systolic intervals occurred with pindolol therapy, although some patients had significant alterations in their STIs." | 3.66 | Pindolol and systolic time intervals in patients with hypertension. ( Carliner, NH; Fisher, ML; Hamilton, BP; Hamilton, JH; Hammond, JJ; Jacks-Nagle, VL; Janoski, AH; Kirkendall, WM; Plotnick, GD; Robinson, M, 1982) |
| "Basal hemodynamics and plasma catecholamines were measured in 10 patients with systolic hypertension, 7 males and 3 females, aged 38-69 years (Group 1), and in 10 patients with systolic and diastolic hypertension, 7 males and 3 females, aged 40-65 years (Group 2); the same measurements were repeated after acute pharmacological alpha and beta-blockade with Labetalol, 100 mg iv, or Propranolol, 10 mg iv, plus Phentolamine, 10 mg iv." | 3.66 | Adrenergic activity in systolic hypertension. ( Agabiti-Rosei, E; Alicandri, C; Beschi, M; Boni, E; Castellano, M; Fariello, R; Muiesan, G; Muiesan, ML; Romanelli, G, 1982) |
| "Fifteen elderly patients whose hypertension was controlled by conventional propranolol 80 mg twice a day had their medication changed to one capsule of 'Inderal' LA (160 mg) daily." | 3.66 | The use of long-acting propranolol ('Inderal' LA) in the management of elderly hypertensive patients. ( Baber, NS; Hamdy, C; McAinsh, J; Tovey, D, 1982) |
| " To determine the effects of antihypertensive drugs on heart rate and blood velocity 15 patients with hypertension were treated with placebo, hydrochlorothiazide, nadolol, propranolol and hydralazine in sequence." | 3.66 | Effects of antihypertensive agents on blood velocity: implications for atherogenesis. ( Spence, JD, 1982) |
| "The disposition of orally administered propranolol has been studied in twelve patients with mild to moderate hypertension." | 3.66 | Variable first-pass elimination of propranolol following single and multiple oral doses in hypertensive patients. ( McBride, JW; McCoy, HG; Rylander, ML; Sawchuk, RJ; Wargin, WA, 1982) |
| "1 The anti-hypertensive effects of intravenously and intracisternally administered (+/-)-propranolol were studied in anaesthetized dogs with acute neurogenic (sino-aortic denervation) hypertension." | 3.66 | Effect of intracisternal 5,-7-dihydroxytryptamine on the acute antihypertensive action of propranolol in the sino-aortic denervated anaesthetized dog. ( Montastruc, JL; Montastruc, P, 1981) |
| "Propranolol is widely employed in hemodialysis patients for the control of renin-dependent hypertension." | 3.66 | Propranolol-associated hypoglycemia in patients on maintenance hemodialysis. ( Gelfand, M; Knepshield, J; Novello, A; Preuss, HG; Zarate, A, 1981) |
| "1 The rates of noradrenaline spillover to, and removal from, plasma were measured in ten patients with essential hypertension treated with propranolol, to ascertain if long-term administration of this drug reduces sympathetic nervous system tone." | 3.66 | Effect of propranolol on noradrenaline kinetics in patients with essential hypertension. ( Bobik, A; Esler, M; Jackman, G; Jennings, G; Leonard, P; Skews, H, 1981) |
| "Eighty-seven patients with intractable hypertension received minoxidil for a mean duration of 27 months (range three months to five years)." | 3.66 | Minoxidil in the management of intractable hypertension. ( Fife, R; Henderson, I; Isles, C; Kennedy, AC; Mackay, A, 1981) |
| "A hypertensive women was treated throughout pregnancy with propranolol 40 mg daily without complication." | 3.66 | Anti-hypertensive therapy with propranolol during pregnancy and lactation. ( Taylor, EA; Turner, P, 1981) |
| " Own examinations showed that in 32 patients with essential hypertension of stage I (after Baumann and Nitschkoff) under therapeutic doses of 50--80 mg propranolol a day in none of the 18 chemical parameters tested after a four weeks' treatment significant deviations relevant to practice appeared in comparison to the parameters before treatment." | 3.66 | [Effect of drugs on laboratory diagnosis--effect of propranolol on selected laboratory values]. ( Böhme, HR; Hentschel, E; Lasek, R; Reinelt, D, 1981) |
| "The disposition of the pharmacologically active 4-hydroxypropranolol (HO-P), its glucuronic acid conjugate (HO-P-G), and propranolol were compared after single intravenous and oral doses of propranolol in 6 normal subjects and after long-term therapy in 32 patients with hypertension or coronary artery disease." | 3.66 | 4-Hydroxypropranolol and its glucuronide after single and long-term doses of propranolol. ( Conradi, EC; Fagan, TC; Gaffney, TE; Walle, T; Walle, UK, 1980) |
| "In 26 patients with essential hypertension who were on continuous chlorthalidone therapy, 1 and 3 daily doses of propranolol were compared in a crossover study." | 3.66 | One and three doses of propranolol a day in hypertension. ( Boer, P; Dorhout Mees, EJ; Geyskes, GG; van Asten, P; van den Brink, G, 1980) |
| "Three patients with no history of asthma or allergy developed bronchospasm while taking propranolol for hypertension." | 3.66 | Propranolol-related bronchospasm in patients without history of asthma. ( Adler, S; Bruns, FJ; Fraley, DS; Segel, DP, 1980) |
| "The effects of propranolol on blood pressure, plasma catecholamine concentration and platelet aggregation were examined in 16 patients with uncomplicated primary hypertension." | 3.66 | Hypertension and propranolol therapy: effect on blood pressure, plasma catecholamines and platelet aggregation. ( Aledort, L; Vlachakis, ND, 1980) |
| "A combination of propranolol and hydrallazine was administered to 13 patients with longstanding hypertension during 15 pregnancies." | 3.66 | Propranolol and hydrallazine in the management of essential hypertension in pregnancy. ( Bott-Kanner, G; Joel-Cohen, SJ; Reisner, SH; Rosenfeld, JB; Schweitzer, A, 1980) |
| " The common factor in all 5 patients was propranolol administration for the treatment of hypertension." | 3.66 | Hypoglycemia in chronic hemodialysis patients: association with propranolol use. ( Albin, J; Grajower, MM; Walter, L, 1980) |
| "The influence of two beta-adrenoceptor antagonists, propranolol and pindolol, on the haemodynamic effects of papaverine, isoprenaline and noradrenaline was investigated in 9 male patients with first degree essential hypertension." | 3.66 | Influence of propranolol and pindolol on the haemodynamic effects of papaverine, isoprenaline and noradrenaline in hypertensive patients. ( Chu, D; Cocco, G; Haeusler, G; Schweda, E; Strozzi, C, 1980) |
| "Pericardial effusions are occasionally observed in patients treated with the new oral vasodilator, minoxidil." | 3.66 | Pericardial effusion associated with minoxidil therapy. ( Chatterjee, K; Houston, MC; McChesney, JA, 1981) |
| "Pretreatment with 6-hydroxydopamine abolished the antihypertensive effects of intravenously and intracisternally administered dl-propranolol in dogs with acute neurogenic hypertension." | 3.66 | [Can blockade of presynaptic adrenergic beta receptors explain the antihypertensive effects of propranolol?]. ( Montastruc, JL; Montastruc, P, 1979) |
| " 20 subjects with uncomplicated essential hypertension were studied, 10 of whom were on propranolol treatment." | 3.66 | Renin secretion by the human kidney. ( Birkenhäger, WH; De Leeuw, PW; Falke, HE; Van Soest, GA, 1978) |
| " In 20 subjects with uncomplicated essential hypertension, 10 of whom were on propranolol treatment, several blood samples were drawn simultaneously from the renal artery and vein after angiographic studies." | 3.66 | Noradrenaline secretion by the human kidney. ( Birkenhäger, WH; de Leeuw, PW; Falke, HE; Punt, R, 1978) |
| " Sixteen patients (11 male, five female), median age 41 years, with essential hypertension insufficiently controlled by hydrochlorothiazide (75 mg/day; diastolic blood pressure greater than or equal to 100 mmHg), were studied." | 3.66 | Angiotensin II blockade during combined thiazide-beta-adrenoreceptor-blocker treatment. ( Giese, J; Ibsen, H; Leth, A; McNair, A, 1979) |
| "A regimen consisting of chlorthalidone, hydralazine and propranolol would be useful in some hypertensive patients with coronary artery disease or aortic dissection if it could be shown that reflex cardiac stimulation induced by hydralazine is completely neutralized by propranolol." | 3.66 | Echocardiographic assessment of the effect of an antihypertensive regimen on left ventricular performance. ( Belasco, RN; Moyer, JP; Pittman, AW; Woods, JW, 1979) |
| "The diagnostic and therapeutic value of the angiotensin converting enzyme inhibitor teprotide (SQ 20881) was assessed in 18 patients with hypertensive emergencies." | 3.66 | Converting enzyme inhibition in hypertensive emergencies. ( Brunner, HR; Chobanian, AV; Gavras, H; Gavras, I; Kershaw, GR; Liang, CS; Tifft, CP, 1979) |
| "We have described two patients with propranolol-induced severe diarrhea, confirmed by rechallenge with the drug." | 3.66 | Severe diarrhea secondary to propranolol. ( Fuller, TJ; Horvath, F; Marbury, TC; Nelson, EW; Uhlemann, ER, 1979) |
| "A 24-year-old man with diagnosed pheochromocytoma of the organ of Zukerkandl, was successfully treated with propranolol hydrochloride to lower his blood pressure." | 3.66 | Norepinephrine-secreting tumor of the organ of Zuckerkandl. Response to propranolol alone. ( Daniel, TM; Newsome, HH; Weir, GC, 1979) |
| "The role of hepatic drug-metabolizing enzyme activity for plasma propranolol and sotalol levels was investigated in 68 patients with hypertension or angina pectoris by comparing elimination rate with antipyrine kinetics and cytochrome P-450 content in the liver." | 3.66 | Plasma clearance of propranolol and sotalol and hepatic drug-metabolizing enzyme activity. ( Anttila, M; Järvensivu, P; Pelkonen, RO; Sotaniemi, EA; Sundquist, H, 1979) |
| " In eight patients with essential hypertension (EHT) and six patients with renovascular hypertension (RVHT) peripheral venous enzymatically active and inactive renin values were followed after acute stimulation of renin release by the vasodilating agent diazoxide (300 mg intravenously)." | 3.66 | Evidence for activation of circulating inactive renin by the human kidney. ( Derkx, FH; Man In 'T Veld, AJ; Schalekamp, MA; Verhoeven, RP; Wenting, GJ, 1979) |
| "A case is presented herein of alopecia developing in a patient receiving propranolol." | 3.66 | Propranolol and alopecia. ( Hilder, RJ, 1979) |
| "Five dialysis patients with residual hypertension were treated with a new sustained-release formulation of propranolol (160 mg per capsule) in a dosage of 1 to 2 capsules per day." | 3.66 | Raynaud's phenomenon in hypertensive dialysis patients taking a sustained-release propranolol formulation. ( Gabriel, R; Poulter, N, 1979) |
| "Total exchangeable body potassium (KE) was determined in fifteen patients with essential hypertension, and total exchangeable body sodium (NaE) in ten, before and after propranolol administration for 2-3 months." | 3.66 | Effect of propranolol on total exchangeable body potassium and total exchangeable body sodium in essential hypertension. ( Pedersen, A; Pedersen, EB; Pedersen, G, 1979) |
| " Propranolol and metoprolol were given in the diet of spontaneously hypertensive (SH) rats during the development of hypertension." | 3.66 | Protein synthesis and composition of cardiac and vascular tissue in spontaneously hypertensive rats and the effects of beta-adrenergic antagonist treatment. ( Boström, SL; Fryklund, J, 1979) |
| "The onset of DOCA-salt hypertension in male Sprague-Dawley rats was prevented during 11 weeks of oral treatment with indapamide (0." | 3.66 | The effects of long term oral treatment with indapamide on the development of DOCA-salt hypertension in rats: vascular reactivity studies. ( Hicks, PE, 1979) |
| "The effect of long-term treatment of hypertension with propranolol, alone or in combination with hydrochlorothiazide and/or dihydralazine, was investigated in 93 patients with various types of hypertension." | 3.66 | [Long-term treatment of arterial hypertension with propranolol. Combination with diuretics and dihydrazinophthalazine]. ( Ambrosio, G; Corgnati, A; Dal Palù, C; Palatini, P; Pessina, AC, 1978) |
| "The effect of abrupt withdrawal of propranolol on serum concentrations of triiodothyronine (T3) and thyroxine (T4) was investigated in 5 patients with uncomplicated essential hypertension." | 3.66 | Propranolol withdrawal and thyroid hormones in patients with essential hypertension. ( Kristensen, BO; Steiness, E; Weeke, J, 1978) |
| "Eleven patients with essential hypertension were given hydralazine (25 mg b." | 3.66 | Renal plasma flow and cardiac output during hydralazine and propranolol treatment in essential hypertension. ( Falch, DK; Norman, N; Odegaard, AE, 1978) |
| "Twenty-five women were treated with propranolol during 26 pregnancies complicated by hypertension." | 3.66 | Propranolol for the treatment of hypertension in pregnancy. ( Eliahou, HE; Mashiach, S; Reisin, E; Romem, I; Serr, DM; Silverberg, DS, 1978) |
| "In 16 patients with hypertension, BP could not be controlled satisfactorily by treatment with propranolol alone (mean dosage 325 mg/day)." | 3.66 | Changes in plasma volume and extracellular fluid volume and after addition of hydralazine to propranolol treatment in patients with hypertension. ( Ibsen, H; Jensen, HA; Leth, A; Rasmussen, K, 1978) |
| "The antihypertensive effect of oral propranolol was studied in 9 children with hypertension." | 3.66 | Propranolol as an antihypertensive agent in children. ( Griswold, WR; Higgins, S; McNeal, R; Mendoza, SA; Sellers, BB, 1978) |
| "A retrospective study is presented of the effect of propranolol on fetal outcome in pregnancies complicated by maternal hypertension." | 3.66 | The possible adverse effect of propranolol on the fetus in pregnancies complicated by severe hypertension. ( Beard, RW; Belsey, E; Cohen, SL; Lieberman, BA; Pinker, GD; Stirrat, GM, 1978) |
| "In fifteen patients with hypertension, inadequately controlled during treatment with propranolol alone (mean dosage 333 mg/day), plasma volume (PV) and extracellular fluid volume (ECV) were determined." | 3.66 | Changes in plasma volume and extracellular fluid volume after addition of prazosin to propranolol treatment in patients with hypertension. ( Ibsen, H; Jensen, HA; Leth, A; Rasmussen, K, 1978) |
| "Minoxidil-induced sequential changes in plasma renin activity, urinary aldosterone and norepinephrine excretion were assessed in 11 patients with severe hypertension receiving propranolol or oxprenolol, chlorthalidone and spironolactone." | 3.66 | [Long-term minoxidil therapy: renin, aldosterone, noradrenaline and the need for beta blockers]. ( Brunner, HR; Ferguson, RK; Gavras, H; Jaeger, P; Jéquier, E; Turini, GA, 1978) |
| "By a combined vasodilator-[diisopropylamine (disostat), dihydralazine (depressan)] furosemide- (furesis-) infusion therapy was tried to achieve a new stabilisation of the blood pressure of therapy-refractory patients with hypertension." | 3.66 | [Drug-induced readjustment of therapy-resistant hypertension]. ( Herrmann, R; Kiesewetter, R, 1978) |
| "The hemodynamic mechanism of the hypotensive effect of propranolol was studied by quantitative radiocardiography in 8 patients with dialysis-resistant hypertension." | 3.66 | Chronic hemodynamic effects of propranolol treatment in dialysis-refractory hypertension. ( Contini, C; Maggiore, Q; Monzani, G; Zoccali, C, 1978) |
| "Hemodynamic and renin studies at rest and during graded upright ergometry were performed in 21 patients with essential hypertension before and after propranolol." | 3.65 | [Exercise hemodynamics and renin before and after acute beta block in patients with essential hypertension]. ( Bühler, FR; Burkart, F; Küng, M; Pfisterer, M, 1976) |
| "Changes in blood pressure, plasma renin activity, and hemodynamic components were studied in 23 patients with essential hypertension treated with oral pindolol or propranolol." | 3.65 | Effects of beta-adrenergic blocking agents on the blood pressure, plasma renin activity and hemodynamics of hypertensive patients. ( Hara, A; Matsunaga, M; Motohara, S; Ogino, K; Saito, M, 1977) |
| "Spontaneously hypertensive (SHR) and Wistar-Kyoto (WKY) rats were treated with beta-adrenergic receptor inhibiting drugs (either propranolol or timolol) from conception until 12 weeks of age to determine if this therapy would alter the development of systemic hypertension or left ventricular hypertrophy." | 3.65 | Development of SHR hypertension and cardiac hypertrophy during prolonged beta blockade. ( Frohlich, ED; Pfeffer, JM; Pfeffer, MA; Weiss, AK, 1977) |
| ") has been studied in 10 patients with various forms of hypertension under four different conditions: before and after salt depletion and with or without propranolol treatment." | 3.65 | Renin dependency of blood-pressure. Analysis by angiotensin II antagonist P113 in hypertensive patients treated with salt depletion and propranolol. ( Boer, P; Dorhout Mees, EJ; Geyskes, GG; Vos, J, 1976) |
| " Acute stimulation of renin release by isoprenaline, tilting, or diazoxide in 13 normotensive individuals and in 9 patients with essential hypertension increased active plasma-renin and reduced inactive plasma-renin." | 3.65 | Inactive renin in human plasma. ( Derkx, FH; Man in 't Veld, AJ; Schalekamp, MA; Verhoeven, RP; von Gool, JM; Wenting, GJ, 1976) |
| " Significantly augmented non-uniform flow changes, however, were produced by ganglion stimulation during hypertension caused by aortic constriction or by methoxamine." | 3.65 | Non-uniform myocardial blood flow caused by stellate ganglion stimulation. ( Uchida, Y; Ueda, H, 1975) |
| "In the dog, the intra-venous injection of practolol (1 to 3 mg/kg) reduces the hypertension provoked by vagotomy and sino-aortic nerves section, or by intra-venous administration of potassium cyanide." | 3.65 | [Effect of practolol on experimental hypertension in dogs]. ( Baïsset, A; Besombes, JP; Montastruc, P, 1975) |
| "The stimulating effect of theophylline on the plasma renin activity (PRA) under beta-receptor blockade by propranolol or practolol was investigated in 27 patients with essential hypertension of degree I-II." | 3.65 | [The influence of propranolol, practolol and theophylline on the plasma renin activity (author's transl)]. ( Klaus, D; Klumpp, F; Lemke, R; Zehner, J, 1975) |
| "The blood pressure response to propranolol treatment was analyzed retrospectively in 187 patients with benign essential hypertension." | 3.65 | Unexpected pressor responses to propranolol in essential hypertension. An interaction between renin, aldosterone and sympathetic activity. ( Case, DB; Drayer, JI; Keim, HJ; Laragh, JH; Weber, MA, 1976) |
| "To understand the role of the renin-angiotensin-aldosterone system in the pathogenesis of human hypertension, in serial studies we have blocked the system using three different pharmacologic probes: 1) reduction of renin secretion by administration of the beta receptor blocker, propranolol; 2) blockade of the action of angiotensin II by infusion of saralasin, a competitive antagonist of angiotensin II; and 3) blockade of the enzymatic conversion of angiotensin I to angiotensin II by infusing a nonapeptide competitive inhibitor." | 3.65 | Blockade of renin or angiotensin for understanding human hypertension: a comparison of propranolol, saralasin and converting enzyme blockade. ( Case, DB; Keim, H; Laragh, JH; Wallace, JM, 1977) |
| "The influence of beta-adrenergic blockade (160 mg per day of propranolol for four weeks) on plasma renin activity, plasma volume, and arterial pressure was explored in 20 patients with essential hypertension with hyper-reninemia from long-term diuretic therapy." | 3.65 | Beta-adrenergic blockade in diuretic-treated patients with essential hypertension. ( Bravo, EL; Dustan, HP; Tarazi, RC, 1975) |
| "Studies were carried out in 69 patients with essential hypertension to examine the relationship between changes in plasma renin activity (PRA) and arterial pressure (BP) in response to a beta-adrenergic blocking agent, propranolol." | 3.65 | Dissociation between renin and arterial pressure responses to beta-adrenergic blockade in human essential hypertension. ( Bravo, EL; Dustan, HP; Lewis, JW; Tarazi, RC, 1975) |
| "Ten children with hypertension poorly controlled with other drugs and high peripheral plasma renin activity after renal transplantation were treated with propranolol." | 3.65 | Treatment of high-renin hypertension with propranolol in children after renal transplantation. ( Holliday, MA; Orloff, S; Potter, DE; Salvatierra, O; Schambelan, M, 1977) |
| "Sympathetic adrenergic nervous activity during operantly conditioned hypertension was evaluated by assessing the effects of specific alpha-(phentolamine or phenoxybenzamine) and beta- (propranolol) adrenergic blockers in baboons reinforced for increasing diastolic pressure in daily, 12-h sessions." | 3.65 | Sympathetic adrenergic blockade effects upon operantly conditioned blood pressure elevations in baboons. ( Brady, JV; Goldstein, DS; Harris, AH, 1977) |
| "Ten hypertensive patients were treated with propranolol throughout pregnancy." | 3.65 | [Treatment of arterial hypertension with propranolol in pregnant women. 10 cases]. ( Kreft, C; Tcherdakoff, Ph, 1977) |
| "The effect of propranolol on diurnal variability of BP and plasma noradrenaline levels was assessed in 15 patients with uncomplicated essential hypertension." | 3.65 | Effects of beta-adrenergic blockade on diurnal variability of blood pressure and plasma noradrenaline levels. ( Birkenhäger, WH; de Leeuw, PW; Falke, HE; Kho, TL; Vandongen, R; Wester, A, 1977) |
| "In a study of 10 patients suffering from hypertension the results showed that combination treatment with prazosin, cyclopenthiazide and a beta-blocker produced a significant fall in blood pressure." | 3.65 | Prazosin combined with thiazide diuretic and beta-blocker in the treatment of hypertension. ( Bhoola, R; Seedat, MA; Seedat, YK, 1977) |
| "In 79 patients with essential hypertension, treatment with propranolol hydrochloride and chlorthalidone together produced significantly greater falls in both systolic and diastolic blood pressures than were obtained with either drug alone." | 3.65 | Renin reactivity as a determinant of responsiveness to antihypertensive treatment. ( Case, DB; Drayer, JI; Laragh, JH; Lopez-Ovejero, JA; Weber, MA, 1977) |
| ") were followed monthly in patients with essential hypertension on metolazone, 5 mg daily for three months and with added propranolol, 40 to 160 mg, for the subsequent three months." | 3.65 | Antihypertensive and renin angiotensin effects of metolazone with and without propranolol. ( Barrett, JD; Eggena, P; Sambhi, MP; Thananopavarn, C; Tuck, M; Wiedman, C, 1977) |
| "Sixteen patients with essentialy hypertension were treated with propranolol 160 to 640 mg daily for three months." | 3.65 | Plasma concentrations of propranolol in patients with essential hypertension. ( Kanto, J; Kleimola, T; Lehtonen, A, 1977) |
| "The therapeutic efficacy of four antihypertensive regimens (minoxidil, propranolol, and hydrochlorothiazide; propranolol and hydrochlorothiazide; methyldopa and hydroch-orothiazide; and hydrochlorothiazide alone) was evaluated in one child with systolic hypertension and in eight children with systolic and diastolic hypertension." | 3.65 | Management of severe childhood hypertension with minoxidil: a controlled clinical study. ( Mirkin, BL; Sinaiko, AR, 1977) |
| " Propranolol and furosemide were administered concomitantly to control reflex tachycardia and fluid retention." | 3.65 | The outpatient treatment of refractory hypertension with minoxidil. ( Ball, JH; Kleiner, JP; Nelson, WP; Norton, JD, 1977) |
| "To investigate the importance of plasma renin activity in determining the antihypertensive action of propranolol and of heart rate in guiding propranolol therapy, the effect of a graded oral dose of propranolol on blood pressure, plasma renin and heart rate was studied in 24 men with essential hypertension and differing initial levels of renin activity." | 3.65 | Blood pressure, renin activity and heart rate changes during propranolol therapy of hypertension. ( Esler, M; Zweifler, A, 1977) |
| "Systolic time intervals, including preejection period (PEP) and left ventricular ejection time (LVET), were studied in patients with permanent essential hypertension before and after intra-venous administration of propranolol 0." | 3.65 | Effect of certain antiadrenergic agents on systolic time intervals in essential hypertension. ( Aboras, NE; Lelguen, CE; Milliez, PM; Roland, EQ; Safar, ME; Weiss, YA, 1977) |
| "The effect of propranolol on serum levels of total and free thyroxine, total and free triiodothyronine, and thyroid-stimulating hormone (TSH) was investigated in 15 clinical euthyroid patients with essential hypertension." | 3.65 | Propranolol-induced increments in total and free serum thyroxine in patients with essential hypertension. ( Kristensen, BO; Weeke, J, 1977) |
| "50 patients with stenocardias in persisting arterial hypertension, of them 33 manifest coronary diseases, were orally treated with doses of propranolol up to 400 mg/die during a longer period." | 3.65 | [Therapy of chronic ischemic heart disease and arterial hypertension by means of beta-receptor blockaders]. ( Dück, K; Knappe, J; Strube, G, 1976) |
| "The acute effects of small doses of intravenous propranolol on renin release and on circulatory dynamics were studied at the time of renal arteriography in 12 persons with essential hypertension." | 3.65 | beta-adrenergic blockade in essential hypertension: reduced renin release despite renal vasoconstriction. ( Adams, DF; Hollenberg, NK; Sullivan, JM, 1976) |
| "The dose of propranolol which produces the optimal therapeutic effect in patients with angina pectoris has been found to vary widely among patients." | 3.65 | The use of drug concentration measurements in studies of the therapeutic response to propranolol. ( Chidsey, C; Favrot, L; Leonetti, G; Morselli, P; Pine, M; Smith, S; Zanchetti, A, 1976) |
| "A study, using non-invasive techniques, was carried out in ten patients with essential hypertension to examine the mechanism of the hypotensive effect of propranolol when used in combination with a potent vasodilator antihypertensive - minoxidil." | 3.65 | Mechanism of the interaction of propranolol and a potent vasodilator antihypertensive agent - minoxidil. ( McNay, J; O'Malley, K; Velasco, M; Wells, J, 1976) |
| "The efficacy and side effects of the combined administration of propranolol and phenoxybenzamine were examined in 19 patients with moderate and moderately severe essential hypertension." | 3.65 | An approach to the treatment of essential hypertension. ( Mendlowitz, M; Vlachakis, ND, 1976) |
| "The records of 185 consecutive patients having myocardial revascularization were reviewed with regard to preoperative administration of propranolol and intraoperative or postoperative complications." | 3.65 | Propranolol therapy in patients undergoing myocardial revascularization. ( Dorney, ER; Douglas, JS; Hatcher, CR; Jones, EL; Kaplan, JA; King, SB, 1976) |
| "These studies indicate that the cardioselective beta-adrenergic blocking drug metoprolol might be expected to be at least as effective for the treatment of arterial hypertension as propranolol." | 3.65 | Studies with a new cardioselective beta-blocker, metoprolol. ( Aurell, M; Johnsson, G; Sannerstedt, R; Svedmyr, N; Werkö, L, 1976) |
| " In patients with mild or moderate essential hypertension, oral propranolol, given in incremental doses, produced a moderate but significant lowering of blood pressure which was correlated with the concentration of propranolol in plasma." | 3.65 | Hypotensive and renin-suppressing activities of propranolol in hypertensive patients. ( Bianchetti, G; Chidsey, CA; Di Salle, E; Leonetti, G; Mayer, G; Morganti, A; Morselli, PL; Terzoli, L; Zanchetti, A, 1975) |
| " Plasma renin activity (PRA) and renin dependency of the blood pressure was analysed in ten patients with various forms of hypertension before and during treatment with volume depletion and/or propranolol." | 3.65 | Change in the renin dependency of blood pressure induced by volume depletion and/or propranolol therapy in hypertensive patients. ( Boer, P; Dorhout Mees, EJ; Geyskes, GG; Vos, J, 1976) |
| " The immediate short-term effects of intravenous injections of propranolol on plasma renin activity were studied in thirty-one normal subjects, 102 patients with benign essential and sixty-six patients with renal hypertension." | 3.65 | The immediate plasma renin response to propranolol: evidence for a different mode of renin release in essential and renal hypertension. ( Braunsteiner, H; Czaykowska, W; Dittrich, P; Skrabal, F, 1976) |
| " The hypotensive effect of propranolol and its correlation with the changes in heart rate, plasma volume and plasma renin activity produced by this drug were studied in normotensive rats and in rats with spontaneous, renovascular and deoxycorticosterone-induced hypertension." | 3.65 | The effects of propranolol on spontaneous and experimental hypertension in the rat. ( Corgnati, A; Oneglia, C; Palatini, P; Palu, CD; Pessina, AC, 1976) |
| " Haemodynamic and renin responses to dynamic exercise before and after intravenous beta-adrenoreceptor blockade with propranolol were compared in twenty-one patients with essential hypertension and either high (n = 7), normal (n = 7) or low plasma renin activity (n = 7)." | 3.65 | Haemodynamic responses to exercise and acute beta-receptor blockade in renin sub-types of essential hypertension. ( Bühler, FR; Burkart, F; Küng, M; Lütold, BE; Pfisterer, M, 1976) |
| " Propranolol, when used for treating arterial hypertension, may influence determinants of both cardiac and vascular function; the consequent changes in cardiac performance may result from the interaction of different and possibly opposite effects." | 3.65 | Cardiac function in the treatment of arterial hypertension with propranolol. ( Bartorelli, C; Fiorentini, C; Guazzi, M; Magrini, F; Olivari, MT; Polese, A, 1976) |
| " 10 patients with essential hypertension were treated with minoxidil and subsequently with a combination of minoxidil plus propranolol." | 3.65 | Control plasma renin activity and changes in sympathetic tone as determinants of minoxidil-induced increase in plasma renin activity. ( McNay, JL; O'Malley, K; Velasco, M; Wells, J, 1975) |
| "Thirteen patients with severe hypertension were treated with combined minoxidil, propranolol, and furosemide (mean daily doses 33 mg, 475 mg, and 578 mg, respectively) for nine to twenty-five months (mean 13." | 3.65 | Long-term treatment of severe hypertension with minoxidil, propranolol and furosemide. ( Bennet, CM; Blaufuss, A; Wilburn, RL, 1975) |
| "Twenty-six patients were selected for treatment with minoxidil on the basis of hypertension which could not be controlled either because of (1) drug failures and/or (2) side effects of drugs." | 3.65 | Minoxidil in severe hypertension: value when conventional drugs have failed. ( Dormois, JC; Nies, AS; Young, JL, 1975) |
| " Propranolol and diuretics were given to prevent reflex tachycardia and fluid retention." | 3.65 | Severe hypertension. Treatment with minoxidil. ( Dunea, G; Mahurkar, SD; Mamdani, B; Mehta, PK; Shansky, RM, 1975) |
| "In 16 normal subjects, in 29 patients with essential hypertension and in 25 patients with renal hypertension plasma renin activity was measured together with pulse rate and blood pressure under resting conditions and 15 minutes after the intravenous administration of 5 mg d-1-propranolol subsequently." | 3.65 | [Different reaction of plasma renin activity after propranolol in essential and renal hypertension]. ( Skrabal, F, 1975) |
| "The effects of propranolol on the circulation and respiration were studied in 38 patients with essential hypertension and symptomatic renal hypertension." | 3.65 | Effects of propranolol on haemodynamic changes and gas exchange at rest, in orthostasis, and on exercise in patients with arterial hypertension. ( Glezer, GA; Megrelishvili, RI; Moskalenko, NP; Zilbert, NL, 1976) |
| "An in vivo study of skeletal muscle paralysis induced by intravenous barium chloride has been made in curarized and non-curarized rats." | 3.65 | Barium-induced skeletal muscle paralysis in the rat, and its relationship to human familial periodic paralysis. ( McArdle, B; Schott, GD, 1974) |
| "When used in the treatment of hypertension propranolol is at least of similar potency to bethanidine, guanethidine, and methyldopa." | 3.65 | Treatment of hypertension with propranolol. ( Gillam, PM; Prichard, BN, 1969) |
| "Amlodipine and ramipril were added to their previous antihypertensive treatment for 12 weeks." | 2.72 | Urinary TGF-beta1 reduction related to a decrease of systolic blood pressure in patients with type 2 diabetes and clinical diabetic nephropathy. ( Bertoluci, MC; Oliveira, FR; Schmid, H; Schmidt, A; Thomazelli, FC; Uebel, D, 2006) |
| "Propranolol CR is an effective antihypertensive formulation that may reduce blood pressure during the morning period of maximum cardiovascular risk." | 2.71 | The antihypertensive efficacy and safety of a chronotherapeutic formulation of propranolol in patients with hypertension. ( Manowitz, N; Neutel, JM; Sica, DA; Weber, MA, 2004) |
| " Patients were randomized to delayed-release propranolol (INP) dosed at 10 p." | 2.71 | Comparison of a chronotherapeutically administered beta blocker vs. a traditionally administered beta blocker in patients with hypertension. ( Neutel, JM; Rotenberg, K, 2005) |
| "Treatment with hydrochlorothiazide diminished the delipidation rate value whereas propranolol mildly increased the removal rate of the remnant particle." | 2.71 | Effects of hydrochlorothiazide and propranolol treatment on chylomicron metabolism in hypertensive objects. ( Bernik, MM; Cazita, PM; Heimann, JC; Nakandakare, ER; Neves, MQ; Nunes, VS; Quintão, EC; Rocha, JC, 2005) |
| " The pharmacokinetic parameters obtained after sublingual or peroral drug administration were: peak plasma concentration (CMAX): 147 +/- 72 vs 41 +/- 12 ng/ml, P < 0." | 2.69 | Pharmacokinetics and pharmacodynamics of propranolol in hypertensive patients after sublingual administration: systemic availability. ( Avakian, SD; Donzella, H; Mansur, AP; Paula, RS; Ramires, JA; Santos, SR, 1998) |
| "Treatment with propranolol significantly decreased BP and HR for 24 h." | 2.69 | Effects of propranolol on cardiovascular and neurohumoral actions of alcohol in hypertensive patients. ( Abe, H; Kawano, Y; Kojima, S; Omae, T; Takishita, S, 1999) |
| "Arterial hypertension is frequently associated with serum lipid abnormalities." | 2.68 | Factors affecting lipoprotein lipase in hypertensive patients. ( Annuzzi, G; D'Orta, G; Di Marino, L; Ferrara, LA; Lucarelli, C; Mancini, M; Marotta, T; Rossi, F; Russo, O, 1995) |
| "The captopril treated patients exhibited favorable changes in several aspects of quality of life: sleep-related, gastrointestinal, and physical activity-related symptoms improved from baseline to end of follow-up." | 2.68 | The effects of replacing beta-blockers with an angiotensin converting enzyme inhibitor on the quality of life of hypertensive patients. ( Anson, O; Neumann, L; Paran, E, 1996) |
| "Propranolol treatment significantly reduced HDL-cholesterol (p < 0." | 2.67 | Metabolic effects of propranolol and hydroflumethiazide treatment in Kenyans with mild to moderate essential hypertension. ( Ogola, EN; Orinda, DA; Yonga, GO, 1993) |
| " No significant difference was observed in the elimination half-life between the two trials." | 2.67 | Differences of chronopharmacokinetic profiles between propranolol and atenolol in hypertensive subjects. ( Ebihara, A; Fujimura, A; Ohashi, K; Shiga, T; Tateishi, T, 1993) |
| " One capsule was taken for three days and then the dosage was doubled for the remainder of a four-week period." | 2.67 | Effect of hydrochlorothiazide, enalapril, and propranolol on quality of life and cognitive and motor function in hypertensive patients. ( Annett, MP; Culbert, JP; McCorvey, E; McKenney, JM; Proctor, JD; Wright, JT, 1993) |
| "Treatment with verapamil caused significant increase of EDF from 61." | 2.67 | [Effects of verapamil and propranolol on the left-ventricular diastolic function in patients with primary arterial hypertension]. ( Markiewicz, M; Rymar, B; Trojnar, R; Wysokiński, A, 1991) |
| "Guanadrel sulfate was also associated with significant decreases in mean fasting plasma glucose and total serum cholesterol, whereas propranolol resulted in an increase in serum triglycerides (p less than 0." | 2.67 | Comparison of the effects of guanadrel sulfate and propranolol on blood pressure, functional capacity, serum lipoproteins and glucose in systemic hypertension. ( Darga, LL; Franklin, BA; Hakim, MJ; Lucas, CP, 1991) |
| "Treatment with reserpine hampered mental activity, including the functions of memory and attention." | 2.67 | [Effect of reserpine and propranolol on mental work capacity and psychological status of workers with hypertension after exposure to neuro-emotional stress]. ( Akhunova, NT; Bokovikov, AN; Dasaeva, LA, 1991) |
| "Propranolol treatment resulted in a decrease of plasma norepinephrine, plasma renin activity, and thromboxane B2 formation." | 2.67 | Fish oil amplifies the effect of propranolol in mild essential hypertension. ( Augustin, S; Goschel, M; Melzer, S; Singer, P, 1990) |
| " After a 2-week single-blind placebo run-in period, patients received indapamide either alone (group I) or in combination with the previous therapy (groups II and III) for 4 months." | 2.67 | Clinical efficacy and quality of life with indapamide alone or in combination with beta blockers or angiotensin-converting enzyme inhibitors. ( Athanassiadis, DI; Boutin, B; Cokkinos, DF; Dimopoulos, CG; Guez, D; Tourkantonis, AA; Toutouzas, PK; Tsakiris, AK, 1990) |
| "Both drugs were effective in the treatment of hypertension." | 2.67 | Nicardipine and propranolol in the treatment of hypertension: similar antihypertensive but dissimilar hemodynamic actions. ( Featherston, W; Gonzalez, DG; Kaplan, NM; Lugo, C; Ralakis, J; Ram, CV, 1990) |
| "Propranolol treated patients had increased "trouble getting breath," bradycardia, shortness of breath or wheezing, and blurred vision." | 2.67 | Self-reported side effects from antihypertensive drugs. A clinical trial. Quality of Life Research Group. ( Baume, RM; Croog, SH; Levine, S; Schoenberger, JA; Sudilovsky, A, 1990) |
| "Nitrendipine is a second-generation dihydropyridine derivative that, though not yet approved in the United States, has been extensively evaluated both there and abroad." | 2.66 | Antihypertensive therapy with nitrendipine: comparison with hydrochlorothiazide and propranolol. ( Massie, BM, 1988) |
| " No clinically relevant pharmacokinetic interactions between cilazapril and propranolol were found." | 2.66 | Pharmacokinetic and pharmacodynamic interactions between the ACE inhibitor cilazapril and beta-adrenoceptor antagonist propranolol in healthy subjects and in hypertensive patients. ( Belz, GG; Breithaupt, K; Erb, K; Essig, J; Hoogkamer, JF; Kleinbloesem, CH; Kneer, J, 1989) |
| " Although some patients remained normotensive after discontinuation of step II drugs, a greater proportion returned to elevated BP than when step II dosage was unchanged." | 2.66 | Effects of reduction in drugs or dosage after long-term control of systemic hypertension. ( Borreson, RE; Fisher, SG; Freis, ED; Hamburger, R; Mezey, KC; Mukherji, B; Neal, WW; Perry, HM; Taguchi, JT; Thomas, JR, 1989) |
| " This difference in drug efficacy persisted throughout the 12-hour dosing interval." | 2.66 | Discrepancy between clinic and ambulatory blood pressure measurement in the evaluation of two antihypertensive agents. ( Cox, JP; Fitzgerald, DJ; O'Brien, E; O'Malley, K, 1989) |
| "Nifedipine was associated with a significant increase in cardiac output and stroke volume at rest and at peak exercise, while propranolol decreased cardiac output at rest and at peak exercise." | 2.66 | Nifedipine, but not propranolol, improves left ventricular systolic and diastolic function in patients with hypertension. ( Boucher, CA; Christensen, DM; Federman, EB; Miller, DD; Ruddy, TD; Zusman, RM, 1989) |
| "Acebutolol was superior to placebo, propranolol, and hydrochlorothiazide in terms of response rate." | 2.66 | Effects of age and race on clinical response to acebutolol in essential hypertension. ( Boyles, PW, 1985) |
| "Acebutolol was shown to be a safe, effective and reliable antihypertensive drug, at least comparable to and probably slightly better than, propranolol in the treatment of hypertension in Black Nigerians." | 2.66 | A double-blind comparison of acebutolol (Sectral) and propranolol (Inderal) in the treatment of hypertension in black Nigerian patients. ( Abengowe, CU, 1985) |
| "Hydrochlorothiazide was used alone in 36 percent of patients, in combination with propranolol in 26 percent, and with methyldopa in 20 percent." | 2.66 | Coronary heart disease and treatment of hypertension. Some Oslo Study data. ( Helgeland, A; Leren, P, 1986) |
| "Celiprolol is a new generation beta blocker with a novel profile of activity that includes a high degree of cardioselectivity, partial beta 2-agonist activity, and possibly a degree of direct peripheral vasodilation." | 2.66 | Antihypertensive therapy with celiprolol: a new cardioselective beta blocker. ( Norris, RJ, 1988) |
| "Propranolol was associated with a documented increase in the degree of bronchial obstruction." | 2.66 | [Effect of different beta-receptor blockers on the respiratory function of patients with chronic obstructive pulmonary disease and arterial hypertension]. ( Dorow, P, 1987) |
| "Treatment with prazosin and propranolol lowered sitting blood pressure to 127/89 mm Hg and 129/91 mm Hg, respectively (not significant), and did not alter the pressor response to smoking." | 2.66 | Assessment of the effects of alpha- and beta-blockade in hypertensive patients who smoke cigarettes. ( Alderman, MH; Laragh, JH; Mann, SJ; Pickering, TG, 1989) |
| "The effect of celiprolol at a daily dosage of 300 mg (19 patients) was compared with that of propranolol at a daily dosage of 120 mg (14 patients) on peripheral blood flow of the calf and foot in a randomized double-blind trial." | 2.66 | [Comparative studies of the effect of a cardioselective and a noncardioselective beta-blocker on peripheral circulation in patients with arterial occlusive disease]. ( Klieber, M; Resch, F, 1986) |
| "Ketanserin is a new strong antiserotoninergic drug that, unlike the previous ones, is selective for 5-hydroxytryptamine receptors." | 2.66 | Effects of ketanserin on blood pressure, peripheral circulation and haemocoagulative parameters in essential hypertensives with or without arteriosclerosis obliterans of the lower limbs. ( Abrignani, MG; Adamo, L; Alaimo, G; Avellone, G; Cutietta, A; Giordano, U; Indovina, A; Novo, S; Pinto, A; Strano, A, 1986) |
| "Treatment with propranolol in non-smoking men in the highest age and blood pressure categories would lead to a reduction in the number having strokes from three to one or two and might possibly reduce the number experiencing myocardial infarction from seven to four." | 2.66 | Stroke and coronary heart disease in mild hypertension: risk factors and the value of treatment. Medical Research Council Working Party. ( , 1988) |
| " Dosage was titrated until blood pressures were normalized (diastolic blood pressure (DBP) less than or equal to 95 mmHg) (1 mmHg = 133." | 2.66 | A novel therapeutic approach for reversal of left ventricular hypertrophy and blood pressure control in hypertensive patients treated with alpha-methyldopa or propranolol. ( Fernandez, PG; Kim, BK; Lee, CC; Snedden, W, 1985) |
| "The propranolol-treated smokers tended to be younger, taller, thinner, and wre more likely to be black." | 2.66 | Cigarette smoking interferes with treatment of hypertension. ( Freis, ED; Henderson, WG; Materson, BJ; Reda, D, 1988) |
| "3." | 2.66 | Changes in calcium metabolic indices during long-term treatment of patients with essential hypertension. ( Bergström, R; Hvarfner, A; Lithell, H; Ljunghall, S; Mörlin, C; Wide, L, 1988) |
| "The patients with complex arrhythmias were older (p less than 0." | 2.66 | Ventricular dysrhythmias in middle-aged hypertensive men treated either with a diuretic agent or a beta-blocker. ( Hardarson, T; Ragnarsson, J; Snorrason, SP, 1987) |
| "Hydrochlorothiazide was added for patients not achieving the treatment goal." | 2.66 | Diltiazem and propranolol in mild to moderate essential hypertension as monotherapy or with hydrochlorothiazide. ( Anderson, M; Bartels, D; Eidelson, BA; Labreche, DG; MacCarthy, EP; Massie, B; Ramanathan, KB; Tubau, JF; Ulep, D; Weiss, RJ, 1987) |
| " The mean supine BP 24 hours post dosing were 177/110 mmHg (placebo), 173/109 mmHg (propranolol) and 164/100 mmHg (atenolol)." | 2.66 | Atenolol or propranolol in hypertensive patients poorly controlled on captopril and frusemide. ( Lovell, HG; Petrie, JC; Robb, OJ; Webster, J; Witte, K, 1987) |
| "Treatment of mild hypertension is becoming increasingly accepted, and many more patients are receiving antihypertensive drugs." | 2.66 | Antihypertensive therapy and quality of life. ( Rakel, RE, 1987) |
| "Nifedipine therapy was associated with an increase in high-density lipoprotein cholesterol levels and a decrease in serum triglyceride levels." | 2.66 | Comparison of nifedipine and propranolol used in combination with diuretics for the treatment of hypertension. ( Christensen, D; Federman, E; Kochar, MS; McCarron, D; Porush, JG; Spitalewitz, S; Zusman, R, 1987) |
| "The Beta-Blocker Heart Attack Trial (BHAT), a double-blind study of 3837 post-myocardial infarction patients, was a multicenter clinical trial that ended early because therapeutic benefit had been demonstrated." | 2.66 | Termination of clinical trials: the beta-blocker heart attack trial and the hypertension detection and follow-up program experience. ( Bell, RL; Curb, JD; Friedman, LM; Payne, GH, 1985) |
| "propranolol retard 160 mg were investigated in a multicentral, double-blind, cross-over study for their action on blood pressure and heart rate in outpatients during ergometer exercise." | 2.66 | Hemodynamic effects of acebutolol and propranolol in hypertensive patients during exercise. ( Reim, HG; Wagner, W, 1985) |
| "Propranolol and placebo were included as positive and negative controls." | 2.65 | Effects of nadolol beta-blockade on blood pressure in hypertension. ( Dennick, LG; Duchin, KL; Groel, JT; Vukovich, RA; Willard, DA, 1980) |
| "Propranolol was the only drug that significantly increased airways obstruction (FEV1, specific airways resistance)." | 2.65 | Labetalol, beta blockers, and acute deterioration of chronic airway obstruction. ( Adam, WR; Barter, CE; Meagher, EJ, 1982) |
| " During a one-year treatment period following the comparative trial, the seven patients who had received bopindolol showed no evidence of tachyphylaxia, the blood-pressure remaining well controlled while the dosage was slightly reduced." | 2.65 | Bopindolol, a new long-acting beta-adrenoceptor antagonist--a randomized comparison against propranolol in hypertensive patients. ( Axthelm, T; Kirch, W, 1983) |
| "Carvedilol was evaluated acutely with invasive (dye-dilution) and noninvasive (plethysmography) technique and showed an acute antihypertensive effect without causing a rise in TPR and with a decrease in regional resistance in the fore-arm." | 2.65 | Beta-adrenoceptor blockade and vasodilatation in essential hypertension. Hemodynamic studies at rest and during exposure to stress. ( Eggertsen, R, 1984) |
| " Dosage was titrated until normotension was attained and patients were then maintained on this treatment for a year." | 2.65 | The correlation of changes in systolic blood pressure with regional anatomical regression of hypertensive left ventricular hypertrophy in patients on chronic antihypertensive therapy (greater than 1 year): alpha-methyldopa compared to propranolol. ( Fernandez, PG; Furlong, L; Gill, V; Kim, BK; Ko, P; Lewis, H; McDonald, J; McManamon, P; Nolan, R; Reichek, N, 1984) |
| " Tapering propranolol dosage is frequently used in the hope of preventing adverse withdrawal events but the success of such a maneuver has not been shown." | 2.65 | Prevention of propranolol withdrawal mechanism by prolonged small dose propranolol schedule. ( Lutterodt, A; Nattel, S; Rangno, RE, 1982) |
| "Enalapril is an effective anti-hypertensive agent with a favourable effect on renal haemodynamics." | 2.65 | Effects of enalapril on blood pressure and renal haemodynamics in essential hypertension. ( de Jong, PE; de Zeeuw, D; Donker, AJ; Navis, GJ, 1983) |
| "Captopril is an effective alternative in the treatment of hypertensive patients not readily controlled with conventional therapy." | 2.65 | The renin-angiotensin system during converting enzyme inhibition with captopril in patients with severe treatment-resistant hypertension. ( Damkjaer Nielsen, M; Giese, J; Ibsen, H; Leth, A; Rasmussen, S, 1984) |
| " Apart from the hydrochlorothiazide dosage which was fixed, the dosage of the other active drugs was titrated incrementally until the target blood pressure level was achieved." | 2.65 | An appraisal of antihypertensive efficacy and adverse reactions with two drug regimens: enalapril maleate as part of triple therapy compared to conventional triple therapy in moderate to severe hypertension. ( Fernandez, PG; Galway, AB; Kim, BK, 1984) |
| " The double regimen caused a drop in pressure of 16/11 mm Hg after one month (daily doses 25 mg chlorthalidone, 103 +/- 25 mg propranolol), and this reduction did not change at the third month in spite of dosage increases (daily doses 25 mg chlorthalidone, 222 +/- 77 mg propranolol)." | 2.65 | A crossover trial of oxdralazine in hypertension. ( Criscuolo, D; Galli, F; Salvadeo, A; Segagni, S; Villa, G, 1983) |
| "Trimazosin was associated with a significant reduction (p less than or equal to 0." | 2.65 | Effect of trimazosin on serum lipid profiles in hypertensive patients. ( Singleton, W; Taylor, CR, 1983) |
| "Propranolol L." | 2.65 | Long acting beta-blockers in the twenty fourth hour. ( Hackett, GI; Harrison, P; Kershaw, S, 1983) |
| " The dose-response curve for the stimulating effect of neostigmine on saliva production was shifted to the right in borderline hypertensive as compared with normotensive subjects." | 2.65 | Studies of salivary flow in borderline hypertension: effects of drugs acting on structures innervated by the autonomic nervous system. ( Rahn, KH; Schols, M; van Baak, MA; van Hooff, M, 1984) |
| "The possibility to apply impedance cardiography technique and individual statistical analysis based on Dixon's criterion to pharmacodynamic studies of single hydralazine ( apressine ), prazosine ( pratsiol ), endralazine ( mirethilan ), propranolol (obsidan) doses is discussed." | 2.65 | [Methodologic approach to individual evaluation of the pharmacodynamic effects of single doses of hydralazine, endralazine, prazosine and propranolol in hypertension patients]. ( Izotov, AI; Postol'nikov, SF; Vygodin, VA, 1984) |
| " Also during treatment, fewer patients receiving hydrochlorothiazide required termination as compared with those receiving propranolol; comparative dosage requirements were lower; additional titration during long-term treatment was required less often, and BP remained lower after withdrawal of the active drugs." | 2.65 | Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension. II. Results of long-term therapy. Veterans Administration Cooperative Study Group on Antihypertensive Agents. ( , 1982) |
| "1 The effects on heart rate and blood pressure after single and multiple dosing (1 month) of a long acting formulation of propranolol 160 mg daily, and conventional propranolol, 80 mg twice daily, or 160 mg daily were compared in 11 moderately hypertensive subjects previously shown to respond to propranolol." | 2.65 | The pharmacodynamics and pharmacokinetics of conventional and long-acting propranolol in patients with moderate hypertension. ( Breckenridge, AM; Green, GJ; MacIver, M; Orme, ML; Serlin, MJ; Sibeon, RG, 1983) |
| "Nifedipine, 30 mg/day, was added and the dose was titrated upwards to 90 mg/day to achieve normal blood pressure." | 2.65 | The combination of propranolol and nifedipine in the treatment of hypertension: acute and long term effects. ( Ishay, DB; Kobrin, I; Leibel, B; Stessman, J; Yagil, Y, 1983) |
| "Labetalol pre-treatment especially seemed to enhance the effect of subsequent propranolol/hydralazine administration." | 2.65 | Comparison of labetalol, propranolol and hydralazine in hypertensive out-patients. ( Donker, AJ; May, JF; ten Berge, BS; van der Veur, E; Wesseling, H, 1982) |
| " Pindolol and propranolol lowered PRA comparably at equivalent dosages, although this effect was not consistently observed in all studies or at all dosage levels." | 2.65 | Pindolol: effects on blood pressure and plasma renin activity. ( Bennett, CM; Glassock, RJ; Gonasun, L; Hamilton, B; Kirkendall, W; Maxwell, M; Weitzman, RE; Winer, N, 1982) |
| "Thus, beta-blocker withdrawal symptoms are reproducible and are indicative of a transient sympathetic hyperresponse." | 2.65 | Abrupt withdrawal of beta-blocking agents in patients with arterial hypertension. Effect on blood pressure, heart rate and plasma catecholamines and prolactin. ( Christensen, NJ; Lanng Nielsen, J; Lederballe Pedersen, O; Mikkelsen, E, 1979) |
| "2 Following 12 weeks' treatment of hypertension with the object of reducing the supine BP to 150/90 mmHg or below, there was a reduction of wall thickness so that only two of the eight continued to show ASH." | 2.65 | Regression of left ventricular hypertrophy during treatment with antihypertensive agents. ( Hill, LS; Monaghan, M; Richardson, PJ, 1979) |
| "Oxprenolol was administered in combination with clortalidone in group B and with phentolamine in group C." | 2.65 | [Beta-blocking agents alone or combined with diuretics or alpha-adrenolytics in the treatment of essential arterial hypertension]. ( D'Agnolo, B; Lupinc, V; Minutillo, S, 1979) |
| " They received in random order: placebo; tienilic acid 250 mg/day; propranolol 80 mg twice daily; and tienilic acid 250 mg/day combined with propranolol 80 mg twice daily." | 2.65 | Biochemical and haematological changes induced by tienilic acid combined with propranolol in essential hypertension. ( Bulpitt, CJ; Havard, CW; Pearson, RM, 1979) |
| "Oxprenolol is a beta-adrenergic blocker with intrinsic sympathomimetic activity." | 2.65 | Hemodynamic effects of oxprenolol and propranolol in hypertension. ( Franciosa, JA; Johnson, SM; Tobian, LJ, 1979) |
| " Although the three treatment regimens were similar with respect to safety and efficacy, the reserpine-hydroflumethiazide combination offers the advantages of more convenient dosage at lower cost." | 2.65 | Step 2 regimens in hypertension. An assessment. ( Berry, C; Finnerty, FA; Gyftopoulos, A; McKenney, A, 1979) |
| " Drug dosage was selected to be proportionate to beta-adrenoreceptor-blocking potency; d-propranolol dosage equalled approximately that of racemic propranolol." | 2.64 | The antihypertensive action of several beta-adrenoreceptor-blocking drugs. ( Waal-Manning, HJ, 1976) |
| "Prazosin appears to be a potent and appropriate third agent." | 2.64 | Evaluation of beta blockade bendrofluazide, and prazosin in severe hypertension. ( Barritt, DW; Heaton, ST; Marshall, AJ; Pocock, J, 1977) |
| " Dose-response curves of isoprenaline were constructed in nine hypertensive patients before and after either propranolol or metoprolol." | 2.64 | Effect of selective and non-selective beta-adrenoreceptor blockade on calf blood flow in hypertensive patients. ( Clement, DL, 1978) |
| "Metoprolol 120 mg/d was significantly superior to propranolol 240 mg/d in holding the diastolic supine blood pressure at less than or equal to 90 mmHg." | 2.64 | South African multicentre study of metoprolol and propranolol in essential hypertension. ( Bosman, AR; Goldberg, B; McKechnie, JK; Offermeier, J; Oosthuizen, OJ, 1977) |
| "Phentolamine has no clinically useful anti-hypertensive effect in conjunction with beta-blockers in patients with essential hypertension." | 2.64 | The transient anti-hypertensive effect of phentolamine in patients receiving beta-blocker treatment. ( Dawson, A; Johnson, BF; Smith, I, 1977) |
| " Pharmacokinetic data were obtained in hypertensive male patients (4) after treatment with 14C-radioactively labelled acebutolol hydrochloride." | 2.64 | [Pharmacokinetics of acebutolol]. ( Collins, RF, 1975) |
| "Propranolol 60 mg/day was no better than placebo in reducing blood pressure." | 2.64 | Propranolol in hypertension: a dose-response study. ( Galloway, DB; Glover, SC; Hendry, WG; Lewis, JA; Logie, AW; Petrie, JC; Simpson, WT; Smith, MC, 1976) |
| "With propranolol, findings were 138 +/- 3/106 +/- 2 to 123 +/- 3/89 +/- 3; in 7 of 12 to less than 91 mm Hg and from 91 to 95 in 4 subjects." | 2.64 | Antihypertensive effects of oxprenolol and propranolol. ( Materson, BJ; Michael, UF; Oster, JR; Perez-Stable, EC, 1976) |
| "Labetalol was more effective in lowering blood pressure but less effective in reducing pulse rate of plasma angiotensin II concentration." | 2.64 | Effect of blood pressure angiotensin II and aldosterone concentrations during treatment of severe hypertension with intravenous labetalol: comparison with propranolol. ( Brown, JJ; Fraser, R; Lever, AF; Morton, JJ; Robertson, JI; Rosei, EA; Trust, PM, 1976) |
| "5." | 2.64 | Clinical evaluation of atenolol in hypertension. ( Aberg, H; Hansson, L; Henningsen, NC; Jameson, S; Karlberg, BE; Westerlund, A, 1976) |
| "Increments in heart rate during the TNG test (sublingual nitroglycerin with assumption of upright posture), passive head-up tilt, and postrecumbency standing were compared to the effects of intravenous isoproterenol in 15 mild hypertensives during administration of placebo and two dosage levels of propranolol." | 2.64 | Heart rate responses during treatment of hypertension with propranolol. The clinical usefulness of the nitroglycerin test. ( Hansson, L; Zweifler, AJ, 1976) |
| "Propranolol treatment gave a sustained reduction of PRA." | 2.64 | Plasma renin activity and blood pressure during long term treatment with propranolol and diuretic. ( Hesse, B; Nielsen, I; Steiness, E, 1976) |
| "Treatment with propranolol resulted in marked suppression of the plasma renin activity (1." | 2.64 | Intrapatient comparison of treatment with chlorthalidone, spironolactone and propranolol in normoreninemic essential hypertension. ( Benraad, TJ; Drayer, JI; Festen, J; Kloppenborg, PW; van't Laar, A, 1975) |
| "Labile hypertension is often associated with elevated cardiac output, increased plasma renin activity (PRA) and urinary cyclic AMP excretion in response to upright posture and to isoproterenol." | 2.64 | Effect of propranolol on cyclic AMP excretion and plasma renin activity in labile essentrial hypertension. ( Boucher, R; Cuche, JL; Genest, J; Hamet, P; Kuchel, O, 1973) |
| "When propranolol was withdrawn blood pressures rapidly rose to hypertensive levels, though not to untreated levels." | 2.63 | Controlled trial of propranolol in hypertension. ( Cowen, KJ; Zacharias, FJ, 1970) |
| "Hypertension is an important risk factor for adverse cardiovascular events including stroke, myocardial infarction, heart failure and renal failure." | 2.55 | Pharmacotherapy for hypertension in adults aged 18 to 59 years. ( Gueyffier, F; Musini, VM; Puil, L; Salzwedel, DM; Wright, JM, 2017) |
| "Beta blockers used for the treatment of hypertension may be associated with increased risk for new-onset diabetes mellitus (DM)." | 2.44 | A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus. ( Bangalore, S; Grossman, E; Messerli, FH; Parkar, S, 2007) |
| "Type 2 diabetes is becoming very common and is closely linked to physical inactivity and obesity." | 2.41 | Beta-blockers and diabetes: the bad guys come good. ( Cruickshank, JM, 2002) |
| " Most antihypertensives can be given once or twice daily without the need for sustained-release dosage forms." | 2.39 | Selected factors that influence responses to antihypertensives. Choosing therapy for the uncomplicated patient. ( Carter, BL; Elliott, WJ; Frohlich, ED; Mann, RJ; Moore, MA; Roberts, RW, 1994) |
| "Verapamil was associated with constipation." | 2.38 | Quality of life in the treatment of hypertension. The effect of calcium antagonists. ( Bulpitt, C; Fletcher, A, 1992) |
| "Hypertension is an asymptomatic conditions which can be life threatening." | 2.38 | Beta blockers and quality of life. ( Cruikshank, JM; McAinsh, J, 1992) |
| " If standard doses of beta-blockers are used in PM subjects, they may be susceptible to concentration-related adverse reactions and they may also require lower and less frequent dosing for control of angina pectoris." | 2.37 | Oxidation phenotype and the metabolism and action of beta-blockers. ( Lennard, MS, 1985) |
| "The chronic use of propranolol is characterized by 10%-20% decrements of renal plasma flow (RPF) and glomerular filtration rate (GFR)." | 2.37 | Beta blockers and renal function: a reappraisal. ( Epstein, M; Oster, JR, 1985) |
| "(2) Treatment with propranolol decreases the aggregatory response to ADP, but it may enhance the response to epinephrine." | 2.37 | Platelet aggregation in hypertension and the effects of antihypertensive treatment. ( Nyrop, M; Zweifler, AJ, 1988) |
| "Pindolol is a beta-adrenoceptor-blocking drug with partial agonist activity (intrinsic sympathomimetic activity [ISA])." | 2.36 | Clinical pharmacology of pindolol. ( Aellig, WH, 1982) |
| "Amiodarone is an extremely potent drug which is effective for both supraventricular as well as ventricular arrhythmias." | 2.36 | New antiarrhythmic drugs. ( Hess, DS; Scheinman, MM, 1983) |
| "Although drug treatment of hypertension is associated with improved survival and decreased vascular complications, drug compliance is a major problem in the control of hypertension." | 2.36 | Antihypertensive pharmacology. ( Freed, CR; Gerber, JG; Nies, AS, 1980) |
| "Labetalol was 6-10 times less potent than phentolamine in blocking alpha-adrenoreceptors and 1." | 2.35 | A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug. ( Brittain, RT; Levy, GP, 1976) |
| "Treatment with methimazole, propranolol, hydrocortisone, and Lugol's iodine solution was used." | 1.56 | Thyroid Storm in a Toddler Presenting as a Febrile Seizure. ( Ladd, JM; Sabsabi, B; von Oettingen, JE, 2020) |
| "Propranolol treatment did not modify diuresis or natriuresis in any experimental group." | 1.51 | Is renal ß-adrenergic-WNK4-NCC pathway important in salt hypertension of Dahl rats? ( Hojná, S; Kopkan, L; Vaněčková, I; Vaňourková, Z; Zicha, J, 2019) |
| "Propranolol has shown to be effective in treating the hypermetabolic state secondary to a major burn injury." | 1.48 | The Safety and Efficacy of Propranolol in Reducing the Hypermetabolic Response in the Pediatric Burn Population. ( Andersen, CR; Blumenthal, E; Herndon, DN; Meyer, WJ; Ojeda, S; Robles, L; Stevens, P, 2018) |
| "Propranolol treatment did not modify obesogenic effect of HFD feeding." | 1.46 | Propranolol treatment lowers blood pressure, reduces vascular inflammatory markers and improves endothelial function in obese mice. ( Brum, PC; Carneiro, EM; da Silva Franco, N; Davel, AP; Guizoni, DM; Lubaczeuski, C; Santos-Silva, JC; Victorio, JA, 2017) |
| " The bioavailability of IGF-1 at both mRNA and protein levels were measured by quantitative real-time PCR and Western blot respectively." | 1.43 | Decrease of the insulin-like growth factor-1 bioavailability in spontaneously hypertensive rats with erectile dysfunction. ( Cheng, SP; Huang, H; Huang, JB; Liu, RH; Mao, FJ; Pan, H; Sun, YL; Xiao, S; Zhong, GJ; Zhou, ZY, 2016) |
| "Hypotension was caused by a drug interaction between adrenaline and chlorpromazine through the activation of the β-adrenergic receptor and showed a dose-dependent effect." | 1.40 | Hemodynamic changes by drug interaction of adrenaline with chlorpromazine. ( Higuchi, H; Ishii-Maruhama, M; Maeda, S; Miyawaki, T; Tomoyasu, Y; Yabuki, A, 2014) |
| "Pomolic acid has recently shown hypotensive effect in rats." | 1.37 | Pomolic acid of Licania pittieri elicits endothelium-dependent relaxation in rat aortic rings. ( Alvarado-Castillo, C; Cardozo, A; Estrada, O; Fernández, AZ; González-Guzmán, JM; Salazar-Bookaman, M, 2011) |
| "Propranolol users were significantly less likely to present with a T4 (odds ratio [OR], 0." | 1.37 | Beta blockers and breast cancer mortality: a population- based study. ( Barron, TI; Bennett, K; Connolly, RM; Sharp, L; Visvanathan, K, 2011) |
| "Hypertension was observed in THS and THO groups." | 1.35 | The effect of ovariectomy on cardiac autonomic control in rats submitted to aerobic physical training. ( Blanco, JH; Maida, KD; Silveira, LC; Souza, HC; Tezini, GC, 2008) |
| "Mirtazapine is a noradrenergic and specific serotonergic antidepressant." | 1.35 | Influence of mirtazapine on the hypotensive activity of enalapril and propranolol in spontaneously hypertensive rats. ( Andrzejczak, D; Kocon, K; Zieba, R, 2008) |
| " Additional mechanisms involving blockade of Ca2+ entry in the vascular smooth muscle and increase in NO bioavailability contributes to beneficial effects of long-term propranolol treatment." | 1.34 | Vascular effects of long-term propranolol administration after chronic nitric oxide blockade. ( Antunes, E; Claudino, MA; De Nucci, G; Priviero, FB; Teixeira, CE; Zanesco, A, 2007) |
| "Propranolol pretreatment (4 microg/0." | 1.33 | Cardiovascular excitatory effect on rats of a fraction isolated from the eyestalk of shrimp: Peneaus vanameii. ( Antequera, R; Cedeño, J; Estrada, O; León, L; Romero-Vecchione, E; Rosa, F; Vásquez, J, 2006) |
| " The results obtained show that Adalat in dosage 60 mg daily during 7 days is most effective in cases with concomitant border-line hypertension." | 1.30 | [Premedication with different groups of hypotensive drugs in preparation of patients with concomitant arterial hypertension to planned surgical treatment]. ( Eliutin, DV; Mil'tsyn, AS; Sadchikov, DV, 1998) |
| " Dose-response curves for NE-induced perfusion pressure, VO2, and lactate production in SHR were shifted to the left compared with WKY." | 1.30 | Altered muscle metabolism associated with vasoconstriction in spontaneously hypertensive rats. ( Colquhoun, EQ; Ye, JM, 1998) |
| " Co-administration with propranolol markedly decreased the heart rate, but little affected the heart weight, suggesting changes in the heart rate during the long-term administration of KW-3049 did not largely affect cardiac hypertrophy." | 1.29 | Effect of the new calcium antagonist (+/-)-(R*)-3-[(R*)-1-benzyl-3- piperidyl] methyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5- pyridinedicarboxylate hydrochloride (KW-3049) on cardiac hypertrophy in spontaneously hypertensive rats. ( Deguchi, T; Hara, T; Hattori, O; Kato, Y; Saijyo, T; Suzuki, K; Tanaka, H, 1993) |
| " Chronic administration of propranolol (5 or 50 mg." | 1.29 | Effects of propranolol and atenolol on immobilization stress-induced hypertension and down-regulation of central beta-adrenoceptors in rats. ( Kigoshi, S; Muramatsu, I; Oda, Y; Takita, M, 1995) |
| "The findings indicate that sleep apnea is associated with a diminished beta 2-adrenergic receptor function but no change in postreceptor components and suggest a mechanism for the high comorbidity between sleep apnea and hypertension." | 1.29 | Beta 2-adrenergic receptor characteristics in sleep apnea patients. ( Ancoli-Israel, S; Clausen, JL; Coy, TV; Dimsdale, JE; Mills, PJ; Nelesen, RA, 1995) |
| "A propranolol dose-response was studied for each strain: (1) saline solution controls (n = 18); (2) propranolol, 10 mg/kg subcutaneously (n = 18); (3) propranolol, 30 mg/kg (n = 14)." | 1.29 | Expansion of aortic aneurysms is reduced by propranolol in a hypertensive rat model. ( Gadowski, GR; Hendley, ED; Pilcher, DB; Ricci, MA; Slaiby, JM, 1994) |
| " The hypotensive action of NZ-105 were reproducible after repeated dosing for 12 weeks." | 1.29 | Effects of long-term oral administration of NZ-105, a novel calcium antagonist, with or without propranolol in spontaneously hypertensive rats. ( Kasuya, Y; Masuda, Y; Sakai, T; Shigenobu, K; Shudo, C; Tanaka, S, 1993) |
| "Felodipine was equally effective at both time points." | 1.29 | Time-dependent efficacy of antihypertensive agents in spontaneously hypertensive rats. ( Janssen, BJ; Oosting, J; Struyker-Boudier, HA; Tyssen, CM, 1993) |
| " There were similar time-variant changes in Cmax and tmax for 4-hydroxypropranolol and naphthoxylactic acid." | 1.29 | The effect of age on diurnal variation in the pharmacokinetics of propranolol in hypertensive subjects. ( Ebihara, A; Fujimura, A; Ohashi, K; Shiga, T; Tateishi, T, 1993) |
| "The effects of the chronic administration of bopindolol on the binding characteristics of [3H]CGP12177 and [3H]prazosin to cardiac alpha 1H-, alpha 1L-, beta 1- and beta 2-adrenoceptor subtypes of spontaneously hypertensive rats (SHR) and Wistar Kyoto rats (WKY) were compared with those of two other beta-blockers, atenolol and propranolol." | 1.29 | Effects of chronic administration of bopindolol on the binding characteristics of cardiac alpha 1H-, alpha 1L-, beta 1- and beta 2-adrenoceptor subtypes in cardiac muscles of spontaneously hypertensive rats (SHR). ( Hattori, K; Hosohata, Y; Maruyama, K; Nagatomo, T; Ohnuki, T; Sasaki, K; Suzuki, J; Watanabe, K, 1996) |
| "Captopril-treated hypertensive rats did not differ significantly from control rats with regard to either cognitive performance or brain blood flow." | 1.29 | Effects of captopril and propranolol on cognitive function and cerebral blood flow in aged hypertensive rats. ( Grossmann, M; Mahurin, RK; Pyne, MT; Skinner, MH; Tan, DX, 1996) |
| "Propranolol has been suggested to slow aortic aneurysm (AAA) expansion by a mechanism independent of simple blood pressure (BP) reduction." | 1.29 | Effects of hypertension and propranolol upon aneurysm expansion in the Anidjar/Dobrin aneurysm model. ( Gadowski, GR; Hendley, ED; Nichols, P; Pilcher, DB; Ricci, MA; Slaiby, JM, 1996) |
| "When propranolol was superinfused, glucose uptake and muscle glycogen synthesis in SHR returned to levels similar to those observed in WKY rats during the first step." | 1.29 | Effects of beta-adrenergic blockade on insulin-mediated glucose disposal in hypertensive and normotensive rats. ( Farrace, S; Frontoni, S; Gambardella, S; Menzinger, G; Rossetti, L, 1996) |
| " isoproterenol tachycardia dose-response curves by dose ratios of 5, 18, and 90 in sham rabbits, respectively, and 5, 11, and 23 in wrap rabbits, respectively, indicating significant cardiac beta 1-adrenoceptor antagonism." | 1.28 | Relationship between the sympatholytic action of nebivolol and hypotension. ( Angus, JA; Coles, P; Cox, H; Eisenhofer, G; Ward, JE, 1992) |
| " Selection of the dosage was individual under the control of circulation parameters." | 1.28 | [The action of the new beta-adrenoblocker Lopressor on the hemodynamics of hypertension patients]. ( Maev, IV; V'iuchnova, ES, 1992) |
| "We studied the effects of chronic administration of beta-adrenoceptor antagonists with and without intrinsic sympathomimetic activity (ISA): carteolol (with ISA) and propranolol (without ISA), respectively, on the heart of spontaneously hypertensive rat (SHR) and Wistar Kyoto rat (WKY)." | 1.28 | Effects of chronic administration of carteolol on beta-adrenoceptors in spontaneously hypertensive rat heart. ( Ebii, K; Fujiwara, M; Fukunaga, R; Kimura, Y; Nakayama, S; Saitoh, Y; Taniguchi, T, 1991) |
| " At dosage levels similar to arotinolol, both pindolol and labetalol were less effective in preventing cerebral lesions despite lower blood pressure." | 1.28 | Prevention of cerebral stroke by arotinolol in salt-loaded SHRSP. ( Hara, Y; Maniwa, T; Miyagishi, A; Noguchi, T, 1991) |
| "Oxprenolol treatment did not modify the blood pressure levels in the renal hypertensive rats nor in the spontaneously hypertensive turkeys." | 1.28 | Cardioprotection by beta-blockers: molecular and structural aspects in experimental hypertension. ( Dal Palù, C; Pauletto, P; Pessina, AC; Scannapieco, G; Vescovo, G, 1990) |
| "dl-Propranolol treatment did not alter norepinephrine-stimulated renal cortical or medullary i6-keto-PGF1 alpha or iPGE2 synthesis." | 1.28 | Chronic treatment with propranolol enhances the synthesis of prostaglandins E2 and I2 by the aorta of spontaneously hypertensive rats. ( Daniell, HB; Gaffney, TE; Halushka, PV; Nishimiya, T; Oatis, J; Walle, T; Webb, JG, 1990) |
| " It was found that in a part of patients the long-term administration of antihypertensive drugs led to an increased accumulation of kynurenine as a manifestation of pyridoxal-5-phosphate deficiency." | 1.28 | Increased blood kynurenine level as a factor inhibiting the therapeutic effect of antihypertensive agents in combined long-term treatment of essential hypertension. ( Liepinja, DJ; Rudzite, VK; Silava, AK; Vitols, AV, 1990) |
| " Doses were calculated to produce plasma levels approximating those achieved after oral dosing (0." | 1.28 | Effects of dilevalol on forearm circulation in essential hypertension. ( Cleroux, J; Giannattasio, C; Grassi, G; Mancia, G; Seravalle, G; Zanchetti, A, 1989) |
| "Indenolol is a nonselective beta-adrenoceptor antagonist whose sympathomimetic properties have been shown in vitro but not in human beings." | 1.28 | Indenolol, a beta-blocker with partial agonism at vascular beta-adrenoceptors. ( Pedrinelli, R; Salvetti, A; Taddei, S, 1989) |
| "Hypertension was induced by a methoxamine HCl iv infusion which mimicked the cardiac effects seen in essential hypertension." | 1.28 | Effect of propranolol on the myocardial contractility of normotensive and spontaneously hypertensive rabbits: relationship of pharmacokinetics and pharmacodynamics. ( Chien, YW; Corbo, M; Li, JK; Wang, PR, 1989) |
| "Captopril was also able to reduce the proteinuria of non-diabetic glomerular origin." | 1.28 | Effects of angiotensin converting enzyme inhibitors on the progression of renal failure and proteinuria in humans. ( Alcazar, JM; Gutierrez-Millet, V; Oliet, A; Praga, M; Rodicio, JL; Ruilope, LM, 1989) |
| "Examination included 70 patients with diabetes mellitus in combination with arterial hypertension of different origin (II stage essential hypertension and symptomatic renal arterial hypertension)." | 1.28 | [Use of crystepin in combination with obsidan in patients with diabetes mellitus with arterial hypertension]. ( Leviashvili, BI, 1989) |
| " Cumulative dose-response curves of plasma cyclic AMP concentration obtained in another group of rats after successive subcutaneous injections of isoproterenol showed that the ED50 value of this drug was higher in SHR than in WKY and increased in a parallel manner in the two strains between 7 and 18 weeks of age (respectively from 0." | 1.27 | Age-related changes of in vivo beta-adrenergic responsiveness in normotensive and spontaneously hypertensive rats. ( Bucher, B; Heitz, C; Stoclet, JC, 1984) |
| "Renal hypertension was induced by clamping both renal arteries 4 weeks before pregnancy." | 1.27 | The acute effects of a non-selective beta-adrenergic blocking agent in hypertensive pregnant rats. ( Karlsson, K; Ljungblad, U; Lundgren, Y, 1984) |
| "Propranolol was infused in SHR subcutaneously for 7 days at two concentrations (either 3." | 1.27 | The effect of week-long infusion of propranolol, via an osmotic minipump, on blood pressure, heart rate and vascular responses in spontaneously hypertensive rats. ( Hanig, JP; Sun, CL; Thompson, TJ, 1984) |
| "Two case reports are described, both breast carcinoma patients with metastatic disease." | 1.27 | A call for caution in the use of aminoglutethimide: negative interactions with dexamethasone and beta blocker treatment. ( Baerwald, H; Catane, R; Halpern, J, 1984) |
| " SCH 19927 produced a competitive alpha 1- and beta 1-blockade in vitro as indicated by the parallel shift to the right of the dose-response curves for norepinephrine and isoprenaline, respectively." | 1.27 | Effects of the R, R-isomer of labetalol, SCH 19927, in isolated tissues and in spontaneously hypertensive rats during a repeated treatment. ( Bamonte, F; Forlani, A; Monopoli, A; Ongini, E; Parravicini, L, 1984) |
| " Chronic administration of 100-150mg of captopril tid caused no further blood pressure reduction." | 1.27 | Further studies on the hypernoradrenergic state of treated hypertensives: effect of captopril. ( Anderson, R; Gianotti, L; Kirk, L; Kuhnert, L; Matthews, C; Mitchell, HC; Pettinger, WA; Reed, G, 1983) |
| "Ozolinone is a loop diuretic with two isomers." | 1.27 | Effect of captopril on intrarenal blood flow. ( Giesen, EM; Imbs, JL; Schmidt, M; Schwartz, J, 1984) |
| "Pretreatment with captopril, an inhibitor of the angiotensin-converting enzyme, attenuated the PGE2 pressor effect." | 1.27 | Mechanisms of central prostaglandin E2 hypertension in conscious dogs, sheep, and calves. ( Chimoskey, JE; Hull, SS, 1984) |
| " Chronic administration of dl-propranolol (30 mg/kg b." | 1.27 | Possible role of an endogenous opioid in the antihypertensive action of propranolol in spontaneously hypertensive rats. ( Farsang, C; Kunos, G; Ramirez-Gonzalez, MD; Tchakarov, L, 1983) |
| "Propranolol appears to be a useful antihypertensive drug in the hyperdynamic head-injured patient because it normalizes blood pressure and the underlying hemodynamic abnormalities both by its beta-adrenergic blocking action and by decreasing circulating levels of catecholamines." | 1.27 | Treatment of hypertension associated with head injury. ( Clifton, GL; Grossman, RG; Robertson, CS; Taylor, AA, 1983) |
| "Arotinolol (S-596, ARL) is a beta-adrenoceptor blocking drug with weak alpha-adrenoceptor blocking activity, and may be classified into the fourth generation." | 1.27 | Chronic effects of arotinolol (S-596) in spontaneously hypertensive rats. ( Kawashima, K; Kishi, K; Saito, K; Sokabe, H, 1985) |
| "Propranolol pretreatment did not significantly alter spontaneous NE overflow, total NE overflow, NE overflow/stimulus or fractional NE overflow in either WKY or SHR mesenteric vascular preparations at any of the PNS frequencies used." | 1.27 | Effects of propranolol and yohimbine on periarterial nerve stimulation-induced release of endogenous norepinephrine from the mesenteric vasculature of Wistar Kyoto and spontaneously hypertensive rats. ( Cline, WH; Yamamoto, R, 1988) |
| "Acebutolol has both antihypertensive and antiarrhythmic effects." | 1.27 | Pharmacologic properties of acebutolol: relationship of hydrophilicity to central nervous system penetration. ( Abernethy, DR; Arendt, RM; Greenblatt, DJ, 1985) |
| "Propranolol (PPL) was used as the reference drug." | 1.27 | Chronic effects of a beta-adrenoceptor blocking drug, 4-[3-(tert-butylamino)-2-hydroxypropoxy]-N-methylisocarbostyril hydrochloride (N-696), in hypertensive rats. ( Ishii, Y; Kawase, S; Kawashima, K; Kishi, K; Kubota, N; Sokabe, H, 1985) |
| " PRA activity was significantly and markedly reduced by both bunolol and metoprolol shortly after dosing at a time when HR was significantly reduced but MBP was not." | 1.27 | Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function. ( Antonaccio, MJ; DeForrest, JM; High, J; Sybertz, E, 1986) |
| " If standard doses of some beta-blockers are used in poor metabolizers, these patients may be susceptible to concentration-related adverse reactions and they may also require lower and less frequent dosing for control of angina pectoris." | 1.27 | Debrisoquine polymorphism and the metabolism and action of metoprolol, timolol, propranolol and atenolol. ( Lennard, MS; Silas, JH; Tucker, GT; Woods, HF, 1986) |
| " Patients were treated with propranolol 40 to 160 mg bid for 8 weeks, followed by atenolol 50 to 100 mg given once daily for 8 weeks, and then rechallenged with the required dosage of propranolol for 8 weeks." | 1.27 | A comparison of the side effects of atenolol and propranolol in the treatment of patients with hypertension. ( Chockalingam, A; Drover, A; Fifield, F; Fodor, JG; Pauls, CJ, 1987) |
| "1." | 1.27 | Large arteries in hypertension: heterogeneous haemodynamic response to beta-adrenoceptor antagonists with and without intrinsic sympathomimetic activity. ( Levenson, J; Pithois-Merli, I; Simon, AC, 1987) |
| "In primary hyperaldosteronism, renal kallikrein activity and absolute vascular reaction to BK was increased." | 1.27 | Direct hypotensive action of intravascular bradykinin in man. ( Bönner, G; Kaufmann, W; Schunk, U, 1985) |
| "Enalapril is an inhibitor of the converting enzyme which transforms angiotensin I into angiotensin II, an octapeptide with pharmacological properties uniformly tending to increase blood pressure." | 1.27 | [Clinical pharmacology of enalapril]. ( Giudicelli, JF, 1985) |
| "Pretreatment with propranolol (2." | 1.27 | Adrenomedullary and beta-adrenergic participation in enhanced sympathetic pressor responses of spontaneously hypertensive rats. ( Bucher, B; Stoclet, JC, 1987) |
| "Treatment with nifedipine in combination with furosemide and propranolol led to a more significant decrease in calcium responses than that expressed with monotherapy." | 1.27 | Platelets as a model for studying the action of antihypertensive drugs. ( Avdonin, PV; Kravchenko, AN; Mazaev, AV; Nekrasova, AA; Shkhvatsabaya, IK, 1988) |
| "Propranolol is a commonly used drug; of new and refilled prescriptions, it ranked no." | 1.27 | Hypertensive response to levonordefrin in a patient receiving propranolol: report of case. ( Mito, RS; Yagiela, JA, 1988) |
| " The basis of this noncompliance is multifactorial, but a large component is related to the adverse symptoms produced by the commonly prescribed antihypertensive agents." | 1.27 | Utility of behavioral science techniques in assessing adverse effects of antihypertensive agents. ( Williams, GH, 1987) |
| "Captopril also was most effective at changing blood pressure in WKY, while propranolol and hydralazine had similar blood pressure-lowering effects." | 1.27 | Influence of blood pressure on development of aortic medial smooth muscle hypertrophy in spontaneously hypertensive rats. ( Owens, GK, 1987) |
| "dose, a tachycardia was observed in all rats following initial transient bradycardia." | 1.27 | Tachycardic and hypertensive effects of centrally administered clonidine in conscious rats. ( Imai, Y; Johnston, CI; Nolan, PL, 1986) |
| "Postoperative hypertension is a significant prognostic factor and is associated with an increased incidence of both transient and permanent neurologic deficits." | 1.27 | Control of hypertension following carotid endarterectomy. ( Brown, M; Brown, OW, 1986) |
| "Propranolol was detected by use of a spectrofluorometer equipped with a 20-microL flow-through cell, at excitation and emission wavelengths of 250 and 336 nm." | 1.27 | Determination of propranolol in plasma by radial compression liquid chromatography with fluorometric detection. ( el-Yazigi, A; Martin, CR, 1985) |
| "Propranolol led to an increase of triglycerides and a decrease of HDL cholesterol in plasma, the latter consisting in a small increase of unesterified cholesterol and a larger decrease of cholesteryl esters." | 1.27 | Inhibition of lecithin: cholesterol acyl transfer by propranolol treatment in man. ( Hummel, S; Schauer, I; Schauer, UJ; Thielmann, K, 1985) |
| "Aortic dissection is commonly seen as a manifestation of these processes in the aging population and is the most common catastrophic illness affecting the aorta." | 1.27 | Acute aortic dissection. ( Griffith, GL; Todd, EP, 1985) |
| "Hydrochlorothiazide and binazine treatment decreased systolic and diastolic blood pressure, the total electromechanical systolic time index (QS2I) and the left ventricular ejection time index (LVETI), and increased the PEP/LVET index at rest and after exercise." | 1.27 | Post-exertion changes in left ventricular systolic time intervals in patients with primary hypertension treated with hydrochlorothiazide, binazine, and propranolol. ( Cholewa, M; Górski, L; Markiewicz, K, 1985) |
| " No significant change in plasma half-life occurred and there was no correlation between the mean steady-state propranolol concentration and beta-adrenergic blockade or antihypertensive effect." | 1.26 | Relationship of propranolol pharmacokinetics to antihypertensive effect and beta-adrenergic blockade in the treatment of hypertension. ( Dunning, AJ; Krediet, RT; Offerhaus, L, 1980) |
| "Acebutolol seemed to cause stroke earlier with the more rapid BP elevation." | 1.26 | Effects of beta-adrenergic blocking drugs in hypertensive rats. ( Shiono, K; Sokabe, H; Sukamoto, T; Watanabe, TX, 1980) |
| "Clonidine was given in doses of 0." | 1.26 | Clonidine and prazosin effects in hypernoradrenergic vasodilator-treated and beta-blocker-treated patients. ( Mitchell, HC; Pettinger, WA, 1981) |
| " What remains to be solved is the dosage level." | 1.26 | Clinical experiences with prenalterol as an antidote to Beta-adrenoceptor blockade. ( Kulling, P, 1982) |
| "Treatment with propranolol (2 X 50 mg/kg/day p." | 1.26 | [Antihypertensive action of adrenergic beta-receptor blockers and its effect on the entire sympathetic outflow in spontaneously hypertensive rats]. ( Himori, N; Ishimori, T; Izumi, A; Shiratsuchi, K, 1982) |
| "Captopril was helpful in the management of refractory hypertension in most cases." | 1.26 | Efficacy of an oral angiotensin-converting enzyme inhibitor (captopril) in severe hypertension. ( Julius, S; Nicholls, MG; Zweifler, AJ, 1981) |
| "Captopril was equally effective in reducing blood pressure both when administered alone (25 mg: -29/-17; 50 mg: -37/-23 mm Hg) and after chronic treatment with propranolol (25 mg: -33/-20; 50 mg: -30/-20 mm Hg)." | 1.26 | Acute hypotensive and renin-stimulating actions of captopril before and during treatment with a beta-blocking drug. ( Biachini, C; Bramati, E; Gradnik, R; Leonetti, G; Terzoli, L; Tusa, M; Zanchetti, A, 1982) |
| " Full dose-response curves for isoproterenol were constructed in BP and HR." | 1.26 | The ratio of cardiac to vascular beta-receptor blockade of atenolol and propranolol in spontaneously hypertensive rats in vivo. ( Kudo, Y; Sokabe, H, 1982) |
| " Chronic administration of propranolol to SHR for three consecutive weeks by Alzet minipump reduced systolic arterial pressure but did not reverse the indices of myocardial hypertrophy." | 1.26 | Effect of chronic administration of clonidine and propranolol on the myocardium of spontaneously hypertensive rats. ( Greenberg, S; Wilborn, WM, 1982) |
| " A booster dosage of 5 to 20 mg of minoxidil was given at four hours if the diastolic BP exceeded 100 mm Hg." | 1.26 | Rapid control of severe hypertension with minoxidil. ( Alpert, MA; Bauer, JH, 1982) |
| "Atenolol treatment abolished almost completely these hemodynamic changes." | 1.26 | [Effect of pretreatment with atenolol and propranolol on sympatho-adrenal and cardiovascular responses to acute insulin-induced hypoglycaemia in the hypertensive patient]. ( Cannella, G; Cesura, AM; Giambelli, A; Maiorca, R; Picotti, GB; Scolari, F; Tosoni, S, 1982) |
| " Chronic administration of obsidan (0." | 1.26 | [Clinical and experimental study of the effect of obsidan and hemiton on the blood kallikrein-kinin system]. ( Abdullina, RN; Akhmetova, BKh; Davidenko, IuD; Didenko, RG, 1982) |
| "Until recently acute renal failure in scleroderma has been uniformly fatal." | 1.26 | Medical treatment of hypertension and renal failure in scleroderma. ( Barnett, AJ, 1981) |
| "Seven patients (4 with subarachnoid hemorrhage, 2 with intracerebral hemorrhage, and 1 with massive cerebral infarction) had acute arterial hypertension refractory to control by several antihypertensive drugs (hydralazine, sodium nitroprusside, alpha-methyldopa, and trimethaphan camsylate) used singly or in combination." | 1.26 | Catecholamine-associated refractory hypertension following acute intracranial hemorrhage: control with propranolol. ( Baldwin, CA; Feibel, JH; Joynt, RJ, 1981) |
| "Criteria for the choice of drug dosage are established." | 1.26 | [Determination of the criteria for selecting the optimal obsidan and hypothiazide treatment regimen in hypertension based on mathematical modelling data]. ( Churnosov, EV; Katiukhin, VN; Temirov, AA, 1981) |
| " 4 Forearm blood flow, at rest, was significantly reduced at 2 h after dosing with propranolol, but not after acebutolol." | 1.26 | The effects of oral acebutolol and propranolol on forearm blood flow in hypertensive patients. ( Ireland, MA; Littler, WA, 1981) |
| "Pindolol was 71." | 1.26 | The distribution of propranolol, pindolol and atenolol between human erythrocytes and plasma. ( Taylor, EA; Turner, P, 1981) |
| "The hypotensive effect of nifedipine (a Ca2+-antagonist) was studied in acute tests and during the long-term administration of the drug together with propranolol." | 1.26 | Hypotensive action of nifedipine (Ca2+-antagonist) and propranolol in acute trials and its long-term therapy of hypertensive coronary heart disease patients. ( Aoki, K; Kato, K; Kawaguchi, Y; Kondo, S; Mochizuki, A; Sato, K; Yamamoto, M, 1981) |
| "Propranolol therapy was associated with a 25% decrease in PRA (p less than 0." | 1.26 | Effects of propranolol on aldosterone plasma concentration and aldosterone metabolic clearance in hypertensive patients. ( Grim, CE; Parkinson, CA; Pratt, JH, 1980) |
| " The resting heart rate is faster with labetalol than with an equivalent dosage of propranolol." | 1.26 | Comparison of labetalol and propranolol in treatment of hypertension. ( Harvald, B, 1980) |
| "2 Seven subjects with untreated essential hypertension were studied before and 2 months after commencing treatment with propranolol LA once daily in the morning, results showing that smooth control of blood pressure and heart rate occurred throughout 24 h." | 1.26 | Propranolol LA and ambulatory blood pressure. ( Balasubramanian, V; Craig, MW; Mann, S; Raftery, EB, 1980) |
| "During hyperreflexia the pre-ejection period/left ventricular ejection time (PEP/LVET) ratio and the PEP and electromechanical systole (QS2) reduced, suggesting positive inotropic effects." | 1.26 | Sympathetic hyperreflexia in tetraplegics. The value of systolic time intervals in assessing drug effects. ( Sommers, DK, 1980) |
| " The measure was used to survey compliance with 20 common drugs prescribed to 419 outpatients for long-term administration on regular schedules." | 1.26 | Variations in patient compliance with common long-term drugs. ( Carter, WB; Dohan, JJ; Inui, TS; Pearlman, RA; Pecoraro, RE, 1980) |
| " Propildazine at the above dose in combination with propranolol (1 mg/kg i." | 1.26 | Renal function studies with propildazine alone and in combination with propranolol in dogs. ( Dorigotti, L; Semeraro, C, 1980) |
| "Propranolol did not cause this pressor effect in prehypertensive (seven week old) SHRs." | 1.26 | Beta-adrenergic receptor blocking drugs in spontaneous hypertension. ( Levy, JV, 1976) |
| " At the same time, the new system efficiently exploits the long-term use of diuretic therapy alone in low-renin patients in whom volume excess seems a causal factor." | 1.26 | Modern system for treating high blood pressure based on renin profiling and vasoconstriction-volume analysis: a primary role for beta blocking drugs such as propranolol. ( Laragh, JH, 1976) |
| "They are effective in any fast arrhythmia." | 1.26 | Present state of alpha and beta adrenergic drugs III. Beta blocking agents. ( Ahlquist, RP, 1977) |
| "Complications of hypertension are by far the greatese preventable public health problem in many of the developed countries of the world." | 1.26 | Additive effect of beta-adrenergic blockers in combination with vasodilators in lowering blood pressure. ( Mitchell, HC; Pettinger, WA, 1976) |
| " Resistance to alpha adrenergic blocking agents developed when the patient's daily propranolol dosage was lowered from 10 to 1 mg/kg." | 1.26 | Childhood pheochromocytoma: treatment with alpha methyl tyrosine for resistant hypertension. ( DeQuattro, V; Grushkin, CM; Lieberman, E; Robinson, RG, 1977) |
| "Pindolol do not lower PRA in normotensive rats but increases levels of PRA in spontaneously hypertensive rats." | 1.26 | [Action of 3-beta adrenolytics on plasma renin activity measured by radioimmunology in genetically hypertensive rats]. ( Lacroix, P; Le Pollés, JB; Linée, P; Pape, D; Van den Driessche, J, 1977) |
| "Phentolamine was 3 to 5 times less effective than phenoxybenzamine and E-643." | 1.26 | Antihypertensive effect of combined treatment with alpha- and beta-adrenergic blockers in the spontaneously hypertensive rat. ( Igarashi, T; Nakajima, Y; Ohtake, S, 1977) |
| " During long-term use alpha-methyldopa frequently reduces the total peripheral resistance and the reduction in cardiac output is usually modest, at rest as well as during exercise." | 1.26 | alpha-Methyldopa and beta-blockers in hypertension--a comparison of their haemodynamic effects. ( Lund-Johansen, P, 1978) |
| "3." | 1.26 | Prevention and reversal of isolation-induced systolic arterial hypertension in rats by treatment with beta-adrenoceptor antagonists. ( Bennett, T; Gardiner, SM, 1979) |
| "Chronic hypertension was induced in Wistar rats with intact kidneys by subcutaneous implantation of 50 mg of deoxycorticosterone acetate (DOCA) in wax and addition of sodium chloride (9 g/l) to the drinking water." | 1.26 | Dependence of deoxycorticosterone/salt hypertension in the rat on the activity of adrenergic cardiac nerves. ( Bell, C; McLachlan, EM, 1979) |
| "The isoproterenol-induced increase in plasma cyclic adenosine 3':5'-monophosphate (cAMP) reflects the response of adenylate cyclase to beta-adrenergic stimulation, whereas a non-beta-receptor-mediated increase occurs with the administration of glucagon." | 1.26 | Plasma cyclic adenosine 3':5'-monophosphate response to isoproterenol and glucagon in hyperkinetic borderline (labile) hypertension. ( Fraysse, J; Genest, J; Guthrie, GP; Hamet, P; Kuchel, O; Messerli, FH; Nowaczynski, W; Tolis, G, 1976) |
| "Rebound hypertension has been reported after saralasin infusion in several patients with accelerated or malignant hypertension." | 1.26 | Drug interactions with saralasin. ( Keeton, TK; Mitchell, HC; Pettinger, WA, 1979) |
| "Prazosin appears to be a suitable substitute for hydralazine as an effective vasodialator if thiazides plus propranolol or thiazides plus reserpine or alpha-methyldopa are not effective." | 1.26 | Propranolol and newer antihypertensive drugs in the management of hypertension. ( Moser, M, 1979) |
| " The fall in blood pressure during beta-adrenergic blockade with a low dosage of propranolol apparently does not depend on changed baroreflex sensitivity, but on the intrinsic action of this drug on beta-receptors." | 1.26 | Baroreflex sensitivity in hypertension during beta-adrenergic blockade. ( Dunning, AJ; Krediet, RT, 1979) |
| "The occurrence of hypertensive crises, arrhythmias and hypotensive crises during surgery for pheochromocytoma can be prevented both preoperatively and intraoperatively by adequate alpha-adrenergic blockade and volume replacement." | 1.26 | [Medical support in surgery for pheochromocytoma]. ( Schmucki, O, 1979) |
| "7 years) with severe essential hypertension (n = 21) and renovascular hypertension (n = 1) were treated with a mean daily dosage of 16." | 1.26 | [Minoxidil in treatment resistant hypertension]. ( Furrer, J; Nussberger, J; Reuteler, H; Siegenthaler, W; Studer, A; Tenschert, W; Vetter, W, 1979) |
| "In MHS the hypertension is more of a systolic type and is of primarily renal origin." | 1.26 | Cardiovascular control in the Milan strain of spontaneously hypertensive rat (MHS) at "rest" and during acute mental "stress". ( Bianchi, G; Folkow, B; Hallbäck, M; Jones, JV, 1977) |
| "The hypertension was related to an elevated plasma renin activity and was controlled with propranolol." | 1.26 | Systemic hypertension after surgical treatment of a congenital arteriovenous malformation. ( Fellows, KE; Nadas, AS; Rocchini, AP; Rosenthal, A; Schuster, S, 1978) |
| "Treatment with propranolol and hydralazine was effective in controlling her blood pressure and was continued throughout her next two pregnancies, both of which were successful." | 1.26 | Treatment with propranolol and hydralazine throughout pregnancy in a hypertensive patient. A case report. ( Bott-Kanner, G; Joel-Cohen, J; Rosenfeld, JB; Schoenfeld, A; Schweitzer, A, 1978) |
| "Treatment with propranolol hydrochloride (Deralin [Israel]; Inderal, comparable US product) intravenously administered in a total dose of 284 mg during a period of 18 hours, was followed by clinical remission associated with a decline in urinary excretion of porphyrin precursors." | 1.26 | Treatment of acute intermittent porphyria with large doses of propranolol. ( Atsmon, A; Douer, D; Pinkhas, J; Weinberger, A, 1978) |
| " Plasma renin concentration and the aortic renin content of the spontaneously hypertensive rat showed divergent changes in response to a blood pressure fall associated with acute diuretic therapy, chronic administration of hydrallazine and in some animals in response to chronic administration of propranolol." | 1.26 | Partial characterization of aortic renin in the spontaneously hypertensive rat and its interrelationship with plasma renin, blood pressure and sodium balance. ( Barrett, JD; Eggena, P; Sambhi, MP, 1978) |
| "Propranolol was marketed for clinical use as 'Inderal' by the Pharmaceuticals Division of Imperial Chemical Industries, UK, where this original work had been done." | 1.26 | Protection from morbidity and mortality from first infarcts: the case for beta-blockade. ( Lambert, DM, 1978) |
| "Mortality rate from aortic ruptures was highest (43." | 1.26 | Relation of hemodynamics to the incidence of diethylstilbestrol-induced aortic ruptures in hypertensive and hypotensive lines of turkeys. ( Simpson, CF, 1978) |
| "Systolic hypertension is difficult to control in the elderly, but this is not an excuse for denying these patients the benefits of carefully controlled antihypertensive treatment, particularly when target organ disease is present." | 1.26 | Should you treat systolic hypertension in elderly patients? ( Tarazi, RC, 1978) |
| "Propranolol treatment reduced blood pressure increases to i." | 1.26 | Increased blood pressure responses to central angiotensin II in spontaneously hypertensive rats. ( Ganten, D; Ganten, U; Johnson, AK; Mann, JF; Schaz, K; Simon, W, 1978) |
| " By titrating dosage against the response of blood pressure and pulse rate, propranolol hydrochloride was administered orally at 160 mg/day in four divided doses." | 1.26 | Blood pressure responses to catecholamines during beta-adrenergic blockade with propranolol in hypertensive subjects. ( DeGuia, D; Mendlowitz, M; Vlachakis, ND, 1977) |
| "Treatment of hypertension is the first step in the prophylaxis of atherosclerosis." | 1.26 | Hypertension--the fledgling of modern medical practice. ( Page, IH, 1977) |
| "The hypertension was responsive to propranolol therapy." | 1.26 | Sustained hypertension after section of the glossopharyngeal nerve. ( Hollifield, JW; Nies, AS; Ripley, RC, 1977) |
| "The major reason for treating hypertension is to avoid complications of the disease as it affects "target organs." | 1.26 | Prevention of some complications of essential hypertension. ( Grissom, RL; Gust, WF, 1977) |
| "One patient with acrodermatitis enteropathica complicated by hypertension is presented." | 1.26 | Hypertension in a patient with acrodermatitis enteropathica. ( Aberg, H; Michaëlsson, G; Walldius, G, 1976) |
| " The biological half-life was reduced and the central volume of distribution, volume of distribution at pseudo-equilibrium and total clearance (TC) were markedly increased." | 1.26 | Comparison of the pharmacokinetics of intravenous dl-propranolol in borderline and permanent hypertension. ( Alexandre, JM; Chevillard, C; Frydman, A; Lemaire, P; Safar, ME; Simon, A; Weiss, YA, 1976) |
| "Propranolol was not effective in DOCA rats and produced a significant blood pressure reduction in SHR 48 hr after acute administration." | 1.26 | Antihypertensive activity of a propranolol analog (ORF 12,592) in rodents. ( Greenslade, FC; Heilman, RD; Ram, N, 1976) |
| "Propranolol was used in more than 80% of the cases." | 1.26 | Treatment of hypertension in middle-aged men: a feasibility study in a community. ( Aberg, H; Hedstrand, H, 1976) |
| "Three different regimens of drug treatment for hypertension were compared with regard to the development of undesirable side-effects in a group of 53 patients attending a hypertension clinic." | 1.26 | Some side-effects of alpha-methyldopa. ( Pillay, VK, 1976) |
| "However, a group of subjects with untreated hypertension showed a significantly smaller initial inflow during the suction." | 1.25 | The influence of age and the level of arterial blood pressure on the changes in forearm blood flow resulting from sudden alterations in local vascular transmural pressure. ( Fentem, PH; Yates, JM, 1975) |
| "Propranolol was given to 15 patients and I." | 1.25 | Dopamine-beta-hydroxylase after treatment with beta-blockers in hypertension. ( Aberg, H; Hedstrand, H; Ross, SB; Wetterberg, L, 1975) |
| "Propranolol was given to 10 hypertensive patients with CGN and hypotensive effect on renal function was observed." | 1.25 | Therapy and prognosis of hypertension in chronic nephritis. ( Kajiwara, N, 1975) |
| "Treatment with propranolol was effective in abolishing the syncopal episodes, by reducing the post-tussive gradient and facilitating a more rapid return to normal of aortic pressure." | 1.25 | Idiopathic hypertrophic subaortic stenosis presenting as cough syncope. ( Ahmad, M; White, CW; Zimmerman, TJ, 1975) |
| "Propranolol, when given in high dosage to rats, did not induce an increase in hepatic delta-aminolaevulic acid synthetase, an enzyme which is raised in human and drug-induced animal porphyria." | 1.25 | Acute intermittent porphyria: response of tachycardia and hypertension to propranolol. ( Beattie, AD; Goldberg, A; Moore, MR; Ward, RL, 1973) |
| " At dose-levels causing effective blockade of beta-receptors propranolol and MJ 1999 had no hypotensive effect after short- or long-term administration to conscious hypertensive rats and dogs." | 1.25 | A comparison of some cardiovascular properties of propranolol, MJ 1999 and quinidine in relation to their effects in hypertensive animals. ( Farmer, JB; Levy, GP, 1968) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2123 (86.06) | 18.7374 |
| 1990's | 228 (9.24) | 18.2507 |
| 2000's | 66 (2.68) | 29.6817 |
| 2010's | 44 (1.78) | 24.3611 |
| 2020's | 6 (0.24) | 2.80 |
| Authors | Studies |
|---|---|
| Baldwin, JJ | 2 |
| Lumma, WC | 1 |
| Lundell, GF | 1 |
| Ponticello, GS | 2 |
| Raab, AW | 1 |
| Engelhardt, EL | 2 |
| Hirschmann, R | 2 |
| Sweet, CS | 3 |
| Scriabine, A | 4 |
| Wu, ES | 1 |
| Cole, TE | 1 |
| Davidson, TA | 1 |
| Blosser, JC | 1 |
| Borrelli, AR | 1 |
| Kinsolving, CR | 1 |
| Milgate, TE | 1 |
| Parker, RB | 1 |
| Atkinson, JG | 1 |
| Wasson, BK | 1 |
| Kreighbaum, WE | 1 |
| Matier, WL | 1 |
| Dennis, RD | 1 |
| Minielli, JL | 1 |
| Deitchman, D | 1 |
| Perhach, JL | 2 |
| Comer, WT | 1 |
| Lalloz, L | 1 |
| Loppinet, V | 1 |
| Coudert, G | 1 |
| Guillaumet, G | 1 |
| Loubinoux, B | 1 |
| Labrid, C | 1 |
| Beaughard, M | 1 |
| Dureng, G | 1 |
| Lamar, JC | 1 |
| Bai, R | 1 |
| Huang, X | 1 |
| Yang, X | 1 |
| Hong, W | 1 |
| Tang, Y | 1 |
| Yao, H | 2 |
| Jiang, J | 1 |
| Liu, J | 1 |
| Shen, M | 1 |
| Wu, X | 1 |
| Xu, J | 1 |
| Kodama, T | 1 |
| Kameshima, S | 1 |
| Otani, K | 1 |
| Okada, M | 1 |
| Yamawaki, H | 1 |
| Esler, M | 8 |
| Kjeldsen, SE | 3 |
| Pathak, A | 1 |
| Grassi, G | 3 |
| Kreutz, R | 1 |
| Mancia, G | 4 |
| Zicha, J | 1 |
| Hojná, S | 1 |
| Vaňourková, Z | 1 |
| Kopkan, L | 1 |
| Vaněčková, I | 1 |
| Segarra, AB | 2 |
| Prieto-Gomez, I | 1 |
| Banegas, I | 1 |
| Martínez-Cañamero, M | 2 |
| Luna, JD | 1 |
| de Gasparo, M | 2 |
| Ramírez-Sánchez, M | 2 |
| Ladd, JM | 1 |
| Sabsabi, B | 1 |
| von Oettingen, JE | 1 |
| Ranasinghe, HN | 1 |
| Fernando, N | 1 |
| Handunnetti, S | 1 |
| Weeratunga, PN | 1 |
| Katulanda, P | 2 |
| Rajapakse, S | 2 |
| Galappatthy, P | 2 |
| Constantine, GR | 2 |
| Amssayef, A | 1 |
| Ajebli, M | 1 |
| Eddouks, M | 1 |
| Brewster, R | 1 |
| Lee, J | 1 |
| Nguyen, E | 1 |
| Ward, V | 1 |
| Duan, L | 1 |
| Ng, A | 1 |
| Chen, W | 1 |
| Spencer, HT | 1 |
| Nguyen, J | 1 |
| Shen, AY | 1 |
| Lee, MS | 1 |
| da Silva Franco, N | 1 |
| Lubaczeuski, C | 1 |
| Guizoni, DM | 1 |
| Victorio, JA | 1 |
| Santos-Silva, JC | 1 |
| Brum, PC | 1 |
| Carneiro, EM | 1 |
| Davel, AP | 1 |
| Zhang, Y | 2 |
| Sun, N | 1 |
| Jiang, X | 1 |
| Xi, Y | 1 |
| Musini, VM | 1 |
| Gueyffier, F | 1 |
| Puil, L | 1 |
| Salzwedel, DM | 1 |
| Wright, JM | 1 |
| Prieto, I | 1 |
| Tsutsui, Y | 1 |
| Sunada, K | 1 |
| Radwan, RR | 1 |
| Mohamed, HA | 1 |
| Ali, HE | 1 |
| Mahmoud, GA | 1 |
| Eibel, B | 1 |
| Kristochek, M | 1 |
| Peres, TR | 1 |
| Dias, LD | 1 |
| Dartora, DR | 1 |
| Casali, KR | 1 |
| Kalil, RAK | 1 |
| Lehnen, AM | 1 |
| Irigoyen, MC | 2 |
| Markoski, MM | 1 |
| Ojeda, S | 1 |
| Blumenthal, E | 1 |
| Stevens, P | 1 |
| Andersen, CR | 1 |
| Robles, L | 1 |
| Herndon, DN | 1 |
| Meyer, WJ | 1 |
| de Moura Leão, MF | 1 |
| Duarte, JA | 1 |
| Sauzen, PD | 1 |
| Piccoli, JDCE | 1 |
| de Oliveira, LFS | 1 |
| Machado, MM | 1 |
| Lezama-Martinez, D | 1 |
| Flores-Monroy, J | 1 |
| Fonseca-Coronado, S | 1 |
| Hernandez-Campos, ME | 1 |
| Valencia-Hernandez, I | 1 |
| Martinez-Aguilar, L | 1 |
| Costa, A | 1 |
| Bosone, D | 1 |
| Cotta Ramusino, M | 1 |
| Perini, G | 1 |
| Ghiotto, N | 1 |
| Zoppi, A | 4 |
| D Apos Angelo, A | 1 |
| Fogari, R | 5 |
| Beleford, DT | 1 |
| Diab, M | 1 |
| Qubty, WF | 1 |
| Malloy, MJ | 1 |
| Long, RK | 1 |
| Shieh, JT | 1 |
| Ollague Sierra, JE | 1 |
| Ollague Torres, JM | 1 |
| Snelder, N | 1 |
| Ploeger, BA | 1 |
| Luttringer, O | 1 |
| Rigel, DF | 1 |
| Fu, F | 1 |
| Beil, M | 1 |
| Stanski, DR | 1 |
| Danhof, M | 1 |
| Stawowy, P | 1 |
| Higuchi, H | 1 |
| Yabuki, A | 1 |
| Ishii-Maruhama, M | 1 |
| Tomoyasu, Y | 1 |
| Maeda, S | 1 |
| Miyawaki, T | 1 |
| Holme, I | 4 |
| Matsuura, N | 1 |
| Nagasawa, K | 2 |
| Minagawa, Y | 1 |
| Ito, S | 1 |
| Sano, Y | 1 |
| Yamada, Y | 1 |
| Hattori, T | 1 |
| Watanabe, S | 1 |
| Murohara, T | 1 |
| Nagata, K | 1 |
| Shimojo, GL | 1 |
| Palma, RK | 1 |
| Brito, JO | 1 |
| Sanches, IC | 1 |
| De Angelis, K | 1 |
| Zhou, ZY | 2 |
| Cheng, SP | 1 |
| Huang, H | 1 |
| Sun, YL | 1 |
| Xiao, S | 1 |
| Liu, RH | 1 |
| Mao, FJ | 1 |
| Zhong, GJ | 1 |
| Huang, JB | 1 |
| Pan, H | 1 |
| Kiriyama, A | 1 |
| Honbo, A | 1 |
| Nishimura, A | 1 |
| Shibata, N | 1 |
| Iga, K | 1 |
| Zhou, HM | 1 |
| Zhong, ML | 1 |
| Wang, RH | 1 |
| Long, CL | 1 |
| Zhang, YF | 1 |
| Cui, WY | 1 |
| Wang, H | 1 |
| Subramaniam, A | 1 |
| Grauer, R | 1 |
| Beilby, D | 1 |
| Tiruvoipati, R | 1 |
| Maida, KD | 2 |
| Gastaldi, AC | 1 |
| de Paula Facioli, T | 1 |
| de Araújo, JE | 2 |
| de Souza, HC | 1 |
| Ranasinghe, P | 1 |
| Weeratunga, P | 1 |
| Weeraratne, C | 1 |
| Senarath, U | 1 |
| Berg, T | 1 |
| Degerman, E | 1 |
| Tasken, K | 1 |
| Tezini, GC | 1 |
| Silveira, LC | 2 |
| Blanco, JH | 2 |
| Souza, HC | 4 |
| Andrzejczak, D | 1 |
| Kocon, K | 1 |
| Zieba, R | 1 |
| Rossi, BR | 1 |
| Mazer, D | 1 |
| Jacinto, CP | 1 |
| Di Sacco, TH | 1 |
| Cesarino, EJ | 1 |
| Martins-Pinge, MC | 1 |
| Cozza, IC | 1 |
| Martins-Dias, DP | 1 |
| Moritz, KM | 1 |
| Dodic, M | 1 |
| Jefferies, AJ | 1 |
| Wintour, EM | 1 |
| DeMatteo, R | 1 |
| Singh, RR | 1 |
| Evans, RG | 1 |
| Peters, R | 1 |
| Beckett, N | 1 |
| Tan, F | 1 |
| Thai, AC | 1 |
| Cheah, WK | 1 |
| Mukherjee, JJ | 1 |
| Gayen, JR | 1 |
| Gu, Y | 1 |
| O'Connor, DT | 7 |
| Mahata, SK | 1 |
| Sato, T | 1 |
| Arai, M | 1 |
| Goto, S | 1 |
| Togari, A | 1 |
| Chen, WQ | 1 |
| Cai, H | 1 |
| Zhang, C | 1 |
| Ji, XP | 1 |
| O-Uchi, J | 1 |
| Lopes, CM | 1 |
| Hersh, EV | 1 |
| Giannakopoulos, H | 1 |
| Estrada, O | 2 |
| González-Guzmán, JM | 1 |
| Salazar-Bookaman, M | 1 |
| Fernández, AZ | 1 |
| Cardozo, A | 1 |
| Alvarado-Castillo, C | 1 |
| Tkachenko, EY | 1 |
| Kozyreva, TV | 1 |
| Shrivas, K | 1 |
| Patel, DK | 1 |
| Schuller, HM | 1 |
| Ganz, PA | 1 |
| Cole, SW | 1 |
| Barron, TI | 1 |
| Connolly, RM | 1 |
| Sharp, L | 1 |
| Bennett, K | 1 |
| Visvanathan, K | 1 |
| Hassan, N | 1 |
| Maldonado-Valderrama, J | 1 |
| Gunning, AP | 1 |
| Morris, VJ | 1 |
| Ruso, JM | 1 |
| Yang, ZH | 1 |
| Wang, XH | 1 |
| Cao, H | 1 |
| Chen, D | 1 |
| Wang, YZ | 1 |
| Zhou, HH | 1 |
| Peng, M | 1 |
| Liu, QL | 1 |
| Wan, SP | 1 |
| Szewczyk, M | 1 |
| Richter, C | 1 |
| Briese, V | 1 |
| Richter, DU | 1 |
| Moraes Miguel, F | 1 |
| Alexandre Grings, L | 1 |
| Borges Pereira, G | 1 |
| Diego Leite, R | 1 |
| Vieira, A | 1 |
| Frade de Sousa, NM | 1 |
| Simão, R | 1 |
| Prestes, J | 1 |
| Baran, M | 1 |
| Kanik, A | 1 |
| Can, E | 1 |
| Parildar, M | 1 |
| Pala, EE | 1 |
| Helvaci, M | 1 |
| Doskina, EV | 1 |
| Varani, K | 2 |
| Manfredini, R | 2 |
| Iannotta, V | 1 |
| Pancaldi, C | 1 |
| Cattabriga, E | 1 |
| Uluoglu, C | 1 |
| Borea, PA | 2 |
| Portaluppi, F | 2 |
| Rakić, D | 2 |
| Rumboldt, Z | 3 |
| Bagatin, J | 3 |
| Polić, S | 3 |
| von Kanel, R | 1 |
| Dimsdale, JE | 2 |
| Adler, KA | 1 |
| Dillon, E | 1 |
| Perez, CJ | 1 |
| Mills, PJ | 2 |
| Kirichenko, AA | 1 |
| Ebzeeva, EIu | 1 |
| Centeno, RF | 1 |
| Yu, YL | 1 |
| Claxton, CR | 1 |
| Brands, MW | 2 |
| Takamitsu, Y | 1 |
| Nakanishi, T | 1 |
| Nishihara, F | 1 |
| Hasuike, Y | 1 |
| Izumi, M | 1 |
| Inoue, T | 1 |
| Hiraoka, K | 1 |
| Itahana, R | 1 |
| Miyagawa, K | 1 |
| Cruickshank, JM | 3 |
| Ferrer, M | 2 |
| Salaices, M | 3 |
| Sánchez, M | 1 |
| Balfagón, G | 3 |
| Tamaya-Mori, N | 1 |
| Uemura, K | 1 |
| Tanaka, S | 4 |
| Iguchi, A | 1 |
| PRICHARD, BN | 18 |
| GILLAM, PM | 5 |
| TSOLAKAS, TC | 1 |
| DAVIES, JP | 1 |
| ORAM, S | 2 |
| Kobayashi, N | 1 |
| Mita, S | 1 |
| Yoshida, K | 3 |
| Honda, T | 1 |
| Kobayashi, T | 1 |
| Hara, K | 1 |
| Nakano, S | 1 |
| Tsubokou, Y | 1 |
| Matsuoka, H | 1 |
| Höcht, C | 1 |
| Opezzo, JA | 1 |
| Taira, CA | 1 |
| Sakuragi, T | 1 |
| Yasumoto, M | 1 |
| Higa, K | 1 |
| Nitahara, K | 1 |
| Yasunari, K | 1 |
| Maeda, K | 1 |
| Nakamura, M | 4 |
| Watanabe, T | 1 |
| Yoshikawa, J | 1 |
| Asada, A | 1 |
| Zeller, A | 1 |
| Handschin, D | 1 |
| Gyr, N | 1 |
| Martina, B | 1 |
| Battegay, E | 1 |
| Sica, DA | 1 |
| Neutel, JM | 2 |
| Weber, MA | 17 |
| Manowitz, N | 1 |
| Ruiz-Feria, CA | 1 |
| Yang, Y | 1 |
| Nishimura, H | 1 |
| Delva, P | 2 |
| Pastori, C | 2 |
| Degan, M | 2 |
| Montesi, G | 1 |
| Lechi, A | 3 |
| Tuev, AV | 1 |
| Poteshkina, NG | 1 |
| Grigoriadi, NE | 1 |
| Maina, CI | 1 |
| Ogunde, M | 1 |
| Punda, A | 1 |
| Marković, V | 1 |
| Lukin, A | 1 |
| Rotenberg, K | 1 |
| Bernik, MM | 1 |
| Heimann, JC | 1 |
| Nakandakare, ER | 1 |
| Cazita, PM | 1 |
| Nunes, VS | 1 |
| Rocha, JC | 1 |
| Neves, MQ | 1 |
| Quintão, EC | 1 |
| Beyan, C | 1 |
| Kaptan, K | 1 |
| Ifran, A | 1 |
| Perlini, S | 2 |
| Palladini, G | 2 |
| Ferrero, I | 2 |
| Tozzi, R | 2 |
| Fallarini, S | 1 |
| Facoetti, A | 1 |
| Nano, R | 1 |
| Clari, F | 2 |
| Busca, G | 2 |
| Ferrari, AU | 2 |
| Bertoluci, MC | 1 |
| Uebel, D | 1 |
| Schmidt, A | 1 |
| Thomazelli, FC | 1 |
| Oliveira, FR | 1 |
| Schmid, H | 1 |
| Osadchii, O | 1 |
| Woodiwiss, A | 1 |
| Deftereos, D | 1 |
| Norton, G | 1 |
| Gatti, C | 1 |
| Vezzoli, M | 1 |
| Cesana, F | 1 |
| Janetti, MB | 1 |
| Finsterer, J | 1 |
| Gelpi, E | 1 |
| Rosa, F | 1 |
| Cedeño, J | 1 |
| León, L | 1 |
| Romero-Vecchione, E | 1 |
| Vásquez, J | 1 |
| Antequera, R | 1 |
| Rossi, P | 1 |
| Nappi, G | 1 |
| Sakamoto, T | 1 |
| Yoshioka, T | 1 |
| Shirakawa, Y | 1 |
| Kamei, T | 1 |
| Murata, A | 1 |
| Asari, Y | 1 |
| Okumura, T | 1 |
| Endo, Y | 1 |
| Shimazu, T | 1 |
| Tomioka, J | 1 |
| Sontheimer, D | 1 |
| Hitchcock, K | 1 |
| Saseen, J | 1 |
| Materson, BJ | 5 |
| Priviero, FB | 1 |
| Teixeira, CE | 1 |
| Claudino, MA | 1 |
| De Nucci, G | 3 |
| Zanesco, A | 2 |
| Antunes, E | 3 |
| Bangalore, S | 1 |
| Parkar, S | 1 |
| Grossman, E | 1 |
| Messerli, FH | 2 |
| Nozawa, H | 1 |
| Akiyama, Y | 1 |
| Sunaga, S | 1 |
| Tsurita, G | 1 |
| Varela, JA | 1 |
| Alamán Orbañanos, B | 1 |
| Negrete Calderón, N | 1 |
| Martín-Romo Capilla, J | 1 |
| Becerra Cayetano, A | 1 |
| Fleming, J | 4 |
| Hamer, J | 4 |
| Waal, HJ | 2 |
| Kernohan, RJ | 1 |
| Fitzgerald, JD | 4 |
| Renner, C | 1 |
| Rouffy, J | 1 |
| Moir, TW | 1 |
| DeBra, DW | 1 |
| van Gool, J | 1 |
| Marsman, AJ | 1 |
| Adams, CW | 1 |
| Nance, WE | 1 |
| Baczko, A | 1 |
| Dabrowska, B | 1 |
| Wocial, B | 1 |
| Mosley, C | 1 |
| Taylor, A | 1 |
| Slutsky, RA | 1 |
| Cervenka, J | 3 |
| Morgan, TO | 4 |
| Jain, AK | 2 |
| McMahon, FG | 4 |
| Ryan, JR | 2 |
| Maronde, R | 1 |
| Vlachakis, N | 2 |
| Mroczek, W | 1 |
| Drayer, JI | 12 |
| Fritschka, E | 1 |
| Distler, A | 3 |
| Gotzen, R | 2 |
| Thiede, HM | 1 |
| Philipp, T | 1 |
| Davies, RO | 2 |
| Irvin, JD | 1 |
| Kramsch, DK | 1 |
| Walker, JF | 2 |
| Moncloa, F | 2 |
| Bucher, B | 3 |
| Heitz, C | 1 |
| Stoclet, JC | 3 |
| Fernandez, PG | 6 |
| Kim, BK | 5 |
| Snedden, W | 3 |
| Nolan, R | 2 |
| Ko, P | 2 |
| VandenBurg, MJ | 4 |
| Robinson, PJ | 1 |
| Cooper, WD | 2 |
| Currie, WJ | 2 |
| Levenson, JA | 4 |
| Safar, ME | 9 |
| Simon, AC | 8 |
| Maarek, BE | 1 |
| Bolli, P | 4 |
| Erne, P | 1 |
| Ji, BH | 1 |
| Block, LH | 1 |
| Kiowski, W | 6 |
| Bühler, FR | 16 |
| Rosendorff, C | 3 |
| Goodman, C | 2 |
| Coull, A | 2 |
| Frishman, W | 1 |
| Duchin, KL | 1 |
| Vukovich, RA | 1 |
| Dennick, LG | 1 |
| Groel, JT | 1 |
| Willard, DA | 1 |
| Lilja, M | 1 |
| Jounela, AJ | 1 |
| Juustila, H | 1 |
| Mattila, MJ | 2 |
| Serlin, MJ | 2 |
| Orme, ML | 2 |
| Baber, NS | 5 |
| Sibeon, RG | 2 |
| Laws, E | 1 |
| Breckenridge, A | 2 |
| Smits, JF | 9 |
| van Essen, H | 5 |
| Struyker-Boudier, HA | 11 |
| Dahlöf, C | 3 |
| Ljung, B | 3 |
| Ablad, B | 3 |
| Ebihara, A | 4 |
| Leren, P | 7 |
| Foss, PO | 1 |
| Helgeland, A | 9 |
| Hjermann, I | 3 |
| Lund-Larsen, PG | 2 |
| Nadezhdina, EA | 2 |
| Kurbatov, VS | 1 |
| Golov, AG | 1 |
| Kupriianova, OO | 2 |
| Leenen, FH | 6 |
| Coenen, CH | 1 |
| Zonderland, M | 1 |
| Maas, AH | 1 |
| El Mehairy, MM | 1 |
| Shaker, A | 1 |
| Ramadan, M | 1 |
| Hamza, S | 1 |
| Tadros, SS | 2 |
| Török, E | 1 |
| Istvánffy, M | 1 |
| Halmágyi, M | 1 |
| Wagner, M | 1 |
| Csukás, M | 1 |
| Pogson, GW | 1 |
| Sharma, J | 1 |
| Crouch, TT | 1 |
| Heel, RC | 1 |
| Brogden, RN | 1 |
| Pakes, GE | 1 |
| Speight, TM | 1 |
| Avery, GS | 1 |
| Garvey, HL | 1 |
| Woodhouse, BL | 1 |
| Châtel, R | 1 |
| Weidmann, P | 5 |
| Reubi, F | 1 |
| Rahn, KH | 18 |
| Markov, KhM | 1 |
| Pinelis, VG | 1 |
| Dvoriakovskaia, GM | 1 |
| Kozlov, AV | 1 |
| Krediet, RT | 3 |
| Dunning, AJ | 2 |
| Offerhaus, L | 2 |
| Ellis, D | 1 |
| Gartner, JC | 1 |
| Sukamoto, T | 1 |
| Shiono, K | 1 |
| Watanabe, TX | 2 |
| Sokabe, H | 6 |
| Berglund, G | 16 |
| Andersson, O | 11 |
| Trauth, HA | 1 |
| Koch-Weser, J | 12 |
| Frishman, WH | 11 |
| Newman, BR | 1 |
| Schultz, LK | 1 |
| Hart, GR | 1 |
| Anderson, RJ | 1 |
| Moses, JW | 1 |
| Borer, JS | 1 |
| Obukhov, GA | 1 |
| Mitchell, HC | 10 |
| Pettinger, WA | 15 |
| Dusseau, JW | 2 |
| Smith, TL | 2 |
| Hutchins, PM | 2 |
| Matsunaga, K | 3 |
| Ueda, M | 3 |
| Light, KC | 4 |
| Miyamoto, M | 1 |
| Koike, H | 1 |
| Ito, K | 2 |
| Nishino, H | 1 |
| Arensberg, D | 2 |
| Degenring, FH | 2 |
| Walch, HG | 1 |
| Ziegler, E | 2 |
| Golikov, AP | 1 |
| Vaniev, SB | 1 |
| Berestov, AA | 1 |
| Maĭorov, NI | 1 |
| Orlov, AI | 1 |
| de Clavière, M | 1 |
| Heyndrickx, JP | 1 |
| Brotelle, R | 1 |
| Colot, M | 1 |
| Juan, D | 1 |
| McLeod, AA | 1 |
| Shand, DG | 9 |
| Huysmans, FT | 1 |
| Thien, TA | 1 |
| Koene, RA | 1 |
| Meier, A | 1 |
| Mordasini, R | 1 |
| Riesen, W | 1 |
| Bachmann, C | 1 |
| Groop, L | 3 |
| Tötterman, KJ | 5 |
| Harno, K | 2 |
| Gordin, A | 2 |
| Day, JL | 2 |
| Metcalfe, J | 2 |
| Simpson, CN | 1 |
| Houben, H | 3 |
| Thien, T | 4 |
| van 't Laar, A | 3 |
| Potapova, GN | 1 |
| Popov, EG | 1 |
| Gabbasov, ZA | 1 |
| Arabidze, GG | 2 |
| Kutsenko, AI | 1 |
| Bhan, RD | 1 |
| Giacomelli, F | 1 |
| Wiener, J | 1 |
| Fuerst, M | 1 |
| Bretzke, G | 1 |
| Aellig, WH | 1 |
| Moser, M | 3 |
| Gorlin, R | 2 |
| Adam, WR | 1 |
| Meagher, EJ | 1 |
| Barter, CE | 1 |
| Kulling, P | 1 |
| Klein, NA | 1 |
| Klein, P | 1 |
| Strom, JA | 3 |
| Tawil, R | 1 |
| Strair, R | 1 |
| Wong, B | 1 |
| Roth, S | 1 |
| LeJemtel, TH | 1 |
| Pollack, S | 1 |
| Sonnenblick, EH | 2 |
| Whitsett, TL | 1 |
| Levin, DC | 1 |
| Manion, CV | 1 |
| Bai, TR | 1 |
| Webb, D | 1 |
| Hamilton, M | 1 |
| Burnier, M | 1 |
| Biollaz, J | 1 |
| Brunner, DB | 1 |
| Gavras, H | 9 |
| Brunner, HR | 14 |
| Cremona-Barbaro, A | 1 |
| Ishimori, T | 1 |
| Shiratsuchi, K | 1 |
| Izumi, A | 1 |
| Himori, N | 1 |
| Lepäntalo, M | 3 |
| Tsukiyama, H | 1 |
| Otsuka, K | 1 |
| Horii, M | 1 |
| Yoshii, Y | 1 |
| Hatori, Y | 1 |
| Nakamura, Y | 2 |
| Nemoto, E | 1 |
| Yamato, T | 1 |
| Sakai, T | 2 |
| Yamamoto, Y | 2 |
| Burris, JF | 6 |
| Epstein, M | 2 |
| Oster, JR | 3 |
| Lohmann, FW | 2 |
| Wirz-Justice, A | 1 |
| Kräuchi, K | 1 |
| Campbell, IC | 1 |
| Feer, H | 1 |
| Dawes, PM | 4 |
| Beevers, DG | 1 |
| Severova, NL | 1 |
| de Leeuw, PW | 7 |
| Birkenhäger, WH | 12 |
| Kato, H | 1 |
| Kurihara, J | 1 |
| Takata, Y | 1 |
| Kunugi, H | 1 |
| Miyajima, Y | 1 |
| Heimburger, M | 1 |
| Denoroy, L | 1 |
| Renaud, B | 1 |
| Sassard, J | 2 |
| Cohen, Y | 3 |
| Wepierre, J | 3 |
| Joyal, F | 1 |
| Bourque, M | 1 |
| Kuchel, O | 7 |
| Larochelle, P | 2 |
| Lundborg, P | 1 |
| Lager, I | 2 |
| Ostman, J | 1 |
| Elmfeldt, D | 2 |
| Wedel, H | 1 |
| Wilhelmsen, L | 3 |
| Erina, EV | 10 |
| Charyev, KhE | 4 |
| González-Gómez, A | 4 |
| Gamio Capestany, F | 2 |
| Hernández-Cañero, A | 4 |
| García-Barreto, D | 4 |
| Obel, AO | 1 |
| Levenson, J | 6 |
| Simon, A | 5 |
| Maarek, B | 1 |
| Totomoukouo, J | 1 |
| Gitelman, R | 1 |
| Bouthier, J | 2 |
| Safar, M | 4 |
| Kudo, Y | 2 |
| Kawashima, K | 3 |
| Goto, Y | 2 |
| Krämer, B | 1 |
| Kübler, W | 1 |
| Jackson, EA | 1 |
| Sullman, SA | 1 |
| Kubik, MM | 2 |
| Coote, JH | 1 |
| Tötterman, K | 1 |
| Groop, PH | 1 |
| Kala, R | 1 |
| Tolppanen, EM | 1 |
| Fyhrquist, F | 2 |
| Goliakov, VN | 1 |
| Zimin, IuV | 1 |
| Lefkowitz, RJ | 1 |
| Caron, MG | 1 |
| Stiles, GL | 1 |
| Karlsson, K | 1 |
| Lundgren, Y | 2 |
| Ljungblad, U | 1 |
| Johns, VJ | 1 |
| Awai, LE | 1 |
| Mekori, YA | 1 |
| Boer, P | 10 |
| Dorhout Mees, EJ | 6 |
| Danesh, BJ | 1 |
| Brunton, J | 1 |
| Sumner, DJ | 1 |
| Furberg, CD | 1 |
| Friedewald, WT | 1 |
| Sun, CL | 1 |
| Thompson, TJ | 1 |
| Hanig, JP | 1 |
| Ostapiuk, FE | 2 |
| Khvoĭnitskiĭ, VA | 1 |
| Haywood, LJ | 2 |
| Kirch, W | 2 |
| Axthelm, T | 1 |
| Freis, ED | 10 |
| Moyse, D | 1 |
| Halpern, J | 1 |
| Catane, R | 1 |
| Baerwald, H | 1 |
| Eggertsen, R | 1 |
| Kaiser, P | 2 |
| Monopoli, A | 1 |
| Bamonte, F | 1 |
| Forlani, A | 1 |
| Ongini, E | 1 |
| Parravicini, L | 1 |
| Brater, DC | 1 |
| Anderson, S | 1 |
| Kaplan, NM | 3 |
| Ram, CV | 4 |
| Aylward, PE | 2 |
| Elliott, JM | 2 |
| McRitchie, RJ | 3 |
| West, MJ | 6 |
| Chalmers, JP | 5 |
| Wheatley, D | 2 |
| Bianchini, C | 3 |
| Terzoli, L | 6 |
| Leonetti, G | 11 |
| Banfi, E | 2 |
| Castelli, D | 2 |
| Zanchetti, A | 12 |
| Bauer, JH | 4 |
| Alpert, MA | 2 |
| Pratt, JH | 2 |
| Yager, CJ | 1 |
| Grim, CE | 4 |
| Parkinson, CA | 2 |
| Nicholson, GD | 1 |
| Alleyne, GA | 1 |
| Valdes, G | 2 |
| Westerman, RL | 1 |
| Yamori, Y | 1 |
| Tarazi, RC | 24 |
| Ooshima, A | 1 |
| Goldstein, DS | 2 |
| Pedersen, EB | 8 |
| Mogensen, CE | 4 |
| Larsen, JS | 3 |
| Gemma, G | 1 |
| Montanari, G | 2 |
| Suppa, G | 1 |
| Paralovo, A | 1 |
| Franceschini, G | 1 |
| Mantero, O | 1 |
| Sirtori, CR | 2 |
| MacGregor, GA | 4 |
| Rotellar, C | 1 |
| Markandu, ND | 4 |
| Smith, SJ | 2 |
| Sagnella, GA | 2 |
| Heuer, LJ | 1 |
| Tomlinson, B | 1 |
| Walden, RJ | 1 |
| Bhattacharjee, P | 1 |
| Morgan, T | 6 |
| Adam, W | 2 |
| Hodgson, M | 2 |
| Hollenberg, NK | 3 |
| Francis, CK | 1 |
| Cleman, M | 1 |
| Berger, HJ | 1 |
| Davies, RA | 1 |
| Giles, RW | 1 |
| Black, HR | 2 |
| Vita, N | 1 |
| Zito, RA | 1 |
| Zaret, BL | 1 |
| Reichek, N | 1 |
| Gill, V | 1 |
| McDonald, J | 1 |
| Furlong, L | 1 |
| Lewis, H | 1 |
| McManamon, P | 1 |
| England, JF | 1 |
| Laragh, JH | 29 |
| Waeber, B | 5 |
| Liberatore, C | 2 |
| Platania, A | 2 |
| Reda, G | 2 |
| Lauro, R | 2 |
| Lederle, RM | 1 |
| Klaus, D | 9 |
| Braun, B | 4 |
| Tsuchiya, S | 1 |
| Ogawa, K | 1 |
| Satake, T | 1 |
| Zweifler, AJ | 6 |
| Julius, S | 23 |
| Nicholls, MG | 1 |
| Golub, MS | 1 |
| Tuck, ML | 1 |
| Fittingoff, DB | 1 |
| Chatelain, P | 1 |
| Waelbroeck, M | 1 |
| Camus, JC | 1 |
| De Neef, P | 1 |
| Robberecht, P | 1 |
| Roba, J | 2 |
| Christophe, J | 1 |
| Kubo, T | 2 |
| Misu, Y | 1 |
| Amann, FW | 3 |
| Hulthén, L | 1 |
| Andrén, L | 2 |
| Hansson, L | 29 |
| Björkman, M | 1 |
| Rangno, RE | 3 |
| Nattel, S | 1 |
| Lutterodt, A | 2 |
| Biachini, C | 1 |
| Gradnik, R | 1 |
| Tusa, M | 1 |
| Bramati, E | 1 |
| Frieswick, GM | 1 |
| Shideman, FE | 1 |
| Baker, SP | 1 |
| Katovich, MJ | 1 |
| Tanaka, N | 2 |
| Kawahira, K | 1 |
| Kudo, A | 1 |
| Kashima, T | 3 |
| Tanaka, H | 3 |
| Ramirez-Gonzalez, MD | 2 |
| Farsang, C | 2 |
| Tchakarov, L | 2 |
| Kunos, G | 2 |
| Asano, M | 1 |
| Aoki, K | 6 |
| Matsuda, T | 1 |
| Cabrera, R | 1 |
| Toruncha, A | 1 |
| Sen, S | 2 |
| Motulsky, HJ | 1 |
| Insel, PA | 1 |
| Isles, CG | 1 |
| Johnson, JK | 1 |
| Chernow, B | 2 |
| Zaloga, GP | 2 |
| Lake, CR | 3 |
| Coleman, MD | 1 |
| Ziegler, MG | 2 |
| Navis, GJ | 1 |
| de Jong, PE | 2 |
| Donker, AJ | 4 |
| de Zeeuw, D | 1 |
| Holly, JM | 1 |
| Goodwin, FJ | 1 |
| Sharman, VL | 1 |
| Marsh, FP | 1 |
| Inouye, I | 1 |
| Massie, B | 3 |
| Benowitz, N | 1 |
| Simpson, P | 2 |
| Loge, D | 2 |
| Topic, N | 1 |
| Rasmussen, S | 2 |
| Damkjaer Nielsen, M | 2 |
| Ibsen, H | 10 |
| Leth, A | 6 |
| Giese, J | 3 |
| Galway, AB | 2 |
| Bouthier, JD | 2 |
| Benetos, A | 1 |
| Achimastos, A | 1 |
| Fouchard, M | 1 |
| Maarek, BC | 1 |
| Luca, C | 1 |
| Marchini, F | 1 |
| Usardi, MM | 1 |
| Cottier, C | 2 |
| Cressman, MD | 2 |
| Gifford, RW | 6 |
| Silverstein, DK | 1 |
| Karliner, JS | 1 |
| Avigdor, L | 2 |
| Lichstein, E | 1 |
| Morganroth, J | 1 |
| Harrist, R | 1 |
| Hubble, E | 1 |
| Flamenbaum, V | 1 |
| Salvadeo, A | 2 |
| Villa, G | 2 |
| Segagni, S | 2 |
| Galli, F | 1 |
| Criscuolo, D | 2 |
| Staessen, J | 5 |
| Fagard, R | 6 |
| Lijnen, P | 6 |
| Verschueren, LJ | 2 |
| Amery, A | 8 |
| Rühle, W | 1 |
| Berndt, H | 1 |
| Jäättelä, A | 2 |
| Mäki, O | 1 |
| Stevens, JD | 2 |
| Binstok, G | 1 |
| Mullane, JF | 2 |
| Woods, JW | 3 |
| Pittman, AW | 3 |
| del Greco, F | 2 |
| Huang, C | 1 |
| Morledge, JH | 1 |
| Montenero, AS | 1 |
| Mazzari, M | 1 |
| Schiavoni, G | 1 |
| Manzoli, U | 1 |
| Gherardi, S | 1 |
| Grant, RP | 1 |
| Jenkins, LC | 1 |
| Singleton, W | 2 |
| Taylor, CR | 1 |
| Friedman, B | 1 |
| Gray, JM | 1 |
| Gross, S | 1 |
| Levit, SA | 1 |
| Schlesinger, Z | 1 |
| Ravid, M | 2 |
| Meshulam, R | 1 |
| Takada, Y | 1 |
| Shimizu, H | 1 |
| Kazatani, Y | 2 |
| Azechi, H | 1 |
| Hiwada, K | 2 |
| Kokubu, T | 3 |
| Misson, R | 1 |
| Merkel, T | 1 |
| Cutler, RE | 1 |
| Gianotti, L | 1 |
| Reed, G | 1 |
| Kirk, L | 1 |
| Kuhnert, L | 1 |
| Matthews, C | 1 |
| Anderson, R | 1 |
| Antani, J | 1 |
| Buckle, JW | 1 |
| Turner, J | 1 |
| Cohen, M | 2 |
| Hayes, G | 1 |
| Johnson, BF | 3 |
| Romero, L | 2 |
| Johnson, J | 1 |
| Marwaha, R | 2 |
| Saruta, T | 1 |
| Micossi, P | 1 |
| Pollavini, G | 1 |
| Raggi, U | 1 |
| Librenti, MC | 1 |
| Garimberti, B | 1 |
| Beggi, P | 1 |
| Mann, A | 1 |
| Akbar, fA | 2 |
| Pearce, MY | 1 |
| Macdonald, IA | 2 |
| Bennett, T | 3 |
| Brown, AM | 1 |
| Wilcox, RG | 3 |
| Skene, AM | 2 |
| Sato, R | 1 |
| Sawada, S | 1 |
| Hidaka, H | 1 |
| Matsuzaki, K | 1 |
| Bachmann, H | 1 |
| Imbs, JL | 4 |
| Schmidt, M | 3 |
| Giesen, EM | 2 |
| Schwartz, J | 4 |
| Hull, SS | 1 |
| Chimoskey, JE | 1 |
| Hornung, RS | 2 |
| Jones, RI | 2 |
| Gould, BA | 2 |
| Sonecha, T | 2 |
| Raftery, EB | 5 |
| Niarchos, AP | 2 |
| Velasco, M | 8 |
| Morillo, J | 1 |
| Ramirez, A | 1 |
| Hernández, E | 2 |
| Vizcarrondo, H | 1 |
| Urbin-Aquintana, A | 1 |
| López, JM | 1 |
| Medrano, G | 1 |
| Hernández-Pieretti, O | 4 |
| Ohman, P | 1 |
| Aurell, M | 2 |
| Asplund, J | 1 |
| Conradsson, T | 1 |
| Delin, K | 1 |
| Forslund, T | 1 |
| Frithz, G | 3 |
| Herlitz, H | 1 |
| Karlberg, B | 2 |
| Zucchelli, P | 1 |
| Zuccalà, A | 1 |
| Santoro, A | 1 |
| Degli Esposti, E | 1 |
| Sturani, A | 1 |
| Chiarini, C | 1 |
| Mann, SJ | 2 |
| Krakoff, LR | 2 |
| Lowenstein, I | 1 |
| Alterman, L | 1 |
| Zelen, R | 1 |
| Bank, DE | 1 |
| Bank, N | 1 |
| Halawa, B | 3 |
| Astvad, K | 1 |
| Krogh, A | 1 |
| Sidenius, J | 1 |
| Kocemba, J | 3 |
| Kawecka-Jaszcz, K | 3 |
| Scheinman, MM | 2 |
| Hess, DS | 1 |
| Pandit, RB | 1 |
| Heller, LJ | 1 |
| Stauffer, EK | 1 |
| Hunyor, SN | 4 |
| Nelson, GI | 2 |
| Donnelly, GL | 1 |
| Greenberg, S | 5 |
| Wilborn, WM | 1 |
| Shanks, RG | 3 |
| Savioli, RM | 1 |
| Savioli Neto, F | 1 |
| Lima, EV | 1 |
| Alonso, G | 1 |
| Martins, LR | 1 |
| Del Nero Júnior, E | 1 |
| Lopez, LM | 1 |
| Gefter, ML | 1 |
| Hemmes, RJ | 1 |
| Halperin, AK | 1 |
| Gross, KM | 1 |
| Rogers, JF | 1 |
| Cubeddu, LX | 4 |
| Dons, RF | 1 |
| Caldwell, JR | 3 |
| Frade, PD | 1 |
| Reddy, PJ | 1 |
| Mayer, JH | 1 |
| Kelly, AR | 1 |
| Alboni, P | 2 |
| Pirani, R | 3 |
| Filippi, L | 1 |
| Scarfo', S | 1 |
| De Lorenzi, E | 1 |
| Tomasi, AM | 3 |
| Masoni, A | 3 |
| Patterson, JF | 1 |
| Werber, AH | 1 |
| Bryan, WJ | 1 |
| Fink, GD | 2 |
| Chopra, BK | 1 |
| Miranda, B | 3 |
| Ruilope, L | 2 |
| Mancheño, E | 1 |
| Arribas, F | 1 |
| García-Robles, R | 1 |
| Alcázar, JM | 5 |
| Nieto, J | 2 |
| Sancho, J | 1 |
| Rodicio, JL | 5 |
| de Villa, LF | 1 |
| Babak, OIa | 1 |
| Bolland, G | 1 |
| Völkner, E | 2 |
| Helbing, B | 1 |
| Reuter, HM | 1 |
| Bauer, B | 1 |
| Webster, J | 4 |
| Petrie, JC | 6 |
| McLean, I | 1 |
| Hawksworth, GM | 2 |
| Dorigotti, L | 2 |
| Carpi, C | 1 |
| Bertoli, G | 1 |
| Mariani, PL | 1 |
| Abman, SH | 1 |
| Warady, BA | 1 |
| Lum, GM | 1 |
| Koops, BL | 1 |
| Taube, C | 1 |
| Höhler, H | 1 |
| Lorenz, S | 1 |
| Förster, W | 1 |
| Mittleman, HS | 1 |
| Mittleman, RE | 1 |
| Elser, B | 1 |
| Walter, NM | 1 |
| Whitworth, JA | 2 |
| Kincaid-Smith, P | 6 |
| Oppenheim, G | 1 |
| Nielsen, PE | 1 |
| Jørgensen, F | 1 |
| Pasotti, C | 1 |
| Ferrari, GP | 1 |
| van Baak, M | 3 |
| van Hooff, M | 3 |
| Schols, M | 3 |
| Alabaster, SL | 1 |
| Gogel, HK | 1 |
| McCarthy, DM | 1 |
| Bolling, SF | 1 |
| Flaherty, JT | 1 |
| Potter, AM | 1 |
| Gardner, TJ | 1 |
| Mörl, H | 4 |
| Fager, G | 1 |
| Bondjers, G | 1 |
| Olofsson, SO | 1 |
| Smith, U | 1 |
| Wiklund, O | 1 |
| Volkov, VS | 1 |
| Tsikulin, AE | 1 |
| Zeligs, MA | 1 |
| Lockhart, CH | 1 |
| Olson, K | 1 |
| Benowitz, NL | 2 |
| Pentel, P | 1 |
| Solomon, S | 1 |
| Hotchkiss, E | 1 |
| Saravay, SM | 1 |
| Bayer, C | 1 |
| Ramsey, P | 1 |
| Blum, RS | 1 |
| Nezu, M | 1 |
| Miura, Y | 3 |
| Adachi, M | 2 |
| Kimura, S | 1 |
| Toriyabe, S | 1 |
| Ishizuka, Y | 1 |
| Ohashi, H | 1 |
| Sugawara, T | 1 |
| Takahashi, M | 1 |
| Wysokiński, A | 3 |
| Florkiewicz, H | 1 |
| Pluta, A | 1 |
| Markiewicz, M | 8 |
| Kowalewski, J | 1 |
| Leshchinskiĭ, LA | 1 |
| Logacheva, IV | 2 |
| Nikolaeva, VA | 2 |
| Plastinina, RA | 2 |
| Polischuk, MA | 1 |
| Winterfeld, HJ | 1 |
| Siewert, H | 2 |
| Strangfeld, D | 2 |
| Celiwanov, II | 1 |
| Yamakado, T | 1 |
| Oonishi, N | 1 |
| Kondo, S | 3 |
| Noziri, A | 1 |
| Nakano, T | 1 |
| Takezawa, H | 1 |
| Yasuhara, H | 2 |
| Tonooka, M | 1 |
| Wada, I | 1 |
| Oguchi, K | 1 |
| Sakamoto, K | 1 |
| Kamijo, K | 1 |
| Guevara, F | 1 |
| Birkhead, JS | 1 |
| Vaughan Williams, EM | 1 |
| Gwilt, DJ | 1 |
| Tanqueray, A | 1 |
| Cazes, C | 1 |
| Smith, MT | 2 |
| Livingstone, I | 2 |
| Eadie, MJ | 2 |
| Hooper, WD | 1 |
| Triggs, EJ | 1 |
| Husum, B | 1 |
| Vester-Andersen, T | 1 |
| Buchmann, G | 1 |
| Bolwig, TG | 1 |
| Hackett, GI | 2 |
| Harrison, P | 2 |
| Kershaw, S | 2 |
| Saldanha, RV | 1 |
| Macruz, R | 2 |
| Santana, PC | 1 |
| de Lima, JJ | 1 |
| Zalc, S | 1 |
| Pileggi, F | 4 |
| Malini, PL | 4 |
| Strocchi, E | 3 |
| Ambrosioni, E | 9 |
| Matsuura, A | 1 |
| Matsuda, S | 1 |
| Diuk, KD | 1 |
| Dück, KD | 5 |
| Knappe, J | 5 |
| Gore, RD | 1 |
| Ben-Ishay, D | 1 |
| Pessina, AC | 10 |
| Hlede, M | 3 |
| Morandin, F | 1 |
| Casiglia, E | 1 |
| Gava, R | 1 |
| Agnoletto, V | 1 |
| Locatelli, C | 1 |
| Dal Palu, C | 5 |
| Lorenz, D | 1 |
| Rustin, MH | 1 |
| Coomes, EN | 1 |
| Brin, VB | 1 |
| Zonis, BIa | 2 |
| Decina, P | 1 |
| Malitz, S | 1 |
| Sackeim, HA | 1 |
| Holzer, J | 1 |
| Yudofsky, S | 1 |
| Kochar, MS | 3 |
| Kalbfleisch, JH | 1 |
| Blumenthal, SS | 1 |
| Maierhofer, WJ | 1 |
| Margulis, E | 1 |
| Binder, D | 1 |
| Cohen, AW | 1 |
| Greenberg, G | 3 |
| Brennan, PJ | 4 |
| Miall, WE | 6 |
| Lowenstein, J | 3 |
| Neusy, AJ | 2 |
| Murakami, E | 4 |
| Takekoshi, N | 2 |
| Matsui, S | 2 |
| Murakami, H | 2 |
| van Baak, MA | 4 |
| Spence, JD | 3 |
| Perkins, DG | 2 |
| Kline, RL | 2 |
| Adams, MA | 1 |
| Haust, MD | 2 |
| Andreasen, F | 3 |
| Jakobsen, P | 2 |
| Kornerup, HJ | 3 |
| Pedersen, OL | 3 |
| Weeke, J | 4 |
| Herbert, M | 1 |
| Foss, OP | 1 |
| Iurenev, AP | 2 |
| Hamdy, RC | 1 |
| Davies, A | 1 |
| Arnold, K | 1 |
| Tovey, JD | 1 |
| Saimbi, SS | 1 |
| Short, MD | 1 |
| Exton-Smith, AN | 1 |
| Silke, B | 2 |
| Hussain, M | 1 |
| Verma, SP | 1 |
| Taylor, SH | 4 |
| Inouye, IK | 1 |
| Massie, BM | 3 |
| Tubau, JF | 3 |
| Dolan, JG | 1 |
| Mushlin, AI | 1 |
| Izotov, AI | 1 |
| Postol'nikov, SF | 2 |
| Vygodin, VA | 6 |
| Murphy, MB | 1 |
| Sugrue, D | 1 |
| Trayner, I | 1 |
| Kaufman, S | 1 |
| Dollery, CT | 12 |
| Thompson, GR | 1 |
| Myers, MG | 2 |
| Woollard, ML | 1 |
| Bowker, CH | 1 |
| Weissinger, J | 1 |
| Dujovne, CA | 2 |
| DeCoursey, S | 1 |
| Krehbiel, P | 1 |
| Jackson, B | 1 |
| Chernoff, S | 1 |
| Doyle, AE | 2 |
| Sharma, JN | 1 |
| Granter, S | 1 |
| Zachariah, PK | 3 |
| Purdy, RE | 1 |
| Sato, K | 4 |
| Vandongen, R | 5 |
| Beilin, LJ | 5 |
| Lalor, C | 1 |
| Wall, BP | 1 |
| Dart, AM | 1 |
| McHardy, K | 1 |
| Barber, HE | 1 |
| Rodrigues, E | 1 |
| Lawson, AA | 2 |
| Kho, TL | 4 |
| Thijssen, H | 1 |
| Malmberg, L | 2 |
| Fagerberg, SE | 4 |
| Groop, LC | 1 |
| Wajngarten, M | 3 |
| Solorzano, J | 1 |
| Godoy, M | 2 |
| Barretto, AC | 3 |
| Richter-Heinrich, E | 1 |
| Homuth, V | 3 |
| Gohlke, HR | 2 |
| Heinrich, B | 1 |
| Schmidt, KH | 1 |
| Wiedemann, R | 1 |
| Heine, H | 1 |
| Cannella, G | 1 |
| Picotti, GB | 1 |
| Giambelli, A | 1 |
| Scolari, F | 1 |
| Cesura, AM | 1 |
| Tosoni, S | 1 |
| Maiorca, R | 1 |
| Román, O | 3 |
| Valenzuela, MA | 1 |
| Salazar, R | 1 |
| Fong Chi, S | 1 |
| Zminkowska, U | 1 |
| Herrmann, RM | 1 |
| Kiesewetter, R | 2 |
| Kuhn, J | 1 |
| Strube, G | 3 |
| Holtz, H | 2 |
| Heinrich, J | 2 |
| Laufer, J | 1 |
| Passwell, J | 1 |
| Keren, G | 1 |
| Brandt, N | 1 |
| Cohen, BE | 1 |
| BLoem, TJ | 1 |
| Lindner, PC | 1 |
| Taylor, RG | 1 |
| Crisp, AJ | 1 |
| Hoffbrand, BI | 2 |
| Maguire, A | 1 |
| Jacobs, HS | 1 |
| Banks, RA | 1 |
| Bayliss, J | 1 |
| Roulston, JE | 2 |
| Jones, JC | 1 |
| Floras, JS | 4 |
| Jones, JV | 7 |
| Hassan, MO | 4 |
| Sleight, P | 5 |
| Hubbell, FA | 1 |
| Coucello, JA | 1 |
| Bicho, MP | 1 |
| Ventura, AJ | 1 |
| Friesen, RM | 1 |
| Bonet, JF | 1 |
| Diehm, C | 2 |
| Schettler, G | 2 |
| Seaman, JJ | 1 |
| Longe, RL | 1 |
| Calvert, JC | 1 |
| Dall'Aglio, E | 1 |
| Chang, H | 1 |
| Reaven, G | 1 |
| Flamenbaum, W | 3 |
| Stiff, JL | 1 |
| Harris, DB | 1 |
| MacIver, M | 1 |
| Green, GJ | 1 |
| Breckenridge, AM | 1 |
| Foster, CA | 1 |
| Aston, SJ | 1 |
| Craswell, PW | 1 |
| Bevan, EB | 1 |
| de Boo, T | 2 |
| Lemmens, W | 2 |
| Binkhorst, R | 1 |
| van't Laar, A | 4 |
| Robertson, CS | 1 |
| Clifton, GL | 1 |
| Taylor, AA | 3 |
| Grossman, RG | 1 |
| Yagil, Y | 1 |
| Leibel, B | 1 |
| Kobrin, I | 1 |
| Stessman, J | 1 |
| Ishay, DB | 1 |
| Necchi, G | 2 |
| Agostoni, PG | 2 |
| Moruzzi, P | 3 |
| Mondadori, C | 2 |
| Guazzi, M | 5 |
| Kolber-Postepska, B | 1 |
| Kleinrok, Z | 1 |
| De Longraye, J | 1 |
| Gervais, C | 1 |
| Akhmetova, BKh | 1 |
| Didenko, RG | 1 |
| Abdullina, RN | 1 |
| Davidenko, IuD | 1 |
| Agostini, PG | 1 |
| Bauer, GE | 1 |
| Ross, M | 1 |
| Larkin, H | 1 |
| Frewin, DB | 2 |
| Penhall, RK | 2 |
| Leonello, PP | 1 |
| Clapp, RJ | 1 |
| Kristensen, BO | 5 |
| Barnett, AJ | 1 |
| Rathaus, M | 1 |
| Bernheim, J | 1 |
| Walstad, RA | 2 |
| Berg, KJ | 2 |
| Wessel-Aas, T | 2 |
| Nilsen, OG | 1 |
| Nyberg, G | 3 |
| du Cailar, C | 1 |
| Maillé, JG | 1 |
| Jones, W | 1 |
| Solymoss, BC | 1 |
| Chabot, M | 1 |
| Goulet, C | 1 |
| Delva, E | 1 |
| Grondin, CM | 1 |
| Ahmad, S | 1 |
| Bruce, RA | 1 |
| Hossack, KF | 1 |
| DeRouen, TA | 1 |
| Bergler, JH | 1 |
| Pennington, AC | 1 |
| Metcalfe, M | 1 |
| Vlachakis, ND | 6 |
| Nicholls, DP | 1 |
| Husaini, MH | 1 |
| Bulpitt, CJ | 7 |
| Stephens, MD | 1 |
| Butler, AG | 1 |
| Berkowitz, RL | 1 |
| Ferguson, RK | 5 |
| Vlasses, PH | 2 |
| Koplin, JR | 2 |
| Shirinian, A | 1 |
| Burke, JF | 1 |
| Alexander, JC | 1 |
| Lieberman, E | 3 |
| Wing, LM | 1 |
| Mulligan, J | 1 |
| Walkley, J | 1 |
| Grygiel, JJ | 1 |
| Graham, JR | 1 |
| Ferlinz, J | 3 |
| Easthope, JL | 2 |
| Hughes, D | 2 |
| Siegel, J | 2 |
| Tobis, J | 2 |
| Aronow, WS | 5 |
| Melkild, A | 2 |
| Gerber, JG | 3 |
| Freed, CR | 1 |
| Nies, AS | 8 |
| Imai, Y | 3 |
| Abe, K | 4 |
| Otsuka, Y | 2 |
| Irokawa, N | 2 |
| Yasujima, M | 2 |
| Saito, K | 2 |
| Sakurai, Y | 2 |
| Chiba, S | 2 |
| Ito, T | 3 |
| Sato, M | 2 |
| Haruyama, T | 2 |
| Yoshinaga, K | 3 |
| Wilkinson, R | 2 |
| Stevens, IM | 1 |
| Pickering, M | 1 |
| Robson, V | 1 |
| Hawkins, T | 1 |
| Kerr, DN | 1 |
| Harry, JD | 2 |
| Franciosa, JA | 3 |
| Johnson, SM | 2 |
| Tobian, LJ | 2 |
| Hanks, GW | 1 |
| Omata, K | 1 |
| Barden, A | 1 |
| Tunney, A | 1 |
| Watanabe, Y | 1 |
| Richer, C | 1 |
| Venturini-Souto, N | 1 |
| Boissier, JR | 1 |
| Giudicelli, JF | 2 |
| Jeffers, TA | 2 |
| Robb, OJ | 2 |
| Scott, AK | 2 |
| Huang, CM | 1 |
| Quintanilla, A | 1 |
| Molteni, A | 1 |
| Santucci, A | 4 |
| Aguglia, F | 4 |
| de Mattia, G | 3 |
| Gnecchi, M | 2 |
| Cicconetti, P | 4 |
| Federico, M | 2 |
| Marson, O | 2 |
| de Almeida, FA | 2 |
| Draibe, SA | 1 |
| Alves Filho, G | 2 |
| Ribeiro, AB | 2 |
| Ajzen, H | 1 |
| Kohlmann Junior, O | 1 |
| Figueiredo, JF | 1 |
| Landymore, RW | 1 |
| Murphy, DA | 1 |
| Kinley, E | 1 |
| Parrott, J | 1 |
| Sai, O | 1 |
| Quirbi, AA | 1 |
| Sowers, JR | 1 |
| Barrett, JD | 3 |
| Sambhi, MP | 3 |
| Matson, JR | 1 |
| Norby, LH | 1 |
| Robillard, JE | 1 |
| Shul'ga, IuD | 3 |
| Adubaev, OA | 1 |
| Baru, IM | 1 |
| Bhagat, BD | 2 |
| Karumanchi, VC | 1 |
| Pina, JI | 1 |
| Smith, RD | 1 |
| Tessman, DK | 1 |
| Kaplan, HR | 1 |
| England, JD | 2 |
| Merkle, GW | 1 |
| Bader, PI | 1 |
| Creason, PL | 1 |
| Townsend, DW | 1 |
| Conn, PS | 1 |
| Lakes, MK | 1 |
| Campbell, NM | 1 |
| Studer, A | 2 |
| Lüscher, T | 2 |
| Siegenthaler, W | 3 |
| Vetter, W | 3 |
| Jones, RM | 1 |
| Knight, PR | 1 |
| Lameyer, LD | 1 |
| Hesse, CJ | 1 |
| Sjöberg, KH | 1 |
| Blaufox, MD | 1 |
| Wexler, JP | 1 |
| Sherman, RA | 1 |
| Scharf, SC | 1 |
| Lee, HB | 1 |
| Bjerregaard, P | 1 |
| Blum, M | 1 |
| Algueti, A | 1 |
| Bauminger, S | 1 |
| Aviram, A | 1 |
| Ayalon, D | 1 |
| Wells, PH | 1 |
| Kaplan, JA | 3 |
| Ellis, ME | 1 |
| Sahay, JN | 1 |
| Chatterjee, SS | 1 |
| Ellis, SH | 1 |
| Gillespie, MN | 1 |
| Atkinson, JE | 1 |
| Turbek, JA | 1 |
| Diamond, L | 1 |
| Spach, MO | 2 |
| Bloch, R | 1 |
| Pieri, R | 4 |
| Stella, M | 2 |
| Savino, L | 1 |
| Pirrelli, A | 6 |
| Weinberger, MH | 2 |
| Pickering, TG | 4 |
| Case, DB | 5 |
| Sullivan, PA | 2 |
| Dard, SA | 1 |
| Parlier, HR | 1 |
| Pauleau, NE | 1 |
| Vincent, ML | 1 |
| Sassard, JE | 1 |
| van der Veur, E | 2 |
| ten Berge, BS | 2 |
| May, JF | 1 |
| Wesseling, H | 2 |
| Luborsky, L | 1 |
| Crits-Christoph, P | 1 |
| Brady, JP | 1 |
| Kron, RE | 1 |
| Weiss, T | 1 |
| Levy, L | 1 |
| Gajendragadkar, SV | 1 |
| Schork, MA | 1 |
| Glassock, RJ | 1 |
| Weitzman, RE | 1 |
| Bennett, CM | 1 |
| Maxwell, M | 1 |
| Hamilton, B | 1 |
| Winer, N | 2 |
| Kirkendall, W | 1 |
| Gonasun, L | 1 |
| Hamilton, BP | 3 |
| Hamilton, J | 1 |
| Kirkendall, WM | 4 |
| Gonasun, LM | 3 |
| Langrall, H | 1 |
| Krupp, P | 1 |
| Fanchamps, A | 1 |
| Reisman, L | 1 |
| Selden, RV | 1 |
| Virtanen, K | 1 |
| Jänne, J | 1 |
| Frick, MH | 4 |
| Houtzagers, JJ | 1 |
| Chadha, DR | 1 |
| Heagerty, AM | 1 |
| Russell, GI | 1 |
| Bing, RF | 1 |
| Thurston, H | 2 |
| Swales, JD | 2 |
| Caris, TN | 1 |
| Eason, E | 1 |
| Costom, B | 1 |
| Papageorgiou, AN | 1 |
| Bhalla, RC | 1 |
| Sharma, RV | 1 |
| Morrison, SC | 1 |
| Kumana, CR | 1 |
| Rudnick, KV | 1 |
| Haynes, B | 1 |
| Jones, NL | 1 |
| Urbina-Quintana, A | 3 |
| Andrews-Figueroa, P | 1 |
| Nieves, D | 1 |
| Guevara-Casado, J | 1 |
| Volpe, M | 4 |
| Trimarco, B | 4 |
| Ricciardelli, B | 4 |
| Vigorito, C | 2 |
| de Luca, N | 5 |
| Rengo, F | 1 |
| Condorelli, M | 5 |
| Negroni, S | 1 |
| Magnani, B | 8 |
| Preston, RA | 2 |
| Zarate, NA | 1 |
| Rosales, CB | 1 |
| Zschaeck, DW | 1 |
| Frances, A | 1 |
| Kaplan, HS | 1 |
| Takeda, K | 2 |
| Nakagawa, Y | 1 |
| Chin, WP | 1 |
| Imai, S | 2 |
| Minovich, AI | 2 |
| Chikviladze, RI | 1 |
| Gomez, G | 2 |
| Veber, VR | 3 |
| Gaevskiĭ, IuG | 2 |
| Bazyka, LA | 1 |
| Sanfelippo, JF | 1 |
| Hammond, JJ | 3 |
| Jacks-Nagle, VL | 1 |
| Plotnick, GD | 1 |
| Fisher, ML | 1 |
| Hamilton, JH | 1 |
| Robinson, M | 1 |
| Carliner, NH | 1 |
| Janoski, AH | 1 |
| Langlois, S | 1 |
| Pasternack, A | 1 |
| Pörsti, P | 2 |
| Pöyhönen, L | 1 |
| McCrory, WW | 1 |
| Willems, WJ | 1 |
| Harder, DR | 1 |
| Contney, SJ | 1 |
| McCubbin, JW | 1 |
| Stekiel, WJ | 1 |
| McNeil, GN | 1 |
| Shaw, PK | 1 |
| Dock, DS | 1 |
| Alicandri, CL | 1 |
| Agabiti-Rosei, E | 4 |
| Fariello, R | 3 |
| Beschi, M | 2 |
| Boni, E | 3 |
| Castellano, M | 2 |
| Montini, E | 1 |
| Romanelli, G | 2 |
| Zaninelli, A | 2 |
| Muiesan, G | 3 |
| Alicandri, C | 2 |
| Muiesan, ML | 2 |
| Ogilvie, R | 1 |
| Nadeau, J | 2 |
| Hamdy, C | 1 |
| Tovey, D | 1 |
| McAinsh, J | 3 |
| Moss, HB | 1 |
| Procci, WR | 1 |
| Bailie, GR | 1 |
| Wilborn, W | 1 |
| Abate, G | 1 |
| Polimeni, RM | 1 |
| Di Peppe, MC | 1 |
| Guarino, F | 1 |
| Troja, C | 1 |
| Marisi, F | 1 |
| Cerritelli, E | 1 |
| Brillante, C | 1 |
| De Angelis, M | 1 |
| Tuttle, R | 1 |
| Elias, B | 1 |
| McCleary, M | 1 |
| Endy, T | 1 |
| Di Veroli, C | 1 |
| Compagno, S | 1 |
| Iugoli, AR | 1 |
| Anshelevich, IuV | 1 |
| Dumesh, SZ | 1 |
| Slaĭdyn', AK | 1 |
| Sporan, VG | 1 |
| Greminger, P | 1 |
| Vetter, H | 7 |
| Boerlin, HJ | 1 |
| Baumgart, P | 1 |
| Havelka, J | 1 |
| Walger, P | 1 |
| Andriani, M | 1 |
| Drago, G | 1 |
| Alibrandi, F | 1 |
| Ciappa, A | 1 |
| Wargin, WA | 1 |
| Sawchuk, RJ | 1 |
| McBride, JW | 1 |
| McCoy, HG | 1 |
| Rylander, ML | 1 |
| Barenbaum, ES | 1 |
| Polishchuk, MA | 1 |
| Globus, M | 1 |
| Melamed, E | 1 |
| Keren, A | 1 |
| Tzivoni, D | 1 |
| Stern, S | 1 |
| Fea, F | 1 |
| Salvioli, G | 1 |
| Planca, E | 1 |
| Pelliccioli, I | 1 |
| Foti, F | 1 |
| Colombo, G | 1 |
| Netto, MP | 2 |
| Solórzano, JA | 1 |
| Mady, C | 2 |
| Moscovici, H | 1 |
| Yasbeck Júnior, P | 1 |
| Fadul Neto, J | 1 |
| Levy, Y | 1 |
| Kafka, M | 1 |
| Brook, JG | 2 |
| Halkin, H | 1 |
| Duncan, AW | 1 |
| Tibballs, J | 1 |
| Sutherland, SK | 1 |
| Bielmann, P | 1 |
| Leduc, G | 1 |
| Davignon, J | 1 |
| Saunderson, H | 1 |
| Fernandez, L | 1 |
| Rudolph, W | 3 |
| Dirschinger, J | 1 |
| Merkulova, NK | 1 |
| Feibel, JH | 2 |
| Baldwin, CA | 2 |
| Joynt, RJ | 2 |
| Ozovko, GI | 1 |
| Katiukhin, VN | 1 |
| Temirov, AA | 1 |
| Churnosov, EV | 1 |
| Elghozi, JL | 1 |
| Dagher, G | 1 |
| Garay, RP | 1 |
| Vasmant, D | 1 |
| Girard, F | 1 |
| Meyer, P | 1 |
| Brooks, CS | 1 |
| Weinstein, I | 1 |
| Wilcox, HH | 1 |
| Heimberg, M | 1 |
| Burch, RN | 1 |
| Barkley, R | 1 |
| Hatzinikolaou, P | 1 |
| Gavras, I | 3 |
| van Brummelen, P | 1 |
| Van den Bosch, RA | 1 |
| Nykamp, FP | 1 |
| De Jong, W | 4 |
| Pietruschka, WD | 2 |
| Scheuch, K | 1 |
| Gruber, G | 2 |
| Tomaschewskaja, LI | 1 |
| Reuschel, I | 2 |
| Montastruc, JL | 8 |
| Montastruc, P | 13 |
| Herrmann, JM | 2 |
| Hiemstra, S | 2 |
| Hoenig, B | 1 |
| Mehta, PJ | 1 |
| Acharya, VN | 1 |
| Chawla, KP | 1 |
| Gandhi, AK | 1 |
| Talwalkar, NC | 1 |
| Masuya, K | 1 |
| Nomura, M | 1 |
| Fujita, S | 1 |
| Tsuji, S | 1 |
| Chatani, T | 1 |
| Emoto, J | 1 |
| Tsugawa, H | 1 |
| Hashimoto, A | 1 |
| Thomsen, P | 1 |
| Otipka, N | 1 |
| Borba, P | 1 |
| Tenório, J | 1 |
| Didier, M | 1 |
| França, P | 1 |
| Santos, A | 1 |
| Zarate, A | 1 |
| Gelfand, M | 1 |
| Novello, A | 1 |
| Knepshield, J | 1 |
| Preuss, HG | 1 |
| Mazurek, W | 1 |
| Schröder, HE | 1 |
| Thiele, P | 1 |
| Vander Elst, E | 1 |
| Dombey, SL | 1 |
| Lawrence, J | 1 |
| Vlassak, W | 1 |
| Alderman, MH | 4 |
| Sasso, EH | 1 |
| Comberg, HU | 1 |
| Ey, A | 1 |
| Ireland, MA | 1 |
| Littler, WA | 4 |
| Jackman, G | 1 |
| Leonard, P | 1 |
| Skews, H | 1 |
| Bobik, A | 2 |
| Jennings, G | 1 |
| Taylor, EA | 3 |
| Turner, P | 4 |
| Saavedra, JM | 2 |
| Kato, K | 3 |
| Kawaguchi, Y | 2 |
| Mochizuki, A | 2 |
| Yamamoto, M | 1 |
| Wexler, BC | 1 |
| McMurtry, JP | 1 |
| Mackay, A | 1 |
| Isles, C | 1 |
| Henderson, I | 1 |
| Fife, R | 1 |
| Kennedy, AC | 2 |
| Hambsch, K | 1 |
| Sokolov, EI | 1 |
| Kolokolenkina, RP | 1 |
| Belova, EV | 3 |
| Imataka, K | 1 |
| Yamaoki, K | 1 |
| Oouchi, Y | 1 |
| Yazaki, Y | 2 |
| Wendt, RL | 1 |
| Much, DR | 1 |
| Bergey, JL | 1 |
| Wicks, TC | 1 |
| Carrasco, RM | 2 |
| da Rocha, MM | 1 |
| Luna, RL | 2 |
| Hentschel, E | 2 |
| Böhme, HR | 2 |
| Lasek, R | 1 |
| Reinelt, D | 1 |
| Misceo, N | 1 |
| Strippoli, MC | 1 |
| Bertello, F | 1 |
| Gaita, F | 1 |
| Montemurro, D | 1 |
| Gamalero, S | 1 |
| Commodo, E | 1 |
| Bocchiardo, M | 1 |
| Rosettani, E | 1 |
| Brusca, A | 1 |
| Patterson, JH | 1 |
| Self, TH | 1 |
| Wicke, W | 1 |
| Johnston, PE | 1 |
| Miller, ST | 1 |
| Bickers, WJ | 1 |
| Walle, T | 6 |
| Conradi, EC | 4 |
| Walle, UK | 4 |
| Fagan, TC | 3 |
| Gaffney, TE | 5 |
| van den Brink, G | 1 |
| van Asten, P | 1 |
| Geyskes, GG | 8 |
| van der Wall, E | 1 |
| Erkelens, DW | 1 |
| van der Hem, GK | 1 |
| Doorenbos, H | 1 |
| Sanmarco, ME | 1 |
| Pontius, S | 1 |
| Selvester, RH | 1 |
| Fraley, DS | 1 |
| Bruns, FJ | 1 |
| Segel, DP | 1 |
| Adler, S | 1 |
| Aledort, L | 2 |
| Coleman, TG | 1 |
| Solomon, LR | 1 |
| Lieberman, A | 1 |
| Kronzon, I | 1 |
| Colvin, S | 1 |
| Lieberman, I | 1 |
| Bott-Kanner, G | 2 |
| Schweitzer, A | 2 |
| Reisner, SH | 1 |
| Joel-Cohen, SJ | 1 |
| Rosenfeld, JB | 4 |
| Yamaguchi, I | 1 |
| Kopin, IJ | 2 |
| Traver, JA | 1 |
| Sanz Guajardo, D | 1 |
| Botella, J | 1 |
| Liard, JF | 2 |
| Takeshita, A | 3 |
| Matsuguchi, H | 1 |
| Saxena, PR | 1 |
| van Boom, M | 1 |
| van Doorn, K | 1 |
| Cairo-Rawlins, WI | 1 |
| Goldberg, AP | 2 |
| Hagberg, J | 1 |
| Delmez, JA | 1 |
| Carney, RM | 1 |
| McKevitt, PM | 1 |
| Ehsani, AA | 1 |
| Harter, HR | 2 |
| Atanacković, D | 1 |
| Stefanović, L | 1 |
| Trifunović, S | 2 |
| Draganić, N | 1 |
| Sćekić, V | 1 |
| Grajower, MM | 1 |
| Walter, L | 1 |
| Albin, J | 1 |
| Kushins, L | 1 |
| Cybulska, I | 4 |
| Wasowska-Ciszek, T | 1 |
| Watkins, J | 2 |
| Abbott, EC | 1 |
| Hensby, CN | 1 |
| de Champlain, J | 2 |
| Cousineau, D | 2 |
| Lapointe, L | 2 |
| Chu, D | 1 |
| Cocco, G | 1 |
| Schweda, E | 1 |
| Haeusler, G | 1 |
| Strozzi, C | 1 |
| Adams, WR | 1 |
| Gibberd, RW | 1 |
| Feely, J | 2 |
| Harvald, B | 2 |
| Mann, S | 1 |
| Craig, MW | 1 |
| Balasubramanian, V | 1 |
| Hørlyck, K | 1 |
| Carlisle, R | 3 |
| Porter, A | 1 |
| Hill, ID | 1 |
| Sommers, DK | 2 |
| Houston, MC | 1 |
| McChesney, JA | 1 |
| Chatterjee, K | 1 |
| Punt, R | 2 |
| Svensson, TH | 1 |
| Almgren, O | 2 |
| Elam, M | 1 |
| Engberg, G | 1 |
| Hallberg, H | 1 |
| Thorén, P | 2 |
| Pigato, R | 2 |
| Palatini, P | 6 |
| Inui, TS | 1 |
| Carter, WB | 1 |
| Pecoraro, RE | 1 |
| Pearlman, RA | 1 |
| Dohan, JJ | 1 |
| de Moraes, AV | 1 |
| Martnelli Filho, M | 1 |
| Dauar, D | 1 |
| Ebaid, M | 1 |
| Décourt, LV | 1 |
| Schauer, I | 2 |
| Schauer, U | 1 |
| Rühling, K | 1 |
| Thielmann, K | 2 |
| Semeraro, C | 1 |
| Zeis, PM | 1 |
| Thanopoulos, B | 1 |
| Pierroutsakos, IN | 1 |
| Koukoutsakis, PM | 1 |
| Shapiro, AP | 2 |
| Traub, YM | 2 |
| Pérez-Stable, EJ | 3 |
| Coates, TJ | 3 |
| Baron, RB | 2 |
| Biró, BS | 1 |
| Hauck, WW | 3 |
| McHenry, KS | 1 |
| Gardiner, PS | 2 |
| Feigal, D | 1 |
| Prochaska, JO | 1 |
| Iarema, NI | 2 |
| Rudyk, BI | 1 |
| Metelitsa, VI | 12 |
| Duda, SG | 7 |
| Ostrovskaia, TP | 7 |
| Filatova, NP | 7 |
| Mukhamedzhanova, GF | 2 |
| Siegrist, J | 1 |
| Broer, M | 2 |
| Gava, NS | 1 |
| Véras-Silva, AS | 1 |
| Negrão, CE | 1 |
| Krieger, EM | 2 |
| Kato, Y | 1 |
| Saijyo, T | 1 |
| Hattori, O | 1 |
| Suzuki, K | 2 |
| Hara, T | 1 |
| Deguchi, T | 1 |
| Ahn, C | 2 |
| Mercando, AD | 2 |
| Epstein, S | 2 |
| Santajuliana, D | 1 |
| Zukowska-Grojec, Z | 1 |
| Osborn, JW | 1 |
| Bogoyevitch, MA | 1 |
| Fuller, SJ | 1 |
| Sugden, PH | 1 |
| D'Amico, M | 1 |
| Berrino, L | 1 |
| Maione, S | 1 |
| Filippelli, A | 1 |
| Pizzirusso, A | 1 |
| Vitagliano, S | 1 |
| Rossi, F | 2 |
| Taddei, S | 5 |
| Virdis, A | 1 |
| Mattei, P | 1 |
| Favilla, S | 1 |
| Salvetti, A | 7 |
| Takita, M | 1 |
| Oda, Y | 1 |
| Kigoshi, S | 1 |
| Muramatsu, I | 1 |
| Paran, E | 2 |
| Holzberg, G | 1 |
| Mazor, M | 1 |
| Zmora, E | 1 |
| Insler, V | 1 |
| Coy, TV | 1 |
| Ancoli-Israel, S | 1 |
| Clausen, JL | 1 |
| Nelesen, RA | 1 |
| Sowinski, KM | 1 |
| Burlew, BS | 1 |
| Johnson, JA | 1 |
| Marotta, T | 1 |
| Ferrara, LA | 1 |
| Di Marino, L | 1 |
| Mancini, M | 1 |
| Annuzzi, G | 1 |
| Russo, O | 1 |
| D'Orta, G | 1 |
| Lucarelli, C | 1 |
| Nielson, KA | 1 |
| Jensen, RA | 1 |
| Rommel, T | 1 |
| Demisch, L | 1 |
| Plato, PA | 1 |
| Mondon, CE | 1 |
| Reaven, GM | 1 |
| Sasaki, J | 2 |
| Kajiyama, G | 1 |
| Kusukawa, R | 1 |
| Mori, H | 1 |
| Koga, S | 2 |
| Takagi, R | 1 |
| Ogawa, N | 1 |
| Arakawa, K | 3 |
| Belz, GG | 7 |
| Breithaupt, K | 7 |
| Erb, K | 4 |
| Kaila, T | 1 |
| Iisalo, E | 1 |
| Lehtonen, A | 3 |
| Saarimaa, H | 1 |
| Parfenova, EV | 5 |
| Krasnikova, TL | 5 |
| Aripova, NA | 3 |
| Nauman, E | 2 |
| D'iakonova, EG | 3 |
| Masenko, VP | 4 |
| Mazaev, AV | 3 |
| Carter, BL | 2 |
| Frohlich, ED | 18 |
| Elliott, WJ | 1 |
| Moore, MA | 1 |
| Mann, RJ | 1 |
| Roberts, RW | 1 |
| Malysheva, NV | 1 |
| Lerman, OV | 1 |
| Shastun, RS | 1 |
| Manoshkina, EM | 2 |
| Piotrovskiĭ, VK | 1 |
| Rumiantsev, DO | 1 |
| Belolipetskaia, VG | 1 |
| Filippenko, NG | 1 |
| Povetkin, SV | 2 |
| Smirnova, II | 1 |
| Dementéva, NG | 1 |
| Bredikhin, VT | 1 |
| Abdel-Rahman, AA | 1 |
| Ding, YA | 2 |
| Chou, TC | 1 |
| Lin, KC | 1 |
| Yonga, GO | 2 |
| Ogola, EN | 2 |
| Orinda, DA | 1 |
| Slaiby, JM | 2 |
| Ricci, MA | 2 |
| Gadowski, GR | 2 |
| Hendley, ED | 2 |
| Pilcher, DB | 2 |
| Wolfel, EE | 1 |
| Selland, MA | 1 |
| Mazzeo, RS | 1 |
| Reeves, JT | 1 |
| Arribas, S | 1 |
| Marín, J | 2 |
| Ponte, A | 1 |
| Shudo, C | 1 |
| Masuda, Y | 1 |
| Shigenobu, K | 1 |
| Kasuya, Y | 1 |
| Amaral, FT | 1 |
| Salgado, HC | 2 |
| Janssen, BJ | 1 |
| Oosting, J | 1 |
| Tyssen, CM | 1 |
| Naumann, E | 2 |
| Blau, A | 1 |
| Herzog, D | 1 |
| Herz, I | 1 |
| Battler, A | 1 |
| Schechter, P | 1 |
| Eliahou, HE | 2 |
| Kingwell, BA | 1 |
| Krause, L | 1 |
| Labreche, DG | 2 |
| Kondos, GT | 1 |
| Bartels, DW | 1 |
| Bauman, JL | 1 |
| Haczyński, J | 1 |
| Spring, A | 1 |
| Doria, E | 1 |
| Alimento, M | 1 |
| Riva, S | 1 |
| Muratori, M | 1 |
| Tamborini, G | 1 |
| Arad, M | 1 |
| Solomon, A | 1 |
| Roth, A | 1 |
| Atsmon, J | 1 |
| Rabinowitz, B | 1 |
| Chakrabarti, A | 1 |
| Sharma, PL | 5 |
| Anand, KS | 1 |
| Mittal, S | 1 |
| Singh, NP | 1 |
| Aĭvazian, TA | 1 |
| Shiga, T | 2 |
| Fujimura, A | 2 |
| Tateishi, T | 2 |
| Ohashi, K | 2 |
| Arriaga-Gracia, J | 1 |
| Sánchez-Garcia, JL | 1 |
| González-García, CA | 1 |
| Garg, KC | 1 |
| Singhal, KC | 1 |
| Kumar, S | 1 |
| Lal, A | 1 |
| McCorvey, E | 1 |
| Wright, JT | 1 |
| Culbert, JP | 1 |
| McKenney, JM | 1 |
| Proctor, JD | 1 |
| Annett, MP | 1 |
| Poulter, NR | 1 |
| Sanderson, JE | 1 |
| Thompson, AV | 1 |
| Sever, PS | 1 |
| Chang, CL | 1 |
| Galinier, M | 1 |
| Rougé, P | 1 |
| Albenque, JP | 1 |
| Assoun, B | 1 |
| Massabuau, P | 1 |
| Fauvel, JM | 1 |
| Bounhoure, JP | 1 |
| Serio, M | 1 |
| Potenza, MA | 1 |
| Montagnani, M | 1 |
| Mansi, G | 1 |
| Mitolo-Chieppa, D | 1 |
| Jirillo, E | 1 |
| Nederfors, T | 1 |
| Sharma, S | 1 |
| Mitra, S | 1 |
| Arora, D | 1 |
| Pershad, D | 1 |
| Singh, H | 1 |
| Hosohata, Y | 1 |
| Sasaki, K | 1 |
| Maruyama, K | 1 |
| Ohnuki, T | 1 |
| Hattori, K | 1 |
| Suzuki, J | 1 |
| Watanabe, K | 1 |
| Nagatomo, T | 1 |
| Stauber, RE | 1 |
| Heinemann, A | 1 |
| Trauner, M | 1 |
| Krejs, GJ | 1 |
| Matsuura, H | 1 |
| Skinner, MH | 1 |
| Tan, DX | 1 |
| Grossmann, M | 1 |
| Pyne, MT | 1 |
| Mahurin, RK | 1 |
| Barone, FC | 1 |
| Nelson, AH | 1 |
| Ohlstein, EH | 1 |
| Willette, RN | 1 |
| Sealey, JE | 3 |
| Campbell, WG | 1 |
| Feuerstein, GZ | 1 |
| Cronenwett, JL | 1 |
| Nichols, P | 1 |
| Keen, HL | 1 |
| Alonso-Galicia, M | 1 |
| Hall, JE | 1 |
| Anson, O | 1 |
| Neumann, L | 1 |
| Teno, S | 1 |
| Tanabe, A | 2 |
| Nomura, K | 1 |
| Demura, H | 2 |
| Farrace, S | 1 |
| Frontoni, S | 1 |
| Gambardella, S | 1 |
| Menzinger, G | 1 |
| Rossetti, L | 1 |
| Luther, HP | 1 |
| Wallukat, G | 1 |
| Dasaeva, LA | 2 |
| Vertel', AE | 1 |
| Iskenderov, BG | 1 |
| Tatarchenko, IP | 1 |
| Sun, Z | 1 |
| Cade, JR | 1 |
| Fregly, MJ | 1 |
| Rowland, NE | 1 |
| Siegrist, I | 1 |
| Mutoh, T | 1 |
| Tsubone, H | 1 |
| Nishimura, R | 1 |
| Sasaki, N | 1 |
| Berbaum, MW | 1 |
| Bredle, DL | 1 |
| Futamara, W | 1 |
| Fernandez, A | 1 |
| Crowther, TR | 1 |
| Vieweg, WV | 1 |
| Zaslavskaia, RM | 4 |
| Goncharov, LF | 1 |
| Zholdin, BK | 1 |
| Bisengalieva, GK | 1 |
| Sadchikov, DV | 1 |
| Eliutin, DV | 1 |
| Mil'tsyn, AS | 1 |
| Zhamankulov, KA | 1 |
| Zhumabaeva, TN | 1 |
| Teĭblium, MM | 3 |
| Sardelić, S | 1 |
| Pivac, N | 1 |
| Ljutic, D | 1 |
| Naranca, M | 1 |
| Bojić, L | 1 |
| Kovacić, Z | 1 |
| Yoshimoto, T | 1 |
| Naruse, M | 1 |
| Irie, K | 1 |
| Seki, T | 1 |
| Tanaka, M | 1 |
| Imaki, T | 1 |
| Naruse, K | 1 |
| Muraki, T | 1 |
| Matsuda, Y | 1 |
| Mansur, AP | 1 |
| Avakian, SD | 2 |
| Paula, RS | 1 |
| Donzella, H | 1 |
| Santos, SR | 1 |
| Ramires, JA | 2 |
| Brynne, L | 2 |
| Karlsson, MO | 2 |
| Paalzow, LK | 2 |
| Silhol, F | 1 |
| Bouchlaghem, K | 1 |
| Maximovitch, A | 1 |
| Vaisse, B | 1 |
| Poggi, L | 1 |
| Ruiz-Vega, H | 1 |
| Acosta-Urzua, LF | 1 |
| Carranza-Madrigal, J | 1 |
| Huape-Arreola, MS | 1 |
| Cooper, JW | 1 |
| Ye, JM | 1 |
| Colquhoun, EQ | 1 |
| Nguyen, T | 1 |
| El Salibi, E | 1 |
| Rouleau, JL | 1 |
| Costa, SK | 1 |
| Hyslop, S | 1 |
| Nathan, LP | 1 |
| Brain, SD | 1 |
| Chillon, JM | 2 |
| Baumbach, GL | 2 |
| Chen, X | 2 |
| Corradi, L | 1 |
| Preti, P | 1 |
| Mugellini, A | 1 |
| Lusardi, P | 1 |
| Negrusz-Kawecka, M | 1 |
| Kawano, Y | 3 |
| Abe, H | 2 |
| Kojima, S | 2 |
| Takishita, S | 1 |
| Omae, T | 4 |
| Brown, RA | 1 |
| Jefferson, L | 1 |
| Sudan, N | 1 |
| Lloyd, TC | 1 |
| Ren, J | 1 |
| Manso, AM | 1 |
| Encabo, A | 1 |
| Simon, HB | 1 |
| Kuo, TB | 1 |
| Yang, CC | 1 |
| Gessi, S | 1 |
| Caiazza, A | 1 |
| Halliday, R | 2 |
| Acree, M | 1 |
| Rudd, P | 1 |
| Antic, V | 1 |
| Kiener-Belforti, F | 1 |
| Tempini, A | 1 |
| Van Vliet, BN | 1 |
| Montani, JP | 1 |
| Tsunoda, M | 1 |
| Takezawa, K | 1 |
| Santa, T | 1 |
| Ina, Y | 1 |
| Nagashima, K | 1 |
| Ohmori, K | 1 |
| Kobayashi, S | 1 |
| Imai, K | 1 |
| Hertzan-Levy, S | 1 |
| Skutelsky, E | 1 |
| Arad, T | 1 |
| Wollman, Y | 1 |
| Chernihovsky, T | 1 |
| Polak-Charcon, S | 1 |
| Iaina, A | 1 |
| Ballejo, G | 1 |
| Salgado, MC | 1 |
| Da Silva, VJ | 1 |
| Ruiz-Marcos, FM | 1 |
| Ortíz, MC | 1 |
| Fortepiani, LA | 1 |
| Nadal, FJ | 1 |
| Atucha, NM | 1 |
| García-Estañ, J | 1 |
| Su, JZ | 1 |
| Chen, SC | 1 |
| Wu, KG | 1 |
| Chen, DG | 1 |
| Rui, HB | 1 |
| Wang, XY | 1 |
| Wang, HJ | 1 |
| Hart, CY | 1 |
| Meyer, DM | 1 |
| Tazelaar, HD | 1 |
| Grande, JP | 1 |
| Burnett , JC | 1 |
| Housmans, PR | 1 |
| Redfield, MM | 1 |
| Shabanov, VA | 1 |
| Terekhina, EV | 1 |
| Kostrov, VA | 1 |
| Pacca, SR | 1 |
| de Azevedo, AP | 1 |
| De Oliveira, CF | 1 |
| De Luca, IM | 1 |
| Stepp, DW | 1 |
| Frisbee, JC | 1 |
| Pissarek, M | 1 |
| Ermert, J | 1 |
| Oesterreich, G | 1 |
| Bier, D | 1 |
| Coenen, HH | 1 |
| Corcoy, R | 1 |
| Ménard, J | 6 |
| de Boisdeffre, B | 1 |
| Ducrocq, MB | 1 |
| Plouin, PF | 3 |
| Corvol, P | 6 |
| Bengtsson, C | 3 |
| Rodger, JC | 1 |
| Sheldon, CD | 1 |
| Lerski, RA | 1 |
| Livingstone, WR | 1 |
| Mroczek, WJ | 2 |
| Lee, WR | 1 |
| Davidov, ME | 4 |
| Finnerty, FA | 4 |
| Turner, R | 1 |
| White, P | 1 |
| Benton, F | 1 |
| Marshall, AJ | 2 |
| Roberts, CJ | 1 |
| Barritt, DW | 2 |
| Del Vicario, M | 1 |
| Moorthy, K | 1 |
| King, J | 1 |
| Cassidy, J | 1 |
| Davidson, C | 1 |
| Thadani, U | 1 |
| Beretta-Piccoli, C | 1 |
| Ziegler, W | 1 |
| Hirsch, D | 1 |
| de Châtel, RD | 1 |
| Reubi, FC | 1 |
| Waal-Manning, HJ | 2 |
| Nomura, T | 1 |
| Nazarenko, VR | 1 |
| Levy, JV | 1 |
| Brittain, RT | 1 |
| Levy, GP | 2 |
| Kelly, KL | 1 |
| Weinstock, M | 1 |
| Lohmöller, G | 4 |
| Lydtin, H | 5 |
| Ahlquist, RP | 2 |
| Rosei, EA | 4 |
| Fraser, R | 4 |
| Morton, JJ | 4 |
| Brown, JJ | 4 |
| Lever, AF | 4 |
| Robertson, JI | 5 |
| Trust, PM | 4 |
| Malatray, J | 1 |
| Gautier, E | 1 |
| Lundgren, B | 1 |
| Carlsson, E | 1 |
| Fellenius, E | 1 |
| Burkart, F | 5 |
| Pfisterer, M | 5 |
| Küng, M | 3 |
| Talbot, S | 1 |
| Lütold, BE | 4 |
| Werkö, L | 4 |
| Lewis, P | 1 |
| Stumpe, KO | 11 |
| Kolloch, R | 6 |
| Gramann, W | 4 |
| Krück, F | 7 |
| Ressel, C | 2 |
| Higuchi, M | 2 |
| Kralberg, BE | 1 |
| Tolagen, K | 4 |
| Honour, AJ | 1 |
| Woods, JR | 2 |
| Dandavino, A | 1 |
| Murayama, K | 1 |
| Brinkman, CR | 2 |
| Assali, NS | 1 |
| Matsunaga, M | 1 |
| Hara, A | 1 |
| Ogino, K | 1 |
| Motohara, S | 1 |
| Saito, M | 1 |
| Guédon, J | 1 |
| Lucsko, M | 1 |
| Chaignon, M | 1 |
| Aubert, Ph | 1 |
| Blum, I | 3 |
| Atsmon, A | 4 |
| Rick, JH | 1 |
| Oparil, S | 1 |
| Kolloch, RE | 3 |
| Zacchello, F | 2 |
| Kudrin, AN | 1 |
| Davydova, ON | 1 |
| Krendal', FP | 1 |
| Robinson, RG | 1 |
| DeQuattro, V | 6 |
| Grushkin, CM | 1 |
| Pfeffer, MA | 2 |
| Pfeffer, JM | 1 |
| Weiss, AK | 1 |
| Güllner, HG | 1 |
| Wester, A | 5 |
| Falke, HE | 4 |
| Buckingham, RE | 2 |
| Hamilton, TC | 2 |
| Robson, D | 1 |
| Buu, NT | 1 |
| Hamet, P | 6 |
| Guthrie, GP | 3 |
| Cuche, JL | 3 |
| Boucher, R | 3 |
| Genest, J | 6 |
| Sivertsson, R | 3 |
| Graham, RM | 2 |
| Stokes, GS | 4 |
| Pape, D | 1 |
| Lacroix, P | 1 |
| Linée, P | 1 |
| Le Pollés, JB | 1 |
| Van den Driessche, J | 1 |
| Igarashi, T | 1 |
| Nakajima, Y | 1 |
| Ohtake, S | 1 |
| Sasaki, T | 1 |
| Kajiwara, N | 2 |
| Koshino, M | 1 |
| Takahashi, G | 1 |
| Kogure, M | 1 |
| Yamada, A | 1 |
| Conway, J | 7 |
| Greenwood, DT | 1 |
| Middlemiss, DN | 1 |
| Overlack, A | 3 |
| Samizadeh, A | 1 |
| Losse, H | 1 |
| Wessels, F | 1 |
| Oka, M | 1 |
| Mäkelä, M | 1 |
| George, CF | 2 |
| Basishvili, NZ | 1 |
| Sannerstedt, R | 4 |
| Grobecker, H | 2 |
| Nielsen, I | 2 |
| Steiness, E | 4 |
| Hesse, B | 2 |
| Bordia, A | 1 |
| Khabya, BL | 1 |
| Hartikainen, M | 1 |
| Tchobroutsky, C | 1 |
| Lund-Johansen, P | 1 |
| Beierholm, EA | 1 |
| Sørensen, MB | 1 |
| Thorshauge, C | 1 |
| Lubbe, WF | 2 |
| Kowski, W | 1 |
| Bertel, O | 2 |
| Rosenthal, J | 1 |
| Meurer, KA | 2 |
| Escobar-Jimenez, F | 1 |
| Zoupas, C | 1 |
| Lang, R | 2 |
| Laaser, U | 1 |
| Kuschinsky, G | 1 |
| Raptis, S | 1 |
| Welzel, D | 2 |
| Milliez, P | 3 |
| Tcherdakoff, P | 3 |
| Dubois, D | 1 |
| Petitcolas, J | 1 |
| Monnier, JC | 1 |
| Honore, P | 1 |
| Lanciaux, B | 1 |
| Boulogne, M | 1 |
| Gardiner, SM | 1 |
| Lederballe Pedersen, O | 1 |
| Mikkelsen, E | 1 |
| Lanng Nielsen, J | 1 |
| Christensen, NJ | 2 |
| Eliasson, K | 5 |
| Lins, LE | 1 |
| Sundqvist, K | 1 |
| Overlack, O | 1 |
| Hill, LS | 2 |
| Monaghan, M | 1 |
| Richardson, PJ | 2 |
| Bell, C | 1 |
| McLachlan, EM | 1 |
| Watson, RD | 2 |
| Stallard, TJ | 2 |
| Knapp, MF | 1 |
| Linden, RJ | 1 |
| Stoker, JB | 1 |
| Newcombe, C | 1 |
| Morganti, A | 6 |
| Lopez-Ovejero, JA | 4 |
| Magometschnigg, D | 3 |
| Bonelli, J | 3 |
| Kaik, G | 2 |
| Rameis, H | 1 |
| Jung, N | 1 |
| Herold, M | 1 |
| Lauten, A | 1 |
| Sugawara, K | 2 |
| Takami, N | 2 |
| Ozaki, M | 2 |
| Reuben, SR | 1 |
| Gale, EV | 1 |
| Blake, P | 1 |
| Pratilas, V | 1 |
| Pratila, MG | 1 |
| Hitzenberger, G | 2 |
| Turini, GA | 3 |
| Louis, WJ | 2 |
| Rand, MJ | 1 |
| McNeil, JJ | 1 |
| Drummer, O | 1 |
| Jarrott, B | 1 |
| Rasmussen, K | 6 |
| Jensen, HA | 8 |
| Palmer, GC | 1 |
| Minutillo, S | 1 |
| Lupinc, V | 1 |
| D'Agnolo, B | 1 |
| Dugrais, G | 1 |
| Winnock, S | 1 |
| Castagne, A | 1 |
| Bonnet, A | 1 |
| Torrielli, R | 1 |
| Janvier, G | 1 |
| Taylor, EM | 1 |
| Roe, AM | 1 |
| Slater, RA | 1 |
| Fand, RS | 1 |
| Angelino, PF | 3 |
| Lavezzaro, GC | 1 |
| Castaldo, D | 1 |
| Kolsters, G | 4 |
| Schalekamp, MA | 11 |
| Zaal, GA | 4 |
| Lloyd-Mostyn, RH | 1 |
| Harris, AL | 1 |
| Vos, J | 3 |
| Kaye, SB | 1 |
| Shaw, KM | 1 |
| Ross, EJ | 1 |
| Bjaeldager, P | 1 |
| Broch-Moller, B | 1 |
| Pettinger, W | 1 |
| Parker, T | 1 |
| Hull, A | 1 |
| Long, D | 1 |
| Prati, R | 1 |
| Pocock, J | 1 |
| Heaton, ST | 1 |
| Waldek, S | 1 |
| Osborne, DR | 1 |
| Skegg, DC | 1 |
| Doll, R | 1 |
| Atlas, SA | 1 |
| Moon, C | 1 |
| Durão, V | 1 |
| Prata, MM | 1 |
| Gonçalves, LM | 1 |
| Fuss, O | 1 |
| Derkx, FH | 3 |
| von Gool, JM | 1 |
| Wenting, GJ | 2 |
| Verhoeven, RP | 2 |
| Man in 't Veld, AJ | 6 |
| Helson, L | 1 |
| Duque, L | 1 |
| Gillies, A | 1 |
| Wilson, M | 3 |
| Morgan, G | 3 |
| Carney, S | 2 |
| O'Brien, ET | 3 |
| Pryor, JP | 1 |
| Khan, O | 1 |
| Pearson, RM | 2 |
| Havard, CW | 4 |
| FitzGerald, G | 1 |
| Petrie, A | 1 |
| Lijnen, PJ | 1 |
| Amery, AK | 1 |
| Fagard, RH | 1 |
| Cumming, AM | 1 |
| Seedat, YK | 9 |
| Dargie, HJ | 5 |
| Daniel, J | 1 |
| Gierlichs, HW | 3 |
| Planz, G | 4 |
| Planz, R | 3 |
| Stephany, W | 2 |
| Uchida, Y | 1 |
| Ueda, H | 3 |
| Chilla, R | 1 |
| Arglebe, C | 1 |
| Davy, M | 2 |
| Mashiro, I | 1 |
| Kinoshita, M | 1 |
| Tomonaga, G | 1 |
| Hoshino, T | 1 |
| Shimono, Y | 1 |
| Baïsset, A | 4 |
| Besombes, JP | 4 |
| Mikkelsen, HI | 2 |
| Wadskov, S | 2 |
| Sondergaard, J | 2 |
| Enger, E | 1 |
| van Ketel, WG | 1 |
| Soesman-van Waadenoyen Kernekamp, A | 1 |
| Bumpus, FM | 1 |
| Yamada, T | 2 |
| Kubota, T | 1 |
| Endo, T | 1 |
| Komatus, H | 1 |
| Oba, M | 1 |
| Nagata, H | 1 |
| Izumiyama, T | 1 |
| Noresson, E | 2 |
| Folkow, B | 3 |
| Hallbäck-Nordlander, M | 1 |
| Schmid, G | 1 |
| Hempel, K | 1 |
| Fricke, L | 1 |
| Wernze, H | 1 |
| Heidland, A | 1 |
| Zehner, J | 6 |
| Klumpp, F | 3 |
| Lemke, R | 3 |
| Tolis, G | 1 |
| Fraysse, J | 2 |
| Nowaczynski, W | 1 |
| Wei, JW | 1 |
| Janis, RA | 1 |
| Daniel, EE | 1 |
| Fushimi, H | 1 |
| Kobayashi, Y | 1 |
| Koyama, T | 1 |
| Miyata, M | 1 |
| Matsuyuki, Y | 1 |
| Sugase, T | 1 |
| Shima, K | 1 |
| Tarui, S | 1 |
| Keim, HJ | 2 |
| Wallace, JM | 3 |
| Keim, H | 1 |
| Squadrito, G | 2 |
| Saitta, A | 2 |
| Frisina, N | 4 |
| Longo, G | 1 |
| Cucinotta, D | 1 |
| Frölich, JC | 1 |
| Hollifield, JW | 4 |
| Michelakis, AM | 2 |
| Vesper, BS | 1 |
| Wilson, JP | 1 |
| Seyberth, HJ | 1 |
| Frölich, WH | 1 |
| Oates, JA | 1 |
| Enger, SC | 1 |
| Cass, E | 1 |
| Kadar, D | 1 |
| Stein, HA | 1 |
| Salako, LA | 1 |
| Falase, AO | 1 |
| Aderounmu, AF | 1 |
| Van Herwaarden, CL | 5 |
| Fennis, JF | 5 |
| Bravo, EL | 8 |
| Dustan, HP | 18 |
| Zacest, R | 3 |
| Lewis, JW | 1 |
| Sakurai, H | 1 |
| Nivatpumin, T | 1 |
| Yipintsoi, T | 1 |
| Penpargkul, S | 1 |
| Scheuer, J | 1 |
| Henning, M | 2 |
| Hultberg, E | 1 |
| Bjerle, P | 4 |
| Jacobsson, KA | 2 |
| Agert, G | 2 |
| Hessenbruch, V | 1 |
| Düsing, R | 2 |
| Frisch, P | 2 |
| Marbet, G | 1 |
| Greer, M | 1 |
| Moses, C | 1 |
| Van Soest, GA | 1 |
| McKenzie, JK | 1 |
| Reisin, E | 2 |
| Clement, DL | 1 |
| Keeton, TK | 1 |
| Flemma, RJ | 1 |
| Staller, B | 1 |
| O'rourke, RA | 4 |
| Schnitzler, RN | 1 |
| Potter, DE | 1 |
| Schambelan, M | 1 |
| Salvatierra, O | 1 |
| Orloff, S | 1 |
| Holliday, MA | 1 |
| Bosman, AR | 1 |
| Goldberg, B | 1 |
| McKechnie, JK | 1 |
| Offermeier, J | 1 |
| Oosthuizen, OJ | 1 |
| Lindborg, B | 3 |
| Sugioka, K | 1 |
| Mao, W | 1 |
| Woods, J | 1 |
| Mueller, RA | 1 |
| Binkhorst, RA | 3 |
| van t'Laar, A | 1 |
| Bryan, RK | 1 |
| Hoobler, SW | 3 |
| Rosenzweig, J | 1 |
| Weller, JM | 1 |
| Purdy, JM | 1 |
| Riddiough, MA | 1 |
| Simon, G | 2 |
| Zweifler, A | 4 |
| Randall, O | 3 |
| Hua, AS | 3 |
| Macdonald, IM | 1 |
| Myers, JB | 2 |
| Fang, P | 2 |
| Wilkinson, PR | 1 |
| Mitchell, JR | 2 |
| Pool, JL | 3 |
| Rollins, DE | 2 |
| Bartter, FC | 2 |
| Shaw, J | 3 |
| Zacharias, FJ | 6 |
| Cowen, KJ | 4 |
| Karlberg, BE | 7 |
| Aberg, H | 14 |
| Westerlund, A | 7 |
| Jameson, S | 4 |
| Henningsen, NC | 4 |
| Dawson, A | 1 |
| Smith, I | 1 |
| Young, JL | 2 |
| Plaza Pérez, JJ | 1 |
| Casado Pérez, S | 2 |
| Losada Cabrera, M | 1 |
| Hernando Avendaño, L | 2 |
| Burgess, CD | 1 |
| Wadsworth, J | 1 |
| Espiner, EA | 1 |
| Mansfield, H | 1 |
| Miles, K | 1 |
| Epstein, SE | 1 |
| Sullivan, JM | 3 |
| Kirsh, MM | 1 |
| Behrendt, DM | 1 |
| Jackson, AP | 1 |
| Dhadphale, P | 1 |
| Alseri, S | 1 |
| Brymer, J | 1 |
| Orringer, MB | 1 |
| Sloan, H | 1 |
| Hall, D | 2 |
| Loracher, C | 1 |
| Charocopos, F | 1 |
| Keusch, GW | 1 |
| Campese, V | 2 |
| Lee, DB | 1 |
| Upham, AT | 1 |
| Massry, SG | 1 |
| Aminu, J | 1 |
| Vere, DW | 2 |
| Jaeger, P | 2 |
| Ozokvo, GI | 2 |
| Lowenthal, DT | 3 |
| Onesti, G | 4 |
| Mutterperl, R | 1 |
| Affrime, M | 1 |
| Martinez, EW | 1 |
| Kim, KE | 2 |
| Busby, P | 1 |
| Shirk, J | 1 |
| Swartz, C | 1 |
| Perry, HM | 2 |
| Douglas-Jones, AP | 3 |
| Lee, A | 1 |
| Mattiasson, I | 1 |
| Pugsley, DJ | 2 |
| Nassim, M | 2 |
| Armstrong, BK | 3 |
| Beilin, L | 1 |
| Sullivan, PC | 1 |
| Tifft, CP | 2 |
| Chobanian, AV | 4 |
| Gantt, CL | 1 |
| Wright, AD | 2 |
| Barber, SG | 1 |
| Kendall, MJ | 2 |
| Poole, PH | 1 |
| Fabricius, J | 1 |
| Thomsen, A | 1 |
| Clausen, N | 1 |
| Damsgaard, T | 1 |
| Mellemgaard, K | 1 |
| Steiner, JA | 2 |
| Cooper, R | 1 |
| Gear, JS | 1 |
| Ledingham, JG | 1 |
| Friedlander, DH | 1 |
| Antonaccio, MJ | 2 |
| Harris, D | 1 |
| Goldenberg, H | 1 |
| High, JP | 1 |
| Rubin, B | 1 |
| MacLeod, SM | 1 |
| Kaplan, H | 1 |
| Ogilvie, RI | 2 |
| Ruedy, J | 1 |
| Sellers, EM | 1 |
| Ti, TY | 1 |
| Serup, J | 2 |
| Németh, M | 1 |
| Tényi, I | 1 |
| Pár, A | 1 |
| Wauters, JP | 1 |
| Schaller, MD | 1 |
| McNair, A | 1 |
| Woods, JO | 1 |
| Cerasola, G | 1 |
| Morici, ML | 1 |
| Amico, LM | 1 |
| Biondo, S | 1 |
| Caputo, V | 2 |
| Balsano, F | 3 |
| Moran, JF | 1 |
| Derkac, WM | 1 |
| Conkle, DM | 1 |
| Harris, AH | 1 |
| Brady, JV | 1 |
| Mathur, PP | 1 |
| Riley, RL | 2 |
| Richardson, CP | 1 |
| Reavey-Cantwell, NH | 1 |
| Steichele, C | 1 |
| Moyer, JP | 1 |
| Belasco, RN | 1 |
| Kershaw, GR | 1 |
| Liang, CS | 2 |
| Allonen, H | 1 |
| Kleimola, T | 2 |
| Adamska-Dyniewska, H | 1 |
| Gajewska, B | 1 |
| Taburet, AM | 1 |
| Horvath, F | 1 |
| Marbury, TC | 1 |
| Uhlemann, ER | 1 |
| Nelson, EW | 1 |
| Fuller, TJ | 1 |
| Warren, SE | 1 |
| Ebert, E | 1 |
| Swerdlin, AH | 1 |
| Steinberg, SM | 1 |
| Stone, R | 1 |
| Yen, TT | 1 |
| Pearson, DV | 1 |
| Feigenbaum, LZ | 1 |
| Luft, FC | 1 |
| Grim, CM | 1 |
| Klotman, PE | 1 |
| Van Huysse, JW | 1 |
| Bune, A | 1 |
| Ryan, C | 2 |
| Halloran, TJ | 1 |
| Newsome, HH | 1 |
| Weir, GC | 1 |
| Daniel, TM | 1 |
| Kuokkanen, K | 1 |
| Sotaniemi, EA | 1 |
| Anttila, M | 1 |
| Pelkonen, RO | 1 |
| Järvensivu, P | 1 |
| Sundquist, H | 1 |
| Pritchard, F | 1 |
| Schneck, D | 1 |
| Hayes, A | 1 |
| Glasser, SP | 1 |
| Spoto, E | 1 |
| Solomon, DA | 1 |
| Smith, BF | 1 |
| Carr, ML | 1 |
| Maniscalco, BS | 1 |
| Safar, MA | 1 |
| Kheder, AM | 1 |
| Levy, BI | 1 |
| Moreno-González, A | 2 |
| Vernon, C | 1 |
| Sakula, A | 1 |
| Hilder, RJ | 1 |
| Nijkamp, FP | 2 |
| Van Den Bosch, R | 1 |
| Thulin, T | 1 |
| Schersten, B | 1 |
| Vikesdal, O | 1 |
| Williams, AJ | 1 |
| Wong, L | 1 |
| Nation, RL | 1 |
| Chiou, WL | 1 |
| Mehta, PK | 2 |
| Maling, TJ | 1 |
| van Rooijen, GJ | 1 |
| Wenger, NK | 1 |
| Schmucki, O | 1 |
| Yoshimura, M | 1 |
| Takahashi, H | 2 |
| Takashina, R | 1 |
| Kajita, Y | 1 |
| Miyazaki, T | 1 |
| Hachiya, T | 1 |
| Ijichi, H | 1 |
| Ochi, Y | 1 |
| Schnaper, HW | 1 |
| Collins, MA | 1 |
| Linshaw, MA | 1 |
| Stapleton, FB | 2 |
| Gruskin, AB | 1 |
| Baluarte, HJ | 1 |
| Harbin, GL | 1 |
| Iriuchijima, J | 2 |
| Szadowska, A | 1 |
| Szmigielska, H | 1 |
| Szmigielski, A | 1 |
| Mazur, M | 1 |
| Poulter, N | 1 |
| Gabriel, R | 1 |
| Smits, JM | 1 |
| Pedersen, G | 1 |
| Pedersen, A | 1 |
| Easterling, DE | 1 |
| Tenschert, W | 1 |
| Reuteler, H | 1 |
| Furrer, J | 1 |
| Nussberger, J | 1 |
| Pérez-Medina, T | 1 |
| Gamio-Capestany, F | 1 |
| Agrawal, RL | 2 |
| Alliott, RJ | 1 |
| George, M | 1 |
| Trafford, JA | 1 |
| Jequier, PW | 1 |
| Lishman, JD | 1 |
| Turner, JR | 1 |
| Boriskina, GM | 1 |
| Gulak, PV | 1 |
| Posmnov, IuV | 1 |
| Boström, SL | 1 |
| Fryklund, J | 1 |
| Dunn, FG | 2 |
| Lorimer, AR | 2 |
| Lawrie, TD | 2 |
| Ambrosio, GB | 1 |
| Donadon, W | 1 |
| Pagnan, A | 1 |
| Zamboni, S | 1 |
| Mauro, B | 2 |
| Savagnone, E | 2 |
| Gruppillo, P | 1 |
| Cecchi, CA | 1 |
| Hicks, PE | 1 |
| Engel, R | 1 |
| Halberg, F | 1 |
| Nelson, W | 1 |
| Hallbäck, M | 2 |
| Bianchi, G | 1 |
| Tcherdakoff, Ph | 2 |
| Kreft, C | 3 |
| Pruyn, SC | 1 |
| Phelan, JP | 1 |
| Buchanan, GC | 1 |
| Routledge, PA | 1 |
| Seedat, MA | 1 |
| Bhoola, R | 1 |
| Petkova, M | 1 |
| Popova, N | 2 |
| Kolarova, R | 1 |
| Ianev, K | 1 |
| Kolareva, R | 1 |
| Chalukova, G | 1 |
| Delibasheva, A | 1 |
| Moatti, J | 1 |
| Chodakowska, J | 1 |
| Raczyński, J | 1 |
| Roca-Cusachs Coll, A | 1 |
| Anguera de Sojo, I | 1 |
| Serra Coll, J | 1 |
| Nolla Panadés, J | 1 |
| Aymami Soler, A | 1 |
| Midol-Monnet, M | 1 |
| Cugini, P | 2 |
| Manconi, R | 2 |
| Serdoz, R | 1 |
| Mancini, A | 1 |
| Meucci, T | 1 |
| Glorioso, S | 1 |
| Romeo, B | 1 |
| Borsatti, A | 1 |
| Todesco, S | 1 |
| Mongeau, JG | 1 |
| Biron, P | 1 |
| Pichardo, ML | 1 |
| Redlich, B | 1 |
| Nechwatal, W | 3 |
| Isbary, J | 3 |
| Greding, H | 3 |
| König, E | 3 |
| Coglitore, G | 1 |
| O'Dea, K | 1 |
| Tank, C | 1 |
| Kaplovitz, H | 1 |
| Marino, AJ | 1 |
| Owens, CJ | 1 |
| Brackett, NC | 1 |
| Longworth, DL | 1 |
| Felts, JH | 1 |
| Buckalew, WM | 1 |
| Hamilton, RW | 1 |
| Kedrov, AA | 1 |
| Kedrova, AN | 1 |
| Somova, LV | 1 |
| Corgnati, A | 6 |
| Ambrosio, G | 1 |
| Kaukinen, S | 1 |
| Ylitalo, P | 1 |
| Rocchini, AP | 2 |
| Rosenthal, A | 2 |
| Schuster, S | 1 |
| Fellows, KE | 1 |
| Nadas, AS | 1 |
| Nakada, T | 2 |
| Lovenberg, W | 2 |
| Will, RJ | 1 |
| Walker, OM | 1 |
| Traugott, RC | 1 |
| Treasure, RL | 1 |
| Wood, AJ | 1 |
| Doxey, JC | 1 |
| Wark, JD | 1 |
| Larkins, RG | 1 |
| Tomoike, H | 1 |
| Falch, DK | 2 |
| Odegaard, AE | 2 |
| Norman, N | 2 |
| Strauss, HC | 1 |
| Evans, GT | 1 |
| Wallace, A | 1 |
| Melville, DI | 1 |
| Silverberg, DS | 1 |
| Romem, I | 1 |
| Mashiach, S | 1 |
| Serr, DM | 1 |
| Spinelli, C | 1 |
| Covi, G | 1 |
| Lechi, C | 1 |
| Arosio, E | 1 |
| Zatti, M | 1 |
| Scuro, LA | 1 |
| Uchida, K | 1 |
| Yamamoto, I | 1 |
| Ishise, S | 2 |
| Morimoto, S | 1 |
| Takeda, R | 1 |
| Schoenfeld, A | 1 |
| Joel-Cohen, J | 1 |
| Angell-James, JE | 1 |
| Douer, D | 1 |
| Weinberger, A | 1 |
| Pinkhas, J | 1 |
| Yoshida, T | 2 |
| Kato, S | 3 |
| Takikawa, K | 2 |
| Ehrlich, W | 1 |
| Rodriguez-Lopez, E | 1 |
| Griswold, WR | 1 |
| McNeal, R | 1 |
| Mendoza, SA | 1 |
| Sellers, BB | 1 |
| Higgins, S | 1 |
| Valori, C | 1 |
| Biancifiori, M | 1 |
| Pinchi, G | 1 |
| Romero, E | 1 |
| Bertoncini, H | 1 |
| Guevara, J | 1 |
| Grell, GA | 1 |
| Deragon, G | 1 |
| Regoli, D | 1 |
| Rioux, F | 1 |
| Pritchard, JF | 1 |
| Schneck, DW | 1 |
| Racz, WJ | 1 |
| Hayes, AH | 1 |
| Sandifer, MG | 1 |
| Lieberman, BA | 1 |
| Stirrat, GM | 1 |
| Cohen, SL | 1 |
| Beard, RW | 1 |
| Pinker, GD | 1 |
| Belsey, E | 1 |
| Delvin, DG | 2 |
| Colliard, M | 1 |
| Berrard, E | 1 |
| Dupay, A | 1 |
| Bernaille, JM | 1 |
| Eggena, P | 2 |
| Ebel, H | 3 |
| Lübke, H | 1 |
| Witzgall, H | 2 |
| Whitehill, R | 1 |
| Hakala, MW | 1 |
| Lambert, DM | 2 |
| Simpson, CF | 1 |
| Nishiyama, K | 1 |
| Nishiyama, A | 1 |
| Oh, MS | 1 |
| Carroll, HJ | 1 |
| Skoglund, RR | 1 |
| Daggett, RB | 1 |
| Fernández Alvarez, O | 1 |
| Jéquier, E | 1 |
| Renshaw, DC | 1 |
| Walsh, GM | 1 |
| Baricos, WH | 1 |
| MacPhee, AA | 1 |
| Lediashova, GA | 1 |
| McSorley, PD | 1 |
| Warren, DJ | 2 |
| Johnson, AK | 1 |
| Simon, W | 1 |
| Schaz, K | 1 |
| Ganten, U | 1 |
| Ganten, D | 1 |
| Mann, JF | 1 |
| Wright, GL | 1 |
| Knecht, E | 1 |
| Badger, D | 1 |
| Samueloff, S | 1 |
| Toraason, M | 1 |
| Dukes-Dobos, F | 1 |
| Herrmann, R | 1 |
| Maggiore, Q | 2 |
| Zoccali, C | 2 |
| Monzani, G | 1 |
| Contini, C | 1 |
| Polak, G | 1 |
| Reid, JL | 2 |
| Hamilton, CA | 1 |
| Jones, DH | 1 |
| Simpson, N | 1 |
| Page, RL | 1 |
| Kritikou, PE | 1 |
| Gyftopoulos, A | 1 |
| Berry, C | 1 |
| McKenney, A | 1 |
| Kågedal, B | 2 |
| Tegler, L | 2 |
| Collins, RF | 1 |
| Tacquet, A | 1 |
| Bergman, B | 1 |
| Pulliam, CC | 1 |
| Werk, EE | 1 |
| Waider, W | 1 |
| Allen, CA | 1 |
| Schmidy, M | 1 |
| Jensen, HE | 2 |
| Sherman, K | 1 |
| Zwagg, RV | 1 |
| Galloway, DB | 2 |
| Millar, HR | 1 |
| Smith, MC | 2 |
| Wood, RA | 1 |
| Lewis, JA | 2 |
| Simpson, WT | 2 |
| Glover, SC | 1 |
| Hendry, WG | 1 |
| Logie, AW | 1 |
| Balansard, P | 1 |
| Libes, M | 1 |
| Leyris, R | 1 |
| Jullien, G | 1 |
| Joanny, P | 1 |
| Gerard, R | 1 |
| Michael, UF | 1 |
| Perez-Stable, EC | 1 |
| Davies, PS | 1 |
| Altman, J | 1 |
| Gordan, P | 1 |
| Grünfeld, JP | 1 |
| Stutterheim, A | 1 |
| Mees, EJ | 5 |
| De Plaen, JF | 1 |
| Reybrouck, T | 2 |
| Sederberg-Olsen, P | 3 |
| Ronne, H | 1 |
| Andersen, B | 1 |
| Roberts, R | 2 |
| Carney, SL | 2 |
| Nassim, MA | 1 |
| Boakes, AJ | 2 |
| Graham, BR | 2 |
| Mann, AH | 1 |
| Martin, WB | 1 |
| Zins, GR | 1 |
| Freyburger, WA | 1 |
| Lewis, PJ | 1 |
| Davis, JO | 1 |
| Biagini, M | 1 |
| Misefari, M | 1 |
| Mayer, G | 2 |
| Morselli, PL | 2 |
| Di Salle, E | 2 |
| Chidsey, CA | 7 |
| Thompson, FO | 1 |
| Joekes, AM | 2 |
| Alexandre, JM | 2 |
| Meignan, M | 1 |
| Bergman, H | 2 |
| Cramer, K | 2 |
| Forsberg, SA | 2 |
| Johnsen, V | 2 |
| Lundkvist, L | 2 |
| Rutle, O | 2 |
| Sjolyst, R | 2 |
| DeGuia, D | 1 |
| Mendlowitz, M | 2 |
| Page, IH | 4 |
| Ripley, RC | 1 |
| Mookherjee, S | 1 |
| Eich, RH | 1 |
| Obeid, AI | 1 |
| Smulyan, H | 1 |
| Moskalenko, NP | 4 |
| Glezer, GA | 4 |
| Mergelishvili, RI | 1 |
| Zil'bert, NL | 3 |
| Thananopavarn, C | 1 |
| Tuck, M | 1 |
| Wiedman, C | 1 |
| Kanto, J | 1 |
| Grenfell, RF | 1 |
| Grissom, RL | 1 |
| Gust, WF | 1 |
| Vaĭntsvaĭg, PM | 1 |
| Booker, WM | 1 |
| Hyde, A | 1 |
| Fletcher, A | 2 |
| Hawthorne, D | 1 |
| Sinaiko, AR | 2 |
| Mirkin, BL | 2 |
| Kikawada, R | 2 |
| Noro, C | 2 |
| Brym, E | 1 |
| Sznajderman, M | 3 |
| Januszewicz, W | 1 |
| Kleiner, JP | 1 |
| Ball, JH | 1 |
| Nelson, WP | 1 |
| Norton, JD | 1 |
| Buñag, RD | 2 |
| Krasnova, KN | 1 |
| Iakovleva, AA | 1 |
| Vul'fson, IN | 1 |
| Stella, A | 1 |
| Kley, R | 3 |
| Lommel, H | 3 |
| Roland, EQ | 1 |
| Lelguen, CE | 1 |
| Aboras, NE | 1 |
| Weiss, YA | 3 |
| Milliez, PM | 1 |
| Esumi, K | 1 |
| Ennvu, K | 1 |
| Olatunde, A | 1 |
| Akinkugbe, OO | 2 |
| Leak, D | 1 |
| Carroll, JJ | 1 |
| Robinson, DC | 1 |
| Ashworth, EJ | 1 |
| Kobayashi, H | 2 |
| Suganuma, Y | 2 |
| Saito, N | 1 |
| Zanchetti, AS | 1 |
| Kramer, HJ | 1 |
| Plaza de los Reyes, M | 1 |
| Lazcano, F | 1 |
| Orozco, R | 1 |
| Osorio, I | 1 |
| Passalaqua, W | 1 |
| Marzullo, E | 1 |
| Campino, C | 1 |
| Pla, C | 1 |
| Fernandes, M | 2 |
| Manfrin, M | 1 |
| Sala, C | 1 |
| Raper, AJ | 2 |
| Jessee, EF | 1 |
| Texter, JH | 1 |
| Giffler, RF | 1 |
| Hietala, TS | 1 |
| Carlsson, A | 1 |
| Jonasson, J | 1 |
| Ganguly, A | 1 |
| LaCombe, MA | 1 |
| Ongcharit, C | 1 |
| Tungsanga, K | 1 |
| McCarty, R | 1 |
| Chiueh, CC | 1 |
| Aström, H | 1 |
| Vallin, H | 1 |
| Sjoerdsma, A | 2 |
| Smelova, MA | 1 |
| Baliasnaia, NF | 2 |
| Pushkar', IuT | 1 |
| Elizarova, NA | 1 |
| Rappolt, RT | 1 |
| Gray, GR | 1 |
| Inaba, DS | 1 |
| Larsson, O | 2 |
| Maddern, PJ | 1 |
| Davis, NJ | 1 |
| McGlew, I | 1 |
| Oh, T | 1 |
| Knarr, JW | 1 |
| Sato, I | 2 |
| Tazumi, K | 2 |
| Shimazaki, H | 1 |
| Page, LT | 1 |
| Yager, HM | 1 |
| Sidd, JJ | 1 |
| Collinson, J | 1 |
| Clark, AB | 1 |
| Dunn, M | 1 |
| Dalske, HF | 1 |
| Wolf, GL | 1 |
| Dück, K | 1 |
| Adams, DF | 1 |
| Chidsey, C | 2 |
| Pine, M | 1 |
| Favrot, L | 1 |
| Smith, S | 1 |
| Morselli, P | 2 |
| O'Malley, K | 5 |
| Wells, J | 3 |
| McNay, J | 1 |
| Brundin, T | 1 |
| Edhag, O | 1 |
| Lundman, T | 1 |
| Horký, K | 4 |
| Kopecká, J | 5 |
| Greogorová, I | 1 |
| Dvoráková, J | 1 |
| Dafgård, T | 2 |
| Ivert, A | 2 |
| Jäderberg, E | 2 |
| Lindahl, T | 2 |
| Olsson, W | 2 |
| Treis, F | 2 |
| Wahlberg, F | 2 |
| Lopez-Ovejero, J | 1 |
| Wenger, HC | 1 |
| Zharko, KP | 2 |
| Cherniakova, IA | 1 |
| Pilipenke, NI | 1 |
| Laursen, PA | 1 |
| Moller, BB | 1 |
| Schweizer, RT | 1 |
| Bartus, SA | 1 |
| Riley, E | 1 |
| Montello, M | 1 |
| Fraser, HS | 1 |
| Carr, AC | 1 |
| Michaëlsson, G | 1 |
| Walldius, G | 1 |
| Jones, EL | 1 |
| Dorney, ER | 1 |
| King, SB | 1 |
| Douglas, JS | 1 |
| Hatcher, CR | 1 |
| Chevillard, C | 1 |
| Frydman, A | 1 |
| Lemaire, P | 1 |
| Weiss, Y | 3 |
| Palù, CD | 2 |
| Watson, LS | 1 |
| Schweizer, W | 1 |
| Peart, WS | 2 |
| Ram, N | 1 |
| Heilman, RD | 1 |
| Greenslade, FC | 1 |
| Slabý, A | 4 |
| Dösková, M | 4 |
| Mares, P | 1 |
| Tvrzická, E | 1 |
| Urbánek, J | 1 |
| Vinogradov, S | 1 |
| Skorepa, J | 1 |
| Armanini, D | 1 |
| Guido, R | 1 |
| Fallo, F | 1 |
| Opocher, G | 1 |
| Mantero, F | 1 |
| Basu, DP | 1 |
| Chatterjee, MK | 1 |
| Maiti, AK | 1 |
| Roy, RB | 1 |
| Witzgall, U | 1 |
| Froer, KL | 1 |
| Rinke, H | 1 |
| Nicita-Mauro, V | 1 |
| Ciraolo, O | 1 |
| Corvaja, E | 1 |
| Buemi, M | 2 |
| Ceruso, D | 1 |
| Maranò, A | 2 |
| Oneglia, C | 3 |
| Dal, C | 1 |
| Fiorentini, C | 4 |
| Olivari, MT | 3 |
| Polese, A | 4 |
| Magrini, F | 2 |
| Rotem, CE | 1 |
| Johnsson, G | 2 |
| Svedmyr, N | 1 |
| Korn, A | 1 |
| Rumiński, W | 1 |
| Portzer, D | 1 |
| Bianchetti, G | 2 |
| Hull, AR | 1 |
| Long, DL | 1 |
| Prati, RC | 1 |
| Parker, TF | 1 |
| Ibrahim, MM | 3 |
| Skrabal, F | 3 |
| Czaykowska, W | 2 |
| Dittrich, P | 2 |
| Braunsteiner, H | 2 |
| Pugsley, D | 1 |
| Armstrong, B | 1 |
| Stewart, IM | 1 |
| Bartorelli, C | 2 |
| Hedstrand, H | 3 |
| Darwin, K | 1 |
| Hilditch, A | 1 |
| Loveday, B | 1 |
| Reeves, M | 1 |
| Parker, FB | 1 |
| Neville, JF | 1 |
| Hanson, EL | 1 |
| Mohiuddin, S | 1 |
| Webb, WR | 1 |
| Makker, SP | 1 |
| Ancić, V | 1 |
| Cikoś, J | 1 |
| Kovać, M | 1 |
| Kloppenborg, PW | 1 |
| Festen, J | 1 |
| Benraad, TJ | 1 |
| Ferrario, CM | 1 |
| Manger, WM | 1 |
| Nik-Akhtar, B | 1 |
| Rashed, MA | 1 |
| Khakpour, M | 1 |
| Groover, ME | 1 |
| Simpson, WE | 1 |
| Fulghum, JE | 1 |
| Hickler, RB | 1 |
| Fentem, PH | 1 |
| Yates, JM | 1 |
| McNay, JL | 3 |
| Randall, OS | 3 |
| Esler, MD | 2 |
| Ellis, C | 2 |
| Bennett, J | 1 |
| Megrelishvili, RI | 3 |
| Komarov, FI | 1 |
| Felechko, FN | 1 |
| Ostrovskaia, VI | 1 |
| Mytareva, IL | 1 |
| Ferguson, HC | 1 |
| McKinney, GR | 1 |
| Gutiérrez Millet, V | 1 |
| Ruilope Urioste, LM | 1 |
| James, TN | 1 |
| Isobe, JH | 1 |
| Urthaler, F | 1 |
| Wetterberg, L | 2 |
| Ross, SB | 1 |
| Fujita, R | 1 |
| Kumura, F | 1 |
| Wellens, D | 1 |
| Snoeckx, L | 1 |
| De Reese, R | 1 |
| Kruger, R | 1 |
| Van de Water, A | 1 |
| Woutens, L | 1 |
| Reneman, RS | 1 |
| Wilburn, RL | 1 |
| Blaufuss, A | 1 |
| Bennet, CM | 1 |
| Tsuyusaki, T | 1 |
| Muramatsu, J | 1 |
| Kakubari, Y | 1 |
| Tanaka, K | 2 |
| Fukiyama, K | 1 |
| Kumamoto, K | 1 |
| Oniki, H | 1 |
| Sakamoto, A | 1 |
| Kaneko, K | 1 |
| Wijdeveld, P | 1 |
| Koene, R | 1 |
| Dormois, JC | 1 |
| White, CW | 1 |
| Zimmerman, TJ | 1 |
| Ahmad, M | 1 |
| Lasagna, L | 2 |
| Wardell, WM | 1 |
| Mamdani, B | 1 |
| Shansky, RM | 1 |
| Mahurkar, SD | 1 |
| Dunea, G | 2 |
| Maronde, RF | 1 |
| Briggs, WA | 2 |
| Cirksena, WJ | 2 |
| Price, WE | 1 |
| Gibson, TP | 2 |
| Ellis, CN | 3 |
| Cubey, RB | 1 |
| Mikhaĭlov, AA | 2 |
| Kavtaradze, VG | 1 |
| Pincus, R | 1 |
| Groth, KD | 1 |
| Kohler, S | 1 |
| Steiner, M | 2 |
| Wysenbeek, H | 1 |
| Tatro, DS | 1 |
| Chavez-Pardo, R | 1 |
| Lehner, JP | 1 |
| Van Es, JC | 1 |
| Díaz de Losada, JM | 1 |
| Pillay, VK | 1 |
| Schmidt, TH | 1 |
| Schonecke, OW | 1 |
| Krull, F | 1 |
| Selbmann, HK | 1 |
| Schäfer, N | 1 |
| von Uexküll, T | 1 |
| Werner, I | 1 |
| Krönig, B | 1 |
| Schumann, G | 1 |
| Walter, B | 1 |
| Rossi, G | 1 |
| Lupi, A | 1 |
| Shkhvatsabaia, IK | 6 |
| Kozdoba, OA | 1 |
| Harrison, T | 1 |
| Sisca, TS | 1 |
| Wood, WH | 1 |
| Mundy, GR | 2 |
| Raisz, LG | 1 |
| Collste, P | 1 |
| Holland, OB | 1 |
| Bard, RH | 1 |
| Simon, LS | 1 |
| Yorkston, NJ | 1 |
| Zaki, SA | 1 |
| Themen, J | 1 |
| Zilbert, NL | 1 |
| London, GM | 2 |
| Milliez, PL | 1 |
| Bogoliubov, VM | 1 |
| Lyskova, MN | 1 |
| Gribkova, IN | 1 |
| Kruglova, ZG | 1 |
| Bulpitt, C | 1 |
| Porter, JP | 1 |
| Reyes Toso, CF | 1 |
| Linares, LM | 1 |
| Rodríguez, RR | 1 |
| Tada, Y | 1 |
| Tsuda, Y | 1 |
| Otsuka, T | 1 |
| Kimura, H | 1 |
| Kusaba, T | 1 |
| Sakata, T | 1 |
| Wendt, T | 1 |
| Lipponi, G | 1 |
| Lucantoni, C | 1 |
| Antonicelli, R | 1 |
| Gaetti, R | 1 |
| Franssen, C | 1 |
| Wollersheim, H | 1 |
| de Haan, A | 1 |
| Addy, JH | 1 |
| Cruikshank, JM | 1 |
| Lithell, H | 2 |
| Pollare, T | 1 |
| Vessby, B | 1 |
| Giannattasio, C | 2 |
| Seravalle, G | 2 |
| Cattaneo, BM | 1 |
| Perondi, R | 1 |
| James, IM | 1 |
| Yogendran, L | 1 |
| McLaughlin, K | 1 |
| Munro, C | 1 |
| Kahan, T | 3 |
| Pedrinelli, R | 6 |
| Hjemdahl, P | 3 |
| Ward, JE | 1 |
| Coles, P | 1 |
| Cox, H | 1 |
| Eisenhofer, G | 1 |
| Angus, JA | 2 |
| Woch, W | 1 |
| Kokot, F | 5 |
| Grzeszczak, W | 2 |
| Zukowska-Szczechowska, E | 3 |
| Wiecek, A | 1 |
| Irzyniec, T | 1 |
| Maev, IV | 2 |
| V'iuchnova, ES | 1 |
| Ruiz de la Fuente Tirado, S | 1 |
| Cortina Greus, P | 1 |
| Alfonso Sanchez, JL | 1 |
| Saiz Sanchez, C | 1 |
| Sabater Pons, A | 1 |
| Gonzalez Arraez, JI | 1 |
| Cortes Vizcaino, C | 1 |
| Tomashets, EA | 1 |
| Mazur, NA | 1 |
| Kryzhanovskaia, II | 1 |
| Korolenko, SS | 1 |
| Kuriata, AV | 1 |
| Geĭchenko, VP | 1 |
| Uza, G | 1 |
| Koziara, Z | 1 |
| Lakomski, B | 1 |
| Bihar, PV | 1 |
| Chernoguz, LS | 4 |
| Zanozdra, NS | 4 |
| Kupchinskaia, EG | 3 |
| Duława, J | 1 |
| Kokot, M | 1 |
| Burkhart, KK | 1 |
| Lee, D | 1 |
| Mendes de Leon, CF | 1 |
| Jenkins, CD | 2 |
| Croog, SH | 5 |
| Levine, S | 5 |
| Sudilovsky, A | 4 |
| Persson, PB | 1 |
| Ehmke, H | 1 |
| Kirchheim, HR | 1 |
| Ting, CT | 3 |
| Chou, CY | 1 |
| Chang, MS | 2 |
| Wang, SP | 2 |
| Chiang, BN | 2 |
| Yin, FC | 3 |
| Poncet, MF | 1 |
| Tavernier, G | 1 |
| Damase-Michel, C | 1 |
| Tran, MA | 1 |
| Berlan, M | 1 |
| Ebii, K | 1 |
| Fukunaga, R | 1 |
| Taniguchi, T | 1 |
| Fujiwara, M | 1 |
| Nakayama, S | 1 |
| Saitoh, Y | 1 |
| Kimura, Y | 1 |
| Panarace, G | 2 |
| Sega, R | 1 |
| Marazzi, ME | 1 |
| Bombelli, M | 1 |
| Vulpis, V | 1 |
| Antonacci, A | 1 |
| Leto di Priolo, S | 1 |
| Libretti, A | 2 |
| Cantor, A | 1 |
| Cristal, N | 1 |
| Halabi, A | 1 |
| Endell, W | 1 |
| Halabi, I | 1 |
| Erb, KA | 3 |
| Essig, J | 3 |
| Gleerup, G | 1 |
| Hedner, T | 1 |
| Hjørting Hansen, E | 1 |
| Winther, K | 2 |
| Miyagishi, A | 1 |
| Maniwa, T | 1 |
| Noguchi, T | 1 |
| Hara, Y | 1 |
| Grum, DF | 1 |
| Azmy, SS | 1 |
| Kostis, JB | 3 |
| Rosen, RC | 2 |
| Brondolo, E | 1 |
| Taska, L | 1 |
| Smith, DE | 1 |
| Wilson, AC | 1 |
| Trojnar, R | 1 |
| Rymar, B | 1 |
| Shane, E | 1 |
| Kakaliia, EI | 1 |
| Korinteli, MO | 2 |
| Pavlov, AA | 1 |
| Rykin, BA | 1 |
| Corda, L | 1 |
| Valenti, L | 1 |
| Borra, E | 1 |
| Grassi, V | 1 |
| Mansur, Ade P | 1 |
| de Paula, RS | 1 |
| Lithell, HO | 1 |
| Gross, P | 1 |
| Koppenhagen, K | 1 |
| Wudel, E | 1 |
| Burger, KJ | 1 |
| Distler, GA | 1 |
| Chu, NF | 1 |
| Wang, DJ | 1 |
| Chen, LM | 1 |
| Shieh, SM | 1 |
| Sung, PK | 1 |
| Vorob'ev, LP | 1 |
| Kaziulin, AN | 1 |
| Gumbatov, NB | 1 |
| Mamedova, RN | 1 |
| Mustafaev, II | 2 |
| Kasumova, FZ | 1 |
| Umudov, KhM | 1 |
| Orudzheva, AK | 1 |
| Weir, MR | 1 |
| Josselson, J | 1 |
| Ekelund, LG | 4 |
| Korc, M | 1 |
| Stein, GH | 1 |
| Wolbach, RA | 1 |
| Champion, D | 1 |
| Green, KG | 2 |
| Cleophas, TJ | 2 |
| Asselt, LM | 1 |
| Oudshoorn, NH | 1 |
| Quadir, SU | 1 |
| Callaway, E | 1 |
| Duncan, JJ | 1 |
| Vaandrager, H | 1 |
| Farr, JE | 1 |
| Kohl, HW | 1 |
| Gordon, NF | 1 |
| Stoschitzky, K | 1 |
| Lindner, W | 1 |
| Armentano, R | 2 |
| Cabrera, E | 2 |
| Barra, J | 2 |
| Breitbart, G | 1 |
| Pichel, R | 2 |
| Pauletto, P | 1 |
| Vescovo, G | 1 |
| Scannapieco, G | 1 |
| Tettamanti, F | 1 |
| Poletti, L | 1 |
| Rizzardi, G | 1 |
| Fiocchi, G | 1 |
| Tokarenko, II | 3 |
| Andrushchenko, EV | 2 |
| Chmir, VP | 1 |
| Krasovskaia, EA | 1 |
| Malanchuk, TA | 1 |
| Polishchuk, II | 1 |
| Iashchenko, OB | 1 |
| Scruggs, KD | 2 |
| Martin, NB | 3 |
| Broeder, CE | 3 |
| Hofman, Z | 3 |
| Thomas, EL | 3 |
| Wambsgans, KC | 3 |
| Wilmore, JH | 3 |
| Darga, LL | 1 |
| Hakim, MJ | 1 |
| Lucas, CP | 1 |
| Franklin, BA | 1 |
| Tsuda, K | 2 |
| Masuyama, Y | 4 |
| Stone, CK | 1 |
| Wellington, KL | 1 |
| Willick, A | 1 |
| Sullebarger, JT | 1 |
| Bokovikov, AN | 1 |
| Akhunova, NT | 1 |
| Skołuda, A | 1 |
| Kozłowska, F | 1 |
| Paradowski, S | 1 |
| Gracz, M | 1 |
| Spessot, M | 1 |
| Kukes, VG | 2 |
| Rumiantsev, AS | 1 |
| Gneushev, ET | 2 |
| Al'perovich, BR | 1 |
| Svetyĭ, LI | 1 |
| Nasyrov, MN | 1 |
| Taratuta, TV | 1 |
| Kokutsov, A | 1 |
| Petev, L | 1 |
| Ramanathan, KB | 2 |
| Ratts, TE | 1 |
| Griffin, B | 1 |
| Shalaev, SV | 1 |
| Igoshina, LIu | 1 |
| Purgina, GIa | 1 |
| Andikian, TI | 1 |
| Gapon, LI | 1 |
| Nishimiya, T | 1 |
| Daniell, HB | 1 |
| Webb, JG | 1 |
| Oatis, J | 1 |
| Halushka, PV | 1 |
| Schaller, K | 1 |
| Braun, C | 1 |
| Krause, E | 1 |
| Edelson, JT | 1 |
| Weinstein, MC | 1 |
| Tosteson, AN | 1 |
| Williams, L | 1 |
| Lee, TH | 1 |
| Goldman, L | 1 |
| Patten, SB | 1 |
| Rudzite, VK | 1 |
| Vitols, AV | 2 |
| Liepinja, DJ | 1 |
| Silava, AK | 1 |
| Singer, P | 1 |
| Melzer, S | 1 |
| Goschel, M | 1 |
| Augustin, S | 1 |
| Contard, F | 1 |
| Rappaport, L | 1 |
| Samuel, JL | 1 |
| Swynghedauw, B | 3 |
| Kleinbloesem, CH | 4 |
| Wolf, GK | 2 |
| Corwin, J | 1 |
| Peselow, E | 1 |
| Feenan, K | 1 |
| Rotrosen, J | 1 |
| Fieve, R | 1 |
| Shimamoto, H | 3 |
| Shimamoto, Y | 3 |
| Sakata, S | 2 |
| Athanassiadis, DI | 1 |
| Dimopoulos, CG | 1 |
| Tsakiris, AK | 1 |
| Cokkinos, DF | 1 |
| Tourkantonis, AA | 1 |
| Toutouzas, PK | 1 |
| Boutin, B | 1 |
| Guez, D | 1 |
| Cuspidi, C | 1 |
| Sampieri, L | 1 |
| Pessina, A | 1 |
| Semplicini, A | 2 |
| Cinotti, G | 1 |
| Morabito, S | 1 |
| Rappelli, A | 1 |
| Brinchmann-Hansen, O | 1 |
| Christensen, CC | 1 |
| Myhre, K | 1 |
| Steiner, SS | 1 |
| Friedhoff, AJ | 1 |
| Wilson, BL | 1 |
| Wecker, JR | 1 |
| Santo, JP | 1 |
| Ooboshi, H | 1 |
| Sadoshima, S | 1 |
| Fujii, K | 1 |
| Ibayashi, S | 1 |
| Fujishima, M | 1 |
| Adibaev, OA | 1 |
| Aleĭnikov, VK | 2 |
| Kazymov, MS | 1 |
| Ruilope, LM | 3 |
| Krishchuk, AA | 1 |
| Savitskiĭ, SIu | 1 |
| Popova, LI | 1 |
| Jesek, JK | 2 |
| Ivy, JL | 1 |
| Colombo, F | 1 |
| Porro, T | 1 |
| Orlandi, L | 1 |
| Borchini, M | 1 |
| Sivkov, II | 1 |
| Rozinov, IuI | 1 |
| Mamedov, TSh | 1 |
| Alkhazov, AI | 1 |
| Levchuk, VP | 1 |
| Demchenkov, IuIa | 1 |
| Mitrofanov, VA | 1 |
| Holzer, BC | 1 |
| Randolph, C | 1 |
| Taska, LS | 1 |
| Miller, MH | 1 |
| Koryt'ko, IN | 1 |
| Gonzalez, DG | 1 |
| Featherston, W | 1 |
| Lugo, C | 1 |
| Ralakis, J | 1 |
| Berenson, GS | 1 |
| Shear, CL | 1 |
| Chiang, YK | 1 |
| Webber, LS | 1 |
| Voors, AW | 1 |
| Gandy, W | 2 |
| Stapper, GJ | 1 |
| Skarda, IJ | 1 |
| Liepinia, DJ | 1 |
| Voita, DU | 1 |
| Skards, JV | 1 |
| O'Connell, MB | 1 |
| Gross, CR | 1 |
| Stewart, KJ | 1 |
| Effron, MB | 1 |
| Valenti, SA | 1 |
| Kelemen, MH | 1 |
| Pescatello, LS | 1 |
| Mack, GW | 1 |
| Leach, CN | 1 |
| Nadel, ER | 1 |
| Long, J | 1 |
| Gillilan, R | 1 |
| Lee, SG | 1 |
| Kim, CR | 1 |
| Plantholt, S | 1 |
| Ades, PA | 2 |
| Gunther, PG | 2 |
| Meyer, WL | 1 |
| Gibson, TC | 1 |
| Maddalena, J | 1 |
| Orfeo, T | 1 |
| Schoenberger, JA | 3 |
| Baume, RM | 2 |
| Kishi, K | 2 |
| Fiocchi, R | 1 |
| Rorive, G | 3 |
| deGrau, A | 1 |
| Foti, A | 1 |
| Kim, SJ | 1 |
| DeQuattro, E | 1 |
| Allen, J | 1 |
| Ol'binskaia, LI | 1 |
| Vartanova, OA | 1 |
| Doshan, HD | 2 |
| Rosenthal, RR | 1 |
| Brown, R | 1 |
| Slutsky, A | 1 |
| Applin, WJ | 2 |
| Caruso, FS | 1 |
| Beattie, A | 2 |
| Matthys, H | 1 |
| Rühle, KH | 1 |
| Braig, H | 1 |
| Pohl, M | 1 |
| Maarek, BL | 1 |
| Bouthier, JA | 1 |
| Novo, S | 3 |
| Alaimo, G | 3 |
| Giordano, U | 2 |
| Raineri, A | 2 |
| Strano, A | 3 |
| Blaton, V | 1 |
| Hollez, P | 1 |
| Hoffman, IS | 1 |
| Franklin, SS | 1 |
| Tonkon, MJ | 1 |
| Kirschenbaum, MA | 1 |
| Dobak, JD | 1 |
| Henderson, K | 1 |
| Beinfeld, MC | 1 |
| Westfall, TC | 1 |
| Faulhaber, HD | 3 |
| Gruner, R | 1 |
| Menz, M | 1 |
| Hartrodt, W | 2 |
| Schmidt, J | 1 |
| Mohnike, W | 1 |
| Nash, DT | 1 |
| Brobyn, R | 1 |
| Kann, J | 1 |
| Levy, B | 1 |
| Margolis, R | 2 |
| Reeves, R | 1 |
| Sperling, DC | 1 |
| Sweet, D | 1 |
| Zager, P | 1 |
| McCormack, PM | 1 |
| Latham, AN | 3 |
| Mee, F | 1 |
| Atkins, N | 1 |
| Gries, J | 1 |
| Kretzschmar, R | 1 |
| Neumann, BW | 1 |
| Pino, ME | 1 |
| Pereda, T | 1 |
| Valenzuela, A | 1 |
| Leviashvili, BI | 4 |
| Marino, D | 1 |
| Giacobbe, MS | 1 |
| Squadrito, F | 1 |
| Cinquegrani, M | 1 |
| Barát, E | 1 |
| Huszár, E | 1 |
| Vértes, K | 1 |
| Debreczeni, LA | 1 |
| Beckmann, ML | 2 |
| Hoogkamer, JF | 1 |
| Kneer, J | 1 |
| Prisant, LM | 1 |
| Carr, AA | 1 |
| Nelson, EB | 1 |
| Velasquez, MT | 1 |
| Svishchenko, EP | 1 |
| Callens-el Amrani, F | 2 |
| Paolaggi, F | 2 |
| Dineen, M | 1 |
| Favier, RJ | 1 |
| Ghaemmaghami, F | 3 |
| Sempore, B | 1 |
| Desplanches, D | 2 |
| Mayet, MH | 1 |
| Frutoso, J | 1 |
| Gharib, C | 3 |
| Flandrois, R | 1 |
| Sherwood, A | 2 |
| Petrin, J | 1 |
| Egan, BM | 1 |
| Ruddy, MC | 1 |
| Bialy, GB | 1 |
| Sacks, FM | 1 |
| Creager, MA | 1 |
| Gallagher, SJ | 1 |
| Loscalzo, J | 1 |
| Dzau, VJ | 1 |
| Cleroux, J | 1 |
| Johnson, B | 2 |
| Vaccarino, V | 1 |
| Cremoncini, M | 1 |
| Gianfranceschi, G | 1 |
| Sirtori, M | 1 |
| Kawanishi, DT | 2 |
| Reid, CL | 1 |
| Gonzales, A | 1 |
| Rahimtoola, SH | 1 |
| Herrick, AL | 1 |
| Davis, JM | 1 |
| Weir, RJ | 1 |
| Koide, M | 1 |
| Tuan, RS | 1 |
| Corbo, M | 1 |
| Wang, PR | 1 |
| Li, JK | 1 |
| Chien, YW | 1 |
| Rukavina, Z | 1 |
| Aksamija, M | 1 |
| Witkowska, M | 1 |
| Lukasik, S | 1 |
| Kawecka, M | 1 |
| Moszczyńska, J | 1 |
| Karolko, B | 1 |
| Rizvi, SN | 1 |
| Rajvanshi, P | 1 |
| Verma, G | 1 |
| Lessem, JN | 2 |
| Barone, EJ | 1 |
| Berl, T | 1 |
| Detwiler, J | 1 |
| Lewin, AT | 1 |
| Lubash, GD | 1 |
| McGowan, RL | 1 |
| Gersema, LM | 1 |
| Williams, GO | 1 |
| Schabold, K | 1 |
| Thomas, JR | 1 |
| Fisher, SG | 1 |
| Hamburger, R | 1 |
| Borreson, RE | 1 |
| Mezey, KC | 2 |
| Mukherji, B | 1 |
| Neal, WW | 2 |
| Taguchi, JT | 1 |
| Chellingsworth, MC | 1 |
| Singh, BM | 1 |
| Pasi, J | 1 |
| O'Rourke, MF | 1 |
| Kelly, RP | 1 |
| Avolio, AP | 1 |
| Hayward, C | 1 |
| Wallin, JD | 2 |
| Gorwit, J | 1 |
| Michelson, EL | 2 |
| Bedsole, GD | 1 |
| Cubbon, J | 1 |
| Poland, MP | 2 |
| Shapiro, W | 1 |
| Charlap, S | 3 |
| Schuna, AA | 1 |
| Vejraska, BD | 1 |
| Hiatt, JG | 1 |
| Kochar, M | 1 |
| Day, R | 1 |
| Goodfriend, TL | 1 |
| Maclean, D | 2 |
| Mitchell, ET | 1 |
| Laing, EM | 1 |
| Macdonald, FC | 1 |
| Gough, KJ | 1 |
| Dow, RJ | 1 |
| McDevitt, DG | 1 |
| Mejia, A | 1 |
| Fletcher, AE | 1 |
| Chester, PC | 2 |
| Hawkins, CM | 1 |
| Pike, LA | 1 |
| Kupchinskaia, SG | 1 |
| Primak, GF | 1 |
| Korchinskaia, OI | 1 |
| Uzawa, H | 1 |
| O'Brien, E | 1 |
| Cox, JP | 1 |
| Fitzgerald, DJ | 1 |
| Gorwit, JI | 1 |
| Datta, SR | 1 |
| Praga, M | 1 |
| Oliet, A | 2 |
| Gutierrez-Millet, V | 1 |
| Yadav, S | 1 |
| Khalil, A | 1 |
| Hahn, W | 1 |
| Richard, F | 1 |
| Pigman, EC | 1 |
| Puras, A | 1 |
| Tikhonov, VP | 1 |
| Statsenko, ME | 1 |
| Khramov, IuA | 1 |
| Osmolovskiĭ, VS | 1 |
| Solov'eva, TA | 1 |
| Rubaĭ, IN | 1 |
| Ooi, WL | 2 |
| Madhavan, S | 1 |
| Cohen, H | 1 |
| Liu, ZR | 1 |
| Zhu, SX | 1 |
| Meza, N | 1 |
| López, H | 1 |
| Zusman, RM | 1 |
| Christensen, DM | 1 |
| Federman, EB | 1 |
| Ruddy, TD | 1 |
| Miller, DD | 1 |
| Boucher, CA | 1 |
| Garofalo, JL | 2 |
| Rothschild, A | 2 |
| Rothschild, M | 2 |
| Greenberg, SM | 2 |
| Soberman, J | 3 |
| Ram, Z | 1 |
| Spiegelman, R | 1 |
| Findler, G | 1 |
| Hadani, M | 1 |
| Kazarian, AB | 2 |
| Sozinov, VN | 1 |
| Paramonov, LV | 1 |
| Kniazev, RP | 1 |
| Kästner, C | 1 |
| Zott, HJ | 1 |
| Wallrabe, D | 1 |
| Spence, CD | 1 |
| Coghlan, JP | 1 |
| Denton, DA | 1 |
| Mills, EH | 1 |
| Nelson, MA | 1 |
| Scoggins, BA | 1 |
| Reuter, W | 1 |
| Zander, B | 1 |
| Mädebach, H | 1 |
| Korichneva, IL | 2 |
| Suvorov, IuI | 2 |
| Lo, M | 1 |
| Su, DF | 1 |
| Julien, C | 1 |
| Cerutti, C | 1 |
| Vincent, M | 1 |
| Parfyonova, EV | 1 |
| Suvorov, YI | 1 |
| Yamamoto, R | 1 |
| Cline, WH | 1 |
| McInnes, GT | 2 |
| Findlay, IN | 2 |
| Murray, G | 2 |
| Cleland, JG | 1 |
| Dornhorst, A | 1 |
| Powell, SH | 1 |
| Pensky, J | 1 |
| Rietbrock, N | 1 |
| Woodcock, BG | 1 |
| Abernethy, DR | 1 |
| Arendt, RM | 1 |
| Greenblatt, DJ | 2 |
| Davidov, M | 1 |
| Boyles, PW | 1 |
| Abengowe, CU | 1 |
| Lennard, MS | 2 |
| Arranz, CT | 1 |
| Balaszczuk, AM | 1 |
| Martínez-Seeber, A | 1 |
| Kubota, N | 1 |
| Ishii, Y | 1 |
| Kawase, S | 1 |
| Leary, P | 1 |
| Mayol, R | 1 |
| Capone, P | 2 |
| Taylor, S | 1 |
| Sromovsky, JA | 2 |
| Skoczeń, M | 1 |
| Lewis, RV | 1 |
| Jackson, PR | 1 |
| Ramsay, LE | 2 |
| Langsteger, W | 1 |
| Lind, P | 1 |
| Eber, O | 1 |
| Rigby, JW | 1 |
| Niegowska, J | 1 |
| Zawadzki, Z | 1 |
| Singh, BN | 2 |
| Rebanal, P | 1 |
| Piontek, M | 1 |
| Nademanee, K | 1 |
| Smirnov, GB | 1 |
| Sirakova, V | 2 |
| Penkov, N | 2 |
| Kaponov, Kh | 2 |
| Dimitrov, G | 1 |
| High, J | 1 |
| DeForrest, JM | 1 |
| Sybertz, E | 1 |
| Molling, J | 1 |
| Leuschner, U | 1 |
| Meyer, FP | 1 |
| Walther, H | 1 |
| Vykhovaniuk, IV | 2 |
| Radiukhin, VA | 2 |
| Ustinova, SE | 2 |
| Margetts, B | 1 |
| deKlerk, N | 1 |
| Rogers, P | 1 |
| Brown, MJ | 1 |
| Brown, J | 1 |
| Tucker, GT | 1 |
| Silas, JH | 1 |
| Woods, HF | 1 |
| Waller, PC | 1 |
| Vayssairat, M | 1 |
| Mathieu, JF | 1 |
| Bonin, M | 1 |
| Housset, E | 1 |
| Goldstein, J | 1 |
| Zager, PG | 2 |
| Sutton, JM | 1 |
| Sirgo, MA | 2 |
| Plachetka, JR | 2 |
| Riant, P | 1 |
| Urien, S | 1 |
| Albengres, E | 1 |
| Duche, JC | 1 |
| Tillement, JP | 1 |
| Leeman, M | 2 |
| Naeije, R | 2 |
| Degaute, JP | 2 |
| Brackman, F | 2 |
| Prost, JF | 2 |
| Thomas, J | 1 |
| Paillard, F | 1 |
| Lantz, B | 1 |
| Leviel, F | 1 |
| Ardaillou, R | 1 |
| Vincent, HH | 3 |
| Boomsma, F | 4 |
| Zawada, ET | 1 |
| Chelly, JE | 1 |
| Doursout, MF | 1 |
| Buckley, JP | 1 |
| Eikenburg, DC | 1 |
| Schwartz, DD | 1 |
| Hylander, B | 4 |
| Böhm, RO | 2 |
| Arends, BG | 1 |
| van Hooff, ME | 1 |
| Leman, RB | 1 |
| Pratt, CM | 1 |
| Nath, C | 1 |
| Fodor, JG | 1 |
| Chockalingam, A | 1 |
| Drover, A | 1 |
| Fifield, F | 1 |
| Pauls, CJ | 1 |
| Tsuda, S | 1 |
| Nishio, I | 1 |
| Norris, RJ | 1 |
| Pithois-Merli, I | 1 |
| Dorow, P | 1 |
| Madden, DJ | 3 |
| Blumenthal, JA | 3 |
| Nyrop, M | 1 |
| Kozlova, MV | 1 |
| Kalentchuk, VU | 1 |
| Shkhvatsabaya, IK | 2 |
| Glazer, N | 1 |
| Wollam, G | 1 |
| Cangiano, J | 1 |
| Gaevyĭ, MD | 1 |
| Meacham, CP | 1 |
| Handy, MA | 1 |
| LeWinter, MM | 1 |
| Vanholder, R | 1 |
| Lamiere, N | 1 |
| Ringoir, S | 1 |
| Neupert, A | 1 |
| Fischer, W | 1 |
| Lamon, KD | 1 |
| Okin, S | 1 |
| Huberfeld, SI | 1 |
| Laifer, L | 1 |
| Lapsker, J | 1 |
| Derkx, F | 1 |
| Leon, AS | 1 |
| Hunninghake, DB | 1 |
| Belcher, J | 1 |
| Stoulil, J | 1 |
| Lasser, NL | 1 |
| Nash, J | 1 |
| Lasser, VI | 1 |
| Hamill, SJ | 1 |
| Batey, DM | 1 |
| McClure, AD | 1 |
| De Quattro, V | 1 |
| Iureneva, AP | 1 |
| Salenko, BB | 1 |
| Khramelashvili, VV | 1 |
| Klieber, M | 1 |
| Resch, F | 1 |
| Abrignani, MG | 2 |
| Cutietta, A | 2 |
| Pepine, CJ | 1 |
| Avellone, G | 1 |
| Pinto, A | 1 |
| Adamo, L | 1 |
| Indovina, A | 1 |
| Cuocolo, A | 2 |
| De Simone, A | 2 |
| Mele, AF | 1 |
| Weiss, RJ | 2 |
| Bent, B | 1 |
| Lembo, G | 2 |
| Rosiello, G | 1 |
| Marcheggiano, R | 1 |
| Raponi, M | 1 |
| Di Cristinzi, I | 1 |
| Lande, K | 1 |
| Eide, I | 1 |
| Gjesdal, K | 1 |
| Moiseev, VS | 1 |
| Ivleva, AIa | 1 |
| Akopian, LM | 1 |
| Krasnobaeva, GM | 1 |
| Basem, AS | 1 |
| Gao, PJ | 1 |
| Zhang, WZ | 1 |
| Shen, JQ | 1 |
| Guazzi, MD | 1 |
| Barbier, P | 1 |
| Loaldi, A | 1 |
| Montorsi, P | 1 |
| Tosi, E | 1 |
| Nirasawa, Y | 1 |
| Temma, K | 1 |
| Akera, T | 1 |
| Kapoor, V | 1 |
| Cain, M | 1 |
| Herrera-Acosta, J | 1 |
| Pérez-Grovas, H | 1 |
| Fernández, M | 1 |
| Arriaga, J | 1 |
| Bönner, G | 1 |
| Schunk, U | 1 |
| Kaufmann, W | 1 |
| Rucinska, E | 1 |
| Vickers, FF | 1 |
| Espie, J | 1 |
| Vervoort-Peters, LH | 1 |
| Rousch, MJ | 1 |
| Thijssen, HH | 1 |
| Allen, MT | 1 |
| Obrist, PA | 1 |
| Langer, AW | 1 |
| Gotoh, M | 1 |
| van Schaik, BA | 1 |
| Kettner, N | 1 |
| Knudsen, JB | 1 |
| Gormsen, J | 1 |
| Jensen, J | 1 |
| Tsujimoto, G | 1 |
| Hashimoto, K | 1 |
| Hoffman, BB | 1 |
| Peart, S | 2 |
| Rossi, GP | 1 |
| Bongiovì, S | 1 |
| Perissinotto, F | 1 |
| Samà, B | 1 |
| Mozzato, MG | 1 |
| Wittenberg, C | 1 |
| Brodde, OE | 1 |
| Daul, AE | 1 |
| Wang, XL | 1 |
| Michel, MC | 1 |
| Galal, O | 1 |
| Cervi, V | 1 |
| van den Meiracker, AH | 2 |
| van Eck, HJ | 1 |
| Reda, DJ | 1 |
| Song, XP | 1 |
| Chen, PP | 1 |
| Chai, XS | 1 |
| Byyny, RL | 1 |
| LoVerde, M | 1 |
| Bennett, JM | 1 |
| Weich, DJ | 1 |
| Schoeman, HS | 1 |
| Kimura, G | 1 |
| Deguchi, F | 1 |
| Ashida, T | 1 |
| Yoshimi, H | 1 |
| Imanishi, M | 1 |
| Kawamura, M | 1 |
| Bochsler, JA | 1 |
| Simmons, RL | 1 |
| Ward, PJ | 1 |
| Maziĭ, SA | 1 |
| Senik, EA | 1 |
| Turashvili, GA | 1 |
| Zisel'man, SB | 1 |
| Ikeda, M | 2 |
| Iimura, O | 1 |
| Ishii, M | 1 |
| Kaneko, Y | 2 |
| Mizuno, Y | 1 |
| Takeda, T | 1 |
| Nakamura, H | 2 |
| Naukkarinen, VA | 2 |
| Hurt, E | 2 |
| Silva, H | 2 |
| Feldstein, E | 1 |
| Camejo, G | 2 |
| Krantz, DS | 2 |
| McKee, DC | 2 |
| Jullien, JL | 1 |
| Oster, G | 1 |
| Huse, DM | 1 |
| Delea, TE | 1 |
| Savage, DD | 1 |
| Colditz, GA | 1 |
| Emara, MK | 1 |
| Saadah, AM | 1 |
| Jiao, PH | 1 |
| Allen, JW | 1 |
| Lee, CC | 1 |
| Ayuso Gatell, A | 1 |
| Martínez Ferrer, JR | 1 |
| Trenchs Verdaguer, X | 1 |
| Pujol Colomer, J | 1 |
| Reda, D | 1 |
| Henderson, WG | 1 |
| Norès, JM | 1 |
| Lignières, G | 1 |
| Cranfield, FR | 1 |
| Walters, EG | 1 |
| Markanday, S | 1 |
| Shelton, JR | 1 |
| Bacić, A | 1 |
| Grgić, G | 1 |
| Buklijas, J | 1 |
| Bura, J | 1 |
| Titkov, IuS | 1 |
| Minkin, SR | 1 |
| Moshkin, AP | 1 |
| Rudaseva, LP | 1 |
| Avdonin, PV | 1 |
| Kravchenko, AN | 1 |
| Nekrasova, AA | 1 |
| Baklavadzhian, OG | 1 |
| Darbinian, AG | 1 |
| Taturian, IKh | 1 |
| Hvarfner, A | 1 |
| Bergström, R | 1 |
| Mörlin, C | 1 |
| Wide, L | 1 |
| Ljunghall, S | 1 |
| Grajek, S | 1 |
| Pyda, M | 1 |
| Kmiecik-Kaźmierczak, E | 1 |
| Brocki, Z | 1 |
| Nikisch, B | 1 |
| Trap-Jensen, J | 1 |
| Mito, RS | 1 |
| Yagiela, JA | 1 |
| Clive, J | 1 |
| Uchitel', IA | 1 |
| Carle, WK | 1 |
| Latta, D | 1 |
| Lees, CT | 1 |
| Lough, JR | 1 |
| Pender, J | 1 |
| Ross, JR | 1 |
| Sefton, S | 1 |
| Peers, EM | 1 |
| Richardson, PD | 1 |
| Brismar, K | 1 |
| Rössner, S | 1 |
| Ragnarsson, J | 1 |
| Hardarson, T | 1 |
| Snorrason, SP | 1 |
| Williams, GH | 2 |
| MacCarthy, EP | 1 |
| Anderson, M | 1 |
| Eidelson, BA | 1 |
| Ulep, D | 1 |
| Bartels, D | 1 |
| Seto, S | 1 |
| Aoi, W | 1 |
| Iwami, K | 1 |
| Yamaguchi, T | 1 |
| Ashizawa, N | 1 |
| Kusano, S | 1 |
| Baba, K | 1 |
| Doi, Y | 1 |
| Kuramochi, M | 1 |
| Hashiba, K | 1 |
| Hamada, M | 1 |
| Shigematsu, Y | 1 |
| Mahajan, V | 1 |
| Puri, R | 1 |
| Gattani, RK | 1 |
| Chatterji, T | 1 |
| Testa, MA | 2 |
| Hudson, CF | 1 |
| Joseph, SP | 1 |
| Lawrie, DM | 1 |
| Thirkettle, JL | 1 |
| Allsopp, D | 1 |
| Saunders, E | 1 |
| Curry, C | 1 |
| Hinds, J | 1 |
| Kong, BW | 1 |
| Medakovic, M | 1 |
| Poland, M | 1 |
| Roper, K | 1 |
| Danielsson, A | 1 |
| Ek, B | 1 |
| Steen, L | 1 |
| Suhr, O | 1 |
| Karppinen, K | 1 |
| Sarna, S | 1 |
| Brennan, P | 1 |
| Murray, GD | 1 |
| Enderlein, J | 1 |
| Bauer, E | 1 |
| Brosowski, KH | 1 |
| Voigt, S | 1 |
| Singhal, K | 1 |
| Siwach, SB | 1 |
| Gupta, DK | 1 |
| Gupta, SP | 1 |
| Man in't Veld, AJ | 1 |
| Samuel, P | 1 |
| Chin, B | 1 |
| Schoenfeld, BH | 1 |
| Schaefer, EJ | 1 |
| Strause, L | 1 |
| Saltman, P | 1 |
| Parmer, RJ | 1 |
| Koller, W | 1 |
| Orebaugh, C | 1 |
| Lawson, L | 1 |
| Potempa, K | 1 |
| Crowe, PF | 1 |
| Finnegan, OC | 1 |
| Russell, CJ | 1 |
| Varma, MP | 1 |
| Witte, K | 1 |
| Lovell, HG | 1 |
| Dollery, C | 1 |
| Simon, J | 1 |
| Ol'kha, RP | 1 |
| Rudakova, OG | 1 |
| Panfilov, IuA | 1 |
| Kriukov, NN | 1 |
| Lapina, ML | 1 |
| Leshchinskiĭ, PM | 2 |
| Makarova, NA | 1 |
| Almazov, II | 1 |
| Hoffmann-Traeger, A | 1 |
| Peiker, G | 2 |
| Glöckner, R | 2 |
| Wittmann, I | 1 |
| Balogh, A | 1 |
| Henschel, L | 1 |
| Oganov, RG | 2 |
| Zidek, W | 1 |
| Ottens, E | 1 |
| Heckmann, U | 1 |
| Tanabe, T | 1 |
| Ogasawara, Y | 1 |
| Takei, Y | 1 |
| Fukui, T | 1 |
| Fujimori, I | 1 |
| Maeda, T | 1 |
| Abe, A | 1 |
| Iyori, S | 1 |
| Tamura, T | 1 |
| Sanderson, JH | 2 |
| Habeck, JO | 1 |
| Huckstorf, C | 1 |
| Wurzelmann, J | 1 |
| Aronson, M | 1 |
| Masur, D | 1 |
| Nartowicz, E | 1 |
| Burduk, P | 1 |
| Karwowski, J | 1 |
| Baez, MA | 1 |
| Alvarez, CR | 1 |
| Weidler, DJ | 1 |
| Meltzer, VN | 1 |
| Tindira, CA | 1 |
| Naumovich, AD | 1 |
| Kimmel, B | 1 |
| Goldberger, J | 1 |
| Phillippides, G | 1 |
| Klein, N | 1 |
| Dargie, H | 1 |
| Cleland, J | 1 |
| Findlay, I | 1 |
| McInnes, G | 1 |
| Pashkova, TL | 1 |
| Dobrotvorskaia, TE | 1 |
| Samofanova, MS | 1 |
| Shengeliia, RG | 1 |
| Gillies, AH | 1 |
| Smith, AJ | 1 |
| Floate, LF | 1 |
| Brown, B | 1 |
| Klerman, GL | 1 |
| Hilden, T | 2 |
| Paul, O | 1 |
| Maltz, MB | 1 |
| Davies, DW | 1 |
| Lau, CP | 1 |
| Creamer, JE | 1 |
| Banim, SO | 1 |
| Camm, AJ | 1 |
| van der Meulen, J | 1 |
| Reijn, E | 1 |
| Heidendal, GA | 1 |
| Oe, PL | 1 |
| Johnston, GD | 1 |
| Finch, MB | 1 |
| Ebel, DL | 1 |
| Rhymer, AR | 1 |
| Stahl, E | 1 |
| Tipping, R | 1 |
| Widgren, B | 2 |
| Owens, GK | 1 |
| Kaler, SG | 1 |
| Patrinos, ME | 1 |
| Lambert, GH | 1 |
| Myers, TF | 1 |
| Karlman, R | 1 |
| Anderson, CL | 1 |
| Rakel, RE | 1 |
| Sekeff, JA | 1 |
| Bueno, MS | 1 |
| Weitzel, LH | 1 |
| Thevenard, RS | 1 |
| Azevedo, Ade C | 1 |
| Pandhi, P | 4 |
| Sahai, J | 1 |
| Wahi, PL | 3 |
| Sharma, BK | 4 |
| Zusman, R | 1 |
| Christensen, D | 1 |
| Federman, E | 1 |
| McCarron, D | 1 |
| Porush, JG | 1 |
| Spitalewitz, S | 1 |
| Mooy, J | 1 |
| Böhm, R | 2 |
| Does, R | 1 |
| Petri, H | 1 |
| van Kemenade, J | 1 |
| Thompson, SG | 1 |
| Balfe, JA | 1 |
| Pelech, AN | 1 |
| Barker, GA | 1 |
| Balfe, JW | 1 |
| Olley, PM | 1 |
| Prokopova, TN | 2 |
| Kiamil', EM | 1 |
| Bakhshaliev, AB | 1 |
| Iagizarova, NM | 1 |
| Mamedova, FD | 1 |
| Kocharli, MB | 1 |
| DiPette, DJ | 1 |
| Rogers, A | 1 |
| Leitschuh, M | 1 |
| Hyer, SL | 1 |
| Taylor, D | 1 |
| Barham, J | 1 |
| Wilson, J | 1 |
| Vince, FP | 1 |
| Rubin, PC | 1 |
| Butters, L | 1 |
| McCabe, R | 1 |
| Kelman, A | 1 |
| Desai, SP | 1 |
| Pierce, EC | 1 |
| Fleming, TC | 1 |
| Laporte, JR | 1 |
| Majcherczyk, S | 1 |
| Mikulski, A | 1 |
| Sjölander, M | 1 |
| Thachil, J | 1 |
| Zeller, JR | 1 |
| Petri, J | 1 |
| Gauquelin, G | 2 |
| Allevard, AM | 1 |
| Favier, R | 1 |
| Augoyard, G | 1 |
| Geelen, G | 1 |
| Ibanez, J | 1 |
| Bouzeghrane, F | 1 |
| Cherbal, F | 1 |
| Meunier, C | 1 |
| Iunusov, RA | 1 |
| Burykh, LN | 1 |
| Sviridova, NI | 1 |
| Nievel, JG | 1 |
| Packard, RC | 1 |
| Smirnova, IP | 1 |
| Gorbas', IM | 1 |
| Wright, CE | 1 |
| Malacco, E | 1 |
| Mailland, F | 1 |
| Bosisio, E | 1 |
| Meroni, R | 1 |
| Dagani, R | 1 |
| Renesto, E | 1 |
| Bevilacqua, M | 1 |
| Takada, T | 1 |
| Nakata, K | 1 |
| Yamauchi, H | 1 |
| Iso, T | 1 |
| Jacobsen, BA | 1 |
| Fjeldborg, P | 1 |
| Blunck, G | 1 |
| Traeger, A | 2 |
| Nolan, PL | 1 |
| Johnston, CI | 1 |
| Woodson, LC | 1 |
| Coyle, J | 1 |
| Cruess, D | 1 |
| Rostock, G | 1 |
| Prehm, C | 1 |
| Lindström, BL | 1 |
| Holtzman, JL | 1 |
| Finley, D | 1 |
| Berry, DA | 1 |
| Varshitskiĭ, MG | 1 |
| Purfürst, WD | 1 |
| Günther, KH | 1 |
| Hujer, W | 1 |
| Brown, OW | 1 |
| Brown, M | 1 |
| Hall, WD | 1 |
| Smith, VE | 1 |
| Wollam, GL | 1 |
| White, WB | 1 |
| Lubis, HR | 1 |
| Silalahi, M | 1 |
| Brin, KP | 1 |
| Lin, SJ | 1 |
| Due, DL | 1 |
| Giguere, GC | 1 |
| Silverstein, W | 1 |
| Lewin, NA | 1 |
| Goldfrank, L | 1 |
| Whelan, TV | 1 |
| Szlachcic, J | 1 |
| Hirsch, AT | 1 |
| Vollmer, C | 1 |
| Henderson, S | 1 |
| Cantarelli, EL | 1 |
| Pereira, R | 1 |
| Garret, M | 1 |
| Moreira, CR | 1 |
| Chan, KW | 1 |
| Feng, PH | 1 |
| Jayaratnam, FJ | 1 |
| Almazov, VA | 1 |
| Shliakhto, EV | 1 |
| Bershadskiĭ, BG | 1 |
| Lebedev, SV | 1 |
| Tsyrlin, VA | 1 |
| Goloshchapov, OA | 2 |
| Pribylova, NN | 1 |
| Kotova, LN | 1 |
| Nozhnova, LP | 1 |
| Nieszporek, T | 1 |
| Mleczko, Z | 1 |
| Trembecki, J | 1 |
| Wahl, J | 1 |
| Turlapaty, P | 1 |
| Bergmans, MG | 1 |
| Jonker, GJ | 1 |
| Kock, HC | 1 |
| Oren, A | 1 |
| Rotmensch, HH | 1 |
| Riley, LJ | 1 |
| Aslam, S | 1 |
| Andersson, OK | 1 |
| Gidding, SS | 1 |
| Beekman, R | 1 |
| Szpunar, CA | 1 |
| Moorehead, C | 1 |
| Behrendt, D | 1 |
| McMahon, T | 1 |
| Macieira-Coelho, E | 1 |
| Garcia-Alves, M | 1 |
| Reis-Valle, A | 1 |
| Wojciechowska, M | 1 |
| George, RB | 1 |
| Light, RW | 1 |
| Hudson, LD | 1 |
| Conrad, SA | 1 |
| Chetty, K | 1 |
| Manocha, K | 1 |
| Burford, JG | 1 |
| Sethi, V | 1 |
| Wahl, PL | 1 |
| Kida, O | 1 |
| Morotomi, Y | 1 |
| Higa, T | 1 |
| Vidt, DG | 2 |
| Mohler, H | 1 |
| Sánchez, RA | 1 |
| Moledo, LI | 1 |
| Iglesias, GH | 1 |
| Marcó, EJ | 1 |
| Brito, M | 1 |
| Gilbert, BH | 1 |
| Otorii, T | 1 |
| Ohkubo, K | 1 |
| Takata, S | 1 |
| Ogawa, J | 1 |
| Okuwa, H | 1 |
| Yagi, S | 1 |
| Iwase, N | 1 |
| Ikeda, T | 1 |
| Hattori, N | 1 |
| Mohr, JP | 1 |
| Kyle, MC | 1 |
| Pollack, MH | 1 |
| Rosenbaum, JF | 1 |
| Cassem, NH | 1 |
| Yaginuma, T | 1 |
| Noda, T | 1 |
| Tsuchiya, M | 2 |
| Takazawa, K | 1 |
| Kotoda, K | 1 |
| Hosoda, S | 1 |
| Paparella, N | 1 |
| Candini, GC | 1 |
| Vilkovyskiĭ, FA | 1 |
| Olevskiĭ, IKh | 1 |
| Klimenko, VS | 1 |
| Freitag, M | 1 |
| Pospiech, R | 1 |
| Pentel, PR | 1 |
| Asinger, RW | 1 |
| Westerman, RF | 1 |
| Schouten, JA | 1 |
| Hengeveld, WL | 1 |
| Wouda, AA | 1 |
| Kaijser, L | 1 |
| Moy, J | 1 |
| el-Yazigi, A | 1 |
| Martin, CR | 1 |
| Bell, RL | 1 |
| Curb, JD | 1 |
| Friedman, LM | 1 |
| Payne, GH | 1 |
| Reim, HG | 1 |
| Wagner, W | 1 |
| Jutrin, I | 1 |
| Christ, DD | 1 |
| Wilson, MJ | 1 |
| Perova, NV | 1 |
| Metel'skaia, VA | 1 |
| Campbell, JW | 1 |
| Mulvihill-Wilson, J | 1 |
| Gaffney, FA | 1 |
| Blomqvist, CG | 1 |
| Oh, VM | 1 |
| Chia, BL | 2 |
| Zhang, TJ | 1 |
| Du, CL | 1 |
| Lin, RL | 1 |
| Cohen, L | 2 |
| Kitzes, R | 1 |
| Schauer, UJ | 1 |
| Hummel, S | 1 |
| Hovell, MF | 1 |
| Geary, DC | 1 |
| Black, DR | 1 |
| Kamachi, K | 1 |
| Kirk, R | 1 |
| Elder, J | 1 |
| Siegert, C | 1 |
| Griffith, GL | 1 |
| Todd, EP | 1 |
| Marmur, A | 1 |
| Berkovitch, Y | 1 |
| Aviram, M | 1 |
| Markiewicz, K | 1 |
| Górski, L | 1 |
| Cholewa, M | 1 |
| Olander, R | 6 |
| Symons, C | 1 |
| Wood, JB | 1 |
| Juel-Jensen, BE | 1 |
| Gorchien, A | 1 |
| Stewart-Wynne, EG | 1 |
| Reddy, J | 2 |
| Randeree, M | 1 |
| Beahan, PG | 1 |
| Leedman, RL | 1 |
| Gross, F | 1 |
| Brichard, G | 1 |
| Podolsky, S | 1 |
| Pattavina, CG | 1 |
| Lawrence, T | 1 |
| Frankl, WS | 1 |
| Goodwin, JF | 2 |
| Hainer, V | 1 |
| Reisenauer, R | 3 |
| Fournier, A | 1 |
| Lagrue, G | 1 |
| Schmitt, H | 1 |
| Danil'chenko, MA | 1 |
| Zakharova, AV | 1 |
| Warden, JC | 1 |
| Erikssen, J | 1 |
| Storm-Mathisen, H | 1 |
| Thornell, IR | 2 |
| Deruyttere, M | 1 |
| Wall, B | 1 |
| Bodem, G | 1 |
| Stenbaek, O | 2 |
| De Takats, G | 1 |
| Ludden, CT | 1 |
| Bohidar, NR | 1 |
| Numao, Y | 1 |
| Thompson, FD | 1 |
| Harrison, DC | 1 |
| Simpson, FO | 3 |
| Rackensperger, W | 1 |
| Gaupp, R | 1 |
| Mattke, DJ | 1 |
| Schwarz, D | 1 |
| Stutte, KH | 1 |
| Cottier, P | 1 |
| Weiss, L | 2 |
| Paterson, JW | 1 |
| Linko, E | 1 |
| Siitonen, L | 1 |
| Ruosteenoja, R | 1 |
| Shinebourne, E | 4 |
| Dickinson, CJ | 1 |
| Delius, W | 1 |
| Krüger, K | 1 |
| Prys-Roberts, C | 1 |
| Corbett, JL | 1 |
| Kerr, JH | 2 |
| Smith, AC | 1 |
| Spalding, JM | 1 |
| Vanche, J | 3 |
| Beaton, GR | 1 |
| Kramer, R | 1 |
| Simpson, RD | 1 |
| Boréus, LO | 1 |
| Broberger, U | 1 |
| Nergårdh, A | 1 |
| Zetterqvist, P | 1 |
| Muscholl, E | 1 |
| Constantin, B | 1 |
| Condat, P | 1 |
| Jourde, M | 1 |
| Condat, M | 1 |
| Lapalus, P | 1 |
| Lazar, M | 1 |
| Alday, LE | 1 |
| Moreyra, E | 1 |
| Amuchástegui, LM | 1 |
| Madoery, RJ | 1 |
| Russek, HI | 1 |
| Roumagnac, M | 1 |
| Hawlina, A | 1 |
| Kersting, F | 1 |
| Roch-Arveiller, M | 1 |
| Jaillon, P | 1 |
| Hecklé, J | 1 |
| Cheymol, G | 1 |
| Lupu, AN | 1 |
| Maxwell, MH | 1 |
| White, FN | 1 |
| Bühler, R | 1 |
| Laidlaw, JC | 1 |
| Laverty, R | 1 |
| Barbeau, A | 1 |
| Kilcoyne, MM | 1 |
| Robie, NW | 1 |
| Israili, ZH | 1 |
| Ulrych, M | 3 |
| Nantel, A | 1 |
| Gilfrich, HJ | 2 |
| Schmahl, FW | 1 |
| Deptalla, H | 1 |
| Wiegershausen, B | 1 |
| Eichbaum, FW | 1 |
| Spanoudis, S | 1 |
| Aguiar, A | 1 |
| Ramos, AO | 1 |
| Cotonat, J | 2 |
| Duchêne-Marullaz, P | 1 |
| Prat, J | 1 |
| Gilmore, E | 2 |
| Weil, J | 1 |
| Mićić, R | 1 |
| Smith, JE | 1 |
| McKee, EB | 1 |
| Kidera, GJ | 1 |
| Bristow, M | 1 |
| Hayase, S | 1 |
| Ito, H | 1 |
| Wagner, J | 1 |
| Anlauf, M | 1 |
| Heimsoth, V | 1 |
| Bock, KD | 4 |
| Wilkinson, JC | 1 |
| Gilmore, HR | 1 |
| Picchio, F | 2 |
| Russo, F | 3 |
| Sanguinetti, M | 3 |
| Branzi, A | 3 |
| Maresta, A | 3 |
| Malcolm, J | 2 |
| Malcolm-Thomas, B | 1 |
| McAllister, RG | 1 |
| Bhargava, KP | 1 |
| Srivastava, RK | 1 |
| Gottlieb, TB | 1 |
| Katz, FH | 1 |
| Gysling, E | 1 |
| Loggie, JM | 1 |
| Van Maanen, EF | 1 |
| Bracchetti, D | 1 |
| Catizone, L | 1 |
| Perri, G | 1 |
| Strunge, P | 1 |
| Ingstrup, HM | 1 |
| Lochte, JJ | 1 |
| Zimmermann-Nielsen, C | 1 |
| Lambelin, G | 1 |
| De Schaepdryver, AF | 1 |
| Stewart-Wynne, E | 1 |
| von Egidy, H | 1 |
| Doba, N | 1 |
| Reis, DJ | 1 |
| O'Brien, BW | 1 |
| Garbus, SB | 1 |
| Cheah, JS | 1 |
| Nelson, H | 1 |
| Loggie, J | 1 |
| Dalen, JE | 1 |
| Alpert, JS | 1 |
| Cohn, LH | 1 |
| Black, H | 1 |
| Collins, JJ | 1 |
| Zammit Maempel, JV | 1 |
| Simpson, LL | 1 |
| Soato, GG | 1 |
| Sabbaga, E | 2 |
| Chocair, PR | 2 |
| Ianhez, LE | 2 |
| Massola, VC | 2 |
| Pechan, J | 1 |
| Ondrejicka, M | 1 |
| Janotka, M | 1 |
| Kellerová, E | 1 |
| Ohman, U | 1 |
| Granberg, PO | 1 |
| Hjern, B | 1 |
| Sjöberg, HE | 1 |
| Pohl, JE | 1 |
| Costa, V | 1 |
| Minuzzo, I | 1 |
| Salvador, M | 1 |
| Marco, J | 1 |
| Couderc, JJ | 1 |
| Aoyagi, H | 1 |
| Memezawa, H | 1 |
| Hoshima, M | 1 |
| Yokoyama, M | 1 |
| Tokue, A | 1 |
| Tsukada, O | 1 |
| Aso, Y | 1 |
| Fleckenstein, L | 1 |
| Mazzullo, JM | 1 |
| Sundaresan, PR | 1 |
| Weintraub, M | 1 |
| Shoshkes, M | 1 |
| Kusus, T | 1 |
| Daniel, W | 1 |
| Schierl, W | 1 |
| Ackenheil, M | 1 |
| Kempter, H | 1 |
| Niklas, M | 1 |
| Walter, I | 1 |
| Malmcrona, R | 4 |
| Rosenhall, L | 2 |
| Hood, B | 2 |
| Mitchell, I | 1 |
| Lodge, R | 1 |
| Clark, DW | 1 |
| Goldberg, LI | 1 |
| Morrelli, HF | 1 |
| Brahm, M | 1 |
| Fulton, RM | 1 |
| Fulton, EH | 1 |
| Comerford, MB | 1 |
| Pringle, A | 1 |
| Somer, T | 1 |
| Luomanmäki, K | 1 |
| Laver, MC | 1 |
| Moyer, JH | 1 |
| Travis, KW | 1 |
| Sims, JK | 1 |
| Uhl, RR | 1 |
| Abernethy, JD | 1 |
| Carlier, J | 1 |
| De Tollenaere, G | 1 |
| Stoker, LM | 1 |
| Olatunde, IA | 1 |
| Mazurowa, A | 1 |
| Oczkowicz, A | 1 |
| Surma, M | 1 |
| Salo, M | 1 |
| Laaksonen, V | 1 |
| Sommerfeldt, H | 1 |
| Latz, A | 1 |
| Wijsenbeek, H | 1 |
| Lockwood, PW | 1 |
| Thomas, B | 1 |
| Halberstam, MJ | 1 |
| Wildenthal, K | 1 |
| Crie, JS | 1 |
| Vastagh, GF | 1 |
| Gunnert, G | 1 |
| Lundberg, A | 1 |
| Söderberg, H | 1 |
| Harrison, TS | 2 |
| Naidoo, DN | 1 |
| Beattie, AD | 1 |
| Moore, MR | 1 |
| Goldberg, A | 1 |
| Ward, RL | 1 |
| Vaughan, ED | 2 |
| Baer, L | 2 |
| Matts, SG | 1 |
| Vávra, I | 1 |
| Tom, H | 1 |
| Greselin, E | 1 |
| Biró, L | 2 |
| Szebeni, A | 2 |
| Csàszàr, G | 2 |
| Naess, K | 1 |
| Korner, PI | 1 |
| Uther, JB | 1 |
| Richards, JG | 1 |
| Serebrovskaia, IuA | 1 |
| Kiseleva, ZM | 1 |
| Shershevskiĭ, BM | 1 |
| Zhestikova, ES | 1 |
| Goldberg, S | 1 |
| Tomesch, W | 1 |
| Müller, E | 1 |
| Fagrell, B | 1 |
| McCarthy, G | 1 |
| Wester, PO | 1 |
| Leski, M | 1 |
| Phanh Tam, N | 1 |
| Krauss, XH | 3 |
| Basset, A | 1 |
| Batts, JA | 1 |
| Tchilinguirian, NG | 1 |
| Passmore, J | 1 |
| Schott, GD | 1 |
| McArdle, B | 1 |
| Freier, DT | 1 |
| Cohen, EL | 1 |
| Wilson, L | 1 |
| Miller, CD | 1 |
| Sova, J | 1 |
| McMurtry, RJ | 1 |
| Traub, Y | 1 |
| Rosenfeld, J | 1 |
| Kedra, M | 2 |
| Folliot, A | 1 |
| Jirák, R | 1 |
| Pavlát, J | 1 |
| Gandhi, MJ | 1 |
| Rao, VC | 1 |
| Kumar, B | 1 |
| Castan, R | 1 |
| Conn, RD | 1 |
| Richardson, DW | 1 |
| Freund, J | 1 |
| Gear, AS | 1 |
| Mauck, HP | 1 |
| Preston, LW | 1 |
| Humphreys, GS | 1 |
| Schvacabaja, IK | 1 |
| Mjasnikov, LA | 1 |
| Metelica, VI | 1 |
| Grigorjanc, RA | 1 |
| Katila, M | 1 |
| Kiesenwetter, R | 1 |
| Tourniaire, A | 1 |
| Tartulier, M | 1 |
| Blum, J | 1 |
| Deyrieux, F | 1 |
| Thames, MD | 1 |
| Kontos, HA | 1 |
| Raynaud, R | 1 |
| Morand, P | 2 |
| Brochier, M | 1 |
| Raynaud, P | 2 |
| Fauchier, JP | 2 |
| Chatelain, B | 1 |
| Warembourg, H | 1 |
| Ducloux, G | 1 |
| Wache, F | 1 |
| Fossati, G | 1 |
| Masters, AM | 1 |
| Kobayashi, K | 1 |
| Aminu, JM | 1 |
| Henry, JL | 1 |
| Calaresu, FR | 1 |
| Lindsay, J | 1 |
| Hurst, JW | 1 |
| Hopkins, SJ | 1 |
| Prestt, J | 1 |
| Vickers, J | 1 |
| Wall, BG | 1 |
| De Cesaris, R | 1 |
| MacKinnon, J | 1 |
| Axford, AT | 1 |
| Gilchrist, L | 1 |
| Pascual, AV | 1 |
| London, R | 1 |
| Nicolescu, RF | 1 |
| Willems, D | 1 |
| Hamby, RI | 1 |
| Roberts, GS | 1 |
| Meron, JM | 1 |
| Wolfson, S | 1 |
| Strubelt, O | 1 |
| Wendel, U | 1 |
| Zetler, G | 1 |
| van Buchem, FS | 1 |
| Drion, EF | 1 |
| Wigbout, M | 1 |
| Bosschieter, E | 1 |
| Izawa, Y | 1 |
| Nishimoto, N | 1 |
| Kamiyama, H | 1 |
| Meciani, L | 1 |
| Ricci, G | 1 |
| Sabatini, G | 1 |
| Boeri, S | 1 |
| Pirovano, E | 1 |
| Zani, D | 1 |
| Melara, D | 1 |
| Kenedi, I | 1 |
| Kozul, VJ | 1 |
| Rosenblum, WI | 1 |
| Retan, JW | 1 |
| Kluthe, R | 1 |
| Müller, H | 1 |
| Steim, H | 1 |
| Fox, CA | 1 |
| Rosenblum, R | 1 |
| Delman, AJ | 1 |
| Ellestad, MH | 1 |
| Aigner, A | 1 |
| Baumgartl, P | 1 |
| Bolzano, K | 1 |
| Raas, E | 1 |
| Dubiel, J | 1 |
| Gabryś, B | 1 |
| Schley, G | 2 |
| Hocevar, V | 2 |
| Merguet, P | 3 |
| Rausch-Stroomann, JG | 3 |
| Schröder, E | 3 |
| Schümann, HJ | 3 |
| Kroon, BJ | 1 |
| Cooperman, LH | 1 |
| Day, GM | 1 |
| Molzahn, M | 1 |
| Dissmann, T | 1 |
| Gebhardt, W | 1 |
| Wegener, M | 1 |
| Zix, R | 1 |
| Klemm, D | 1 |
| Büchner, C | 1 |
| Reindell, H | 1 |
| Delius, L | 1 |
| Kühns, K | 1 |
| Wettich, JE | 1 |
| Samwer, KF | 1 |
| Miasnikov, LA | 2 |
| Krasnikov, IuA | 2 |
| Nikolaeva, EN | 1 |
| Grigor'iants, RA | 1 |
| Malméjac, J | 1 |
| Rieu, M | 1 |
| Roux, A | 1 |
| Wassermann, D | 1 |
| Orr, D | 1 |
| Jones, I | 1 |
| Tewari, SN | 2 |
| Grant, RH | 1 |
| Farmer, JB | 1 |
| Rosenblum, I | 1 |
| Rosenblum, G | 1 |
| Nicotero, JA | 1 |
| Beamer, V | 1 |
| Moutsos, SE | 1 |
| Kaul, CL | 1 |
| Grewal, RS | 1 |
| Murata, T | 2 |
| Kuemmerle, HP | 1 |
| Dorph, S | 1 |
| Binder, C | 1 |
| Enenkel, W | 1 |
| Polzer, K | 1 |
| Kubicek, F | 1 |
| Kunimoto, K | 1 |
| Abe, M | 1 |
| Ota, M | 1 |
| Yogosawa, T | 1 |
| Nishiguchi, M | 1 |
| Kuramoto, K | 1 |
| Murata, K | 1 |
| Nakao, K | 1 |
| Davis, JN | 1 |
| Frankel, E | 1 |
| Paar, D | 1 |
| Whittington-Coleman, PJ | 1 |
| Kato, M | 1 |
| Komata, KE | 1 |
| Gross, H | 1 |
| Kirchheim, H | 1 |
| Liu, CT | 1 |
| Huggins, RA | 1 |
| Hoff, HE | 1 |
| Richards, FA | 1 |
| Papacostas, CA | 1 |
| Reed, JP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| 2%-Mepivacaine With Two Different Vasoconstrictors; 1:20.000 Levonordefrin or 1:100.000 Epinephrin for Local Anesthesia in Third Molar Surgery: A Comparative Randomized Clinical Trial[NCT02603198] | 30 participants (Anticipated) | Interventional | 2014-08-31 | Active, not recruiting | |||
| Safety of Local Dental Anesthesia in Patients With Cardiac Channelopathies[NCT03182777] | 31 participants (Actual) | Interventional | 2015-05-31 | Completed | |||
| Melablock: A Multicentre Randomized, Double---blinded and Placebo---controlled Clinical Trial on the Efficacy and Safety of Once Daily Propranolol 80 mg Retard for the Prevention of Cutaneous Malignant Melanoma Recurrence[NCT02962947] | Phase 2/Phase 3 | 546 participants (Anticipated) | Interventional | 2017-06-30 | Not yet recruiting | ||
| Effect of Combined Antihypertensive Therapy on Blood Pressure and Sexual Function in Patients With Essential Hypertension[NCT01238705] | Phase 4 | 280 participants (Anticipated) | Interventional | 2008-04-30 | Recruiting | ||
| Heart Rate Lowering Efficacy and Respiratory Safety of Ivabradine in Patients With Obstructive Airway Disease[NCT01365286] | Phase 4 | 40 participants (Actual) | Interventional | 2009-05-31 | Completed | ||
| [NCT00000492] | Phase 3 | 0 participants | Interventional | 1977-09-30 | Completed | ||
| The PACE-MI Registry Study - Outcomes of Beta-blocker Therapy After Myocardial Infarction (OBTAIN)[NCT00430612] | 7,057 participants (Actual) | Observational [Patient Registry] | 2009-05-31 | Completed | |||
| "Sub-Study Evaluating the Quality of Different Methods of Obtaining Informed Consent"[NCT00794729] | 250 participants (Anticipated) | Observational | 2008-10-16 | Completed | |||
| A Multicenter Randomized Controlled Trial of Exercise in Aortic Dissection Survivors[NCT05610462] | 126 participants (Anticipated) | Interventional | 2023-01-01 | Active, not recruiting | |||
| Cardiorespiratory and Acid-basic Imbalance Caused by Use of Face Mask, During Physical Exercices[NCT05270538] | 57 participants (Actual) | Interventional | 2020-11-12 | Completed | |||
| Addressing HyperteNsion and Diabetes Through Community-Engaged Systems in Puno, Peru (ANDES Study)[NCT05524987] | 1,068 participants (Anticipated) | Interventional | 2022-11-30 | Not yet recruiting | |||
| Propranolol Versus Placebo for Induction of Labor in Nulliparous Patients: a Double-blind Randomized Controlled Trial[NCT03348683] | Phase 2 | 240 participants (Actual) | Interventional | 2017-12-11 | Completed | ||
| Propranolol for Prolonged Labor: A Randomized Controlled Trial (PRO-Labor Trial)[NCT04741698] | Phase 1 | 80 participants (Actual) | Interventional | 2021-07-27 | Completed | ||
| The Bogalusa Heart Study[NCT00005129] | 11,737 participants (Actual) | Observational | 1972-06-30 | Active, not recruiting | |||
| A Safe Ketamine-Based Therapy for Treatment Resistant Depression[NCT01179009] | 20 participants (Actual) | Interventional | 2012-04-30 | Completed | |||
| The Effect of Vascular Distensibility on Endothelial-Dependent Vasoreactivity in Patients With Systolic Hypertension Before and After Receiving Oral Alagebrium for 8 Weeks.[NCT00277875] | Phase 2 | 25 participants | Interventional | 2004-02-29 | Completed | ||
| Study of The Effect of Vascular Distensibility on Endothelial-Dependent Vasoreactivity in Subjects With Systolic Hypertension Before and After Receiving Oral Alagebrium or Placebo for 8 Weeks (STRETCH)[NCT00302250] | Phase 2 | 70 participants | Interventional | 2006-02-28 | Completed | ||
| Effects of Nebivolol on Microvascular Perfusion in the Skeletal Muscles During Exercise in Hypertensive Patients[NCT01501929] | Phase 4 | 32 participants (Actual) | Interventional | 2010-08-31 | Completed | ||
| [NCT00000485] | Phase 3 | 0 participants | Interventional | 1971-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Time of latent labor defined as <6cm of cervical dilation. (NCT03348683)
Timeframe: average of 24 hours
| Intervention | hours (Mean) |
|---|---|
| Propranolol | 11.0 |
| Placebo | 11.2 |
Count of fetus with fetal bradycardia (<110bpm for >10 minutes within 30 minutes of study drug administration) (NCT03348683)
Timeframe: 30 minutes from drug administration
| Intervention | Participants (Count of Participants) |
|---|---|
| Propranolol | 1 |
| Placebo | 0 |
Count of fetus with fetal heart rate decelerations within 30 minutes of study drug administration (NCT03348683)
Timeframe: 30 minutes from drug administration
| Intervention | Participants (Count of Participants) |
|---|---|
| Propranolol | 15 |
| Placebo | 13 |
"Neonatal outcome - Number of neonates with hypoglycemia (blood glucose <50).~This population includes only the neonates who had heelsticks to check their blood glucose, which is not a universal practice and was not required by the protocol or IRB. The neonates included were those who met the nursery's risk-based protocol to check blood glucose after birth (ex: infants of diabetic mothers, fetal growth restriction, macrosomia, or symptoms suggestive of hypoglycemia)" (NCT03348683)
Timeframe: Day 1
| Intervention | Participants (Count of Participants) |
|---|---|
| Propranolol | 11 |
| Placebo | 8 |
"Composite neonatal outcome score was for any of the following morbidity: Neonatal Intensive Care Unit (NICU) admission, respiratory support (CPAP, nasal cannula, intubation), culture proven sepsis, radiographically proven intracranial hemorrhage, necrotizing enterocolitis, hypoglycemia (for those infants who had sugar checked), and neonatal death.~The composite score was computed as a score of 1 for any indication of neonatal morbidity - neonates who experienced at least one morbidity and the components are given equal weights. Patients who had no evidence of the predefined neonatal morbidities are subsequently given a score of 0. The minimum is 0 and maximum is 1." (NCT03348683)
Timeframe: Day 1
| Intervention | Participants (Count of Participants) |
|---|---|
| Propranolol | 21 |
| Placebo | 28 |
"Composite maternal morbidity score consists of a count of postpartum hemorrhage, transfusion, hysterectomy, placental abruption, chorioamnionitis, shoulder dystocia, episiotomy, higher order laceration, and ICU admission.~The composite score was computed as a score of 1 for any indication of maternal morbidity, that is the participant experienced at least one maternal morbidity, and the components are given equal weights. Participants who had no evidence of the predefined maternal morbidities are subsequently given a score of 0. The minimum is 0 and maximum is 1." (NCT03348683)
Timeframe: average of 24 hours
| Intervention | Participants (Count of Participants) |
|---|---|
| Propranolol | 35 |
| Placebo | 49 |
Greater than 500cc of blood expelled during a vaginal delivery or greater than 1000cc of blood expelled during a cesarean section (NCT03348683)
Timeframe: 30 minutes from drug administration
| Intervention | Participants (Count of Participants) |
|---|---|
| Propranolol | 15 |
| Placebo | 26 |
The time of induction (based on time of foley balloon placement for cervical ripening or misoprostol administration) to the time of delivery of the infant. (NCT03348683)
Timeframe: average of 24 hours
| Intervention | hours (Mean) |
|---|---|
| Propranolol | 13.8 |
| Placebo | 14.3 |
Number of various mode of delivery - count of Vaginal delivery, vacuum assisted vaginal delivery, forceps assisted vaginal delivery, cesarean section (NCT03348683)
Timeframe: average of 24 hours
| Intervention | Participants (Count of Participants) | |||
|---|---|---|---|---|
| Spontaneous vaginal delivery | Vacuum assisted vaginal delivery | Forceps assisted vaginal delivery | Cesarean section | |
| Placebo | 61 | 10 | 8 | 40 |
| Propranolol | 64 | 3 | 8 | 46 |
The Montgomery-Asberg Depression Rating Scale (MADRS) is a 10-item scale that measures the severity of depression, with a higher score indicating a higher level of depression. The range of scores is 0 to 60. (NCT01179009)
Timeframe: 8 weeks
| Intervention | Scores on a scale (Mean) |
|---|---|
| Ketamine 100-hour Infusion | -9.0 |
| Ketamine 40-minute Infusion | -6.4 |
Endothelial cell (EC) was collected after a 20-guage angiocatheter was inserted into the contralateral forearm vein under sterile conditions. Three J-shaped vascular guidewires (St. Jude, St. Paul, MN) were advanced sequentially into the vein up to 10 cm. Endothelial cells were collected by gentle abrasion and placed into a dissociation buffer (0.5% bovine serum albumin, 2mM EDTA, and 100 ug/ml heparin in PBS). Endothelial cells were recovered from the tips of guide wires by repeated washing into collection tubes and subsequent centrifugation. EC were incubated with monoclonal antibodies against the polyclonal antibodies against NADPH oxidase p47 subunit. The intensity of staining was measured using fluorescence microscopy. (NCT01501929)
Timeframe: 12 weeks
| Intervention | Ratio human to HUVEC p47Phox expression (Mean) |
|---|---|
| Metoprolol | 0.47 |
| Nebivolol | 0.44 |
Microvascular perfusion of skeletal muscle were measured during handgrip at 20 cycle per minute after 12 weeks of metoprolol, and after 12 weeks of nebivolol (NCT01501929)
Timeframe: 12 weeks
| Intervention | video intensity units/ second (Median) |
|---|---|
| Metoprolol | 43.938 |
| Nebivolol | 74.584 |
149 reviews available for propranolol and Blood Pressure, High
| Article | Year |
|---|---|
Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Cardiovascular Diseases; Comorbidity | 2022 |
Comparative efficacy of β-blockers on mortality and cardiovascular outcomes in patients with hypertension: a systematic review and network meta-analysis.
Topics: Adrenergic beta-Antagonists; Age Factors; Antihypertensive Agents; Atenolol; Coronary Disease; Human | 2017 |
Pharmacotherapy for hypertension in adults aged 18 to 59 years.
Topics: Adult; Antihypertensive Agents; Bendroflumethiazide; Blood Pressure; Cause of Death; Coronary Diseas | 2017 |
Divergent profile between hypothalamic and plasmatic aminopeptidase activities in WKY and SHR. Influence of beta-adrenergic blockade.
Topics: Adrenergic beta-Antagonists; Aminopeptidases; Animals; Blood Pressure; Diuresis; Drinking; Eating; H | 2018 |
Hypertension, dementia, and antihypertensive treatment: implications for the very elderly.
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inh | 2009 |
Beta-adrenergic blocking agents and dental vasoconstrictors.
Topics: Adrenergic beta-Antagonists; Anesthesia, Dental; Anesthetics, Local; Bradycardia; Drug Interactions; | 2010 |
Beta-adrenergic blocking agents and dental vasoconstrictors.
Topics: Adrenergic beta-Antagonists; Anesthesia, Dental; Anesthetics, Local; Bradycardia; Drug Interactions; | 2010 |
Beta-adrenergic blocking agents and dental vasoconstrictors.
Topics: Adrenergic beta-Antagonists; Anesthesia, Dental; Anesthetics, Local; Bradycardia; Drug Interactions; | 2010 |
Beta-adrenergic blocking agents and dental vasoconstrictors.
Topics: Adrenergic beta-Antagonists; Anesthesia, Dental; Anesthetics, Local; Bradycardia; Drug Interactions; | 2010 |
Beta-blockers and diabetes: the bad guys come good.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Bisoprolol; Coronary Disease; Diabet | 2002 |
[Guidelines for the treatment of acute chemical poisoning-11-symptomatic therapy 4. Management of circulation for drug overdose and poisoning].
Topics: Acute Disease; Anti-Anxiety Agents; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atropine; Cardiac | 2007 |
Clinical inquiries. Are there big differences among beta-blockers in treating essential hypertension?
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Dose-R | 2007 |
Variability in response to antihypertensive drugs.
Topics: Adult; Age Factors; Aged; Antihypertensive Agents; Black or African American; Blood Pressure Determi | 2007 |
A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Blood Glucose; Body Mass Index; Diab | 2007 |
Enalapril worldwide experience.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Cell Count; Blood Pressure; Captopril; Dipeptides; D | 1984 |
Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 9. Nadolol: a new long-acting beta-adrenoceptor blocking drug.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Animals; Arrhythmias, Cardiac; Cats; Guinea Pigs; Half | 1980 |
[Clinical pharmacology of beta-adrenoceptor blocking drugs and therapeutic use in hypertension (author's transl)].
Topics: Adrenergic beta-Antagonists; Adult; Animals; Biological Availability; Blood Pressure; Cardiac Output | 1980 |
Nadolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Biological Availability; Cardiac Output; Depression, C | 1980 |
beta-Adrenoceptor antagonists: new drugs and new indications.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Glaucoma; Humans; Hypertension; Kinetics; Me | 1981 |
Withdrawal syndromes and the cessation of antihypertensive therapy.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Clonidine; Humans; Hypertension; Propranolol; | 1981 |
Beta-adrenergic antagonists in the treatment of patients with heart disease.
Topics: Acebutolol; Adrenergic beta-Agonists; Alprenolol; Animals; Arrhythmias, Cardiac; Bronchial Spasm; Ca | 1981 |
[Use of beta-adrenergic blockers in neurologic and psychiatric clinical practice].
Topics: Adrenergic beta-Antagonists; Alcoholism; Anti-Anxiety Agents; Cardiovascular Diseases; Humans; Hyper | 1981 |
Pharmacologic agents in the management of pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Angina Pectoris; Humans; Hypertension; Intrao | 1982 |
Clinical pharmacology of pindolol.
Topics: Adrenergic beta-Agonists; Cardiac Output; Depression, Chemical; Dose-Response Relationship, Drug; He | 1982 |
Beta-blockers and the kidney.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Cardiac Output; Glomerular Filtration | 1982 |
Renal effects of beta blockade in essential hypertension.
Topics: Adrenergic beta-Antagonists; Hemodynamics; Humans; Hypertension; Kidney; Norepinephrine; Propranolol | 1983 |
The effect of adrenergic blockade on potassium concentrations in different conditions.
Topics: Adrenergic beta-Antagonists; Aldosterone; Animals; Epinephrine; Humans; Hypertension; Pindolol; Pota | 1983 |
beta-adrenergic blockade and diabetes mellitus. A review.
Topics: Adrenergic beta-Antagonists; Alprenolol; Blood Glucose; Catecholamines; Diabetes Mellitus, Type 1; D | 1983 |
Practical therapeutics: the use of beta-adrenergic blocking agents in African patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Black People; Clini | 1983 |
[Withdrawal phenomena after chronic beta-blockade. Causes and therapeutic consequences].
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Calcium Channel Blockers; Coronary Disease; Death | 1984 |
Comparative review of beta-blocking agents.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Atenolol; Humans; Hypertension; | 1984 |
[Beta-blocker withdrawal syndrome].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Animals; Arrhythmias, Cardiac; Catecholamines; Coronar | 1984 |
Mechanisms of membrane-receptor regulation. Biochemical, physiological, and clinical insights derived from studies of the adrenergic receptors.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Affinity Labels; Animals; Asthma; Catecholamines; Coron | 1984 |
Beta-blocking drugs for arrhythmias, hypertension, and ischemic heart disease.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Animals; Arrhythmias, Cardiac; Atenolol; Blood Pressur | 1984 |
The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Atenolol; Clinical Trials as Topic; Humans | 1984 |
The beta-adrenergic blockade withdrawal phenomenon.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Catecholamines; Heart Rate; Humans; Hypertension; Plat | 1983 |
The kidney and strategies for the treatment of hypertension.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calc | 1984 |
The renin system and future trends in management of high blood pressure.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Antihypertensive Agents; Blood | 1980 |
[Cyclic AMP and essential arterial hypertension. Role of the adrenergic system].
Topics: Animals; Autonomic Nervous System; Cyclic AMP; Humans; Hypertension; Isoproterenol; Propranolol; Rat | 1980 |
Perioperative cardiac cure.
Topics: Arrhythmias, Cardiac; Coronary Disease; Digitalis Glycosides; Electrocardiography; Heart Diseases; H | 1983 |
Studies on the effect of prazosin on blood pressure and serum lipids in Japanese hypertensive patients.
Topics: Blood Pressure; Cholesterol; Drug Evaluation; Humans; Hypertension; Japan; Lipids; Pindolol; Prazosi | 1984 |
Concept of anti-renin system therapy. Historic perspective.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Captopril; Crotalid Venoms; History, 20th Century; | 1984 |
New antiarrhythmic drugs.
Topics: Amiodarone; Angina Pectoris; Anti-Arrhythmia Agents; Blood Circulation; Bradycardia; Diltiazem; Half | 1983 |
Hypertension and calcium antagonists.
Topics: Airway Resistance; Antihypertensive Agents; Calcium Channel Blockers; Humans; Hypertension; Labetalo | 1982 |
Anti-hypertensive drugs in the pregnant patient.
Topics: Antihypertensive Agents; Chronic Disease; Clonidine; Diazoxide; Diuretics; Female; Fetus; Furosemide | 1980 |
Blood pressure and primary hypertension in childhood and adolescence.
Topics: Adolescent; Adult; Antihypertensive Agents; Blood Pressure Determination; Cardiovascular Diseases; C | 1980 |
Antihypertensive pharmacology.
Topics: Adolescent; Adult; Antihypertensive Agents; Clonidine; Diazoxide; Diuretics; Guanethidine; Humans; H | 1980 |
Optimal management of patients with ischemic heart disease for noncardiac surgery by complementary anesthesiologist and cardiologist interaction.
Topics: Aged; Anesthesia; Anesthesiology; Arrhythmias, Cardiac; Cardiology; Cerebrovascular Disorders; Coron | 1981 |
Pindolol: experience gained in 10 years of safety monitoring.
Topics: Clinical Trials as Topic; Drug Evaluation; Humans; Hypertension; Pindolol; Propranolol | 1982 |
Management of systemic hypertension in children.
Topics: Adolescent; Antihypertensive Agents; Child; Clonidine; Diazoxide; Diet, Sodium-Restricted; Diuretics | 1982 |
Selected factors that influence responses to antihypertensives. Choosing therapy for the uncomplicated patient.
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Angiotensin-Converting Enzyme Inhibitors; Ant | 1994 |
[Arterial hypertension following aortic coarctation correction].
Topics: Age Factors; Aortic Coarctation; Humans; Hypertension; Postoperative Complications; Propranolol | 1993 |
[The systemic problems in the dental treatment of the elderly patients].
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Aged; Anesthetics, Local; Blood Pressure; Con | 1996 |
Variables that affect the expansion rate and rupture of abdominal aortic aneurysms.
Topics: Adrenergic beta-Antagonists; Aortic Aneurysm, Abdominal; Aortic Rupture; Comorbidity; Diastole; Dise | 1996 |
Beta-blockers vs. thiazides in the treatment of hypertension: a review of the experience of the large national trials.
Topics: Adrenergic beta-Antagonists; Bendroflumethiazide; Clinical Trials as Topic; Coronary Disease; Diuret | 1990 |
[Use of beta blockaders in the treatment of arterial hypertension].
Topics: Adrenergic beta-Antagonists; Blood Pressure; Dihydralazine; Diuretics; Ethanolamines; Humans; Hypert | 1975 |
The properties of beta-adrenoceptor antagonists.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Animals; Cell Membrane; Heart Rate; Humans; Hypertensi | 1976 |
The use of propranolol in hypertension: a review.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Drug Therapy, Combination; Humans; Hypertension; Propra | 1976 |
A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Autonomic Fibers, Preganglionic; | 1976 |
Beta-blockers in hypertension. A review.
Topics: Adrenergic beta-Antagonists; Brain; Drug Therapy, Combination; Humans; Hypertension; Patient Accepta | 1976 |
The presynaptic effect of beta-adrenoceptor antagonists on noradrenergic neurones.
Topics: Adrenal Medulla; Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Electric Stimulation; | 1976 |
[Beta receptor blockaders in the treatment of hypertension].
Topics: Adrenergic beta-Antagonists; Angiotensin II; Antihypertensive Agents; Dose-Response Relationship, Dr | 1976 |
Pathophysiology of propranolol in hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aldosterone; Angiotensin II; Blood Pressure; Cardiac Output; Diu | 1977 |
Beta-adrenergic blockade in hypertension.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angiotensin II; Animals; Brain; Dose-Response Relationship, | 1977 |
The essential action of propranolol in hypertension.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Cardiac Output; Cats; Central Nervous System; | 1976 |
Acute and long-term studies of the mechanisms of action of beta-blocking drugs in lowering blood pressure.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aldosterone; Blood Pressure; Circadian Rhy | 1976 |
Clinical pharmacology of antihypertensive drugs.
Topics: Adrenergic alpha-Antagonists; Aldosterone; Angiotensin II; Antihypertensive Agents; Bethanidine; Blo | 1977 |
Recent advances in the treatment of hypertension.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Chronic Disease; Clonidine; Diazoxide; Drug Th | 1977 |
Effects of beta-adrenoceptor blocking agents on haemodynamic parameters.
Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Hemodynamics; Humans; Hypertension; Pindolol | 1977 |
Central nervous actions of beta-adrenoreceptor antagonists.
Topics: Adrenergic beta-Antagonists; Animals; Anxiety; Behavior; Central Nervous System; Central Nervous Sys | 1978 |
[Pharmacologic functional examination in arterial hypertension].
Topics: Adrenergic beta-Antagonists; Angiotensin II; Blood Pressure; Diagnosis, Differential; Diuretics; Fer | 1977 |
Clinical usefulness of the beta-adrenergic antagonists.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Angina Pectoris; Antihypertensive Agents; Anx | 1978 |
[Incidence of beta-blockers on plasma renin activity. Present status].
Topics: Acebutolol; Adrenergic beta-Antagonists; Aldosterone; Blood Pressure; Depression, Chemical; Dose-Res | 1978 |
beta-Adrenoceptor blocking drugs and hypertension.
Topics: Adrenal Medulla; Adrenergic beta-Antagonists; Anesthesia; Animals; Antihypertensive Agents; Blood Pr | 1979 |
Anaesthetic management of phaeochromocytoma.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthesia, Inha | 1979 |
Beta-adrenoceptor-blocking agents in the management of hypertension.
Topics: Adrenergic beta-Antagonists; Alprenolol; Blood Pressure; Brain; Cardiac Output; Drug Evaluation; Hea | 1979 |
[Drug therapy in hypertension 1977. Empirical and rational viewpoints].
Topics: Adrenergic Agents; Adrenergic beta-Antagonists; Age Factors; Aged; Blood Volume; Diuretics; Drug The | 1978 |
The renin system in essential, renovascular and adrenocortical hypertension: an overview.
Topics: Aldosterone; Blood Volume; Female; Humans; Hyperaldosteronism; Hypertension; Hypertension, Malignant | 1977 |
Beta-adrenergic blockade in some cardiovascular diseases.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Cardiovascular Diseases; Heart F | 1975 |
[Therapy and differential therapy with beta sympathicolytic drugs].
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Arrhythmias, Cardiac; Cardiomyopathy, Hype | 1975 |
Preventing, detecting and managing adverse reactions of antihypertensive agents in the ambulant patient with essential hypertension.
Topics: Antihypertensive Agents; Benzothiadiazines; Clonidine; Diuretics; Drug Interactions; Ethacrynic Acid | 1977 |
Hypertension: update, 1977.
Topics: Benzothiadiazines; Catecholamines; Child; Diuretics; Female; Humans; Hypertension; Hypertension, Ren | 1977 |
Physiologic and biochemical profile of hypertension for rational clinical management.
Topics: Adrenal Gland Diseases; Angiotensins; Body Fluid Compartments; Chlorthalidone; Diuretics; Guanethidi | 1978 |
New drugs in hypertension.
Topics: Antihypertensive Agents; Bethanidine; Clonidine; Debrisoquin; Female; Humans; Hypertension; Male; Pr | 1977 |
[Propranolol therapy in hypertension].
Topics: Antihypertensive Agents; Bradycardia; Bronchial Spasm; Cardiac Output; Drug Therapy, Combination; Ha | 1978 |
Minoxidil therapy in refractory hypertension analysis of 155 patients.
Topics: Adult; Animals; Body Weight; Drug Therapy, Combination; Female; Humans; Hypertension; Hypertrichosis | 1978 |
Drug therapy of hypertension.
Topics: Angiotensin II; Antihypertensive Agents; Blood Pressure; Clonidine; Diuretics; Drug Evaluation; Huma | 1978 |
[The sympathetic nervous system and essential hypertension].
Topics: Atenolol; Catecholamines; Clonidine; Guanethidine; Humans; Hypertension; Methyldopa; Norepinephrine; | 1979 |
[Propranolol in treatment of hypertension in pregnancy].
Topics: Female; Hemodynamics; Humans; Hypertension; Infant, Newborn; Pregnancy; Pregnancy Complications; Pre | 1979 |
Diazoxide.
Topics: Blood Pressure; Cardiac Output; Diazoxide; Diuretics; Drug Synergism; Emergencies; Female; Half-Life | 1976 |
Drug therapy. Hydralazine.
Topics: Antibodies, Antinuclear; Arthritis, Rheumatoid; Blood Pressure; Cardiac Output; Chronic Disease; Dru | 1976 |
Renin and the therapy of hypertension.
Topics: Animals; Antihypertensive Agents; Cardiovascular Diseases; Clonidine; Diazoxide; Diuretics; Dogs; Fe | 1976 |
Propranolol, renin and hypertension: a review.
Topics: Adolescent; Adult; Aged; Aldosterone; Blood Pressure; Child; Clinical Trials as Topic; Female; Human | 1976 |
Haemodynamic effects of propranolol in hypertension: a review.
Topics: Animals; Blood Circulation; Blood Pressure; Cardiac Output; Coronary Circulation; Drug Therapy, Comb | 1976 |
Angiotensin antagonists as diagnostic and pharmacologic tools.
Topics: Aldosterone; Angiotensin II; Blood Pressure; Humans; Hypertension; Kidney; Kinetics; Propranolol; Re | 1976 |
The second Volhard Lecture: The use of blocking agents to define the functions of the renin--angiotensin system.
Topics: Aldosterone; Angiotensin II; Animals; Blood Pressure; Calcium; Dogs; Hypertension; Hypertension, Ren | 1975 |
Clinical pharmacology of propranolol.
Topics: Administration, Oral; Arrhythmias, Cardiac; Biological Availability; Cardiac Output; Cardiovascular | 1975 |
Drug therapy: Propranolol.
Topics: Administration, Oral; Angina Pectoris; Arrhythmia, Sinus; Arrhythmias, Cardiac; Cardiomyopathy, Hype | 1975 |
Drug therapy: clonidine, a new antihypertensive drug.
Topics: Blood Pressure; Brain; Clonidine; Drug Interactions; Drug Therapy, Combination; Hemodynamics; Humans | 1975 |
Quality of life in the treatment of hypertension. The effect of calcium antagonists.
Topics: Calcium Channel Blockers; Captopril; Humans; Hypertension; Male; Nifedipine; Propranolol; Quality of | 1992 |
Beta blockers and quality of life.
Topics: Adrenergic beta-Antagonists; Atenolol; Calcium; Cholinesterase Inhibitors; Humans; Hypertension; Pro | 1992 |
Medical management of asymptomatic primary hyperparathyroidism.
Topics: Administration, Oral; Calcium; Calcium, Dietary; Cimetidine; Diphosphonates; Diuretics; Humans; Hype | 1991 |
Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism.
Topics: Antihypertensive Agents; Atenolol; Blood Pressure; Captopril; Double-Blind Method; Glucose; Humans; | 1991 |
[Specific and nonspecific effects of beta receptor blockers: stereoselectively different properties exemplified by (R)- and (S)-propranolol].
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Coronary Disease; Exercise Test; Hemodynamics; Hu | 1990 |
Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Cholesterol; Cost-Benefit Analysis; Humans; Hyperten | 1990 |
Propranolol and depression: evidence from the antihypertensive trials.
Topics: Clinical Trials as Topic; Depressive Disorder; Humans; Hypertension; Meta-Analysis as Topic; Propran | 1990 |
Calcium antagonists in the treatment of hypertension.
Topics: Biological Transport, Active; Calcium; Calcium Channel Blockers; Captopril; Diltiazem; Diuretics; Dr | 1985 |
Cerebrospinal fluid norepinephrine levels in essential hypertension: effects of drug treatment and withdrawal.
Topics: Adult; Clonidine; Dopamine; Double-Blind Method; Epinephrine; Humans; Hypertension; Methyldopa; Midd | 1987 |
Effects of arterial dilator agents on central aortic systolic pressure and on left ventricular hydraulic load.
Topics: Adult; Aging; Aorta; Blood Pressure; Blood Pressure Determination; Brachial Artery; Hemodynamics; Hu | 1989 |
Propranolol.
Topics: Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Child; Child, Preschool; Humans; Hypertension; I | 1989 |
Oxidation phenotype and the metabolism and action of beta-blockers.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Animals; Drug Interactions; Ethanolamines; Humans; Hyp | 1985 |
[Beta-blockers in the therapy of arterial hypertension in pregnancy].
Topics: Adrenergic beta-Antagonists; Diuretics; Female; Humans; Hypertension; Methyldopa; Oxprenolol; Pre-Ec | 1985 |
Enalapril in hypertension and congestive heart failure. Overall review of efficacy and safety.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Blood Pressure; Enalapril; Female | 1985 |
[Beta-blockaders in the treatment of hypertension in pregnancy].
Topics: Adrenergic beta-Antagonists; Atenolol; Drug Evaluation; Female; Humans; Hypertension; Metoprolol; Ox | 1985 |
Beta blockers and renal function: a reappraisal.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blood Urea Nitrogen; Cardiac Output; Creatinine; Dog | 1985 |
Platelet aggregation in hypertension and the effects of antihypertensive treatment.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Calcium Channel Blockers; Humans; Hypertension | 1988 |
Therapeutic effect and complication profile of clonidine-beta-blocker combinations.
Topics: Adrenergic beta-Antagonists; Cardiovascular Diseases; Clonidine; Drug Combinations; Humans; Hyperten | 1988 |
Safety profile of celiprolol.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Antihypertensive Agents; Atenolol; Celiprolol; Chlorth | 1988 |
Adrenergic activity and myocardial anatomy and function in essential hypertension.
Topics: Animals; Antihypertensive Agents; Cardiomegaly; Catecholamines; Heart; Hemodynamics; Humans; Hyperte | 1985 |
Cost effectiveness of labetalol and propranolol in the treatment of hypertension among blacks.
Topics: Aged; Black People; Clinical Trials as Topic; Cost-Benefit Analysis; Female; Humans; Hypertension; L | 1987 |
Effects of smoking on the heart and peripheral circulation.
Topics: Atenolol; Blood Pressure; Coronary Circulation; Heart Rate; Humans; Hypertension; Propranolol; Regio | 1988 |
Ethnics differences in the reactions to drugs and xenobiotics. Antihypertensive agents.
Topics: Antihypertensive Agents; Bendroflumethiazide; Black People; Clinical Trials as Topic; Diuresis; Diur | 1986 |
Racial difference in response to antihypertensive drugs. A focus on verapamil.
Topics: Antihypertensive Agents; Black People; Clinical Trials as Topic; Humans; Hypertension; Male; Potassi | 1986 |
Fetal supraventricular tachycardia. Review of the literature.
Topics: Adult; Cesarean Section; Digitalis; Drug Therapy, Combination; Electric Countershock; Electrocardiog | 1985 |
Beta-adrenergic receptor blocking drugs.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Aortic Aneurysm; Aortic Valve; Arrhythmias | 1973 |
Treatment of the cardiomyopathies.
Topics: Adrenergic beta-Antagonists; Alcoholism; Angina Pectoris; Anticoagulants; Atrial Fibrillation; Blood | 1973 |
[Use of beta-receptor blocking agents in the treatment of arterial hypertension].
Topics: Adrenergic beta-Antagonists; Blood Pressure; Cardiac Output; Depression, Chemical; Diuretics; Humans | 1973 |
[Clinical application of beta-blockaders].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Anxiety Diso | 1973 |
Adrenergic drugs in the treatment of hypertension.
Topics: Adrenergic beta-Antagonists; Blood Pressure Determination; Chlorothiazide; Follow-Up Studies; Gangli | 1973 |
Beta-adrenergic receptor blocking drugs in hypertension.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alprenolol; Antidepressive Agents; Antihy | 1974 |
[Problems in drug therapy of hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Benzimidazoles; Benzothiadiazines; Card | 1974 |
Choice of antihypertensive drugs for the treatment of hypertension, including hypertensive emergencies.
Topics: Antihypertensive Agents; Bethanechol Compounds; Clonidine; Diazoxide; Diuretics; Emergencies; Ferric | 1974 |
Clinical significance of hemodynamic findings in hypertension.
Topics: Angiotensin II; Blood Pressure; Blood Viscosity; Blood Volume; Cardiac Output; Cardiomegaly; Diureti | 1973 |
The mechanisms of action of some antihypertensive drugs.
Topics: Animals; Antihypertensive Agents; Brain; Bretylium Compounds; Clonidine; Debrisoquin; Diuretics; Gua | 1973 |
[Review on internal medicine, 1973--nephrology. 5. The renin-angiotensin system (author's transl)].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cerebrovascular D | 1974 |
[The beta-adrenolytics].
Topics: Angina Pectoris; Arrhythmias, Cardiac; Cardiovascular Diseases; Ethanolamines; Heart Diseases; Human | 1968 |
[Beta-receptor-blocking agents and their current clinical significance].
Topics: Adrenal Gland Neoplasms; Amino Alcohols; Angina Pectoris; Anilides; Arrhythmias, Cardiac; Blood Pres | 1968 |
[Beta-receptor-blocking agents and anesthesia].
Topics: Adrenal Gland Neoplasms; Anesthesia; Angina Pectoris; Arrhythmias, Cardiac; Asthma; Cardiomyopathy, | 1969 |
[Advancement in preoperative treatment of patients with pheochromocytoma].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Humans; Hypertension; Phenoxybenzamine; P | 1969 |
[Contribution to the pharmacology of the beta-adrenolytics].
Topics: Adrenergic beta-Antagonists; Anesthesia, Local; Animals; Arousal; Arrhythmias, Cardiac; Asthma; Card | 1970 |
The treatment of chronic hypertension.
Topics: Adult; Blood Pressure Determination; Chronic Disease; Diuretics; Female; Ganglionic Blockers; Guanet | 1971 |
[Beta adrenergic drugs in arterial hypertension].
Topics: Action Potentials; Adrenergic beta-Antagonists; Alprenolol; Antihypertensive Agents; Blood Pressure; | 1972 |
The autonomic nervous system and some aspects of the use of autonomic drugs in children. II.
Topics: Adrenergic beta-Antagonists; Aortic Valve Stenosis; Asthma; Autonomic Agents; Bronchitis; Cardiomyop | 1972 |
Propranolol.
Topics: Administration, Oral; Angina Pectoris; Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Humans; H | 1973 |
Correlation of pathophysiology and pharmacotherapy in primary hypertension.
Topics: Blood Pressure; Cardiac Output; Cardiac Volume; Diuretics; Furosemide; Guanethidine; Heart Failure; | 1973 |
Vasodilator drugs in the treatment of hypertension.
Topics: Administration, Oral; Cardiac Output; Diazoxide; Diuretics; Dose-Response Relationship, Drug; Drug S | 1974 |
Hypertensive emergencies.
Topics: Acute Kidney Injury; Adrenal Gland Neoplasms; Antihypertensive Agents; Aortic Aneurysm; Blood Volume | 1974 |
Propranolol.
Topics: Administration, Oral; Angina Pectoris; Arrhythmias, Cardiac; Asthma; Blood Pressure; Cardiac Output; | 1974 |
Individualization of antihypertensive drug therapy.
Topics: Blood Volume; Cardiac Output; Diuretics; Guanethidine; Humans; Hydralazine; Hypertension; Intestinal | 1974 |
Individualization of propranolol therapy.
Topics: Angina Pectoris; Aortic Valve; Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Humans; Hypertens | 1974 |
[Chemotherapy of hypertension].
Topics: Benzothiadiazines; Blood Pressure; Guanethidine; Humans; Hydralazine; Hypertension; Methyldopa; Mono | 1969 |
[Side effects of antihypertensive therapy].
Topics: Acetazolamide; Antihypertensive Agents; Blood Pressure; Furosemide; Humans; Hydralazine; Hydrochloro | 1970 |
706 trials available for propranolol and Blood Pressure, High
| Article | Year |
|---|---|
The impact of propranolol on nitric oxide and total antioxidant capacity in patients with resistant hypertension-evidence from the APPROPRIATE trial.
Topics: Aged; Antihypertensive Agents; Antioxidants; Blood Pressure; Blood Pressure Monitoring, Ambulatory; | 2020 |
Effect of Evening Bromazepam Administration on Blood Pressure and Heart Rate in Mild Hypertensive Patients.
Topics: Administration, Oral; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Bromazepam; Circadian R | 2019 |
Addition of Propranolol in Resistant Arterial hypertension Treatment (APROPRIATE study): study protocol for a randomized double-blind placebo-controlled trial.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Arterial Pressure; Bl | 2017 |
Effects of doxazosin and propranolol on A2A adenosine receptors in essential hypertension.
Topics: Adenosine-5'-(N-ethylcarboxamide); Adult; Antihypertensive Agents; Binding, Competitive; Blood Press | 2002 |
Effects of four antihypertensive monotherapies on cardiac mass and function in hypertensive patients with left ventricular hypertrophy: randomized prospective study.
Topics: Adult; Aged; Antihypertensive Agents; Chlorthalidone; Croatia; Echocardiography; Female; Heart Ventr | 2002 |
Effects of nonspecific beta-adrenergic stimulation and blockade on blood coagulation in hypertension.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Blood Coagulation; Cross-Over Studies; | 2003 |
Effects of carvedilol on oxidative stress in polymorphonuclear and mononuclear cells in patients with essential hypertension.
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Biomarkers; Blood Pressure; C-Reactive P | 2004 |
The antihypertensive efficacy and safety of a chronotherapeutic formulation of propranolol in patients with hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Chronot | 2004 |
Effects of atenolol and propranolol on platelet aggregation in moderate essential hypertension: randomized crossover trial.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Cross-Over Studies; Female; Humans; Hypertension; Male | 2005 |
Comparison of a chronotherapeutically administered beta blocker vs. a traditionally administered beta blocker in patients with hypertension.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Area Under Curve; Blo | 2005 |
Effects of hydrochlorothiazide and propranolol treatment on chylomicron metabolism in hypertensive objects.
Topics: Adult; Aged; Antihypertensive Agents; Cholesterol Esters; Chylomicrons; Female; Hemodynamics; Humans | 2005 |
Urinary TGF-beta1 reduction related to a decrease of systolic blood pressure in patients with type 2 diabetes and clinical diabetic nephropathy.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Gluco | 2006 |
Comparative effects of antihypertensive therapy with guanabenz and propranolol on renal vascular resistance and left ventricular mass.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Body Weight; Double-Blind Method; Guanabenz; G | 1984 |
Crossover comparison of nitrendipine with propranolol in patients with essential hypertension.
Topics: Adult; Blood Pressure; Body Weight; Calcium Channel Blockers; Catecholamines; Humans; Hypertension; | 1984 |
Left ventricular changes after chronic therapy with enalapril maleate in moderate to severe hypertensive patients.
Topics: Adult; Blood Pressure; Cardiomegaly; Chlorides; Creatinine; Diastole; Dipeptides; Double-Blind Metho | 1984 |
Effect of oral MK-421 and propranolol on the forearm arterial circulation in essential hypertension: a preliminary report.
Topics: Administration, Oral; Clinical Trials as Topic; Enalapril; Forearm; Humans; Hypertension; Muscles; P | 1983 |
Effects of nadolol beta-blockade on blood pressure in hypertension.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Clinical Trials as Topic; Depression, Chemical; Dose-Re | 1980 |
Interaction of clonidine and beta-blockers.
Topics: Adrenergic beta-Antagonists; Adult; Animals; Atenolol; Blood Pressure; Clinical Trials as Topic; Clo | 1980 |
Propranolol in the control of blood pressure: a dose-response study.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Clinical Trials as Topic; Dose-Response Relation | 1980 |
Effect of propranolol and prazosin on blood lipids. The Oslo Study.
Topics: Cerebrovascular Disorders; Cholesterol; Coronary Disease; Drug Antagonism; Drug Therapy, Combination | 1980 |
Nadolol and propranolol in the treatment of hypertension: a double-blind comparison.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Clinical Trials as Topic; Dose-Response Relationship, Drug | 1980 |
Clinical-pharmacological evaluation of a new beta blocker, GYKI-41099 (tobanum).
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Blood Pressure; Cardiac Output; Clinical Trials as T | 1980 |
beta-blockers or diuretics in hypertension? A six year follow-up of blood pressure and metabolic side effects.
Topics: Adrenergic beta-Antagonists; Bendroflumethiazide; Blood Glucose; Blood Pressure; Clinical Trials as | 1981 |
Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Report of Medical Research Council Working Party on Mild to Moderate Hypertension.
Topics: Adult; Bendroflumethiazide; Clinical Trials as Topic; Double-Blind Method; Erectile Dysfunction; Fem | 1981 |
Influence of beta-blocking drugs on glucose metabolism in patients with non-insulin dependent diabetes mellitus.
Topics: Adrenergic beta-Antagonists; Aged; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus; Doubl | 1982 |
Adrenergic mechanisms in control of plasma lipid concentrations.
Topics: Adrenergic beta-Antagonists; Atenolol; Cholesterol; Cholesterol, HDL; Clinical Trials as Topic; Fatt | 1982 |
Beta-blockers may have role in preeclampsia.
Topics: Adrenergic beta-Antagonists; Atenolol; Birth Weight; Clinical Trials as Topic; Female; Humans; Hyper | 1982 |
beta-Blockers and myocardial infarction.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Clinical Trials as Topic; Death, Sudden; Diuretic | 1982 |
Labetalol, beta blockers, and acute deterioration of chronic airway obstruction.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Ethanolamines; Humans; Hypertension; Labetalol; Lung Di | 1982 |
Comparison of oral propranolol and verapamil for combined systemic hypertension and angina pectoris. A placebo-controlled double-blind randomized crossover trial.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; | 1982 |
Effect of long-term beta-adrenergic-blockade on calf blood flow in hypertensive patients.
Topics: Adrenergic beta-Antagonists; Aged; Ankle; Arm; Blood Pressure; Female; Hemodynamics; Humans; Hyperte | 1983 |
Thiazide or beta-blocker for hypertension?
Topics: Clinical Trials as Topic; Double-Blind Method; Humans; Hydrochlorothiazide; Hypertension; Propranolo | 1983 |
Incidence and importance of metabolic side-effects during antihypertensive therapy.
Topics: Adrenergic beta-Antagonists; Bendroflumethiazide; Blood Glucose; Cholesterol; Clinical Trials as Top | 1983 |
[Comparative evaluation of the therapeutic effect of various classes of beta-blockaders in patients with hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Clinical Trials as Topic; Echocardiography; Hear | 1983 |
Practical therapeutics: the use of beta-adrenergic blocking agents in African patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Black People; Clini | 1983 |
Effects of alpha- and beta-blocker antihypertensive therapy on blood lipids: a multicenter trial.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; | 1984 |
Propranolol vs metoprolol vs labetalol: a comparative study in essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Double-Blind Method; Female; Humans; Hypertensio | 1984 |
Effect of beta-blocking drugs on beta-cell function and insulin sensitivity in hypertensive non-diabetic patients.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Glucose; C-Peptide; Double-Blind Method; Erythro | 1984 |
Comparison between short-term renal haemodynamic effects of propranolol and nadolol in essential hypertension: a cross-over study.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Blood Pressure; Female; Glomerular Filt | 1984 |
The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Atenolol; Clinical Trials as Topic; Humans | 1984 |
[Use of the new beta-adrenoblockader Corgard in ischemic heart disease and arterial hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Clinical Trials as Topic; Coronar | 1984 |
Single-agent and combination therapy of essential hypertension.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Aldosterone; Blood Pressure; Diuretics; Drug Therapy | 1984 |
Coronary heart disease mortality/morbidity and risk in blacks. I: Clinical manifestations and diagnostic criteria: the experience with the Beta Blocker Heart Attack Trial.
Topics: Actuarial Analysis; Adrenergic beta-Antagonists; Black or African American; Cholesterol; Clinical Tr | 1984 |
Coronary heart disease mortality/morbidity and risk in blacks. I: Clinical manifestations and diagnostic criteria: the experience with the Beta Blocker Heart Attack Trial.
Topics: Actuarial Analysis; Adrenergic beta-Antagonists; Black or African American; Cholesterol; Clinical Tr | 1984 |
Coronary heart disease mortality/morbidity and risk in blacks. I: Clinical manifestations and diagnostic criteria: the experience with the Beta Blocker Heart Attack Trial.
Topics: Actuarial Analysis; Adrenergic beta-Antagonists; Black or African American; Cholesterol; Clinical Tr | 1984 |
Coronary heart disease mortality/morbidity and risk in blacks. I: Clinical manifestations and diagnostic criteria: the experience with the Beta Blocker Heart Attack Trial.
Topics: Actuarial Analysis; Adrenergic beta-Antagonists; Black or African American; Cholesterol; Clinical Tr | 1984 |
Bopindolol, a new long-acting beta-adrenoceptor antagonist--a randomized comparison against propranolol in hypertensive patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Drug Evaluation; Female; Heart Rate; Human | 1983 |
Veterans Administration cooperative study on nadolol as monotherapy and in combination with a diuretic.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Bendroflumethiazide; Clinical Trials as Topic; Diure | 1984 |
Beta-adrenoceptor blockade and vasodilatation in essential hypertension. Hemodynamic studies at rest and during exposure to stress.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Carbazoles; Carvedilol; Clinical Trials as Topic; Drug The | 1984 |
Physical performance and muscle metabolism during beta-adrenergic blockade in man.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Clinical Trials as Topic; Energy Metab | 1984 |
Psychological stress and cardiovascular diseases.
Topics: Anti-Anxiety Agents; Bendroflumethiazide; Cardiovascular Diseases; Clinical Trials as Topic; Cloraze | 1984 |
Minoxidil in the management of moderate hypertension.
Topics: Blood Pressure; Drug Therapy, Combination; Humans; Hypertension; Hypertrichosis; Minoxidil; Proprano | 1980 |
Plasma lipid and lipoprotein changes in hypertensive patients treated with propranolol and prazosin.
Topics: Apoproteins; Blood Glucose; Blood Pressure; Cholesterol; Humans; Hypertension; Lipoproteins; Prazosi | 1982 |
Adverse reactions to long-term diuretic therapy for hypertension.
Topics: Adrenergic beta-Antagonists; Benzothiadiazines; Diuretics; Humans; Hypertension; Long-Term Care; Pro | 1984 |
The correlation of changes in systolic blood pressure with regional anatomical regression of hypertensive left ventricular hypertrophy in patients on chronic antihypertensive therapy (greater than 1 year): alpha-methyldopa compared to propranolol.
Topics: Adult; Blood Pressure; Cardiomegaly; Echocardiography; Female; Heart Rate; Humans; Hypertension; Mal | 1984 |
The influence of beta blockers upon plasma cyclic AMP levels.
Topics: Alprenolol; Cyclic AMP; Humans; Hypertension; Middle Aged; Pindolol; Propranolol | 1980 |
Haemodynamic effects of noise exposure before and after beta 1-selective and non-selective beta-adrenoceptor blockade in patients with essential hypertension.
Topics: Adult; Hemodynamics; Humans; Hypertension; Male; Metoprolol; Middle Aged; Noise; Propanolamines; Pro | 1981 |
Prevention of propranolol withdrawal mechanism by prolonged small dose propranolol schedule.
Topics: Adult; Aged; Blood Pressure; Dose-Response Relationship, Drug; Drug Administration Schedule; Epineph | 1982 |
Effects of enalapril on blood pressure and renal haemodynamics in essential hypertension.
Topics: Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Dipeptides; Enalapril; Humans; Hy | 1983 |
The effect of captopril and propranolol on the responses to posture and isometric exercise in patients with essential hypertension.
Topics: Adult; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Fe | 1983 |
The renin-angiotensin system during converting enzyme inhibition with captopril in patients with severe treatment-resistant hypertension.
Topics: Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Blo | 1984 |
An appraisal of antihypertensive efficacy and adverse reactions with two drug regimens: enalapril maleate as part of triple therapy compared to conventional triple therapy in moderate to severe hypertension.
Topics: Adult; Antihypertensive Agents; Clinical Trials as Topic; Dipeptides; Drug Therapy, Combination; Ena | 1984 |
Comparison of oral MK 421 and propranolol in mild to moderate essential hypertension and their effects on arterial and venous vessels of the forearm.
Topics: Adult; Antihypertensive Agents; Blood Flow Velocity; Blood Pressure; Brachial Artery; Clinical Trial | 1984 |
Enalapril in essential hypertension: a comparative study with propranolol. Enalapril in Hypertension Study Group (UK).
Topics: Adult; Blood Pressure; Body Weight; Dipeptides; Double-Blind Method; Enalapril; Female; Humans; Hype | 1984 |
Use of clonidine and propranolol as monotherapy in borderline hypertension.
Topics: Adult; Blood Pressure; Blood Pressure Determination; Clinical Trials as Topic; Clonidine; Double-Bli | 1983 |
Influence of beta-blocking drugs on glucose metabolism in hypertensive, non-diabetic patients.
Topics: Adult; Aged; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus; Double-Blind Method; Fatty | 1983 |
Controversies in hypertension: mild hypertension, isolated systolic hypertension, and the choice of a step one drug.
Topics: Adult; Aged; Antihypertensive Agents; Bendroflumethiazide; Blood Pressure; Clinical Trials as Topic; | 1983 |
[Evaluation by practicing physicians of the antihypertensive efficacy of debrisoquin, methyldopa and propranolol].
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Debrisoquin; Female; Heart Rate; Humans; Hype | 1983 |
Antihypertensive effect of propranolol at rest and during exercise.
Topics: Adult; Blood Pressure; Dose-Response Relationship, Drug; Heart Rate; Humans; Hypertension; Male; Phy | 1983 |
Effect of propranolol on ventricular arrhythmia. The beta-blocker heart attack trial experience.
Topics: Adult; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Diabetes Complications; Diuretics; Doub | 1983 |
Comparison of propranolol or hydrochlorothiazide alone for treatment of hypertension. III. Evaluation of the renin-angiotensin system.
Topics: Blood Pressure; Clinical Trials as Topic; Furosemide; Humans; Hydrochlorothiazide; Hypertension; Mal | 1983 |
A crossover trial of oxdralazine in hypertension.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Chlorthalidone; Clinical Trials as Topic; Drug Thera | 1983 |
Double-blind comparison between propranolol and bendroflumethiazide in captopril-treated resistant hypertensive patients.
Topics: Bendroflumethiazide; Body Weight; Captopril; Clinical Trials as Topic; Double-Blind Method; Drug Res | 1983 |
[Hypertension treatment with nifedipine (Corinfar)].
Topics: Adolescent; Adult; Aged; Blood Pressure; Clinical Trials as Topic; Dose-Response Relationship, Drug; | 1983 |
Comparison of long-acting propranolol and conventional metoprolol in the treatment of hypertension.
Topics: Adult; Aged; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Female; Hea | 1983 |
Propranolol-hydralazine combination in essential hypertension.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blin | 1983 |
Indoramin as second step therapy in the management of benign essential hypertension.
Topics: Blood Pressure; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Hydrochlorothia | 1983 |
Mild hypertension.
Topics: Clinical Trials as Topic; Double-Blind Method; Humans; Hydrochlorothiazide; Hypertension; Propranolo | 1983 |
Double-blind comparison of trimazosin and propranolol in essential hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, C | 1983 |
Effect of trimazosin on serum lipid profiles in hypertensive patients.
Topics: Antihypertensive Agents; Cholesterol; Cholesterol, HDL; Clinical Trials as Topic; Double-Blind Metho | 1983 |
United States experience with oxprenolol in hypertension.
Topics: Blood Pressure; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hy | 1983 |
Effects of oxprenolol versus propranolol on myocardial performance and myocardial O2 consumption in hypertensive patients.
Topics: Cardiac Output; Clinical Trials as Topic; Diuretics; Double-Blind Method; Female; Humans; Hypertensi | 1983 |
Comparison of blood pressure, plasma lipid and cardiac performance responses to prazosin versus propranolol in thiazide-treated hypertensive patients.
Topics: Adult; Aged; Blood Pressure; Cholesterol; Cholesterol, HDL; Clinical Trials as Topic; Diuretics; Dru | 1984 |
A double-blind comparison of indoramin and propranolol in the treatment of moderate to severe essential hypertension.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Female; Heart Rate; Huma | 1983 |
Single-blind comparison of penbutolol and long-acting propranolol in general practice.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Family Practice; Female; Humans; Hypertension | 1983 |
Changes in serum lipid levels during antihypertensive therapy.
Topics: Adult; Aged; Cholesterol; Cholesterol, HDL; Clinical Trials as Topic; Dose-Response Relationship, Dr | 1984 |
Hypertension: psychological aspects and diagnostic impact in a clinical trial.
Topics: Adult; Bendroflumethiazide; Blood Pressure; Clinical Trials as Topic; Female; Follow-Up Studies; Hum | 1984 |
Spironolactone and propranolol in the management of hypertension.
Topics: Adult; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Midd | 1984 |
The effects of acute or chronic ingestion of propranolol or metoprolol on the metabolic and hormonal responses to prolonged, submaximal exercise in hypertensive men.
Topics: Blood Glucose; Catecholamines; Fatty Acids, Nonesterified; Glycerol; Growth Hormone; Humans; Hydroco | 1984 |
Propranolol versus chlorthalidone--a prospective therapeutic trial in children with chronic hypertension.
Topics: Adolescent; Blood Pressure; Child; Child, Preschool; Chlorthalidone; Chronic Disease; Clinical Trial | 1984 |
Propranolol versus verapamil for the treatment of essential hypertension.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Exercise Test; Female; Heart Rate; Humans; Hyperten | 1984 |
A comparative study on the effects of pindolol and propranolol on systemic and cardiac haemodynamics in hypertensive patients.
Topics: Adult; Aged; Blood Pressure; Coronary Circulation; Heart Rate; Hemodynamics; Humans; Hypertension; M | 1983 |
A long-term follow-up of patients with essential hypertension treated with captopril.
Topics: Adult; Aged; Captopril; Clinical Trials as Topic; Female; Follow-Up Studies; Hemodynamics; Humans; H | 1984 |
Advantages of diuretics.
Topics: Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Humans; Hydrochlorothiazide; Hyperten | 1984 |
[Effectiveness of propranolol in the treatment of arterial hypertension in elderly patients].
Topics: Adult; Age Factors; Aged; Blood Pressure; Clinical Trials as Topic; Humans; Hypertension; Male; Midd | 1984 |
[Penbutolol and propranolol in the treatment of hypertension. A double-blind comparative study in general practice].
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Age | 1984 |
[Effective propranolol dose in the treatment of arterial hypertension].
Topics: Adolescent; Adult; Age Factors; Aged; Blood Pressure; Clinical Trials as Topic; Female; Humans; Hype | 1984 |
Combined pre- and after-load reduction in hypertensive patients with cardiomegaly and normal filling pressure.
Topics: Aged; Cardiomegaly; Hemodynamics; Humans; Hypertension; Middle Aged; Physical Exertion; Prazosin; Pr | 1981 |
Verapamil and propranolol: a comparison of two antihypertensive agents.
Topics: Adult; Aged; Blood Pressure; Double-Blind Method; Electrocardiography; Female; Heart Rate; Humans; H | 1984 |
Heart rate and QT interval in subjects adapted to beta-blockade: bradycardia and hypotension as uncorrelated adaptations.
Topics: Adaptation, Physiological; Adult; Aged; Blood Pressure; Electrocardiography; Heart Rate; Humans; Hyp | 1983 |
Chronic propranolol administration during pregnancy. Maternal pharmacokinetics.
Topics: Adult; Blood Pressure; Drug Evaluation; Female; Humans; Hypertension; Kinetics; Middle Aged; Pregnan | 1983 |
Long acting beta-blockers in the twenty fourth hour.
Topics: Blood Glucose; Blood Pressure; Delayed-Action Preparations; Drug Evaluation; Electrocardiography; Ex | 1983 |
Effects of prazosin and propranolol on serum lipids in patients with essential hypertension.
Topics: Blood Pressure; Cholesterol; Drug Therapy, Combination; Female; Humans; Hypertension; Lipoproteins; | 1984 |
Studies of salivary flow in borderline hypertension: effects of drugs acting on structures innervated by the autonomic nervous system.
Topics: Adult; Atropine; Autonomic Agents; Autonomic Nervous System; Blood Pressure; Heart Rate; Humans; Hyp | 1984 |
The effects of acute or chronic ingestion of propranolol or metoprolol on the physiological responses to prolonged, submaximal exercise in hypertensive men.
Topics: Adult; Aged; Blood Pressure; Emotions; Heart Rate; Humans; Hypertension; Male; Metoprolol; Middle Ag | 1984 |
Serum glucose levels during long-term observation of treated and untreated men with mild hypertension. The Oslo study.
Topics: Adult; Antihypertensive Agents; Blood Glucose; Body Weight; Drug Therapy, Combination; Fasting; Huma | 1984 |
Rest and exercise hemodynamic effects of sequential alpha-1-adrenoceptor (trimazosin) and beta-adrenoceptor (propranolol) antagonism in essential hypertension.
Topics: Adult; Blood Pressure; Cardiac Output; Drug Therapy, Combination; Echocardiography; Hemodynamics; Hu | 1984 |
[Methodologic approach to individual evaluation of the pharmacodynamic effects of single doses of hydralazine, endralazine, prazosine and propranolol in hypertension patients].
Topics: Adult; Antihypertensive Agents; Cardiac Output; Cardiography, Impedance; Humans; Hydralazine; Hypert | 1984 |
Beta adrenoceptor antagonism and pressor response to phenylephrine.
Topics: Adult; Aged; Blood Pressure; Double-Blind Method; Drug Interactions; Female; Heart Rate; Humans; Hyp | 1984 |
Reduced peripheral vascular symptoms in elderly patients treated with alpha-methyldopa--a comparison with propranolol.
Topics: Aged; Blood Pressure; Body Temperature; Extremities; Female; Humans; Hypertension; Male; Methyldopa; | 1984 |
Serum lipids in normo- and hyperlipidemics after methyldopa and propranolol.
Topics: Adult; Aged; Cholesterol; Cholesterol, LDL; Female; Humans; Hyperlipidemias; Hypertension; Lipids; L | 1984 |
Comparison of propranolol and hydrochlorothiazide for thr initial treatment of hypertension. I. Results of short-term titration with emphasis on racial differences in response. Veterans Administration Cooperative Study Group on Antihypertensive agents.
Topics: Adult; Aged; Black People; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Humans; Hy | 1982 |
Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension. II. Results of long-term therapy. Veterans Administration Cooperative Study Group on Antihypertensive Agents.
Topics: Adult; Aged; Blood Pressure; Body Weight; Clinical Trials as Topic; Double-Blind Method; Heart Rate; | 1982 |
Comparison of antihypertensive efficacy: propranolol versus oxprenolol in accelerated hypertension.
Topics: Clinical Trials as Topic; Double-Blind Method; Humans; Hypertension; Male; Oxprenolol; Posture; Prop | 1982 |
Acute hypotensive, hemodynamic effects of long-term treatment with niludipine, a Ca2+-antagonist, in patients with essential hypertension. Niludipine monotherapy and combination with a beta-blocker and a diuretic).
Topics: Adult; Benzothiadiazines; Blood Pressure; Calcium Channel Blockers; Drug Therapy, Combination; Femal | 1982 |
Single dose administration of propranolol in hypertension: a comparison of two formulations using clinic and home blood pressure measurements.
Topics: Blood Pressure Determination; Capsules; Clinical Trials as Topic; Delayed-Action Preparations; Femal | 1982 |
The effect of propranolol on luteinising hormone and prolactin plasma concentrations in hypertensive women.
Topics: Female; Humans; Hypertension; Luteinizing Hormone; Middle Aged; Pituitary Hormone-Releasing Hormones | 1982 |
Comparison of sustained-release clonidine and long-acting propranolol in the treatment of hypertension.
Topics: Adult; Aged; Clinical Trials as Topic; Clonidine; Delayed-Action Preparations; Double-Blind Method; | 1982 |
[Combination therapy of hypertension. Results of a study with Docidrazin].
Topics: Bendroflumethiazide; Blood Pressure; Clinical Trials as Topic; Drug Combinations; Female; Humans; Hy | 1982 |
Peripheral vasodilatation in the treatment of hypertension. Prazosin compared with hydralazine in patients not responding to beta-receptor blockade.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Drug Resistance; Drug Therapy, Combinati | 1982 |
No effect of propranolol and metoprolol on tolbutamide-stimulated insulin-secretion in hypertensive diabetic and non-diabetic patients.
Topics: Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Double-Blind Method; Female; Hu | 1982 |
[Treatment of arterial hypertension in patients refractory to therapeutic diuretics. Comparative study of verapamil and propranolol].
Topics: Adult; Chlorthalidone; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Hyperten | 1982 |
Effectiveness of behavioral treatment methods compared to pharmacological therapy and self recordings of blood pressure in essential hypertensives (preliminary report).
Topics: Behavior Therapy; Blood Pressure; Humans; Hypertension; Propanolamines; Propranolol; Relaxation Ther | 1982 |
[Guanfacine in primary arterial hypertension: a long-term open clinical study].
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combinatio | 1982 |
[Results of long-term therapy in hypertension].
Topics: Blood Pressure; Dihydralazine; Drug Therapy, Combination; Female; Humans; Hypertension; Long-Term Ca | 1980 |
[Average time prognosis of hypertension in qualitatively different treatment protocols].
Topics: Aged; Blood Pressure; Dihydralazine; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hyperte | 1980 |
Metoprolol in angina pectoris complicated by essential hypertension. A clinical comparison of the antianginal efficacy of metoprolol slow-release tablets (Durules) given once daily and propranolol tablets given twice daily.
Topics: Adult; Angina Pectoris; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; | 1981 |
Captopril in essential hypertension; contrasting effects of adding hydrochlorothiazide or propranolol.
Topics: Adult; Aged; Aldosterone; Body Weight; Captopril; Clinical Trials as Topic; Drug Therapy, Combinatio | 1982 |
Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
Topics: Adolescent; Adult; Aged; Atenolol; Blood Pressure; Clinical Trials as Topic; Delayed-Action Preparat | 1982 |
The pharmacodynamics and pharmacokinetics of conventional and long-acting propranolol in patients with moderate hypertension.
Topics: Adult; Blood Pressure; Delayed-Action Preparations; Female; Humans; Hypertension; Kinetics; Male; Mi | 1983 |
Propranolol in pregnancy three year prospective study.
Topics: Blood Pressure; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Kinetics; Lactates; | 1983 |
Hemodynamic effects of isometric exercise and mental arithmetic in hypertension treated with selective and nonselective beta-blockade.
Topics: Adolescent; Adult; Blood Pressure; Epinephrine; Female; Forearm; Heart Rate; Humans; Hypertension; I | 1983 |
The combination of propranolol and nifedipine in the treatment of hypertension: acute and long term effects.
Topics: Adult; Aged; Drug Therapy, Combination; Humans; Hypertension; Male; Middle Aged; Nifedipine; Propran | 1983 |
Labetalol and propranolol in mild hypertensives: comparison of blood pressure and plasma volume effects.
Topics: Adult; Aged; Blood Pressure; Body Weight; Drug Therapy, Combination; Ethanolamines; Female; Humans; | 1980 |
Labetalol in the treatment of hypertension in patients with normal and impaired renal function.
Topics: Adult; Aged; Double-Blind Method; Ethanolamines; Female; Half-Life; Humans; Hypertension; Kidney Dis | 1982 |
Effects of labetalol and propranolol on the peripheral circulation in hypertensive patients.
Topics: Adult; Aged; Blood Pressure; Double-Blind Method; Ethanolamines; Extremities; Female; Humans; Hypert | 1982 |
Informed consent: how much does the patient understand?
Topics: Adult; Clinical Trials as Topic; Comprehension; Consent Forms; Double-Blind Method; Educational Meas | 1980 |
Hemodynamic effect of propranolol therapy in relationship to renin status and plasma catecholamines in primary hypertension.
Topics: Adult; Blood Pressure; Catecholamines; Clinical Trials as Topic; Female; Heart Rate; Hemodynamics; H | 1980 |
Comparison of labetalol and propranolol in hypertension.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Ethanolamines; Female; H | 1980 |
Comparison of labetalol, hydrallazine, and propranolol in the therapy of moderate hypertension.
Topics: Antihypertensive Agents; Clinical Trials as Topic; Drug Therapy, Combination; Ethanolamines; Female; | 1980 |
Antihypertensive and hemodynamic effects of oxprenolol versus propranolol.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Heart Rate; Hemodynamics; Humans; Hypertension; Midd | 1980 |
[Peripress (Prazosin)-a new antihypertensive drug. Open trial in ambulatory patients with prazos in administered alone or in combination with beta-blocker].
Topics: Blood Pressure; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Hypertension; Prazosin; | 1980 |
[Cross-over trial with Peripress (prazosin) and Apresolin (hydralazin), both in combination with beta-blocker].
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Cross-Sectional Studies; Drug Evaluation; Dru | 1980 |
A study of the effects of atenolol and propranolol on renal function in patients with essential hypertension.
Topics: Adult; Atenolol; Blood Pressure; Creatinine; Female; Heart Rate; Humans; Hypertension; Kidney; Male; | 1980 |
Exercise performance in mildly hypertensive patients. Impairment by propranolol but not oxprenolol.
Topics: Adult; Blood Pressure; Cardiac Output; Clinical Trials as Topic; Double-Blind Method; Heart Rate; He | 1980 |
Single daily dose penbutolol in the treatment of hypertension: a double blind crossover comparison with propranolol.
Topics: Adult; Analysis of Variance; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Doub | 1980 |
Atenolol, sustained-release oxprenolol, and long-acting propranolol in hypertension.
Topics: Adult; Atenolol; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Female; | 1980 |
Treatment of mild hypertension: a five year controlled drug trial. The Oslo study.
Topics: Adult; Blood Pressure; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Disease; Drug T | 1980 |
Comparison of antihypertensive effects of captopril and propranolol in essential hypertension.
Topics: Adult; Aged; Captopril; Clinical Trials as Topic; Diastole; Double-Blind Method; Heart Rate; Humans; | 1981 |
[Adrenergic alpha- and beta receptor blockaders in hypertension].
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Hypertension; Mi | 1981 |
Circulatory effects of stress in essential hypertension.
Topics: Adult; Blood Pressure; Catecholamines; Clinical Trials as Topic; Cold Temperature; Double-Blind Meth | 1981 |
Beta adrenoreceptor-blocking drugs once daily in essential hypertension: a comparison of propranolol, pindolol and atenolol.
Topics: Administration, Oral; Adolescent; Adult; Atenolol; Blood Glucose; Blood Pressure Determination; Clin | 1981 |
Right ventricular performance in essential hypertension after beta-blockade.
Topics: Clinical Trials as Topic; Double-Blind Method; Heart; Heart Ventricles; Hemodynamics; Humans; Hypert | 1981 |
The patient with mild to moderate essential hypertension: peripheral renin activity and a comparative drug study.
Topics: Adult; Age Factors; Blood Pressure; Chlorothiazide; Clinical Trials as Topic; Double-Blind Method; D | 1981 |
Long-acting beta-blockers in the twenty-fourth hour. A comparison in hypertension.
Topics: Adult; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Exercise Test; Fe | 1981 |
Metoprolol in high renin hypertension. A comparison with propranolol.
Topics: Adult; Clinical Trials as Topic; Female; Glomerular Filtration Rate; Humans; Hypertension; Hypertens | 1981 |
Metoprolol and propranolol in the treatment of essential hypertension - a long-term comparative study.
Topics: Adult; Aged; Clinical Trials as Topic; Female; Humans; Hypertension; Male; Metoprolol; Middle Aged; | 1981 |
Left ventricular ejection fraction and its response to therapy in essential hypertension.
Topics: Adult; Aged; Captopril; Cardiac Output; Exercise Test; Female; Heart Ventricles; Humans; Hypertensio | 1981 |
Correlation between propranolol in plasma and urine, renin-aldosterone system and blood pressure in essential hypertension.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Clinical Trials as Topic; Female; Humans; Hypertension; Ma | 1981 |
Effect of antihypertensive drugs on plasma renin activity and urinary excretion of prostaglandin E2.
Topics: Antihypertensive Agents; Blood Pressure; Chlorthalidone; Dinoprostone; Female; Humans; Hydralazine; | 1981 |
The hypotensive effect of propranolol in captopril-treated patients does not involve the plasma renin--angiotensin--aldosterone system.
Topics: Captopril; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; | 1981 |
Cardioselectivity of atenolol in asthmatic patients.
Topics: Airway Resistance; Asthma; Atenolol; Clinical Trials as Topic; Double-Blind Method; Forced Expirator | 1981 |
[Effect of propranolol on diuretic activity of furosemide hypertensive patients (author's transl)].
Topics: Aldosterone; Diuresis; Drug Synergism; Female; Furosemide; Humans; Hypertension; Male; Osmolar Conce | 1981 |
Comparison of labetalol, propranolol and hydralazine in hypertensive out-patients.
Topics: Adult; Clinical Trials as Topic; Drug Therapy, Combination; Ethanolamines; Female; Humans; Hydralazi | 1982 |
Treatment of essential hypertension. A comparison between nadolol, once daily, and propranolol, four times daily.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Female; Heart Rate; Humans; Hypertension; Mal | 1982 |
Propranolol-hydrochlorothiazide combination in essential hypertension.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Femal | 1982 |
Usefulness of home BP determination in treating borderline hypertension.
Topics: Adult; Aged; Blood Pressure Determination; Clinical Trials as Topic; Clonidine; Double-Blind Method; | 1982 |
Pindolol: effects on blood pressure and plasma renin activity.
Topics: Adult; Blood Pressure; Chlorthalidone; Clinical Trials as Topic; Double-Blind Method; Female; Humans | 1982 |
Pulmonary function in hypertensive patients treated with pindolol: a report of two studies.
Topics: Chlorthalidone; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hypertension; Male; M | 1982 |
Adverse reactions to pindolol administration.
Topics: Chlorthalidone; Clinical Trials as Topic; Double-Blind Method; Humans; Hydrochlorothiazide; Hyperten | 1982 |
Pindolol: experience gained in 10 years of safety monitoring.
Topics: Clinical Trials as Topic; Drug Evaluation; Humans; Hypertension; Pindolol; Propranolol | 1982 |
Response of blood pressure and plasma norepinephrine to propranolol, metoprolol and clonidine during isometric and dynamic exercise in hypertensive patients.
Topics: Adult; Aged; Blood Pressure; Clonidine; Exercise Test; Female; Heart Rate; Humans; Hypertension; Iso | 1982 |
Once-daily penbutolol or atenolol can replace combination therapy in essential hypertension.
Topics: Atenolol; Blood Pressure; Chlorthalidone; Dose-Response Relationship, Drug; Drug Therapy, Combinatio | 1982 |
Selective and nonselective beta-adrenoceptor blockade in hypertension: responses to changes in posture, cold and exercise.
Topics: Blood Pressure; Cold Temperature; Dose-Response Relationship, Drug; Heart Rate; Humans; Hypertension | 1982 |
The autonomic nervous tone abnormalities in the genesis of the impaired baroreflex responsiveness in borderline hypertensive subjects.
Topics: Adult; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Male; Neostigmine; Phenylephrine; P | 1982 |
Renal haemodynamics after chronic treatment with labetalol and propranolol.
Topics: Adult; Aged; Blood Pressure; Ethanolamines; Female; Heart Rate; Humans; Hypertension; Labetalol; Mal | 1982 |
Comparison of withdrawal phenomena after propranolol, metoprolol, and pindolol.
Topics: Adult; Aged; Blood Pressure; Heart Rate; Humans; Hypertension; Isoproterenol; Metoprolol; Middle Age | 1982 |
Effect of pindolol and propranolol on renal function of patients with hypertension.
Topics: Adult; Female; Humans; Hypertension; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Pind | 1982 |
The acute and chronic effect of oxprenolol and propranolol on peripheral blood flow in hypertensive patients.
Topics: Adult; Aged; Double-Blind Method; Extremities; Humans; Hypertension; Middle Aged; Oxprenolol; Propra | 1982 |
[Atenolol, pindolol and propranolol in essential hypertension: response rate and tolerance].
Topics: Adult; Atenolol; Blood Pressure; Dose-Response Relationship, Drug; Drug Tolerance; Female; Humans; H | 1982 |
[Comparative study of labetolol and propranolol in patients with untreated hypertension].
Topics: Adult; Aged; Double-Blind Method; Ethanolamines; Female; Humans; Hypertension; Labetalol; Male; Midd | 1981 |
Effects of diuretic and propranolol on plasma lipoprotein lipids.
Topics: Adult; Blood Pressure; Glycolates; Heart Rate; Humans; Hypertension; Lipids; Lipoproteins; Male; Mid | 1981 |
[Propranolol, triamteren and hydrochlorothiazide in fixed combinations in the treatment of hypertension (author's transl)].
Topics: Adolescent; Adult; Blood Pressure; Double-Blind Method; Drug Combinations; Female; Heart Rate; Human | 1981 |
Controlled comparison of the effects of furosemide and hydrochlorothiazide added to propranolol in the treatment of hypertension.
Topics: Adult; Aged; Blood Pressure; Body Weight; Drug Therapy, Combination; Female; Furosemide; Heart Rate; | 1981 |
[Changes in renal arterial flow during the treatment of essential arterial hypertension; prazosin in comparison with propranolol].
Topics: Adult; Blood Urea Nitrogen; Creatinine; Glomerular Filtration Rate; Hemodynamics; Humans; Hypertensi | 1980 |
Treatment of essential hypertension with a combination of propranolol and bendrofluazide.
Topics: Adult; Bendroflumethiazide; Blood Pressure; Double-Blind Method; Drug Combinations; Drug Therapy, Co | 1980 |
Attenuation of hypotensive effect of propranolol and thiazide diuretics by indomethacin.
Topics: Adult; Aged; Benzothiadiazines; Body Weight; Diuretics; Double-Blind Method; Female; Humans; Hyperte | 1980 |
Renal blood flow and noradrenaline secretion during treatment with propranolol.
Topics: Adult; Blood Flow Velocity; Humans; Hypertension; Kidney; Middle Aged; Norepinephrine; Propranolol; | 1980 |
Comparison of a lifestyle modification program with propranolol use in the management of diastolic hypertension.
Topics: Adult; Analysis of Variance; Blood Pressure; Diastole; Female; Follow-Up Studies; Humans; Hypertensi | 1995 |
[The effect of long-term monotherapy with preparations from the 4 basic groups of antihypertensive agents on the quality of life in patients with mild and moderate arterial hypertension. The Multicenter Captopril and the Quality of Life Study. The working
Topics: Adult; Antihypertensive Agents; Azerbaijan; Captopril; Humans; Hydrochlorothiazide; Hypertension; Ma | 1995 |
Effect of propranolol on circadian variation of ventricular arrhythmias in elderly patients with heart disease and complex ventricular arrhythmias.
Topics: Aged; Aged, 80 and over; Cardiac Complexes, Premature; Circadian Rhythm; Humans; Hypertension; Middl | 1995 |
[The long-term monotherapy with preparations from the 4 basic groups of antihypertensive agents of patients with mild and moderate arterial hypertension. The Multicenter Captopril and the Quality of Life Study. The working group of the Multicenter Captopr
Topics: Adult; Azerbaijan; Captopril; Hemodynamics; Humans; Hydrochlorothiazide; Hypertension; Male; Middle | 1995 |
Effect of propranolol on circadian variation of myocardial ischemia in elderly patients with heart disease and complex ventricular arrhythmias.
Topics: Aged; Aged, 80 and over; Arrhythmias, Cardiac; Circadian Rhythm; Death, Sudden, Cardiac; Electrocard | 1995 |
Beta-adrenergic blocking agents in the treatment of pregnancy-induced hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Blood Glucose; Blood Pressure; Drug Therapy, Combination; Female | 1995 |
Factors affecting lipoprotein lipase in hypertensive patients.
Topics: Blood Pressure; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Insulin; Lipid | 1995 |
Influence of chronic beta-adrenoreceptor blocker treatment on melatonin secretion and sleep quality in patients with essential hypertension.
Topics: Adult; Depression, Chemical; Double-Blind Method; Female; Humans; Hypertension; Male; Melatonin; Mid | 1994 |
Effect of bevantolol and propranolol on serum lipids in patients with essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Apolipoproteins; Blood Pressure; Fatty Acids, Nonesterifie | 1994 |
Review of studies on the clinical pharmacodynamics of cilazapril.
Topics: Administration, Oral; Aged; Angiotensin I; Blood Pressure; Captopril; Cardiac Output; Cilazapril; Cr | 1994 |
Extent of beta 1- and beta 2-receptor occupancy in plasma assesses the antagonist activity of metoprolol, pindolol, and propranolol in the elderly.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Animals; Double-Blind Method; Female; Humans; | 1993 |
[Differences in hemodynamic effects of the cardioselective beta-adrenoblocker acebutolol and non-selective beta-adrenoblocker propranolol in long-term antihypertensive therapy].
Topics: Acebutolol; Dose-Response Relationship, Drug; Echocardiography; Electrocardiography; Hemodynamics; H | 1993 |
[Pharmaco -- genetic approach to the improvement of beta-adrenoblocker therapy in the treatment of hypertension].
Topics: Acebutolol; Adult; Blood Pressure; Humans; Hypertension; Lipid Peroxidation; Male; Middle Aged; Penb | 1993 |
Effects of long-acting propranolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension.
Topics: Adult; Aged; beta-Thromboglobulin; Blood Flow Velocity; Blood Platelets; Blood Pressure; Dose-Respon | 1994 |
Metabolic effects of propranolol and hydroflumethiazide treatment in Kenyans with mild to moderate essential hypertension.
Topics: Adolescent; Adult; Aged; Drug Monitoring; Female; Humans; Hydroflumethiazide; Hypertension; Kenya; M | 1993 |
Systemic hypertension at 4,300 m is related to sympathoadrenal activity.
Topics: Adrenal Glands; Adult; Altitude; Blood Pressure; Epinephrine; Heart Rate; Humans; Hypertension; Isop | 1994 |
Variability in plasma lipoprotein profiles when comparing diltiazem and propranolol.
Topics: Adult; Delayed-Action Preparations; Diltiazem; Double-Blind Method; Humans; Hypertension; Lipoprotei | 1993 |
Modification of exercise performance by sharp reduction of blood pressure. A study in patients with uncomplicated hypertension.
Topics: Anaerobic Threshold; Blood Pressure; Captopril; Double-Blind Method; Exercise Tolerance; Female; Hum | 1993 |
[Effect of long-term monotherapy with propranolol and nifedipine on the quality of life and psychological status of patients with hypertension].
Topics: Adult; Blood Pressure; Chronic Disease; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nifedip | 1993 |
Comparative study of the efficacy and tolerability of hydroflumethiazide versus propranolol in Africans with mild to moderate hypertension.
Topics: Adult; Aged; Black People; Blood Pressure; Diastole; Female; Humans; Hydroflumethiazide; Hypertensio | 1993 |
Nicardipine or propranolol combined with hydrochlorothiazide in patients with essential hypertension.
Topics: Adult; Aged; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hy | 1993 |
Differences of chronopharmacokinetic profiles between propranolol and atenolol in hypertensive subjects.
Topics: Administration, Oral; Adult; Aged; Atenolol; Circadian Rhythm; Female; Humans; Hypertension; Intesti | 1993 |
Effect of hydrochlorothiazide, enalapril, and propranolol on quality of life and cognitive and motor function in hypertensive patients.
Topics: Aged; Cognition; Double-Blind Method; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; | 1993 |
Comparison of nifedipine and propranolol as second line agent for hypertension in black Kenyans.
Topics: Adult; Aged; Black People; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Humans; H | 1993 |
A controlled study of the effect of balanced general anaesthesia on cognitive functions in hypertensives on propranolol.
Topics: Adult; Anesthesia, General; Cognition; Female; Humans; Hypertension; Male; Propranolol; Reference Va | 1995 |
The effects of replacing beta-blockers with an angiotensin converting enzyme inhibitor on the quality of life of hypertensive patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Blood | 1996 |
[The treatment with antihypertensive and nootropic preparations of hypertension patients working under neuroemotional stress].
Topics: Adult; Antihypertensive Agents; Attention; Drug Therapy, Combination; Humans; Hypertension; Male; Me | 1996 |
[The Multicenter Captopril and the Quality of Life Study: the effect of antihypertensive agents from the basic groups on the quality of life of patients in different populations. The working group of the Multicenter Captopril and the Quality of Life Study
Topics: Antihypertensive Agents; Azerbaijan; Captopril; Demography; Humans; Hydrochlorothiazide; Hypertensio | 1996 |
[Chronopharmacodynamics of betacap (long-acting propranolol) in patients with hypertension stage II].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Chronotherapy; Delayed-Action Preparations; Electrocardiog | 1998 |
Comparison of chlorthalidone, propranolol and bopindolol in six-month treatment of arterial hypertension.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Chlorthalidone; Double-Blind Method; Female; Humans; Hyp | 1998 |
Pharmacokinetics and pharmacodynamics of propranolol in hypertensive patients after sublingual administration: systemic availability.
Topics: Administration, Sublingual; Adult; Antihypertensive Agents; Biological Availability; Blood Pressure; | 1998 |
Differential chronergy of propranolol effects on heart rate in healthy and hypertensive subjects.
Topics: Adult; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Placebos; Propranolol; Time Fact | 1998 |
Baroreflex sensitivity and the blood pressure response to beta-blockade.
Topics: Adolescent; Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Barorefle | 1999 |
Beta-blocker effects on plasma lipids during prolonged treatment of hypertensive patients with hypercholesterolemia.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Analysis of Variance; Atenolol; Bisopr | 1999 |
Effects of propranolol on cardiovascular and neurohumoral actions of alcohol in hypertensive patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Alcohol Drinking; Asian People; Blood Pressure; Cardiac Ou | 1999 |
The effects of propranolol on cognitive function and quality of life: a randomized trial among patients with diastolic hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Cognition; Depression; Diastole; | 2000 |
[Changes in blood rheological properties in patients with hypertension].
Topics: Adrenergic beta-Antagonists; Blood; Blood Viscosity; Calcium Channel Blockers; Diuretics; Drug Thera | 2001 |
Comparison between metoprolol and propranolol as antihypertensive agents. A double-blind cross-over study.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Body Weight; Clinical Trials as Topic; Depression, Chem | 1976 |
Effect of timolol versus propranolol on hypertension and hemodynamics.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Urea Nitrogen; Cardiac Catheterization; Clinical Tri | 1976 |
Comparison of antihypertensive activity of beta-blocking drugs during chronic treatment.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Chronic Disease; Clinical Trials as Topic; Dose- | 1976 |
[Interrelations between blood pressure, blood volume, plasma renin and urinary catecholamines during beta-blockade in essential hypertension (author's transl)].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Benzofurans; Blood Pressure; Blood Volume; Body Weight; Ca | 1976 |
The antihypertensive action of several beta-adrenoreceptor-blocking drugs.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Depression, Chemical; Female; Humans; Hypertension; Mal | 1976 |
Antianxiety drug trials in hypertension [proceedings].
Topics: Anti-Anxiety Agents; Anxiety; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Hypertens | 1977 |
The effect of mental arithmetic in normotensive and hypertensive subjects, and its modification by beta-adrenergic receptor blockade.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind M | 1977 |
Minoxidil in severe hypertension.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Cardiac Output; Cardiomegaly; Clinical Trials as Top | 1978 |
[Use of beta-adrenergic blockaders in the treatment of arterial hypertension].
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Blood Pressure; Cerebrovascular Circulation; Clinica | 1978 |
Relationship between adrenergic blocking and antihypertensive effects of beta receptor antagonists.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Clin | 1976 |
Hemodynamic effects of adrenergic beta-receptor blocking agents.
Topics: Adrenergic beta-Antagonists; Adult; Alprenolol; Cardiac Output; Clinical Trials as Topic; Double-Bli | 1976 |
Acute and long-term salt depletion and beta-blockade: plasma renin activity response and its relation to blood pressure reduction in long-term treatment.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Diet, Sodium-Restricted; Diuretics; Female; Furo | 1978 |
Penbutolol, a new non-selective beta-adrenergic blocking compound in the treatment of hypertension. A comparision with propranolol.
Topics: Adrenergic beta-Antagonists; Adult; Clinical Trials as Topic; Cyclopentanes; Double-Blind Method; Dr | 1978 |
Randomised study of six beta-blockers and a thiazide diuretic in essential hypertension.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Atenolol; Bendroflumethiazide; Clinical Trials as To | 1978 |
[A field study with the combination of Pindolol and Clopamid in antihpertensive therapy (author's transl)].
Topics: Adrenergic beta-Antagonists; Blood Pressure; Clopamide; Diuretics; Drug Therapy, Combination; Humans | 1978 |
Metoprolol (Lopressor).
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Humans; Hypertension; Metoprolol; Propanolami | 1978 |
Abrupt withdrawal of beta-blocking agents in patients with arterial hypertension. Effect on blood pressure, heart rate and plasma catecholamines and prolactin.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Catecholamines; Clinical Trials as Topic; Female | 1979 |
Diuretics, beta-blockers or both as treatment for essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Blood Pressure; Drug Therapy, Combination; Fe | 1979 |
Regression of left ventricular hypertrophy during treatment with antihypertensive agents.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Cardiomegaly; Echocardiography; Female; He | 1979 |
Effects of 4 beta-adrenoceptor blocking drugs on blood pressure and exercise heart rate in hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Depression, Chemical; Female; Heart Ra | 1979 |
The effects of alpha- and beta-adrenergic receptor blockers on the pressure responses to isometric exercise in hypertensive patients.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Blood Pressure; Humans; Hypertensi | 1979 |
The position of beta-blockers in antihypertensive therapy. Comparison with other antihypertensive agents.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Blood Pressure; Clinical Trials a | 1979 |
Clinical pharmacology of adrenergic-blocking drugs.
Topics: Adrenergic beta-Antagonists; Alprenolol; Biological Availability; Blood Pressure; Clinical Trials as | 1979 |
[Beta-blocking agents alone or combined with diuretics or alpha-adrenolytics in the treatment of essential arterial hypertension].
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Diuretics; Drug Therapy, Combination; | 1979 |
A report on the clinical efficacy of nadolol--a new long acting beta-blocker.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Antihypertensive Agents; Clinical Trials | 1979 |
Modification by propranolol of cardiovascular effects of induced hypoglycaemia.
Topics: Arrhythmia, Sinus; Blood Pressure; Bradycardia; Diabetes Complications; Drug Antagonism; Electrocard | 1975 |
Letter: Hypoglycaemia in propranolol-treated dialysis patients.
Topics: Blood Glucose; Drug Evaluation; Female; Humans; Hypertension; Hypoglycemia; Kidney Failure, Chronic; | 1976 |
Evaluation of beta blockade bendrofluazide, and prazosin in severe hypertension.
Topics: Adult; Aged; Atenolol; Bendroflumethiazide; Blood Pressure; Clinical Trials as Topic; Drug Evaluatio | 1977 |
Another trial in mild hypertension?
Topics: Bendroflumethiazide; Blood Pressure; Clinical Trials as Topic; Cost-Benefit Analysis; Humans; Hypert | 1977 |
Modification of antihypertensive effect of beta-adrenoceptor-blocking agents by inhibition of endogenous prostaglandin synthesis.
Topics: Adult; Blood Pressure; Drug Antagonism; Drug Therapy, Combination; Female; Humans; Hypertension; Ind | 1977 |
Hypertension treated by salt restriction.
Topics: Blood Pressure; Chlorothiazide; Diet, Sodium-Restricted; Follow-Up Studies; Humans; Hypertension; Ma | 1978 |
Biochemical and haematological changes induced by tienilic acid combined with propranolol in essential hypertension.
Topics: Adult; Aged; Blood Pressure; Blood Sedimentation; Clinical Trials as Topic; Creatinine; Diuretics; D | 1979 |
Aphthous ulcers of mouth from captopril.
Topics: Adult; Captopril; Clinical Trials as Topic; Female; Humans; Hypertension; Proline; Propranolol; Stom | 1979 |
Minoxidil in resistant hypertension.
Topics: Blood Pressure; Drug Combinations; Female; Follow-Up Studies; Furosemide; Humans; Hypertension; Male | 1977 |
Studies on the effects of propanolol on plasma catecholamine levels in patients with essential hypertension.
Topics: Adult; Clinical Trials as Topic; Dopamine beta-Hydroxylase; Epinephrine; Hematocrit; Humans; Hyperte | 1978 |
[Treatment of essential hypertension with propranolol (author's transl)].
Topics: Adult; Age Factors; Aldosterone; Blood Pressure; Clinical Trials as Topic; Creatinine; Cyclic AMP; F | 1976 |
Reduction of plasma renin activity by inhibition of the fatty acid cyclooxygenase in human subjects: independence of sodium retention.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Body Weight; Clinical Trials as Topic; Creatinine; Cycloox | 1979 |
HDL-cholesterol in antihypertensive treatment. The Oslo Study.
Topics: Adult; Antihypertensive Agents; Cholesterol; Humans; Hydrochlorothiazide; Hypertension; Lipoproteins | 1979 |
Comparative beta-adrenoreceptor-blocking effects and pharmacokinetics or propranolol and pindolol in hypertensive Africans.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Heart Rate; Humans; Hypertensi | 1979 |
A comparison of timolol and propranolol in essential hypertension.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Evalua | 1975 |
Adrenergic beta-receptor blockade in essential hypertension: a comparison between pindolol (Visken) and propranolol (Inderal).
Topics: Adrenergic beta-Antagonists; Adult; Animals; Blood Pressure; Clinical Trials as Topic; Female; Heart | 1975 |
[Effect of chronic beta-adrenergic blockade on blood pressure and release of renin, aldosterone and cortisol in essential hypertension (author's transl)].
Topics: Adrenergic beta-Antagonists; Adult; Aldosterone; Blood Pressure; Circadian Rhythm; Clinical Trials a | 1975 |
Effects of indomethacin alone and during diuretic or beta-adrenoreceptor-blockade therapy on blood pressure and the renin system in essential hypertension.
Topics: Adult; Benzothiadiazines; Blood Pressure; Diuretics; Drug Therapy, Combination; Female; Humans; Hype | 1978 |
Effect of selective and non-selective beta-adrenoreceptor blockade on calf blood flow in hypertensive patients.
Topics: Blood Pressure; Heart Rate; Humans; Hypertension; Isoproterenol; Leg; Metoprolol; Propanolamines; Pr | 1978 |
South African multicentre study of metoprolol and propranolol in essential hypertension.
Topics: Clinical Trials as Topic; Female; Humans; Hypertension; Male; Metoprolol; Middle Aged; Propanolamine | 1977 |
Propranolol in hypertension. A study in general practice.
Topics: Clinical Trials as Topic; Family Practice; Humans; Hypertension; Propranolol | 1977 |
An unsuccessful attempt to treat hypertension with acupuncture.
Topics: Acupuncture Therapy; Blood Pressure; Chlorthalidone; Clinical Trials as Topic; Dopamine beta-Hydroxy | 1977 |
Effects of adrenaline during treatment with propranolol and metoprolol.
Topics: Blood Pressure; Clinical Trials as Topic; Epinephrine; Humans; Hypertension; Metoprolol; Propanolami | 1977 |
Propranolol in the treatment of essential hypertension.
Topics: Adolescent; Adult; Blood Pressure; Clinical Trials as Topic; Drug Synergism; Drug Therapy, Combinati | 1977 |
Effect of minoxidil on blood pressure and hemodynamics in severe hypertension.
Topics: Adult; Aldosterone; Blood Pressure; Cardiac Output; Clinical Trials as Topic; Drug Therapy, Combinat | 1977 |
Randomised controlled trial of treatment for mild hypertension: design and pilot trial. Report of Medical Research Council Working Party on Mild to Moderate Hypertension.
Topics: Adult; Bendroflumethiazide; Clinical Trials as Topic; Economics, Medical; England; Female; Humans; H | 1977 |
Effect of beta adrenoceptor antagonists on baroreceptor reflex sensitivity in hypertension.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Heart Rate; Humans; Hypertension; Male; Middle Aged | 1977 |
Pathophysiologic and pharmacokinetic determinants of the antihypertensive response to propranolol.
Topics: Adolescent; Adult; Biopharmaceutics; Blood Pressure; Clinical Trials as Topic; Dose-Response Relatio | 1977 |
Studies with prazosin--a new effective hypotensive agent. II. Two double-blind cross-over studies comparing the effects of prazosin and hydrallazine.
Topics: Adult; Chlorothiazide; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Fem | 1977 |
A comparative trial of clonidine, propranolol and placebo in the treatment of moderate hypertension.
Topics: Adult; Aged; Blood Pressure; Body Weight; Clinical Trials as Topic; Clonidine; Double-Blind Method; | 1977 |
Renin-aldosterone profiling in hypertension.
Topics: Aldosterone; Angiotensin II; Benzothiadiazines; Clinical Trials as Topic; Diagnosis, Differential; D | 1977 |
Nightmares, asthma and pindolol.
Topics: Adolescent; Adult; Aged; Bronchial Spasm; Clinical Trials as Topic; Double-Blind Method; Dreams; Fem | 1977 |
Response to once-a-day Visken dosage.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Female; Humans; | 1977 |
Comparison of propranolol and atenolol in hypertension.
Topics: Atenolol; Blood Pressure; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind M | 1977 |
Antihypertensive effect of atenolol--a Swedish multicentre study.
Topics: Atenolol; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Humans; Hypertension; Propa | 1977 |
The transient anti-hypertensive effect of phentolamine in patients receiving beta-blocker treatment.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Drug Therapy, Combinati | 1977 |
[Minoxidil in acute arterial hypertension. Experience of 6 cases].
Topics: Adolescent; Adult; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Female; Hum | 1977 |
Haemodynamic effects of adrenaline during treatment of hypertensive patients with propranolol and metoprolol.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Drug Interactions; Epinephrine; Hemodynamics; | 1977 |
Cardiovascular responses to mianserin hydrochloride: a comparison with tricyclic antidepressant drugs.
Topics: Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Bethanidine; Blood Pressure; Cardiovascular | 1978 |
Response of blood pressure and the renin-angiotensin-aldosterone axis to hypotensive therapy: comparison of propranolol with spironolactone.
Topics: Adult; Aldosterone; Angiotensin II; Blood Pressure; Clinical Trials as Topic; Female; Furosemide; Hu | 1977 |
Effects of propranolol and atenolol on blood pressure and plasma renin activity in patients with moderate hypertension.
Topics: Adult; Atenolol; Blood Pressure; Clinical Trials as Topic; Depression, Chemical; Double-Blind Method | 1977 |
Myocardial revascularization in patients receiving long-term propranolol therapy.
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Hemodynamics; Humans; Hypertension; Middle A | 1978 |
[Therapy of severe hypertension with minoxidil, beta blockers and diuretics--long term results].
Topics: Blood Pressure; Cardiac Output; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination | 1977 |
A longitudinal study of the mechanisms of action of debrisoquine and propranolol.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Debrisoquin; Double-Blind Method; Female; Humans; H | 1978 |
Relationships of renin and aldosterone to antihypertensive effects of spironolactone and propranolol.
Topics: Adult; Aldosterone; Antihypertensive Agents; Clinical Trials as Topic; Female; Humans; Hypertension; | 1978 |
[Effect of apressin and its combination with obzidan on central hemodynamic indices in the treatment of hypertension].
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Diastole; Drug Evaluation; Drug Therapy, Combinatio | 1978 |
Long-term clinical effects, bioavailability, and kinetics of minoxidil in relation to renal function.
Topics: Adolescent; Adult; Aged; Biological Availability; Blood Pressure; Clinical Trials as Topic; Female; | 1978 |
Veterans Administration cooperative studies of hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Humans; Hypertension | 1978 |
Once daily propranolol in the treatment of mild to moderate hypertension: a dose range finding study.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Female; Hu | 1978 |
Long-term clinical experience with atenolol--a new selective beta-1-blocker with few side-effects from the central nervous system.
Topics: Adult; Aged; Alprenolol; Atenolol; Central Nervous System; Clinical Trials as Topic; Drug Evaluation | 1979 |
A controlled trial of labetalol (Trandate), propranolol and placebo in the management of mild to moderate hypertension.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Ethanolamines; Female; Heart R | 1979 |
A comparative study of the effects of oxprenolol versus propranolol in essential hypertension.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Female; Hum | 1979 |
Studies with prazosin--a new effective hypotensive agent. III. An acute double-blind cross-over study comparing the effects of single doses of prazosin and hydrallazine in combination with propranolol and a diuretic.
Topics: Adult; Aged; Benzothiadiazines; Blood Pressure; Clinical Trials as Topic; Diuretics; Double-Blind Me | 1978 |
Effects of beta 1-selective and non-selective beta-blockade on blood pressure, plasma renin activity and plasma aldosterone in hypertensive patients.
Topics: Adult; Aldosterone; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; | 1979 |
Beta-adrenoceptor-blocking drugs and blood sugar control in diabetes mellitus.
Topics: Adult; Aged; Blood Glucose; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Dou | 1979 |
Effects of propranolol and metoprolol on haemodynamic and respiratory indices and on perceived exertion during exercise in hypertensive patients.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Heart Rate; Hemodynamics; Humans; Hypertension | 1979 |
Haemodynamic parameters in hypertensive patients treated with a diuretic and with a diuretic in combination with a beta-blocker.
Topics: Adult; Clinical Trials as Topic; Diuretics; Double-Blind Method; Drug Evaluation; Drug Therapy, Comb | 1979 |
Antihypertensive effect of a non-selective (propranolol) and a cardioselective (metoprolol) beta-adrenoceptor blocking agent at rest and during exercise.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Exerc | 1979 |
Beta-adrenoceptor blocking drugs and diuretics in hypertension.
Topics: Bendroflumethiazide; Blood Pressure; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Hy | 1979 |
Vascular symptoms in patients with primary Raynaud's phenomenon are not exacerbated by propranolol or labetalol.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Ethanolamines; Female; H | 1979 |
The fixed combination of propranolol and bendrofluazide in the treatment of hypertension.
Topics: Adult; Aged; Bendroflumethiazide; Capsules; Clinical Trials as Topic; Double-Blind Method; Drug Comb | 1979 |
Comparison of a once daily long-acting formulation of propranolol with conventional propranolol given twice daily in patients with mild to moderate hypertension.
Topics: Adult; Aged; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Female; Hum | 1979 |
Captopril and propranolol in mild and moderate essential hypertension: preliminary report.
Topics: Adolescent; Adult; Aged; Captopril; Female; Humans; Hypertension; Male; Proline; Propranolol; Respir | 1979 |
Hemodynamic effects of oxprenolol and propranolol in hypertension.
Topics: Adult; Blood Pressure; Cardiac Output; Clinical Trials as Topic; Double-Blind Method; Heart Rate; He | 1979 |
Propranolol and tienilic acid in essential hypertension.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Glyco | 1979 |
Antihypertensive efficacy of propranolol given twice daily.
Topics: Adolescent; Adult; Aged; Blood Pressure; Clinical Trials as Topic; Drug Administration Schedule; Fem | 1979 |
Nepresol in the treatment of hypertension of major severity.
Topics: Adult; Blood Pressure; Blood Urea Nitrogen; Clinical Trials as Topic; Creatinine; Drug Therapy, Comb | 1979 |
Does the renin-angiotensin system maintain blood pressure in both hypertensive and normotensive subjects? A comparison of propranolol, saralasin and captopril.
Topics: Angiotensin II; Angiotensins; Blood Pressure; Captopril; Humans; Hypertension; Male; Proline; Propra | 1979 |
Long-acting or conventional propanolol in hypertension?
Topics: Adult; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Female; Humans; H | 1979 |
Comparison of captopril with propranolol in the treatment of mild and moderate essential hypertension.
Topics: Adult; Blood Pressure; Captopril; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug T | 1979 |
Antihypertensive effect of sotalol and propranolol a double-blind crossover study.
Topics: Blood Pressure; Clinical Trials as Topic; Heart Rate; Humans; Hypertension; Male; Middle Aged; Propr | 1977 |
[Treatment of hypertension with propranolol in internal medicine and general practice. A field trial with a simplified twice daily administration of Dociton 80 (author's transl)].
Topics: Bradycardia; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Hypertension; Male; Middle A | 1977 |
Antihypertensive effect and plasma levels of labetalol. A comparison with propranolol and dihydrallazine.
Topics: Adult; Dihydralazine; Drug Therapy, Combination; Ethanolamines; Female; Heart Rate; Humans; Hydralaz | 1979 |
Beta-blockers, blood sugar control, and renal function.
Topics: Atenolol; Creatinine; Humans; Hypertension; Propanolamines; Propranolol | 1979 |
Antihypertensive effect of prazosin in combination with methyldopa, clonidine, or propranolol.
Topics: Adult; Blood Pressure; Clonidine; Drug Combinations; Drug Evaluation; Female; Heart Rate; Humans; Hy | 1979 |
Effects of atenolol and propranolol when added to long-term antihypertensive diuretic therapy.
Topics: Administration, Oral; Adult; Atenolol; Blood Pressure; Chlorthalidone; Dose-Response Relationship, D | 1979 |
Comparison of the effects of atenolol and propranolol in labile hypertension.
Topics: Adult; Atenolol; Blood Pressure; Heart Rate; Humans; Hypertension; Male; Propanolamines; Propranolol | 1979 |
The treatment of hypertension with propranolol and bendrofluazide.
Topics: Adult; Aged; Bendroflumethiazide; Double-Blind Method; Drug Combinations; Humans; Hypertension; Midd | 1979 |
Objective measurement of performance during acute stress in patients with essential hypertension: assessment of the effects of propranolol and metoprolol.
Topics: Adult; Automobile Driving; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Male; Metoprolo | 1979 |
Standardized stress and hypertension: comparison of effect of propranolol and methyldopa.
Topics: Adult; Blood Pressure; Female; Humans; Hypertension; Male; Methyldopa; Middle Aged; Propranolol; Str | 1978 |
Effect of propranolol on sympathetic nervous activity in hydrallazine-treated hypertensive patients.
Topics: Adult; Blood Pressure; Catecholamines; Female; Heart Rate; Humans; Hydralazine; Hypertension; Male; | 1978 |
[Treatment of essential hypertension with a combination of propranolol, spironolactone-thiabutazide and dihydralazine (author's transl)].
Topics: Anxiety; Bradycardia; Dihydralazine; Drug Therapy, Combination; Female; Humans; Hydralazine; Hydroch | 1978 |
The renin-aldosterone system and thiazide-induced depletion of total body potassium in essential hypertension.
Topics: Adult; Aged; Aldosterone; Body Weight; Chlorothiazide; Drug Therapy, Combination; Female; Humans; Hy | 1978 |
Effects of propranolol and metoprolol on the peripheral circulation.
Topics: Blood Flow Velocity; Blood Pressure; Depression, Chemical; Humans; Hypertension; Male; Metoprolol; M | 1978 |
[Hemodynamic changes in patients with arterial hypertension after beta-receptor blockade with propranolol and metoprolol (author's transl)].
Topics: Cardiac Catheterization; Heart Rate; Hemodynamics; Humans; Hypertension; Metoprolol; Propanolamines; | 1978 |
Metabolic consequences of atenolol and propranolol in treatment of essential hypertension.
Topics: Adult; Atenolol; Blood Glucose; Cholesterol; Fatty Acids, Nonesterified; Glucagon; Growth Hormone; H | 1979 |
Step 2 regimens in hypertension. An assessment.
Topics: Adult; Aged; Blood Pressure; Drug Therapy, Combination; Female; Humans; Hydroflumethiazide; Hyperten | 1979 |
Renin concentrations and effects of propranolol and spironolactone in patients with hypertension.
Topics: Administration, Oral; Adult; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Hy | 1976 |
[Pharmacokinetics of acebutolol].
Topics: Acebutolol; Animals; Autoradiography; Clinical Trials as Topic; Half-Life; Humans; Hypertension; Mal | 1975 |
[Comparative study of acebutolol and propranolol in the treatment of arterial hypertension].
Topics: Acebutolol; Adult; Aged; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Hypertension; Ma | 1975 |
Controlled treatment of primary hypertension with propranolol and spironolactone. A crossover study with special reference to initial plasma renin activity.
Topics: Adult; Aldosterone; Angiotensin II; Clinical Trials as Topic; Drug Therapy, Combination; Female; Hum | 1976 |
Renin profiling in hypertension and its use in treatment with propranolol and chlorthalidone.
Topics: Adult; Age Factors; Black People; Blood Pressure; Chlorthalidone; Clinical Trials as Topic; Female; | 1976 |
Letter: Effect of propranolol on urine concentration.
Topics: Clinical Trials as Topic; Humans; Hypertension; Kidney Concentrating Ability; Osmolar Concentration; | 1976 |
[Experience with the combination of beta receptor blockader and hydralazine in the treatment of hypertension].
Topics: Adult; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Female; Headache; Human | 1976 |
Editorial: Propranolol again: order out of chaos?
Topics: Blood Pressure; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Humans; Hypertension | 1976 |
Proposed mechanisms of propranolol's antihypertensive effect in essential hypertension.
Topics: Blood Pressure; Clinical Trials as Topic; Depression, Chemical; Diuretics; Dose-Response Relationshi | 1976 |
Methyldopa and propranolol or practolol in moderate hypertension.
Topics: Adult; Aged; Clinical Trials as Topic; Drug Combinations; Female; Humans; Hypertension; Male; Methyl | 1976 |
Propranolol in hypertension: a dose-response study.
Topics: Adult; Aged; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Humans; Hypertensio | 1976 |
[Propranolol and arterial hypertension: study with frequent daily checking of blood pressure and serum levels after 1 week of treatment].
Topics: Blood Pressure; Clinical Trials as Topic; Drug Evaluation; Female; Heart Rate; Humans; Hypertension; | 1975 |
Antihypertensive effects of oxprenolol and propranolol.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Humans; Hydrochlorot | 1976 |
[Dose-effect test of Xipamid in hypertension as compared with other antihypertensive drugs].
Topics: Bethanidine; Blood Pressure; Clinical Trials as Topic; Diuretics; Dose-Response Relationship, Drug; | 1976 |
A comparison of the antihypertensive effect of atenolol (ICI 66 082) and propranolol.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Clinical Trials as Topic | 1976 |
Comparison of the antihypertensive effect of propranolol and practolol combined with chlorthalidone.
Topics: Antihypertensive Agents; Blood Pressure; Chlorthalidone; Clinical Trials as Topic; Depression, Chemi | 1975 |
[Clinical testing of a new beta blocking agent--atenolol--in hypertension].
Topics: Adult; Atenolol; Clinical Trials as Topic; Drug Evaluation; Humans; Hypertension; Middle Aged; Place | 1976 |
Propranolol, renin and hypertension: a review.
Topics: Adolescent; Adult; Aged; Aldosterone; Blood Pressure; Child; Clinical Trials as Topic; Female; Human | 1976 |
The effect on blood pressure of beta-adrenoceptor blocking drugs administered once daily and their duration of action when therapy is ceased.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Drug Administration Schedule; Humans; Hypertension; | 1976 |
Comparative potency of atenolol and propranolol as beta-adrenergic blocking agents in man.
Topics: Adult; Atenolol; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Evaluation; Female | 1976 |
[Treatment of arterial hypertension with propranolol (Inderal) in general practice].
Topics: Clinical Trials as Topic; Diuretics; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hyp | 1976 |
Beta-adrenergic receptor blocking drugs, hypertension and plasma renin.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Furosemide; Humans; Hypertension; Male; Middl | 1975 |
Controlled comparison of labetalol and propranolol in the management of severe hypertension.
Topics: Adult; Antibodies, Antinuclear; Aspartate Aminotransferases; Blood Pressure; Clinical Trials as Topi | 1976 |
Effect of blood pressure angiotensin II and aldosterone concentrations during treatment of severe hypertension with intravenous labetalol: comparison with propranolol.
Topics: Aldosterone; Angiotensin II; Blood Pressure; Clinical Trials as Topic; Ethanolamines; Heart Rate; Hu | 1976 |
Clinical evaluation of atenolol in hypertension.
Topics: Antihypertensive Agents; Atenolol; Clinical Trials as Topic; Humans; Hypertension; Lung Diseases, Ob | 1976 |
Differential effects of acute and chronic beta-adrenoreceptor blockade on blood pressure and the renin-angiotensin-aldosterone system in essential hypertension.
Topics: Adult; Aldosterone; Angiotensin II; Clinical Trials as Topic; Humans; Hypertension; Male; Pindolol; | 1976 |
A within-patient comparison of bethanidine, methyldopa and propranolol in the treatment of hypertension.
Topics: Bethanidine; Clinical Trials as Topic; Diuretics; Guanidines; Humans; Hypertension; Methyldopa; Phys | 1976 |
Medical Research Council's Treatment Trial for mild hypertension: an interim report.
Topics: Adult; Bendroflumethiazide; Clinical Trials as Topic; Female; Humans; Hypertension; Male; Middle Age | 1976 |
A cross-over study between hydrallazine and prazosin.
Topics: Clinical Trials as Topic; Humans; Hydralazine; Hypertension; Prazosin; Propranolol; Quinazolines | 1976 |
The use of minoxidil, an experimental arteriolar dilator, in 510 patients with refractory hypertension.
Topics: Clinical Trials as Topic; Diuretics; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hyp | 1975 |
A comparison of propranolol and compound RO3-4787 in the treatment of arterial hypertension in man.
Topics: Adult; Aged; Benzofurans; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Drug Evalua | 1975 |
Long-term propranolol treatment of resistant arterial hypertension in haemodialysed patients.
Topics: Adult; Clinical Trials as Topic; Clonidine; Dose-Response Relationship, Drug; Drug Therapy, Combinat | 1975 |
Blood pressure decrease and responsiveness to renin-releasing stimuli under increasing doses of propranolol in patients with essential hypertension.
Topics: Blood Pressure; Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; Hypertension; Po | 1975 |
Changes in plasma renin activity and blood pressure after acute and chronic administration of beta-adrenergic receptor-blocking drugs.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Humans; Hypertension; Ma | 1975 |
Some haemodynamic effects of compound AH 5158 compared with propranolol, propranolol plus hydrallazine, and diazoxide: the use of AH 5158 in the treatment of hypertension.
Topics: Blood Pressure; Cardiac Output; Clinical Trials as Topic; Diazoxide; Drug Therapy, Combination; Etha | 1975 |
Minoxidil treatment of severe hypertension.
Topics: Adult; Blood Pressure; Blood Urea Nitrogen; Body Weight; Diuretics; Drug Therapy, Combination; Elect | 1975 |
Antihypertensive effect and side-effects of treatment with beta blockers- a comparative study between oxprenolol and propranolol.
Topics: Adult; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Oxprenolol; Prop | 1976 |
Heart rate responses during treatment of hypertension with propranolol. The clinical usefulness of the nitroglycerin test.
Topics: Adult; Aged; Clinical Trials as Topic; Heart Rate; Humans; Hypertension; Hypotension, Orthostatic; M | 1976 |
[Triamterene in the treatment of hypertension with hydrochlorothiazide and propranolol (author's transl)].
Topics: Acid-Base Equilibrium; Adult; Aged; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; | 1977 |
Effect of atenolol on exercise haemodynamics in angina pectoris and hypertension (abstract).
Topics: Angina Pectoris; Atenolol; Hemodynamics; Humans; Hypertension; Physical Exertion; Propanolamines; Pr | 1977 |
Antihypertensive effect and side-effects of bendroflumethiazide and propranolol.
Topics: Bendroflumethiazide; Blood Glucose; Blood Pressure; Heart Rate; Humans; Hypertension; Insulin; Male; | 1976 |
[Hemodynamic changes under metoprolol compared to propranolol in hypertensive patients].
Topics: Adult; Heart Rate; Humans; Hypertension; Metoprolol; Middle Aged; Propanolamines; Propranolol; Renin | 1976 |
The problems of morbidity and therapy in borderline hypertension.
Topics: Adult; Bendroflumethiazide; Blood Pressure; Female; Humans; Hypertension; Male; Middle Aged; Persona | 1976 |
Serum dopamine beta-hydroxylase activity in essential hypertension.
Topics: Dopamine beta-Hydroxylase; Humans; Hypertension; Phentolamine; Propranolol | 1976 |
Effects of intravenous labetalol on blood pressure, angiotensin II and aldosterone in hypertension: comparison with propranolol.
Topics: Aldosterone; Angiotensin II; Depression, Chemical; Ethanolamines; Heart Rate; Humans; Hypertension; | 1976 |
Combined alpha- and beta-adrenoreceptor blockade in hypertension: a controlled trial of labetalol (AH 5158) compared with propranolol and placebo.
Topics: Adult; Aged; Ethanolamines; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Physical Exe | 1976 |
Plasma renin activity and blood pressure during long term treatment with propranolol and diuretic.
Topics: Adult; Bendroflumethiazide; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hypertension | 1976 |
Treatment of hypertension with an antihypertensive agent possessing vasodilator activity.
Topics: Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Drug Synergism; Drug Therapy, Com | 1975 |
Effect of salt depletion and propranolol on blood pressure and plasma renin activity in various forms of hypertension.
Topics: Adult; Aged; Blood Pressure; Body Weight; Bromine; Chlorthalidone; Clinical Trials as Topic; Diet, S | 1975 |
[Inderal in the treatment of high blood pressure].
Topics: Adult; Aged; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Hypertension; Male; Middle A | 1975 |
Clinical application of new antihypertensive drugs.
Topics: Antihypertensive Agents; Bethanidine; Clinical Trials as Topic; Diazoxide; Humans; Hypertension; Imi | 1975 |
Intrapatient comparison of treatment with chlorthalidone, spironolactone and propranolol in normoreninemic essential hypertension.
Topics: Adult; Aldosterone; Blood Pressure; Body Weight; Chlorthalidone; Clinical Trials as Topic; Creatinin | 1975 |
[Antihypertensive effect and adverse effects of treatment with beta-blocking agents].
Topics: Adult; Clinical Trials as Topic; Diarrhea; Dyspnea; Female; Humans; Hypertension; Male; Middle Aged; | 1975 |
Effect of beta adrenergic blocking agents (alprenolol and propranolol) in essential hypertension.
Topics: Adult; Alprenolol; Antihypertensive Agents; Drug Evaluation; Female; Heart Rate; Humans; Hypertensio | 1975 |
Letter: Paradoxical effect of pindolol.
Topics: Dose-Response Relationship, Drug; Humans; Hypertension; Pindolol; Propranolol | 1975 |
Letter: Prazosin in treatment of hypertension.
Topics: Humans; Hydralazine; Hypertension; Male; Piperazines; Propranolol; Quinazolines | 1975 |
["Crossover" double-blind study on the antihypertensive effect of propranolol and practolol].
Topics: Adult; Antihypertensive Agents; Blood Pressure; Female; Humans; Hypertension; Male; Middle Aged; Pra | 1975 |
Acute hemodynamic effects of carvedilol in comparison with propranolol in patients with coronary heart disease.
Topics: Adrenergic beta-Antagonists; Adult; Angioplasty, Balloon, Coronary; Antihypertensive Agents; Carbazo | 1992 |
The influence of different beta-blocking drugs on the peripheral circulation in Raynaud's phenomenon and in hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Blood Flow Velocity; Blood Pressure; Double-Blind Method; Female | 1992 |
Metabolic effects of pindolol and propranolol in a double-blind cross-over study in hypertensive patients.
Topics: Aged; Double-Blind Method; Female; Glucose; Humans; Hypertension; Insulin; Lipids; Lipoproteins; Mal | 1992 |
Blood pressure lowering and cerebral blood flow: a comparison of the effects of carvedilol and propranolol on the cerebral circulation in hypertensive patients.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pr | 1992 |
[The efficacy of nitrendipine in patients with stable arterial hypertension. The data from a cooperative study in the USSR. The Working Group for the Cooperative Study of Nitrendipine].
Topics: Adult; Chi-Square Distribution; Drug Tolerance; Humans; Hydrochlorothiazide; Hypertension; Lipids; M | 1992 |
[Evaluation of the effectiveness of delayed-action propranolol in the treatment of arterial hypertension].
Topics: Adult; Blood Pressure; Delayed-Action Preparations; Drug Administration Schedule; Female; Heart Rate | 1992 |
[Effects of furosemide, propranolol and nifedipine on urinary excretion of Tamm-Horsfall protein in patients with arterial hypertension].
Topics: Adult; Circadian Rhythm; Female; Furosemide; Humans; Hypertension; Male; Middle Aged; Mucoproteins; | 1992 |
Relation of hostility to medication adherence, symptom complaints, and blood pressure reduction in a clinical field trial of antihypertensive medication.
Topics: Adult; Anger; Antihypertensive Agents; Blood Pressure; Captopril; Hostility; Humans; Hypertension; M | 1992 |
Calcium entry blockade and adrenergic vascular reactivity in hypertensives: differences between nicardipine and diltiazem.
Topics: Adrenergic alpha-Antagonists; Adult; Biological Transport; Blood Vessels; Calcium Channel Blockers; | 1991 |
Comparison of the new alpha 1-blocker alfuzosin with propranolol as first-line therapy in hypertension.
Topics: Adrenergic alpha-Antagonists; Adult; Antihypertensive Agents; Blood Pressure; Double-Blind Method; E | 1991 |
Isotonic and isometric responses of blood pressure and heart rate in mild to moderate hypertension with isradipine and propranolol.
Topics: Adult; Aged; Blood Pressure; Calcium Channel Blockers; Clinical Trials as Topic; Dose-Response Relat | 1990 |
Hemodynamic effects of brefanolol and propranolol assessed by noninvasive methods in patients with arterial hypertension.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Cardiac Output; Cardiography, Impedance; Ethanolamines; | 1990 |
Clinical pharmacodynamic studies with cilazapril and a combination of cilazapril and propranolol.
Topics: Adolescent; Adult; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cardiac | 1991 |
Does antihypertensive therapy affect the natural protection against thrombosis?
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Fi | 1991 |
Superiority of nonpharmacologic therapy compared to propranolol and placebo in men with mild hypertension: a randomized, prospective trial.
Topics: Diet, Reducing; Diet, Sodium-Restricted; Double-Blind Method; Exercise Therapy; Humans; Hypertension | 1992 |
[Effects of verapamil and propranolol on the left-ventricular diastolic function in patients with primary arterial hypertension].
Topics: Adult; Blood Flow Velocity; Diastole; Echocardiography, Doppler; Female; Humans; Hypertension; Male; | 1991 |
[Screening of single doses of the main antihypertensive drugs at rest and during various exercise tests in patients with hypertension].
Topics: Adult; Blood Pressure; Drug Evaluation; Exercise; Exercise Test; Humans; Hydrochlorothiazide; Hypert | 1991 |
[The results of the comparative study of nadolol, propranolol, prazosin and hydrochlorothiazide in patients with arterial hypertension in a 12-month stepped-plan treatment (cooperative research). The Working Group of the Cooperative Program to Study New P
Topics: Adult; Blood Pressure; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Nadolol; Prazos | 1991 |
The results of the comparative study of nadolol, propranolol, prazosin and hydrochlorothiazide in patients with arterial hypertension in a 12-month stepped-plan treatment (cooperative research). The Working Group of the Cooperative Program to Study New Pr
Topics: Adult; Blood Pressure; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Male; M | 1991 |
Home blood pressure monitoring: advantages and limitations.
Topics: Blood Pressure Determination; Clonidine; Coronary Disease; Double-Blind Method; Humans; Hypertension | 1991 |
[Comparison of the effects of diazepam, nifedipine, propranolol and a combination of nifedipine and propranolol, by sublingual administration, in patients with hypertensive crisis].
Topics: Administration, Sublingual; Adult; Aged; Blood Pressure; Diazepam; Drug Therapy, Combination; Female | 1991 |
Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism.
Topics: Antihypertensive Agents; Atenolol; Blood Pressure; Captopril; Double-Blind Method; Glucose; Humans; | 1991 |
[The hemodynamic effects of isradipine and nifedipine in hypertension].
Topics: Adult; Blood Pressure; Cardiac Output; Dihydropyridines; Female; Heart; Heart Function Tests; Humans | 1991 |
[Metabolic effects of chlorothiazide and propranolol on essential hypertension--a double-blind, cross-over design clinical trial].
Topics: Adult; Blood Pressure; Chlorothiazide; Double-Blind Method; Female; Heart Rate; Humans; Hypertension | 1991 |
[Comparative effectiveness of various beta adrenergic blockaders in hypertension].
Topics: Acebutolol; Adult; Blood Pressure; Humans; Hypertension; Male; Middle Aged; Penbutolol; Propranolol | 1991 |
[Value of isometric and dynamic exercise tests with standard drug doses for selecting long-term antihypertensive treatment with vasodilators, adrenergic beta blockaders and diuretics].
Topics: Adult; Exercise; Exercise Test; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Nifedi | 1991 |
[State of the hypophyseal-gonadal system in patients with hypertension during long-term treatment with nadolol and anaprilin].
Topics: Adult; Estradiol; Follicle Stimulating Hormone; Humans; Hypertension; Luteinizing Hormone; Male; Mid | 1991 |
Nicardipine as antihypertensive monotherapy: positive effects on quality of life.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Metho | 1991 |
British MRC trial of treatment for mild hypertension--a more favorable interpretation.
Topics: Bendroflumethiazide; Cerebrovascular Disorders; Dose-Response Relationship, Drug; England; Humans; H | 1991 |
A pressor effect of noncardioselective beta blockers in mildly hypertensive patients during surgery under anesthesia.
Topics: Aged; Anesthesia, General; Blood Pressure; Female; Humans; Hypertension; Male; Metoprolol; Middle Ag | 1991 |
Effect of intrinsic sympathomimetic activity on the ability of hypertensive patients to derive a cardiorespiratory training effect during chronic beta-blockade.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Combined Modality Therapy; Double-Blind Method; Exercis | 1990 |
Comparative effects of celiprolol, propranolol, oxprenolol, and atenolol on respiratory function in hypertensive patients with chronic obstructive lung disease.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Celiprolol; Forced Expiratory Volume | 1990 |
[Effect of anapriline on myocardial contraction and systemic vascular resistance in patients with stage II hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Humans; Hypertension; Middle Aged; Myoc | 1990 |
Stroke volume during submaximal exercise in endurance-trained normotensive subjects and in untrained hypertensive subjects with beta blockade (propranolol and pindolol).
Topics: Adult; Cardiac Output; Double-Blind Method; Exercise; Exercise Test; Heart Rate; Humans; Hypertensio | 1991 |
Comparison of the effects of guanadrel sulfate and propranolol on blood pressure, functional capacity, serum lipoproteins and glucose in systemic hypertension.
Topics: Antihypertensive Agents; Blood Glucose; Cholesterol; Double-Blind Method; Exercise Test; Female; Gua | 1991 |
Acute hemodynamic effects of pinacidil in hypertensive patients with and without propranolol pretreatment.
Topics: Adult; Antihypertensive Agents; Double-Blind Method; Female; Forearm; Guanidines; Heart Rate; Hemody | 1991 |
[Effect of reserpine and propranolol on mental work capacity and psychological status of workers with hypertension after exposure to neuro-emotional stress].
Topics: Humans; Hypertension; Male; Occupational Diseases; Propranolol; Psychomotor Performance; Psychophysi | 1991 |
Comparative effects of propranolol and diltiazem on systolic and diastolic left ventricular function in essential hypertension.
Topics: Blood Pressure; Diltiazem; Double-Blind Method; Echocardiography; Female; Heart Rate; Humans; Hypert | 1990 |
[Comparative study of hypotensive effects of foridon and corinfar (results of the single-blind placebo-controlled study)].
Topics: Adult; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Humans; Hypertension; Mid | 1990 |
[Effect of long-term therapy with prazosin/propranolol on blood pressure and cardiopulmonary function in essential hypertension].
Topics: Adult; Blood Pressure; Drug Therapy, Combination; Echocardiography; Electrocardiography; Exercise Te | 1990 |
Propranolol and depression: evidence from the antihypertensive trials.
Topics: Clinical Trials as Topic; Depressive Disorder; Humans; Hypertension; Meta-Analysis as Topic; Propran | 1990 |
Fish oil amplifies the effect of propranolol in mild essential hypertension.
Topics: Adult; Blood Pressure; Cholesterol; Docosahexaenoic Acids; Drug Combinations; Drug Synergism; Eicosa | 1990 |
Disorders of decision in affective disease: an effect of beta-adrenergic dysfunction?
Topics: Arousal; Attention; Bipolar Disorder; Brain; Clinical Trials as Topic; Decision Making; Depressive D | 1990 |
Influences of propranolol and atenolol on the circadian rhythm of heart rate in elderly patients with essential hypertension.
Topics: Aged; Aged, 80 and over; Atenolol; Blood Pressure; Circadian Rhythm; Electrocardiography; Female; He | 1990 |
Clinical efficacy and quality of life with indapamide alone or in combination with beta blockers or angiotensin-converting enzyme inhibitors.
Topics: Adult; Aged; Blood Pressure; Captopril; Consumer Behavior; Diuretics; Drug Combinations; Drug Tolera | 1990 |
Evaluation of the efficacy and safety of enalapril plus hydrochlorothiazide plus methyldopa vs standard triple therapy in the treatment of moderate to severe hypertension: results from a multicentre study.
Topics: Blood Pressure; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Enalapril; Female; | 1990 |
The response of the light reflex of retinal vessels to reduced blood pressure in hypertensive patients.
Topics: Adult; Analysis of Variance; Blood Pressure; Densitometry; Double-Blind Method; Female; Fundus Oculi | 1990 |
Antihypertensive therapy and quality of life: a comparison of atenolol, captopril, enalapril and propranolol.
Topics: Adult; Aged; Analysis of Variance; Atenolol; Captopril; Cognition; Double-Blind Method; Enalapril; H | 1990 |
[Comparative evaluation of the effects of isoptin and obsidan on central and cerebral hemodynamics in patients with hypertension during physical exercise].
Topics: Adult; Cerebrovascular Circulation; Clinical Trials as Topic; Exercise; Exercise Test; Female; Hemod | 1990 |
[Role of a beta adrenergic blocking agent nadolol (corgard) in prevention of arterial hypertension: a 6-month treatment (cooperative study)].
Topics: Adult; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Mult | 1990 |
[Effect of adrenergic beta receptor blockaders and thiazide diuretics on gastric acid and gastrin secretion in patients with essential hypertension].
Topics: Adult; Antacids; Depression, Chemical; Female; Gastric Acid; Gastrins; Humans; Hydrochlorothiazide; | 1990 |
Influence of converting enzyme inhibition on glomerular filtration rate and proteinuria.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Therapy, Combination; Female; Furos | 1990 |
[Effect of the treatment on hemodynamic indicators and plasma testosterone level in patients with juvenile hypertension].
Topics: Adolescent; Adult; Antihypertensive Agents; Hemodynamics; Humans; Hypertension; Nifedipine; Proprano | 1990 |
Changes in plasma free fatty acids and glycerols during prolonged exercise in trained and hypertensive persons taking propranolol and pindolol.
Topics: Adult; Double-Blind Method; Fatty Acids, Nonesterified; Glycerol; Humans; Hypertension; Male; Oxygen | 1990 |
CNS side effects of centrally-active antihypertensive agents: a prospective, placebo-controlled study of sleep, mood state, and cognitive and sexual function in hypertensive males.
Topics: Adult; Affect; Aged; Antihypertensive Agents; Central Nervous System Diseases; Clonidine; Cognition; | 1990 |
Nicardipine and propranolol in the treatment of hypertension: similar antihypertensive but dissimilar hemodynamic actions.
Topics: Antihypertensive Agents; Exercise Test; Hemodynamics; Humans; Hypertension; Middle Aged; Nicardipine | 1990 |
Combined low-dose medication and primary intervention over a 30-month period for sustained high blood pressure in childhood.
Topics: Adolescent; Black People; Child; Chlorthalidone; Drug Therapy, Combination; Female; Follow-Up Studie | 1990 |
The effect of single-dose phenylpropanolamine on blood pressure in patients with hypertension controlled by beta blockers.
Topics: Adult; Atenolol; Blood Pressure; Double-Blind Method; Drug Administration Schedule; Humans; Hyperten | 1990 |
Effects of diltiazem or propranolol during exercise training of hypertensive men.
Topics: Adolescent; Adult; Blood Pressure; Diltiazem; Exercise; Exercise Test; Heart Rate; Humans; Hypertens | 1990 |
Thermoregulation in mildly hypertensive men during beta-adrenergic blockade.
Topics: Analysis of Variance; Body Temperature Regulation; Hemodynamics; Humans; Hypertension; Male; Metopro | 1990 |
Cardiac and skeletal muscle adaptations to training in systemic hypertension and effect of beta blockade (metoprolol or propranolol).
Topics: Adaptation, Physiological; Adult; Exercise Therapy; Female; Heart; Hemodynamics; Humans; Hypertensio | 1990 |
Self-reported side effects from antihypertensive drugs. A clinical trial. Quality of Life Research Group.
Topics: Adult; Age Factors; Aged; Antihypertensive Agents; Captopril; Clinical Trials as Topic; Double-Blind | 1990 |
Double-blind comparison of ketanserin with propranolol in hypertensive patients: interim report.
Topics: Adult; Aged; Antihypertensive Agents; Body Weight; Clinical Trials as Topic; Double-Blind Method; Fe | 1985 |
Celiprolol, atenolol and propranolol: a comparison of pulmonary effects in asthmatic patients.
Topics: Adrenergic beta-Antagonists; Asthma; Atenolol; Celiprolol; Forced Expiratory Volume; Humans; Hyperte | 1986 |
Celiprolol in the treatment of hypertension: a comparison with propranolol.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Celiprolol; Clinical Trials as Topic; Double-Blind Method; | 1986 |
Bronchosparing properties of celiprolol, a new beta 1, alpha 2-blocker, in propranolol-sensitive asthmatic patients.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Asthma; Celiprolol; Forced Expirat | 1986 |
Ketanserin versus propranolol in the treatment of mild and moderate essential hypertension: corroboration with ambulatory blood pressure monitoring.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hypertension; | 1987 |
Serum cholesterol during ketanserin and propranolol administration in hypertensive patients.
Topics: Body Weight; Cholesterol; Female; Heart Rate; Humans; Hypertension; Ketanserin; Lipoproteins, HDL; L | 1987 |
Cerebrospinal fluid norepinephrine levels in essential hypertension: effects of drug treatment and withdrawal.
Topics: Adult; Clonidine; Dopamine; Double-Blind Method; Epinephrine; Humans; Hypertension; Methyldopa; Midd | 1987 |
Randomized, double-blind comparison of transdermal clonidine with oral propranolol.
Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Aged; Blood Pressure; Clonidine; | 1987 |
Double-blind comparison of ketanserin and propranolol in hypertensive patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Blood Pressure; Body Weight; Chromatography, High | 1988 |
Prolonged calcium channel blocker therapy of hypertension.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Hy | 1988 |
Comparison of quality of life on nitrendipine and propranolol.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hypertension; Male; Midd | 1988 |
Antihypertensive therapy with nitrendipine: comparison with hydrochlorothiazide and propranolol.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hydrochl | 1988 |
The efficacy and duration of action of sustained-release verapamil in essential hypertension.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Met | 1989 |
Effects of pindolol and propranolol on blood lipids in hypertensive patients.
Topics: Aged; Blood Pressure; Female; Humans; Hypertension; Lipids; Male; Middle Aged; Pindolol; Propranolol | 1989 |
Prostacyclin synthesis is increased during propranolol therapy for essential hypertension.
Topics: 6-Ketoprostaglandin F1 alpha; Blood Pressure; Clinical Trials as Topic; Creatinine; Double-Blind Met | 1989 |
Haemodynamic and hormonal effects of cilazapril in comparison with propranolol in healthy subjects and in hypertensive patients.
Topics: Adult; Aged; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cardiac Output | 1989 |
Pharmacokinetic and pharmacodynamic interactions between the ACE inhibitor cilazapril and beta-adrenoceptor antagonist propranolol in healthy subjects and in hypertensive patients.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cilazapril; Female; Heart Rate; Hum | 1989 |
Isradipine vs propranolol in hydrochlorothiazide-treated hypertensives. A multicenter evaluation.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Administration Sched | 1989 |
Influence of the angiotensin converting enzyme inhibitor cilazapril, the beta-blocker propranolol and their combination on haemodynamics in hypertension.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Cilazapril; Drug Therapy, Combination; Female; Hemo | 1989 |
Fosenopril, an angiotensin-converting enzyme inhibitor, and propranolol: comparative effects at rest and exercise on blood pressure, hormonal variables, and plasma potassium in essential hypertension.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Double-Blind Method; Exercise | 1989 |
Intrinsic sympathomimetic activity counteracts beta-blocker inhibition of renin activation.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Double-Blind Method; Female; Heart Rate; Humans; Hypert | 1989 |
Effects of alpha- and beta-adrenergic antagonists on plasma apolipoproteins and forearm blood flow in patients with mild hypertension.
Topics: Adult; Apolipoproteins; Clinical Trials as Topic; Double-Blind Method; Female; Forearm; Humans; Hydr | 1989 |
Lipid effects of celiprolol, a new cardioselective beta-blocker, versus propranolol.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Celiprolol; Cholesterol; Chromatography, High Pressure Liq | 1989 |
Clinical effects of low-dose captopril plus a thiazide diuretic on mild to moderate essential hypertension: a multicenter double-blind comparison with propranolol. Captopril Research Group of Japan.
Topics: Adult; Aged; Benzothiadiazines; Blood Pressure; Captopril; Clinical Trials as Topic; Diuretics; Doub | 1985 |
Captopril: contrasting effects of adding hydrochlorothiazide, propranolol, or nifedipine.
Topics: Blood Pressure; Body Weight; Captopril; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hype | 1985 |
Treatment of hypertension with a fixed ratio combination of long-acting propranolol and bendrofluazide, and influence of age of the subject.
Topics: Adult; Age Factors; Aged; Aspartate Aminotransferases; Bendroflumethiazide; Delayed-Action Preparati | 1989 |
Evaluation of the efficacy of prazosin versus propranolol as initial antihypertensive therapy.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Female; Heart Rate; Humans; Hypertension; Lip | 1989 |
Nicardipine and propranolol in the treatment of essential hypertension.
Topics: Adult; Aged; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hyperte | 1989 |
Once-daily propranolol for hypertension: a comparison of regular-release, long-acting, and generic formulations.
Topics: Adult; Aged; Clinical Trials as Topic; Cross-Sectional Studies; Delayed-Action Preparations; Drug Ad | 1989 |
Effects of reduction in drugs or dosage after long-term control of systemic hypertension.
Topics: Antihypertensive Agents; Clinical Trials as Topic; Clonidine; Drug Administration Schedule; Follow-U | 1989 |
The effects of verapamil, diltiazem, nifedipine and propranolol on metabolic control in hypertensives with non-insulin dependent diabetes mellitus.
Topics: Aged; Blood Glucose; Blood Pressure; Cholesterol; Diabetes Mellitus, Type 2; Diltiazem; Female; Fruc | 1989 |
Dilevalol compared with propranolol and placebo for systemic hypertension.
Topics: Aged; Double-Blind Method; Drug Administration Schedule; Female; Heart Rate; Humans; Hypertension; L | 1989 |
Labetalol compared with propranolol in patients with both angina pectoris and systemic hypertension: a double-blind study.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Exercis | 1989 |
Lack of interaction between sulindac or naproxen and propranolol in hypertensive patients.
Topics: Blood Pressure; Blood Urea Nitrogen; Body Weight; Clinical Trials as Topic; Creatinine; Drug Interac | 1989 |
Comparison of the efficacy and acceptability of nicardipine and propranolol, alone and in combination, in mild to moderate hypertension.
Topics: Adult; Aged; Blood Chemical Analysis; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; | 1989 |
Practical utility of blood pressure readings obtained by self-determination.
Topics: Adult; Blood Pressure Determination; Clinical Trials as Topic; Clonidine; Double-Blind Method; Femal | 1989 |
The effects of verapamil and propranolol on quality of life in hypertension.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Humans; Hypertension; Middle Aged; Patient Dropouts | 1989 |
Comparative effects of bunazosin and propranolol on serum lipids and apolipoproteins in patients with essential hypertension.
Topics: Apolipoproteins; Blood Pressure; Female; Humans; Hypertension; Lipids; Lipoproteins; Male; Middle Ag | 1989 |
Discrepancy between clinic and ambulatory blood pressure measurement in the evaluation of two antihypertensive agents.
Topics: Ambulatory Care; Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Double-Blind | 1989 |
A multicenter double-blind study of the efficacy and safety of once and twice daily dilevalol compared to propranolol.
Topics: Adolescent; Adult; Aged; Blood Pressure; Double-Blind Method; Drug Administration Schedule; Female; | 1989 |
Clinical usefulness of low-dose captopril on mild to moderate essential hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzothiadiazines; Captopril; Clinical Trials as Topic; Di | 1989 |
An assessment of Half-Inderal LA and Inderal LA in the treatment of hypertension in elderly subjects.
Topics: Aged; Bendroflumethiazide; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Bli | 1989 |
[The comparative results of a short course of nadolol and propranolol treatment of arterial hypertension patients (cooperative research). The Working Group of the Cooperative Program for the Study of New Preparations in Preventing Arterial Hypertension].
Topics: Adult; Blood Pressure; Electrocardiography; Glucose Tolerance Test; Heart Rate; Humans; Hypertension | 1989 |
[Dose-reduced antihypertensive agents--use in complex nonmedicamentous therapy of hypertension].
Topics: Adult; Combined Modality Therapy; Dose-Response Relationship, Drug; Feeding Behavior; Humans; Hypert | 1989 |
Comparison of the effects of pindolol and propranolol on exercise performance in young men with systemic hypertension.
Topics: Adult; Blood Pressure; Cardiac Output; Double-Blind Method; Exercise; Exercise Test; Heart Rate; Hum | 1989 |
[Hemodynamic effects of hydrochlorothiazide, propranolol and a combination of pindolol and clopamide in patients with essential hypertension].
Topics: Clopamide; Drug Combinations; Hemodynamics; Humans; Hydrochlorothiazide; Hypertension; Pindolol; Pro | 1989 |
Nifedipine, but not propranolol, improves left ventricular systolic and diastolic function in patients with hypertension.
Topics: Adult; Aged; Blood Pressure; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; M | 1989 |
The nifedipine gastrointestinal therapeutic system in the treatment of hypertension.
Topics: Chemistry, Pharmaceutical; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Hyperte | 1989 |
[Modification of vasoprotective omega-3-fatty acids--a previously unknown side effect of propranolol therapy?].
Topics: Adult; Eicosapentaenoic Acid; Female; Humans; Hypertension; Male; Middle Aged; Propranolol | 1988 |
Cardiovascular responses to verapamil and propranolol in hypertensive patients.
Topics: Adult; Aged; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Female; Hemodynamics; H | 1985 |
Aggravation by propranolol of hyperglycaemic effect of hydrochlorothiazide in type II diabetics without alteration of insulin secretion.
Topics: Aged; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Synergism; Drug Thera | 1985 |
Acebutolol in essential hypertension: results of two multicenter studies against placebo and propranolol.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Aged; Body Weight; Clinical Trials as Topic; Double- | 1985 |
Effects of age and race on clinical response to acebutolol in essential hypertension.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Black People; Clinical Trials as | 1985 |
A double-blind comparison of acebutolol (Sectral) and propranolol (Inderal) in the treatment of hypertension in black Nigerian patients.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Aged; Black People; Blood Pressure; Body Weight; Dos | 1985 |
Cardioselective and nonselective beta-adrenoceptor blocking drugs in hypertension: a comparison of their effect on blood pressure during mental and physical activity.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Bicycling; Blood Pressure; Female; H | 1985 |
MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party.
Topics: Adult; Bendroflumethiazide; Blood Pressure; Cerebrovascular Disorders; Clinical Trials as Topic; Cor | 1985 |
A comparison of celiprolol and propranolol in the treatment of hypertension in one hundred and seventy-nine subjects.
Topics: Adrenergic beta-Antagonists; Celiprolol; Clinical Trials as Topic; Double-Blind Method; Humans; Hype | 1985 |
[Effect of celiprolol compared to propranolol on thyroid metabolism].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Celiprolol; Female; Humans; Hypertension; Male; Middle Age | 1985 |
Beta blockade and intermittent claudication.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Clinical Trials as Topic; Coronary Disease; Female; Gait; | 1985 |
Coronary heart disease and treatment of hypertension. Some Oslo Study data.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Blood Glucose; Carbohydrate | 1986 |
Calcium antagonists and beta blockers in the control of mild to moderate systemic hypertension, with particular reference to verapamil and propranolol.
Topics: Adrenergic beta-Antagonists; Atrioventricular Node; Calcium Channel Blockers; Clinical Trials as Top | 1986 |
Oslo Hypertension Study.
Topics: Adrenergic beta-Antagonists; Adult; Blood Glucose; Cholesterol, HDL; Coronary Disease; Follow-Up Stu | 1986 |
Blood pressure and catecholamines following exercise during selective beta-blockade in hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Catecholamines; Epinephrine; Female; Heart Rate; | 1986 |
[Hemodynamic study, under hot and cold conditions, of the digital artery in arterial hypertension and the effects of cardioselective and non-cardioselective beta blocker treatment].
Topics: Adrenergic beta-Agonists; Adult; Arteries; Cold Temperature; Female; Fingers; Hemodynamics; Hot Temp | 1986 |
Comparative tolerability of labetalol versus propranolol, atenolol, pindolol, metoprolol, and nadolol.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Clinical Trials as Topic; Female; Humans; Hypert | 1986 |
Acute central and renal haemodynamic responses to tertatolol and propranolol in patients with arterial hypertension following head injury.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Cardiac Output; Craniocerebral Trauma; Female; | 1986 |
Is beta 1-antagonism essential for the antihypertensive action of beta-blockers?
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Clinical Trials as Topic; Double-Blind | 1987 |
Renal hemodynamic changes after beta-blocker-diuretic combination therapy in azotemic hypertensive patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Drug Therapy, Combination; Glomerular Filtration Rate; Hum | 1986 |
Responses to mental stress and physical provocations before and during long term treatment of hypertensive patients with beta-adrenoceptor blockers or hydrochlorothiazide.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Cyclic AMP; Epinephrine; Female; Glycerol; Heart | 1987 |
Long-term antihypertensive therapy with beta-blockers: submaximal exercise capacity and metabolic effects during exercise.
Topics: Adrenergic beta-Antagonists; Adult; Electrocardiography; Energy Metabolism; Exercise Test; Female; H | 1987 |
Efficacy and safety of sustained-release diltiazem as replacement therapy for beta blockers and diuretics for stable angina pectoris and coexisting essential hypertension: a multicenter trial.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Benzothiadiazines; Blood Pressure; Clinic | 1987 |
The blood pressure responses of thiazide-resistant hypertensives to a once-a-day bevantolol regimen.
Topics: Adrenergic beta-Antagonists; Adult; Benzothiadiazines; Blood Pressure; Diuretics; Drug Administratio | 1987 |
Antihypertensive therapy with celiprolol: a new cardioselective beta blocker.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Celiprolol; Clinical Trials as Topic | 1988 |
Coronary heart disease in the Medical Research Council trial of treatment of mild hypertension. Medical Research Council Working Party on Mild Hypertension.
Topics: Adult; Bendroflumethiazide; Clinical Trials as Topic; Coronary Disease; Death, Sudden; Female; Human | 1988 |
[Effect of different beta-receptor blockers on the respiratory function of patients with chronic obstructive pulmonary disease and arterial hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Betaxolol; Blood Pressure; Female; Heart Rate; Humans; Hypertens | 1987 |
Effects of beta-blockade and exercise on cardiovascular and cognitive functioning.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Diastole; Heart Rate; Hemodynamics; Hu | 1988 |
Bevantolol vs propranolol: a double-blind controlled trial in essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Clinical Trials as Topic; Double-Blind Met | 1988 |
Comparison of betaxolol, a new beta 1-adrenergic antagonist, to propranolol in the treatment of mild to moderate hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Betaxolol; Clinical Trials as Topic; Female; Heart Rate; H | 1988 |
Hypertension, exercise, and beta-adrenergic blockade.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Combined Modality Therapy; Double-Blind Method; | 1988 |
Therapeutic effect and complication profile of clonidine-beta-blocker combinations.
Topics: Adrenergic beta-Antagonists; Cardiovascular Diseases; Clonidine; Drug Combinations; Humans; Hyperten | 1988 |
Safety profile of celiprolol.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Antihypertensive Agents; Atenolol; Celiprolol; Chlorth | 1988 |
Effects of acute and chronic beta-adrenoceptor blockade on baroreflex sensitivity in humans.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Blood Pressure; Female; Heart Rate; | 1988 |
Serotonergic blockade compared with beta-adrenergic blockade in systemic hypertension: a double-blind comparison of ketanserin with propranolol.
Topics: Adrenergic beta-Antagonists; Adult; Bleeding Time; Blood Platelets; Blood Pressure; Double-Blind Met | 1988 |
Compound ICI 118,551, a beta 2-adrenoceptor antagonist, lowers blood pressure.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Double-Blind Method; Humans; Hypertension; Isopr | 1985 |
Comparative effects of prazosin and propranolol on blood lipid profiles in hypertensive, hypercholesterolemic patients. Preliminary results.
Topics: Adult; Aged; Apoproteins; Blood Pressure; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholester | 1989 |
Assessment of the effects of alpha- and beta-blockade in hypertensive patients who smoke cigarettes.
Topics: Adult; Aged; Blood Pressure; Humans; Hypertension; Lipoproteins; Middle Aged; Prazosin; Propranolol; | 1989 |
Effects of antihypertensive therapy on blood pressure control, cognition, and reactivity. A placebo-controlled comparison of prazosin, propranolol, and hydrochlorothiazide.
Topics: Antihypertensive Agents; Blood Pressure; Cognition; Heart Rate; Humans; Hydrochlorothiazide; Hyperte | 1989 |
Hemodynamic and metabolic effects of the calcium channel blocking agent nitrendipine.
Topics: Administration, Oral; Adult; Aged; Blood Glucose; Blood Pressure; Cholesterol; Chromatography, High | 1986 |
[Comparative studies of the effect of a cardioselective and a noncardioselective beta-blocker on peripheral circulation in patients with arterial occlusive disease].
Topics: Aged; Arterial Occlusive Diseases; Blood Pressure; Celiprolol; Foot; Humans; Hypertension; Leg; Midd | 1986 |
Effects of ketanserin on ambulatory blood pressure monitoring in patients with essential hypertension.
Topics: Adult; Ambulatory Care; Blood Pressure Determination; Female; Humans; Hypertension; Ketanserin; Male | 1986 |
Non-surgical strategies to prevent death in coronary artery disease.
Topics: Adult; Angioplasty, Balloon; Cholesterol, Dietary; Clinical Trials as Topic; Coronary Disease; Femal | 1985 |
Effects of ketanserin on blood pressure, peripheral circulation and haemocoagulative parameters in essential hypertensives with or without arteriosclerosis obliterans of the lower limbs.
Topics: Adult; Antihypertensive Agents; Arteriosclerosis Obliterans; Blood Coagulation; Blood Pressure; Doub | 1986 |
Treatment of essential hypertension with PN 200-110 (isradipine).
Topics: Blood Pressure; Calcium Channel Blockers; Clinical Trials as Topic; Double-Blind Method; Drug Therap | 1987 |
Diltiazem-induced left ventricular mass regression in hypertensive patients.
Topics: Adult; Aged; Blood Pressure; Cardiomegaly; Clinical Trials as Topic; Delayed-Action Preparations; Di | 1987 |
Comparison of the antihypertensive effect of enalapril and propranolol in black South Africans.
Topics: Adult; Antihypertensive Agents; Black People; Blood Pressure; Clinical Trials as Topic; Dipeptides; | 1985 |
Long-term enalapril--a new converting enzyme inhibitor--in the treatment of mild to moderate essential hypertension, results of a worldwide multiclinic study. Comparing two ways of analyzing data.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Enalapril; Female; Human | 1985 |
Comparison of enalapril and propranolol in essential hypertension.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Enalapril; Female; Hormones; H | 1986 |
Effect of metoprolol and propranolol on platelet aggregation and cAMP level in hypertensive patients.
Topics: Adenosine Diphosphate; Adult; Aged; Cyclic AMP; Epinephrine; Female; Humans; Hypertension; Male; Met | 1986 |
Time course of changes in blood pressure, aldosterone and body fluids during enalapril treatment: a double-blind randomized study vs hydrochlorothiazide plus propranolol in essential hypertension.
Topics: Adult; Aldosterone; Blood Pressure; Body Fluids; Clinical Trials as Topic; Double-Blind Method; Drug | 1986 |
Volume (weight) loss and blood pressure response following thiazide diuretics.
Topics: Black People; Blood Pressure; Diuretics; Dose-Response Relationship, Drug; Humans; Hydrochlorothiazi | 1988 |
Propranolol increases prostacyclin synthesis in patients with essential hypertension.
Topics: Adult; Blood Pressure; Blood Vessels; Epoprostenol; Female; Humans; Hypertension; Indomethacin; Male | 1988 |
Double-blind study comparing indoramin and propranolol in the treatment of black patients with hypertension.
Topics: Adult; Amiloride; Black People; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Drug | 1988 |
Verapamil SR and propranolol LA: a comparison of efficacy and side effects in the treatment of mild to moderate hypertension.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Met | 1988 |
[Use of beta adrenergic receptor blockaders in industrial workers with neurocirculatory asthenia of the hypertensive type].
Topics: Adult; Clinical Trials as Topic; Female; Humans; Hypertension; Male; Middle Aged; Neurocirculatory A | 1988 |
Comparative double-blind study of ketanserin versus propranolol in the treatment of essential hypertension.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Female; Hu | 1988 |
Serum lipid changes in patients with mild to moderate essential hypertension taking nicardipine and propranolol.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hypertension; Lipids; Male; Mi | 1988 |
Effects of prazosin and propranolol on blood lipids and lipoproteins in hypertensive patients.
Topics: Adult; Aged; Apolipoprotein A-I; Apolipoproteins A; Blood Pressure; Cholesterol; Cholesterol, LDL; C | 1986 |
Memory performance by mild hypertensives following beta-adrenergic blockade.
Topics: Adult; Atenolol; Heart Rate; Humans; Hypertension; Male; Memory Disorders; Middle Aged; Propranolol; | 1986 |
The mild hypertension dilemma: results of the British MRC trial.
Topics: Adult; Antihypertensive Agents; Bendroflumethiazide; Cardiovascular Diseases; Cerebrovascular Disord | 1986 |
Effect of prazosin and propranolol on lipoproteins of hypertensive patients.
Topics: Adult; Aged; Apolipoprotein A-I; Apolipoproteins A; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; | 1987 |
Cost effectiveness of labetalol and propranolol in the treatment of hypertension among blacks.
Topics: Aged; Black People; Clinical Trials as Topic; Cost-Benefit Analysis; Female; Humans; Hypertension; L | 1987 |
Stroke and coronary heart disease in mild hypertension: risk factors and the value of treatment. Medical Research Council Working Party.
Topics: Adult; Age Factors; Bendroflumethiazide; Blood Pressure; Cerebrovascular Disorders; Coronary Disease | 1988 |
A novel therapeutic approach for reversal of left ventricular hypertrophy and blood pressure control in hypertensive patients treated with alpha-methyldopa or propranolol.
Topics: Adult; Blood Pressure; Cardiomegaly; Clinical Trials as Topic; Echocardiography; Female; Heart Rate; | 1985 |
Cigarette smoking interferes with treatment of hypertension.
Topics: Adult; Bendroflumethiazide; Black People; Double-Blind Method; Humans; Hydrochlorothiazide; Hyperten | 1988 |
A comparative study of Spiroprop and Moducren in the treatment of mild to moderate hypertension in general practice.
Topics: Adolescent; Amiloride; Antihypertensive Agents; Drug Combinations; Female; Humans; Hydrochlorothiazi | 1988 |
Changes in calcium metabolic indices during long-term treatment of patients with essential hypertension.
Topics: Adult; Bendroflumethiazide; Blood Pressure; Calcium; Fatty Acids, Nonesterified; Female; Humans; Hyp | 1988 |
Sexual symptoms in hypertensive patients. A clinical trial of antihypertensive medications.
Topics: Adult; Aged; Antihypertensive Agents; Captopril; Clinical Trials as Topic; Diuretics; Double-Blind M | 1988 |
A comparison of felodipine and propranolol as additions to hydrochlorothiazide in the treatment of hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; | 1988 |
Melatonin secretion related to side-effects of beta-blockers from the central nervous system.
Topics: Adult; Atenolol; Circadian Rhythm; Clinical Trials as Topic; Double-Blind Method; Humans; Hypertensi | 1988 |
Ventricular dysrhythmias in middle-aged hypertensive men treated either with a diuretic agent or a beta-blocker.
Topics: Aged; Amiloride; Arrhythmias, Cardiac; Bendroflumethiazide; Clinical Trials as Topic; Drug Combinati | 1987 |
Diltiazem and propranolol in mild to moderate essential hypertension as monotherapy or with hydrochlorothiazide.
Topics: Adult; Age Factors; Clinical Trials as Topic; Diltiazem; Double-Blind Method; Drug Resistance; Drug | 1987 |
Mild hypertension--a therapeutic dilemma. The results of the MRC trial in Britain.
Topics: Adult; Bendroflumethiazide; Cerebrovascular Disorders; Clinical Trials as Topic; Female; Humans; Hyp | 1987 |
A randomised double blind cross over trial of atenolol and propranolol in mild to moderate hypertension.
Topics: Adult; Aged; Atenolol; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hypertension; | 1987 |
Effects of antihypertensive medications on vitality and well-being.
Topics: Adaptation, Psychological; Antihypertensive Agents; Attitude to Health; Captopril; Clinical Trials a | 1987 |
A comparative study of conventional and long-acting formulations of propranolol in essential hypertension.
Topics: Clinical Trials as Topic; Dosage Forms; Double-Blind Method; Female; Hemodynamics; Humans; Hypertens | 1987 |
Labetalol compared with propranolol in the treatment of black hypertensive patients.
Topics: Adolescent; Adult; Aged; Black People; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, | 1987 |
An update on the Medical Research Council Hypertension Trial.
Topics: Adult; Bendroflumethiazide; Blood Pressure; Cerebrovascular Disorders; Clinical Trials as Topic; Fem | 1987 |
Nicardipine in the treatment of essential hypertension controlled 6-month-study comparing nicardipine with propranolol at rest and during exercise.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Electrocardiography; Female; Humans; Hyperten | 1987 |
Comparison of nicardipine and propranolol in the treatment of mild and moderate hypertension.
Topics: Adult; Blood Pressure; Body Weight; Cholesterol; Clinical Trials as Topic; Double-Blind Method; Huma | 1987 |
Oslo study: treatment of mild hypertension. A five-year controlled drug study.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Drug Therapy, Combination; | 1987 |
Further results of the MRC treatment trial for mild hypertension.
Topics: Bendroflumethiazide; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Disease; Death, S | 1987 |
Effects of calcium antagonism and beta-blockade on haemodynamic responses to stress.
Topics: Adult; Aged; Arousal; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, C | 1987 |
[The blood pressure-regulating role of the renin-angiotensin system in essential hypertension before and after emotional stress].
Topics: Adult; Blood Pressure; Heart Rate; Humans; Hypertension; Male; Propranolol; Renin; Renin-Angiotensin | 1987 |
Comparison of the onset of the antihypertensive action of pindolol and propranolol. A 24 h haemodynamic study.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Hemodynamics; Humans; Hypertension; Male; Middle Ag | 1987 |
Comparison of the effect of pindolol vs propranolol on the lipid profile in patients treated for hypertension.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Clinical Trials as Topic; Double-Blind Method; Hum | 1987 |
Results of MRC (UK) trial of drug therapy for mild hypertension.
Topics: Adult; Bendroflumethiazide; Blood Pressure; Cerebrovascular Disorders; Clinical Trials as Topic; Fem | 1987 |
Nitrendipine as an antihypertensive agent.
Topics: Adult; Aged; Ambulatory Care; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Female; | 1987 |
Double-blind comparison of Inderal LA (160 mg), Half-Inderal LA (80 mg), and Half-Inderal LA plus bendrofluazide (2.5 mg) in the treatment of elderly hypertensive patients.
Topics: Aged; Bendroflumethiazide; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; | 1987 |
Serum zinc is unaffected by effective captopril treatment of hypertension.
Topics: Blood Pressure; Captopril; Clinical Trials as Topic; Copper; Double-Blind Method; Humans; Hypertensi | 1987 |
Multicenter comparison of the nifedipine gastrointestinal therapeutic system and long-acting propranolol in patients with mild to moderate systemic hypertension receiving diuretics. A preliminary experience.
Topics: Adult; Blood Pressure; Delayed-Action Preparations; Diuretics; Female; Heart Rate; Humans; Hypertens | 1987 |
Pindolol-induced tremor.
Topics: Aged; Clinical Trials as Topic; Double-Blind Method; Humans; Hypertension; Male; Pindolol; Propranol | 1987 |
A double-blind study of Inderex in the treatment of essential hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Bendroflumethiazide; Clinical Trials as Topic; Delayed-Action | 1987 |
Atenolol or propranolol in hypertensive patients poorly controlled on captopril and frusemide.
Topics: Aged; Aldosterone; Atenolol; Blood Pressure; Captopril; Clinical Trials as Topic; Creatinine; Double | 1987 |
The Medical Research Council Hypertension Trial: the smoking patient.
Topics: Adult; Bendroflumethiazide; Cerebrovascular Disorders; Coronary Disease; Female; Humans; Hypertensio | 1988 |
Short-term behavioral effects of beta-adrenergic medications in men with mild hypertension.
Topics: Adult; Atenolol; Behavior; Blood Pressure; Emotions; Humans; Hypertension; Male; Memory; Middle Aged | 1988 |
The effects of prazosin and propranolol in combination with thiazide diuretics on blood pressure and serum lipids: a multicentre study.
Topics: Benzothiadiazines; Blood Pressure; Diuretics; Drug Therapy, Combination; Heart Rate; Humans; Hyperte | 1987 |
Effects of the non-steroidal anti-inflammatory drugs, piroxicam or sulindac, on the antihypertensive actions of propranolol and verapamil.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Double-Blind Method; | 1987 |
Comparison of the effects of prazosin versus propranolol on plasma lipoprotein lipids in patients receiving hemodialysis.
Topics: Blood Pressure; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Female; H | 1986 |
Calcium-channel blockers for combined angina pectoris and systemic hypertension.
Topics: Adult; Aged; Angina Pectoris; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Chr | 1986 |
Combination of verapamil and beta blockers in systemic hypertension.
Topics: Adult; Aged; Atrioventricular Node; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; D | 1986 |
Twice-daily verapamil for hypertension: a comparison with propranolol.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Drug Administration Schedule; Female; Heart Rate; H | 1986 |
[Use of adrenergic blockaders in hypertension].
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Dioxanes; Dioxins; Humans; Hypertension; Middle Age | 1986 |
[Analysis of hypotensive and hemodynamic effects of prazosin in patients with hypertension].
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Clinical Trials as Topic; Drug Therapy, Combination; Fe | 1986 |
Effect of trial therapy on subsequent therapy. A review of patients with hypertension who have completed a pharmacological intervention study.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Family Practice; Humans; H | 1986 |
The effects of antihypertensive therapy on the quality of life.
Topics: Adult; Aged; Blood Pressure; Captopril; Clinical Trials as Topic; Double-Blind Method; Humans; Hydro | 1986 |
Ethnics differences in the reactions to drugs and xenobiotics. Antihypertensive agents.
Topics: Antihypertensive Agents; Bendroflumethiazide; Black People; Clinical Trials as Topic; Diuresis; Diur | 1986 |
[Treatment of mild hypertension].
Topics: Adult; Clinical Trials as Topic; Diuretics; Female; Humans; Hypertension; Male; Middle Aged; Propran | 1986 |
The Medical Research Council Trial.
Topics: Adult; Bendroflumethiazide; Blood Pressure; Clinical Trials as Topic; Female; Humans; Hypertension; | 1986 |
Comparison of nitrendipine with propranolol and its use in combined cardiovascular therapy.
Topics: Aged; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hype | 1986 |
The effects of oral nitrendipine and propranolol, alone and in combination, on hypertensive patients with special reference to AV conduction.
Topics: Administration, Oral; Adult; Atrioventricular Node; Blood Pressure; Clinical Trials as Topic; Double | 1986 |
Comparison of the effects of penbutolol and propranolol on glomerular filtration rate in hypertensive patients with impaired renal function.
Topics: Blood Pressure; Clinical Trials as Topic; Creatinine; Double-Blind Method; Glomerular Filtration Rat | 1986 |
Peripheral vascular effects of bufuralol in hypertensive and normal subjects: a comparison with propranolol and pindolol.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Ethanolamines; Fingers; Forear | 1986 |
Racial difference in response to antihypertensive drugs. A focus on verapamil.
Topics: Antihypertensive Agents; Black People; Clinical Trials as Topic; Humans; Hypertension; Male; Potassi | 1986 |
Effect of Clinoril (sulindac, MSD), piroxicam and placebo on the hypotensive effect of propranolol in patients with mild to moderate essential hypertension.
Topics: Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Humans; Hypertension; Indenes; Piroxi | 1986 |
Low-dose antihypertensive treatment with a thiazide diuretic is not diabetogenic. A 10-year controlled trial with bendroflumethiazide.
Topics: Bendroflumethiazide; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus; Follow-Up Studies; | 1986 |
Antihypertensive therapy and quality of life.
Topics: Antihypertensive Agents; Attitude to Health; Captopril; Clinical Trials as Topic; Humans; Hypertensi | 1987 |
[Mild or moderate arterial hypertension. Clinical, phonomechanocardiographic and echocardiographic evaluation of pindolol and propranolol].
Topics: Clinical Trials as Topic; Double-Blind Method; Echocardiography; Hemodynamics; Humans; Hypertension; | 1986 |
Double-blind, randomized, cross-over clinical trial of metoprolol and propranolol in mild to moderate essential hypertension.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hyperten | 1987 |
Comparison of nifedipine and propranolol used in combination with diuretics for the treatment of hypertension.
Topics: Adult; Blood Pressure; Cholesterol, HDL; Clinical Trials as Topic; Diuretics; Double-Blind Method; D | 1987 |
The effects of verapamil and propranolol on exercise tolerance in hypertensive patients.
Topics: Adult; Clinical Trials as Topic; Humans; Hypertension; Male; Middle Aged; Physical Endurance; Propra | 1987 |
The relationship between smoking and the response to anti-hypertensive treatment in mild hypertensives in the Medical Research Council's trial of treatment.
Topics: Adult; Bendroflumethiazide; Blood Pressure; Clinical Trials as Topic; Diastole; Female; Follow-Up St | 1987 |
Postoperative hypertension after repair of coarctation of aorta in children: protective effect of propranolol?
Topics: Adolescent; Aortic Coarctation; Blood Pressure; Catecholamines; Child; Child, Preschool; Clinical Tr | 1987 |
The effects of propranolol and metoprolol on skin blood flow in diabetic patients.
Topics: Adult; Aged; Diabetes Complications; Diabetes Mellitus; Female; Humans; Hypertension; Male; Metoprol | 1987 |
Metabolic effects of verapamil and propranolol during submaximal endurance exercise in patients with essential hypertension.
Topics: Adult; Blood Glucose; Blood Pressure; Glycerol; Heart Rate; Humans; Hypertension; Lactates; Male; Mi | 1987 |
Comparison of concomitant nicardipine hydrochloride and propranolol with propranolol alone in patients with essential hypertension.
Topics: Adult; Aged; Aged, 80 and over; Double-Blind Method; Drug Therapy, Combination; Drug Tolerance; Fema | 1987 |
Acute and long-term haemodynamic effects of propranolol and indenolol in hypertension.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Cardiac Output; Female; Heart Rate; Hemodynamics; Hu | 1986 |
The effects of single-dose atenolol, labetalol, and propranolol on cardiac and vascular function.
Topics: Aged; Atenolol; Cardiac Output; Cardiovascular System; Heart Rate; Humans; Hypertension; Labetalol; | 1986 |
A comparative study of two beta-blocker-diuretic combinations in the treatment of hypertension.
Topics: Acebutolol; Adult; Aged; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertensio | 1986 |
Diltiazem versus propranolol in essential hypertension: responses of rest and exercise blood pressure and effects on exercise capacity.
Topics: Blood Pressure; Diltiazem; Double-Blind Method; Heart Rate; Humans; Hypertension; Male; Middle Aged; | 1987 |
Comparison of acebutolol and propranolol in essential hypertension.
Topics: Acebutolol; Adult; Aged; Antibodies, Antinuclear; Blood Pressure; Body Weight; Clinical Trials as To | 1985 |
Crossover comparison of captopril and propranolol as step 2 agents in hypertension.
Topics: Adult; Blood Pressure; Captopril; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochloro | 1985 |
"Inderex" therapy in general practice.
Topics: Adult; Aged; Bendroflumethiazide; Blood Pressure; Clinical Trials as Topic; Drug Combinations; Famil | 1985 |
A double-blind crossover clinical trial of labetalol and propranolol in patients of essential hypertension.
Topics: Clinical Trials as Topic; Double-Blind Method; Ethanolamines; Female; Humans; Hypertension; Labetalo | 1985 |
Fixed ratio combination of propranolol and bendrofluazide in the treatment of hypertension.
Topics: Adult; Aged; Bendroflumethiazide; Blood Pressure; Clinical Trials as Topic; Drug Combinations; Femal | 1985 |
[A 10-year follow-up of men with mild hypertension. Bendroflumethiazide and propranolol give equal effect in treatment of high blood pressure].
Topics: Bendroflumethiazide; Blood Glucose; Clinical Trials as Topic; Follow-Up Studies; Humans; Hypertensio | 1985 |
Therapeutic effect of propranolol on paradoxical hypertension after repair of coarctation of the aorta.
Topics: Aortic Coarctation; Blood Pressure; Child; Clinical Trials as Topic; Female; Heart Rate; Humans; Hyp | 1985 |
Propranolol versus labetalol: interesting differences in efficacy.
Topics: Adult; Aged; Black People; Clinical Trials as Topic; Double-Blind Method; Ethanolamines; Humans; Hyp | 1985 |
[Comparison of hypotensive effectiveness of propranolol and atenolol in combined treatment of primary hypertension].
Topics: Adult; Atenolol; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Hydrochlorothi | 1985 |
Comparison of the effects of labetalol and hydrochlorothiazide on the ventilatory function of hypertensive patients with asthma and propranolol sensitivity.
Topics: Adolescent; Adult; Aged; Asthma; Clinical Trials as Topic; Drug Evaluation; Female; Forced Expirator | 1985 |
Double-blind cross-over clinical trial of acebutolol and propranolol in mild to moderate essential hypertension.
Topics: Acebutolol; Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hypertension | 1985 |
[Development of sodium dependence in the prolonged treatment of essential hypertension with propranolol].
Topics: Adult; Clinical Trials as Topic; Drug Tolerance; Humans; Hypertension; Male; Middle Aged; Plasma Vol | 1985 |
Verapamil and beta-blockers in hypertension: a beneficial drug interaction?
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Human | 1985 |
Prazosin once or twice daily?
Topics: Adult; Aged; Amiloride; Atenolol; Blood Pressure; Chlorthalidone; Drug Therapy, Combination; Female; | 1985 |
Effects of atenolol, labetalol and propranolol on the peripheral circulation in hypertensive patients without obstructive vascular disease.
Topics: Adolescent; Adult; Atenolol; Blood Circulation; Ethanolamines; Female; Fingers; Humans; Hypertension | 1985 |
Effect of beta 1-selective and nonselective beta blockade on blood pressure relative to physical performance in men with systemic hypertension.
Topics: Adult; Atenolol; Blood Pressure; Cardiac Output; Double-Blind Method; Exercise Test; Heart Rate; Hum | 1985 |
Termination of clinical trials: the beta-blocker heart attack trial and the hypertension detection and follow-up program experience.
Topics: Adult; Aged; Clinical Trials as Topic; Data Collection; Double-Blind Method; Follow-Up Studies; Huma | 1985 |
Termination of clinical trials: the beta-blocker heart attack trial and the hypertension detection and follow-up program experience.
Topics: Adult; Aged; Clinical Trials as Topic; Data Collection; Double-Blind Method; Follow-Up Studies; Huma | 1985 |
Termination of clinical trials: the beta-blocker heart attack trial and the hypertension detection and follow-up program experience.
Topics: Adult; Aged; Clinical Trials as Topic; Data Collection; Double-Blind Method; Follow-Up Studies; Huma | 1985 |
Termination of clinical trials: the beta-blocker heart attack trial and the hypertension detection and follow-up program experience.
Topics: Adult; Aged; Clinical Trials as Topic; Data Collection; Double-Blind Method; Follow-Up Studies; Huma | 1985 |
Hemodynamic effects of acebutolol and propranolol in hypertensive patients during exercise.
Topics: Acebutolol; Adolescent; Adult; Aged; Blood Pressure; Female; Heart Rate; Hemodynamics; Humans; Hyper | 1985 |
The relative antihypertensive potency of propranolol, oxprenolol, atenolol, and metoprolol given once daily. A double-blind, crossover, placebo-controlled study in ambulatory patients.
Topics: Adult; Aged; Analysis of Variance; Atenolol; Blood Pressure; Body Weight; Delayed-Action Preparation | 1985 |
Single and combined therapy for systemic hypertension with propranolol, hydralazine and hydrochlorothiazide: hemodynamic and neuroendocrine mechanisms of action.
Topics: Adult; Drug Therapy, Combination; Exercise Test; Female; Hemodynamics; Humans; Hydralazine; Hydrochl | 1985 |
Effects of long-acting propranolol on blood pressure and heart rate in hypertensive Chinese.
Topics: Adult; Blood Pressure; China; Delayed-Action Preparations; Double-Blind Method; Exercise Test; Femal | 1985 |
Alpha and beta adrenergic blockade in hypertension.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Blood Pressure; Body Weight; Clini | 1972 |
Experiences with beta-adrenergic blockade drugs in hypertension.
Topics: Adrenergic beta-Antagonists; Black or African American; Black People; Ethnicity; Humans; Hypertensio | 1973 |
[Practolol in anesthesia (ICI 50.172, Eraldin)].
Topics: Acetanilides; Adolescent; Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Amino Alcohols; Ane | 1972 |
Beta-blockers and plasma renin activity in hypertension.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aldosterone; Benzothiadiazines; Blood Pressure; Crea | 1974 |
[New antihypertensive agents. 3. Propranolol].
Topics: Adrenergic beta-Antagonists; Evaluation Studies as Topic; Humans; Hypertension; Placebos; Propranolo | 1972 |
Antihypertensive and hemodynamic properties of the new beta adrenergic blocking agent timolol.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Amino Alcohols; Antihypertensive Agents; Blood Pr | 1973 |
[Comparative studies on propranolol and practolol].
Topics: Adrenergic beta-Antagonists; Cardiac Output; Clinical Trials as Topic; Heart Rate; Humans; Hypertens | 1973 |
[Treatment of acute schizophrenic psychosis with beta-adrenergic blocking agents (author's transl)].
Topics: Acute Disease; Adrenergic beta-Antagonists; Adult; Blood Pressure; Catatonia; Clinical Trials as Top | 1974 |
[Treatment of arterial hypertension using beta-blockaders].
Topics: Adrenergic beta-Antagonists; Alprenolol; Clinical Trials as Topic; Drug Evaluation; Humans; Hyperten | 1974 |
Effect of propranolol in mild hypertension.
Topics: Adult; Aged; Clinical Trials as Topic; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Midd | 1966 |
Effects of beta-adrenergic blockade during exercise in hypertensive and ischaemic heart-disease.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Cardiac Output; Clinical Trials as Topic; Female; Hear | 1967 |
Beta-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity.
Topics: Administration, Oral; Adult; Aged; Blood Pressure; Cardiac Output; Clinical Trials as Topic; Depress | 1973 |
A comparison of propranolol and prindolol in the treatment of essential hypertension.
Topics: Aged; Blood Pressure; Clinical Trials as Topic; Female; Heart Rate; Humans; Hypertension; Male; Midd | 1974 |
Studies on the antihypertensive action of the optical isomers of propranolol in man.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Heart Rate; Humans; Hypert | 1974 |
Effect of propranolol on cyclic AMP excretion and plasma renin activity in labile essentrial hypertension.
Topics: Adolescent; Adult; Blood Pressure; Clinical Trials as Topic; Cyclic AMP; Female; Heart Rate; Humans; | 1973 |
[Labile hypertension: hormonal characteristic and implications of the "second messenger"].
Topics: Adult; Blood Pressure Determination; Cardiac Output; Cyclic AMP; Diet; Female; Humans; Hypertension; | 1973 |
Plasma adenosine 3',5'-cyclic monophosphate in human hypertension.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Arteriosclerosis; Blood Pressure; Child; Clinical Trials | 1974 |
The therapeutic role of propranolol.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Hypertrophic; Cli | 1969 |
Beta-adrenergic blocking therapy in hypertension: selection of patients.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Blood Volume; Body Surface Area; Cardiac Output; | 1970 |
[Treatment of hypertension by adrenergic beta receptor blockaders].
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Humans; Hypertension; Placebos; Propranolol | 1971 |
Propranolol therapy in essential hypertension. Observations on predictability of therapeutic response.
Topics: Administration, Oral; Adult; Aged; Aldosterone; Blood Pressure; Cardiac Output; Creatinine; Dose-Res | 1974 |
Propranolol therapy in essential hypertension.
Topics: Administration, Oral; Adult; Aged; Alkaline Phosphatase; Arteries; Aspartate Aminotransferases; Bloo | 1972 |
Propranolol in hypertension. Report on 158 patients treated up to one year.
Topics: Adult; Aged; Airway Obstruction; Blood Pressure; Bradycardia; Clinical Trials as Topic; Creatinine; | 1972 |
Adjuvant effect of bendrofluazide on propranolol in hypertension.
Topics: Adult; Bendroflumethiazide; Clinical Trials as Topic; Evaluation Studies as Topic; Female; Humans; H | 1972 |
Comparison between alprenolol and propranolol as antihypertensive agents. A double-blind cross-over study.
Topics: Adult; Alprenolol; Blood Pressure; Body Weight; Clinical Trials as Topic; Female; Heart Rate; Humans | 1972 |
Guancydine: a new antihypertensive agent. Use with quinethazone and guanethidine or propranolol.
Topics: Antihypertensive Agents; Anxiety; Aspartate Aminotransferases; Blood Pressure; Clinical Trials as To | 1972 |
[Comparison between propranolol and methyldopa in the treatment of hypertension (a double-blind trial)].
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Depression, Chemical; Female; Humans; Hyperte | 1973 |
The effect of practolol ("Eraldin") in the long-term treatment of severe and moderate hypertension.
Topics: Clinical Trials as Topic; Diuretics; Electrocardiography; Female; Humans; Hypertension; Male; Middle | 1973 |
The organization of a multi-centre randomized control therapeutic trial for mild to moderate hypertension.
Topics: Adult; Blood Pressure Determination; Clinical Trials as Topic; Female; Guanethidine; Humans; Hyperte | 1973 |
A long-term study of the antihypertensive effect of alprenolol.
Topics: Adult; Aged; Alprenolol; Blood Pressure Determination; Chlorthalidone; Clinical Trials as Topic; Del | 1974 |
Alprenolol and propranolol in the treatment of hypertension: a comparative study.
Topics: Adult; Alprenolol; Blood Pressure; Clinical Trials as Topic; Depression, Chemical; Diuretics; Drug E | 1974 |
Long-term effect of alprenolol as antihypertensive agent.
Topics: Adult; Airway Obstruction; Alprenolol; Blood Pressure; Body Weight; Chlorthalidone; Clinical Trials | 1974 |
Double-blind comparison of two beta-blocking drugs with previous therapy in the treatment of hypertension.
Topics: Blood Pressure; Chlorothiazide; Clinical Trials as Topic; Female; Humans; Hypertension; Male; Pindol | 1974 |
The effct of propranolol on plasma renin activity and blood pressure in mild essential hypertension.
Topics: Administration, Oral; Adult; Aged; Black People; Blood Pressure; Clinical Trials as Topic; Creatinin | 1974 |
The Australian National Blood Pressure Study.
Topics: Adult; Aged; Antihypertensive Agents; Australia; Chlorothiazide; Clinical Trials as Topic; Clonidine | 1974 |
Experimentation with propranolol in hypertension.
Topics: Administration, Oral; Adolescent; Adult; Aged; Clinical Trials as Topic; Female; Humans; Hypertensio | 1973 |
Double blind study with propranolol in the treatment of hypertension.
Topics: Adult; Aged; Bronchial Spasm; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Female | 1973 |
Effects of acute and chronic administration of propranolol on blood pressure and plasma renin activity in hypertensive patients.
Topics: Adolescent; Adult; Aldosterone; Benzothiadiazines; Blood Pressure; Clinical Trials as Topic; Diet, S | 1974 |
Practolol-propranolol. A comparison of antihypertensive effect.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Depression, Chemical; Female; Heart Rate; Humans; H | 1974 |
Proceedings: Beta-adrenergic blockers in the treatment of hypertension: experience with propranolol at the U.C.H. Ibadan, Nigeria.
Topics: Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Nigeria; Pl | 1974 |
Blood pressure crisis following withdrawal of clonidine (Catapres, Catapresan), with special reference to arterial and urinary catecholamine levels, and suggestions for acute management.
Topics: Adult; Blood Pressure; Catecholamines; Clonidine; Female; Humans; Hypertension; Male; Middle Aged; P | 1973 |
A within-patient comparison of alprenolol and propranolol in hypertension.
Topics: Adult; Alprenolol; Blood Pressure; Depression, Chemical; Female; Heart Rate; Humans; Hypertension; M | 1973 |
Effect of propranolol on elevated arterial blood pressure.
Topics: Adult; Aged; Antihypertensive Agents; Bilirubin; Blood Cell Count; Blood Pressure; Blood Urea Nitrog | 1968 |
Ineffectiveness of propranolol in hypertensive Jamaicans.
Topics: Black People; Clinical Trials as Topic; Female; Humans; Hypertension; Jamaica; Male; Middle Aged; Pl | 1968 |
Controlled trial of propranolol in hypertension.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Female; Humans; Hypertension; Hypotension; Ma | 1970 |
[Results of clinical testing of carbochromen in chronic coronary insufficiency].
Topics: Adult; Aged; Antihypertensive Agents; Aortic Arch Syndromes; Blood Circulation; Blood Volume; Cardia | 1970 |
Beta receptor antagonism in hypertension; comparison with the effect of adrenergic neurone inhibition on cardiovascular responses.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Female; Forearm; Guanethidine; Guanidines; Humans; | 1970 |
Combined dihydralazine and propranolol in the treatment of hypertension.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Female; Guanidines; Humans; Hydralazine; Hype | 1970 |
[Propranolol, pharmacological considerations and clinical use].
Topics: Adult; Aged; Arteriosclerosis; Cardiovascular System; Female; Heart Diseases; Humans; Hypertension; | 1969 |
Anaesthesia for laryngoscopy. A comparison of the cardiovascular effects of cocaine and lignocaine.
Topics: Aged; Anesthesia, Intravenous; Anesthesia, Local; Cardiovascular System; Cocaine; Heart; Heart Rate; | 1968 |
Effects of propranolol on the pressor response to noxious stimuli in hypertensive patients.
Topics: Adult; Blood Pressure; Cardiac Output; Cold Temperature; Epinephrine; Fatty Acids, Nonesterified; Fe | 1968 |
Hyperdynamic beta-adrenergic circulatory state. Increased beta-receptor responsiveness.
Topics: Adult; Autonomic Nervous System; Blood Circulation; Blood Pressure; Cardiac Output; Cardiovascular D | 1969 |
Treatment of hypertension with propranol.
Topics: Humans; Hypertension; Propranolol | 1969 |
1624 other studies available for propranolol and Blood Pressure, High
| Article | Year |
|---|---|
Symbiotic approach to drug design: antihypertensive beta-adrenergic blocking agents.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Chemistry, Pharmaceutical; Dogs; Hype | 1979 |
Flavones. 1. Synthesis and antihypertensive activity of (3-phenylflavonoxy)propanolamines without beta-adrenoceptor antagonism.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Chemical Phenomena; Chemistry; Flavon | 1987 |
Heterocyclic analogues of the antihypertensive beta-adrenergic blocking agent (S)-2-[3-(ter-butylamino)-2-hydroxypropoxy]-3-cyanopyridine.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Dogs; Female; Heart R | 1980 |
Antihypertensive indole derivatives of phenoxypropanolamines with beta-adrenergic receptor antagonist and vasodilating activity.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Hypertension; Indoles; Male; Propanol | 1980 |
2-Benzodioxinylaminoethanols: a new class of beta-adrenergic blocking and antihypertensive agents.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Dioxins; Dose-Response Relationship, | 1981 |
Novel hybrids of natural isochroman-4-one bearing N-substituted isopropanolamine as potential antihypertensive candidates.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Chromones; Dose-Respo | 2013 |
Eukaryotic elongation factor 2 kinase inhibitor, A484954 induces diuretic effect via renal vasorelaxation in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Disease Models, Animal; Diuretics; Elongation Factor 2 Kinase; Humans; Hype | 2021 |
Is renal ß-adrenergic-WNK4-NCC pathway important in salt hypertension of Dahl rats?
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Hypertension; Male; Propranolol; Protein Serin | 2019 |
Functional and neurometabolic asymmetry in SHR and WKY rats following vasoactive treatments.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Captopril; Frontal Lobe; Humans; Hypertension; Mal | 2019 |
Thyroid Storm in a Toddler Presenting as a Febrile Seizure.
Topics: Child, Preschool; Female; Graves Disease; Humans; Hydrocortisone; Hypertension; Iodides; Methimazole | 2020 |
Aqueous extract of oakmoss produces antihypertensive activity in L-NAME-induced hypertensive rats through sGC-cGMP pathway.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Aorta, Thoracic; Arterial Pressure; B | 2021 |
Managing Persistent Hypertension and Tachycardia Following Septic Shock, Limb Ischemia, and Amputation: The Role for β-Blockade.
Topics: Adrenergic beta-Antagonists; Amputation, Surgical; Cefepime; Child; Clindamycin; Debridement; Diagno | 2021 |
β-Blocker Exposure in Pregnancy and Risk of Fetal Cardiac Anomalies.
Topics: Adrenergic beta-Antagonists; Age Factors; Arrhythmias, Cardiac; Atenolol; Body Mass Index; Californi | 2017 |
Propranolol treatment lowers blood pressure, reduces vascular inflammatory markers and improves endothelial function in obese mice.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Diet, High-Fat; Endot | 2017 |
A Combination of Dexmedetomidine and Lidocaine Is a Cardiovascularly Safe Dental Local Anesthetic for Hypertensive Rats Treated With a Nonselective β-Adrenergic Antagonist.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic beta-Antagonists; Anesthesia, Dental; Anesthesia, L | 2017 |
Radiation preparation of L-arginine/acrylic acid hydrogel matrix patch for transdermal delivery of propranolol HCl in hypertensive rats.
Topics: Acrylates; Administration, Cutaneous; Animals; Antihypertensive Agents; Arginine; Blood Pressure; Dr | 2018 |
β-blockers interfere with cell homing receptors and regulatory proteins in a model of spontaneously hypertensive rats.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Antihypertensive Agent | 2018 |
The Safety and Efficacy of Propranolol in Reducing the Hypermetabolic Response in the Pediatric Burn Population.
Topics: Adolescent; Adrenergic beta-Antagonists; Burns; Child; Child, Preschool; Female; Humans; Hypertensio | 2018 |
Cytotoxic and genotoxic effects of antihypertensives distributed in Brazil by social programs: Are they safe?
Topics: Antihypertensive Agents; Atenolol; Brazil; Captopril; Cell Survival; Cells, Cultured; DNA Damage; Do | 2018 |
Combined Antihypertensive Therapies That Increase Expression of Cardioprotective Biomarkers Associated With the Renin-Angiotensin and Kallikrein-Kinin Systems.
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme | 2018 |
Schimke immunoosseous dysplasia and management considerations for vascular risks.
Topics: Anticholesteremic Agents; Antihypertensive Agents; Arteriosclerosis; Atorvastatin; Benzazepines; Blo | 2019 |
Annular telangiectatic perivascular angiomatosis: a paradoxical adverse event of propranolol.
Topics: Aged, 80 and over; Angiomatosis; Antihypertensive Agents; Female; Humans; Hypertension; Propranolol; | 2013 |
Drug effects on the CVS in conscious rats: separating cardiac output into heart rate and stroke volume using PKPD modelling.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amiloride; Amlodipine; Animals; Atropine; Enalapril; | 2014 |
[My hypertensive patient wants beta blockers. Are they not obsolete?].
Topics: Adrenergic beta-Antagonists; Atenolol; Drug Substitution; Germany; Guideline Adherence; Humans; Hype | 2014 |
Hemodynamic changes by drug interaction of adrenaline with chlorpromazine.
Topics: Animals; Antipsychotic Agents; Arterial Pressure; Catheterization, Peripheral; Chlorpromazine; Dose- | 2014 |
Long-term survival in the randomized trial of drug treatment in mild to moderate hypertension of the Oslo study 1972-3.
Topics: Adult; Aged; Antihypertensive Agents; Drug Therapy, Combination; Follow-Up Studies; Humans; Hyperten | 2015 |
Restraint stress exacerbates cardiac and adipose tissue pathology via β-adrenergic signaling in rats with metabolic syndrome.
Topics: Adipose Tissue; Adrenergic beta-Antagonists; Animals; Echocardiography; Glucose Intolerance; Hyperte | 2015 |
Dynamic resistance training decreases sympathetic tone in hypertensive ovariectomized rats.
Topics: Animals; Antihypertensive Agents; Atropine Derivatives; Autonomic Nervous System; Body Weight; Brady | 2015 |
Decrease of the insulin-like growth factor-1 bioavailability in spontaneously hypertensive rats with erectile dysfunction.
Topics: Animals; Antihypertensive Agents; Blotting, Western; Cyclic GMP; Disease Models, Animal; Enzyme-Link | 2016 |
Pharmacokinetic-pharmacodynamic analyses of antihypertensive drugs, nifedipine and propranolol, in spontaneously hypertensive rats to investigate characteristics of effect and side effects.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Ca | 2016 |
Synergisms of cardiovascular effects between iptakalim and amlodipine, hydrochlorothiazide or propranolol in anesthetized rats.
Topics: Amlodipine; Animals; Antihypertensive Agents; Blood Pressure; Drug Synergism; Heart Rate; Hydrochlor | 2015 |
Anesthetic management of a myotonic dystrophy patient with paraganglionoma.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthesia, Epid | 2016 |
Physical training associated with Enalapril but not to Losartan, results in better cardiovascular autonomic effects.
Topics: Animals; Antihypertensive Agents; Atropine; Autonomic Nervous System; Baroreflex; Blood Pressure; Co | 2017 |
Increased cAMP signaling can ameliorate the hypertensive condition in spontaneously hypertensive rats.
Topics: Adenylate Cyclase Toxin; Animals; Aorta; Blood Pressure; Cardiac Output; Cyclic AMP; Cyclic Nucleoti | 2009 |
The effect of ovariectomy on cardiac autonomic control in rats submitted to aerobic physical training.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Analysis of Variance; Animals; Atropine Derivativ | 2008 |
Influence of mirtazapine on the hypotensive activity of enalapril and propranolol in spontaneously hypertensive rats.
Topics: Adrenergic alpha-Antagonists; Animals; Antidepressive Agents, Tricyclic; Antihypertensive Agents; Do | 2008 |
Physical exercise attenuates the cardiac autonomic deficit induced by nitric oxide synthesis blockade.
Topics: Adrenergic beta-Antagonists; Analysis of Variance; Animals; Atropine Derivatives; Autonomic Nervous | 2009 |
Nitric oxide synthesis blockade reduced the baroreflex sensitivity in trained rats.
Topics: Adaptation, Physiological; Animals; Atropine Derivatives; Autonomic Nervous System; Baroreflex; Bloo | 2009 |
Haemodynamic characteristics of hypertension induced by prenatal cortisol exposure in sheep.
Topics: Animals; Antihypertensive Agents; Female; Hemodynamics; Hexamethonium; Hydrocortisone; Hypertension; | 2009 |
Unusual presentation of pheochromocytoma with ischemic sigmoid colitis and stenosis.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; C | 2009 |
Global disturbances in autonomic function yield cardiovascular instability and hypertension in the chromogranin a null mouse.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cardiovascular System; Catecholamines; Chromograni | 2009 |
Effects of propranolol on bone metabolism in spontaneously hypertensive rats.
Topics: Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Bone D | 2010 |
Is overall blockade superior to selective blockade of adrenergic receptor subtypes in suppressing left ventricular remodeling in spontaneously hypertensive rats?
Topics: Adrenergic Antagonists; Animals; Apoptosis; Bisoprolol; Blood Pressure; Carbazoles; Carvedilol; Dise | 2010 |
Combined blockade of β- and α₁-adrenoceptors in left ventricular remodeling induced by hypertension: beneficial or not?
Topics: Adrenergic Antagonists; Animals; Bisoprolol; Carbazoles; Carvedilol; Disease Models, Animal; Humans; | 2010 |
Pomolic acid of Licania pittieri elicits endothelium-dependent relaxation in rat aortic rings.
Topics: Animals; Antihypertensive Agents; Aorta; Apyrase; Atropine; Chrysobalanaceae; Dose-Response Relation | 2011 |
Mechanisms of modulation of thermoregulatory reactions during cooling in hypertensive rats by the sympathetic nervous system.
Topics: Adrenergic Antagonists; Animals; Body Temperature Regulation; Cold Temperature; Hypertension; Propra | 2010 |
Matrix-assisted laser desorption/ionization mass spectrometry for quantitative determination of β-blocker drugs in one-drop of human serum sample.
Topics: Adrenergic beta-Antagonists; Chemical Fractionation; Humans; Hydrogen-Ion Concentration; Hypertensio | 2011 |
Beta-adrenergic signaling, a novel target for cancer therapy?
Topics: Adrenergic beta-Antagonists; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Female; Humans; Hyp | 2010 |
Expanding our therapeutic options: Beta blockers for breast cancer?
Topics: Adrenergic beta-Antagonists; Atenolol; Breast Neoplasms; Diabetes Complications; Disease-Free Surviv | 2011 |
Beta blockers and breast cancer mortality: a population- based study.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Breast Neoplasms; Disease Progression; Female; Humans; | 2011 |
Investigating the effect of an arterial hypertension drug on the structural properties of plasma protein.
Topics: Animals; Antihypertensive Agents; Calorimetry, Differential Scanning; Cattle; Chemistry, Pharmaceuti | 2011 |
Increased expression of insulin-like growth factor-binding protein-3 is implicated in erectile dysfunction in two-kidney one-clip hypertensive rats after propranolol treatment.
Topics: Animals; Antihypertensive Agents; Base Sequence; Blotting, Western; DNA Primers; Enzyme-Linked Immun | 2011 |
A retrospective in vitro study of the impact of anti-diabetics and cardioselective pharmaceuticals on breast cancer.
Topics: Adrenergic beta-1 Receptor Antagonists; Bisoprolol; Blood Glucose; Breast Neoplasms; Cell Line, Tumo | 2012 |
Different cardiovascular responses to a resistance training session in hypertensive women receiving propanolol compared with normotensive controls.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Blood Press | 2012 |
Rectal bleeding and hypertensive colopathy in May-Thurner syndrome.
Topics: Adolescent; Colon; Colonic Diseases; Colonic Diseases, Functional; Delayed Diagnosis; Diagnosis, Dif | 2013 |
[A case of familial restrictive cardiomyopathy].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Antihypertensive Agents; Aspirin; Atenolol; Atrial Fibrillation | 2002 |
[The role of depressive disorders in hypertensive disease and possibilities of their correction: assessment of the effect of tianeptine].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antidepressive A | 2002 |
The propanolol-epinephrine interaction revisited: a serious and potentially catastrophic adverse drug interaction in facial plastic surgery.
Topics: Adrenergic beta-Antagonists; Bradycardia; Drug Interactions; Epinephrine; Heart Arrest; Humans; Hype | 2003 |
Nitric oxide opposes glucose-induced hypertension by suppressing sympathetic activity.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Enzyme Inhibitor | 2003 |
A nitric oxide-generating beta-blocking agent prevents renal injury in the rat remnant kidney model. Comparative study of two beta-blocking drugs, nipradilol and propranolol.
Topics: Adrenergic beta-Antagonists; Animals; Cyclic GMP; Enzyme Inhibitors; Hypertension; Kidney; Kidney Di | 2003 |
Different effects of acute clenbuterol on vasomotor response in mesenteric arteries from young and old spontaneously hypertensive rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Aging; Animals; Blood Pressure; Calcitonin G | 2003 |
Aging accelerates dietary lard-induced increase in blood pressure in rats.
Topics: Aging; Animals; Blood Glucose; Dietary Fats; Epinephrine; Glucose; Hypertension; Insulin; Insulin Re | 2003 |
USE OF PROPRANOLOL (INDERAL) IN TREATMENT OF HYPERTENSION.
Topics: Angina Pectoris; Antihypertensive Agents; Chlorothiazide; Guanethidine; Hypertension; Methyldopa; Ph | 1964 |
EFFECT OF A BETA-ADRENERGIC-BLOCKING AGENT ON THELATION IN MITRAL STENOSIS.
Topics: Adrenergic Antagonists; Adrenergic beta-Antagonists; Cardiac Catheterization; Cardiac Output; Heart | 1965 |
Celiprolol activates eNOS through the PI3K-Akt pathway and inhibits VCAM-1 Via NF-kappaB induced by oxidative stress.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Celiprolol; Coronary Vessels; Desoxyc | 2003 |
Anterior hypothalamic beta-adrenergic activity in the maintenance of hypertension in aortic coarctated rats.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Anterior Hypothalamic Nucleus; Aorti | 2004 |
Inadvertent intravenous administration of a high dose of ephedrine.
Topics: Adult; Blood Pressure; Dose-Response Relationship, Drug; Ephedrine; Heart Rate; Humans; Hypertension | 2004 |
Blood pressure and heart rate of students undergoing a medical licensing examination.
Topics: Adrenergic beta-Antagonists; Adult; Antidepressive Agents; Anxiety; Blood Pressure; Educational Meas | 2004 |
Do incremental increases in blood pressure elicit neointimal plaques through endothelial injury?
Topics: Aging; Animals; Aorta, Abdominal; Arginine; Blood Pressure; Chickens; Disease Models, Animal; Endoth | 2004 |
Catecholamine-induced regulation in vitro and ex vivo of intralymphocyte ionized magnesium.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Catecholamines; Epinephrine; Female; Fura-2; | 2004 |
[Structure of the sinus dysfunction in hypertensive patients].
Topics: Adrenergic beta-Antagonists; Adult; Anti-Arrhythmia Agents; Atropine; Electrophysiology; Female; Hea | 2004 |
Reversal of left ventricular hypertrophy by propranolol in hypertensive rats.
Topics: Adrenergic beta-Antagonists; Animals; Hypertension; Hypertrophy, Left Ventricular; Male; Propranolol | 2005 |
Effects of atenolol and propanolol on platelet aggregation in moderate essential hypertension.
Topics: Antihypertensive Agents; Atenolol; Humans; Hypertension; Platelet Aggregation; Propranolol | 2005 |
Sympathectomy or doxazosin, but not propranolol, blunt myocardial interstitial fibrosis in pressure-overload hypertrophy.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Cardiomegaly; Co | 2005 |
Beta blockers for the treatment of primary hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aging; Humans; Hypertension; Middle Aged; Myocardial Infar | 2006 |
Neurotensin-induced myocardial noradrenergic effects in spontaneously hypertensive rats.
Topics: Animals; Atenolol; Blood Pressure; Dose-Response Relationship, Drug; Hypertension; In Vitro Techniqu | 2006 |
Survival benefits of different antiadrenergic interventions in pressure overload left ventricular hypertrophy/failure.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Aorta, Abdominal; Blood Pressure | 2006 |
Mitochondrial disorder aggravated by propranolol.
Topics: Adrenergic beta-Antagonists; Female; Humans; Hypertension; Middle Aged; Mitochondrial Myopathies; Pr | 2006 |
Cardiovascular excitatory effect on rats of a fraction isolated from the eyestalk of shrimp: Peneaus vanameii.
Topics: Animal Structures; Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Blood Pressure; Calcium | 2006 |
Bath-related headache: the first European case.
Topics: Adrenergic beta-Antagonists; Analgesics; Baths; Female; Headache; Humans; Hypertension; Ketorolac; M | 2006 |
Vascular effects of long-term propranolol administration after chronic nitric oxide blockade.
Topics: Acetylcholine; Animals; Antihypertensive Agents; Aorta; Biological Factors; Blood Pressure; Calcium; | 2007 |
Ischemic colitis following colonoscopy in an elderly patient on cardiovascular medication.
Topics: Aged, 80 and over; Arrhythmias, Cardiac; Cardiovascular Agents; Colitis, Ischemic; Colonic Neoplasms | 2007 |
[Rapid preoperative preparation with iopanoic acid in severe liver toxicity due to methimazole: anesthetic implications].
Topics: Adrenergic beta-Antagonists; Adult; Anesthesia, Intravenous; Antithyroid Agents; Chemical and Drug I | 2008 |
[Anesthetic management in a case of recurrent mediastinal paraganglioma].
Topics: 3-Iodobenzylguanidine; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthesia, Genera | 2008 |
Effect of propranolol on left atrial systole in ischaemic and hypertensive heart disease.
Topics: Angina Pectoris; Electricity; Electrocardiography; Heart; Heart Atria; Heart Diseases; Heart Rate; H | 1967 |
Propranolol-induced depression.
Topics: Arrhythmias, Cardiac; Depression; Humans; Hypertension; Propranolol | 1967 |
Haemodynamic effects of propranolol.
Topics: Adult; Aged; Atropine; Heart Rate; Humans; Hypertension; Isoproterenol; Middle Aged; Myocardial Infa | 1967 |
Propranolol-induced depression.
Topics: Depression; Humans; Hypertension; Propranolol | 1967 |
[Therapeutic use of beta-adrenergic blocking agents].
Topics: Arrhythmias, Cardiac; Coronary Disease; Drug Tolerance; Humans; Hypertension; Propranolol; Sympathol | 1967 |
Effect of left ventricular hypertension, ischemia and vasoactive drugs on the myocardial distribution of coronary flow.
Topics: Animals; Coronary Vessels; Dipyridamole; Electrocardiography; Heart; Heart Ventricles; Hypertension; | 1967 |
[Experiences and tests concerning the biological and fluorometric determination of catecholamines and other pressoractive substances in the urine of patients with hypertension].
Topics: Catecholamines; Fluorometry; Humans; Hypertension; Propranolol | 1967 |
Persistent tachycardia, paroxymal hypertension, and seizures: association with hyperglycinuria, dominantly inherited microphthalmia, and cataracts.
Topics: Adult; Amino Acid Metabolism, Inborn Errors; Amino Acids; Cataract; Female; Glycine; Humans; Hyperte | 1967 |
[Clinical evaluation of propranolol in the treatment of hypertension].
Topics: Adult; Aged; Female; Humans; Hypertension; Male; Middle Aged; Propranolol | 1967 |
Comparison of a centrally acting antihypertensive agent and beta-adrenergic blocking agents for the treatment of hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Blood Pressure; Female; Guanabenz | 1984 |
Efficacy and safety of nitrendipine in patients with severe hypertension: a multiclinic study.
Topics: Adult; Aged; Blood Pressure; Calcium Channel Blockers; Drug Therapy, Combination; Female; Heart Rate | 1984 |
The calcium channel blocker nitrendipine in single- and multiple-agent antihypertensive regimens: preliminary report of a multicenter study.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Body Weight; Calcium Channel Blockers; Drug Therapy, Combi | 1984 |
Age-related changes of in vivo beta-adrenergic responsiveness in normotensive and spontaneously hypertensive rats.
Topics: Aging; Animals; Blood Pressure; Cyclic AMP; Hypertension; Isoproterenol; Male; Propranolol; Rats; Ra | 1984 |
The effects of enalapril and propranolol on beta-endorphin-like radioimmunoreactivity in hypertensive patients.
Topics: Adolescent; Adult; beta-Endorphin; Dipeptides; Enalapril; Endorphins; Female; Humans; Hypertension; | 1984 |
Adrenaline induces vasoconstriction through post-junctional alpha 2 adrenoceptors and this response is enhanced in patients with essential hypertension.
Topics: Adult; Epinephrine; Female; Forearm; Humans; Hypertension; Male; Middle Aged; Nitroprusside; Prazosi | 1984 |
Effect of antihypertensive therapy on left ventricular function and myocardial perfusion at rest and during exercise.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Coronary Circulation; Enalapril; Female; Heart | 1984 |
Cardiovascular effects of chronic infusion of propranolol in the conscious spontaneously hypertensive rat.
Topics: Animals; Blood Pressure; Hemodynamics; Hypertension; Infusions, Parenteral; Male; Propranolol; Rats; | 1980 |
Pre- and postjunctional beta-adrenoceptor mediated effects on transmitter release and effector response in the isolated rat portal vein.
Topics: Animals; Autacoids; Electric Stimulation; Female; Hypertension; Isoproterenol; Male; Metoprolol; Mus | 1980 |
[Characteristics of the cardiovascular system reaction in children with arterial hypertension to the use of the Soviet beta-blockader, anaprilin].
Topics: Adolescent; Adrenergic beta-Antagonists; Blood Pressure; Cardiovascular System; Child; Child, Presch | 1980 |
Effects of cardioselective and nonselective beta-blockade on dynamic exercise performance in mildly hypertensive men.
Topics: Adrenergic beta-Antagonists; Adult; Analysis of Variance; Atenolol; Blood Chemical Analysis; Blood G | 1980 |
Pulmonary edema with low-dose propranolol in pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adult; Diagnosis, Differential; Female; Human | 1980 |
Reversal of clonidine-induced hypotension by beta-adrenoceptor blocking drugs.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Clonidine; Drug Interactions; Female; Heart Ra | 1980 |
[The use of beta blockaders in the treatment of hypertension: possibilities of a combined therapy method].
Topics: Adrenergic beta-Antagonists; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Propranolol | 1980 |
The influence of beta receptor blocking drugs on plasma catecholamine levels in patients with essential hypertension.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Catecholamines; Humans; Hypertension; Male; Propranolol | 1980 |
[Hemodynamic characteristics of spontaneous (hereditarily determined) hypertension in rats. II. The role of the sympathetic nervous system].
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Cardiovascular System; Hemodynamics; Hypertens | 1980 |
Relationship of propranolol pharmacokinetics to antihypertensive effect and beta-adrenergic blockade in the treatment of hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Half-Life; Hemodynamics; Humans; Hypertension; Kinetics; M | 1980 |
The intraoperative medical management of childhood pheochromocytoma.
Topics: Adolescent; Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Chil | 1980 |
Renal effects of beta-adrenoceptor blockade.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Angiotensin II; Animals; Blood Pressure; Cardia | 1980 |
Effects of beta-adrenergic blocking drugs in hypertensive rats.
Topics: Acebutolol; Adrenergic beta-Antagonists; Animals; Cerebrovascular Disorders; Hypertension; Kidney; M | 1980 |
[Antihypertensive treatment with beta receptor blockers and obstructive ventilatory disorder (author's transl)].
Topics: Adrenergic beta-Antagonists; Adult; Bronchitis; Dose-Response Relationship, Drug; Female; Humans; Hy | 1981 |
Epinephrine-resistant anaphylaxis in a patient taking propranolol hydrochloride.
Topics: Adrenergic beta-Antagonists; Airway Obstruction; Anaphylaxis; Drug Resistance; Epinephrine; Female; | 1981 |
Clonidine and prazosin effects in hypernoradrenergic vasodilator-treated and beta-blocker-treated patients.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Body Weight; Clonidine; Diastole; Diuretics; Female; Hu | 1981 |
Acute effects of salbutamol on arteriolar vasodilatation and blood pressure in spontaneously hypertensive rats.
Topics: Albuterol; Amyl Nitrite; Animals; Arteries; Blood Pressure; Heart Rate; Hypertension; Muscles; Propr | 1981 |
[Hemodynamic effects of some beta-adrenergic blocking agents in conscious spontaneously hypertensive rats (author's transl)].
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Cardiac Output; Heart Rate; Hemodynamics; Hype | 1981 |
Young Psychophysiologist Award address, 1980. Cardiovascular responses to effortful active coping: implications for the role of stress in hypertension development.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Blood Pressure; Competitive Behavior; Heart Rate; Hu | 1981 |
Antihypertensive activity of bucumolol, a beta-adrenergic blocking agent, in spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Coumarins; Disease Models, Animal; Hypertensio | 1981 |
The role of beta adrenergic blocking agents in the management of the patient with acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Coronary Disease; Drug Administration Schedule; Heart Rate; Humans; Hyp | 1981 |
[Hypertension treatment with a new retard form of a beta-blocker (result of a practice study)].
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Blood Pressure; Delay | 1981 |
[Use of beta-adrenoblockaders in the therapy of the syndromes accompanying acute myocardial infarct].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Cardiac Output; Hemodynamics; Humans | 1981 |
Variability in the preventive action of the B-blockers on genetic hypertension in the rat.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Blood Pressure; Dose-Response Relation | 1980 |
Atenolol: a long-acting beta 1- adrenoceptor antagonist.
Topics: Adrenergic beta-Antagonists; Atenolol; Humans; Hypertension; Kinetics; Propanolamines; Propranolol | 1982 |
Beta-blockers in pregnancy.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Female; Fetus; Humans; Hypertension; In | 1982 |
Combined intravenous administration of diazoxide and beta-blocking agent in acute treatment of severe hypertension or hypertensive crisis.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Diazoxide; Drug Therapy, Combination; Female; He | 1982 |
Reversal or prevention of diuretic-induced alterations in serum lipoproteins with betablockers.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Chlorthalidone; Cholesterol; Cholesterol, HDL; Drug | 1982 |
Propranolol and beta-adrenergic receptor blocking drugs in the treatment of hypertension.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Cardiac Volume; Dose-Response Relationship, Dr | 1982 |
Effect of low-dose epinephrine infusion on hemodynamics after selective and nonselective beta-blockade in hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Drug Interactions; Epinephrine; Female; Heart Ra | 1982 |
[Effect of adrenergic beta-receptor blockaders on thrombocyte aggregation capacity in arterial hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Blood Coagulation; Glomerulonephritis; Humans; Hypertension; Mal | 1982 |
Adrenoreceptor blockade in angiotensin-induced hypertension: effect on rat coronary arteries and myocardium.
Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Arterioles; Blood Pressure; Coronary Vessels; | 1982 |
[Effect of beta receptor blockers on carbohydrate metabolism].
Topics: Adrenergic beta-Antagonists; Aged; Blood Glucose; Carbohydrate Metabolism; Coronary Disease; Diabete | 1981 |
Clinical experiences with prenalterol as an antidote to Beta-adrenoceptor blockade.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Anesthesia; Cardiac Catheterizat | 1982 |
Comparison of the beta 1 and beta 2 adrenoceptor blocking properties of acebutolol and propranolol.
Topics: Acebutolol; Adrenergic beta-Antagonists; Blood Pressure; Double-Blind Method; Forced Expiratory Flow | 1982 |
Treatment of hypertension with beta-adrenoceptor blocking drugs.
Topics: Adrenergic beta-Antagonists; Atenolol; Female; Humans; Hypertension; Male; Propranolol | 1982 |
Alpha and beta adrenoceptor blockade in normotensive and deoxycorticosterone (DOC)-hypertensive rats; plasma vasopressin and vasopressin pressor effect.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Arginine Vasopressin; Blood Pres | 1983 |
Propranolol and depression.
Topics: Depression; Female; Humans; Hypertension; Male; Middle Aged; Propranolol | 1983 |
[Antihypertensive action of adrenergic beta-receptor blockers and its effect on the entire sympathetic outflow in spontaneously hypertensive rats].
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Hypertension; Pindolo | 1982 |
Possible significance of the pharmacological differentiation of beta-blocking agents in hemodynamic effects in essential hypertension.
Topics: Acebutolol; Adrenergic beta-Antagonists; Atenolol; Carteolol; Hemodynamics; Humans; Hypertension; Me | 1983 |
[Changes in serum lipids during drug therapy of hypertension].
Topics: Adrenergic beta-Antagonists; Diuretics; Drug Therapy, Combination; Growth Hormone; Humans; Hypertens | 1982 |
Adrenoceptor changes in spontaneous hypertensive rats: a circadian approach.
Topics: Adrenergic alpha-Antagonists; Animals; Blood Pressure; Brain; Brain Stem; Cerebral Cortex; Circadian | 1983 |
Thiazide or beta-blocker for hypertension.
Topics: Black People; Dose-Response Relationship, Drug; Humans; Hydrochlorothiazide; Hypertension; Propranol | 1983 |
[Effect of anaprilin on cardiac hemodynamic indices in elderly hypertensive patients].
Topics: Adrenergic beta-Antagonists; Aged; Drug Evaluation; Electrocardiography; Heart; Hemodynamics; Humans | 1983 |
Effects of prolonged administration of indenolol in hypertensive rats.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Body Weight; Cardiomegaly; Heart Rate; Hyperte | 1983 |
Effects of chronic beta-blocker treatment on catecholamine levels in spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Brain; Dopamine; Epinephrine; Heart Rate; Hype | 1983 |
[Peripheral vascular effects of metoprolol, pindolol and propranolol in hypertensive patients].
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Catecholamines; Female; Hemodynamics; Humans; Hy | 1983 |
Adrenergic blockade and hypoglycaemia.
Topics: Adrenergic beta-Antagonists; Blood Glucose; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Glucag | 1983 |
Modification of blood pressure and systolic time intervals by diuretics and beta-blockers in essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Diuretics; Female; Furosemide; Heart R | 1983 |
Comparative effects of beta-adrenergic blockade in systolic hypertension according to age.
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Blood Pressure; Hemodynamics; Humans; Hypertension; | 1983 |
Effects of acute and chronic treatments with atenolol and propranolol on cardiovascular responses to handling stress in spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressure; Dose-Response Relationship, Drug; Ha | 1983 |
The acute effects of a non-selective beta-adrenergic blocking agent in hypertensive pregnant rats.
Topics: Adrenergic beta-Antagonists; Animals; Cardiac Output; Female; Heart Rate; Hemodynamics; Hypertension | 1984 |
Insect sting anaphylaxis and beta-adrenergic blockade: a relative contraindication.
Topics: Adrenergic beta-Antagonists; Adult; Anaphylaxis; Bee Venoms; Bees; Desensitization, Immunologic; Epi | 1984 |
Antihypertensive effect and degree of beta-adrenoceptor blockade after short-term and semi-chronic propranolol therapy.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Blood Pressure; Electrolytes; Female; H | 1984 |
The effect of week-long infusion of propranolol, via an osmotic minipump, on blood pressure, heart rate and vascular responses in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Drug Implants; Heart Rate; Hemodynamics; Hypertension; Male; Osmotic Pressu | 1984 |
Peripheral hemodynamic effects of short-term nadolol administration in essential hypertension.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Blood Pressure; Female; Forearm; Heart Rate; Hemodyn | 1984 |
A call for caution in the use of aminoglutethimide: negative interactions with dexamethasone and beta blocker treatment.
Topics: Adrenergic beta-Antagonists; Aged; Aminoglutethimide; Brain Neoplasms; Breast Neoplasms; Dexamethaso | 1984 |
Effects of the R, R-isomer of labetalol, SCH 19927, in isolated tissues and in spontaneously hypertensive rats during a repeated treatment.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Aorta, Thoracic; Blood Pressure; | 1984 |
Beta-adrenergic blockade alone does not decrease renal perfusion in black hypertensives.
Topics: Adrenergic beta-Antagonists; Atenolol; Blood Pressure; Glomerular Filtration Rate; Heart Rate; Human | 1984 |
Cardiac performance in the conscious rabbit with acute hypertension following brainstem lesions coinciding with the A1 group of catecholamine neurons.
Topics: Adrenergic beta-Antagonists; Animals; Heart; Hemodynamics; Hypertension; Male; Medulla Oblongata; My | 1984 |
[Hypotensive and renin-stimulating action of captopril at first and during treatment with a beta-blocker].
Topics: Adrenergic beta-Antagonists; Blood Pressure; Captopril; Drug Interactions; Humans; Hypertension; Pro | 1982 |
Renal function in long-term minoxidil-treated patients.
Topics: Adult; Blood Pressure; Clonidine; Creatinine; Diuretics; Female; Humans; Hypertension; Hypertension, | 1980 |
Rapid reduction of severe hypertension with minoxidil.
Topics: Adult; Blood Pressure; Body Weight; Dose-Response Relationship, Drug; Female; Furosemide; Hemodynami | 1980 |
Increased aldosterone metabolic clearance in hypertensive patients treated with minoxidil: an effect of greater hepatic perfusion.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Diuretics; Humans; Hypertension; Indocyanine Green; Liver; | 1980 |
Effect of beta-receptor-blocking agents on cardiovascular structural changes in spontaneous and noradrenaline-induced hypertension in rats.
Topics: Animals; Aorta; Atenolol; Heart Ventricles; Hydralazine; Hypertension; Male; Norepinephrine; Organ S | 1980 |
Plasma norepinephrine as an indicator of sympathetic neural activity in clinical cardiology.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Diazepam; Drug Interactions; He | 1981 |
Effects of exercise on urinary excretion of albumin and beta 2-microglobulin in young patients with mild essential hypertension without treatment and during long-term propranolol treatment.
Topics: Adult; Albuminuria; beta 2-Microglobulin; Beta-Globulins; Blood Pressure; Female; Glomerular Filtrat | 1981 |
Elevated arteriolar adenosine 3',5'-cyclic monophosphate production by SHR.
Topics: 1-Methyl-3-isobutylxanthine; Albuterol; Animals; Arterioles; Blood Pressure; Body Weight; Cyclic AMP | 1982 |
Contrasting effects of nifedipine, captopril, and propranolol in normotensive and hypertensive subjects.
Topics: Adult; Blood Pressure; Calcium Channel Blockers; Captopril; Humans; Hypertension; Male; Nifedipine; | 1982 |
[Interaction between antihypertensive and antirheumatic agents].
Topics: Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Aprotinin; Captopril; Dogs; Drug Antagon | 1983 |
The impact on serum lipids of combinations of diuretics and beta-blockers and of beta-blockers alone.
Topics: Adrenergic beta-Antagonists; Cholesterol, HDL; Diuretics; Drug Therapy, Combination; Humans; Hydroch | 1984 |
Left ventricular systolic performance during upright bicycle exercise in patients with essential hypertension.
Topics: Adult; Aged; Blood Pressure; Cardiomegaly; Coronary Disease; Exercise Test; Female; Heart; Heart Ven | 1983 |
Enhancement by diuretics of the antihypertensive action of long-term angiotensin converting enzyme blockade.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Child; | 1980 |
[Captopril in the treatment of essential hypertension (author's transl)].
Topics: Adult; Aldosterone; Anemia; Captopril; Humans; Hypertension; Middle Aged; Peptidyl-Dipeptidase A; Po | 1980 |
Plasma levels of cyclic nucleotides in patients with essential hypertension.
Topics: Adult; Aged; Blood Pressure; Cyclic AMP; Cyclic GMP; Diuretics; Female; Hemodynamics; Humans; Hypert | 1980 |
Efficacy of an oral angiotensin-converting enzyme inhibitor (captopril) in severe hypertension.
Topics: Administration, Oral; Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Therapy, Comb | 1981 |
Cyclic nucleotide phosphodiesterase in the aorta of spontaneously hypertensive rats : variation with age and effect of propranolol.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Age Factors; Animals; Aort | 1980 |
Effect of propranolol therapy on aldosterone responses to angiotensin II and adrenocorticotropic hormone in essential hypertension.
Topics: Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Humans; Hypertension; Male; Middle Aged; P | 1981 |
Comparative effects of alpha-methyldopa, propranolol and hydralazine therapy on cardiac adenylate cyclase activity in normal and spontaneously hypertensive rats.
Topics: Adenylyl Cyclases; Animals; Antihypertensive Agents; Glucagon; Hydralazine; Hypertension; Male; Meth | 1981 |
Anti-hypertensive effects of propranolol unaltered by 6-hydroxydopamine given intraventricularly to SHR.
Topics: Animals; Blood Pressure; Brain; Female; Heart Rate; Hydroxydopamines; Hypertension; Injections, Intr | 1981 |
Decrease in alpha-adrenoceptor-mediated vasoconstriction parallels the antihypertensive response to propranolol in patients with normal renin essential hypertension.
Topics: Adult; Humans; Hypertension; Male; Middle Aged; Prazosin; Propranolol; Receptors, Adrenergic; Recept | 1981 |
Acute hypotensive and renin-stimulating actions of captopril before and during treatment with a beta-blocking drug.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Dose-Response Relationship, Dru | 1982 |
Altered inotropic responsiveness to isoproterenol of hearts from spontaneously hypertensive rats during development.
Topics: Age Factors; Animals; Blood Pressure; Hypertension; In Vitro Techniques; Isoproterenol; Myocardial C | 1982 |
Chronic propranolol treatment decreases cardiac beta-adrenoceptors in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Dihydroalprenolol; Heart; Heart Rate; Hypertension; Kinetics; Male; Propran | 1982 |
Dependence of the cardiovascular effects of pindolol on the individual sympathetic nervous activity.
Topics: Adult; Atropine; Female; Heart Rate; Hemodynamics; Humans; Hypertension; Infusions, Parenteral; Male | 1982 |
Opiate antagonists reverse the centrally mediated antihypertensive action of propranolol in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Heart Rate; Hypertension; Male; Narcotic Antagonists; Propranolol; Rats; Ra | 1982 |
Reduced beta adrenoceptor interactions of norepinephrine enhance contraction in the femoral artery from spontaneously hypertensive rats.
Topics: Animals; Aorta, Thoracic; Female; Femoral Artery; Hypertension; In Vitro Techniques; Isoproterenol; | 1982 |
Effects of oral atenolol and propranolol on blood pressure, heart rate and plasma cyclic adenosine 3':5'-monophosphate in borderline hypertensive patients.
Topics: Adolescent; Adult; Atenolol; Blood Pressure; Cyclic AMP; Female; Heart Rate; Humans; Hypertension; M | 1982 |
Regression of myocardial hypertrophy and influence of adrenergic system.
Topics: Animals; Blood Pressure; Cardiomegaly; Catecholamines; Dose-Response Relationship, Drug; Hydralazine | 1983 |
Platelet alpha 2-adrenergic receptors in treated and untreated essential hypertension.
Topics: Adult; Blood Platelets; Guanabenz; Humans; Hypertension; Male; Middle Aged; Platelet Aggregation; Pr | 1983 |
The ratio of cardiac to vascular beta-receptor blockade of atenolol and propranolol in spontaneously hypertensive rats in vivo.
Topics: Animals; Atenolol; Blood Vessels; Female; Heart; Hemodynamics; Hypertension; Isoproterenol; Propanol | 1982 |
Phaeochromocytoma and diabetes mellitus: further evidence that alpha 2 receptors inhibit insulin release in man.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Diabetes Mellitus; Humans; Hypertension; Insulin; Male; Midd | 1983 |
Effect of antihypertensive therapy on sympathetic nervous system activity in patients with essential hypertension.
Topics: Antihypertensive Agents; Captopril; Clonidine; Guanethidine; Humans; Hydrochlorothiazide; Hypertensi | 1984 |
Monotherapy in mild to moderate hypertension: comparison of hydrochlorothiazide, propranolol and prazosin.
Topics: Adult; Aged; Blood Pressure; Erythrocytes; Female; Heart; Heart Rate; Humans; Hydrochlorothiazide; H | 1984 |
Beta 1 - beta 2 blocking activity of propranolol and metoprolol in the unanaesthetized genetically hypertensive and normotensive rat.
Topics: Animals; Blood Pressure; Heart Rate; Hypertension; Isoproterenol; Male; Metoprolol; Pressoreceptors; | 1984 |
Modification by preoperative beta-blockade of the renin response to infrarenal aortic cross-clamping.
Topics: Adult; Aged; Aorta, Abdominal; Constriction; Female; Humans; Hypertension; Male; Middle Aged; Postop | 1983 |
Orthostatic hypertension with nephroptosis and aortitis disease.
Topics: Aortitis; Captopril; Drug Therapy, Combination; Female; Humans; Hypertension; Kidney; Middle Aged; P | 1984 |
Further studies on the hypernoradrenergic state of treated hypertensives: effect of captopril.
Topics: Blood Pressure; Captopril; Diuretics; Epinephrine; Female; Furosemide; Humans; Hypertension; Male; M | 1983 |
Comparative effects of propranolol and prazosin upon serum lipids in thiazide- treated hypertensive patients.
Topics: Adult; Blood Pressure; Cholesterol; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertens | 1984 |
Effects of metoprolol and propranolol on glucose tolerance and insulin secretion in diabetes mellitus.
Topics: Adult; Aged; Blood Pressure; Diabetes Complications; Diabetes Mellitus; Double-Blind Method; Female; | 1984 |
[Captopril in the management of hypertension].
Topics: Animals; Captopril; Drug Therapy, Combination; Humans; Hypertension; Male; Middle Aged; Proline; Pro | 1984 |
Effect of captopril on intrarenal blood flow.
Topics: Animals; Captopril; Diuresis; Diuretics; Dogs; Furosemide; Glomerular Filtration Rate; Humans; Hyper | 1984 |
Mechanisms of central prostaglandin E2 hypertension in conscious dogs, sheep, and calves.
Topics: Anesthesia; Angiotensin II; Animals; Captopril; Carotid Arteries; Cattle; Chemoreceptor Cells; Dinop | 1984 |
Renin dependency of blood pressure in isolated systolic hypertension.
Topics: Adult; Aged; Blood Pressure; Captopril; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; | 1984 |
Characteristics of hypertension in primary IgA glomerulonephritis.
Topics: Adolescent; Adult; Aldosterone; Child; Female; Glomerulonephritis, IGA; Humans; Hypertension; Indome | 1984 |
Hypertensive crisis caused by hypoglycemia and propranolol.
Topics: Adult; Humans; Hypertension; Hypoglycemia; Insulin; Male; Propranolol | 1984 |
Comparison of long-term renal hemodynamic effects of methyldopa and propranolol in patients with hypertension and renal insufficiency.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Female; Furosemide; Humans; Hypertension; Kidney Diseases; | 1984 |
Is the renin-angiotensin system involved in urinary concentration mechanisms?
Topics: Angiotensin II; Animals; Dogs; Furosemide; Humans; Hypertension; Kidney Concentrating Ability; Kinet | 1984 |
[Docidrazin. Long-term observation with a 3-component antihypertensive agent].
Topics: Adult; Aged; Antihypertensive Agents; Bendroflumethiazide; Drug Combinations; Female; Humans; Hydral | 1983 |
Long term propranolol and hydralazine in hypertension.
Topics: Adult; Drug Combinations; Humans; Hydralazine; Hypertension; Long-Term Care; Propranolol | 1984 |
Long-term follow-up study of hypertensive patients by practicing internists after a controlled drug trial.
Topics: Antihypertensive Agents; Blood Pressure; Debrisoquin; Double-Blind Method; Drug Therapy, Combination | 1984 |
Membrane potentials and contractile events of hypertrophied rat cardia muscle.
Topics: Action Potentials; Animals; Cardiomegaly; Electric Stimulation; Hypertension; In Vitro Techniques; M | 1981 |
Effect of chronic administration of clonidine and propranolol on the myocardium of spontaneously hypertensive rats.
Topics: Animals; Body Water; Cardiomegaly; Clonidine; Glycosaminoglycans; Heart; Hypertension; Muscle Protei | 1982 |
Studies with long acting propranolol.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Delayed-Action Preparations; Half-Life; Heart Rate; Humans; H | 1984 |
[Radioisotopic and phonomechanocardiographic evaluation of the effects of propranolol and pindolol on left ventricular function in patients with systemic arterial hypertension].
Topics: Adult; Female; Heart Ventricles; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Phonocardiog | 1984 |
Once-daily propranolol for hypertension.
Topics: Adult; Aged; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Propranolo | 1984 |
Verapamil and propranolol in essential hypertension.
Topics: Adult; Aged; Blood Pressure; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; | 1984 |
Exercise-induced hypoglycemia following propranolol in a patient after gastric fundoplication surgery.
Topics: Adult; Blood Glucose; Gastric Fundus; Humans; Hydrochlorothiazide; Hypertension; Hypoglycemia; Male; | 1984 |
An evaluation of a new patient compliance index using plasma propranolol levels.
Topics: Adult; Aged; Analysis of Variance; Biological Availability; Blood Pressure; Chromatography, High Pre | 1984 |
Latent abnormalities of sinus node function in patients with organic heart disease and normal sinus node on clinical basis.
Topics: Adolescent; Adult; Aged; Atropine; Autonomic Nerve Block; Autonomic Nervous System; Female; Heart Di | 1984 |
Propranolol-induced mania.
Topics: Adult; Bipolar Disorder; Humans; Hypertension; Male; Propranolol | 1984 |
Hemodynamic and neural mechanisms of acute neurogenic hypertension in the rat.
Topics: Acute Disease; Adrenal Medulla; Adrenalectomy; Animals; Atropine; Autonomic Nerve Block; Biomechanic | 1984 |
Efficacy of combination of propranolol and hydralazine versus alpha-methyldopa in hypertension.
Topics: Adult; Aged; Drug Therapy, Combination; Humans; Hydralazine; Hypertension; Methyldopa; Middle Aged; | 1984 |
[Beta-adrenergic blockers and renin-angiotensin-aldosterone system in healthy individuals and patients with arterial hypertension].
Topics: Adult; Atenolol; Female; Humans; Hypertension; Hypertension, Renal; Male; Middle Aged; Propranolol; | 1984 |
[Usefulness of xipamide alone or associated with a beta blocker in the treatment of idiopathic arterial hypertension].
Topics: Adult; Diuretics; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Mi | 1984 |
[Endogenous opioid peptides in borderline arterial hypertension].
Topics: Adolescent; Adult; Aging; Endorphins; Female; Hemodynamics; Humans; Hypertension; Male; Propranolol; | 1984 |
[Psychological and physical performance standards of borderline hypertensive patients before and during treatment with propranolol].
Topics: Adult; Auditory Perception; Blood Pressure; Discrimination Learning; Exercise Test; Heart Rate; Huma | 1984 |
Flurbiprofen interaction with single doses of atenolol and propranolol.
Topics: Adult; Aldosterone; Atenolol; Blood Pressure; Body Weight; Female; Flurbiprofen; Heart Rate; Humans; | 1984 |
Effects of pildralazine alone and in combination on severe hypertension and cerebrovascular lesions in saline-drinking spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Cerebrovascular Disorders; Drug Therapy, Combination; Female; Hydrochloroth | 1984 |
Systemic hypertension in infants with bronchopulmonary dysplasia.
Topics: Bronchopulmonary Dysplasia; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Infant; In | 1984 |
The role of TXA2 in hypertension.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Antihypertensive Agents; Aorta; Blood Pressure; Clonidine; Di | 1984 |
Cocaine.
Topics: Cocaine; Emergencies; Fever; Humans; Hypertension; Propranolol; Seizures; Substance-Related Disorder | 1984 |
Minoxidil in severe hypertension.
Topics: Adult; Aged; Drug Therapy, Combination; Female; Furosemide; Humans; Hypertension; Male; Middle Aged; | 1983 |
Propranolol-induced depression: mechanism and management.
Topics: Adult; Angina Pectoris; Atenolol; Depressive Disorder; Female; Humans; Hypertension; Male; Middle Ag | 1983 |
An unusual young male with exercise induced, severe hypertensive spikes. What's the diagnosis?
Topics: Adult; Drug Therapy, Combination; Furosemide; Humans; Hypertension; Male; Minoxidil; Physical Exerti | 1983 |
Studies on salivary flow in borderline hypertension.
Topics: Adult; Catecholamines; Humans; Hypertension; Male; Phentolamine; Propranolol; Reference Values; Sali | 1983 |
Importance of cardiac pacing in the analysis of vagal and sympathetic contributions to baroreflex control of cardiac performance in the conscious rabbit.
Topics: Animals; Blood Pressure; Cardiac Pacing, Artificial; Hypertension; Myocardial Contraction; N-Methyls | 1984 |
Propranolol withdrawal and variceal hemorrhage.
Topics: Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension; Male; Middle Aged | 1983 |
Propranolol-induced postoperative hypertension following coronary artery bypass grafting.
Topics: Adult; Aged; Coronary Artery Bypass; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; | 1984 |
[Ambulatory treatment of hypertension with the beta blocker propranolol (Indobloc)].
Topics: Ambulatory Care; Female; Humans; Hypertension; Male; Middle Aged; Propranolol | 1983 |
Effects of anti-hypertensive therapy on serum lipoproteins. Treatment with metoprolol, propranolol and hydrochlorothiazide.
Topics: Adipose Tissue; Apolipoproteins; Blood Glucose; Catecholamines; Fatty Acids; Humans; Hydrochlorothia | 1983 |
Haemodynamic effects of the optical isomers of beta-receptor blocking agents.
Topics: Blood Pressure; Cardiac Output; Double-Blind Method; Heart Rate; Hemodynamics; Humans; Hypertension; | 1983 |
[Mental changes in hypertensive patients during long-term ambulatory treatment].
Topics: Adult; Ambulatory Care; Antihypertensive Agents; Clonidine; Diuretics; Female; Humans; Hydrochloroth | 1983 |
Perioperative hypoglycemia in a child treated with propranolol.
Topics: Anesthesia, Inhalation; Child; Child, Preschool; Ear, Middle; Fasting; Female; Humans; Hypertension; | 1983 |
Management of cocaine poisoning.
Topics: Animals; Arrhythmias, Cardiac; Cocaine; Diazepam; Humans; Hypertension; Propranolol; Sympathetic Ner | 1983 |
Impairment of memory function by antihypertensive medication.
Topics: Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Memory; Mental Recall; Met | 1983 |
The role of epinephrine in essential hypertension.
Topics: Adolescent; Adult; Blood Pressure; Epinephrine; Female; Glucagon; Heart Rate; Humans; Hypertension; | 1983 |
[Effect of propranolol on selected functions of blood platelets in patients with primary arterial hypertension].
Topics: Adult; Anticoagulants; Female; Humans; Hypertension; Male; Middle Aged; Platelet Aggregation; Propra | 1983 |
[Effect of the combined administration of alpha- and beta-adrenergic blockaders (propranolol and phentolamine) on central and renal hemodynamics during the treatment of patients with arterial hypertension].
Topics: Drug Therapy, Combination; Hemodynamics; Humans; Hypertension; Middle Aged; Phentolamine; Propranolo | 1983 |
[Swim therapy in elderly patients with essential hypertension treated with beta receptor blockers].
Topics: Aged; Blood Pressure; Combined Modality Therapy; Heart Rate; Humans; Hypertension; Male; Middle Aged | 1983 |
Effects of diltiazem on cardiovascular responses during exercise in systemic hypertension and comparison with propranolol.
Topics: Adult; Benzazepines; Blood Pressure; Cardiac Output; Diltiazem; Exercise Test; Female; Heart Rate; H | 1983 |
Hemodynamics and monoamine oxidase activity in spontaneously hypertensive rats (SHR).
Topics: Animals; Blood Pressure; Brain; Heart Rate; Hemodynamics; Hypertension; Kinetics; Male; Monoamine Ox | 1983 |
[Behavior of the arterial pressure in patients taking atenolol and propranolol under the influence of alcohol].
Topics: Alcohol Drinking; Atenolol; Blood Pressure; Female; Humans; Hypertension; Male; Propranolol | 1983 |
Electroconvulsive therapy and intracranial aneurysm. Prevention of blood pressure elevation in a normotensive patient by hydralazine and propranolol.
Topics: Adult; Anesthesia, Intravenous; Depressive Disorder; Electroconvulsive Therapy; Female; Humans; Hydr | 1983 |
[Prazosin in moderate or severe essential arterial hypertension not controlled with chlorthalidone. A multicenter study].
Topics: Adult; Blood Pressure; Chlorthalidone; Drug Therapy, Combination; Female; Humans; Hypertension; Male | 1983 |
Propranolol and renal hemodynamics at rest and during exercise.
Topics: Adult; Blood Pressure; Heart Rate; Hemodynamics; Humans; Hypertension; Middle Aged; Physical Exertio | 1983 |
Subacute studies on hemodynamic effects of propranolol in conscious spontaneously hypertensive rats (SHR).
Topics: Animals; Dopamine beta-Hydroxylase; Hemodynamics; Hypertension; Male; Propranolol; Rats; Rats, Inbre | 1983 |
[Long-term treatment of arterial hypertension with a new combined preparation obsilazin].
Topics: Blood Pressure; Dihydralazine; Drug Combinations; Humans; Hydralazine; Hypertension; Propranolol; Pr | 1983 |
[Use of propranolol in essential hypertension--results of a 10-year therapeutic course study].
Topics: Adolescent; Adult; Aged; Blood Pressure; Drug Therapy, Combination; Female; Follow-Up Studies; Heart | 1983 |
Possible role of an endogenous opioid in the antihypertensive action of propranolol in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Endorphins; Hear | 1983 |
Safety and efficacy of a three-drug regimen for the treatment of hypertension: hydrochlorothiazide, propranolol, and guanadrel.
Topics: Adult; Antihypertensive Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Gua | 1983 |
[Long-term effectiveness of nifedipine combined with propranolol in the treatment of hypertension].
Topics: Adult; Aged; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle | 1983 |
Effects of propranolol therapy on renal function and body fluid composition.
Topics: Blood Pressure; Body Fluids; Electrolytes; Humans; Hypertension; Kidney; Kidney Function Tests; Male | 1983 |
Comparison of sotalol and propranolol in mild to moderate essential hypertension.
Topics: Adult; Blood Pressure; Drug Evaluation; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; | 1983 |
[Human pharmacology of carteolol].
Topics: Administration, Oral; Blood Platelets; Carteolol; Coronary Disease; Hemodynamics; Humans; Hypertensi | 1983 |
Comparison of propranolol and propranolol LA in hypertension using 24-hr noninvasive blood pressure monitoring.
Topics: Adult; Aged; Blood Pressure; Circadian Rhythm; Delayed-Action Preparations; Female; Heart Rate; Huma | 1983 |
[Comparative evaluation of the hemodynamic effect of a single administration of cordanum and obzidan in patients with arterial hypertension].
Topics: Adolescent; Adult; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Propanolamines; Pr | 1983 |
Cardiac arrest during ECT modified by beta-adrenergic blockade.
Topics: Aged; Coronary Disease; Depressive Disorder; Diabetes Complications; Electroconvulsive Therapy; Fema | 1984 |
Prazosin versus propranolol plus prazosin: a comparison in diuretic-treated hypertensive patients.
Topics: Aged; Blood Pressure; Drug Therapy, Combination; Heart Rate; Humans; Hydrochlorothiazide; Hypertensi | 1984 |
The effect of propranolol on the nonstress test.
Topics: Adolescent; Adult; Female; Fetal Monitoring; Fetus; Humans; Hypertension; Pregnancy; Pregnancy Compl | 1984 |
Effects of diuretic and beta-blocker therapy in the Medical Research Council Trial.
Topics: Adult; Bendroflumethiazide; Blood Pressure; Electrocardiography; England; Female; Humans; Hypertensi | 1984 |
Nifedipine in hypertension and heart failure.
Topics: Adult; Aged; Blood Pressure; Delayed-Action Preparations; Drug Therapy, Combination; Female; Heart F | 1984 |
Hemodynamic modification of aortic atherosclerosis. Effects of propranolol vs hydralazine in hypertensive hyperlipidemic rabbits.
Topics: Animals; Aortic Diseases; Arteriosclerosis; Cholesterol; Hemodynamics; Hydralazine; Hyperlipidemias; | 1984 |
Changes in blood chemistry in hypertensive patients during propranolol therapy.
Topics: Adult; Blood Proteins; Cholesterol; Creatinine; Female; Humans; Hypertension; Male; Middle Aged; Pro | 1984 |
[Therapeutic effect of obzidan and its influence on the hemodynamics of hypertension patients].
Topics: Adolescent; Adult; Chronic Disease; Drug Evaluation; Echocardiography; Female; Heart Ventricles; Hem | 1984 |
The short-term effects of reducing elevated blood pressure in elderly patients with propranolol and dyazide.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Cardiac Output; Cerebrovascular Circulation; Cognitio | 1984 |
Failure of antihypertensive therapy with diuretic, beta-blocking and calcium channel-blocking drugs to consistently reverse left ventricular diastolic filling abnormalities.
Topics: Benzazepines; Blood Pressure; Cardiac Volume; Diltiazem; Female; Heart; Heart Rate; Heart Ventricles | 1984 |
Hypertension, vascular headaches, and seizures after carotid endarterectomy. Case report and therapeutic considerations.
Topics: Carotid Arteries; Endarterectomy; Female; Humans; Hypertension; Middle Aged; Phenobarbital; Prazosin | 1984 |
Effects of short term beta adrenoreceptor blockade on serum lipids and lipoproteins in patients with hypertension or coronary artery disease.
Topics: Adult; Angina Pectoris; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Lipids; Lipoprotei | 1984 |
Propranolol can inhibit the development of hypertension in SHR.
Topics: Animals; Blood Pressure; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Hea | 1984 |
Rapid control of severe hypertension with minoxidil.
Topics: Adult; Blood Pressure; Drug Therapy, Combination; Female; Furosemide; Humans; Hypertension; Male; Mi | 1982 |
The role of aldosterone in the response to treatment of primary hypertension.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Chlorthalidone; Female; Humans; Hypertension; Male; Middle | 1982 |
Effects of acute and long-term beta-adrenoceptor blockade with propranolol on haemodynamics, plasma catecholamines and renin in essential hypertension.
Topics: Adult; Catecholamines; Epinephrine; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; N | 1982 |
[Effect of pretreatment with atenolol and propranolol on sympatho-adrenal and cardiovascular responses to acute insulin-induced hypoglycaemia in the hypertensive patient].
Topics: Adult; Atenolol; Blood Glucose; Blood Pressure; Catecholamines; Female; Heart Rate; Hemodynamics; Hu | 1982 |
Effects of propranolol and atenolol on plasma renin activity and systolic time intervals in borderline hypertension.
Topics: Adolescent; Adult; Atenolol; Blood Pressure; Depression, Chemical; Electrocardiography; Female; Hear | 1982 |
[Hypotensive and renin-stimulating action of captopril before and during treatment with beta-blockers].
Topics: Captopril; Humans; Hypertension; Proline; Propranolol; Renin | 1982 |
[Effect of hypotensive drugs on plasma renin activity in primary hypertension].
Topics: Adult; Aged; Antihypertensive Agents; Clopamide; Dihydroergotoxine; Drug Combinations; Enzyme Inhibi | 1980 |
Raised plasma renin activity in the hypertension of the Guillain-Barré syndrome.
Topics: Child; Humans; Hypertension; Male; Polyradiculoneuropathy; Propranolol; Renin | 1981 |
Plasma sex hormone concentrations in men with hypertension treated with methyldopa and/or propranolol.
Topics: Adult; Aged; Erectile Dysfunction; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Humans; H | 1981 |
Effects on the renin-angiotensin system of agents acting at central and peripheral adrenergic receptors.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Clonidine; Double-Blind Method; Female; Humans; Hypertensi | 1983 |
Monotherapy in the treatment of hypertension.
Topics: Benzothiadiazines; Blood Pressure; Diet, Sodium-Restricted; Diuretics; Humans; Hypertension; Myocard | 1983 |
[Urinary excretion of catecholamines and their metabolites in labile arterial hypertension].
Topics: Adolescent; Adult; Catecholamines; Dopamine; Female; Homovanillic Acid; Humans; Hypertension; Middle | 1983 |
The antiarrhythmic effects of verapamil and propranolol in aminophylline toxic dogs.
Topics: Aminophylline; Animals; Arrhythmias, Cardiac; Blood Gas Analysis; Dogs; Electrocardiography; Hemodyn | 1983 |
[Effects of propranolol and metoprolol on peripheral circulation in intermittent claudication].
Topics: Aged; Humans; Hypertension; Intermittent Claudication; Male; Metoprolol; Middle Aged; Propanolamines | 1983 |
Physical assessment. The heart.
Topics: Auscultation; Furosemide; Heart; Heart Auscultation; Heart Diseases; Humans; Hypertension; Male; Mid | 1983 |
Disparate effects of prazosin and propranolol on lipid metabolism in a rat model.
Topics: Animals; Cholesterol; Disease Models, Animal; Hypertension; Lipid Metabolism; Lipoproteins, VLDL; Ma | 1983 |
Metabolic consequences of antihypertensive therapy.
Topics: Antihypertensive Agents; Blood Glucose; Carbohydrate Metabolism; Hormones; Humans; Hydrochlorothiazi | 1983 |
Urine and plasma propranolol.
Topics: Adult; Chromatography, Gas; Creatinine; Female; Humans; Hypertension; Male; Middle Aged; Orosomucoid | 1983 |
Clonidine withdrawal complicated by amitriptyline therapy.
Topics: Aged; Amitriptyline; Anxiety; Clonidine; Female; Humans; Hypertension; Intraoperative Care; Methyldo | 1983 |
Propranolol-epinephrine interaction: a potential disaster.
Topics: Autonomic Nervous System; Bradycardia; Cardiovascular Physiological Phenomena; Drug Interactions; Ep | 1983 |
Treatment of hypertension associated with head injury.
Topics: Adolescent; Adult; Craniocerebral Trauma; Epinephrine; Hemodynamics; Humans; Hydralazine; Hypertensi | 1983 |
[Efficacy of nifedipine in combination with propranolol in the therapy of primary arterial hypertension of moderate degree].
Topics: Drug Evaluation; Drug Therapy, Combination; Humans; Hypertension; Nifedipine; Propranolol | 1982 |
[Effect of various hypotensive drugs on the plasma level of kininogen and prekallikrein in hypertension].
Topics: Adult; Antihypertensive Agents; Blood Pressure; Female; Furosemide; Humans; Hypertension; Kallikrein | 1980 |
[Avlocardyl].
Topics: Drug Interactions; Humans; Hypertension; Propranolol | 1982 |
[Clinical and experimental study of the effect of obsidan and hemiton on the blood kallikrein-kinin system].
Topics: Adolescent; Adult; Animals; Clonidine; Drug Evaluation; Drug Evaluation, Preclinical; Female; Humans | 1982 |
[Efficacy of nifedipine in combination with propranolol in the therapy of primary arterial hypertension of moderate degree].
Topics: Drug Therapy, Combination; Humans; Hypertension; Nifedipine; Propranolol | 1982 |
Antihypertensive treatment inhibiting the progression of diabetic nephropathy.
Topics: Adult; Blood Pressure; Diabetic Nephropathies; Glomerular Filtration Rate; Humans; Hypertension; Mal | 1980 |
Atenolol in hypertension: follow-up of patients crossed over to this agent from propranolol, pindolol or metoprolol.
Topics: Adult; Aged; Atenolol; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; Humans | 1980 |
HDL-cholesterol, triglycerides and vascular complications in essential hypertension.
Topics: Adult; Aged; Cardiovascular Diseases; Cholesterol; Female; Humans; Hydroflumethiazide; Hypertension; | 1981 |
Medical treatment of hypertension and renal failure in scleroderma.
Topics: Acute Kidney Injury; Adult; Female; Humans; Hydralazine; Hypertension; Minoxidil; Propranolol; Scler | 1981 |
Effect of propranolol treatment on the urinary excretion of prostaglandins E2 and F2 alpha in patients with essential hypertension.
Topics: Adult; Blood Pressure; Dinoprost; Dinoprostone; Drug Therapy, Combination; Female; Furosemide; Human | 1982 |
MB creatine kinase and the evaluation of myocardial injury following aortocoronary bypass operation.
Topics: Angina Pectoris; Coronary Artery Bypass; Coronary Vessels; Creatine Kinase; Extracorporeal Circulati | 1980 |
Sclerosing peritonitis and propranolol.
Topics: Angina Pectoris; Colon; Gastrointestinal Hemorrhage; Humans; Hypertension; Male; Middle Aged; Perito | 1981 |
Predictive value of symptom-limited exercise for risk assessment of primary and secondary events due to coronary heart disease in men.
Topics: Adult; Coronary Artery Bypass; Coronary Disease; Electrocardiography; Exercise Test; Follow-Up Studi | 1981 |
Captopril in severe treatment-resistant hypertension.
Topics: Adolescent; Adult; Aged; Blood Pressure; Captopril; Female; Furosemide; Heart Rate; Humans; Hydralaz | 1980 |
Management of severe hypertension with nifedipine in combination with clonidine or propranolol.
Topics: Adult; Blood Pressure; Clonidine; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hypertens | 1980 |
Effect of propranolol on the urinary excretion of prostaglandin E and plasma renin activity in hypertensive patients.
Topics: Adolescent; Adult; Aldosterone; Angiotensin II; Blood Pressure; Female; Humans; Hypertension; Male; | 1980 |
Effect of propranolol on the renin response to frusemide in man.
Topics: Adult; Blood Pressure; Furosemide; Humans; Hypertension; Male; Propranolol; Pulse; Renin | 1980 |
Combined effects of phenoxybenzamine and propranolol in hypertensive rats.
Topics: Animals; Antihypertensive Agents; Body Weight; Heart Rate; Hypertension; Male; Phenoxybenzamine; Pro | 1980 |
beta-Adrenoreceptor blockage and genetic hypertension development in rats.
Topics: Acebutolol; Animals; Atenolol; Blood Pressure; Body Weight; Depression, Chemical; Hemodynamics; Hype | 1980 |
[Essential hypertension with low levels of plasma renin activity: effects of propranolol on aldosteronemia, plasma volume and electrolyte balance].
Topics: Adult; Aldosterone; Female; Humans; Hypertension; Male; Middle Aged; Plasma Volume; Propranolol; Ren | 1980 |
[Treatment of mild and moderate essential arterial hypertension with captopril].
Topics: Adult; Aged; Blood Pressure; Captopril; Drug Therapy, Combination; Female; Humans; Hypertension; Mal | 1980 |
[Treatment of severe arterial hypertension with captopril].
Topics: Adult; Blood Pressure; Captopril; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension | 1980 |
Suppression of renin production in patients undergoing coronary artery bypass.
Topics: Adult; Aged; Coronary Artery Bypass; Coronary Disease; Humans; Hypertension; Intensive Care Units; M | 1980 |
Dopaminergic modulation of renin release.
Topics: Animals; Blood Pressure; Dopamine; Dopamine Antagonists; Hypertension; Levodopa; Male; Metoclopramid | 1981 |
Interaction of minoxidil and captopril in the treatment of refractory hypertension.
Topics: Acidosis; Adolescent; Aldosterone; Captopril; Creatinine; Drug Interactions; Female; Humans; Hyperka | 1981 |
Propranolol in the treatment of renin-mediated hypertension.
Topics: Humans; Hypertension; Juxtaglomerular Apparatus; Propranolol; Receptors, Adrenergic; Renin; Sympathe | 1980 |
Acute tolerance to prazosin in conscious hypertensive rats: involvement of the renin-angiotensin system.
Topics: Angiotensin II; Animals; Captopril; Cardiovascular Agents; Clonidine; Dose-Response Relationship, Dr | 1981 |
Captopril combined with thiazide lowers renin substrate concentration: implications for methodology in renin assays.
Topics: Angiotensinogen; Angiotensins; Captopril; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hy | 1981 |
[Captopril in treatment-resistant hypertension (author's transl)].
Topics: Adult; Captopril; Diastole; Drug Combinations; Female; Furosemide; Humans; Hydralazine; Hydrochlorot | 1980 |
Cardiovascular and hormonal responses to electroconvulsive therapy. Modification of an exaggerated response in an hypertensive patient by beta-receptor blockade.
Topics: Aged; Catecholamines; Depression, Chemical; Electroconvulsive Therapy; Female; Hemodynamics; Humans; | 1981 |
Propranolol and sotalol augment the coronary vasodilatory action of prostacyclin (PGI2) in rabbit isolated hearts.
Topics: Animals; Drug Synergism; Epoprostenol; Heart; Hypertension; In Vitro Techniques; Perfusion; Proprano | 1981 |
[Comparative effect of SQ 14225 and propranolol in mild and moderate arterial hypertension].
Topics: Adolescent; Adult; Captopril; Female; Humans; Hypertension; Male; Proline; Propranolol | 1981 |
Role of sympathetic nervous system activity in the blood pressure response to long-term captopril therapy in severely hypertensive patients.
Topics: Aldosterone; Blood Pressure; Captopril; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hype | 1982 |
Comparison of antihypertensive and hormonal effects of captopril and propranolol at rest and during exercise.
Topics: Aldosterone; Blood Pressure; Captopril; Drug Therapy, Combination; Humans; Hypertension; Male; Physi | 1982 |
Aldosterone in sustained essential hypertension.
Topics: Adult; Aldosterone; Extracellular Space; Humans; Hypertension; Inulin; Liver Circulation; Male; Midd | 1982 |
Behavioral versus pharmacological treatments for essential hypertension--a needed comparison.
Topics: Adult; Behavior Therapy; Biofeedback, Psychology; Blood Pressure; Drug Therapy, Combination; Humans; | 1982 |
The addition of prazosin to standard triple therapy in the treatment of severe hypertension.
Topics: Adult; Aged; Bendroflumethiazide; Blood Pressure; Drug Therapy, Combination; Electrocardiography; Fe | 1982 |
Hypertension in older patients: what drugs to use and when.
Topics: Aged; Antihypertensive Agents; Clonidine; Diuretics; Humans; Hypertension; Hypotension, Orthostatic; | 1982 |
Hypertension in neonatal thyrotoxicosis.
Topics: Female; Humans; Hypertension; Hyperthyroidism; Infant, Newborn; Infant, Newborn, Diseases; Propranol | 1982 |
Characteristics of hormone-stimulated adenylate cyclase in vascular smooth muscle: altered activity in spontaneously hypertensive rat.
Topics: Adenylyl Cyclases; Animals; Aorta; Dose-Response Relationship, Drug; Guanosine Triphosphate; Hyperte | 1982 |
Effect of indoramin and propranolol on cardiovascular response to cold in hypertensive patients.
Topics: Adult; Blood Pressure; Cold Temperature; Drug Therapy, Combination; Heart Rate; Hemodynamics; Humans | 1982 |
Propranolol effects on autonomic function in hypertensive men.
Topics: Adult; Autonomic Nervous System; Blood Pressure; Heart Rate; Humans; Hypertension; Male; Middle Aged | 1982 |
Prazosin and propranolol in preoperative management of pheochromocytoma.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Drug Therapy, Combination; Female; Humans; Hypertension; | 1982 |
Patient on hypertensive drug has increasing erectile problems.
Topics: Erectile Dysfunction; Humans; Hypertension; Male; Middle Aged; Propranolol | 1982 |
A comparison of antihypertensive effects of atenolol and propranolol in the spontaneously hypertensive, DOCA/saline hypertensive and renal hypertensive rats.
Topics: Animals; Antihypertensive Agents; Atenolol; Desoxycorticosterone; Hypertension; Hypertension, Renal; | 1982 |
[Hemodynamic changes during exertion in patients with hypertension treated with propranolol].
Topics: Hemodynamics; Humans; Hypertension; Male; Physical Exertion; Propranolol; Time Factors | 1982 |
The effect of different antihypertensive therapies on plasma lipids.
Topics: Aged; Bendroflumethiazide; Cholesterol; Ethanolamines; Female; Humans; Hypertension; Labetalol; Lipo | 1982 |
[Effect of anapryline on the autonomic regulation of cardiovascular system and hemodynamic indices in men and women with hypertension].
Topics: Female; Hemodynamics; Humans; Hypertension; Male; Parasympathetic Nervous System; Propranolol; Sex F | 1982 |
Noncardiac surgery and anesthesia in patients with heart disease.
Topics: Aged; Anesthesia; Anesthesia, Conduction; Anesthesia, Epidural; Anesthesia, Inhalation; Anesthesia, | 1982 |
Pindolol and systolic time intervals in patients with hypertension.
Topics: Adult; Blood Pressure; Chlorthalidone; Double-Blind Method; Female; Humans; Hypertension; Male; Midd | 1982 |
Effects of d- and l-propranolol on the acute hypotension induced by pindolol in conscious spontaneously hypertensive rats (SHR).
Topics: Animals; Antihypertensive Agents; Drug Interactions; Hemodynamics; Hypertension; Male; Pindolol; Pro | 1982 |
Essential hypertension in childhood.
Topics: Adolescent; Child; Diet, Sodium-Restricted; Electrocardiography; Humans; Hydrochlorothiazide; Hypert | 1982 |
Sympathetic supraspinal control of venous membrane potential in spontaneous hypertension in vivo.
Topics: Animals; Blood Pressure; Hypertension; Male; Membrane Potentials; Microelectrodes; Norepinephrine; P | 1982 |
Substitution of atenolol for propranolol in a case of propranolol-related depression.
Topics: Angina Pectoris; Atenolol; Depressive Disorder; Female; Humans; Hypertension; Imipramine; Middle Age | 1982 |
Aortic rigidity and plasma catecholamines in essential hypertensive patients.
Topics: Adult; Aged; Aorta, Thoracic; Blood Pressure; Compliance; Epinephrine; Hemodynamics; Humans; Hyperte | 1982 |
Adrenergic activity in systolic hypertension.
Topics: Aged; Epinephrine; Female; Hemodynamics; Humans; Hypertension; Labetalol; Male; Middle Aged; Norepin | 1982 |
Vasodilator capacity of forearm vessels in hypertension.
Topics: Atropine; Autonomic Nervous System; Blood Pressure; Forearm; Heart Rate; Humans; Hypertension; Male; | 1982 |
The use of long-acting propranolol ('Inderal' LA) in the management of elderly hypertensive patients.
Topics: Aged; Blood Pressure; Delayed-Action Preparations; Female; Heart Rate; Humans; Hypertension; Male; M | 1982 |
Sexual dysfunction associated with oral antihypertensive medication: a critical survey of the literature.
Topics: Antihypertensive Agents; Clonidine; Diuretics; Erectile Dysfunction; Guanethidine; Humans; Hypertens | 1982 |
Propranolol-use in the elderly.
Topics: Aged; Angina Pectoris; Humans; Hypertension; Propranolol | 1982 |
Effect of clonidine and propranolol on venous smooth muscle from spontaneously hypertensive rats.
Topics: Animals; Body Water; Clonidine; Female; Glycosaminoglycans; Hemodynamics; Hypertension; Lipid Metabo | 1982 |
Effects of antihypertensive agents on blood velocity: implications for atherogenesis.
Topics: Adult; Aged; Antihypertensive Agents; Arteriosclerosis; Blood Flow Velocity; Blood Pressure; Female; | 1982 |
[Beta-blockers and arterial hypertension: comparison between nadolol and propranolol].
Topics: Aged; Drug Administration Schedule; Drug Evaluation; Female; Humans; Hypertension; Male; Middle Aged | 1982 |
Paradoxical relationship between the superior cervical ganglia and the antihypertensive action of propranolol in the spontaneous hypertensive rat.
Topics: Animals; Blood Pressure; Denervation; Ganglia, Sympathetic; Heart Rate; Hypertension; Isoproterenol; | 1982 |
[Spironolactone and propranolol in combination therapy of arterial hypertension].
Topics: Adult; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Propranolol; Spir | 1982 |
[Complications after intravenous administration of anti-arrhythmia agents].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Drug Ad | 1982 |
[The combination of minoxidil, a beta-blocking agent, and a diuretic in the therapy of refractory hypertension].
Topics: Adult; Aged; Drug Therapy, Combination; Female; Furosemide; Humans; Hypertension; Male; Middle Aged; | 1982 |
Variable first-pass elimination of propranolol following single and multiple oral doses in hypertensive patients.
Topics: Administration, Oral; Adult; Biological Availability; Chromatography, Gas; Half-Life; Humans; Hypert | 1982 |
[Combined use of alpha- and beta-adrenergic blockers with vasodilators in hypertensive crises].
Topics: Adult; Dipyridamole; Droperidol; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Midd | 1982 |
[Cerebral blood flow in hypertension].
Topics: Adult; Aged; Cerebrovascular Circulation; Female; Humans; Hypertension; Male; Methyldopa; Middle Age | 1982 |
[Effectiveness of antihypertensive treatment with labetalol as compared with the combination of hydralazine and propranolol].
Topics: Adult; Drug Evaluation; Drug Therapy, Combination; Ethanolamines; Female; Humans; Hydralazine; Hyper | 1981 |
[Various cycloergometric variables in patients with uncomplicated borderline arterial hypertension. Effect of chlorthalidone and propranolol].
Topics: Adult; Blood Pressure; Chlorthalidone; Exercise Test; Heart Rate; Humans; Hypertension; Male; Middle | 1982 |
[Slow-release hydralazine in the treatment of essential arterial hypertension].
Topics: Adult; Blood Pressure; Delayed-Action Preparations; Female; Humans; Hydralazine; Hypertension; Male; | 1982 |
[Pharmacokinetics of sustained release propranolol and results in the treatment of hypertension].
Topics: Adult; Aged; Blood Pressure; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Hyper | 1980 |
Effects of Sydney funnel-web spider envenomation in monkeys, and their clinical implications.
Topics: Acidosis; Acute Disease; Animals; Arrhythmias, Cardiac; Catecholamines; Cats; Dogs; Fever; Hypertens | 1980 |
[Selective beta blockaders (metoprolol) versus non selective (propranolol): comparative effects on the composition of lipoprotein fractions and on blood pressure].
Topics: Blood Pressure; Cholesterol; Double-Blind Method; Female; Humans; Hyperlipidemias; Hypertension; Lip | 1980 |
Confusion between warfarin and propranolol leading to warfarin overdosage.
Topics: Aged; Hemorrhage; Humans; Hypertension; Male; Medication Errors; Propranolol; Warfarin | 1981 |
[Standard therapy of acute myocardial infarction.--II. Management of hemodynamic complications. (author's transl)].
Topics: Analgesics; Atropine; Digoxin; Dobutamine; Dopamine; Drug Therapy, Combination; Heart Failure; Heart | 1981 |
[Plasma dopamine beta-hydroxylase activity in hypertension treated with adrenergic beta receptor blockaders].
Topics: Adult; Dopamine; Dopamine beta-Hydroxylase; Enzyme Inhibitors; Humans; Hypertension; Propranolol | 1981 |
Catecholamine-associated refractory hypertension following acute intracranial hemorrhage: control with propranolol.
Topics: Adult; Aged; Antihypertensive Agents; Cerebral Hemorrhage; Epinephrine; Female; Humans; Hypertension | 1981 |
[Regional and central hemodynamic changes during the treatment of hypertension with obsidan, apressin and their combination].
Topics: Adolescent; Adult; Drug Evaluation; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hydrala | 1981 |
[Determination of the criteria for selecting the optimal obsidan and hypothiazide treatment regimen in hypertension based on mathematical modelling data].
Topics: Adult; Drug Therapy, Combination; Hemodynamics; Humans; Hydrochlorothiazide; Hypertension; Mathemati | 1981 |
A case of juvenile essential hypertension: implications of erythrocyte net Na+, K+ flux measurement.
Topics: Blood Pressure; Erythrocytes; Humans; Hypertension; Infant; Male; Potassium; Propranolol; Sodium | 1981 |
Role of vasopressin, catecholamines, and plasma volume in hypertonic saline-induced hypertension.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Desoxycorticosterone; Hypertension; Male; Nephrectomy | 1981 |
Plasma noradrenaline concentration and alpha-adrenoceptor-mediated vasoconstriction in normotensive and hypertensive man.
Topics: Adolescent; Adult; Aged; Blood Pressure; Female; Forearm; Heart Rate; Humans; Hypertension; Male; Mi | 1981 |
The cardiovascular effects of propranolol in adrenalectomized spontaneously hypertensive rats and the opposing influence of rauwolscine.
Topics: Adrenalectomy; Animals; Blood Pressure; Cardiac Output; Catecholamines; Heart Rate; Hypertension; Ma | 1981 |
[Heart rate and blood pressure under psychological and physical laboratory stress in young hypertensive patients following long-term therapy with the beta receptor blocker propranolol].
Topics: Adult; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Physical Exertion; Propranolol; Str | 1981 |
Effect of intracisternal 5,-7-dihydroxytryptamine on the acute antihypertensive action of propranolol in the sino-aortic denervated anaesthetized dog.
Topics: 5,7-Dihydroxytryptamine; Afferent Pathways; Anesthesia; Animals; Blood Pressure; Bradycardia; Brain; | 1981 |
A combination of propranolol and hydralizine for the treatment of severe hypertension.
Topics: Drug Therapy, Combination; Humans; Hydralazine; Hypertension; Propranolol | 1981 |
Effect of chronic administration of clonidine, propranolol and alpha-methyldopa on extensibility and biochemical properties of the veins in renal and spontaneous hypertension.
Topics: Adipose Tissue; Animals; Antihypertensive Agents; Body Water; Clonidine; DNA; Elasticity; Female; He | 1981 |
Treatment of severe hypertension and hypertensive emergency with nifedipine, a calcium antagonistic agent.
Topics: Administration, Oral; Adult; Aged; Calcium; Drug Synergism; Drug Therapy, Combination; Emergencies; | 1981 |
[Treatment of moderate and severe hypertension with minoxidil (author's transl)].
Topics: Creatinine; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Mino | 1981 |
[Comparative study of the association of propranolol-chlorthalidone and the fixed combination of timolol-hydrochlorothiazide-amiloride in the treatment of arterial hypertension].
Topics: Amiloride; Antihypertensive Agents; Chlorthalidone; Diuretics; Drug Therapy, Combination; Humans; Hy | 1981 |
Propranolol-associated hypoglycemia in patients on maintenance hemodialysis.
Topics: Adult; Humans; Hypertension; Hypoglycemia; Male; Propranolol; Renal Dialysis; Uremia | 1981 |
[Effect of propranolol and atenolol on peripheral tissue blood flow and effective plasma flow through the kidneys].
Topics: Adult; Atenolol; Blood Circulation; Humans; Hypertension; Leg; Male; Neurocirculatory Asthenia; Plas | 1981 |
[Comparative studies on combination treatment of chronic hypertension].
Topics: Adult; Blood Pressure; Dihydralazine; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypert | 1981 |
[Control of arterial hypertension at the work site of the patient: retrospective review of prazosin and propanolol].
Topics: Adult; Aged; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Occupational Heal | 1980 |
[Peripheral arterial vasoocclusive disease: no absolute contraindication to beta receptor blockers (author's transl)].
Topics: Arterial Occlusive Diseases; Heart Rate; Humans; Hypertension; Male; Middle Aged; Propranolol | 1981 |
The effects of oral acebutolol and propranolol on forearm blood flow in hypertensive patients.
Topics: Acebutolol; Administration, Oral; Adult; Blood Pressure; Female; Forearm; Heart Rate; Humans; Hypert | 1981 |
Effect of propranolol on noradrenaline kinetics in patients with essential hypertension.
Topics: Adult; Humans; Hypertension; Kinetics; Middle Aged; Norepinephrine; Propranolol; Sympathetic Nervous | 1981 |
The distribution of propranolol, pindolol and atenolol between human erythrocytes and plasma.
Topics: Adolescent; Adult; Aged; Atenolol; Erythrocytes; Female; Humans; Hypertension; Male; Middle Aged; Pi | 1981 |
Spontaneously (genetic) hypertensive rats: naloxone-reversible and propranolol-reversible decrease in pain sensitivity.
Topics: Animals; Hypertension; Male; Naloxone; Pain; Propranolol; Rats; Rats, Inbred Strains; Sensory Thresh | 1981 |
Hypotensive action of nifedipine (Ca2+-antagonist) and propranolol in acute trials and its long-term therapy of hypertensive coronary heart disease patients.
Topics: Antihypertensive Agents; Blood Pressure; Calcium; Coronary Disease; Drug Therapy, Combination; Human | 1981 |
Propranolol-induced alterations in the pathophysiology of spontaneously hypertensive rats.
Topics: Aging; Aldosterone; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Corticosterone; F | 1981 |
Minoxidil in the management of intractable hypertension.
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Edema; Female; Furosemide; Hirsutism; Humans; Hy | 1981 |
[Degrees of severity of drug interactions].
Topics: Antacids; Anti-Bacterial Agents; Arrhythmias, Cardiac; Drug Administration Schedule; Drug Interactio | 1981 |
[Correlation of the central and peripheral hemodynamic components in the mechanism of hypertension under emotional stress].
Topics: Adolescent; Adult; Blood Volume; Hemodynamics; Humans; Hypertension; Male; Mental Processes; Middle | 1981 |
Anti-hypertensive therapy with propranolol during pregnancy and lactation.
Topics: Breast Feeding; Female; Humans; Hypertension; Infant, Newborn; Lactation; Milk, Human; Pregnancy; Pr | 1981 |
[Hemodynamic responses to supine bicycle exercise in juvenile hypertensive subjects: an echocardiographic assessment (author's transl)].
Topics: Adult; Blood Pressure; Echocardiography; Exercise Test; Heart Rate; Hemodynamics; Humans; Hypertensi | 1981 |
Comparative antihypertensive effects of propranolol and metoprolol in DOC-treated rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Desoxycorticosterone; Heart Rate; Hypertension; Ma | 1981 |
[Behavior of the blood pressure curve during the ergometric stress test, in treated and non-treated hypertensive patients].
Topics: Adult; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Male; Methyldopa; Middle Aged; Phys | 1981 |
[Arterial hypertension in university students].
Topics: Adolescent; Adult; Ambulatory Care; Germany, East; Humans; Hypertension; Hypertension, Renal; Physic | 1981 |
[Effect of drugs on laboratory diagnosis--effect of propranolol on selected laboratory values].
Topics: Adolescent; Adult; Clinical Laboratory Techniques; Female; Humans; Hypertension; Male; Propranolol | 1981 |
[Beta-block and the pressure response to the DAF test].
Topics: Adult; Female; Humans; Hypertension; Male; Propranolol; Stress, Psychological | 1981 |
Aortic atherosclerosis in hypertensive rabbits treated with anti-hypertensive agents having different effects on arterial flow disturbances. 1. Extent of surface involvement.
Topics: Animals; Antihypertensive Agents; Aorta; Aorta, Abdominal; Aorta, Thoracic; Arteriosclerosis; Blood | 1981 |
[Conventional propranolol and long-acting propranolol in arterial hypertension].
Topics: Adult; Aged; Delayed-Action Preparations; Humans; Hypertension; Middle Aged; Propranolol | 1981 |
Single daily dosing of propranolol in hypertension.
Topics: Dose-Response Relationship, Drug; Humans; Hypertension; Propranolol | 1980 |
4-Hydroxypropranolol and its glucuronide after single and long-term doses of propranolol.
Topics: Administration, Oral; Adult; Coronary Disease; Drug Administration Schedule; Female; Glucuronates; H | 1980 |
One and three doses of propranolol a day in hypertension.
Topics: Adolescent; Adult; Blood Pressure; Chlorthalidone; Depression, Chemical; Dreams; Drug Administration | 1980 |
Effect of indomethacin in two siblings with a renin-dependent hypertension, hyperaldosteronism and hypokalemia.
Topics: Adolescent; Adult; Angiotensin II; Drug Therapy, Combination; Female; Humans; Hyperaldosteronism; Hy | 1980 |
Abnormal blood pressure response and marked ischemic ST-segment depression as predictors of severe coronary artery disease.
Topics: Adult; Aged; Blood Pressure; Coronary Disease; Electrocardiography; Exercise Test; Female; Humans; H | 1980 |
Propranolol-related bronchospasm in patients without history of asthma.
Topics: Bronchial Spasm; Female; Humans; Hypertension; Male; Middle Aged; Propranolol | 1980 |
Hypertension and propranolol therapy: effect on blood pressure, plasma catecholamines and platelet aggregation.
Topics: Blood Pressure; Catecholamines; Epinephrine; Female; Heart Rate; Humans; Hypertension; Isometric Con | 1980 |
Effects of propranolol on baroreceptor reflex sensitivity in the conscious spontaneously hypertensive rats (SHR) [proceedings].
Topics: Animals; Hypertension; Male; Pressoreceptors; Propranolol; Rats; Reflex | 1980 |
Acute hemodynamic effects of propranolol in the conscious spontaneously hypertensive rat (SHR) [proceedings].
Topics: Animals; Hemodynamics; Hypertension; Male; Propranolol; Rats | 1980 |
Propranolol: an unrecognized cause of central nervous system dysfunction in patients undergoing cardiopulmonary bypass.
Topics: Aortic Aneurysm; Aortic Dissection; Cardiopulmonary Bypass; Humans; Hypertension; Male; Middle Aged; | 1980 |
Propranolol and hydrallazine in the management of essential hypertension in pregnancy.
Topics: Adult; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Hypoglycemia; Infant, N | 1980 |
Effects of propranolol on aldosterone plasma concentration and aldosterone metabolic clearance in hypertensive patients.
Topics: Adult; Aldosterone; Blood Pressure; Female; Humans; Hypertension; Male; Metabolic Clearance Rate; Mi | 1980 |
Blood pressure, plasma catecholamines, and sympathetic outflow in pithed SHR and WKY rats.
Topics: Animals; Blood Pressure; Decerebrate State; Epinephrine; Hypertension; Male; Norepinephrine; Practol | 1980 |
[Treatment of arterial hypertension. Experience with the use of a hydralazine and propranolol combination].
Topics: Adult; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Male; Middle Aged; Prop | 1980 |
Cardiogenic hypertension: experimental evidence from a comparison between intravenous and intracoronary administration of dobutamine in conscious dogs.
Topics: Animals; Blood Pressure; Cardiac Output; Catecholamines; Coronary Vessels; Dobutamine; Dogs; Hyperte | 1980 |
Effect of coronary occlusion on arterial baroreflex control of heart rate.
Topics: Animals; Arteries; Blood Pressure; Coronary Disease; Dogs; Electrocardiography; Heart; Heart Rate; H | 1980 |
Electromagnetic flow-probe implantation for cardiac output measurements in rabbits.
Topics: Animals; Cardiac Output; Electromagnetic Phenomena; Female; Hemodynamics; Hypertension; Isoprotereno | 1980 |
The metabolic and psychological effects of exercise training in hemodialysis patients.
Topics: Adult; Anemia; Blood Glucose; Blood Pressure; Carbohydrate Metabolism; Cholesterol; Female; Follow-U | 1980 |
Pathophysiological characteristics of labile hypertensive patients determined by the cold pressor test.
Topics: Adult; Atropine; Blood Pressure; Cardiac Output; Cold Temperature; Diazepam; Female; Hemodynamics; H | 1980 |
[Changes in the radiorenography curve in hypertensive patients under the influence of a beta adrenergic antagonist (propranolol)].
Topics: Adult; Female; Humans; Hypertension; Kidney; Male; Middle Aged; Propranolol; Radioisotope Renography | 1980 |
Hypoglycemia in chronic hemodialysis patients: association with propranolol use.
Topics: Adult; Aged; Female; Humans; Hypertension; Hypoglycemia; Male; Propranolol; Renal Dialysis; Uremia | 1980 |
Clonidine withdrawal, propranolol, and rebound hypertension.
Topics: Clonidine; Drug Administration Schedule; Humans; Hypertension; Propranolol | 1980 |
[Treatment of arterial hypertension in old age].
Topics: Age Factors; Aged; Allopurinol; Antihypertensive Agents; Blood Pressure; Clonidine; Drug Therapy, Co | 1980 |
Evidences supporting an increased sympathetic tone and reactivity in a subgroup of patients with essential hypertension.
Topics: Adult; Aging; Blood Pressure; Catecholamines; Diagnosis, Differential; Epinephrine; Female; Heart Ra | 1980 |
Comparison of the effects of propranolol and labetalol on renal haemodynamics at rest and during exercise in essential hypertension.
Topics: Adult; Ethanolamines; Female; Glomerular Filtration Rate; Hemodynamics; Humans; Hypertension; Kidney | 1980 |
Influence of propranolol and pindolol on the haemodynamic effects of papaverine, isoprenaline and noradrenaline in hypertensive patients.
Topics: Adult; Blood Pressure; Drug Interactions; Heart Rate; Hemodynamics; Humans; Hypertension; Isoprotere | 1980 |
Failure of therapy to improve prognosis in elderly males with hypertension.
Topics: Aged; Benzothiadiazines; Diet, Sodium-Restricted; Diuretics; Humans; Hypertension; Male; Methyldopa; | 1980 |
Beta-adrenoceptor-blocking drugs, growth hormone and acromegaly.
Topics: Acromegaly; Adult; Aged; Female; Glucose; Growth Hormone; Humans; Hypertension; Male; Middle Aged; O | 1980 |
Effect of propranolol and labetalol on renal haemodynamics at rest and during exercise in essential hypertension.
Topics: Blood Pressure; Ethanolamines; Female; Glomerular Filtration Rate; Heart Rate; Humans; Hypertension; | 1980 |
Comparison of labetalol and propranolol in treatment of hypertension.
Topics: Blood Pressure; Ethanolamines; Female; Heart Rate; Humans; Hypertension; Labetalol; Male; Propranolo | 1980 |
Propranolol LA and ambulatory blood pressure.
Topics: Adult; Aged; Blood Pressure; Delayed-Action Preparations; Heart Rate; Humans; Hypertension; Male; Mi | 1980 |
Changes in glomerular filtration rate during long-term treatment with propranolol and peripheral vasodilators in patients with arterial hypertension.
Topics: Glomerular Filtration Rate; Humans; Hypertension; Propranolol; Time Factors; Vasodilator Agents | 1980 |
Cardiovascular responses in hypertensive outpatients starting oral propranolol, determined from the brachial pulse upstroke.
Topics: Administration, Oral; Adult; Blood Pressure; Female; Hemodynamics; Humans; Hypertension; Male; Middl | 1980 |
Sympathetic hyperreflexia in tetraplegics. The value of systolic time intervals in assessing drug effects.
Topics: Adult; Guanethidine; Humans; Hypertension; Labetalol; Male; Middle Aged; Myocardial Contraction; Phe | 1980 |
Pericardial effusion associated with minoxidil therapy.
Topics: Furosemide; Humans; Hypertension; Male; Middle Aged; Minoxidil; Pericardial Effusion; Propranolol; P | 1981 |
alpha- and beta-adrenoreceptor-mediated control of brain noradrenaline neurons and antihypertensive therapy.
Topics: Action Potentials; Albuterol; Animals; Brain; Clonidine; Dopamine; Hypertension; Locus Coeruleus; Ma | 1980 |
[Alpha-methyldopa and renal function in arterial hypertension].
Topics: Antihypertensive Agents; Clonidine; Dihydralazine; Humans; Hydrochlorothiazide; Hypertension; Hypert | 1980 |
Is the antihypertensive effect of propranolol caused by an action within the central nervous system?
Topics: Animals; Blood Pressure; Brain; Heart Rate; Hypertension; Propranolol; Rats | 1980 |
Variations in patient compliance with common long-term drugs.
Topics: Angina Pectoris; Blood Pressure; Drug Therapy; Humans; Hydrochlorothiazide; Hypertension; Patient Co | 1980 |
The psychophysiology of borderline hypertension.
Topics: Atropine; Heart Rate; Humans; Hypertension; Personality Inventory; Personality Tests; Propranolol; S | 1981 |
[Behavior of certain echocardiographic variables in patients with uncomplicated borderline arterial hypertension - influence of chlorthalidone and propranolol].
Topics: Adult; Chlorthalidone; Echocardiography; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Prop | 1980 |
The effect of propranolol treatment on total cholesterol, HDL cholesterol, triglycerides. Postheparin lipolytic activity and lecithin:cholesterol acyltransferase in hypertensive individuals.
Topics: Adolescent; Adult; Cholesterol; Humans; Hypertension; Lipoprotein Lipase; Lipoproteins, HDL; Male; M | 1980 |
Renal function studies with propildazine alone and in combination with propranolol in dogs.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Dogs; Female; Glomerular Filtration Rate; Hydrazin | 1980 |
Complete atrioventricular block associated with propranolol therapy.
Topics: Child; Electrocardiography; Heart Block; Humans; Hypertension; Kidney Failure, Chronic; Male; Propra | 1981 |
Complications of antihypertensive therapy.
Topics: Antihypertensive Agents; Benzothiadiazines; Clonidine; Diuretics; Female; Guanethidine; Humans; Hydr | 1981 |
Disease management needs new paradigms.
Topics: Clinical Trials as Topic; Humans; Hypertension; Life Style; Propranolol | 1995 |
[The lipid peroxidation indices of hypertension patients undergoing combined therapy with anaprilin, korinfar and hypothiazide].
Topics: Adult; Antihypertensive Agents; Antioxidants; Drug Evaluation; Drug Therapy, Combination; Female; Hu | 1995 |
Low-intensity exercise training attenuates cardiac beta-adrenergic tone during exercise in spontaneously hypertensive rats.
Topics: Animals; Atropine Derivatives; Blood Pressure; Heart; Heart Rate; Hypertension; Male; Oxygen Consump | 1995 |
Effect of the new calcium antagonist (+/-)-(R*)-3-[(R*)-1-benzyl-3- piperidyl] methyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5- pyridinedicarboxylate hydrochloride (KW-3049) on cardiac hypertrophy in spontaneously hypertensive rats.
Topics: Aldosterone; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cardiomegal | 1993 |
Contribution of alpha- and beta- adrenoceptors and neuropeptide-Y to autonomic dysreflexia.
Topics: Animals; Autonomic Nervous System Diseases; Blood Pressure; Ganglionic Blockers; Heart Rate; Hexamet | 1995 |
cAMP and protein synthesis in isolated adult rat heart preparations.
Topics: 1-Methyl-3-isobutylxanthine; Adenine Nucleotides; Animals; Colforsin; Cyclic AMP; Cyclic AMP-Depende | 1993 |
Endothelin-1 in rat periaqueductal gray area induces hypertension via glutamatergic receptors.
Topics: Animals; Blood Pressure; Drug Interactions; Endothelins; Hypertension; Male; Microinjections; Periaq | 1995 |
Angiotensin II and sympathetic activity in sodium-restricted essential hypertension.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Blood Pressure; Diet, | 1995 |
Effects of propranolol and atenolol on immobilization stress-induced hypertension and down-regulation of central beta-adrenoceptors in rats.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressure; Cerebral Cortex; Dihydroalprenolol; | 1995 |
Beta 2-adrenergic receptor characteristics in sleep apnea patients.
Topics: Adenosine Monophosphate; Adrenergic beta-Antagonists; Adult; Humans; Hypertension; Isoproterenol; Mi | 1995 |
Racial differences in sensitivity to the negative chronotropic effects of propranolol in healthy men.
Topics: Adult; Black People; Exercise Test; Humans; Hypertension; Linear Models; Male; Propranolol; Referenc | 1995 |
Beta-adrenergic receptor antagonist antihypertensive medications impair arousal-induced modulation of working memory in elderly humans.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitor | 1994 |
Nutritional status modifies insulin-mediated glucose uptake in spontaneously hypertensive rats.
Topics: Animals; Blood Glucose; Eating; Epinephrine; Fasting; Glucose; Hypertension; Insulin; Insulin Secret | 1994 |
[The effect of obzidan monotherapy on the beta 2-adrenoreceptors of the lymphocyte adenylate cyclase system in hypertension patients].
Topics: Adenylyl Cyclases; Adult; Drug Evaluation; Heart Ventricles; Humans; Hypertension; Lymphocytes; Male | 1993 |
Acute effects of ethanol on cardiac output and its derivatives in spontaneously hypertensive and normotensive rats.
Topics: Animals; Blood Pressure; Cardiac Output; Ethanol; Hypertension; Prazosin; Propranolol; Rats; Rats, I | 1994 |
Expansion of aortic aneurysms is reduced by propranolol in a hypertensive rat model.
Topics: Analysis of Variance; Animals; Aortic Aneurysm, Abdominal; Dose-Response Relationship, Drug; Female; | 1994 |
Norepinephrine-induced relaxations in rat aorta mediated by endothelial beta adrenoceptors. Impairment by ageing and hypertension.
Topics: Aging; Animals; Aorta; Arginine; Endothelium, Vascular; Hypertension; In Vitro Techniques; Isoproter | 1994 |
Effects of long-term oral administration of NZ-105, a novel calcium antagonist, with or without propranolol in spontaneously hypertensive rats.
Topics: Administration, Oral; Aldosterone; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel | 1993 |
Time-dependent efficacy of antihypertensive agents in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Captopril; Circadian Rhythm; Clonidine; Felodipine | 1993 |
[The effect of obzidan and visken on the regulation of the lymphocyte beta 2-adrenoreceptor adenylate cyclase system during physical loading in hypertension patients].
Topics: Adenylyl Cyclases; Adult; Analysis of Variance; Exercise Test; Humans; Hypertension; Lymphocytes; Ma | 1993 |
Cardiovascular effects of nisoldipine in essential hypertension.
Topics: Administration, Oral; Adult; Aged; Blood Pressure; Cardiac Output; Female; Heart Rate; Hemodynamics; | 1994 |
The effect of hypertensive episodes and cardiac hypertrophy on the canine cardiac baroreflex.
Topics: Analysis of Variance; Animals; Baroreflex; Blood Pressure; Body Weight; Disease Models, Animal; Dogs | 1994 |
[Effect of treatment with propranolol or pindolol on the left ventricular myocardium mass in patients with slight essential arterial hypertension].
Topics: Adult; Aged; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Pindolo | 1993 |
Postexercise syncope: evidence for increased activity of the sympathetic nervous system.
Topics: Adult; Arousal; Atenolol; Bradycardia; Epinephrine; Exercise Test; Heart Arrest; Humans; Hypertensio | 1993 |
A study on withdrawal related haemodynamic response in chronic propranolol treated conscious rats.
Topics: Animals; Blood Pressure; Heart Rate; Hypertension; Male; Propranolol; Rats; Rats, Wistar; Substance | 1993 |
Carpal tunnel syndrome with propranolol.
Topics: Carpal Tunnel Syndrome; Female; Humans; Hypertension; Middle Aged; Propranolol | 1993 |
The effect of age on diurnal variation in the pharmacokinetics of propranolol in hypertensive subjects.
Topics: Adult; Age Factors; Aged; Circadian Rhythm; Eating; Female; Humans; Hypertension; Male; Middle Aged; | 1993 |
Adverse reactions to propranolol, a non-selective beta-adrenergic blocking agent in hypertensive patients--a collaborative study.
Topics: Adverse Drug Reaction Reporting Systems; Female; Follow-Up Studies; Humans; Hypertension; Male; Midd | 1993 |
[Absence of the effect of nitric oxide on pulmonary and systemic hypertension induced by sino-aortic denervation].
Topics: Administration, Inhalation; Animals; Antihypertensive Agents; Carotid Sinus; Denervation; Dogs; Hemo | 1995 |
Beta-adrenoceptor responsiveness of splenic macrophages in normotensive and hypertensive rats.
Topics: Animals; Blood Pressure; Catecholamines; Hypertension; Isoproterenol; Macrophages; Male; Phenylephri | 1996 |
Xerostomia: prevalence and pharmacotherapy. With special reference to beta-adrenoceptor antagonists.
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Aged, 80 and over; Amylases; Antihypertensive | 1996 |
Effects of chronic administration of bopindolol on the binding characteristics of cardiac alpha 1H-, alpha 1L-, beta 1- and beta 2-adrenoceptor subtypes in cardiac muscles of spontaneously hypertensive rats (SHR).
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Hypertension; In Vitro Techniques; Membranes; Myocar | 1996 |
Divergent effects of propranolol and nadolol in isolated mesenteric arteries from normal and portal hypertensive rats.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Hypertension; Male; Mesentery; Methox | 1996 |
Effects of captopril and propranolol on cognitive function and cerebral blood flow in aged hypertensive rats.
Topics: Animals; Antihypertensive Agents; Captopril; Cerebrovascular Circulation; Cognition; Hypertension; M | 1996 |
Chronic carvedilol reduces mortality and renal damage in hypertensive stroke-prone rats.
Topics: Adrenergic beta-Antagonists; Aldosterone; Animals; Antihypertensive Agents; Blood Pressure; Body Wei | 1996 |
Effects of hypertension and propranolol upon aneurysm expansion in the Anidjar/Dobrin aneurysm model.
Topics: Adrenergic beta-Antagonists; Aged; Animals; Antihypertensive Agents; Aortic Aneurysm, Abdominal; Aor | 1996 |
Chronic adrenergic receptor blockade does not prevent hyperinsulinemia-induced hypertension in rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood Glucose; Blood Pressure; D | 1996 |
Acutely exacerbated hypertension and increased inflammatory signs due to radiation treatment for metastatic pheochromocytoma.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Bone Neoplasms; Female; Heart Rate; Humans; Hyperten | 1996 |
Effects of beta-adrenergic blockade on insulin-mediated glucose disposal in hypertensive and normotensive rats.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Glucose; Glycogen Synthase; Hypertension; Insu | 1996 |
Alpha 1-adrenergic receptor antibodies in patients with primary hypertension.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Anta | 1997 |
[The characteristics of the effect of obzidan on the cardiac hemodynamics in patients with an artificial pacemaker when used one time and over a course of treatment].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Chronic Disease; Combined Modality Therapy; Female; Heart; | 1996 |
Effect of chronic treatment with propranolol on the cardiovascular responses to chronic cold exposure.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Body Weight; Cardiomegaly; Cold Temperature; H | 1997 |
Cardiovascular reflex mechanisms by topical instillation of capsaicin and distilled water into the larynx in anesthetized dogs.
Topics: Administration, Topical; Anesthesia, General; Animals; Anti-Arrhythmia Agents; Antihypertensive Agen | 1997 |
Absence of significant adverse effects from low-dose subcutaneous epinephrine in dermatologic procedures.
Topics: Adrenergic beta-Antagonists; Aged; Anesthesia, Local; Anesthetics, Local; Antihypertensive Agents; B | 1997 |
Musical hallucinations induced by propranolol.
Topics: Aged; Aged, 80 and over; Brain; Female; Hallucinations; Humans; Hypertension; Music; Neurocognitive | 1998 |
[Betacap efficiency in elderly patients with coronary heart disease and essential hypertension].
Topics: Adrenergic beta-Antagonists; Blood Pressure; Cardiography, Impedance; Delayed-Action Preparations; E | 1998 |
[Premedication with different groups of hypotensive drugs in preparation of patients with concomitant arterial hypertension to planned surgical treatment].
Topics: Adult; Antihypertensive Agents; Calcium Channel Blockers; Clonidine; Female; Humans; Hypertension; H | 1998 |
Beta-adrenoceptor antagonist propranolol potentiates hypotensive action of natriuretic peptides.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Aorta; Atrial Natriuretic Factor; Blo | 1998 |
Concentration-effect relationship of l-propranolol and metoprolol in spontaneous hypertensive rats after exercise-induced tachycardia.
Topics: Adrenergic beta-Antagonists; Animals; Blood Proteins; Dose-Response Relationship, Drug; Heart Rate; | 1998 |
[The absolute cardiovascular risk: a valid but incomplete concept].
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Chlorothiazide; Humans; Hypertension; Proprano | 1998 |
Fatal asymptomatic hypoglycemia in an elderly insulin-dependent diabetic patient taking an oral beta-blocking medication.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Diabetes Mellitus, Type 1; Diabetic Angiopathies | 1998 |
Altered muscle metabolism associated with vasoconstriction in spontaneously hypertensive rats.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Glucose; Hypertension; Lactic Acid | 1998 |
Reduced periinfarction mortality as a result of long-term therapy with captopril but not hydralazine or propranolol in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Captopril; Collagen; Electric Stimulation; Heart R | 1998 |
Activation by Phoneutria nigriventer spider venom of autonomic nerve fibers in the isolated rat heart.
Topics: Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Animals; Anti-Arrhythmia Agents; Arachnid | 1998 |
Effects of an angiotensin-converting enzyme inhibitor and a beta-blocker on cerebral arterioles in rats.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Arterioles; Blood Pr | 1999 |
Preliminary communication on intralymphocyte ionized magnesium in hypertensive patients under treatment with beta-blockers.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Atenolol; Calcium; Female; Humans; Hy | 1999 |
[Studies of lymphocyte membrane transport of sodium in patients with essential hypertension].
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Biological Transport; Cell Membrane Permeability; | 1999 |
Mechanism-based modeling of rebound tachycardia after chronic l-propranolol infusion in spontaneous hypertensive rats.
Topics: Adrenergic beta-Antagonists; Algorithms; Animals; Chromatography, High Pressure Liquid; Half-Life; H | 1999 |
Acetaldehyde depresses myocardial contraction and cardiac myocyte shortening in spontaneously hypertensive rats: role of intracellular Ca2+.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1999 |
Changes of cardiac calcium homeostasis in spontaneously hypertensive rats.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1999 |
I am a 46-year-old man with hypertension. I recently started taking Inderal for my blood pressure. I feel fine and my pressure is way down, but I can no longer get my pulse up when I work out on my treadmill or bike. Does that mean I won't benefit from ex
Topics: Adrenergic beta-Antagonists; Heart Rate; Humans; Hypertension; Male; Middle Aged; Propranolol | 1999 |
Altered frequency characteristic of central vasomotor control in SHR.
Topics: Action Potentials; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood Pressur | 2000 |
Platelet alpha2-adrenoceptor alterations in patients with essential hypertension are normalized after treatment with doxazosin but not propranolol.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Blood Platelet | 2000 |
The search for high-yield, low-risk antihypertensive treatment.
Topics: Adrenergic beta-Antagonists; Age Factors; Antihypertensive Agents; Cognition; Comorbidity; Confoundi | 2000 |
Role of the sympathetic nervous system during the development of obesity-induced hypertension in rabbits.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Blood Pressure D | 2000 |
New approach for measurement of sympathetic nervous abnormality in conscious, spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Dihydropyridines; Heart Rate; Hypertension; Male; Norepinephrine; Propranol | 2000 |
Glomerular basement membrane polyanion distribution and nitric oxide in spontaneous hypertensive rats: effects of salt loading and antihypertensive therapy with propranolol.
Topics: Animals; Antihypertensive Agents; Basement Membrane; Blood Pressure; Diet, Sodium-Restricted; Female | 2000 |
Cardiac sympathetic overactivity and decreased baroreflex sensitivity in L-NAME hypertensive rats.
Topics: Animals; Antihypertensive Agents; Atropine Derivatives; Baroreflex; Enzyme Inhibitors; Fourier Analy | 2001 |
Mechanisms of the increased pressor response to vasopressors in the mesenteric bed of nitric oxide-deficient hypertensive rats.
Topics: Acetylcholine; Animals; Antihypertensive Agents; Arteries; Blood Pressure; Disease Models, Animal; D | 2001 |
Effects of perindopril, propranolol, and dihydrochlorothiazide on cardiovascular remodelling in spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Age | 1999 |
Effects of an angiotensin-converting enzyme inhibitor and a beta-blocker on cerebral arteriolar dilatation in hypertensive rats.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cere | 2001 |
Load versus humoral activation in the genesis of early hypertensive heart disease.
Topics: Angiotensin II; Animals; Catecholamines; Diastole; Disease Models, Animal; Dogs; Endothelin-1; Heart | 2001 |
Hypertension and the kidney: implications of the kidney for effective antihypertensive therapy
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Hypertension; Kidney; Nadolol; Propranolol; Re | 1987 |
Attenuation of hypertension, cardiomyocyte hypertrophy, and myocardial fibrosis by beta-adrenoceptor blockers in rats under long-term blockade of nitric oxide synthesis.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressu | 2002 |
Augmented adrenergic vasoconstriction in hypertensive diabetic obese Zucker rats.
Topics: Angiotensin II; Animals; Arteries; Arterioles; Blood Pressure; Diabetes Mellitus; Endothelins; Heart | 2002 |
Relative uptake, metabolism, and beta-receptor binding of (1R,2S)-4-(18)F-fluorometaraminol and (123)I-MIBG in normotensive and spontaneously hypertensive rats.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Animals; Autoradiography; Cardiomyopathies; Hear | 2002 |
Iatrogenic adrenergic crisis.
Topics: Adrenergic Agonists; Adrenergic beta-Antagonists; Drug Interactions; Epinephrine; Female; Humans; Hy | 2002 |
Intermittent claudication complicating beta-blockade.
Topics: Adrenergic beta-Antagonists; Coronary Disease; Female; Humans; Hypertension; Intermittent Claudicati | 1976 |
Vasodilator administration in the presence of beta-adrenergic blockade.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Blood Pressure; Cardiovascular System; Dia | 1976 |
The management of hypertension with special reference to debrisoquine and beta blockade.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Debrisoquin; Diuretics; Female; Humans; Hy | 1976 |
Raynaud's phenomenon as side effect of beta-blockers in hypertension.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Female; Humans; Hypertension; Male; Methyldopa; Middle | 1976 |
Discovery of the hypotensive effect of propranolol.
Topics: Animals; Blood Pressure; Chick Embryo; Ethanolamines; Female; Humans; Hypertension; Propranolol | 1976 |
Once-daily treatment of hypertension.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Hypertension; Metoprolol; Pindolol; | 1976 |
Central beta-adrenergic receptors for blood pressure regulation in spontaneously hypertensive rats.
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Blood Pressure; Depression, Chemical; Hypertension; Me | 1976 |
[Effect of obsidan on cardiohemodynamic indicators in hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; P | 1976 |
Beta-adrenergic receptor blocking drugs in spontaneous hypertension.
Topics: Adrenergic beta-Antagonists; Aging; Alprenolol; Animals; Blood Pressure; Hypertension; Male; Metopro | 1976 |
Modern system for treating high blood pressure based on renin profiling and vasoconstriction-volume analysis: a primary role for beta blocking drugs such as propranolol.
Topics: Adrenergic beta-Antagonists; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Propranolol | 1976 |
Present state of alpha and beta adrenergic drugs III. Beta blocking agents.
Topics: Adrenergic beta-Antagonists; Anxiety; Arrhythmias, Cardiac; Asthma; Heart Diseases; Humans; Hyperten | 1977 |
Labetalol, an alpha- and beta-adrenergic blocking drug in the treatment of hypertension.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Blood Pressure; Ethanolamines; Humans; Hy | 1977 |
Acute hypotensive effect of combined beta1-adrenoceptor blockade and beta2-adrenoceptor stimulation in spontaneously hypertensive rats (SHR).
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Depression, Chemical | 1977 |
[Exercise hemodynamics and renin before and after acute beta block in patients with essential hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Female; Heart Rate; Hemodynamics; Humans; Hypertension; Male; Mi | 1976 |
[Essential hypertension: adrenergic control system, renin-angiotensin effector axis, kidney and age].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aging; Angiotensin II; Catecholamines; Diuretics; Humans; | 1976 |
Angina in hypertensive patients. With particular reference to the negative chronotropic effects of sympatholytic therapy.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Bethanidine; Blood Pressure; Debrisoquin; Drug Therapy | 1976 |
Renin and age as determinants of a predominantly betablocker-based antihypertensive drug program.
Topics: Adrenergic beta-Antagonists; Adult; Aging; Aldosterone; Angiotensin II; Antihypertensive Agents; Blo | 1976 |
Different antihypertensive effect of beta-blocking drugs in low and normal-high renin hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Depression, Chemical; Diuretics; Female; H | 1976 |
Blood pressure variability in patients on beta-blockers.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Depression, Chemical; Heart Rate; Humans; Hypert | 1976 |
Pharmacokinetic considerations in the choice of beta-blockers and their dosage.
Topics: Adrenergic beta-Antagonists; Half-Life; Humans; Hypertension; Propranolol | 1976 |
Additive effect of beta-adrenergic blockers in combination with vasodilators in lowering blood pressure.
Topics: Adrenergic beta-Antagonists; Clonidine; Drug Therapy, Combination; Female; Humans; Hypertension; Mal | 1976 |
Labetalol (AH5158), a competitive alpha- and beta-receptor blocking drug, in the management of hypertension.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aldosterone; Angiotensin II; Cloni | 1976 |
Autonomic control of cardiovascular functions during neonatal development and in adult sheep.
Topics: Acetylcholine; Animals; Animals, Newborn; Arrhythmias, Cardiac; Atropine; Autonomic Nerve Block; Aut | 1977 |
Effects of beta-adrenergic blocking agents on the blood pressure, plasma renin activity and hemodynamics of hypertensive patients.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Blood Volume; Cardiac Output; Female; Heart Rate | 1977 |
Management of hypertension.
Topics: Adrenergic alpha-Antagonists; Benzothiadiazines; Clonidine; Diuretics; Ethacrynic Acid; Furosemide; | 1977 |
[Indications and limits for the use of beta-blockaders (beta-adrenergic inhibitors) in the treatment of hypertension].
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Blood Pressure; Humans; Hypertension; Propranol | 1977 |
Hypertension complicating treatment with beta-adrenergic blocking drugs.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Angina Pectoris; Femal | 1977 |
Drug treatment of hypertension.
Topics: Clonidine; Diazoxide; Diuretics; Ganglionic Blockers; Guanethidine; Humans; Hydralazine; Hypertensio | 1977 |
Beta-blocking agents in the treatment of hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Ambulatory Care; Blood Pressure; Central Nervous Sy | 1977 |
[beta Blocking agents in arterial hypertension].
Topics: Adrenergic beta-Antagonists; Angiotensin II; Hemodynamics; Humans; Hypertension; Propranolol; Renin | 1977 |
[Choice of drugs in the treatment of hypertension].
Topics: Adolescent; Adrenergic beta-Antagonists; Antihypertensive Agents; Child; Child, Preschool; Diuretics | 1977 |
[Pharmacologic incompatibility of neuroleptics and tranquilizers with other medicines].
Topics: Amphetamine; Animals; Anti-Anxiety Agents; Anti-Arrhythmia Agents; Anticonvulsants; Antipsychotic Ag | 1977 |
Childhood pheochromocytoma: treatment with alpha methyl tyrosine for resistant hypertension.
Topics: Adrenal Gland Neoplasms; Catecholamines; Child; Drug Combinations; Humans; Hypertension; Male; Methy | 1977 |
Development of SHR hypertension and cardiac hypertrophy during prolonged beta blockade.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Cardiac Output; Cardiomegaly; Central Venous P | 1977 |
Clonidine and the vasodilating beta blocker antihypertensive drug interaction.
Topics: Adrenergic beta-Antagonists; Adult; Aldosterone; Blood Pressure; Clonidine; Drug Interactions; Femal | 1977 |
"Tailored" application of beta-blockers in hypertension: a continuing dilemma.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Cardiac Output; Humans; Hypertension; Midd | 1977 |
Studies on the cardiovascular effects of pindolol in DOCA/saline hypertensive rats.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Animals; Blood Pressure; Desoxycorticosterone; Dr | 1977 |
Catecholamines, cyclic AMP and renin in two contrasting forms of essential hypertension.
Topics: Adrenergic beta-Antagonists; Catecholamines; Cyclic AMP; Furosemide; Humans; Hypertension; Isoproter | 1977 |
Peripheral haemodynamics in essential hypertension.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Blood Pressure; Cardiac Output; Hemodynamics; Huma | 1977 |
[Action of 3-beta adrenolytics on plasma renin activity measured by radioimmunology in genetically hypertensive rats].
Topics: Adrenergic beta-Antagonists; Animals; Benzopyrans; Humans; Hypertension; Isoproterenol; Pindolol; Pr | 1977 |
Antihypertensive effect of combined treatment with alpha- and beta-adrenergic blockers in the spontaneously hypertensive rat.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Animals; Dose-Response Relationship, Drug; Drug | 1977 |
Effects of several beta-blockers on hemodynamics of SHR [proceedings].
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Cardiac Output; Hemodynamics; Hypertension; Pr | 1977 |
[Effect of alpha and beta-adrenergic blockades on plasma renin activity (author's transl)].
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Humans; Hyperten | 1977 |
[Effects of kitchen salt and beta sympatholytics on the course of blood pressure in the hereditary, spontaneously hypertensive rat (SH rats, Münster strain)].
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Disease Models, Animal; Hypertension; Metoprol | 1977 |
beta-adrenoceptor antagonists: their increasing use and its consequences.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Humans; Hypertension; Propranolo | 1978 |
[Antihypertensive and hemodynamic effects of beta-receptor blockaders with various action spectra].
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Hemodynamics; Humans; Hyperten | 1976 |
[Sympatho-neuronal and sympatho-adrenal activity in experimental and essential hypertension].
Topics: Adrenal Glands; Adrenergic Fibers; Animals; Dopamine beta-Hydroxylase; Epinephrine; Humans; Hyperten | 1977 |
beta-Blocking drug therapy in hypertension.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Humans; Hypertension; Propranolol | 1978 |
Beta blocking agents in cardiovascular diseases.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Heart Diseases; Humans; Hyperten | 1976 |
Beta blocking drugs and the treatment of hypertension.
Topics: Adrenergic beta-Antagonists; Humans; Hypertension; Propranolol | 1978 |
[Beta blocking agents during pregnancy].
Topics: Adrenergic beta-Antagonists; Adult; Animals; Female; Fetus; Humans; Hypertension; Infant, Newborn; L | 1978 |
alpha-Methyldopa and beta-blockers in hypertension--a comparison of their haemodynamic effects.
Topics: Adrenergic beta-Antagonists; Alprenolol; Hemodynamics; Humans; Hypertension; Methyldopa; Metoprolol; | 1978 |
The haemodynamic effects of sodium nitroprusside-induced hypotension during beta-adrenergic blockade and anaesthesia. A case report.
Topics: Adrenergic beta-Antagonists; Adult; Anesthesia, Inhalation; Antihypertensive Agents; Cardiac Output; | 1978 |
Report on Round Table on renin suppression and the hypotensive action of beta-adrenergic-blocking drugs.
Topics: Adrenergic beta-Antagonists; Animals; Dogs; Humans; Hypertension; Propranolol; Rabbits; Renin | 1975 |
Possible mechanism of action of propranolol in hypertension.
Topics: Adrenal Glands; Animals; Blood Pressure; Hypertension; Male; Propranolol; Rats; Time Factors; Tyrosi | 1978 |
[The potential of beta-blockaders in the management of hypertension].
Topics: Adrenergic beta-Antagonists; Age Factors; Blood Pressure; Diuretics; Drug Therapy, Combination; Drug | 1978 |
[Beta-blockers and arterial hypertension in the pregnant woman].
Topics: Adrenergic beta-Antagonists; Female; Fetal Heart; Humans; Hypertension; Maternal-Fetal Exchange; Pre | 1978 |
[beta-blockers and high risk pregnancies. Viewpoint of the nephrologist and the obstetrician].
Topics: Acebutolol; Adrenergic beta-Antagonists; Female; Humans; Hypertension; Pindolol; Pregnancy; Pregnanc | 1978 |
[Value of hydralazine-beta blockader association in hypertension of pregnancy].
Topics: Adrenergic beta-Antagonists; Adult; Drug Therapy, Combination; Female; Fetus; Humans; Hydralazine; H | 1978 |
Prevention and reversal of isolation-induced systolic arterial hypertension in rats by treatment with beta-adrenoceptor antagonists.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Heart Rate; Hypertension; Male; Metoprolol; Proprano | 1979 |
Antihypertensive drugs for the aging.
Topics: Aged; Antihypertensive Agents; Clonidine; Ganglionic Blockers; Guanethidine; Humans; Hypertension; M | 1979 |
Vasospastic phenomena in patients treated with beta-adrenoceptor blocking agents.
Topics: Adrenergic beta-Antagonists; Alprenolol; Blood Circulation; Cardiac Output; Female; Humans; Hyperten | 1979 |
Dependence of deoxycorticosterone/salt hypertension in the rat on the activity of adrenergic cardiac nerves.
Topics: Adrenergic beta-Antagonists; Adrenergic Fibers; Amines; Animals; Atenolol; Blood Pressure; Cardiac S | 1979 |
Effects of beta-adrenoreceptor antagonists on sino-aortic baroreflex sensitivity and blood pressure in hypertensive man.
Topics: Acebutolol; Adolescent; Adrenergic beta-Agonists; Adult; Aging; Blood Pressure; Female; Heart Rate; | 1979 |
Contrasting effects of acute beta blockade with propranolol on plasma catecholamines and renin in essential hypertension: a possible basis for the delayed antihypertensive response.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Blood Pressure; Catecholamines; Epineph | 1979 |
Hemodynamic changes in hypertensive patients at rest and during physical exercise before and after acute i.v. administration of bufuralol-HCl or propranolol.
Topics: Adrenergic beta-Antagonists; Adult; Benzofurans; Ethanolamines; Hemodynamics; Humans; Hypertension; | 1979 |
[Can blockade of presynaptic adrenergic beta receptors explain the antihypertensive effects of propranolol?].
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Catecholamines; Dogs; Female; Hydroxydopamines | 1979 |
[The treatment of critical hypertension with depressan and obsidan infusions].
Topics: Adrenergic beta-Antagonists; Cardiac Output; Dihydralazine; Drug Therapy, Combination; Humans; Hydra | 1979 |
Hypotensive action of OPC-1427, a new beta-adrenergic blocking agent in rats.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Depression, Chemical; Desoxycorticosterone; He | 1979 |
Relative importance of cardioselectivity and partial agonism in the treatment of hypertension in the patient with air-flow obstruction.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Airway Obstruction; Heart; Humans; Hypertensi | 1979 |
Plasma concentration and antihypertensive effect of beta-receptor blockers.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Drug Evaluation; Heart Rate; Humans; Hypertension; Oxpr | 1979 |
Changes in glomerular filtration rate during long term treatment with propranolol and peripheral vasodilators in patients with arterial hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Female; Glomerular Filtration Rate; Humans; Hydralazine; Hyperte | 1979 |
Alterations in myocardial adenylate cyclase in spontaneously hypertensive rats.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Albuterol; Animals; Catecholamines; Clonidine; Glucagon | 1979 |
[General anesthesia in the hypertensive dialyzed renal failure patient treated with beta-blockers].
Topics: Adrenergic beta-Antagonists; Anesthesia, General; Humans; Hypertension; Kidney Failure, Chronic; Pro | 1979 |
SK&F 92657, a novel antihypertensive acting by precapillary vasodilatation and beta-adrenoreceptor blockade.
Topics: Adrenergic beta-Antagonists; Animals; Arteries; Blood Pressure; Cats; Guinea Pigs; Heart Atria; Hear | 1979 |
[Effect of acebutolol, a cardioselective beta-adrenoceptor blocking agent, on the blood pressure in rats (author's transl)].
Topics: Acebutolol; Adrenergic beta-Antagonists; Animals; Blood Pressure; Desoxycorticosterone; Female; Hear | 1979 |
[Combination of beta-blocking agents, diuretics and pressidil (minoxidil) in severe arterial hypertension resisting other therapy].
Topics: Adrenergic beta-Antagonists; Adult; Chlorthalidone; Diuretics; Drug Therapy, Combination; Female; Fu | 1978 |
Haemodynamic setting of essential hypertension as a guide to management.
Topics: Antihypertensive Agents; Arteries; Blood Pressure; Cardiac Output; Clonidine; Diazoxide; Diuretics; | 1975 |
Letter: Clonidine withdrawal and blockade.
Topics: Clonidine; Drug Synergism; Humans; Hypertension; Propranolol | 1976 |
Renin dependency of blood-pressure. Analysis by angiotensin II antagonist P113 in hypertensive patients treated with salt depletion and propranolol.
Topics: Adolescent; Adult; Angiotensin II; Antihypertensive Agents; Blood Pressure; Brain Injuries; Diet, So | 1976 |
Editorial: Adrenergic-neuron and beta-receptor blockade in hypertension.
Topics: Antihypertensive Agents; Debrisoquin; Drug Evaluation; Drug Therapy, Combination; Humans; Hypertensi | 1976 |
Letter: Bromocriptine and hypertension.
Topics: Acromegaly; Adult; Blood Pressure; Bromocriptine; Drug Therapy, Combination; Ergolines; Humans; Hydr | 1976 |
Propranolol in refractory high-renin dialysis.
Topics: Humans; Hypertension; Propranolol; Renal Dialysis; Renin | 1976 |
Beta blockers for diabetics.
Topics: Aged; Diabetes Complications; Diabetes Mellitus; Female; Humans; Hypertension; Hyperthyroidism; Hypo | 1977 |
Hypertension in the elderly.
Topics: Age Factors; Aged; Diuretics; Female; Humans; Hypertension; Male; Methyldopa; Propranolol | 1977 |
Propranolol and Peyronie's disease.
Topics: Adult; Humans; Hypertension; Male; Penile Induration; Propranolol | 1977 |
Frequency of eye complaints and rashes among patients receiving practolol and propranolol.
Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Conjunctivitis; Corneal Diseases; Eczema; Female | 1977 |
Plasma renin and "prorenin" in essential hypertension during sodium depletion, beta-blockade, and reduced arterial pressure.
Topics: Adult; Blood Pressure; Chlorthalidone; Clonidine; Depression, Chemical; Diet, Sodium-Restricted; Dru | 1977 |
Inactive renin in human plasma.
Topics: Adult; Diazoxide; Enzyme Activation; Humans; Hydrogen-Ion Concentration; Hypertension; In Vitro Tech | 1976 |
Acute brain syndrome after propranolol.
Topics: Brain; Child; Cognition Disorders; Confusion; Female; Humans; Hypertension; Myoclonus; Propranolol; | 1978 |
Beta-blockade withdrawal.
Topics: Dose-Response Relationship, Drug; Humans; Hypertension; Propranolol; Substance Withdrawal Syndrome | 1975 |
Beta blockers and Peyronie's disease.
Topics: Adult; Aged; Humans; Hypertension; Male; Middle Aged; Penile Induration; Practolol; Propranolol | 1979 |
Diabetes and hypertension.
Topics: Blood Pressure; Diabetes Mellitus; Diabetic Nephropathies; Furosemide; Glomerular Filtration Rate; H | 1979 |
Analysis of efficacy of antihypertensive drugs.
Topics: Clonidine; Diastole; Drug Evaluation; Humans; Hypertension; Posture; Propranolol | 1979 |
Influence of once-daily administration of beta-adrenoceptor antagonists on arterial pressure and its variability.
Topics: Acebutolol; Activities of Daily Living; Adolescent; Adult; Bed Rest; Blood Pressure; Circadian Rhyth | 1979 |
Influence of beta blockade on the renin-angiotensin-aldosterone system [proceedings].
Topics: Aldosterone; Angiotensin II; Humans; Hypertension; Metoprolol; Propanolamines; Propranolol; Renin | 1979 |
Hazards of intravenous diazoxide.
Topics: Diazoxide; Heart Rate; Humans; Hypertension; Infusions, Parenteral; Injections, Intravenous; Propran | 1979 |
Propranolol in clinical medicine.
Topics: Administration, Oral; Arrhythmias, Cardiac; Cost-Benefit Analysis; Humans; Hypertension; Propranolol | 1979 |
Non-uniform myocardial blood flow caused by stellate ganglion stimulation.
Topics: Animals; Aortic Valve Stenosis; Blood Pressure; Coronary Circulation; Coronary Disease; Dogs; Electr | 1975 |
[Pharmacotherapy of hypertension and its significance for the function of the salivary glands (author's transl)].
Topics: Animals; Antihypertensive Agents; Autonomic Nervous System; Clonidine; Guanidines; Hypertension; Mas | 1975 |
[Effect of dl-propranolol and l-and d-alprenolol on arterial pressure in awake or anesthesized, normo- or hypertensive rats].
Topics: Alprenolol; Animals; Blood Pressure; Chloralose; Hypertension; Pentobarbital; Propranolol; Rats; Ste | 1975 |
Echocardiographic observations in hypertension.
Topics: Adolescent; Adult; Aged; Amyl Nitrite; Cardiomegaly; Cardiomyopathy, Hypertrophic; Echocardiography; | 1975 |
[Effect of practolol on experimental hypertension in dogs].
Topics: Animals; Blood Pressure; Carotid Arteries; Carotid Sinus; Cyanides; Dogs; Electrocardiography; Femal | 1975 |
Cutaneous reactions to propranolol (Inderal).
Topics: Aged; Angina Pectoris; Arrhythmias, Cardiac; Drug Eruptions; Female; Humans; Hypertension; Male; Mid | 1976 |
[Letter: Propranolol--psoriasiform eruption].
Topics: Drug Eruptions; Humans; Hypertension; Male; Middle Aged; Propranolol; Psoriasis | 1976 |
[A propranolol dermatitis mimicking Lyell's syndrome].
Topics: Drug Eruptions; Humans; Hypertension; Male; Middle Aged; Propranolol; Stevens-Johnson Syndrome | 1977 |
Cardiac hypertrophy and antihypertensive therapy.
Topics: Animals; Cardiomegaly; DNA; Hydroxyproline; Hypertension; Male; Methyldopa; Minoxidil; Myocardium; P | 1977 |
Effects of antihypertensive treatment on left ventricular hypertrophy in patients with essential hypertension.
Topics: Adult; Aged; Animals; Antihypertensive Agents; Cardiomegaly; Electrocardiography; Female; Heart Vent | 1979 |
Cardiovascular 'reactivity' to graded splanchnic nerve stimulation in spontaneously hypertensive and normotensive control rats.
Topics: Animals; Blood Pressure; Cardiac Output; Cardiomegaly; Hemodynamics; Hypertension; Male; Propranolol | 1979 |
[Increased cAMP concentration in parotid secretion in arterial hypertension: relationship to plasma-renin activity (author's transl)].
Topics: Cyclic AMP; Humans; Hypertension; Hypertension, Renal; Metaproterenol; Parotid Gland; Propranolol; R | 1975 |
[The influence of propranolol, practolol and theophylline on the plasma renin activity (author's transl)].
Topics: Adult; Blood Pressure; Cyclic AMP; Heart Rate; Humans; Hypertension; Middle Aged; Practolol; Propran | 1975 |
Plasma cyclic adenosine 3':5'-monophosphate response to isoproterenol and glucagon in hyperkinetic borderline (labile) hypertension.
Topics: Adult; Blood Pressure; Cyclic AMP; Female; Glucagon; Heart; Heart Rate; Hemodynamics; Humans; Hypert | 1976 |
Studies on subcellular fractions from mesenteric arteries of spontaneously hypertensive rats: alterations in both calcium uptake and enzyme activities.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Alkaline Phosphatase; Animals; Azides; Calcium; C | 1976 |
Endocrine function in a case of beta-adrenergic hyperdynamic circulatory state.
Topics: Arginine; Blood Glucose; Cyclic AMP; Female; Glucagon; Growth Hormone; Humans; Hypertension; Insulin | 1976 |
Unexpected pressor responses to propranolol in essential hypertension. An interaction between renin, aldosterone and sympathetic activity.
Topics: Adult; Age Factors; Aldosterone; Blood Pressure; Body Weight; Depression, Chemical; Female; Heart Ra | 1976 |
Blockade of renin or angiotensin for understanding human hypertension: a comparison of propranolol, saralasin and converting enzyme blockade.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Volume; | 1977 |
[P.R.A. and cold pressor test following beta receptor block during arterial hypertensive syndromes].
Topics: Adult; Autonomic Nerve Block; Female; Humans; Hypertension; Male; Middle Aged; Propranolol; Receptor | 1976 |
Effects of propranolol on baroreflex sensitivity in borderline hypertension.
Topics: Adolescent; Adult; Humans; Hypertension; Male; Pressoreceptors; Propranolol; Receptors, Adrenergic, | 1978 |
[Central cardiovascular effect of isoprenaline and some adrenergic beta blocking agents in neurogenic hypertensive dog: role of central beta-adrenoceptors (author's transl)].
Topics: Animals; Blood Pressure; Dogs; Female; Heart Rate; Hypertension; Isoproterenol; Male; Propranolol; R | 1978 |
[Hemodynamics in patients suffering from hyperkinetic cardiac syndromes and in normal persons under psychological stress before and after treatment with propranolol (author's transl)].
Topics: Blood Pressure; Cardiac Output; Cardiac Volume; Depression, Chemical; Heart Diseases; Heart Rate; He | 1979 |
Hazards of phenylephrine topical medication in persons taking propranolol.
Topics: Administration, Topical; Drug Interactions; Female; Humans; Hypertension; Intracranial Aneurysm; Mid | 1979 |
Influence of selective and non-selective beta-adrenoreceptor blockade on the haemodynamic effect of adrenaline during combined antihypertensive drug therapy.
Topics: Adult; Blood Pressure; Epinephrine; Heart Rate; Humans; Hypertension; Metoprolol; Middle Aged; Propa | 1979 |
Beta-adrenergic blockade in diuretic-treated patients with essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Diuretics; Drug Therapy, Combination; Fema | 1975 |
Letter: Effects of beta-adrenergic blockade with propranolol.
Topics: Adrenergic beta-Antagonists; Adult; Female; Humans; Hypertension; Male; Middle Aged; Oxprenolol; Pro | 1975 |
Editorial: Angiotensin blockade: new pharmacologic tools for understanding and treating hypertension.
Topics: Alanine; Angiotensin II; Diuretics; Humans; Hypertension; Hypertension, Renal; Propranolol; Sarcosin | 1975 |
The clinical pharmacology of hypotensive vasodilator drugs.
Topics: Adrenergic beta-Antagonists; Blood Vessels; Cardiac Output; Diuretics; Drug Therapy, Combination; Hu | 1975 |
Renin release, saralasin and the vasodilator-beta-blocker drug interaction in man.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Blood Pressure; Depression, Chemical; Drug Interactions | 1975 |
Dissociation between renin and arterial pressure responses to beta-adrenergic blockade in human essential hypertension.
Topics: Adrenergic beta-Antagonists; Bicarbonates; Blood Pressure; Chlorides; Creatinine; Diuretics; Drug Ad | 1975 |
Antihypertensive effects of beta-blockers in hypertensive rats.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Desoxycorticosterone; | 1975 |
Letter: Hyperthyroidism.
Topics: Adrenergic beta-Antagonists; Female; Fetal Death; Fetal Distress; Fetal Heart; Fetus; Heart Rate; Hu | 1975 |
Increased cardiac contractility in acute uremia: interrelationships with hypertension.
Topics: Animals; Blood Pressure; Blood Urea Nitrogen; Chlorides; Heart Rate; Hydrogen-Ion Concentration; Hyp | 1975 |
[Antihypertensive therapy using beta receptor blockers].
Topics: Adrenergic beta-Antagonists; Alprenolol; Cardiac Output; Heart Rate; Humans; Hypertension; Hypertens | 1975 |
Impaired vasoconstrictor nerve function in spontaneously hypertensive rats after long-term treatment with propranolol and metroprolol.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Dose-Response Relationship, Drug; Female; Hype | 1975 |
Antihypertensive beta blocking action as related to renin and age: a pharmacologic tool to identify pathogenetic mechanisms in essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Blood Pressure; Female; Hemodynamics; Humans; Hyper | 1975 |
Pre-term baby: an inheritance of a different kind.
Topics: Adult; Female; Humans; Hypertension; Infant, Newborn; Infant, Premature, Diseases; Male; Pregnancy; | 1979 |
Drug treatment of mild hypertension: adverse consequences.
Topics: Antihypertensive Agents; Benzothiadiazines; Clonidine; Diuretics; Drug Interactions; Female; Guaneth | 1978 |
A physiological basis for the treatment of essential hypertension.
Topics: Aldosterone; Clonidine; Diuretics; Humans; Hypertension; Propranolol; Renin; Sodium | 1978 |
Renin secretion by the human kidney.
Topics: Humans; Hypertension; Kidney; Propranolol; Renin; Secretory Rate | 1978 |
Acid-activated renin responses to hydrochlorothiazide, propranol and indomethacin.
Topics: Adult; Aldosterone; Blood Pressure; Enzyme Activation; Humans; Hydrochlorothiazide; Hypertension; In | 1978 |
Circulating catecholamines and systolic time intervals in labile and sustained hypertension.
Topics: Catecholamines; Epinephrine; Female; Humans; Hypertension; Male; Myocardial Contraction; Norepinephr | 1978 |
Noradrenaline secretion by the human kidney.
Topics: Aging; Aldosterone; Blood Pressure; Humans; Hypertension; Kidney; Norepinephrine; Propranolol; Renin | 1978 |
Primary hypertension refractory to triple drug treatment - a study on central and peripheral hemodynamics.
Topics: Bendroflumethiazide; Drug Therapy, Combination; Hemodynamics; Humans; Hydralazine; Hydrochlorothiazi | 1979 |
Drug interactions with saralasin.
Topics: Angiotensin II; Angiotensins; Blood Pressure; Blood Volume; Diuretics; Drug Interactions; Humans; Hy | 1979 |
Integrated medical-surgical treatment of pre-infarction syndrome.
Topics: Adult; Aged; Angina Pectoris; Angiocardiography; Aortic Valve Stenosis; Coronary Artery Bypass; Deci | 1977 |
Angina pectoris: an overview.
Topics: Angina Pectoris; Angina Pectoris, Variant; Arterial Occlusive Diseases; Blood Pressure; Coronary Art | 1977 |
Treatment of high-renin hypertension with propranolol in children after renal transplantation.
Topics: Adolescent; Blood Pressure; Child; Humans; Hypertension; Kidney Transplantation; Minoxidil; Proprano | 1977 |
The effects of captopril, propranolol, and indomethacin on blood pressure and plasma renin activity in spontaneously hypertensive and normotensive rats.
Topics: Animals; Blood Pressure; Captopril; Hypertension; Indomethacin; Male; Proline; Propranolol; Rats; Re | 1979 |
[Discontinuation of chronic hemodialysis due to improved kidney function caused by the control of arterial hypertension].
Topics: Adult; Creatinine; Female; Furosemide; Humans; Hypertension; Male; Middle Aged; Nitroprusside; Propr | 1979 |
Angiotensin II blockade during combined thiazide-beta-adrenoreceptor-blocker treatment.
Topics: Adult; Angiotensin II; Atenolol; Blood Pressure; Female; Humans; Hydrochlorothiazide; Hypertension; | 1979 |
Long-term study of oxdralazine in hypertensive patients.
Topics: Antihypertensive Agents; Chlorthalidone; Ethanolamines; Female; Hemodynamics; Humans; Hypertension; | 1979 |
[Action of increasing doses of DL-propranolol on behavior of arterial pressure and plasma renin activity (PRA)].
Topics: Adolescent; Adult; Blood Pressure; Dose-Response Relationship, Drug; Humans; Hypertension; Middle Ag | 1978 |
[Behavior of blood volume and electrolytes in patients with essential hypertension with low plasmatic renin activity (PRA). Effects of treatment with propranolol].
Topics: Adult; Blood Pressure; Blood Volume; Electrolytes; Female; Heart Rate; Humans; Hypertension; Male; M | 1978 |
[Essential hypertension with low plasmatic renin activity (PRA). Effects of propranolol on arterial pressure and reninemia].
Topics: Adult; Blood Pressure; Female; Humans; Hypertension; Male; Middle Aged; Propranolol; Renin | 1978 |
[Essential hypertension with low plasmatic renin activity (PRA). Effects of propranolol on some indices of adrenergic system activity].
Topics: Adult; Blood Pressure; Catecholamines; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; | 1978 |
Pharmacologic control of acute aortic dissection in hypertensive dogs.
Topics: Animals; Aortic Aneurysm; Aortic Dissection; Blood Pressure; Dogs; Drug Therapy, Combination; Ferric | 1978 |
Sympathetic adrenergic blockade effects upon operantly conditioned blood pressure elevations in baboons.
Topics: Adrenergic Fibers; Animals; Blood Pressure; Conditioning, Operant; Depression, Chemical; Haplorhini; | 1977 |
The inhibition of prostaglandin synthetase in vivo by nonsteroidal anti-inflammatory agents.
Topics: Animals; Anti-Inflammatory Agents; Arachidonic Acids; Blood Pressure; Cyclooxygenase Inhibitors; Dru | 1977 |
Propranolol and newer antihypertensive drugs in the management of hypertension.
Topics: Angiotensin II; Clonidine; Diuretics; Humans; Hypertension; Minoxidil; Prazosin; Propranolol; Sarala | 1979 |
Echocardiographic assessment of the effect of an antihypertensive regimen on left ventricular performance.
Topics: Adult; Antihypertensive Agents; Aortic Aneurysm; Aortic Dissection; Chlorthalidone; Coronary Disease | 1979 |
Role of the sympathetic nervous system in mediating the renin response to head-up tilt. Their possible synergism in defending blood pressure against postural changes during sodium deprivation.
Topics: Adult; Blood Pressure; Female; Humans; Hypertension; Hypotension, Orthostatic; Male; Middle Aged; No | 1979 |
Converting enzyme inhibition in hypertensive emergencies.
Topics: Adult; Emergencies; Female; Humans; Hypertension; Male; Middle Aged; Oligopeptides; Propranolol; Ren | 1979 |
[Effect of propranolol on the ability of the liver to metabolize drugs in patients with hypertension].
Topics: Adult; Aged; Antipyrine; Female; Humans; Hypertension; Indocyanine Green; Liver; Male; Middle Aged; | 1979 |
Plasma concentrations of propranolol and 4-hydroxypropranolol in man measured by high pressure liquid chromatography.
Topics: Chromatography, High Pressure Liquid; Humans; Hydroxylation; Hypertension; In Vitro Techniques; Kine | 1979 |
Severe diarrhea secondary to propranolol.
Topics: Atrial Flutter; Diarrhea; Female; Humans; Hypertension; Male; Middle Aged; Propranolol; Tachycardia | 1979 |
Baroreflex sensitivity in hypertension during beta-adrenergic blockade.
Topics: Adult; Aged; Heart Rate; Humans; Hypertension; Middle Aged; Pressoreceptors; Propranolol; Reflex | 1979 |
Practical approach to hypertension. 2. Treatment.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Diet, Sodium-Restricted; Diuretics; Female; Guanethi | 1979 |
Clonidine and propranolol paradoxical hypertension.
Topics: Clonidine; Drug Interactions; Humans; Hypertension; Male; Middle Aged; Propranolol | 1979 |
Steady-state disposition of propranolol and its total metabolites in the spontaneously hypertensive rat: chronic subcutaneous vs. intracerebroventricular infusion with osmotic minipumps.
Topics: Animals; Hypertension; Infusions, Parenteral; Injections, Intraventricular; Injections, Subcutaneous | 1979 |
Nylidrin: a potent anti-hypertensive agent in hypertensive rats.
Topics: Animals; Antihypertensive Agents; Atenolol; Blood Pressure; Desoxycorticosterone; Heart Rate; Hypert | 1979 |
Drug choice for treatment of hypertension at 'step 2'.
Topics: Humans; Hypertension; Methyldopa; Propranolol; Reserpine | 1979 |
Rapid blood pressure control with minoxidil: acute and chronic effects on blood pressure, sodium excretion, and the renin-aldosterone system.
Topics: Adult; Aldosterone; Blood Pressure; Blood Volume; Creatinine; Diuretics; Heart Rate; Humans; Hyperte | 1979 |
Reduction of beta-blocking drugs in hypertensive patients treated with minoxidil.
Topics: Atenolol; Blood Pressure; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Heart | 1979 |
Guidelines for evaluating and treating hypertension.
Topics: Aged; Antihypertensive Agents; Benzothiadiazines; Diuretics; Drug Therapy, Combination; Guanethidine | 1979 |
Propranolol and eye symptoms.
Topics: Aged; Eye Manifestations; Humans; Hypertension; Male; Propranolol | 1979 |
Norepinephrine-secreting tumor of the organ of Zuckerkandl. Response to propranolol alone.
Topics: Adult; Blood Pressure; Chromaffin System; Epinephrine; Humans; Hypertension; Male; Norepinephrine; P | 1979 |
Platelet lipid peroxides as determinant of platelet survival and sympathetic stimulation in patients with hypertension.
Topics: Blood Platelets; Cell Survival; Epinephrine; Female; Humans; Hypertension; Lipids; Male; Norepinephr | 1979 |
Plasma clearance of propranolol and sotalol and hepatic drug-metabolizing enzyme activity.
Topics: Adult; Aged; Angina Pectoris; Antipyrine; Cytochrome P-450 Enzyme System; Female; Half-Life; Humans; | 1979 |
Measurement of naphthoxylactic and naphtoxyacetic acid in human plasma following propranolol administration.
Topics: Chromatography, High Pressure Liquid; Glycolates; Humans; Hypertension; Lactates; Naphthalenes; Prop | 1979 |
When cardiac patients become surgical patients.
Topics: Aged; Anesthesia; Anti-Bacterial Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Bundle-Branch Bl | 1979 |
Systolic hypertension: hemodynamic mechanism and choice of antihypertensive treatment.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Cardiac Output; Compliance; Hemodynamics; Humans; Hy | 1979 |
Effect of intravenous or intracisternal clonidine and propranolol on plasma renin. Activity in hypertensive dogs.
Topics: Animals; Cisterna Magna; Clonidine; Dogs; Drug Evaluation; Female; Hypertension; Injections, Intrave | 1979 |
Fatal rebound hypertension after abrupt withdrawal of clonidine and propranolol.
Topics: Clonidine; Humans; Hypertension; Male; Middle Aged; Propranolol; Substance Withdrawal Syndrome | 1979 |
Evidence for activation of circulating inactive renin by the human kidney.
Topics: Diazoxide; Enzyme Activation; Humans; Hypertension; Kidney; Kinetics; Propranolol; Renin | 1979 |
The role of the baroreceptor reflex in the cardiovascular effects of propranolol in the conscious spontaneously hypertensive rat.
Topics: Animals; Blood Pressure; Denervation; Heart Rate; Hypertension; Male; Pressoreceptors; Propranolol; | 1979 |
Propranolol and alopecia.
Topics: Alopecia; Female; Hair; Humans; Hypertension; Middle Aged; Propranolol | 1979 |
An opposing role for the adrenals in the hypotensive effects of propranolol in the spontaneously hypertensive rat.
Topics: Adrenal Glands; Adrenalectomy; Animals; Blood Pressure; Corticosterone; Disease Models, Animal; Hear | 1979 |
Effects of prazosin on plasma renin activity and blood pressure.
Topics: Adult; Aged; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Placebos; | 1979 |
Paroxysmal neurogenic hypertension and its prevention in patients with cervical spinal cord lesions.
Topics: Adult; Blood Pressure; Ethanolamines; Heart Rate; Humans; Hypertension; Labetalol; Middle Aged; Nore | 1979 |
Propranolol and marathon running.
Topics: Humans; Hypertension; Propranolol; Running | 1979 |
Plasma concentrations of propranolol and 4-hydroxypropranolol during chronic oral propranolol therapy.
Topics: Adult; Aged; Biotransformation; Female; Humans; Hydroxylation; Hypertension; Male; Middle Aged; Prop | 1979 |
Changes in blood pressure, heart rate, and plasma noradrenaline concentration after sudden withdrawal of propranolol.
Topics: Blood Pressure; Female; Heart Rate; Humans; Hypertension; Male; Norepinephrine; Propranolol; Substan | 1979 |
Psychosis. A probable result of propranolol therapy.
Topics: Coronary Disease; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Middle Aged; Propr | 1979 |
[Medical support in surgery for pheochromocytoma].
Topics: Adrenal Gland Neoplasms; Arrhythmias, Cardiac; Humans; Hypertension; Hypotension; Intraoperative Com | 1979 |
Blood pressure variability and plasma catecholamines in man. Effect of propranolol therapy.
Topics: Blood Pressure; Epinephrine; Female; Humans; Hypertension; Male; Middle Aged; Norepinephrine; Postur | 1979 |
Naphthoxylactic acid after single and long-term doses of propranolol.
Topics: Adult; Creatinine; Dose-Response Relationship, Drug; Humans; Hypertension; Kinetics; Lactates; Male; | 1979 |
Effect of prostaglandin E1 on renin and aldosterone in hypertensive patients.
Topics: Adult; Aldosterone; Female; Humans; Hypertension; Indomethacin; Male; Middle Aged; Propranolol; Pros | 1979 |
An assessment of adverse effects of methyldopa and propranolol.
Topics: Humans; Hypertension; Male; Methyldopa; Middle Aged; Propranolol | 1979 |
Traction-related hypertension in children.
Topics: Adolescent; Humans; Hydralazine; Hypertension; Male; Propranolol; Renin; Traction | 1979 |
Lowering of blood pressure in sympathectomized spontaneously hypertensive rats on beta adrenoreceptor blockade [proceedings].
Topics: Animals; Blood Pressure; Hypertension; Propranolol; Rats; Sympathectomy | 1979 |
Propranolol for the treatment of hypertension in pregnancy.
Topics: Female; Humans; Hypertension; Pregnancy; Pregnancy Complications, Cardiovascular; Propranolol | 1979 |
Effect of propranolol and reserpine on the development of vasopressin hypertension in rat.
Topics: Animals; Brain; Hypertension; Lypressin; Male; Norepinephrine; Propranolol; Rats; Renin; Reserpine | 1979 |
Raynaud's phenomenon in hypertensive dialysis patients taking a sustained-release propranolol formulation.
Topics: Delayed-Action Preparations; Female; Humans; Hypertension; Male; Middle Aged; Propranolol; Raynaud D | 1979 |
Propranolol in conscious spontaneously hypertensive rats. I. Cardiovascular effects after subcutaneous and intracerebroventricular administration.
Topics: Animals; Blood Pressure; Heart Rate; Hemodynamics; Hypertension; Injections, Intraventricular; Injec | 1979 |
Propranolol in conscious spontaneously hypertensive rats. II. Disposition after subcutaneous and intracerebroventricular administration.
Topics: Animals; Biotransformation; Hypertension; Injections, Intraventricular; Injections, Subcutaneous; Ma | 1979 |
Effect of propranolol on total exchangeable body potassium and total exchangeable body sodium in essential hypertension.
Topics: Adult; Female; Humans; Hypertension; Male; Middle Aged; Potassium; Propranolol; Sodium | 1979 |
Effect of systemic autonomic inhibition on the hemodynamic response to antihypertensive therapy with timolol.
Topics: Adult; Atropine; Autonomic Nervous System; Blood Pressure; Female; Heart Rate; Hemodynamics; Humans; | 1979 |
Quantitative analysis of naphthoxylactic acid, a major metabolite of propranolol in plasma in man.
Topics: Chromatography, Gas; Gas Chromatography-Mass Spectrometry; Humans; Hypertension; Lactates; Propranol | 1979 |
[Minoxidil in treatment resistant hypertension].
Topics: Adult; Diuretics; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hypertension; Hyperten | 1979 |
[Effect of the beta-adrenoblocker propranolol on adrenaline-stimulated lipolysis in the adipose tissue of spontaneously hypertensive rats].
Topics: Adipose Tissue; Animals; Epinephrine; Hypertension; Kinetics; Lipid Mobilization; Propranolol; Rats | 1979 |
Protein synthesis and composition of cardiac and vascular tissue in spontaneously hypertensive rats and the effects of beta-adrenergic antagonist treatment.
Topics: Animals; Heart; Hypertension; Hypertrophy; Male; Metoprolol; Muscle Proteins; Muscle, Smooth, Vascul | 1979 |
The pathogenesis of propranolol-withdrawal syndrome in essential hypertension.
Topics: Adult; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Propranolol; Substance Withdrawa | 1979 |
[Effects of propranolol on the lipid pattern and post-prandial lipemia in patients with essential arterial hypertension].
Topics: Adult; Cholesterol; Dietary Fats; Fasting; Female; Humans; Hypertension; Lipids; Male; Middle Aged; | 1979 |
[The combination of propranolol, hydrochlorothiazide and spironolactone in the treatment of essential arterial hypertension].
Topics: Adult; Aged; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Mid | 1979 |
[Short-term and median-term effects of tienilic acid in hypertension].
Topics: Adult; Aged; Drug Evaluation; Drug Therapy, Combination; Female; Glycolates; Humans; Hypertension; M | 1979 |
[Cardiovascular complications of severe tetanus (author's transl)].
Topics: Arrhythmias, Cardiac; Catecholamines; Hypertension; Phentolamine; Propranolol; Tetanus | 1979 |
The effects of long term oral treatment with indapamide on the development of DOCA-salt hypertension in rats: vascular reactivity studies.
Topics: Animals; Blood Pressure; Body Weight; Desoxycorticosterone; Diuretics; Eating; Hypertension; Indapam | 1979 |
Stress-induced refractory hypertension following acute cerebrovascular events: control with propranolol.
Topics: Adult; Aged; Cerebrovascular Disorders; Female; Humans; Hypertension; Male; Middle Aged; Propranolol | 1979 |
Rhythmometry gauges treatment of mesor-hypertension in the seventh and eight decades of life.
Topics: Aged; Blood Pressure; Blood Pressure Determination; Circadian Rhythm; Drug Combinations; Humans; Hyd | 1979 |
Cardiovascular control in the Milan strain of spontaneously hypertensive rat (MHS) at "rest" and during acute mental "stress".
Topics: Animals; Atropine; Blood Pressure; Cardiac Output; Heart Rate; Hemodynamics; Humans; Hypertension; N | 1977 |
[Treatment of arterial hypertension with propranolol in pregnant women. 10 cases].
Topics: Adult; Birth Weight; Blood Pressure; Cesarean Section; Delivery, Obstetric; Female; Humans; Hyperten | 1977 |
Effects of beta-adrenergic blockade on diurnal variability of blood pressure and plasma noradrenaline levels.
Topics: Blood Pressure; Circadian Rhythm; Humans; Hypertension; Norepinephrine; Propranolol | 1977 |
Long-term propranolol therapy in pregnancy: maternal and fetal outcome.
Topics: Asphyxia Neonatorum; Bradycardia; Female; Fetal Growth Retardation; Fetus; Humans; Hypertension; Hyp | 1979 |
Long-term propranolol therapy in pregnancy: maternal and fetal outcome.
Topics: Asphyxia Neonatorum; Bradycardia; Female; Fetal Growth Retardation; Fetus; Humans; Hypertension; Hyp | 1979 |
Long-term propranolol therapy in pregnancy: maternal and fetal outcome.
Topics: Asphyxia Neonatorum; Bradycardia; Female; Fetal Growth Retardation; Fetus; Humans; Hypertension; Hyp | 1979 |
Long-term propranolol therapy in pregnancy: maternal and fetal outcome.
Topics: Asphyxia Neonatorum; Bradycardia; Female; Fetal Growth Retardation; Fetus; Humans; Hypertension; Hyp | 1979 |
The present status of propranolol.
Topics: Adrenal Gland Neoplasms; Angina Pectoris; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; | 1979 |
Experimental studies on the anti-hypertensive effect of acebutolol in dogs: further evidence for a central site of action.
Topics: Acebutolol; Animals; Antihypertensive Agents; Dogs; Drug Evaluation, Preclinical; Female; Hypertensi | 1978 |
Prazosin combined with thiazide diuretic and beta-blocker in the treatment of hypertension.
Topics: Blood Pressure; Cyclopenthiazide; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Pindol | 1977 |
[Experimental hypertension in rats and their adrenal activity].
Topics: 11-Hydroxycorticosteroids; Adrenal Cortex; Animals; Hypertension; Male; Propranolol; Rats | 1977 |
[Effect of beta-adrenergic blockade on acid-base balance in experimental hypertension].
Topics: Acidosis; Animals; Hypertension; Kidney; Lung; Male; Propranolol; Rats | 1977 |
[Effects of propranolol in experimental arterial hypertension].
Topics: Animals; Dogs; Hypertension; Propranolol | 1977 |
[Simultaneous administration of dihydralazine, propranolol and a diuretic in the treatment of severe hypertension].
Topics: Adolescent; Adult; Dihydralazine; Diuretics; Drug Therapy, Combination; Female; Humans; Hydralazine; | 1977 |
[Prazosin as an alternative in the treatment of acute hypertension].
Topics: Adult; Aged; Drug Combinations; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hyperten | 1977 |
Acute cardiovascular activity of beta-adrenoceptor blocking drugs in awake or anaesthetized normotensive and hypertensive rats.
Topics: Alprenolol; Anesthesia; Animals; Blood Pressure; Hemodynamics; Hypertension; Kinetics; Male; Propran | 1977 |
[The adrenergic system and the control of the renin and aldosterone circadian rhythm in essential arterial hypertension].
Topics: Adolescent; Adult; Aldosterone; Circadian Rhythm; Female; Humans; Hydrocortisone; Hypertension; Male | 1977 |
Haemodynamic changes during tilt after autonomic blockade in spontaneously hypertensive rats.
Topics: Animals; Atropine; Autonomic Nervous System; Blood Pressure; Cardiac Output; Female; Heart Rate; Hem | 1977 |
[Comparative clinical evaluation of the effectiveness and tolerance of a new antihypertensive agent, DL 150 IT, administered alone and in combination with reserpine or propranolol].
Topics: Adult; Antihypertensive Agents; Drug Evaluation; Drug Therapy, Combination; Ethanolamines; Female; H | 1977 |
Sinus tachycardis in a hypertensive patient: drug withdrawal phenomenon?
Topics: Arrhythmia, Sinus; Female; Humans; Hydralazine; Hypertension; Middle Aged; Propranolol; Substance Wi | 1977 |
Propranolol efficacy in essential hypertension in adolescents.
Topics: Adolescent; Age Factors; Female; Humans; Hypertension; Male; Propranolol | 1977 |
[Diagnostic and therapeutic significance of inhibitors of the renin-angiotensin system].
Topics: Angiotensin II; Animals; Dogs; Humans; Hypertension; Kinins; Oligopeptides; Pindolol; Propranolol; R | 1977 |
[Action of digitalis on beta blockade-induced hemodynamic changes in patients with hypertension].
Topics: Blood Pressure; Cardiac Output; Digoxin; Humans; Hypertension; Physical Exertion; Propranolol; Rest | 1977 |
[Influence of intravenous infusion of aminophylline on plasma renin activity (PRA) during the cold pressor test, before and after beta receptor blocking].
Topics: Adult; Aminophylline; Cold Temperature; Female; Humans; Hypertension; Infusions, Parenteral; Male; M | 1977 |
Development of insulin sensitivity in rat aorta after chronic propranolol treatment.
Topics: Animals; Aorta; Blood Pressure; Body Weight; Chromatography, Thin Layer; Drug Interactions; Glucose; | 1978 |
The comeback of hydralazine.
Topics: Drug Therapy, Combination; Hemodynamics; Humans; Hydralazine; Hypertension; Propranolol | 1978 |
Role of sodium intake in the antihypertensive effect of propranolol.
Topics: Adult; Blood Pressure; Blood Volume; Body Weight; Diet, Sodium-Restricted; Diuretics; Female; Humans | 1978 |
The possible importance of aldosterone as well as renin in the long-term antihypertensive action of propranolol.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Depression, Chemical; Female; Humans; Hypertension; Male; | 1978 |
Minoxidil in scleroderma with hypertension.
Topics: Humans; Hypertension; Male; Middle Aged; Minoxidil; Propranolol; Pyrimidines; Scleroderma, Systemic | 1978 |
[Treatment of chronic cardiac insufficiency by combined use of adrenergic beta receptor blockaders and cardiac glycosides].
Topics: Adult; Aged; Chronic Disease; Coronary Disease; Digoxin; Drug Therapy, Combination; Female; Humans; | 1978 |
[Effect of the beta-receptor blocker propranolol on the catecholamin level and dopamin-beta-hydroxylase in patients with essential hypertension].
Topics: Catecholamines; Dopamine beta-Hydroxylase; Humans; Hypertension; Male; Propranolol | 1978 |
[Long-term treatment of arterial hypertension with propranolol. Combination with diuretics and dihydrazinophthalazine].
Topics: Adult; Dihydralazine; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hydralazine; Hydro | 1978 |
The effects of antihypertensive medication on the control of the cardiovascular system during halothane anaesthesia in rats.
Topics: Anesthesia, Inhalation; Animals; Antihypertensive Agents; Blood Pressure; Clonidine; Drug Evaluation | 1978 |
Systemic hypertension after surgical treatment of a congenital arteriovenous malformation.
Topics: Arteriovenous Malformations; Child; Female; Hemodynamics; Humans; Hypertension; Postoperative Compli | 1978 |
Lysine incorporation in vessels of spontaneously hypertensive rats: effects of adrenergic drugs.
Topics: Animals; Arteries; Blood Pressure; Blood Vessels; Collagen; Elastin; Hypertension; Lysine; Phenoxybe | 1978 |
Long-term treatment of refractory hypertensive patients with minoxidil.
Topics: Adult; Blood Pressure; Clonidine; Drug Evaluation; Drug Interactions; Drug Therapy, Combination; Fem | 1978 |
Sodium nitroprusside and propranolol therapy for management of postcoarctectomy hypertension.
Topics: Administration, Oral; Adolescent; Adult; Aortic Coarctation; Blood Vessel Prosthesis; Child; Child, | 1978 |
Propranolol in the treatment of cardiovascular disease.
Topics: Angina Pectoris; Aortic Aneurysm; Aortic Dissection; Arrhythmias, Cardiac; Cardiomyopathies; Cardiov | 1978 |
Tolmesoxide, a drug that lowers blood pressure by a direct relaxant effect on vascular smooth muscle.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cats; Diuresis; Dose-Response Relationship, Drug; | 1978 |
Pulmonary oedema after propranolol therapy in two cases of phaeochromocytoma.
Topics: Adrenal Gland Neoplasms; Adult; Female; Humans; Hypertension; Male; Pheochromocytoma; Propranolol; P | 1978 |
Propranolol withdrawal and thyroid hormones in patients with essential hypertension.
Topics: Adult; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Propranolol; Sub | 1978 |
Role of autonomic and non-autonomic circulatory components in borderline hypertension in young men.
Topics: Adult; Atropine; Autonomic Nervous System; Blood Pressure; Cardiac Output; Heart Rate; Hemodynamics; | 1978 |
Renal plasma flow and cardiac output during hydralazine and propranolol treatment in essential hypertension.
Topics: Adult; Cardiac Output; Drug Evaluation; Drug Therapy, Combination; Humans; Hydralazine; Hypertension | 1978 |
Adverse effects of sympatholytic agents in patients with hypertension and sinus node dysfunction.
Topics: Aged; Arrhythmia, Sinus; Bradycardia; Clonidine; Electrocardiography; Female; Guanethidine; Heart Ra | 1978 |
Propranolol for the treatment of hypertension in pregnancy.
Topics: Adult; Apgar Score; Chlorthalidone; Female; Fetal Death; Humans; Hypertension; Infant, Newborn; Infa | 1978 |
[Biochemical profile of essential arterial hypertension. Indications for a targeted therapy: experience with propranolol].
Topics: Aldosterone; Drug Evaluation; Humans; Hypertension; Propranolol; Renin | 1978 |
Changes in plasma volume and extracellular fluid volume and after addition of hydralazine to propranolol treatment in patients with hypertension.
Topics: Adult; Aged; Drug Evaluation; Drug Therapy, Combination; Extracellular Space; Female; Humans; Hydral | 1978 |
The determinants of plasma-renin activity in essential hypertension.
Topics: Adolescent; Adult; Humans; Hypertension; Isoproterenol; Kidney; Kidney Tubules, Distal; Male; Middle | 1978 |
Long-term management of hypertension.
Topics: Adult; Diuretics; Female; Guanethidine; Humans; Hypertension; Male; Methyldopa; Middle Aged; Propran | 1978 |
Urinary kallikrein excretion and plasma renin activity in patients with essential hypertension and primary aldosteronism.
Topics: Adult; Female; Humans; Hyperaldosteronism; Hypertension; Kallikreins; Male; Middle Aged; Propranolol | 1978 |
[Plasma renin activity response to isometric handgrip exercise in normotensive and hypertensive patients (author's transl)].
Topics: Adolescent; Adult; Female; Humans; Hypertension; Male; Middle Aged; Muscle Contraction; Physical Exe | 1978 |
Treatment with propranolol and hydralazine throughout pregnancy in a hypertensive patient. A case report.
Topics: Adult; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Pregnancy; Pregnancy Co | 1978 |
Modification of blood pressure and aortic baroreceptor activity in propranolol-treated hypertensive rabbits [proceedings].
Topics: Animals; Blood Pressure; Hypertension; In Vitro Techniques; Pressoreceptors; Propranolol; Rabbits | 1978 |
Treatment of acute intermittent porphyria with large doses of propranolol.
Topics: Administration, Oral; Adult; Female; Humans; Hypertension; Injections, Intravenous; Neurologic Manif | 1978 |
Antihypertensive effect of cardiovascular Ca2+-antagonist in hypertensive patients in the absence and presence of beta-adrenergic blockade.
Topics: Adult; Blood Pressure; Calcium; Cardiac Output; Female; Furosemide; Heart Rate; Humans; Hypertension | 1978 |
Cardiovascular changes in awake dogs caused by suddenly induced aortic hypertension.
Topics: Animals; Assisted Circulation; Atropine; Dogs; Hemodynamics; Hypertension; Intra-Aortic Balloon Pump | 1978 |
Propranolol as an antihypertensive agent in children.
Topics: Adolescent; Child; Child, Preschool; Heart Rate; Humans; Hypertension; Propranolol; Renin | 1978 |
[Role of the adrenergic sympathetic system and diagnostic and therapeutic reflections].
Topics: Adrenergic Fibers; Blood Pressure; Cardiovascular Physiological Phenomena; Catechol O-Methyltransfer | 1978 |
Propranolol in black hypertensives.
Topics: Black People; Humans; Hypertension; Jamaica; Propranolol | 1978 |
The effects of vasodilators in the perfused hind limbs of spontaneously hypertensive and normotensive rats.
Topics: Animals; Drug Interactions; Female; Hindlimb; Hypertension; In Vitro Techniques; Isoproterenol; Nitr | 1978 |
Primary hypertension refractory to triple drug treatment: a study on central and peripheral hemodynamics.
Topics: Benzothiadiazines; Blood Pressure; Cardiac Volume; Diuretics; Drug Resistance; Drug Therapy, Combina | 1978 |
The contribution of propranolol metabolites to the fluorometric assay of propranolol in human plasma.
Topics: Chromatography, Gas; Humans; Hypertension; Propranolol; Spectrometry, Fluorescence | 1978 |
The hypertensive psychiatric patient: pharmacologic problems.
Topics: Antihypertensive Agents; Clonidine; Depression; Diuretics; Drug Interactions; Guanethidine; Humans; | 1978 |
The possible adverse effect of propranolol on the fetus in pregnancies complicated by severe hypertension.
Topics: Birth Weight; Female; Fetal Death; Humans; Hypertension; Infant, Newborn; Pregnancy; Pregnancy Compl | 1978 |
Propranolol in black hypertensives.
Topics: Black People; Humans; Hypertension; Jamaica; Propranolol | 1978 |
Propranolol in hypertension during pregnancy.
Topics: Adult; Female; Humans; Hypertension; Pregnancy; Pregnancy Complications, Cardiovascular; Propranolol | 1978 |
Partial characterization of aortic renin in the spontaneously hypertensive rat and its interrelationship with plasma renin, blood pressure and sodium balance.
Topics: Angiotensin I; Animals; Aorta; Blood Pressure; Female; Hydralazine; Hypertension; Male; Metolazone; | 1978 |
Arterial hypertension induced by femoral lengthening. A canine model.
Topics: Anesthesia, Spinal; Animals; Blood Pressure; Bone Lengthening; Disease Models, Animal; Dogs; Femur; | 1978 |
Changes in plasma volume and extracellular fluid volume after addition of prazosin to propranolol treatment in patients with hypertension.
Topics: Adult; Blood Pressure; Drug Therapy, Combination; Extracellular Space; Female; Humans; Hypertension; | 1978 |
Abnormal renal haemodynamics during exercise in young patients with mild essential hypertension without treatment and during long-term propranolol therapy.
Topics: Adult; Age Factors; Blood Pressure; Female; Glomerular Filtration Rate; Heart Rate; Humans; Hyperten | 1978 |
Protection from morbidity and mortality from first infarcts: the case for beta-blockade.
Topics: Aged; Angina Pectoris; Coronary Disease; Humans; Hypertension; Myocardial Infarction; Propranolol | 1978 |
Relation of hemodynamics to the incidence of diethylstilbestrol-induced aortic ruptures in hypertensive and hypotensive lines of turkeys.
Topics: Animals; Aorta, Abdominal; Aortic Rupture; Cholesterol; Diethylstilbestrol; Hemodynamics; Hypertensi | 1978 |
Systemic and regional flow distribution in normotensive and spontaneously hypertensive young rats subjected to lifetime beta-adrenergic receptor blockade.
Topics: Animals; Body Weight; Cardiac Output; Coronary Circulation; Drinking; Female; Heart; Hemodynamics; H | 1978 |
The predictable relationship between plasma levels and dose during chronic propranolol therapy.
Topics: Adolescent; Adult; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Male; Middle Aged | 1978 |
Should you treat systolic hypertension in elderly patients?
Topics: Age Factors; Antihypertensive Agents; Blood Pressure; Coronary Disease; Diuretics; Heart; Humans; Hy | 1978 |
Hypertension associated with the Guillain-Barré syndrome.
Topics: Catecholamines; Humans; Hypertension; Infant; Male; Polyradiculoneuropathy; Propranolol; Renin | 1978 |
[Propranolol in hypertensive disease].
Topics: Adult; Blood Pressure; Drug Evaluation; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; | 1978 |
[Long-term minoxidil therapy: renin, aldosterone, noradrenaline and the need for beta blockers].
Topics: Adult; Aldosterone; Chlorthalidone; Female; Furosemide; Hirsutism; Humans; Hypertension; Male; Middl | 1978 |
An inhibitory role for the adrenals in the cardiovascular effects of propranolol in the spontaneously hypertensive rat [proceedings].
Topics: Adrenal Glands; Animals; Hemodynamics; Hypertension; Male; Propranolol; Rats | 1978 |
Sex and the cardiac patient.
Topics: Adolescent; Adult; Angina Pectoris; Antihypertensive Agents; Cerebrovascular Disorders; Coitus; Coun | 1978 |
[Diagnostic and therapeutic significance of antagonists of the renin-angiotensin system (author's transl)].
Topics: Angiotensin II; Animals; Blood Pressure; Dogs; Humans; Hypertension; Oligopeptides; Propranolol; Sar | 1978 |
Characteristics of altered oxygen utilization in spontaneously hypertensive rats.
Topics: Animals; Hypertension; Isoproterenol; Lipid Metabolism; Male; Microsomes, Liver; Oxidoreductases, O- | 1978 |
[Treatment of hypertension with a combination of the adrenergic beta receptor blockader, obsidan, and the vasodilator, apressin].
Topics: Adult; Blood Pressure; Drug Synergism; Drug Therapy, Combination; Humans; Hydralazine; Hypertension; | 1978 |
Increased blood pressure responses to central angiotensin II in spontaneously hypertensive rats.
Topics: Angiotensin II; Animals; Blood Pressure; Hypertension; Injections, Intraventricular; Propranolol; Ra | 1978 |
Oxygen consumption in the spontaneously hypertensive rat.
Topics: Animals; Body Temperature; Cold Temperature; Hot Temperature; Hypertension; Male; Oxygen Consumption | 1978 |
[Drug-induced readjustment of therapy-resistant hypertension].
Topics: Dihydralazine; Drug Combinations; Drug Resistance; Furosemide; Humans; Hypertension; Male; Middle Ag | 1978 |
Essential hypertension: new concepts in diagnosis and treatment.
Topics: Angiotensin II; Extracellular Space; Humans; Hypertension; Middle Aged; Propranolol; Renin; Saralasi | 1978 |
Workup and treatment of the average hypertensive patient.
Topics: Benzothiadiazines; Clonidine; Diuretics; Guanethidine; Humans; Hydralazine; Hypertension; Methyldopa | 1978 |
Chronic hemodynamic effects of propranolol treatment in dialysis-refractory hypertension.
Topics: Adult; Blood Pressure; Cardiac Output; Electrocardiography; Female; Hemodynamics; Humans; Hypertensi | 1978 |
Sympathetic nervous function and renin activity in hypertensives on long term drug treatment with propranolol, methyldopa or bendrofluazide.
Topics: Adult; Antihypertensive Agents; Bendroflumethiazide; Blood Pressure; Female; Humans; Hypertension; M | 1978 |
Decreased renal plasma flow during propranolol treatment in essential hypertension.
Topics: Adult; Cardiac Output; Female; Heart Rate; Humans; Hypertension; Kidney; Male; Middle Aged; Plasma V | 1979 |
Cardiovascular effects of sodium nitroprusside in hypertensive patients before and during acute beta-adrenergic blockade.
Topics: Drug Interactions; Female; Ferricyanides; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Myo | 1979 |
[Effect of furosemide, potassium canrenoate and D-L-propranolol on blood pressure in spontaneously hypertensive rat].
Topics: Animals; Blood Pressure; Body Weight; Canrenoic Acid; Furosemide; Hypertension; Male; Models, Biolog | 1976 |
[Equilibration of the treatment of severe arterial hypertension. Significance of d-1 propranolol].
Topics: Aldosterone; Angiotensin II; Blood Pressure; Heart Rate; Humans; Hydralazine; Hypertension; Long-Ter | 1975 |
Beta-adrenergic receptor blockade and renal function.
Topics: Adult; Humans; Hypertension; Kidney; Kidney Failure, Chronic; Long-Term Care; Male; Oxprenolol; Prop | 1976 |
Blood pressure responses to catecholamines during beta-adrenergic blockade with propranolol in hypertensive subjects.
Topics: Adult; Aged; Blood Pressure; Epinephrine; Female; Humans; Hypertension; Male; Middle Aged; Norepinep | 1977 |
[Propranolol induced increase in serum thyroxine (total T-4) in patients with essential hypertension].
Topics: Adult; Female; Humans; Hypertension; Hyperthyroidism; Male; Middle Aged; Propranolol; Substance With | 1977 |
Hypertension--the fledgling of modern medical practice.
Topics: Blood Pressure Determination; Diuretics; Humans; Hypertension; Propranolol | 1977 |
Sustained hypertension after section of the glossopharyngeal nerve.
Topics: Adult; Female; Glossopharyngeal Nerve; Humans; Hypertension; Postoperative Complications; Pressorece | 1977 |
Drugs for hypertension.
Topics: Antihypertensive Agents; Benzothiadiazines; Clonidine; Depression; Diuretics; Drug Combinations; Dru | 1977 |
Renin reactivity as a determinant of responsiveness to antihypertensive treatment.
Topics: Adult; Aged; Aldosterone; Antihypertensive Agents; Blood Pressure; Body Weight; Chlorthalidone; Drug | 1977 |
Hemodynamic and plasma renin effects of propranolol in essential hypertension.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Female; Heart Rate; Hemodynamics; Humans; Hypertension; | 1977 |
[Beta-adrenergic blocking agents in treating sportsmen with hypertension].
Topics: Adolescent; Adult; Female; Humans; Hypertension; Propranolol; Sports Medicine | 1977 |
Antihypertensive and renin angiotensin effects of metolazone with and without propranolol.
Topics: Angiotensin II; Antihypertensive Agents; Blood Pressure; Diuretics; Drug Interactions; Drug Therapy, | 1977 |
Plasma concentrations of propranolol in patients with essential hypertension.
Topics: Adult; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Propranolol; Ren | 1977 |
Treatment of chronic essential hypertension.
Topics: Chlorothiazide; Clonidine; Diabetes Mellitus; Diet, Sodium-Restricted; Gout; Guanethidine; Humans; H | 1977 |
Prevention of some complications of essential hypertension.
Topics: Anesthesia; Antihypertensive Agents; Arteriosclerosis; Clonidine; Diabetes Complications; Drug Incom | 1977 |
Agreement among three different indices of sympathetic nervous system activity in essential hypertension.
Topics: Adolescent; Adult; Cardiac Output; Heart; Heart Rate; Hemodynamics; Humans; Hypertension; Norepineph | 1977 |
[Effect of obsidan on hemodynamics and phase indices (at rest and during physical load in patients with hypertensive disease)].
Topics: Adult; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Physical Exertion; Propranolol | 1977 |
[Behaviour of plasma renin activity during long-term treatment with propranolol (author's transl)].
Topics: Adult; Blood Pressure; Humans; Hypertension; Propranolol; Renin | 1977 |
The effects of propranolol on acute hypertension of anesthetized dogs and on the carotid sinus reflex responses of anesthetized and awake dogs.
Topics: Acute Disease; Angiotensin II; Animals; Blood Pressure; Carotid Artery, External; Carotid Sinus; Den | 1977 |
Management of severe childhood hypertension with minoxidil: a controlled clinical study.
Topics: Adolescent; Child; Child, Preschool; Drug Combinations; Drug Evaluation; Humans; Hydrochlorothiazide | 1977 |
Clinical evaluation of myocardial contractility and its problems.
Topics: Animals; Blood Pressure; Cardiac Output; Dogs; Heart Rate; Humans; Hypertension; Isoproterenol; Myoc | 1977 |
[Propranolol treatment of hypertension in ambulatory care].
Topics: Adolescent; Adult; Aged; Ambulatory Care; Female; Humans; Hypertension; Male; Middle Aged; Propranol | 1977 |
The outpatient treatment of refractory hypertension with minoxidil.
Topics: Adult; Ambulatory Care; Antihypertensive Agents; Body Fluids; Colorado; Female; Furosemide; Hirsutis | 1977 |
Blood pressure, renin activity and heart rate changes during propranolol therapy of hypertension.
Topics: Adult; Blood Pressure; Dose-Response Relationship, Drug; Heart Rate; Humans; Hypertension; Male; Mid | 1977 |
Propranolol in DOCA hypertensive rats: development of hypertension inhibited and pressor responsiveness enhanced.
Topics: Animals; Blood Pressure; Desoxycorticosterone; Drug Interactions; Female; Heart Rate; Hypertension; | 1977 |
[Experience with obzidan treatment of primary arterial hypertension in children and adolescents].
Topics: Adolescent; Child; Female; Humans; Hypertension; Male; Propranolol | 1977 |
Regulation of renin secretion.
Topics: Animals; Blood Pressure; Cats; Denervation; Diuresis; Furosemide; Humans; Hypertension; Kidney; Meth | 1977 |
[Stimulation of renin-angiotensin-aldosterone system as screening test for hypertension].
Topics: Aldosterone; Angiotensin II; Furosemide; Humans; Hypertension; Methods; Propranolol; Renin | 1977 |
Effect of certain antiadrenergic agents on systolic time intervals in essential hypertension.
Topics: Adult; Clonidine; Electrocardiography; Heart Rate; Humans; Hypertension; Male; Methyldopa; Middle Ag | 1977 |
Effect of chronic treatment with propranolol on blood pressure and cardiovascular reactivity in spontaneously hypertensive rats.
Topics: Adrenalectomy; Age Factors; Animals; Blood Pressure; Central Nervous System; Female; Heart Rate; Hem | 1977 |
Beta-adrenergic blockers in the treatment of hypertension--experience with propranolol at Ibadan, Nigeria.
Topics: Adult; Aged; Debrisoquin; Drug Therapy, Combination; Female; Humans; Hydroflumethiazide; Hypertensio | 1977 |
Management of pheochromocytoma during pregnancy.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adult; Cesarean Section; Female; Humans; Hypertension; Phent | 1977 |
Influence of beta-blockade on aldosterone metabolism under normal and low sodium diet in man.
Topics: Acebutolol; Adult; Aldosterone; Angiotensins; Diet, Sodium-Restricted; Humans; Hypertension; Male; M | 1977 |
Effects of beta-blocker (propranolol) on the blood pressure and eye-ground of spontaneously hypertensive rat fed with high-salt diet [proceedings].
Topics: Animals; Blood Pressure; Diet; Heart; Hypertension; Organ Size; Propranolol; Rats; Retinal Vessels; | 1977 |
[Use of beta blockers (propranolol) in the treatment of arterial hypertension during pregnancy].
Topics: Drug Evaluation; Female; Fetus; Humans; Hypertension; Infant, Newborn; Pregnancy; Pregnancy Complica | 1977 |
Neural regulation of renin release: experimental evidence and clinical implications in arterial hypertension.
Topics: Adrenergic Fibers; Angiotensin II; Animals; Hemodynamics; Humans; Hypertension; Juxtaglomerular Appa | 1977 |
[Use of clonidine, furosemide and propranolol in the treatment of different phases of hypertension (author's transl)].
Topics: Adolescent; Adult; Aged; Child; Clonidine; Drug Evaluation; Drug Therapy, Combination; Female; Furos | 1977 |
[Plasma catecholamines and hemodynamics in the course of antihypertensive beta blockade: varying patterns in "propranolol-responders" and "non-responders"].
Topics: Catecholamines; Dopamine; Epinephrine; Hemodynamics; Humans; Hypertension; Norepinephrine; Physical | 1977 |
[Hemodynamic interaction of propranolol and digitalis in patients with arterial hypertension (author's transl)].
Topics: Adult; Aged; Blood Pressure; Capillaries; Cardiac Output; Digoxin; Drug Interactions; Hemodynamics; | 1977 |
Prazosin: its usefulness in hypertension.
Topics: Administration, Oral; Cardiovascular System; Diuretics; Drug Therapy, Combination; Humans; Hypertens | 1977 |
Relation between the hypotensive and renin-suppressing activities of alpha methyldopa in hypertensive patients.
Topics: Adolescent; Adult; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Kidney; Male; Methyldop | 1977 |
Pheochromocytoma of the urinary bladder: a broad clinical spectrum.
Topics: Adult; Catecholamines; Female; Humans; Hypertension; Phenoxybenzamine; Phentolamine; Pheochromocytom | 1977 |
Reduced adrenal amine synthesis in spontaneously hypertensive rats after long-term treatment with propranolol.
Topics: Adrenal Glands; Animals; Biogenic Amines; Diet; Heart Rate; Hypertension; Male; Organ Size; Proprano | 1977 |
Propranolol-induced increments in total and free serum thyroxine in patients with essential hypertension.
Topics: Adolescent; Adult; Female; Humans; Hypertension; Male; Middle Aged; Propranolol; Thyrotropin; Thyrox | 1977 |
Drugs in the treatment of hypertension: pharmacology and interactions.
Topics: Antihypertensive Agents; Guanethidine; Humans; Hydralazine; Hypertension; Male; Methyldopa; Proprano | 1977 |
The renin-angiotensin system in hypertension.
Topics: Aldosterone; Angiotensins; Diuretics; Humans; Hypertension; Juxtaglomerular Apparatus; Propranolol; | 1977 |
Propranolol and propranolol with thiazide in hypertensive Thai patients.
Topics: Adult; Benzothiadiazines; Diuretics; Female; Humans; Hypertension; Male; Middle Aged; Propranolol; S | 1977 |
[Significance of renin-angiotensin system inhibitors in the diagnosis of hypertension].
Topics: Angiotensin II; Animals; Blood Pressure; Disease Models, Animal; Dogs; Enzyme Inhibitors; Humans; Hy | 1977 |
Atenolol and plasma renin concentration in hypertensive patients.
Topics: Atenolol; Hemodynamics; Humans; Hypertension; Physical Exertion; Propanolamines; Propranolol; Renin | 1977 |
Dopamine-beta-hydroxylase activity and catecholamine concentrations in plasma: experimental and essential hypertension.
Topics: Adult; Animals; Atenolol; Dopamine beta-Hydroxylase; Epinephrine; Humans; Hypertension; Norepinephri | 1977 |
Central action as a key to past and future therapy of hypertension.
Topics: Atropine; Brain; Humans; Hypertension; Methyldopa; Pargyline; Phenobarbital; Propranolol; Receptors, | 1977 |
[Treatment of hypertension with beta adrenergic receptor blockaders under ambulatory conditions].
Topics: Adult; Ambulatory Care; Humans; Hypertension; Middle Aged; Propranolol | 1977 |
[Value of simultaneous administration of propranolol, binazine and furosemide in the treatment of hypertension].
Topics: Adult; Drug Therapy, Combination; Female; Furosemide; Humans; Hydrazines; Hypertension; Male; Middle | 1977 |
Letter: Propranolol therapy of hypertension.
Topics: Body Weight; Humans; Hypertension; Propranolol | 1976 |
Letter: Propranolol in the treatment of cardiopressor effects of cocaine.
Topics: Cocaine; Humans; Hypertension; Propranolol; Substance-Related Disorders; Tachycardia | 1976 |
Office management of hypertension.
Topics: Antihypertensive Agents; Diuretics; Guanethidine; Humans; Hydralazine; Hydrochlorothiazide; Hyperten | 1976 |
Case report: pheochromocytoma. Aspects of management.
Topics: Anesthesia; Blood Pressure; Droperidol; Female; Humans; Hypertension; Middle Aged; Nitroprusside; Ph | 1976 |
Letter: Impotence from propranolol?
Topics: Erectile Dysfunction; Humans; Hypertension; Male; Middle Aged; Propranolol | 1976 |
[Disturbed autonomic nervous control of cardiovascular system in labile hypertension--effects of pharmacological denervations on heart rate and arterial pressure (author's transl)].
Topics: Adult; Atropine; Autonomic Nervous System; Blood Pressure; Heart Rate; Humans; Hypertension; Middle | 1976 |
Drugs in the management of hypertension. Part III.
Topics: Antihypertensive Agents; Diazoxide; Drug Therapy, Combination; Ferricyanides; Guanidines; Humans; Hy | 1976 |
Letter: Propranolol in hypertension.
Topics: Humans; Hypertension; Propranolol | 1976 |
A nurse clinician's role in the management of hypertension.
Topics: Adult; Aged; Guanethidine; Humans; Hydralazine; Hypertension; Methyldopa; Middle Aged; Nurse Practit | 1976 |
Renin, aldosterone and arterial pressure responses to acute beta-adrenergic receptor blockage in hypertensive patients.
Topics: Adult; Aldosterone; Blood Pressure; Circadian Rhythm; Humans; Hypertension; Male; Pindolol; Proprano | 1976 |
Propranolol in antihypertensive therapy.
Topics: Dose-Response Relationship, Drug; Humans; Hypertension; Propranolol | 1976 |
Progression of nephropathy in long-term diabetics with proteinuria and effect of initial anti-hypertensive treatment.
Topics: Adolescent; Adult; Albuminuria; Diabetic Nephropathies; Furosemide; Glomerular Filtration Rate; Huma | 1976 |
[Therapy of chronic ischemic heart disease and arterial hypertension by means of beta-receptor blockaders].
Topics: Adult; Coronary Disease; Heart Failure; Humans; Hypertension; Middle Aged; Practolol; Propranolol | 1976 |
beta-adrenergic blockade in essential hypertension: reduced renin release despite renal vasoconstriction.
Topics: Adult; Diet; Female; Hemodynamics; Humans; Hypertension; Infusions, Parenteral; Kidney; Male; Propra | 1976 |
Pediatric hypertension: current therapeutic considerations.
Topics: Adolescent; Child; Child, Preschool; Diuretics; Female; Guanethidine; Humans; Hydralazine; Hypertens | 1976 |
The use of drug concentration measurements in studies of the therapeutic response to propranolol.
Topics: Angina Pectoris; Blood Pressure; Dose-Response Relationship, Drug; Heart Rate; Humans; Hypertension; | 1976 |
Mechanism of the interaction of propranolol and a potent vasodilator antihypertensive agent - minoxidil.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Drug Interactions; Drug Therapy, Combination; Female; H | 1976 |
Effects remaining after withdrawal of long-term beta-receptor blockade. Reduced heart rate and altered haemodynamic response to acute propranolol administration.
Topics: Adaptation, Physiological; Administration, Oral; Adult; Cardiac Output; Heart Rate; Humans; Hyperten | 1976 |
Relationship between plasma renin activity and urinary catecholamines in various types of hypertension.
Topics: Catecholamines; Dopamine; Epinephrine; Humans; Hyperaldosteronism; Hypertension; Hypertension, Malig | 1976 |
Propranolol and diuretic combination in hypertension.
Topics: Diuretics; Dose-Response Relationship, Drug; Drug Combinations; Humans; Hypertension; Propranolol | 1976 |
[Long term follow-up study of 207 hypertensive patients treated with propranolol in outpatient care].
Topics: Adult; Aged; Ambulatory Care; Drug Evaluation; Female; Follow-Up Studies; Humans; Hypertension; Male | 1976 |
A role for renin in rebound hypertension and encephalopathy after infusion of saralasin acetate (Sar1-Ala8-angiotensin II).
Topics: Angiotensin II; Blood Pressure; Female; Headache; Humans; Hypertension; Male; Middle Aged; Propranol | 1976 |
Central antihypertensive effects of propranolol in the spontaneously hypertensive rat.
Topics: Animals; Antihypertensive Agents; Aorta; Blood Pressure; Heart Rate; Hypertension; Injections, Intra | 1976 |
[Effect of adrenergic blockaders in arterial hypertension].
Topics: Adolescent; Adult; Humans; Hypertension; Juxtaglomerular Apparatus; Kidney; Middle Aged; Propranolol | 1976 |
[Blood glucose levels in patients on hemodialysis during propranolol (Inderal) treatment].
Topics: Adult; Aged; Blood Glucose; Female; Humans; Hypertension; Hypoglycemia; Male; Middle Aged; Propranol | 1976 |
Letter: Propranolol blockade of stress reaction.
Topics: Blood Pressure; Catecholamines; Heart Rate; Humans; Hypertension; Intestinal Perforation; Male; Midd | 1976 |
Sustained pressore responsiveness to prolonged hypothalamic stimulation in awake rats.
Topics: Animals; Atropine; Blood Pressure; Electric Stimulation; Female; Heart Rate; Hypertension; Hypertens | 1976 |
Propranolol psychosis.
Topics: Aged; Delusions; Hallucinations; Humans; Hypertension; Male; Middle Aged; Propranolol; Psychoses, Su | 1976 |
Once-daily treatment of hypertension.
Topics: Adult; Aged; Drug Administration Schedule; Female; Humans; Hypertension; Male; Middle Aged; Proprano | 1976 |
[Differentiation of essential hypertensions].
Topics: Furosemide; Humans; Hypertension; Methods; Propranolol | 1976 |
[Propranolol- and furosemide-test in the differential diagnosis of hypertension].
Topics: Diagnosis, Differential; Furosemide; Humans; Hypertension; Propranolol | 1976 |
Hypertension in a patient with acrodermatitis enteropathica.
Topics: Acrodermatitis; Adolescent; Humans; Hypertension; Male; Propranolol; Zinc | 1976 |
An approach to the treatment of essential hypertension.
Topics: Adult; Aged; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Phenoxybenz | 1976 |
Propranolol therapy in patients undergoing myocardial revascularization.
Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Cardiac Output; Cardiopulmonary Bypass; Coronary | 1976 |
Comparison of the pharmacokinetics of intravenous dl-propranolol in borderline and permanent hypertension.
Topics: Cardiac Output; Half-Life; Humans; Hypertension; Injections, Intravenous; Kinetics; Male; Metabolic | 1976 |
Psychological features of patients with hypertension attending follow-up clinics.
Topics: Adjustment Disorders; Adult; Aged; Antihypertensive Agents; Anxiety Disorders; Diuretics; Female; Hu | 1976 |
[Hemodynamic effect of propranolol in permanent arterial hypertension].
Topics: Adult; Chronic Disease; Female; Hemodynamics; Humans; Hypertension; Male; Propranolol | 1976 |
[The hypotensive effect of propranolol: pathophysiological and clinical approach (author's transl)].
Topics: Drug Evaluation; Heart Rate; Humans; Hypertension; Hypertension, Renal; Plasma Volume; Propranolol; | 1976 |
[Therapeutic combinations, side effects and interactions of antihypertensive drugs].
Topics: Antihypertensive Agents; Benzothiadiazines; Clonidine; Dihydralazine; Diuretics; Drug Interactions; | 1976 |
Effect of timolol on hydralazine-induced increase in plasma renin activity in spontaneously hypertensive and normotensive rats.
Topics: Administration, Oral; Animals; Dose-Response Relationship, Drug; Hydralazine; Hypertension; Propanol | 1976 |
Abnormalities of autonomic nervous control in borderline hypertension.
Topics: Adult; Atropine; Cardiac Output; Heart Rate; Hemodynamics; Humans; Hypertension; Male; Personality A | 1976 |
Antihypertensive activity of a propranolol analog (ORF 12,592) in rodents.
Topics: Animals; Antihypertensive Agents; Behavior, Animal; Blood Pressure; Hypertension; Male; Mice; Propra | 1976 |
[Effects of propranolol on plasma lipids and renin activity in young men with labile borderline hypertension (author's transl)].
Topics: Adult; Age Factors; Humans; Hypertension; Lipids; Male; Propranolol; Renin | 1976 |
[Relationship between renin-aldosterone system and efficacy of a beta-blocking agent in hypertensive patients].
Topics: Adult; Aldosterone; Angiotensin II; Female; Humans; Hypertension; Hypertension, Renal; Male; Middle | 1976 |
Beta adrenergic blockade in hypertension.
Topics: Adult; Aged; Humans; Hypertension; Middle Aged; Propranolol | 1976 |
[Effect of the beta receptor blockader propranolol (Dociton) on the plasma concentration of catecholamines in patients with hypertension].
Topics: Catecholamines; Humans; Hypertension; Male; Posture; Propranolol | 1976 |
[Plasma dopamine-beta-hydroxylase during therapy with the beta-receptor blockader propranolol].
Topics: Adolescent; Adult; Aged; Dopamine beta-Hydroxylase; Humans; Hypertension; Middle Aged; Propranolol; | 1976 |
[Influence of propranolol on plasma-renin activity, plasma-aldosterone concentration and blood pressure in patients with essential hypertension].
Topics: Aldosterone; Blood Pressure; Humans; Hypertension; Propranolol; Renin | 1976 |
[Acute and chronic beta-receptor blockade: influence on blood pressure and on the renin-angiotensin-aldosterone system in essential hypertension].
Topics: Aldosterone; Angiotensin II; Blood Pressure; Humans; Hypertension; Pindolol; Propranolol; Pulse; Ren | 1976 |
[Chronic treatment of severe hypertension using minoxidil, propranolol and diuretics].
Topics: Adolescent; Adult; Aged; Diuretics; Female; Humans; Hypertension; Male; Middle Aged; Minoxidil; Prop | 1976 |
[The effect of propranolol in arterial hypertensive syndromes with high plasma renin activity].
Topics: Humans; Hypertension; Propranolol; Renin | 1976 |
[The effect of propranolol on various types of hypertension in the rat].
Topics: Animals; Blood Volume; Desoxycorticosterone; Heart Rate; Hypertension; Hypertension, Renal; Proprano | 1976 |
[The effect of propranolol on capillary permeability in normal and hypertensive rats].
Topics: Animals; Capillary Permeability; Hypertension; Plasma Volume; Portal Vein; Propranolol; Rats; Venous | 1976 |
[Clinical considerations on a group of patients with arterial hypertension treated with propranolol].
Topics: Bradycardia; Diuretics; Drug Therapy, Combination; Humans; Hydralazine; Hypertension; Propranolol | 1976 |
[Functional response of the hypertensive decompensated heart to the removal of adrenergic effects].
Topics: Adult; Aged; Guanethidine; Heart Failure; Humans; Hypertension; Male; Middle Aged; Propranolol; Rese | 1976 |
[Changes in kidney function during hypotensive treatment].
Topics: Adult; Aged; Clonidine; Dihydralazine; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazid | 1976 |
Propranolol therapy in the perioperative period.
Topics: Aged; Angina Pectoris; Humans; Hypertension; Infusions, Parenteral; Male; Middle Aged; Postoperative | 1976 |
The combined effect of propranolol with bethanidine or methyldopa in hypertension.
Topics: Bethanidine; Blood Pressure; Drug Therapy, Combination; Guanidines; Humans; Hypertension; Methyldopa | 1976 |
Studies with a new cardioselective beta-blocker, metoprolol.
Topics: Adult; Blood Pressure; Blood Vessels; Bronchi; Epinephrine; Hemodynamics; Humans; Hypertension; Meto | 1976 |
[Hemodynamics following a 14-day propranolol therapy].
Topics: Administration, Oral; Exercise Test; Hemodynamics; Humans; Hypertension; Propranolol; Time Factors | 1976 |
[Effect of propranolol treatment on on the basal acid secretion (BAO) and 24-hour uropepsin excretion in patients with hypertension].
Topics: Adult; Endopeptidases; Female; Gastric Juice; Humans; Hypertension; Male; Middle Aged; Propranolol; | 1976 |
Geriatric cardiovascular problems.
Topics: Aged; Aging; Anesthesia; Arrhythmias, Cardiac; Blood Circulation; Cardiovascular Physiological Pheno | 1976 |
Hypotensive and renin-suppressing activities of propranolol in hypertensive patients.
Topics: Administration, Oral; Blood Pressure; Depression, Chemical; Furosemide; Heart Rate; Humans; Hyperten | 1975 |
The control of hypertension in patients undergoing regular maintenance hemodialysis.
Topics: Adult; Humans; Hypertension; Middle Aged; Minoxidil; Propranolol; Pyrimidines; Renal Dialysis; Renin | 1975 |
Use of systolic time intervals in studying hypertension.
Topics: Adult; Atropine; Blood Pressure; Heart Rate; Humans; Hypertension; Middle Aged; Myocardial Contracti | 1976 |
Renin unresponsiveness and the effects of oxprenolol, methyldopa and spironolactone in patients with essential hypertension.
Topics: Humans; Hypertension; Methyldopa; Oxprenolol; Pindolol; Posture; Propranolol; Renin; Spironolactone | 1976 |
Change in the renin dependency of blood pressure induced by volume depletion and/or propranolol therapy in hypertensive patients.
Topics: Adolescent; Adult; Blood Pressure; Blood Volume; Diuretics; Female; Humans; Hypertension; Male; Midd | 1976 |
The immediate plasma renin response to propranolol: evidence for a different mode of renin release in essential and renal hypertension.
Topics: Adolescent; Adult; Aged; Depression, Chemical; Female; Humans; Hypertension; Hypertension, Renal; Ma | 1976 |
Sympathotonia in primary hypertension and in a caricature resembling dysautonomia.
Topics: Adolescent; Adult; Age Factors; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Norepin | 1976 |
The effects of propranolol on spontaneous and experimental hypertension in the rat.
Topics: Animals; Blood Proteins; Heart Rate; Hypertension; Hypertension, Renal; Male; Propranolol; Rats; Ren | 1976 |
Haemodynamic responses to exercise and acute beta-receptor blockade in renin sub-types of essential hypertension.
Topics: Adult; Age Factors; Cardiac Output; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Phy | 1976 |
Compared incidence of first myocardial infarction in hypertensive patients under treatment containing propranolol or excluding beta-receptor blockade.
Topics: Adult; Female; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Propranolol | 1976 |
The effect on blood pressure of beta-adrenoreceptor-blocking drugs given once daily.
Topics: Dose-Response Relationship, Drug; Humans; Hypertension; Male; Pindolol; Propranolol; Time Factors | 1976 |
Cardiac function in the treatment of arterial hypertension with propranolol.
Topics: Cardiac Output; Heart; Humans; Hypertension; Male; Propranolol; Vascular Resistance | 1976 |
Treatment of hypertension in middle-aged men: a feasibility study in a community.
Topics: Humans; Hypertension; Male; Middle Aged; Propranolol; Sweden; Time Factors | 1976 |
Haemodynamic and endocrinological changes during anti-hypertensive treatment with a new vasodilator substance (L6150) and propranolol.
Topics: Adult; Aged; Aldosterone; Cardiac Output; Drug Therapy, Combination; Female; Humans; Hypertension; K | 1976 |
Plasma catecholamines and arterial hypertension.
Topics: Catecholamines; Clonidine; Humans; Hypertension; Propranolol; Renin; Sympathetic Nervous System | 1976 |
Effect of propranolol on blood pressure in normal and hypertensive rats.
Topics: Animals; Blood Pressure; Disease Models, Animal; Heart Rate; Hypertension; Hypertension, Renal; Prop | 1975 |
Effect of volume depletion and subsequent propranolol treatment on blood pressure and plasma renin activity in patients with essential and with renovascular hypertension.
Topics: Blood Pressure; Body Water; Diet, Sodium-Restricted; Diuretics; Humans; Hypertension; Hypertension, | 1975 |
Management of acute aortic dissection.
Topics: Antihypertensive Agents; Aortic Aneurysm; Aortography; Blood Pressure Determination; Central Venous | 1975 |
Minoxidil in refractory hypertension.
Topics: Blood Pressure; Child; Creatinine; Female; Furosemide; Humans; Hydralazine; Hypertension; Kidney Tra | 1975 |
Hemodynamic and humoral characteristics of hypertension induced by prolonged stellate ganglion stimulation in conscious dogs.
Topics: Animals; Blood Proteins; Blood Volume; Cardiac Output; Catecholamines; Coronary Circulation; Dogs; E | 1975 |
[Drug combinations in the treatment of primary arterial hypertension].
Topics: Antihypertensive Agents; Blood Volume; Cardiac Output; Diuretics; Drug Combinations; Drug Therapy, C | 1975 |
The early detection and treatment of hypertension.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Chlorothiazide; Diuretics; Female; Florida; Furose | 1975 |
The office management of hypertension.
Topics: Adult; Age Factors; Ambulatory Care; Antihypertensive Agents; Benzothiadiazines; Black or African Am | 1975 |
The influence of age and the level of arterial blood pressure on the changes in forearm blood flow resulting from sudden alterations in local vascular transmural pressure.
Topics: Adult; Age Factors; Aged; Atmospheric Pressure; Benzothiadiazines; Bethanidine; Blood Pressure; Diur | 1975 |
Hyperkinetic heart in severe hypertension: a separate clinical hemodynamic entity.
Topics: Adult; Arrhythmias, Cardiac; Autonomic Nervous System; Blood Pressure; Blood Volume; Cardiac Output; | 1975 |
Control plasma renin activity and changes in sympathetic tone as determinants of minoxidil-induced increase in plasma renin activity.
Topics: Adult; Aged; Blood Pressure; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Ma | 1975 |
[Treatment of hypertension with beta blocking agents].
Topics: Alprenolol; Drug Therapy, Combination; Humans; Hypertension; Oxprenolol; Pindolol; Propranolol | 1975 |
Letter: Renin-sodium profiling and antihypertensive response to beta blockade.
Topics: Blood Pressure; Humans; Hypertension; Posture; Propranolol; Renin; Sodium | 1975 |
Altered cardiac responsiveness and regulation in the normal cardiac output type of borderlind hlpertension.
Topics: Adult; Atropine; Autonomic Nervous System; Blood Pressure Determination; Blood Volume Determination; | 1975 |
[Effect of propranolol on hemodynamic shifts and respiration during physical exertion in patients with hypertensive disease].
Topics: Blood Pressure; Blood Volume; Heart; Hemodynamics; Humans; Hypertension; Physical Exertion; Proprano | 1975 |
[Condition of the contractile capacity of the myocardium in treatment of hypertensive disease with reserpine in combination with propranolol].
Topics: Adult; Drug Therapy, Combination; Female; Heart; Humans; Hypertension; Male; Middle Aged; Myocardial | 1975 |
Evaluation of antihypertensive agents in the stress-induced hypertensive rat.
Topics: Animals; Antihypertensive Agents; Chlorisondamine; Disease Models, Animal; Drug Evaluation, Preclini | 1975 |
[Plasmatic renin activity in essential arterial hypertension. Hyporeninemic hypertension].
Topics: Adult; Female; Humans; Hypertension; Kidney; Male; Middle Aged; Propranolol; Renin; Spironolactone | 1975 |
Analysis of components in a cardiogenic hypertensive chemoreflex.
Topics: Animals; Atropine; Blood Pressure; Bradycardia; Cardiovascular System; Chemoreceptor Cells; Coronary | 1975 |
Studies of the absorption and removal of propranolol in hypertensive patients during therapy.
Topics: Administration, Oral; Chromatography, Gas; Dose-Response Relationship, Drug; Half-Life; Humans; Hype | 1975 |
Dopamine-beta-hydroxylase after treatment with beta-blockers in hypertension.
Topics: Atenolol; Blood Pressure; Dopamine beta-Hydroxylase; Humans; Hypertension; Male; Propanolamines; Pro | 1975 |
Arrythmias and ischemic changes of the heart induced by gastric endoscopic procedures.
Topics: Arrhythmias, Cardiac; Blood Pressure; Coronary Disease; Electrocardiography; Gastroscopy; Heart Rate | 1975 |
Antihypertensive activity of erythro-1-(1-[2-(1,4-benzodioxan-2-yl)-2-OH-ET]-4-piperidyl)-2-benzimidazolinone (R 28935).
Topics: Animals; Antihypertensive Agents; Benzimidazoles; Blood Pressure; Cardiac Output; Clonidine; Dogs; F | 1975 |
Long-term treatment of severe hypertension with minoxidil, propranolol and furosemide.
Topics: Cardiac Catheterization; Drug Therapy, Combination; Echocardiography; Edema; Furosemide; Humans; Hyd | 1975 |
Evaluation of myocardial contractility by the non-invasive method.
Topics: Aged; Atrial Fibrillation; Blood Pressure; Cardiac Output; Depression, Chemical; Digitalis Glycoside | 1975 |
Therapy and prognosis of hypertension in chronic nephritis.
Topics: Adult; Aldosterone; Angiotensin II; Blood Volume; Catecholamines; Chronic Disease; Creatinine; Extra | 1975 |
Relationship between plasma renin activity and blood pressure response to antihypertensive agents. A proposal for management of essential and renal hypertension.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Body Weight; Furosemide; Humans; Hydralazine; Hypert | 1975 |
Proceedings: Effects of beta-blocker (propranolol) on the blood pressure, heart weight and heart rate of spontaneously hypertensive rat fed with high-salt, high-carbohydrate, and low-protein diet.
Topics: Animals; Blood Pressure; Diet; Heart; Heart Rate; Hypertension; Organ Size; Propranolol; Rats | 1975 |
Proceedings: Effect of chronic oral administration of propranolol on spontaneously and renal hypertension rats.
Topics: Administration, Oral; Animals; Disease Models, Animal; Hypertension; Hypertension, Renal; Male; Prop | 1975 |
[Diazoxide: new way in treatment of hypertension].
Topics: Adult; Chlorthalidone; Diazoxide; Diet, Sodium-Restricted; Female; Humans; Hydralazine; Hypertension | 1975 |
Children with hypertension.
Topics: Adolescent; Antihypertensive Agents; Blood Pressure Determination; Child; Child, Preschool; Diuretic | 1975 |
Minoxidil in severe hypertension: value when conventional drugs have failed.
Topics: Adult; Dose-Response Relationship, Drug; Drug Evaluation; Drug Therapy, Combination; Edema; Female; | 1975 |
Idiopathic hypertrophic subaortic stenosis presenting as cough syncope.
Topics: Cardiomyopathy, Hypertrophic; Cough; Humans; Hypertension; Male; Middle Aged; Propranolol; Syncope | 1975 |
Commentary: the FDA, politics, and the public.
Topics: Aspergillosis; Consumer Behavior; Drug Industry; Humans; Hypertension; Legislation, Drug; Politics; | 1975 |
Severe hypertension. Treatment with minoxidil.
Topics: Adult; Black People; Drug Evaluation; Edema; Female; Follow-Up Studies; Guanethidine; Humans; Hypert | 1975 |
The hypertensive patient. An algorithm for treatment.
Topics: Administration, Oral; Blood Pressure; Blood Urea Nitrogen; Clonidine; Creatinine; Diazoxide; Diureti | 1975 |
Letter from ... Chicago. Drug censorship.
Topics: Angina Pectoris; Drug Evaluation; Humans; Hypertension; Legislation, Drug; Propranolol; United State | 1975 |
[Different reaction of plasma renin activity after propranolol in essential and renal hypertension].
Topics: Adolescent; Adult; Blood Pressure; Diagnosis, Differential; Female; Glomerulonephritis; Humans; Hype | 1975 |
Editorial: Non-beta-blocking actions of propranolol.
Topics: Brain; Cardiac Output; Depression, Chemical; Humans; Hypertension; Propranolol; Receptors, Adrenergi | 1975 |
[Arterial hypertension. A new classification and therapy based on renin plasma activity].
Topics: Adult; Blood Pressure; Diuretics; Female; Humans; Hypertension; Male; Middle Aged; Propranolol; Reni | 1975 |
Propranolol in hypertensive dialysis patients: efficacy and compliance.
Topics: Adolescent; Adult; Aged; Blood Pressure; Female; Humans; Hypertension; Male; Middle Aged; Patient Co | 1975 |
Letter: Uses of propranolol.
Topics: Adult; Aged; Child; Humans; Hypertension; Hyperthyroidism; Hypoglycemia; Male; Middle Aged; Migraine | 1975 |
[Value of simultaneous administration of Propranolol and Binazin in the treatment of arterial hypertension].
Topics: Adult; Drug Therapy, Combination; Female; Humans; Hydrazines; Hypertension; Male; Middle Aged; Propr | 1975 |
Relation of renin status to neurogenic vascular resistance in borderline hypertension.
Topics: Adolescent; Adult; Angiotensin II; Atropine; Autonomic Nerve Block; Blood Pressure; Cardiac Output; | 1975 |
Ocular reaction to propranolol and resolution on continued treatment with a different beta-blocking drug.
Topics: Eye Diseases; Female; Humans; Hypertension; Middle Aged; Oxprenolol; Propranolol | 1975 |
[Role of propranolol in the treatment of hypertension].
Topics: Administration, Oral; Blood Pressure; Cardiac Glycosides; Cardiac Output; Depression, Chemical; Diur | 1975 |
[Use of inderal for the treatment of different forms of arterial hypertension].
Topics: Administration, Oral; Adolescent; Adult; Drug Evaluation; Follow-Up Studies; Hemodynamics; Humans; H | 1975 |
The role of propranolol in the management of hypertension.
Topics: Humans; Hypertension; Propranolol | 1975 |
Letter: Are beta blockers better?
Topics: Debrisoquin; Female; Humans; Hypertension; Methyldopa; Propranolol | 1975 |
[Proceedings: Therapy results with various beta-receptor blockaders in patients with stress hypertension under medium severe physical stress].
Topics: Humans; Hypertension; Placebos; Propranolol; Stress, Physiological; Sympatholytics | 1975 |
Propranolol in hypertension.
Topics: Blood Pressure; Diuretics; Humans; Hypertension; Pressoreceptors; Propranolol; Receptors, Adrenergic | 1975 |
Paradoxical rise in blood pressure during propranolol treatment.
Topics: Adolescent; Adult; Female; Humans; Hypertension; Male; Phenoxybenzamine; Phentolamine; Propranolol; | 1975 |
The treatment of gestational hypertension.
Topics: Antihypertensive Agents; Chronic Disease; Diazoxide; Female; Humans; Hydralazine; Hypertension; Hype | 1975 |
[Treatment of hypertension with propranolol in combination with other antihypertensive agents].
Topics: Adult; Antihypertensive Agents; Drug Therapy, Combination; Female; Humans; Hydralazine; Hydrochlorot | 1975 |
Antihypertensive therapy with hydralazine and propranolol: a case history.
Topics: Blood Pressure; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Middle Aged; P | 1975 |
[Use of propranolol in permanent essential hypertension].
Topics: Adult; Blood Pressure; Clopamide; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Place | 1975 |
[Treatment of moderate hypertension, particularly by the general practitioner].
Topics: Adult; Aged; Antihypertensive Agents; Chlorthalidone; Diet, Sodium-Restricted; Female; Humans; Hyper | 1975 |
[Treatment of hypertension using propranolol combined with hydralazine and a thiazidine diuretic. 1st results].
Topics: Adult; Aged; Bendroflumethiazide; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertensi | 1975 |
Some side-effects of alpha-methyldopa.
Topics: Adult; Aged; Chlorthalidone; Drug Therapy, Combination; Erectile Dysfunction; Humans; Hydralazine; H | 1976 |
[Psycho-physiologic study on the behavior of hemodynamic circulatory parameters in various task situations prior to and following intravenous administration of propranolol].
Topics: Hemodynamics; Humans; Hypertension; Injections, Intravenous; Propranolol; Psychological Tests | 1975 |
[Study using propranolol, of the central adrenergic regulation of the diencephalo-pituitary-adrenal gland system in essential arterial hypertension].
Topics: Adrenal Glands; Adult; Diencephalon; Female; Humans; Hydrocortisone; Hypertension; Male; Middle Aged | 1975 |
[Changes in left ventricular function in hypertensive subjects treated with beta-blocking drugs].
Topics: Heart; Hemodynamics; Humans; Hypertension; Propranolol | 1975 |
[Renal factor in the early stages of hypertension].
Topics: Adult; Biopsy, Needle; Blood Pressure; Female; Humans; Hypertension; Kidney; Male; Middle Aged; Prop | 1975 |
Drug regimens for long-term therapy of hypertension.
Topics: Antihypertensive Agents; Chlorthalidone; Diuretics; Guanethidine; Humans; Hydralazine; Hypertension; | 1976 |
Case report. Propranolol-induced lupus syndrome?
Topics: Humans; Hydrazines; Hypertension; Lupus Erythematosus, Systemic; Male; Middle Aged; Practolol; Propr | 1976 |
Applied pharmacology of anti-hypertensive drugs.
Topics: Antihypertensive Agents; Clonidine; Diazoxide; Diuretics; Guanethidine; Humans; Hydralazine; Hyperte | 1976 |
[Dosage spacing in hypertension].
Topics: Humans; Hypertension; Pindolol; Practolol; Propranolol; Sotalol | 1976 |
Propranolol in the treatment of hypertension.
Topics: Arrhythmias, Cardiac; Brain; Bronchial Spasm; Depression, Chemical; Diuretics; Drug Synergism; Heart | 1976 |
Operative and nonoperative hypertension. Recent advances in treatment.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Cushing Syndrome; Diuretics; Humans; Hyperaldosteronism; Hyper | 1976 |
Letter: Elaboration on clinical case.
Topics: Drug Therapy, Combination; Humans; Hydralazine; Hypertension; Propranolol | 1976 |
Letter: Propranolol schedule before paradoxical hypertension.
Topics: Drug Administration Schedule; Humans; Hypertension; Propranolol | 1976 |
Effects of propranolol on haemodynamic changes and gas exchange at rest, in orthostasis, and on exercise in patients with arterial hypertension.
Topics: Blood Volume; Hematocrit; Hemodynamics; Humans; Hypertension; Oxygen; Physical Exertion; Posture; Pr | 1976 |
Isoproterenol sensitivity and total body clearance of propranolol in hypertensive patients.
Topics: Adult; Age Factors; Blood Pressure; Body Weight; Heart Rate; Humans; Hypertension; Isoproterenol; Ma | 1976 |
[Psoriasis-like skin changes during treatment with propranolol (Inderal)].
Topics: Aged; Female; Humans; Hypertension; Male; Middle Aged; Propranolol; Psoriasis; Skin; Time Factors | 1976 |
Treatment of hypertension in middle-aged men. A feasibility study in a community.
Topics: Blood Pressure Determination; Drug Therapy, Combination; Humans; Hydralazine; Hypertension; Male; Mi | 1976 |
Changes in the ratio of plasma to intersitiial fluid volume during long-term antihypertensive therapy.
Topics: Antihypertensive Agents; Drug Therapy, Combination; Extracellular Space; Female; Humans; Hydrochloro | 1976 |
[Influence of anti-arrhythmia agents on electrolyte metabolism].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Coronary Disease; Female; Gallopamil; Humans; Hypertension; Mal | 1976 |
[Saluretics or beta blocking agents in the treatment of hypertension?].
Topics: Bendroflumethiazide; Blood Glucose; Humans; Hypertension; Insulin; Male; Middle Aged; Potassium; Pro | 1976 |
[A question of logic].
Topics: Diazoxide; Furosemide; Humans; Hyperaldosteronism; Hypertension; Kidney Diseases; Male; Middle Aged; | 1976 |
Immediate plasma renin response to propranolol: differentiation between essential and renal hypertension.
Topics: Adolescent; Adult; Aged; Depression, Chemical; Diagnosis, Differential; Female; Humans; Hypertension | 1976 |
beta-Adrenoceptor modulation of renin response to short-term reductions in pressure in young SHR.
Topics: Animals; Blood Flow Velocity; Blood Pressure; Hypertension; Isoproterenol; Propranolol; Rats; Rats, | 1992 |
[Cardiovascular effects of ketamine anesthesia in rats treated with enalapril and propranolol].
Topics: Anesthesia, General; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Enalapril; H | 1992 |
Case report: nifedipine-rifampicin interaction attenuates the effect on blood pressure in a patient with essential hypertension.
Topics: Adrenergic alpha-Antagonists; Aged; Blood Pressure; Drug Interactions; Ethambutol; Female; Humans; H | 1992 |
Clinical and electromyographic evidence of carpal tunnel syndrome in a hypertensive patient with chronic beta-blocker treatment.
Topics: Adrenergic beta-Antagonists; Carpal Tunnel Syndrome; Electromyography; Humans; Hypertension; Magneti | 1992 |
Genetics of hypertension.
Topics: Chromosome Mapping; Genetic Carrier Screening; Ghana; Humans; Hypertension; Propranolol | 1992 |
[Hypertensive heart. Experience in the clinical use of sectral (acebutolol)].
Topics: Acebutolol; Adrenergic beta-Antagonists; Blood Pressure; Humans; Hypertension; Hypertrophy, Left Ven | 1992 |
Effect of oral dilevalol on forearm circulation in essential hypertension.
Topics: Administration, Oral; Antihypertensive Agents; Blood Pressure; Female; Forearm; Heart Rate; Humans; | 1992 |
Nonadrenergic sympathetic vascular control of the human forearm in hypertension: possible involvement of neuropeptide Y.
Topics: Adult; Blood Pressure; Epinephrine; Forearm; Heart Rate; Hemodynamics; Humans; Hypertension; Lower B | 1992 |
Relationship between the sympatholytic action of nebivolol and hypotension.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Benzopyrans; Blood Pressure; Dose-Res | 1992 |
[Effect of thermal dehydration on blood levels of volume- regulating hormones and sweat electrolytes in patients with essential hypertension treated with propranolol].
Topics: Adult; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Volume; Dehydration; Female; Hot Tempe | 1992 |
[The action of the new beta-adrenoblocker Lopressor on the hemodynamics of hypertension patients].
Topics: Adult; Drug Evaluation; Hemodynamics; Humans; Hypertension; Metoprolol; Middle Aged; Propranolol; Ta | 1992 |
Job absenteeism and arterial hypertension: results of a hypertension control program.
Topics: Absenteeism; Adult; Blood Pressure; Clinical Protocols; Costs and Cost Analysis; Diuretics; Humans; | 1992 |
[The dynamics of the concentration of atrial natriuretic factor depending on changes in the arterial pressure level in patients with arterial hypertension].
Topics: Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Captopril; Chronic Disease; Humans; Hydrochl | 1992 |
[The optimization of the hypotensive therapy of hypertension patients taking into account the central hemodynamics and functional tests with obzidan and prazosin].
Topics: Adult; Antihypertensive Agents; Exercise Test; Female; Hemodynamics; Humans; Hypertension; Male; Mid | 1992 |
[The effect of korinfar and anaprilin on lipid peroxidation and the antioxidant system in hypertension patients].
Topics: Adult; Antioxidants; Drug Therapy, Combination; Female; Humans; Hypertension; Lipid Peroxidation; Li | 1992 |
Hypotensive drugs and the cellular energetic potential.
Topics: Antihypertensive Agents; Clonidine; Humans; Hypertension; Nifedipine; Phosphates; Propranolol; Water | 1992 |
[Changes in the humoral systems in juvenile arterial hypertension and their correction by using nifedipine and anaprilin].
Topics: Adolescent; Aldosterone; Angiotensin II; Blood Pressure; Drug Evaluation; Humans; Hypertension; Nife | 1992 |
[The efficacy of a 4-year course of drug treatment for patients with juvenile hypertension].
Topics: Adolescent; Adult; Drug Evaluation; Drug Resistance; Hemodynamics; Humans; Hypertension; Nifedipine; | 1992 |
Intravenous propranolol reverses hypertension after sympathomimetic overdose: two case reports.
Topics: Adult; Blood Pressure; Charcoal; Drug Overdose; Ephedrine; Female; Gastric Lavage; Heart Rate; Human | 1992 |
Blood pressure control in arterial- and cardiopulmonary receptor denervated dogs.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arteries; Blood Pressure; Denervation; Dogs; Fema | 1991 |
Arterial hemodynamics in human hypertension. Effects of adrenergic blockade.
Topics: Adult; Blood Flow Velocity; Cardiac Catheterization; Female; Hemodynamics; Humans; Hypertension; Mal | 1991 |
[Neuropeptide Y, orthosympathetic nervous system, hypertension and alpha-2 adrenergic receptors].
Topics: Animals; Clinical Protocols; Clonidine; Dogs; Hypertension; Neuropeptide Y; Norepinephrine; Proprano | 1991 |
Effects of chronic administration of carteolol on beta-adrenoceptors in spontaneously hypertensive rat heart.
Topics: Aging; Animals; Binding Sites; Blood Pressure; Carteolol; Dihydroalprenolol; Heart Rate; Hypertensio | 1991 |
Prevention of cerebral stroke by arotinolol in salt-loaded SHRSP.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Brain; Cerebrovascular Disorders; Disease Susc | 1991 |
[Reserpine and reserpine-containing preparations in hypertension?].
Topics: Diuretics; Drug Therapy, Combination; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Propra | 1992 |
Does propranolol alter the vascular response to phenylephrine before or during halothane anaesthesia in patients with coronary artery disease?
Topics: Anesthesia, Inhalation; Coronary Artery Bypass; Halothane; Hemodynamics; Humans; Hypertension; Male; | 1992 |
[Long-term prazosin treatment of arterial hypertension in ambulatory care].
Topics: Adult; Aged; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Outpatients | 1991 |
[Side effects of long-term drug therapy of patients with uncomplicated arterial hypertension in a polyclinic].
Topics: Adolescent; Adult; Antihypertensive Agents; Cardiovascular Diseases; Clonidine; Dose-Response Relati | 1991 |
Baroreceptor sensitivity in hypertension and vagal activity.
Topics: Adult; Atropine; Blood Pressure; Heart Rate; Humans; Hypertension; Middle Aged; Phenylephrine; Press | 1991 |
[Pulmonary hemodynamics in patients with hypertension during acute drug tests using obsidan and corinfar].
Topics: Adult; Female; Hemodynamics; Humans; Hypertension; Hypertension, Pulmonary; Male; Middle Aged; Nifed | 1991 |
Propranolol and response bias: an extension of findings reported by Corwin et al.
Topics: Adolescent; Adult; Arousal; Bias; Depressive Disorder; Dose-Response Relationship, Drug; Female; Hum | 1991 |
[Serum myoglobin level as a criterion of the effectiveness of adrenergic beta receptor blockaders].
Topics: Adult; Blood Pressure; Heart Rate; Humans; Hypertension; Male; Myoglobin; Propranolol; Receptors, Ad | 1990 |
Beta-blockers and ACE-inhibitors--further evidence for therapeutic benefit of this combination in hypertension.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cilazapril; Drug Therapy, Com | 1990 |
Effects of muscarinic and beta-adrenergic blockade on the aortic elastic response to epinephrine induced acute hypertension in conscious dogs.
Topics: Acute Disease; Adrenergic beta-Antagonists; Animals; Aorta; Atropine; Blood Pressure; Dogs; Dose-Res | 1990 |
Cardioprotection by beta-blockers: molecular and structural aspects in experimental hypertension.
Topics: Adrenergic beta-Antagonists; Animals; Aorta; Blood Pressure; Calcium-Transporting ATPases; Cardiomeg | 1990 |
[Beta-adrenoblockaders and calcium antagonists in the treatment of patients with ischemic heart disease combined with hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aging; Calcium Channel Blockers; Coronary Disease; Drug Ev | 1990 |
Inhibition of norepinephrine release from vascular adrenergic neurons by oral administration of beta-blocker in DOCA-salt hypertension.
Topics: Administration, Oral; Animals; Blood Pressure; Desoxycorticosterone; Hypertension; Male; Neurons; No | 1991 |
Heterogeneous interference of nicardipine, verapamil, and diltiazem with forearm arteriolar responsiveness to adrenergic stimulation in hypertensive patients.
Topics: Arterioles; Diltiazem; Female; Forearm; Humans; Hypertension; Lower Body Negative Pressure; Male; Ni | 1991 |
[Selected hemodynamic parameters in overweight patients with mild and moderate hypertension treated with low caloric diet].
Topics: Adult; Diet, Reducing; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Obesity; Propr | 1991 |
Calcium entry blockade and agonist-mediated forearm vasoconstriction in hypertensive patients. Difference between nicardipine and verapamil.
Topics: Angiotensin II; Forearm; Humans; Hypertension; Lower Body Negative Pressure; Nicardipine; Phentolami | 1991 |
[The clinical pharmacology and efficacy of the new Soviet calcium antagonist foridon].
Topics: Angina Pectoris; Calcium Channel Blockers; Coronary Disease; Drug Evaluation; Drug Therapy, Combinat | 1990 |
[Blood redistribution between peripheral areas in patients with stage II essential hypertension during treatment with anapriline].
Topics: Abdomen; Adult; Female; Fingers; Head; Hemodynamics; Humans; Hypertension; Leg; Male; Middle Aged; P | 1990 |
[The effect of obzidan on the tolerance for physical loading of hypertension patients].
Topics: Drug Evaluation; Exercise Test; Hemodynamics; Humans; Hypertension; Middle Aged; Physical Endurance; | 1990 |
Chronic treatment with propranolol enhances the synthesis of prostaglandins E2 and I2 by the aorta of spontaneously hypertensive rats.
Topics: Animals; Aorta; Blood Pressure; Dinoprostone; Epoprostenol; Hypertension; Indomethacin; Male; Norepi | 1990 |
Validation of non-invasive measurement of cardiac output. The Ann Arbor experience.
Topics: Carbon Dioxide; Cardiac Output; Echocardiography; Echocardiography, Doppler; Heart Rate; Humans; Hyp | 1990 |
Increased blood kynurenine level as a factor inhibiting the therapeutic effect of antihypertensive agents in combined long-term treatment of essential hypertension.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Cardiac Volume; Cardiomegaly; Clonidine; Drug Therap | 1990 |
Exercise, hypertension, and left ventricular mass.
Topics: Cardiomegaly; Diltiazem; Exercise; Humans; Hypertension; Propranolol | 1990 |
[Remission of left ventricular hypertrophy of hypertensive origin. Experimental data].
Topics: Cardiomegaly; Heart; Humans; Hypertension; Myocardial Contraction; Propranolol | 1990 |
Does the combination of cilazapril and propranolol lower blood pressure at rest and during exercise more pronouncedly than either of the two components given alone?
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cardiac Output; Cilazapril; Drug Th | 1990 |
The effects of ACE inhibitors and other antihypertensive drugs on cardiovascular risk factors and atherogenesis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arteriosclerosis; Calciu | 1990 |
Acute effects of antihypertensive agents on cerebral blood flow in hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Gas Analysis; Captopril; Cerebral Cortex; Cerebrovascular Ci | 1990 |
[Cardiovascular reactivity to isometric stress in patients with stable and borderline hypertension and in normotensive subjects. Effects of alpha sympatholytics and beta blocking agents].
Topics: Adult; Blood Pressure; Exercise; Heart Rate; Humans; Hypertension; Male; Middle Aged; Prazosin; Prop | 1990 |
[Comparative effectiveness of propranolol and acebutolol in arterial hypertension].
Topics: Acebutolol; Adult; Aged; Drug Evaluation; Humans; Hypertension; Middle Aged; Propranolol; Time Facto | 1990 |
[The dynamics of lipid peroxidation in patients with ischemic heart disease and hypertension during anaprilin treatment].
Topics: Coronary Disease; Drug Evaluation; Erythrocyte Membrane; Humans; Hypertension; Lipid Peroxidation; M | 1990 |
Dihydroergotamine interaction with propranolol.
Topics: Adult; Chest Pain; Dihydroergotamine; Drug Interactions; Female; Humans; Hypertension; Hyperthyroidi | 1990 |
A pressor effect of noncardioselective beta-blockers in mildly hypertensive patients during acute hospitalization.
Topics: Adult; Aged; Aged, 80 and over; Atenolol; Blood Pressure; Echocardiography; Female; Heart Rate; Hosp | 1990 |
[The effect of anaprilin on the central and peripheral hemodynamics of patients with hypertension].
Topics: Adult; Chronic Disease; Drug Evaluation; Female; Hemodynamics; Humans; Hypertension; Male; Middle Ag | 1990 |
Haemodynamic resistance of forearm vessels during prolonged drug treatment of essential hypertension.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Chlorthalidone; Clonidine; Drug Therapy, Combination | 1990 |
White-coat hypertension: detection and evaluation.
Topics: Adult; Aged; Blood Pressure; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; M | 1990 |
Chronic effects of arotinolol (S-596) in spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Aldosterone; Animals; Blood Pressure; Body Weight; Heart Rate; Hyperten | 1985 |
Effects of exercise on blood pressure, plasma catecholamines, potassium and the electrocardiogram after diuretic and neural-blocking therapy for moderate hypertension.
Topics: Blood Pressure; Cardiac Complexes, Premature; Catecholamines; Cholesterol; Drug Therapy, Combination | 1985 |
Increased cardiovascular responses to norepinephrine and calcium antagonists in essential hypertension compared with normotension in humans.
Topics: Adult; Angiotensin II; Calcium Channel Blockers; Diltiazem; Hemodynamics; Humans; Hypertension; Male | 1985 |
[Clinical and cardiohemodynamic effects of the new long-acting beta-blocker tobanum].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Cardiac Complexes, Premature; Coronary Di | 1986 |
Comparative effects of propranolol and pindolol on small and large arteries and veins of the forearm circulation in hypertensive man.
Topics: Adult; Arm; Brachial Artery; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Pindolol; | 1986 |
Alterations in blood pressure of normotensive and hypertensive rats following intrathecal injections of neuropeptide Y.
Topics: Adrenergic alpha-Antagonists; Animals; Blood Pressure; Desoxycorticosterone; Heart Rate; Hypertensio | 1988 |
Nitrendipine treatment in so-called therapy-resistant arterial hypertension; effect as monotherapy and in combination with propranolol on blood pressure, heart rate, other hemodynamic parameters, plasma renin activity, and catecholamines.
Topics: Blood Pressure; Catecholamines; Drug Resistance; Drug Therapy, Combination; Female; Heart Rate; Huma | 1988 |
Long-term efficacy and safety of nitrendipine in severe essential hypertension.
Topics: Adult; Aged; Blood Pressure; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Mi | 1988 |
Development of hypertension and life span in stroke-prone spontaneously hypertensive rats during oral long-term treatment with various antihypertensive drugs.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cerebrovascular Disorders; Dihydralazine; Heart; H | 1989 |
[The Kristepin and obzidan treatment of patients with hypertension].
Topics: Adult; Antihypertensive Agents; Chronic Disease; Clopamide; Dihydroergotoxine; Drug Combinations; Dr | 1989 |
Effects of calmodulin and calcium channel blockers on the Ca2+ induced outflow of K+ in intact red blood cells of patients with essential hypertension.
Topics: Adult; Calcimycin; Calcium; Calcium Channel Blockers; Calmodulin; Erythrocytes; Female; Humans; Hype | 1989 |
Effects of propranolol, nalorphine and haloperidol on the breathing and on the metabolism of PGI2 and TXA2 of normotensive and spontaneously hypertensive rats.
Topics: Animals; Epoprostenol; Haloperidol; Hypertension; Inspiratory Capacity; Nalorphine; Propranolol; Rat | 1989 |
[The long-term use of obzidan in patients with hypertension].
Topics: Adult; Cardiomegaly; Drug Evaluation; Hemodynamics; Humans; Hypertension; Middle Aged; Physical Endu | 1989 |
[The heart in patients with hypertension: effects of rilmenidine on experimental cardiac hypertrophy of hypertensive origin in rats].
Topics: Animals; Antihypertensive Agents; Cardiomegaly; Collagen; Heart; Heart Failure; Hypertension; Nephre | 1989 |
Skeletal muscle adaptation to physical training and beta-adrenergic blockade in spontaneously hypertensive rats.
Topics: Adaptation, Physiological; Animals; Blood Pressure; Body Weight; Hypertension; L-Lactate Dehydrogena | 1989 |
Race, borderline hypertension, and hemodynamic responses to behavioral stress before and after beta-adrenergic blockade.
Topics: Adolescent; Adult; Arousal; Black People; Blood Pressure; Cardiac Output; Heart Rate; Hemodynamics; | 1989 |
Increased beta-adrenergic tone enhances arterial compliance in hyperkinetic borderline hypertension.
Topics: Arteries; Hemodynamics; Humans; Hypertension; Propranolol; Receptors, Adrenergic, beta; Vascular Res | 1989 |
Effects of dilevalol on forearm circulation in essential hypertension.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Female; Forearm; Hemodynamics; Humans; | 1989 |
Persistence of sympathetic-mediated forearm vasoconstriction after alpha-blockade in hypertensive patients.
Topics: Adrenergic alpha-Antagonists; Adult; Bretylium Compounds; Dose-Response Relationship, Drug; Female; | 1989 |
Antihypertensive action of beta-adrenoceptor blocking drugs. The role of intrarenal mechanisms.
Topics: Adrenergic beta-Antagonists; Humans; Hypertension; Hypertension, Renovascular; Kidney; Propanolamine | 1989 |
Indenolol, a beta-blocker with partial agonism at vascular beta-adrenoceptors.
Topics: Adrenergic beta-Antagonists; Adult; Blood Flow Velocity; Blood Pressure; Female; Heart Rate; Humans; | 1989 |
Response of blood pressure, cardiac output, peripheral resistance, and exercise performance to substitution of calcium blocker for beta-blocker plus thiazide diuretic therapy in patients with both systemic hypertension and mild stable angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Delayed-Action Preparations; | 1989 |
Remodelling of the heart in DOCA-salt hypertensive rats by propranolol and by an alpha-2 agonist, rilmenidine.
Topics: Adrenergic alpha-Agonists; Analysis of Variance; Animals; Antihypertensive Agents; Blood Pressure; C | 1989 |
Adrenergic regulation of calcium-deficient hypertension in chick embryos.
Topics: Animals; Blood Pressure; Calcium; Chick Embryo; Diastole; Dopamine; Epinephrine; Hypertension; Isopr | 1989 |
Effect of propranolol on the myocardial contractility of normotensive and spontaneously hypertensive rabbits: relationship of pharmacokinetics and pharmacodynamics.
Topics: Animals; Blood Pressure; Disease Models, Animal; Hypertension; Myocardial Contraction; Propranolol; | 1989 |
[The effect of preoperative treatment of hypertension using beta receptor blockers during spinal anesthesia in elderly persons].
Topics: Aged; Anesthesia, Spinal; Hip Fractures; Humans; Hypertension; Preoperative Care; Propranolol | 1989 |
[Effect of long-term treatment with propranolol or hydrochlorothiazide on biochemical risk factors of coronary disease in patients with hypertension].
Topics: Adult; Coronary Disease; Dose-Response Relationship, Drug; Female; Humans; Hydrochlorothiazide; Hype | 1989 |
Comparative evaluation of the antihypertensive effect of timolol and propranolol in patients with essential hypertension.
Topics: Adult; Female; Humans; Hypertension; Male; Middle Aged; Propranolol; Timolol | 1989 |
Propranolol induced Steven-Johnson syndrome.
Topics: Adult; Female; Humans; Hypertension; Propranolol; Stevens-Johnson Syndrome | 1989 |
[Effect of obzidan on hemodynamic indices and the renin and aldosterone levels of the blood plasma in patients with juvenile hypertension].
Topics: Adolescent; Adult; Aldosterone; Drug Evaluation; Drug Resistance; Hemodynamics; Humans; Hypertension | 1989 |
Effects of angiotensin converting enzyme inhibitors on the progression of renal failure and proteinuria in humans.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Therapy, Combination; Female; Furos | 1989 |
[Effect of propranolol therapy on the secretion of insulin, glucagon, gastrin and pancreatic polypeptide in patients with essential hypertension].
Topics: Adolescent; Adult; Female; Gastrins; Glucagon; Humans; Hypertension; Insulin; Insulin Secretion; Mal | 1989 |
Blood pressure and blood pressure variability following withdrawal of propranolol and clonidine.
Topics: Adult; Aged; Blood Pressure; Clonidine; Female; Humans; Hypertension; Male; Middle Aged; Propranolol | 1989 |
Chronic beta-blocker therapy complicating the presentation of cardiac tamponade of malignancy.
Topics: Cardiac Tamponade; Dyspnea; Heart Neoplasms; Humans; Hypertension; Lung Neoplasms; Male; Middle Aged | 1989 |
[Treatment of arterial hypertension in the aged].
Topics: Age Factors; Aged; Diet, Sodium-Restricted; Diuretics; Drug Therapy, Combination; Female; Humans; Hy | 1989 |
[Use of crystepin in combination with obsidan in patients with diabetes mellitus with arterial hypertension].
Topics: Adult; Antihypertensive Agents; Diabetes Complications; Diabetes Mellitus; Diuretics; Drug Therapy, | 1989 |
[Pharmacologic correction of the adverse effects of beta-adrenoblockaders on the kidneys in patients with hypertension].
Topics: Adult; Aged; Female; Humans; Hypertension; Ischemia; Kidney; Male; Middle Aged; Pentoxifylline; Prop | 1989 |
[Hemodynamic types and the effect of anaprilin administered at various hours of the day in patients with hypertension].
Topics: Adult; Aged; Blood Flow Velocity; Circadian Rhythm; Female; Hemodynamics; Humans; Hypertension; Male | 1989 |
[The hypotensive action of anaprilin in hypertension].
Topics: Adolescent; Adult; Bradycardia; Drug Evaluation; Female; Hemodynamics; Humans; Hypertension; Male; M | 1989 |
Treatment-induced blood pressure reduction and the risk of myocardial infarction.
Topics: Blood Pressure; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Male; Middle A | 1989 |
Aortic compliance in human hypertension.
Topics: Adult; Aorta; Compliance; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Propranolol | 1989 |
Aortic compliance in human hypertension.
Topics: Adult; Aorta; Compliance; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Propranolol | 1989 |
Aortic compliance in human hypertension.
Topics: Adult; Aorta; Compliance; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Propranolol | 1989 |
Aortic compliance in human hypertension.
Topics: Adult; Aorta; Compliance; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Propranolol | 1989 |
Delayed postoperative neurological deterioration from prolonged sodium nitroprusside administration. Case report.
Topics: Brain Edema; Cerebral Hemorrhage; Coma; Craniotomy; Cyanides; Ferricyanides; Hematoma; Humans; Hyper | 1989 |
[Central effects of beta adrenergic receptor blockaders, obsidan and trasicor, in arterial hypertension].
Topics: Adult; Alpha Rhythm; Brain; Electroencephalography; Humans; Hypertension; Male; Middle Aged; Oxpreno | 1989 |
[Effects of propranolol on central hemodynamics in hypertensive patients at rest and during stress].
Topics: Adult; Blood Pressure; Cardiac Output; Dose-Response Relationship, Drug; Echocardiography; Exercise | 1989 |
Role of the autonomic nervous system, renin-angiotensin system, and arginine vasopressin during the onset and maintenance of ACTH hypertension in sheep.
Topics: Adrenocorticotropic Hormone; Animals; Arginine Vasopressin; Autonomic Nervous System; Blood Pressure | 1987 |
Constricting and stiffening action of atropine on aortic response to angiotensin in dogs.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Atropine; Dogs; Female; Hypertension; Male; Muscle, Smooth | 1988 |
[Effect of physical load and brief monotherapy with obsidan on the characteristics of beta 2-adrenoreceptors of intact lymphocytes in patients with hypertension].
Topics: Adult; Humans; Hypertension; Lymphocytes; Male; Middle Aged; Physical Exertion; Propranolol; Recepto | 1988 |
[Influence of hypertension and age on the sympathetic and parasympathetic components of cardiac baroreflex in the conscious rat].
Topics: Aging; Animals; Atropine; Heart; Hypertension; Male; Parasympathetic Nervous System; Phenylephrine; | 1988 |
Adrenaline and enhanced vasoconstriction in patients with essential hypertension.
Topics: Epinephrine; Humans; Hypertension; Prazosin; Propranolol; Receptors, Adrenergic, alpha; Vasoconstric | 1988 |
Characteristics of lymphocyte beta-adrenoceptors in essential hypertension: effects of propranolol treatment and dynamic exercise.
Topics: Adenylyl Cyclases; Adult; Humans; Hypertension; Lymphocytes; Male; Middle Aged; Physical Exertion; P | 1988 |
Effects of propranolol and yohimbine on periarterial nerve stimulation-induced release of endogenous norepinephrine from the mesenteric vasculature of Wistar Kyoto and spontaneously hypertensive rats.
Topics: Animals; Electric Stimulation; Hypertension; Male; Norepinephrine; Perfusion; Peripheral Nerves; Pro | 1988 |
[Circadian rise of blood pressure and combined alpha-beta adrenoceptor blockade].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Circadian Rhythm; Cold Temperature; Drug | 1985 |
Otolaryngologists using local anesthetics containing epinephrine.
Topics: Adrenergic beta-Antagonists; Anesthetics, Local; Antihypertensive Agents; Drug Interactions; Epineph | 1985 |
Misleading paper about misleading statistics.
Topics: Blood Pressure; Humans; Hypertension; Nifedipine; Propranolol; Statistics as Topic | 1985 |
Pharmacologic properties of acebutolol: relationship of hydrophilicity to central nervous system penetration.
Topics: Acebutolol; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Blood-Brain Barrier; Cats; C | 1985 |
Role of autonomic nervous system on heart rate in experimental hypertension.
Topics: Animals; Atropine; Autonomic Nervous System; Heart Conduction System; Heart Rate; Hemicholinium 3; H | 1985 |
Chronic effects of a beta-adrenoceptor blocking drug, 4-[3-(tert-butylamino)-2-hydroxypropoxy]-N-methylisocarbostyril hydrochloride (N-696), in hypertensive rats.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Body Weight; Heart Rate; Hypertension; Isoquin | 1985 |
A comparison of celiprolol and propranolol in the treatment of hypertension.
Topics: Adrenergic beta-Antagonists; Celiprolol; Drug Evaluation; Humans; Hypertension; Propanolamines; Prop | 1985 |
Side-effects of beta-blockers assessed using visual analogue scales.
Topics: Acebutolol; Adrenergic beta-Antagonists; Analysis of Variance; Atenolol; Dreams; Fatigue; Humans; Hy | 1985 |
A comparison of the pharmacokinetics of atenolol, metoprolol, oxprenolol and propranolol in elderly hypertensive and young healthy subjects.
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Atenolol; Blood Proteins; Female; Half-Life; | 1985 |
[Effect of 3-month treatment with propranolol, oxprenolol, metoprolol and pindolol on plasma lipids and lipoproteins in patients with primary arterial hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Female; Humans; Hypertension; Lipids; Male; Metoprolol; Mi | 1985 |
[Regression of left-ventricular myocardial hypertrophy in patients with hypertension during long-term treatment with beta-adrenergic blockaders].
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Atenolol; Cardiomegaly; Drug Therapy, C | 1986 |
[Effect of beta-adrenergic blockaders and their combination with an alpha-adrenergic blockader on physical exertion tolerance in patients with hypertension].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Blood Pressure; Drug Therapy, Combination | 1986 |
[Use of crystepin and obsidan in patients with hypertension].
Topics: Adult; Chlorthalidone; Dihydroergotoxine; Drug Combinations; Drug Therapy, Combination; Humans; Hype | 1986 |
[Treatment of hypertension with obsilazin].
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Dihydralazine; Diuretics; Drug Combinat | 1986 |
Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
Topics: Acebutolol; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Blood Pressure; Decerebrate St | 1986 |
[Thin layer chromatographic determination of talinolol, propranolol and triamterene in urine: compliance evaluation of hypertensive patients].
Topics: Adrenergic beta-Antagonists; Adult; Female; Humans; Hypertension; Male; Middle Aged; Patient Complia | 1986 |
[Allergic and other adverse reactions during drug therapy of patients with arterial hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Humans; Hypertension; Male; Middle Aged | 1986 |
[Effect of a beta 2-blocker on the adrenergic receptors of lymphocytes in hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Humans; Hypertension; Lymphocytes; Male; Middle Aged; Monocytes; | 1986 |
Does angiotensin-II protect against strokes?
Topics: Angiotensin II; Bendroflumethiazide; Cerebral Infarction; Cerebrovascular Circulation; Cerebrovascul | 1986 |
Debrisoquine polymorphism and the metabolism and action of metoprolol, timolol, propranolol and atenolol.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Debrisoquin; Genetic Variation; Humans; Hypertension; | 1986 |
Strokes in mild hypertension: diastolic rules.
Topics: Bendroflumethiazide; Blood Pressure Determination; Cerebrovascular Disorders; Diastole; Humans; Hype | 1986 |
High plasma protein binding as a parameter in the selection of betablockers for lactating women.
Topics: Acebutolol; Adrenergic beta-Antagonists; Blood Proteins; Female; Humans; Hypertension; Lactation; Mi | 1986 |
Tertatolol preserves renal perfusion in patients with arterial hypertension after head injury.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Craniocerebral Trauma; Female; Hemodynamics; H | 1986 |
Renal hemodynamic effects of tertatolol in essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Female; Glomerular Filtration Rate; Hemodynamics; Humans; Hypert | 1986 |
Acute central effects of L-glutamate in pentobarbital-anesthetized dogs.
Topics: Anesthesia; Animals; Atropine; Blood Pressure; Cardiovascular System; Dogs; Dose-Response Relationsh | 1987 |
Enhanced stimulus-induced neurotransmitter overflow in epinephrine-induced hypertensive rats is not mediated by prejunctional beta-adrenoceptor activation.
Topics: Animals; Electric Stimulation; Epinephrine; Hypertension; In Vitro Techniques; Male; Neurotransmitte | 1986 |
[Relaxation and rapid filling of the left ventricle in essential hypertension during treatment with a non-selective beta blocker].
Topics: Adrenergic beta-Antagonists; Adult; Female; Heart Ventricles; Humans; Hypertension; Male; Middle Age | 1987 |
A comparison of the side effects of atenolol and propranolol in the treatment of patients with hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Blood Pressure; Female; Heart Rate; Humans; Hype | 1987 |
The role of epinephrine as a neuromodulator in spontaneously hypertensive rats.
Topics: Animals; Electric Stimulation; Epinephrine; Hypertension; Male; Neurotransmitter Agents; Norepinephr | 1987 |
Large arteries in hypertension: heterogeneous haemodynamic response to beta-adrenoceptor antagonists with and without intrinsic sympathomimetic activity.
Topics: Adrenergic beta-Antagonists; Arteries; Brachial Artery; Hemodynamics; Humans; Hypertension; Pindolol | 1987 |
Beta-blocker action on lymphocyte proliferative response in essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Humans; Hypertension; In Vitro Techniques; Lymphocyte Activation | 1988 |
[Autoregulation of the cerebral blood flow in normo- and hypertensive rats under beta-adrenoreceptor blockade].
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Cerebrovascular Circulation; Female; Homeostas | 1988 |
[Modification of hemorheologic parameters by beta-receptor blockers with special reference to propranolol and talinolol].
Topics: Adrenergic beta-Antagonists; Adult; Animals; Blood Flow Velocity; Blood Viscosity; Dose-Response Rel | 1988 |
Severe epinephrine-propranolol interaction.
Topics: Bradycardia; Drug Interactions; Edema; Epinephrine; Humans; Hypertension; Male; Middle Aged; Pharyng | 1989 |
Mrs. McGiver's collapse--unmasking the true cause.
Topics: Aged; Diabetes Mellitus, Type 1; Female; Humans; Hypertension; Hypoglycemia; Propranolol; Syncope | 1989 |
[Left ventricular hypertrophy and neural tonus in hypertension: differences in the action of diuretics and relaxation therapy].
Topics: Adult; Aged; Blood Pressure; California; Cardiomegaly; Diuretics; Drug Therapy, Combination; Epineph | 1986 |
Impaired responsiveness of the ventricular sensory receptor in hypertensive patients with left ventricular hypertrophy.
Topics: Adult; Blood Pressure; Cardiac Output; Cardiomegaly; Central Venous Pressure; Female; Heart Rate; He | 1986 |
Impaired control of vasopressin release in hypertensive subjects with cardiac hypertrophy.
Topics: Adult; Arginine Vasopressin; Blood Pressure; Cardiomegaly; Female; Humans; Hypertension; Lower Body | 1987 |
[Regulation of coronary circulation in patients with hypertensive cardiopathy: role of ventricular mechanoreceptors].
Topics: Adult; Blood Pressure; Cardiomegaly; Coronary Circulation; Female; Humans; Hypertension; Male; Mecha | 1987 |
Does increased platelet release normalize during anti-hypertensive treatment?
Topics: beta-Thromboglobulin; Blood Platelets; Humans; Hypertension; Male; Middle Aged; Platelet Count; Prop | 1987 |
[Hemodynamic effect of a combination of prazosin with cardiac depressants in the treatment of hypertension].
Topics: Anti-Arrhythmia Agents; Celiprolol; Clonidine; Drug Evaluation; Drug Synergism; Drug Therapy, Combin | 1988 |
[Plasma beta-thromboglobulin and platelet factor 4 in essential hypertension].
Topics: Adult; beta-Thromboglobulin; Female; Humans; Hypertension; Male; Platelet Factor 4; Propranolol | 1988 |
Elevation of brachial arterial blood velocity and volumic flow mediated by peripheral beta-adrenoreceptors in patients with borderline hypertension.
Topics: Adult; Blood Flow Velocity; Blood Volume; Brachial Artery; Forearm; Hemodynamics; Humans; Hypertensi | 1985 |
Intrarenal beta-receptor and renal baroreceptor interaction in the control of the renin response to transient reduction of the renal perfusion pressure in man.
Topics: Adult; Cold Temperature; Female; Humans; Hypertension; Hypertension, Renovascular; Juxtaglomerular A | 1985 |
In ability of Na+,K+-ATPase inhibitor to cause hypertension in sodium-loaded or deoxycorticosterone-treated one kidney rats.
Topics: Animals; Atropine; Blood Pressure; Desoxycorticosterone; Digitoxin; Enzyme Inhibitors; Hypertension; | 1985 |
The mechanism of hypertension and bradycardia following lesions of the caudal ventrolateral medulla in the rabbit: the role of sympathetic nerves, circulating adrenaline, vasopressin and renin.
Topics: Adrenalectomy; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine Vasopressin; Bradycardia; | 1985 |
Enalapril in essential hypertension.
Topics: Adult; Aged; Aldosterone; Antihypertensive Agents; Blood Pressure; Catecholamines; Enalapril; Female | 1985 |
Direct hypotensive action of intravascular bradykinin in man.
Topics: Blood Pressure; Bradykinin; Captopril; Diet, Sodium-Restricted; Dose-Response Relationship, Drug; Dr | 1985 |
Beta-adrenoceptors in kidney tubules of spontaneously hypertensive and normotensive rats.
Topics: Animals; Hypertension; In Vitro Techniques; Iodocyanopindolol; Kidney Tubules; Male; Pindolol; Propr | 1986 |
[Clinical pharmacology of enalapril].
Topics: Angiotensin-Converting Enzyme Inhibitors; Chemical Phenomena; Chemistry; Drug Interactions; Enalapri | 1985 |
Evaluation of beta-adrenergic influences on cardiovascular and metabolic adjustments to physical and psychological stress.
Topics: Adolescent; Adult; Avoidance Learning; Blood Pressure; Cardiac Output; Cardiovascular System; Cold T | 1986 |
[Clinical significance of serum angiotensin I-converting enzyme in essential hypertension].
Topics: Adult; Aged; Aldosterone; Angiotensin II; Blood Pressure; Bradykinin; Circadian Rhythm; Creatinine; | 1985 |
Effects of pheochromocytoma on cardiovascular alpha adrenergic receptor system.
Topics: Animals; Aorta, Thoracic; Blood Pressure; Hypertension; In Vitro Techniques; Mesenteric Arteries; My | 1985 |
Role of drugs modifying sympathetic nervous system activity in the treatment of hypertension.
Topics: Binding Sites; Blood Circulation; Brain; Clonidine; Efferent Pathways; Ganglia, Sympathetic; Humans; | 1985 |
Stress levels of adrenaline amplify the blood pressure response to sympathetic stimulation.
Topics: Adolescent; Adult; Blood Pressure; Cold Temperature; Epinephrine; Heart Rate; Humans; Hypertension; | 1986 |
[Effect of enalapril on blood pressure and renal function in mild hypertension].
Topics: Blood Pressure; Enalapril; Glomerular Filtration Rate; Humans; Hypertension; Kidney; Middle Aged; Pr | 1986 |
Dynamic exercise-induced increase in lymphocyte beta-2-adrenoceptors: abnormality in essential hypertension and its correction by antihypertensives.
Topics: Adult; Blood Pressure; Epinephrine; Female; Humans; Hypertension; Lymphocytes; Male; Middle Aged; No | 1987 |
[Effect of treatment with pindolol, acebutolol and propranolol on the density of beta-adrenergic receptors in human lymphocytes].
Topics: Acebutolol; Adult; Angina Pectoris; Humans; Hypertension; Lymphocytes; Male; Middle Aged; Pindolol; | 1987 |
Side effects and metabolic effects of converting enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Humans; Hypertension; Propranolol | 1987 |
The metabolic effects of enalapril.
Topics: Adult; Blood Glucose; Blood Pressure; Enalapril; Female; Humans; Hypertension; Lipids; Male; Middle | 1987 |
Adrenomedullary and beta-adrenergic participation in enhanced sympathetic pressor responses of spontaneously hypertensive rats.
Topics: Adrenal Medulla; Adrenalectomy; Animals; Blood Pressure; Cyclic AMP; Electric Stimulation; Heart Rat | 1987 |
Hemodynamic and hormonal adaptations to beta-adrenoceptor blockade. A 24-hour study of acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
Topics: Acebutolol; Atenolol; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Norepinephrine; Pindolo | 1988 |
[Effects of puerarin on blood pressure and plasma renin activity in spontaneously hypertensive rats].
Topics: Animals; Blood Pressure; Female; Flavonoids; Heart Rate; Hypertension; Isoflavones; Male; Propranolo | 1988 |
Antihypertensive drugs and sodium restriction. Analysis of their interaction based on pressure-natriuresis relationship.
Topics: Antihypertensive Agents; Blood Pressure; Captopril; Diet, Sodium-Restricted; Female; Humans; Hyperte | 1988 |
[Antihypertensive treatment with a long-acting formulation of propranolol in the aged].
Topics: Aged; Aged, 80 and over; Delayed-Action Preparations; Electrocardiography; Female; Humans; Hypertens | 1988 |
[Stress and cardiac pathology].
Topics: Arteriosclerosis; Catecholamines; Coronary Disease; Humans; Hypertension; Platelet Aggregation; Prop | 1987 |
[Hemodynamic indices and the renin and aldosterone levels of the blood plasma in patients with different forms of arterial hypertension undergoing combined kristepin and propranolol treatment].
Topics: Adolescent; Adult; Aldosterone; Clopamide; Dihydroergotoxine; Drug Combinations; Drug Therapy, Combi | 1988 |
The carpal tunnel syndrome in hypertensive patients treated with beta-blockers.
Topics: Adult; Carpal Tunnel Syndrome; Humans; Hypertension; Long-Term Care; Male; Middle Aged; Propranolol | 1988 |
[Comparison on antihypertensive and cardiac effects of guanadrel and propranolol].
Topics: Antihypertensive Agents; Blood Pressure; Female; Guanidines; Hemodynamics; Humans; Hydrochlorothiazi | 1985 |
[Arterial hypertension secondary to Guillain-Barré syndrome. Treatment with a labetalol and chlorpromazine combination. Apropos of a case].
Topics: Aged; Chlorpromazine; Drug Therapy, Combination; Female; Humans; Hypertension; Labetalol; Nitropruss | 1988 |
[Hypertension in pregnant women and beta-blockers. Follow-up of 31 pregnancies].
Topics: Adult; Blood Pressure; Embryonic and Fetal Development; Female; Follow-Up Studies; Humans; Hypertens | 1988 |
[The effect of anesthesia and surgery on hypertensive patients treated with beta receptor blockers].
Topics: Aged; Anesthesia; Blood Pressure; Female; Humans; Hypertension; Male; Middle Aged; Propranolol; Puls | 1988 |
[Effect of obzidan on hemodynamics in persons with a hereditary risk of hypertension].
Topics: Adult; Disease Susceptibility; Female; Hemodynamics; Humans; Hypertension; Male; Propranolol; Risk F | 1988 |
[Electrophoresis of obzidan and magnesium in the combined sanatorium-health resort treatment of patients with hypertension].
Topics: Adult; Combined Modality Therapy; Coronary Artery Disease; Female; Health Resorts; Humans; Hypertens | 1988 |
Platelets as a model for studying the action of antihypertensive drugs.
Topics: Adult; Aminoquinolines; Antihypertensive Agents; Blood Platelets; Calcium; Drug Therapy, Combination | 1988 |
[Functional state of the positive reward system of the hypothalamus in arterial hypertension].
Topics: Animals; Blood Pressure; Cats; Hypertension; Hypothalamus; Male; Myocardial Contraction; Norepinephr | 1988 |
[The influence of a long-acting formulation of propranolol on the circadian rhythm of heart rate in elderly patients with essential hypertension].
Topics: Aged; Aged, 80 and over; Circadian Rhythm; Delayed-Action Preparations; Electrocardiography; Female; | 1988 |
[3 cases of conservatively treated aortic dissecting aneurysm in patients with arterial hypertension. Results of a long-term ambulatory observation].
Topics: Aged; Ambulatory Care; Antihypertensive Agents; Aorta, Abdominal; Aortic Aneurysm; Aortic Dissection | 1988 |
Hypertensive response to levonordefrin in a patient receiving propranolol: report of case.
Topics: Adult; Anesthesia, Dental; Blood Pressure; Drug Interactions; Female; Humans; Hypertension; Mepivaca | 1988 |
[Correlation of the total activity of blood plasma renin with levels of active and inactive renin, angiotensinogen and angiotensin II under different functional loads in patients with hypertension].
Topics: Adult; Angiotensin II; Angiotensinogen; Captopril; Female; Humans; Hypertension; Male; Middle Aged; | 1988 |
Utility of behavioral science techniques in assessing adverse effects of antihypertensive agents.
Topics: Adult; Antihypertensive Agents; Captopril; Humans; Hypertension; Male; Methyldopa; Middle Aged; Pati | 1987 |
Effect of propranolol and indomethacin on the depressor action of captopril in patients with essential hypertension.
Topics: Adult; Blood Pressure; Captopril; Drug Interactions; Female; Humans; Hypertension; Indomethacin; Mal | 1987 |
Enhanced blood pressure response to isometric handgrip exercise in patients with essential hypertension: effects of propranolol and prazosin.
Topics: Adult; Blood Pressure; Epinephrine; Female; Heart Rate; Humans; Hypertension; Isometric Contraction; | 1987 |
A comparative study of captopril & propranolol in essential hypertension.
Topics: Adult; Blood Pressure; Captopril; Female; Humans; Hypertension; Male; Middle Aged; Propranolol | 1987 |
Reflex control of coronary vascular tone by cardiopulmonary receptors in humans.
Topics: Adult; Afferent Pathways; Blood Pressure; Cardiomyopathy, Hypertrophic; Carotid Arteries; Coronary C | 1988 |
[Effect of propranolol on hemodynamic manifestations of emotional stress of different types in patients with arterial hypertension].
Topics: Adult; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Propranolol; Psychological Tests; Psyc | 1988 |
[Chronotherapy of hypertensive patients].
Topics: Adult; Circadian Rhythm; Drug Therapy, Combination; Heart; Hemodynamics; Humans; Hydralazine; Hypert | 1988 |
[Clinical effectiveness of minoxidil in patients with severe forms of arterial hypertension].
Topics: Adult; Chronic Disease; Drug Evaluation; Drug Therapy, Combination; Female; Furosemide; Humans; Hype | 1988 |
The influence of phenobarbital on the pharmacokinetics of propranolol in pregnancy.
Topics: Drug Interactions; Female; Half-Life; Humans; Hypertension; Phenobarbital; Pregnancy; Pregnancy Comp | 1987 |
System approach to testing hypotensive drugs for prevention of arterial hypertension.
Topics: Clinical Trials as Topic; Humans; Hydralazine; Hyperlipidemias; Hypertension; Prazosin; Propranolol | 1987 |
The effect of antihypertensive treatment on the circulating hypertensive factor in the spontaneously hypertensive rat.
Topics: Animals; Antihypertensive Agents; Cross Circulation; Furosemide; Hypertension; Male; Methyldopa; Nif | 1987 |
Half-Inderal LA therapy in general practice.
Topics: Aged; Consumer Behavior; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Huma | 1987 |
The carotid bodies of spontaneously hypertensive rats after long-term antihypertensive treatment with propranolol.
Topics: Animals; Carotid Body; Female; Hypertension; Male; Propranolol; Rats; Rats, Inbred SHR; Time Factors | 1987 |
Neuropsychological effects of antihypertensive drugs.
Topics: Affect; Aged; Aged, 80 and over; Antihypertensive Agents; Cognition Disorders; Depression; Female; H | 1987 |
[Nifedipine in the emergency and chronic treatment of arterial hypertension].
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Chronic Disease; Drug Therapy, Combination; Em | 1987 |
Reactivity to mental stress and cold provocation during long-term treatment with metoprolol, propranolol or hydrochlorothiazide.
Topics: Adult; Blood Pressure; Catecholamines; Cold Temperature; Humans; Hydrochlorothiazide; Hypertension; | 1986 |
Influence of blood pressure on development of aortic medial smooth muscle hypertrophy in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Captopril; Hydralazine; Hypertension; Male; Muscle, Smooth, Vascul | 1987 |
Hypertrichosis and congenital anomalies associated with maternal use of minoxidil.
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Captopril; Female; Humans; Hypertension; Hyper | 1987 |
[Long-term use of prazosin alone and combined with propranolol in patients with essential hypertension].
Topics: Adult; Drug Therapy, Combination; Hemodynamics; Humans; Hypertension; Middle Aged; Prazosin; Propran | 1986 |
[Efficacy of a graded plan for long-term prevention using antihypertensive drugs. Work Group for the Cooperative Study for the Testing of New Preparations for the Prevention of Arterial Hypertension (CSPPAH)].
Topics: Adult; Antihypertensive Agents; Blood Pressure; Diastole; Drug Therapy, Combination; Heart Rate; Hum | 1987 |
[Effect of hypotensive therapy and exercise schedules on the bicycle ergometry indices of essential hypertension patients].
Topics: Adult; Antihypertensive Agents; Benzothiadiazines; Blood Pressure; Diuretics; Drug Therapy, Combinat | 1987 |
Postpropranolol vasodilation in adrenalectomized glucocorticoid hypertensive rats.
Topics: Adrenalectomy; Animals; Cardiac Output; Glucocorticoids; Heart Rate; Hypertension; Male; Microsphere | 1987 |
Inhibition of nuclear polyploidy by propranolol in aortic smooth muscle cells of hypertensive rats.
Topics: Animals; Aorta; Blood Pressure; Cell Nucleus; Hypertension; Male; Muscle, Smooth, Vascular; Myocardi | 1987 |
The influence of pregnancy on drug action: concentration-effect modelling with propranolol.
Topics: Adult; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Kinetics; Pregnancy; Pregnancy Comp | 1987 |
Severe hypertension, propranolol, and acute pulmonary edema.
Topics: Aged; Aged, 80 and over; Drug Therapy, Combination; Heart Failure; Humans; Hydralazine; Hypertension | 1987 |
[Study of tolerance to antihypertensive medication].
Topics: Antihypertensive Agents; Bendroflumethiazide; Drug Tolerance; Humans; Hypertension; Middle Aged; Pro | 1987 |
Increase of renal sympathetic nerve activity by metoprolol or propranolol in conscious spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Heart Rate; Hypertension; Kidney; Male; Metoprolol; Pressoreceptors; Propra | 1987 |
Hypersomnolence with beta-adrenergic blockers.
Topics: Aged; Atenolol; Disorders of Excessive Somnolence; Humans; Hypertension; Male; Propranolol; Sleep Wa | 1987 |
Attenuation by propranolol of exercise training effects in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Body Weight; Heart; Heart Rate; Hemodynamics; Hypertension; Male; Organ Siz | 1987 |
Effects of propranolol and swim-training on blood pressure, plasma electrolytes, and vasopressin in spontaneously hypertensive and normotensive rats.
Topics: Animals; Blood Pressure; Electrolytes; Hypertension; Male; Physical Exertion; Propranolol; Rats; Rat | 1987 |
[Hemodynamic assessment of anti-angina preparations in treating patients with ischemic heart disease with hypertension].
Topics: Adult; Aged; Coronary Disease; Drug Evaluation; Drug Therapy, Combination; Female; Hemodynamics; Hum | 1987 |
Propranolol ... not guilty.
Topics: Drug Combinations; Headache; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Propranol | 1987 |
[Measured walking as a means of secondary prevention of arterial hypertension].
Topics: Adult; Blood Pressure; Exercise Test; Exercise Therapy; Follow-Up Studies; Gait; Humans; Hypertensio | 1987 |
Effects of hypertension and hypercholesterolemia on vasodilatation in the rabbit.
Topics: Acetylcholine; Adenosine; Analysis of Variance; Animals; Body Weight; Female; Guanethidine; Heart Ra | 1986 |
[Combined effect of (2R, 4R)-2-(o-hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidinecarbo xyl ic acid (SA446) with hydrochlorothiazide or propranolol on development of hypertension in spontaneously hypertensive rats (SHR) by long-term administration].
Topics: 3-Mercaptopropionic Acid; Animals; Antihypertensive Agents; Diuresis; Hydrochlorothiazide; Hypertens | 1986 |
Renal haemodynamics during propranolol treatment in patients with arterial hypertension and chronic renal failure.
Topics: Adult; Female; Glomerular Filtration Rate; Humans; Hypertension; Kidney Failure, Chronic; Male; Midd | 1986 |
[Patient compliance of hypertensive patients in ambulatory treatment with Obsidan].
Topics: Adult; Aged; Blood Pressure; Female; Humans; Hypertension; Male; Middle Aged; Patient Compliance; Pr | 1986 |
Tachycardic and hypertensive effects of centrally administered clonidine in conscious rats.
Topics: Animals; Atropine; Blood Pressure; Bradycardia; Clonidine; Heart Rate; Hypertension; Hypotension; In | 1986 |
The effect of propranolol on catecholamine clearance.
Topics: Blood Pressure; Drug Interactions; Half-Life; Humans; Hypertension; Isoproterenol; Norepinephrine; P | 1986 |
[Comparative pharmacokinetic studies on the relative biologic availability of two propranolol preparations in patients with steady state essential hypertension].
Topics: Adult; Biological Availability; Humans; Hypertension; Kinetics; Middle Aged; Propranolol | 1986 |
Adrenoceptor blocking drugs and cold feet in intermittent claudication.
Topics: Aged; Foot; Humans; Hypertension; Intermittent Claudication; Labetalol; Male; Middle Aged; Propranol | 1986 |
Diuretics and myocardial infarction or sudden death.
Topics: Chlorothiazide; Death, Sudden; Humans; Hypertension; Male; Methyldopa; Middle Aged; Myocardial Infar | 1986 |
[Chronotherapy of patients with hypertension using anaprilin].
Topics: Circadian Rhythm; Humans; Hypertension; Propranolol | 1986 |
[Treatment of hypertension with the calcium antagonist korinfar and its combination with obzidan].
Topics: Adult; Calcium Channel Blockers; Chronic Disease; Drug Evaluation; Drug Therapy, Combination; Hemody | 1986 |
[Differing acute effects of propranolol on the hypertensive heart during exercise].
Topics: Adult; Blood Pressure; Cardiac Output; Cardiac Volume; Heart; Heart Diseases; Heart Rate; Humans; Hy | 1986 |
Control of hypertension following carotid endarterectomy.
Topics: Aged; Carotid Artery Diseases; Drug Therapy, Combination; Endarterectomy; Humans; Hydralazine; Hyper | 1986 |
Effect of the calcium channel blocker nitrendipine on left ventricular mass in patients with hypertension.
Topics: Adult; Blood Pressure; Drug Therapy, Combination; Echocardiography; Female; Heart Rate; Heart Ventri | 1986 |
Arterial hemodynamics in human hypertension.
Topics: Adult; Age Factors; Aorta; Arteries; Electric Conductivity; Female; Hemodynamics; Humans; Hypertensi | 1986 |
Postmarketing comparison of labetalol and propranolol in hypertensive patients.
Topics: Adult; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Labetalol; Male; Middle Aged; Produ | 1986 |
Management of the cocaine-intoxicated patient.
Topics: Cocaine; Humans; Hypertension; Propranolol; Substance-Related Disorders | 1987 |
Propranolol, epinephrine, and accelerated hypertension during hemodialysis.
Topics: Adult; Drug Interactions; Epinephrine; Humans; Hypertension; Male; Propranolol; Renal Dialysis | 1987 |
[Echo- and phonomechanocardiographic evaluation of left ventricular function and total peripheral resistance during treatment of systemic arterial hypertension with pindolol and propranolol. A comparative study].
Topics: Adult; Blood Pressure; Echocardiography; Female; Humans; Hypertension; Male; Middle Aged; Myocardial | 1986 |
Minoxidil in the rapid control of severe hypertension.
Topics: Adult; Drug Therapy, Combination; Female; Furosemide; Humans; Hypertension; Male; Middle Aged; Minox | 1986 |
[Baroreflex regulation of circulation in essential hypertension patients treated with anaprilin].
Topics: Administration, Oral; Adolescent; Adult; Female; Hemodynamics; Humans; Hypertension; Injections, Int | 1986 |
[Evaluation of the effect of obsidan in essential hypertension patients with different types of circulation].
Topics: Adolescent; Adult; Cardiac Output; Female; Heart Rate; Hemodynamics; Humans; Hypertension; Male; Mid | 1986 |
[Effect of antihypertensive treatment on the secretion of corticotropin, prolactin, growth hormone and cortisol].
Topics: Adult; Humans; Hydrochlorothiazide; Hydrocortisone; Hypertension; Male; Middle Aged; Pituitary Hormo | 1985 |
Bipolar affective symptoms associated with use of captopril and abrupt withdrawal of pargyline and propranolol.
Topics: Bipolar Disorder; Captopril; Drug Therapy, Combination; Female; Humans; Hypertension; Middle Aged; N | 1985 |
Essential hypertension: a metabolic cause? A hypothesis.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Calcium; Captopril; Female; Humans; Hydrochlorothiazide; H | 1985 |
A new look at the hypertension problem: the role of the renin system for analysis and treatment.
Topics: Angiotensin II; Arginine Vasopressin; Blood Pressure; Calcium; Captopril; Cold Temperature; Enzyme P | 1985 |
Comparison of low-dose captopril and propranolol as second-line drugs in mild and moderate hypertension.
Topics: Adult; Captopril; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male | 1985 |
Hemodynamic and hormonal effects of propranolol on patients with essential hypertension during head-up tilting: a comparison between normal and low cardiac index groups.
Topics: Aged; Blood Pressure; Cardiac Output; Female; Heart Rate; Hemodynamics; Humans; Hypertension; Male; | 1985 |
Glucose tolerance during chronic propranolol treatment.
Topics: Adult; Aged; Blood Glucose; Female; Glucose Tolerance Test; Humans; Hypertension; Insulin; Male; Mid | 1985 |
Central noradrenergic neurons and the hypertensive effects of intracerebroventricularly administered prostaglandin E2 in anaesthetized rabbits.
Topics: Animals; Blood Pressure; Cerebral Ventricles; Dinoprostone; Female; Heart Rate; Hydroxydopamines; Hy | 1985 |
Treating mild hypertension.
Topics: Bendroflumethiazide; Cerebrovascular Disorders; Coronary Disease; Female; Humans; Hypertension; Male | 1985 |
Effect of propranolol on baroreflex control of heart rate in young patients with essential hypertension.
Topics: Adult; Blood Pressure; Heart Rate; Humans; Hypertension; Male; Pressoreceptors; Propranolol; Reflex; | 1986 |
Lacunar stroke.
Topics: Adult; Blood Pressure; Brain; Cerebrovascular Disorders; Diagnosis, Differential; Hemiplegia; Humans | 1986 |
Serial measurements of systolic time intervals during treatment with hydrochlorothiazide alone and combined with other antihypertensive agents.
Topics: Antihypertensive Agents; Drug Therapy, Combination; Electrocardiography; Humans; Hydralazine; Hydroc | 1985 |
Propranolol and depression revisited: three cases and a review.
Topics: Aged; Arrhythmias, Cardiac; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; H | 1985 |
Interaction of left ventricular contraction and aortic input impedance in experimental and clinical studies.
Topics: Animals; Aorta; Atropine; Blood Flow Velocity; Blood Pressure; Cardiac Output; Cardiography, Impedan | 1985 |
A method for evaluating different modes of action of an antiarrhythmic drug in man. The effects of propafenone on sinus nodal functions.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atropine; Autonomic Nervous S | 1985 |
[Effect of anaprilin on the peripheral circulation of patients with arterial hypertension].
Topics: Adult; Blood Flow Velocity; Cardiac Output; Female; Forearm; Hemodynamics; Humans; Hypertension; Mal | 1985 |
[Results of prolonged use of minoxidil in patients with stable and malignant arterial hypertension].
Topics: Adult; Drug Therapy, Combination; Female; Furosemide; Humans; Hypertension; Hypertension, Malignant; | 1985 |
[Blood pressure and heart rate behavior of ergometrically stressed patients with and without beta receptor blocker].
Topics: Adolescent; Adult; Aged; Blood Pressure; Dose-Response Relationship, Drug; Exercise Test; Female; He | 1985 |
Propranolol antagonism of phenylpropanolamine-induced hypertension.
Topics: Administration, Oral; Adult; Blood Pressure; Cardiac Output; Double-Blind Method; Electrocardiograph | 1985 |
Effect of nifedipine and propranolol on blood flow, venous compliance and blood pressure in essential hypertension.
Topics: Adult; Aged; Blood Pressure; Compliance; Drug Therapy, Combination; Forearm; Humans; Hypertension; M | 1985 |
Spiroprop (spironolactone + propranolol) for hypertension.
Topics: Antihypertensive Agents; Drug Combinations; Drug Synergism; Humans; Hypertension; Propranolol; Spiro | 1985 |
Enhanced protein synthesis in the renal arteries of genetically hypertensive rats: its possible role in causing hypertension.
Topics: Animals; Collagen; Hypertension; Organ Size; Phenoxybenzamine; Proline; Propranolol; Protein Biosynt | 1985 |
Salivary flow in borderline hypertension.
Topics: Adult; Atropine; Humans; Hypertension; Male; Neostigmine; Norepinephrine; Phentolamine; Potassium; P | 1985 |
Determination of propranolol in plasma by radial compression liquid chromatography with fluorometric detection.
Topics: Chromatography, Liquid; Female; Fluorometry; Humans; Hypertension; Infant, Newborn; Infant, Newborn, | 1985 |
Hypertensive emergencies.
Topics: Antihypertensive Agents; Blood Pressure; Clonidine; Diazoxide; Emergencies; Humans; Hydralazine; Hyp | 1985 |
Separation of the enantiomers of intact sulfate conjugates of adrenergic drugs by high-performance liquid chromatography after chiral derivatization.
Topics: Chemical Phenomena; Chemistry; Chromatography, High Pressure Liquid; Humans; Hypertension; Propranol | 1985 |
[Effect of obzidan and pratsiol therapy on the blood plasma lipid profile and on the high- and low-density lipoprotein apoproteins in hypertension patients].
Topics: Adult; Apolipoproteins; Apolipoproteins A; Blood Pressure; Drug Evaluation; Humans; Hypertension; Li | 1985 |
A possible teratogenic effect of propranolol.
Topics: Abnormalities, Drug-Induced; Adult; Female; Humans; Hypertension; Infant, Newborn; Pregnancy; Pregna | 1985 |
[Therapeutic effect of nifedipine in the treatment of systemic hypertension].
Topics: Adult; Aged; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; | 1985 |
Pheochromocytoma--a rare cause of hypermagnesemia.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Female; Humans; Hypertension; Magnesium; Middle Aged; Pheoch | 1985 |
Inhibition of lecithin: cholesterol acyl transfer by propranolol treatment in man.
Topics: Cholesterol Esters; Cholesterol, HDL; Glycerol; Humans; Hypertension; Lipoproteins; Male; Phosphatid | 1985 |
Experimental analysis of adherence counseling: implications for hypertension management.
Topics: Adult; Behavior Therapy; Blood Pressure; Body Weight; Counseling; Follow-Up Studies; Humans; Hydroch | 1985 |
[Experiences with propranolol (Obsidan25) in hypertension therapy in pregnancy].
Topics: Blood Pressure; Dihydralazine; Female; Heart Rate; Humans; Hypertension; Infant, Newborn; Kinetics; | 1985 |
Acute aortic dissection.
Topics: Acute Disease; Aged; Aorta, Thoracic; Aortic Dissection; Aortography; Drug Therapy, Combination; Fem | 1985 |
Platelet adhesion in hyperlipidemic and hypertensive patients.
Topics: Adult; Arteriosclerosis; Atenolol; Humans; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinem | 1985 |
[Various effects of obsidan on central hemodynamics].
Topics: Adolescent; Adult; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Myocardial Contrac | 1985 |
[Hypertension in rats caused by metyrapone and heat-stress treatment].
Topics: Animals; Brain; Disease Models, Animal; Dopamine; Hot Temperature; Hypertension; Male; Metyrapone; P | 1985 |
Post-exertion changes in left ventricular systolic time intervals in patients with primary hypertension treated with hydrochlorothiazide, binazine, and propranolol.
Topics: Adult; Aged; Female; Heart Ventricles; Humans; Hydrazines; Hydrochlorothiazide; Hypertension; Male; | 1985 |
Twice-daily propranolol treatment for hypertension.
Topics: Administration, Oral; Humans; Hypertension; Propranolol; Time Factors | 1971 |
Unusual presentation of thyrocardiac disease.
Topics: Aged; Atrial Fibrillation; Carbimazole; Cardiovascular Diseases; Electrocardiography; Female; Heart | 1971 |
Adrenergic blockade in hypertension.
Topics: Amides; Animals; Dogs; Humans; Hypertension; Indoles; Phenoxybenzamine; Piperidines; Propranolol; Va | 1972 |
Propranolol and plasma-renin.
Topics: Cardiac Output; Catecholamines; Cold Temperature; Humans; Hypertension; Propranolol; Renin; Time Fac | 1973 |
Letter: Withdrawal of antihypertensive therapy.
Topics: Blood Pressure; Clonidine; Humans; Hypertension; Phentolamine; Propranolol | 1974 |
Phaeochromocytoma with catecholamine cardiomyopathy successfully treated surgically.
Topics: Acetanilides; Adrenergic beta-Antagonists; Amino Alcohols; Cardiomyopathies; Catecholamines; Central | 1972 |
[Current drugs. Therapy using -blockaders ( -adrenolytics)].
Topics: Acetanilides; Adrenergic beta-Antagonists; Alprenolol; Amino Alcohols; Angina Pectoris; Arrhythmias, | 1973 |
Hyperosmolar nonketotic diabetic coma: a complication of propranolol therapy.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Diabetes Complications; Diabetes Mellitus; Diabet | 1973 |
Management of severe hypertension.
Topics: Benzothiadiazines; Blood Pressure; Clonidine; Diazoxide; Diet, Sodium-Restricted; Disseminated Intra | 1973 |
Beta adrenergic blocking drugs. Present position and future development.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Blood Pressure; Cardiac Output; | 1972 |
Combined treatment of hypertension with vasodilatation and beta-adrenergic blockade.
Topics: Adrenergic beta-Antagonists; Adult; Drug Therapy, Combination; Female; Humans; Hydralazine; Hyperten | 1973 |
Beta-adrenergic blockade and plasma renin activity in borderline hypertension.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Blood Pressure; Circadian Rhythm; Dopamine; Electroc | 1973 |
[Pharmacological basis of the symptomatic treatment of arterial hypertension. I. Hemodynamic effects, mechanisms of action and side effects of antihypertensive agents].
Topics: Angiotensin II; Antihypertensive Agents; Blood Pressure; Clonidine; Diazoxide; Diuretics; Ganglionic | 1973 |
[Experience in the treatment of hypertensive states with beta-blockaders].
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Humans; Hypertension; Hypertension, Renal; Mid | 1973 |
Beta-adrenergic blocking drugs in anaesthesia.
Topics: Adrenergic beta-Antagonists; Anesthesia; Angina Pectoris; Arrhythmias, Cardiac; Cardiac Output; Card | 1973 |
[Beta-blockaders in hypertension].
Topics: Adrenergic beta-Antagonists; Alprenolol; Drug Therapy, Combination; Humans; Hydralazine; Hypertensio | 1973 |
[Letter: Beta blockaders yet again].
Topics: Adrenergic beta-Antagonists; Alprenolol; Humans; Hypertension; Propranolol | 1973 |
Letter: Beta-blocking drugs.
Topics: Adrenergic beta-Antagonists; Humans; Hypertension; Pindolol; Propranolol | 1973 |
Editorial: Adverse reactions to beta-adrenergic blockade.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Bradycardia; Cardiovascular Diseases; Humans; Hy | 1974 |
[Combination of beta blockaders with vasodilator substances in hypertension].
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Drug Therapy, Combination; Humans; Hydralazine | 1974 |
Sympathectomy for hypertension.
Topics: Adrenergic beta-Antagonists; Aldosterone; Angiotensin II; Diuretics; Guanethidine; Humans; Hypertens | 1974 |
Drug combinations as rational antihypertensive therapy.
Topics: Administration, Oral; Antihypertensive Agents; Diuretics; Drug Therapy, Combination; Ganglionic Bloc | 1974 |
[Pharmacology of antihypertensive agents (author's transl)].
Topics: Antihypertensive Agents; Blood Pressure; Bretylium Compounds; Diuretics; Evaluation Studies as Topic | 1974 |
Potentiation of the antihypertensive action of hydralazine by timolol in spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Drug Synergism; Heart Rate; Hydralazine; Hyper | 1974 |
Effects of alpha and beta blockers on hemodynamics of SHR.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Cardiac Output; | 1974 |
Letter: Beta-blockade in the presence of renal disease and hypertension.
Topics: Acute Kidney Injury; Adrenergic beta-Antagonists; Humans; Hypertension; Kidney; Oxprenolol; Proprano | 1974 |
Editorial: The pharmacology and therapeutic use of beta-adrenergic receptor blocking drugs in cardiovascular disease.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Arrhythmias, Cardiac; Cardiovascular Disea | 1974 |
A standard approach to therapy.
Topics: Blood Pressure; Clonidine; Diuretics; Drug Therapy, Combination; Ganglionic Blockers; Guanethidine; | 1974 |
Adrenolytic and vasodilator therapy.
Topics: Adrenergic beta-Antagonists; Benzyl Compounds; Blood Circulation; Cardiac Output; Clonidine; Diazoxi | 1974 |
Letter: Beta-adrenergic blocking agents in renal failure.
Topics: Adrenergic beta-Antagonists; Creatinine; Glomerulonephritis; Humans; Hypertension; Kidney Diseases; | 1974 |
Beta blockers in hypertension.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Bendroflumethiazide; Diuretics; Drug Therapy, | 1973 |
Effects of prolonged treatment with adrenergic beta-receptor antagonists on blood pressure, cardiovascular design and reactivity in spontaneously hypertensive rats (SHR).
Topics: Administration, Oral; Adrenergic beta-Antagonists; Animals; Blood Pressure; Depression, Chemical; Di | 1974 |
Beta-blockade for hypertension.
Topics: Adrenergic beta-Antagonists; Alprenolol; Antihypertensive Agents; Humans; Hypertension; Oxprenolol; | 1974 |
A new beta-adrenergic receptor blocking agent, H 56/28, in the treatment of cardiac arrhythmias.
Topics: Atrial Fibrillation; Blood Pressure; Cardiac Complexes, Premature; Electric Countershock; Female; Hu | 1967 |
The heart in hypertension.
Topics: Heart; Humans; Hypertension; Propranolol | 1968 |
[Observations on the effect of a beta-receptor blocking agent in autonomic heart and circulatory disorders].
Topics: Adult; Arrhythmias, Cardiac; Blood Pressure; Cardiac Complexes, Premature; Electrocardiography; Fema | 1967 |
[On the drug therapy of ergotropic sympathicotonic cardiovascular disorders].
Topics: Adult; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Cardiac Output; Cardiovascular Diseases; | 1967 |
Treatment of sympathetic overactivity in tetanus.
Topics: Adult; Aged; Anesthesia, General; Arrhythmias, Cardiac; Blood Pressure; Cardiovascular Diseases; Chi | 1969 |
Congestive and hypertrophic cardiomyopathies. A decade of study.
Topics: Blood Pressure; Cardiomegaly; Coronary Disease; Death, Sudden; Dilatation; Female; Heart Diseases; H | 1970 |
A new approach to the treatment of hypertension.
Topics: Antihypertensive Agents; Cardiac Output; Ethanolamines; Humans; Hypertension; Propranolol | 1970 |
Changes in glomerular filtration rate during long-term treatment with propranolol in patients with arterial hypertension.
Topics: Adult; Blood Pressure; Chromium Isotopes; Depression, Chemical; Edetic Acid; Female; Glomerular Filt | 1973 |
[Effect of an adrenergic beta receptor inhibitor (propranolol) on arterial hypertension induced by carotid sinus denervation and vagotomy in dogs].
Topics: Animals; Blood Pressure; Cardiac Output; Carotid Sinus; Dogs; Heart Rate; Hypertension; Propranolol; | 1973 |
Propranolol given twice daily in hypertension.
Topics: Administration, Oral; Adult; Blood Pressure; Depression, Chemical; Dose-Response Relationship, Drug; | 1973 |
Malignant pheochromocytoma in a child: treatment with a combination of alpha- and beta-adrenergic blockade.
Topics: Adrenal Gland Neoplasms; Cardiomegaly; Child; Drug Synergism; Female; Humans; Hypertension; Lymphati | 1968 |
[On the importance of the formation of metabolites for the blood pressure-lowering effect of alpha-methyldopa].
Topics: Blood Pressure; Catecholamines; Hypertension; Isoproterenol; Methyldopa; Propranolol | 1967 |
[On some cardiocirculatory effects of ketamine in chloralose-treated dogs].
Topics: Anesthetics; Animals; Chloralose; Cyclohexanes; Dogs; Epinephrine; Heart; Hemodynamics; Hypertension | 1971 |
[Pathogenesis and therapy of tetanus].
Topics: Diazepam; Heart Arrest; Humans; Hypertension; Muscle Cramp; Neuromuscular Nondepolarizing Agents; Pr | 1970 |
Recognizing and treating muscular subaortic stenosis.
Topics: Aged; Amyl Nitrite; Angiography; Aortic Valve; Blood Pressure; Cardiac Catheterization; Cardiomegaly | 1973 |
Minoxidil--an alternative to nephrectomy for refractory hypertension.
Topics: Adult; Antihypertensive Agents; Arrhythmias, Cardiac; Blood Pressure; Cardiomegaly; Diuretics; Elect | 1973 |
The "natural" history of severe angina pectoris with intensive medical therapy alone: a five year prospective study of 133 patients.
Topics: Adult; Aged; Aging; Angina Pectoris; Atrial Fibrillation; Cardiomegaly; Cerebrovascular Disorders; D | 1974 |
[Decreasing effect of propranolol on hypertension induced by potassium cyanide in dogs].
Topics: Animals; Blood Pressure; Chemoreceptor Cells; Cyanides; Dogs; Drug Antagonism; Hypertension; Hypoxia | 1974 |
Aspects of the relation between functional and structural cardiovascular factors in primary hypertension. Experimental studies in spontaneously hypertensive rats.
Topics: Animals; Aorta; Blood Pressure; Capillary Resistance; Cardiac Output; Cardiomegaly; Coronary Circula | 1974 |
[Effects of venom of the scorpion Androctonus mauretanious on electrocardiogram of rats].
Topics: Animals; Atropine; Bradycardia; Electrocardiography; Epinephrine; Heart; Heart Block; Hypertension; | 1974 |
Catecholamine-releasing agent recovered from plasma of subjects with arterial hypertension.
Topics: Adrenal Glands; Adrenalectomy; Angiotensin II; Animals; Catecholamines; Dogs; Humans; Hypertension; | 1970 |
[Essential hypertension: biochemical analysis--selective treatment].
Topics: Aldosterone; Angiotensin II; Humans; Hypertension; Propranolol; Renin; Sodium | 1973 |
Editorial: New knowledge of benign essential hypertension.
Topics: Age Factors; Aldosterone; Angiotensin II; Antihypertensive Agents; Blood Pressure; Ethnicity; Humans | 1973 |
Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles.
Topics: Aldosterone; Angiotensin II; Arteries; Blood Pressure; Diuretics; Humans; Hyperaldosteronism; Hypert | 1973 |
Hormonal profiling in the diagnosis and treatment of essential hypertension.
Topics: Adult; Aldosterone; Angiotensin II; Contraceptives, Oral; Female; Humans; Hyperaldosteronism; Hypert | 1974 |
Hypertension: selection of treatment in relation to the mechanisms raising blood pressure.
Topics: Angiotensin II; Antihypertensive Agents; Blood Pressure; Diuretics; Humans; Hyperaldosteronism; Hype | 1973 |
Adolescent hypertension. II. Characteristics and response to treatment.
Topics: Adolescent; Adult; Angiotensin II; Black or African American; Female; Humans; Hydralazine; Hypertens | 1974 |
Differential effects of propranolol on heart rate and plasma renin activity in patients treated with minoxidil.
Topics: Adult; Aged; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Creatinine; Dogs; Dos | 1974 |
The treatment of hypertension by beta adrenergic blocking drugs.
Topics: Antihypertensive Agents; Ergot Alkaloids; Ethanolamines; Guanethidine; Humans; Hypertension; Isoprot | 1966 |
Hemodynamics of renal arterial diseases and hypertension.
Topics: Adult; Arteries; Arteriosclerosis; Blood Pressure; Blood Volume; Cardiac Output; Female; Ganglionic | 1968 |
[Studies on the antihypertensive effect of beta-receptor-blocking agents].
Topics: Ethanolamines; Humans; Hypertension; Propranolol; Sympatholytics; Time Factors | 1968 |
Influence of antiadrenergic measures on the blood catecholamine level in protracted intracranial hypertension.
Topics: Adrenalectomy; Analysis of Variance; Animals; Blood Pressure; Cerebrovascular Disorders; Dogs; Elect | 1969 |
[Influence of hypocapnic gaseous alkalosis on beta effects of sympathomimetics].
Topics: Acid-Base Equilibrium; Alkalosis; Anesthesia; Animals; Blood Pressure; Carbon Dioxide; Dogs; Ephedri | 1969 |
[Catecholamine determination. Sensitization of "acute amyelic dog" to hypertensive actions of catecholamines after inhibition of beta receptors by pronetalol or propranolol].
Topics: Animals; Biological Assay; Blood Pressure; Catecholamines; Dogs; Epinephrine; Ethanolamines; Hyperte | 1969 |
Propranolol as an antihypertensive agent.
Topics: Adrenergic alpha-Antagonists; Antihypertensive Agents; Cardiac Output; Humans; Hypertension; Physica | 1970 |
Treatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade.
Topics: Adrenergic alpha-Antagonists; Adult; Aldosterone; Antihypertensive Agents; Blood Pressure; Cardiac O | 1970 |
Studies of the effect of beta-adrenergic blockade on abnormal R-ST segment and T-wave changes.
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Atrial Fibrillation; Bundle-Branch Block; Catec | 1970 |
Vasodilation in treatment of hypertension.
Topics: Adrenergic beta-Antagonists; Cardiac Output; Heart; Humans; Hypertension; Propranolol; Sympatholytic | 1970 |
Vasodilation in treatment of hypertension.
Topics: Adrenergic beta-Antagonists; Cardiac Output; Hemodynamics; Humans; Hypertension; Propranolol; Sympat | 1970 |
[Beta-adrenergic receptor blocking agents].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Humans; Hypertension; Propranolo | 1970 |
The medical treatment of hypertension.
Topics: Antihypertensive Agents; Chlorothiazide; Diet Therapy; Emergencies; Furosemide; Ganglionic Blockers; | 1970 |
Hemodynamic responses to tilt and beta-adrenergic blockade in young patients with borderline hypertension.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Age Factors; Blood Pressure; Body Height; Body Weigh | 1970 |
[Comparative studies on the effect of 2 beta receptor blockaders on elevated blood pressure and kidney function].
Topics: 1-Propanol; Adrenergic beta-Antagonists; Amino Alcohols; Blood Pressure; Humans; Hypertension; Kidne | 1969 |
Beta-blockers in hypertension.
Topics: Acetanilides; Adrenergic beta-Antagonists; Amino Alcohols; Heart; Humans; Hypertension; Propranolol; | 1970 |
[The ECG tracing of hypertensive patients treated with beta-blocking drugs].
Topics: Adrenergic beta-Antagonists; Electrocardiography; Heart; Hemodynamics; Humans; Hypertension; Propran | 1970 |
[Effect of beta-adrenergic block on regional circulation].
Topics: Adrenergic beta-Antagonists; Hemodynamics; Humans; Hypertension; Propranolol; Regional Blood Flow; S | 1970 |
The drug treatment of hypertension.
Topics: Aniline Compounds; Antihypertensive Agents; Cardiac Output; Diuretics; Ganglionic Blockers; Guanethi | 1971 |
Plasma volume changes with long-term beta-adrenergic blockade.
Topics: Adrenergic beta-Antagonists; Blood Volume; Blood Volume Determination; Cardiac Output; Hemodynamics; | 1971 |
The effect of chronic adrenergic receptor blockade on plasma renin activity in man.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Blood Pressure; Diet, Sodium-Restricted; Humans; | 1972 |
Analysis of the central receptors concerned in the cardiovascular response induced by intracerebroventricular aconitine.
Topics: Adrenalectomy; Adrenergic beta-Antagonists; Alkaloids; Alkalosis; Animals; Arrhythmias, Cardiac; Atr | 1972 |
Combined therapy with vasodilator drugs and beta-adrenergic blockade in hypertension. A comparative study of minoxidil and hydralazine.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Body Weight; Cardiac Output; Female; Fu | 1972 |
Treatment of essential hypertension with combined vasodilation and beta-adrenergic blockade.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Diuretics; Female; G | 1972 |
Hyperdynamic circulation and hypertension.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Cardiac Output; Heart Rate; Hemodynamics; Humans; Hyper | 1972 |
[Comparison of the hemodynamic effects in man of 2 beta-blockaders: propranolol and practolol].
Topics: Acetanilides; Adrenergic beta-Antagonists; Amino Alcohols; Blood Pressure; Cardiac Output; Coronary | 1972 |
Bilateral phaeochromocytoma in two brothers.
Topics: Adolescent; Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Chil | 1972 |
Mechanism of beta-blockade hypotension.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Cardiac Output; Humans; Hypert | 1972 |
Antihypertensive activity of four blocking agents in spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Antihypertensive Agents; Blood Pressure; Clonidine | 1972 |
Clinical experiences with prindolol (Visken) in the therapy of hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Bradycardia; Female; Humans; Hypertension; Indoles; Male; Middle | 1972 |
[What is assured in treatment with beta receptor blockaders?].
Topics: Acetanilides; Adrenergic beta-Antagonists; Alprenolol; Amino Alcohols; Cresols; Heart Diseases; Huma | 1972 |
Role of central and peripheral adrenergic mechanisms in neurogenic hypertension produced by brainstem lesions in rat.
Topics: Adrenalectomy; Animals; Blood Pressure; Brain; Cardiac Output; Central Nervous System; Heart Rate; H | 1974 |
The management of essential hypertension.
Topics: Antihypertensive Agents; Benzyl Compounds; Debrisoquin; Diazoxide; Diuretics; Guanidines; Humans; Hy | 1974 |
Beta-blocking therapy: Propranolol.
Topics: Cardiac Output; Central Nervous System; Drug Therapy, Combination; Furosemide; Humans; Hydralazine; | 1974 |
Dialysis and volume control.
Topics: Humans; Hydralazine; Hypertension; Minoxidil; Nephrectomy; Propranolol; Renal Dialysis; Sodium; Ultr | 1974 |
Modern concepts in diuretic therapy.
Topics: Blood Volume; Creatinine; Diuretics; Drug Therapy, Combination; Humans; Hyperaldosteronism; Hyperten | 1974 |
Current concepts in the treatment of hypertension.
Topics: Age Factors; Blood Pressure; Diuretics; Humans; Hypertension; Propranolol | 1974 |
Cardioadrenergic factor in essential hypertension.
Topics: Adult; Atropine; Blood Pressure; Cardiac Output; Electrocardiography; Female; Heart; Heart Rate; Hea | 1974 |
Propranolol in the treatment of hypertension in Asians.
Topics: Chlorothiazide; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Methyldopa; Propranol | 1974 |
Pharmacokinetics of oral propranolol in chronic renal disease.
Topics: Female; Half-Life; Hematocrit; Humans; Hypertension; Kidney Failure, Chronic; Male; Propranolol; Rad | 1974 |
Essential hypertension in adolescents.
Topics: Adolescent; Adult; Antihypertensive Agents; Child; Contraceptives, Oral, Synthetic; Diet, Sodium-Res | 1974 |
Practical office management of chronic hypertension.
Topics: Antihypertensive Agents; Drug Therapy, Combination; Guanethidine; Humans; Hydralazine; Hydrochloroth | 1974 |
Dissection of the thoracic aorta. Medical or surgical therapy?
Topics: Adult; Aged; Aorta, Thoracic; Aortic Aneurysm; Aortic Valve Insufficiency; Autonomic Agents; Blood P | 1974 |
Corticosteroids in ventricular tachycardia.
Topics: Adult; Aged; Coronary Disease; Dexamethasone; Female; Heart Ventricles; Humans; Hypertension; Inject | 1974 |
The effect of chemical sympathectomy on vascular responses in spontaneously hypertensive rats.
Topics: Animals; Aorta; Atropine; Blood Pressure; Cocaine; Denervation; Dose-Response Relationship, Drug; Hy | 1974 |
[Hypotensive effect of propranolol and its effect on the blood circulation and respiration].
Topics: Cardiovascular System; Drug Evaluation; Humans; Hypertension; Hypertension, Renal; Propranolol; Resp | 1974 |
[Treatment of arterial hypertension with the Soviet-made beta-blockader anaprilin].
Topics: Adolescent; Adult; Cardiac Output; Humans; Hypertension; Hypertension, Renal; Middle Aged; Propranol | 1974 |
Heart rate after acute hypertension in the rat.
Topics: Animals; Aorta; Atropine; Blood Pressure; Carotid Arteries; Constriction; Electrocardiography; Heart | 1974 |
[Treatemtn of arterial hypertension with the combination of hydralazine and propranolol].
Topics: Adult; Aged; Blood Pressure; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; M | 1974 |
[Treatment of arterial hypertension with the combination of hydralazine and propranolol].
Topics: Adult; Aged; Blood Pressure; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; M | 1974 |
Editorial: Frusemide.
Topics: Ethacrynic Acid; Furosemide; Hypertension; Kidney Failure, Chronic; Loop of Henle; Potassium; Propra | 1974 |
The effect of guanethidine and propranolol on capillary blood flow in subcutaneous tissue and muscle in essential hypertension.
Topics: Adult; Aged; Blood Pressure; Capillaries; Depression, Chemical; Dose-Response Relationship, Drug; Gu | 1974 |
Pheochromocytoma. Diagnosis, management and follow-up in twenty patients.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Adult; Age Factors; Blood Pressure; Catheterization; Epinep | 1974 |
Hypertension with renal impairment: influence of intensive therapy.
Topics: Adolescent; Adult; Chronic Disease; Creatinine; Diazoxide; Female; Glomerulonephritis; Humans; Hyper | 1974 |
[The propranolol-dihydralazine combination in the therapy of systemic arterial hypertension].
Topics: Adult; Drug Combinations; Drug Evaluation; Female; Humans; Hydralazine; Hypertension; Male; Middle A | 1974 |
[Treatment of arterial hypertension with propranolol: our experience].
Topics: Clonidine; Drug Therapy, Combination; Humans; Hypertension; Propranolol | 1974 |
Neurogenic maintenance of peripheral resistance in borderline hypertension.
Topics: Adolescent; Adult; Atropine; Blood Pressure; Cardiac Output; Heart Rate; Hemodynamics; Humans; Hyper | 1974 |
[Arterial hypertension evolving in certain obstructive cardiomyopathies: 10 cases].
Topics: Adolescent; Adult; Antihypertensive Agents; Cardiomyopathy, Hypertrophic; Diet, Sodium-Restricted; D | 1974 |
[Proceedings: Effect of propranolol on plasma renin activity in hypertension].
Topics: Humans; Hypertension; Propranolol; Renin | 1974 |
[Hyperdynamic beta-adrenergic circulatory state with markedly labile hypertension (author's transl)].
Topics: Blood Pressure; Female; Humans; Hypertension; Middle Aged; Nervous System Diseases; Propranolol; Rec | 1974 |
Current medical practice and the Food and Drug Administration. Some evidence for the existing gap.
Topics: Adult; Aged; Allopurinol; Angina Pectoris; Cephalexin; Child; Colchicine; Diuretics; Drug Labeling; | 1974 |
Editorial: Hypertension and depression and their treatment.
Topics: Animals; Antidepressive Agents; Antihypertensive Agents; Clonidine; Depression; Humans; Hypertension | 1973 |
Prindolol in the management of hypertension.
Topics: Adult; Antihypertensive Agents; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Pindo | 1974 |
The use of propranolol with various drug combinations in the treatment of essential hypertension.
Topics: Adult; Aged; Ambulatory Care; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle | 1974 |
Propranol in hypertension.
Topics: Blood Pressure; Cardiac Output; Humans; Hypertension; Propranolol; Pulse; Stress, Psychological | 1972 |
Plasma volume and extracellular fluid volume during long-term treatment with propranolol in essential hypertension.
Topics: Adult; Aged; Blood Pressure; Bromine; Dye Dilution Technique; Electrocardiography; Extracellular Spa | 1972 |
Hemodynamics in essential hypertension.
Topics: Adult; Cardiac Output; Dye Dilution Technique; Hemodynamics; Humans; Hypertension; Norepinephrine; P | 1973 |
Autonomic complications in a case of severe tetanus.
Topics: Aged; Blood Pressure; Central Venous Pressure; Curare; Electric Stimulation; Heart Rate; Humans; Hyp | 1974 |
[Value of polycardiographic tests and radiocardiography for the recognition of hidden heart failure in hypertensive patients].
Topics: Adolescent; Adult; Coronary Disease; Female; Heart Ventricles; Humans; Hypertension; Iodine Radioiso | 1972 |
The maintenance of the circulation during anaesthesia in patients with phaeochromocytoma.
Topics: Adolescent; Adult; Anesthesia, General; Anesthetics; Arrhythmias, Cardiac; Chlorprothixene; Female; | 1972 |
The effect of D- and DL-propranolol on blood pressure and cerebral norepinephrine in rats with DOCA-hypertension.
Topics: Animals; Blood Pressure; Brain; Brain Chemistry; Desoxycorticosterone; Heart Rate; Hypertension; Iso | 1972 |
Further studies with propranolol in psychotic patients. Relation to initial psychiatric state, urinary catecholamines and 3-methoxy-4-hydroxyphenylglycol excretion.
Topics: Acute Disease; Adult; Ataxia; Catecholamines; Chronic Disease; Female; Glycols; Humans; Hypertension | 1972 |
[Pnopanolol in a 2 dose regimen in cases of hypertension].
Topics: Administration, Oral; Adult; Female; Humans; Hydralazine; Hypertension; Male; Middle Aged; Propranol | 1972 |
[Use of propranolol in treatment of hypertension].
Topics: Humans; Hypertension; Propranolol | 1972 |
Renin-like activity in submaxillary gland in several strains of rats including the spontaneously hypertensive rat.
Topics: Aging; Animals; Blood Pressure; Female; Hypertension; Kidney; Male; Nephrectomy; Propranolol; Rats; | 1972 |
[Hemodynamics and anti-hypertensive treatment].
Topics: Antihypertensive Agents; Clonidine; Diuretics; Guanethidine; Hemodynamics; Humans; Hypertension; Met | 1972 |
B(ureaucratic) block of propranolol.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Humans; Hypertension; Propranolol; United States; United Stat | 1973 |
The use of propranolol in the treatment of hypertension.
Topics: Aged; Humans; Hypertension; Middle Aged; Propranolol | 1973 |
Cardiovascular function and survival during severe systemic hypoxaemia: influence of glucose-potassium-insulin solution and of beta-blockade.
Topics: Animals; Blood Circulation; Blood Glucose; Dogs; Glucose; Hypertension; Hypoxia; Insulin; Potassium; | 1973 |
Beta-blockers in the treatment of hypertension.
Topics: Diuretics; Humans; Hypertension; Myocardium; Propranolol | 1973 |
[General practitioners test propranolol (Inderal) in cases of hypertension].
Topics: Adult; Aged; Family Practice; Female; Humans; Hypertension; Male; Middle Aged; Propranolol | 1973 |
Effects of clonidine withdrawal: possible mechanisms and suggestions for management.
Topics: Blood Pressure; Catecholamines; Clonidine; Epinephrine; Heart Rate; Humans; Hypertension; Injections | 1973 |
Role of central blood volume in hyperkinetic borderline hypertension.
Topics: Adolescent; Adult; Atropine; Autonomic Nervous System; Blood Pressure; Blood Volume; Cardiac Output; | 1973 |
Propranolol--new uses.
Topics: Angina Pectoris; Aortic Valve Stenosis; Arrhythmias, Cardiac; Heart Diseases; Humans; Hyperparathyro | 1973 |
[Mechanism of the antihypertensive action of propranolol].
Topics: Adult; Blood Pressure; Cardiac Output; Cardiac Volume; Female; Heart Rate; Humans; Hypertension; Mal | 1973 |
Vasodilation for vasospastic hypertension.
Topics: Diuretics; Humans; Hypertension; Hypertension, Malignant; Minoxidil; Propranolol; Vascular Resistanc | 1973 |
Evaluation of amiloride combined with hydrochlorothiazide (Moduretic) in the treatment of hypertension.
Topics: Adult; Aged; Amiloride; Benzothiadiazines; Diuretics; Drug Combinations; Female; Guanethidine; Human | 1973 |
Acute intermittent porphyria: response of tachycardia and hypertension to propranolol.
Topics: 5-Aminolevulinate Synthetase; Abdomen, Acute; Adolescent; Adult; Antihypertensive Agents; Blood Pres | 1973 |
Adverse reactions to propranolol in hospitalized medical patients: a report from the Boston Collaborative Drug Surveillance Program.
Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Blood Pressure; Boston; Evaluation Studies as To | 1973 |
Antihypertensive action of propranolol. Specific antirenin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertension.
Topics: Adult; Aged; Aldosterone; Antihypertensive Agents; Blood Pressure; Child; Female; Humans; Hypertensi | 1973 |
Hypertension.
Topics: Antihypertensive Agents; Body Weight; Clonidine; Humans; Hypertension; Methyldopa; Propranolol; Smok | 1973 |
Chronic propranolol treatment in young spontaneously hypertensive and normotensive rats.
Topics: Adrenal Glands; Animals; Blood Pressure; Body Weight; Heart; Heart Rate; Hypertension; Kidney; Male; | 1973 |
Long-term medical management of hypertension--an overview.
Topics: Antihypertensive Agents; Diuretics; Humans; Hypertension; Propranolol | 1973 |
[The effect of beta-adrenergic blocking agents on plasma renin activity (author's transl)].
Topics: Adult; Humans; Hypertension; Male; Pindolol; Posture; Propranolol; Renin | 1973 |
The examination of intrinsic heart rate in the differential diagnosis of hyperthyroidism and vegetative dystonia, in hypertension and in congestive heart failure due to coronary sclerosis.
Topics: Adolescent; Adult; Age Factors; Aged; Atropine; Child; Coronary Disease; Diagnosis, Differential; Dy | 1973 |
[A beta blocking agent as an antihypertensive agent].
Topics: Aged; Alprenolol; Drug Evaluation; Female; Humans; Hypertension; Male; Middle Aged; Pindolol; Practo | 1973 |
[Ambulatory antihypertensive therapy using the beta-receptor blockader obsidan].
Topics: Adolescent; Adult; Aged; Blood Pressure; Cardiac Output; Female; Heart Rate; Humans; Hypertension; M | 1973 |
[Propranolol and renin activity. New aspects on effects of beta blockaders in arterial hypertension].
Topics: Blood Pressure; Depression, Chemical; Hypertension; Propranolol; Renin | 1973 |
Autonomic and non-autonomic circulatory components in essential hypertension in man.
Topics: Adolescent; Adult; Atropine; Autonomic Nervous System; Blood Pressure; Body Surface Area; Cardiac Ou | 1973 |
[Therapeutic effect of inderal in the initial stage of hypertensive disease].
Topics: Adolescent; Adult; Catecholamines; Female; Hemodynamics; Humans; Hypertension; Kidney; Male; Middle | 1973 |
[Hemodynamics in patients with early stages of hypertonic disease and its change during inderal treatment].
Topics: Adolescent; Adult; Blood Pressure; Cardiac Output; Female; Hemodynamics; Humans; Hypertension; Male; | 1973 |
[Propranolol therapy of juvenile hypertension].
Topics: Adolescent; Adult; Age Factors; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Male; Prop | 1973 |
Drugs used in the treatment of hypertension.
Topics: Administration, Oral; Antihypertensive Agents; Clonidine; Diazoxide; Diuretics; Ethacrynic Acid; Fer | 1973 |
[Hypertensive leg ulcer--myth or reality?].
Topics: Aged; Antihypertensive Agents; Female; Humans; Hydralazine; Hypertension; Leg Ulcer; Male; Methyldop | 1973 |
[Treatment of periodic hemodialysis-induced arterial hypertension by propranolol. Preliminary note].
Topics: Adolescent; Glomerulonephritis; Humans; Hypertension; Male; Propranolol; Proteinuria; Renal Dialysis | 1973 |
[Inhibition of pressor reflex reactions by propranolol].
Topics: Animals; Blood Pressure; Chloralose; Dogs; Electric Stimulation; Gallamine Triethiodide; Hypertensio | 1973 |
Clinical experience with propranolol in hypertension.
Topics: Administration, Oral; Adult; Antihypertensive Agents; Drug Therapy, Combination; Female; Humans; Hyp | 1973 |
Systemic and renal haemodynamics during antihypertensive treatment with propranolol.
Topics: Blood Pressure; Cardiac Output; Hemodynamics; Humans; Hypertension; Kidney; Myocardial Infarction; P | 1973 |
[Reduction by propranolol of hypertension induced by dephrenation in the dog].
Topics: Animals; Cardiac Output; Denervation; Disease Models, Animal; Dogs; Heart Rate; Hypertension; Phreni | 1973 |
On the mechanism of suppressed plasma-renin activity during beta-adrenergic blockade with propranolol.
Topics: Adult; Aldosterone; Diet, Sodium-Restricted; Diuretics; Female; Humans; Hypertension; Injections, In | 1974 |
Pheochromocytoma in pregnancy: a case report and review of the pathophysiology.
Topics: Adrenal Gland Neoplasms; Adult; Catecholamines; Cesarean Section; Epinephrine; Female; Heart Arrest; | 1974 |
Barium-induced skeletal muscle paralysis in the rat, and its relationship to human familial periodic paralysis.
Topics: Adrenal Glands; Animals; Arrhythmias, Cardiac; Barium; Calcium; Female; Hypertension; Hypokalemia; I | 1974 |
Proceedings: Recurrent pheochromocytoma.
Topics: Abdominal Neoplasms; Adolescent; Adrenal Gland Neoplasms; Adult; Child; Epinephrine; Female; Hormone | 1974 |
Trial of propranolol in hypertension.
Topics: Blood Pressure Determination; Home Nursing; Humans; Hypertension; Propranolol; Time Factors | 1974 |
[New trends in the diagnosis, prognosis and treatment of hypertension].
Topics: Dexamethasone; Guanethidine; Humans; Hydralazine; Hypertension; Methyldopa; Prognosis; Propranolol; | 1974 |
Letter: Propranolol, hypoglycemia, and hypertensive crisis.
Topics: Diabetes Complications; Drug Synergism; Female; Humans; Hypertension; Hypoglycemia; Insulin; Middle | 1974 |
[Treatment of hypertension with propranolol].
Topics: Adolescent; Adult; Aged; Female; Humans; Hypertension; Male; Middle Aged; Propranolol | 1974 |
Editorial: Hypertension and the community.
Topics: Humans; Hypertension; Mass Screening; Middle Aged; Oxprenolol; Propranolol; Scotland | 1974 |
[Results of treatment of arterial hypertension with long-term administration of propranolol].
Topics: Adult; Aged; Drug Evaluation; Female; Humans; Hypertension; Male; Middle Aged; Propranolol; Time Fac | 1974 |
[Anti-hypertensive action of 3 drugs inhibiting the sympathetic nervous system. Hemodynamic and biological study].
Topics: Adult; Clonidine; Female; Hemodynamics; Humans; Hypertension; Male; Methyldopa; Middle Aged; Plasma | 1974 |
[Some thoughts on prevention of arterial hypertension: problems of borderline hypertension in young people (author's transl)].
Topics: Adolescent; Adult; Age Factors; Humans; Hypertension; Male; Pindolol; Propranolol | 1974 |
Propranalol--hydrochlorothiazide in systemic hypertension.
Topics: Adult; Aged; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Mid | 1974 |
[Clinical use of propranolol].
Topics: Alcoholism; Angina Pectoris; Aortic Aneurysm; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flut | 1974 |
Clinical usefulness of beta-adrenergic blocking agents.
Topics: Administration, Oral; Angina Pectoris; Aortic Aneurysm; Arrhythmias, Cardiac; Cardiomyopathy, Hypert | 1974 |
[Severe neurotic tachycardia treated with propranolol. Study of respiratory function and cardiac hemodynamics].
Topics: Adult; Diagnosis, Differential; Female; Hemodynamics; Humans; Hypertension; Hyperthyroidism; Male; N | 1968 |
Mechanisms of baroreceptor-induced changes in heart rate.
Topics: Animals; Atropine; Blood Pressure; Carotid Arteries; Carotid Sinus; Dogs; Heart; Heart Rate; Hyperte | 1970 |
[Obstructive cardiomyopathy in the aged (apropos of 5 cases)].
Topics: Age Factors; Aged; Angiocardiography; Cardiomyopathy, Hypertrophic; Electrocardiography; Female; Hum | 1970 |
[The 1st lead of the carotid sphygmogram in valvular and arterial heart diseases].
Topics: Adolescent; Adult; Aged; Amyl Nitrite; Aortic Valve Insufficiency; Aortic Valve Stenosis; Arterioscl | 1969 |
An internist looks at myocardial revascularization.
Topics: Angina Pectoris; Angiography; Chlordiazepoxide; Collateral Circulation; Coronary Disease; Diazepam; | 1971 |
[The long-term treatment of hypertension in 158 patients with propranonol].
Topics: Adult; Aged; Blood Pressure; Female; Humans; Hypertension; Long-Term Care; Male; Middle Aged; Postur | 1971 |
Clinical studies on apexcardiogram. II. Cardiac movement in thyroid dysfunction and coronary heart disease from the point of apexcardiogram.
Topics: Adolescent; Adult; Angina Pectoris; Arteriosclerosis; Coronary Disease; Electrocardiography; Female; | 1971 |
The effects of oral propranolol on the distensibility of resting superficial veins in man.
Topics: Administration, Oral; Humans; Hypertension; Propranolol; Veins | 1972 |
[Simultaneous sympathetic and parasympathetic blockade in the differential diagnosis of hyperthyroidism and vegetative dystonia].
Topics: Atropine; Coronary Disease; Diagnosis, Differential; Humans; Hypertension; Hyperthyroidism; Proprano | 1972 |
Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations.
Topics: Administration, Oral; Antihypertensive Agents; Blood Pressure; Cardiac Output; Drug Synergism; Follo | 1972 |
Distribution of cardioacceleratory sites in intermediolateral nucleus of the cat.
Topics: Adrenalectomy; Animals; Autonomic Fibers, Preganglionic; Blood Pressure; Cats; Electric Stimulation; | 1972 |
[Value of propranolol in the treatment of arterial hypertension].
Topics: Adult; Aged; Evaluation Studies as Topic; Female; Humans; Hypertension; Male; Middle Aged; Propranol | 1972 |
Management of dissecting aneurysm of the aorta.
Topics: Aorta, Thoracic; Aortic Aneurysm; Guanethidine; Humans; Hypertension; Methyldopa; Propranolol; Trime | 1972 |
New drugs for old. I. Hypertension and cardiac failure.
Topics: Angina Pectoris; Anti-Arrhythmia Agents; Diuretics; Heart Failure; Hypertension; Hypoglycemic Agents | 1972 |
Systemic haemodynamics in borderline arterial hypertension: responses to static exercise before and under the influence of propranolol.
Topics: Adult; Blood Pressure; Brachial Artery; Cardiac Output; Female; Heart Rate; Humans; Hypertension; In | 1972 |
Propranolol in hypertension: a study of long-term therapy, 1964-1970.
Topics: Blood Pressure; Diuretics; Female; Humans; Hypertension; Male; Middle Aged; Propranolol; Retrospecti | 1972 |
Relation of propranolol plasma level to beta-blockade during oral therapy.
Topics: Administration, Oral; Heart Rate; Humans; Hypertension; Isoproterenol; Propranolol; Receptors, Adren | 1972 |
Dependence of arterial pressure on intravascular volume in treated hypertensive patients.
Topics: Adult; Aged; Arteries; Blood Pressure; Female; Furosemide; Guanethidine; Humans; Hydrazines; Hydroch | 1972 |
Hemodynamic studies on hypertension. II. Effects of isoproterenol, propranolol, noradrenaline and phentolamine on the hemodynamics in essential hypertension.
Topics: Adult; Blood Pressure; Cardiac Output; Depression, Chemical; Female; Heart Rate; Hemodynamics; Human | 1972 |
[Effect of propranolol on DOCA-induced experimental hypertension in rats].
Topics: Animals; Blood Pressure; Body Weight; Cardiac Output; Desoxycorticosterone; Hematocrit; Hypertension | 1972 |
Effects of chronic beta-adrenergic blockade on systemic and renal haemodynamic responses to hyperosmotic saline in hypertensive patients.
Topics: Adult; Blood Volume; Cardiac Output; Cardiac Volume; Central Venous Pressure; Female; Hemodynamics; | 1972 |
Participation of central noradrenergic neurons in arterial baroreceptor reflexes in the rabbit. A study with intracisternally administered 6-hydroxydopamine.
Topics: Animals; Aorta; Atropine; Blood Pressure; Brain; Brain Chemistry; Carotid Sinus; Central Nervous Sys | 1972 |
Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases.
Topics: Adult; Aldosterone; Antihypertensive Agents; Blood Pressure; Depression, Chemical; Humans; Hypertens | 1972 |
Propranolol and polythiazide in treatment of hypertension.
Topics: Adult; Black or African American; Blood Pressure; Bronchial Spasm; Drug Synergism; Female; Hallucina | 1972 |
Propranolol in the treatment of hypertension.
Topics: Blood Pressure; Cold Temperature; Drive; Humans; Hypertension; Libido; Propranolol; Raynaud Disease; | 1971 |
Role of parasympathetic inhibition in the hyperkinetic type of borderline hypertension.
Topics: Adolescent; Adult; Atropine; Blood Circulation; Blood Pressure; Cardiac Output; Heart Rate; Humans; | 1971 |
[Arterial hypertension: etiology, diagnosis, treatment].
Topics: Adrenocortical Hyperfunction; Adult; Arteries; Diazoxide; Humans; Hyperaldosteronism; Hypertension; | 1971 |
[Changes in pulse, blood pressure, heart size and ECG following administration of practolol (ICI 50172)].
Topics: Acetanilides; Adult; Arrhythmias, Cardiac; Blood Pressure; Electrocardiography; Exercise Test; Heart | 1971 |
[Effects of Inderal in the treatment of uremic hypertension].
Topics: Adult; Allopurinol; Diabetic Coma; Drug Combinations; Drug Interactions; Female; Humans; Hydralazine | 1971 |
Hypertension and depression: interrelated problems in therapy.
Topics: Antidepressive Agents; Antihypertensive Agents; Depression; Humans; Hypertension; Methyldopa; Physic | 1971 |
[Hypertension therapy with propanolol and hydralazine].
Topics: Adult; Aged; Blood Pressure; Female; Humans; Hydralazine; Hypertension; Male; Middle Aged; Propranol | 1971 |
Treatment of hypertension with propranolol and hydralazine.
Topics: Adult; Creatinine; Drug Interactions; Fatigue; Female; Humans; Hydralazine; Hypertension; Male; Midd | 1971 |
[Studies on the antihypertensive effect of propranolol and oxprenolol in man].
Topics: Adult; Blood Pressure; Cardiac Output; Humans; Hypertension; Oxprenolol; Propranolol | 1971 |
Hypertension and hypertrophic subaortic stenosis.
Topics: Adult; Aged; Amyl Nitrite; Antihypertensive Agents; Aortic Valve; Cardiac Catheterization; Cardiac O | 1971 |
Physiological and clinical aspects of beta adrenergic blockade.
Topics: Angina Pectoris; Blood Glucose; Fatty Acids; Humans; Hypertension; Metabolism; Pheochromocytoma; Pro | 1967 |
Hypotensive, antiarrhythmic and chronotropic action of Trasicor (Ciba 39089--Ba).
Topics: Adult; Aged; Amino Alcohols; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Heart Diseases; H | 1968 |
[The mechanism of tachycardia and increased blood pressure following bilateral vagotomy in rats].
Topics: Animals; Atropine; Autonomic Nervous System; Blood Pressure; Cardiac Output; Heart Rate; Hypertensio | 1969 |
Evidence that the effect of beta-adrenergic blockade on the haemodynamic response of hypertensive patients to exercise is not solely rate-dependent.
Topics: Blood Pressure; Cardiac Output; Electrocardiography; Heart Rate; Humans; Hypertension; Physical Exer | 1969 |
The clinical significance of an ST-segment depression in the electrocardiogram. A seven-year longitudinal study.
Topics: Adult; Aged; Angina Pectoris; Blood Circulation; Body Weight; Cholesterol; Coronary Disease; Coronar | 1969 |
[Application of Inderal in hypertension during light anesthesia].
Topics: Adult; Aged; Anesthesia, General; Blood Pressure; Female; Halothane; Humans; Hypertension; Male; Mid | 1969 |
[Effects of beta adrenergic receptor blockaders studied with propranolol on the ventricular repolarizzation in patients with hypertensive heart disease and chronic coronary insufficiency].
Topics: Adult; Chronic Disease; Coronary Disease; Electrocardiography; Female; Heart Diseases; Heart Ventric | 1969 |
[Arterial hypertension: etiology, differential diagnosis, and therapy].
Topics: Adrenocortical Hyperfunction; Adult; Arteries; Diazoxide; Humans; Hyperaldosteronism; Hypertension; | 1969 |
[Data on the so-called sympathicotonic ECG].
Topics: Electrocardiography; Heart; Heart Diseases; Humans; Hypertension; Propranolol | 1970 |
Hemodynamic aspects of hypertension. Labile hypertension: the problem.
Topics: Adolescent; Adult; Blood Pressure; Cardiac Output; Female; Hemodynamics; Humans; Hypertension; Male; | 1970 |
Physiological comparison of labile and essential hypertension.
Topics: Blood Pressure; Cardiac Output; Diagnosis, Differential; Heart Rate; Humans; Hypertension; Infusions | 1970 |
Antihypertensive effect of nylidrin HCl.
Topics: Alcohols; Animals; Blood Pressure; Depression, Chemical; Desoxycorticosterone; Drug Antagonism; Hype | 1970 |
Vasodilation in treatment of hypertension.
Topics: Humans; Hydralazine; Hypertension; Piperidines; Propranolol; Pyrimidines; Vasodilator Agents | 1970 |
Vasodilation in treatment of hypertension.
Topics: Humans; Hydralazine; Hypertension; Piperidines; Propranolol; Pyrimidines; Vasodilator Agents | 1970 |
[Therapy with beta-receptor blocking agents in cardiology practice].
Topics: Adult; Arrhythmias, Cardiac; Female; Heart Diseases; Humans; Hypertension; Male; Middle Aged; Propra | 1970 |
Haemodynamic studies in hypertensive patients treated by oral proranolol.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Female; Heart Rate; Hemodynamics; Humans; Hypertension; | 1970 |
Reduction in the rise of systolic blood pressure during human coitus by the beta-adrenergic blocking agent, propranolol.
Topics: Blood Pressure; Coitus; Coronary Disease; Female; Humans; Hypertension; Male; Orgasm; Propranolol; T | 1970 |
Propranolol in the treatment of hyperkinetic heart syndrome, idiopathic hypertrophic subaortic stenosis, and systemic hypertension.
Topics: Aortic Aneurysm; Cardiomyopathy, Hypertrophic; Coronary Vessels; Heart Diseases; Humans; Hypertensio | 1970 |
The clinical applications of beta blockade.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Humans; Hypertension; Male; Mid | 1970 |
Hyperdynamic beta-adrenergic circulatory state. An overview.
Topics: Blood Circulation; Body Weight; Heart Rate; Hypertension; Isoproterenol; Propranolol; Receptors, Dru | 1970 |
[Hemodynamic and phonocardiographic changes after propranolol in sympathotonia].
Topics: Adolescent; Adult; Autonomic Nervous System; Blood Pressure; Cardiac Output; Dysautonomia, Familial; | 1970 |
[Effect of Inderal on certain hemodynamic indices in arterial hypertension].
Topics: Adult; Blood Pressure; Female; Hemodynamics; Humans; Hypertension; Injections, Intravenous; Male; Mi | 1970 |
[Anti-hypertensive effectiveness of long-term oral administration of propranolol].
Topics: Adult; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Propranolol | 1970 |
[Changes induced by acute and prolonged administration of propranolol in systemic hemodynamics in hypertensive patients].
Topics: Administration, Oral; Adult; Cardiac Output; Heart Rate; Hemodynamics; Humans; Hypertension; Injecti | 1970 |
[Hypertension and tachycardia in acute intermittent porphyria].
Topics: Adult; Aldosterone; Amino Acids; Anemia; Blood Pressure; Catecholamines; Depression, Chemical; Elect | 1970 |
Propranolol in the South African non-white hypertensive patient.
Topics: Black People; Ethnicity; Humans; Hypertension; India; Propranolol; South Africa | 1971 |
Antihypertensive effects of propranolol. Observations on predictability.
Topics: Adult; Age Factors; Blood Pressure; Blood Volume; Cardiac Output; Female; Humans; Hypertension; Male | 1971 |
Propranolol in hypertension.
Topics: Antihypertensive Agents; Blood Pressure; Humans; Hypertension; Placebos; Propranolol | 1971 |
Alarming reactions to ketamine in patients taking thyroid medication--treatment with propranolol.
Topics: Adult; Analgesics; Anesthesia, Intravenous; Cyclohexanes; Drug Synergism; Female; Humans; Hypertensi | 1971 |
Hypotensive action from combination of propranolol and other hypotensive drugs.
Topics: Antihypertensive Agents; Drug Synergism; Exercise Therapy; Guanethidine; Humans; Hydralazine; Hypert | 1971 |
[Effects of acute and chronic diminution of cardiac output on blood pressure in early hypertention. Hemodynamic alterations after beta-receptor blockade].
Topics: Adolescent; Adult; Arteries; Blood Pressure; Cardiac Output; Female; Heart Rate; Humans; Hypertensio | 1971 |
[Therapeutic experience in the management of hypertonic blood circulation regulation disorders using Inderal].
Topics: Adolescent; Adult; Blood Circulation; Blood Pressure; Blood Volume; Cardiac Output; Dysautonomia, Fa | 1967 |
[Clinical aspects of blood pressure regulation disorders].
Topics: Ergotamine; Humans; Hypertension; Hypotension; Propranolol; Psychophysiologic Disorders | 1967 |
[Risk factors, prognosis, treatment and rehabilitation in myocardial infarct].
Topics: Adult; Age Factors; Aged; Angina Pectoris; Anticoagulants; Cholesterol; Female; Humans; Hypertension | 1967 |
[Symposium on the study of Inderal].
Topics: Angina Pectoris; Arrhythmias, Cardiac; Cardiovascular Diseases; Coronary Disease; Coronary Vessels; | 1967 |
[Clinical effect and hemodynamic changes during the use of Inderal].
Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Blood Flow Velocity; Cardiac Output; Cardiovascu | 1967 |
[Effect of propranolol on vascular reactions to adrenaline and noradrenaline].
Topics: Animals; Dogs; Electrocardiography; Epinephrine; Hypertension; Norepinephrine; Propranolol; Stimulat | 1967 |
Immediate hemodynamic effects of beta-adrenergic blockade with propranolol in normotensive and hypertensive man.
Topics: Adult; Blood Pressure; Cardiac Output; Depression, Chemical; Female; Hemodynamics; Humans; Hypertens | 1968 |
The paradox of beta-adrenergic blockade in hypertension.
Topics: Adult; Blood Pressure; Blood Pressure Determination; Cardiac Output; Depression, Chemical; Female; H | 1968 |
Three cases of severe hypertension controlled with propranolol.
Topics: Adult; Humans; Hypertension; Male; Middle Aged; Propranolol | 1968 |
Propranolol in hypertension.
Topics: Humans; Hypertension; Posture; Propranolol; White People | 1968 |
Propranolol in hypertension.
Topics: Aged; Angina Pectoris; Humans; Hypertension; Male; Middle Aged; Propranolol | 1968 |
A comparison of some cardiovascular properties of propranolol, MJ 1999 and quinidine in relation to their effects in hypertensive animals.
Topics: Anilides; Animals; Blood Pressure; Cardiovascular System; Dogs; Electrocardiography; Female; Heart R | 1968 |
Cardiovascular responses to cyclohexylamine.
Topics: Amines; Animals; Blood Pressure; Bradycardia; Cardiovascular System; Cats; Cocaine; Cyclohexanes; Fe | 1968 |
Effect of physostigmine upon the output of catecholamines from the adrenal gland of the rat.
Topics: Adrenal Glands; Adrenalectomy; Animals; Blood Pressure; Catecholamines; Epinephrine; Hypertension; M | 1968 |
[On pathogenesis of hypertension and tachycardia in acute thallium poisoning and in acute intermittent porphyria].
Topics: Adult; Female; Humans; Hypertension; Levulinic Acids; Male; Phentolamine; Poisoning; Porphyrias; Pro | 1968 |
[A case of obstructive cardiomyopathy of the left ventrixule in an elderly hypertensive patient. Apex cardiographic study and amelioration with propranolol].
Topics: Aged; Cardiomyopathy, Hypertrophic; Female; Humans; Hypertension; Propranolol | 1968 |
Clinic and therapy of the hyperdynamic heart syndrome.
Topics: Dysautonomia, Familial; Electrocardiography; Epinephrine; Heart Diseases; Hemodynamics; Humans; Hype | 1968 |
[Therapy of hypertension with a beta-receptor-antagonist].
Topics: Adult; Aged; Analysis of Variance; Antihypertensive Agents; Blood Pressure Determination; Female; Hu | 1968 |
[The effect of beta-receptor-blocking agents on the ergometric performance study in hypertensive regulation disorders and hyperkinetic heart syndrome].
Topics: Acid-Base Equilibrium; Cardiac Output; Exercise Test; Female; Heart Diseases; Heart Rate; Humans; Hy | 1968 |
Part played by bradycardia in action of propranolol.
Topics: Aortic Valve Stenosis; Heart Rate; Humans; Hypertension; Propranolol | 1968 |
[Cases of myotonic syndromes due to succinylcholine].
Topics: Anesthesia, General; Arrhythmias, Cardiac; Child; Humans; Hypertension; Hypothermia, Induced; Male; | 1968 |
Hemodynamics in juvenile hypertension with special reference to the response to propranolol.
Topics: Adolescent; Adult; Age Factors; Blood Pressure; Blood Volume; Body Surface Area; Cardiac Output; Fem | 1968 |
Increases beta-receptor responsiveness; central or peripheral?
Topics: Autonomic Nervous System; Cardiovascular Diseases; Chemoreceptor Cells; Hypertension; Isoproterenol; | 1969 |
Treatment of hypertension with propranolol.
Topics: Blood Pressure; Cardiac Output; Female; Guanethidine; Guanidines; Humans; Hypertension; Hypotension; | 1969 |
Coronary disease and personality.
Topics: Coronary Disease; Humans; Hypertension; Male; Personality; Propranolol; Psychophysiologic Disorders | 1969 |
[The pathogenesis of hypertension and sinus tachycardia in human thallium intoxication].
Topics: Adult; Aldosterone; Antidotes; Blood Pressure; Catecholamines; Heart Rate; Humans; Hypertension; Inj | 1969 |
Hypotensive effect of propranolol.
Topics: Animals; Blood Pressure; Hypertension; Propranolol; Rabbits; Time Factors | 1969 |
Interactions of sympathomimetic and sympatholytic agents in normotensive and hypertensive subjects.
Topics: Blood Pressure; Heart Rate; Humans; Hypertension; Injections, Intravenous; Isoproterenol; Norepineph | 1969 |
[Hemodynamic causes of the blood pressure rise following bilateral carotid occlusion in the conscious dog].
Topics: Animals; Cardiac Output; Carotid Arteries; Constriction; Dogs; Heart Rate; Hypertension; Phenoxybenz | 1969 |
Peripheral arterial insufficiency. A complication of beta-adrenergic blocking therapy.
Topics: Adult; Blood Circulation; Cardiovascular Diseases; Female; Heart Diseases; Humans; Hypertension; Hys | 1969 |
Mechanisms of intra-arterial Kplus-induced cardiovascular and respiratory responses.
Topics: Animals; Blood Pressure; Chlorisondamine; Dogs; Femoral Artery; Heart; Heart Rate; Hindlimb; Hyperte | 1969 |
Propranolol in hypertension.
Topics: Female; Humans; Hypertension; Male; Middle Aged; Propranolol | 1966 |
Propranolol in hypertension.
Topics: Adult; Antihypertensive Agents; Female; Guanethidine; Humans; Hypertension; Male; Methyldopa; Middle | 1966 |
Influence of beta receptor blockade on certain cardiovascular actions of nicotine.
Topics: Animals; Autonomic Nerve Block; Blood Pressure; Cardiac Output; Dogs; Female; Heart; Heart Rate; Hyp | 1966 |
[Therapeutic methods].
Topics: Amidohydrolases; Ascites; Diuretics; Edema; Heart Diseases; Humans; Hypertension; Propranolol; Water | 1966 |